data_2dnk_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2dnk _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.536 ' HD3' ' CD1' ' A' ' 195' ' ' PHE . 20.5 ttmt . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.869 0.366 . . . . 0.0 110.886 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.541 HD23 ' CD1' ' A' ' 228' ' ' PHE . 24.6 mt -142.83 126.49 16.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.898 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -90.92 116.69 28.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.874 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 4.8 t -110.43 134.55 52.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.098 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -135.13 -156.27 7.63 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.511 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 10.1 mmt 45.31 35.44 1.83 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.785 0.326 . . . . 0.0 110.894 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 77.5 mt -93.67 167.94 11.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.897 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -101.38 154.77 18.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.892 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 86.7 mttt -84.13 41.34 0.81 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.875 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 -127.8 -48.81 1.37 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.897 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -55.33 163.91 1.08 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.879 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 3.8 t -131.33 165.8 22.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.905 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -45.08 -44.36 10.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.917 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . 0.418 ' O ' ' N ' ' A' ' 168' ' ' ARG . 0.1 OUTLIER -57.71 -62.42 1.81 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.861 179.976 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -41.25 -52.29 3.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.889 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.556 HG13 ' CD1' ' A' ' 171' ' ' PHE . 30.0 t -66.95 -28.64 43.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.095 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . 0.418 ' N ' ' O ' ' A' ' 165' ' ' ASP . 18.9 ttt180 -61.88 -64.13 1.03 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.834 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 7.5 mmm180 -59.72 -54.22 48.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.875 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.501 ' O ' ' CB ' ' A' ' 173' ' ' ALA . 9.3 tp -42.08 -66.31 0.37 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.948 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . 0.556 ' CD1' HG13 ' A' ' 167' ' ' VAL . 9.1 m-85 -53.37 -72.21 0.06 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.884 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -40.96 -30.29 0.13 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.842 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.501 ' CB ' ' O ' ' A' ' 170' ' ' LEU . . . -40.11 -30.4 0.09 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.128 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -105.42 -74.34 0.65 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.869 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -105.54 137.92 13.99 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.464 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -48.49 153.34 0.78 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.817 0.342 . . . . 0.0 110.857 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . 0.44 HG22 ' N ' ' A' ' 178' ' ' GLU . 81.5 mt -121.28 138.61 51.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.102 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . 0.44 ' N ' HG22 ' A' ' 177' ' ' ILE . 17.9 mm-40 -88.11 -49.01 7.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.943 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -150.97 160.08 44.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.949 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 41.9 t -145.68 135.16 23.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.851 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 95.4 m -146.99 110.38 4.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.139 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 21.3 mm -71.73 138.94 20.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.129 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 34.9 mt . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.876 179.938 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 18.7 t . . . . . 0 C--O 1.23 0.054 0 CA-C-O 120.973 0.416 . . . . 0.0 110.84 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 39.0 mttt -92.57 16.56 11.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.893 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 65.69 43.53 94.1 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.451 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -154.67 155.74 35.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.809 0.338 . . . . 0.0 110.917 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -162.5 155.61 19.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.116 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' PHE . . . . . 0.536 ' CD1' ' HD3' ' A' ' 152' ' ' LYS . 38.5 m-85 -107.84 119.01 38.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.923 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 46.8 t -122.28 138.55 52.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.122 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.62 160.53 18.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.923 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -131.55 173.13 11.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.922 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 45.0 t -73.61 -44.83 56.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.895 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 1.4 t -143.15 179.92 6.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.835 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . 0.441 ' O ' ' C ' ' A' ' 202' ' ' ALA . 10.7 t-80 -67.18 -61.59 1.85 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.871 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . 0.441 ' C ' ' O ' ' A' ' 201' ' ' HIS . . . -34.24 -62.77 0.31 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.097 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -49.1 -46.88 45.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.905 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -51.64 -56.97 10.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.1 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 62.1 tp60 -53.21 -45.34 68.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.902 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -49.11 -53.32 21.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.064 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -64.29 -40.28 95.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.113 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . 0.499 ' O ' ' N ' ' A' ' 212' ' ' HIS . 71.5 mt -55.95 -66.08 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.137 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 12.9 t30 -59.77 -37.83 80.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.86 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -69.07 -21.7 64.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.128 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . 0.453 ' HB3' ' CD2' ' A' ' 224' ' ' LEU . 85.0 mt -113.88 -74.36 0.62 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.907 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' HIS . . . . . 0.499 ' N ' ' O ' ' A' ' 208' ' ' ILE . 17.8 t60 -51.82 126.55 18.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.835 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 84.11 -6.81 73.89 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.508 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 33.2 t -88.55 -73.82 0.48 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.8 0.333 . . . . 0.0 110.889 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -99.69 -178.31 3.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.896 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 25.3 m -134.31 102.7 5.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.192 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 30.2 mmt -39.99 137.66 1.17 Allowed Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.602 0.715 . . . . 0.0 110.865 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -48.75 124.94 11.88 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.679 2.253 . . . . 0.0 112.35 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 103.64 -47.46 1.1 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.48 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -75.64 145.9 40.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.779 0.323 . . . . 0.0 111.087 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 4.5 t -93.24 -16.34 24.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.856 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 5.5 m -100.05 141.15 33.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.81 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 73.1 m -54.95 155.19 4.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.823 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . 0.453 ' CD2' ' HB3' ' A' ' 211' ' ' LEU . 55.8 tp -43.24 148.57 0.28 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.919 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . 0.41 ' HA ' ' ND1' ' A' ' 212' ' ' HIS . 88.2 t -118.81 113.05 40.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.099 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 22.0 t -136.25 110.28 9.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.161 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 19.2 pttp -130.25 162.45 28.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.86 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 228' ' ' PHE . . . . . 0.541 ' CD1' HD23 ' A' ' 153' ' ' LEU . 49.0 m-85 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.899 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 5.4 ttpm? . . . . . 0 C--O 1.232 0.165 0 CA-C-O 120.806 0.336 . . . . 0.0 110.901 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 47.8 mt -128.59 136.16 50.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.919 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -94.5 131.5 40.14 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.898 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 92.9 t -123.7 129.5 74.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.169 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -125.78 -159.31 10.25 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.478 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER 44.16 30.23 0.42 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.816 0.341 . . . . 0.0 110.918 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 73.3 mt -88.75 157.19 18.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.905 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -101.05 160.46 14.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.843 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 47.2 mttt -83.97 37.54 0.61 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.895 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 55.9 tp60 -123.29 -46.47 2.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.921 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -55.71 151.11 11.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.922 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 3.7 t -126.5 166.26 17.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.879 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -44.37 -47.68 9.72 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.897 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -57.91 -57.04 14.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.876 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 -43.44 -57.04 3.27 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.884 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.57 HG11 ' CE1' ' A' ' 171' ' ' PHE . 61.7 t -61.73 -48.45 88.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.113 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 57.7 mtt180 -41.29 -68.55 0.18 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.87 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 87.6 mtt-85 -58.35 -53.66 55.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.84 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.5 ' O ' ' CB ' ' A' ' 173' ' ' ALA . 12.8 tp -41.07 -66.7 0.31 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.883 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . 0.57 ' CE1' HG11 ' A' ' 167' ' ' VAL . 9.8 m-85 -56.02 -73.3 0.06 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.867 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.454 ' O ' ' N ' ' A' ' 174' ' ' PHE . 0.9 OUTLIER -39.18 -27.78 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.924 -179.94 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.5 ' CB ' ' O ' ' A' ' 170' ' ' LEU . . . -40.66 -25.18 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.1 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . 0.461 ' CZ ' ' HB2' ' A' ' 210' ' ' ALA . 95.6 m-85 -106.69 -70.73 0.78 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.877 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -102.14 -163.46 26.62 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.506 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 35.3 m120 -96.9 160.93 14.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.804 0.335 . . . . 0.0 110.865 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 13.0 mt -128.43 151.28 35.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.119 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 46.9 mm-40 -115.51 -42.54 3.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.915 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -155.18 149.61 26.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.899 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 40.6 t -137.98 143.98 40.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.879 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' THR . . . . . 0.405 HG21 ' N ' ' A' ' 182' ' ' ILE . 56.5 m -150.12 149.15 29.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.148 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.405 ' N ' HG21 ' A' ' 181' ' ' THR . 13.3 mm -115.45 126.13 72.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.128 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 78.6 mt . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.896 179.962 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 53.3 p . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.941 0.4 . . . . 0.0 110.871 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 26.5 mtpt -85.01 26.66 0.83 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.881 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 61.01 31.75 77.73 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.533 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 52.3 m -143.8 150.74 38.99 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.836 0.351 . . . . 0.0 110.894 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -155.52 172.09 18.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.087 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -128.43 130.4 47.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.879 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 48.6 t -127.8 132.96 68.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.126 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 29.2 mttp -104.53 150.03 24.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.869 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . 0.447 ' OH ' ' CB ' ' A' ' 207' ' ' ALA . 3.3 m-85 -123.03 175.36 6.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.949 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 58.0 m -86.36 -34.9 20.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.864 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 75.4 m -147.06 -179.86 7.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.867 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . 0.435 ' O ' ' C ' ' A' ' 202' ' ' ALA . 67.8 t60 -73.42 -63.96 1.09 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.896 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 201' ' ' HIS . . . -34.49 -61.44 0.39 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.05 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -48.47 -44.15 35.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.834 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . 0.411 ' N ' ' O ' ' A' ' 201' ' ' HIS . . . -60.16 -56.14 25.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.119 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 33.0 tp60 -50.66 -46.13 58.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.89 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -54.84 -49.6 70.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.055 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . 0.447 ' CB ' ' OH ' ' A' ' 198' ' ' TYR . . . -63.76 -26.59 68.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.106 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . 0.484 ' O ' ' N ' ' A' ' 212' ' ' HIS . 60.3 mt -70.74 -64.24 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.181 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -58.48 -39.16 79.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.895 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' ALA . . . . . 0.461 ' HB2' ' CZ ' ' A' ' 174' ' ' PHE . . . -66.99 -35.11 79.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.079 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 86.5 mt -102.5 -74.54 0.63 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.94 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' HIS . . . . . 0.484 ' N ' ' O ' ' A' ' 208' ' ' ILE . 33.9 t60 -49.18 134.07 18.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.861 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 70.06 -0.61 21.91 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.531 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -93.34 -71.01 0.67 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.747 0.308 . . . . 0.0 110.863 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -100.05 -178.44 3.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.916 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 7.6 m -136.97 110.3 7.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.139 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -39.26 160.05 0.1 OUTLIER Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.519 0.676 . . . . 0.0 110.915 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.32 103.0 1.54 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.637 2.224 . . . . 0.0 112.367 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 122.47 -49.77 0.87 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.501 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -65.24 150.38 48.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.796 0.331 . . . . 0.0 111.091 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 9.5 m -95.33 -17.38 21.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.848 -179.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 1.1 t -99.82 146.14 26.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.874 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -61.65 152.99 29.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.89 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 59.4 tp -38.71 152.92 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.907 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . 0.409 ' HA ' ' ND1' ' A' ' 212' ' ' HIS . 86.5 t -125.1 104.4 13.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.124 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 8.8 t -128.4 103.06 9.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.121 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 7.6 ptmt -120.76 167.34 12.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.882 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.887 179.959 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 20.3 tttt . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.849 0.357 . . . . 0.0 110.871 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 32.0 mt -127.08 124.99 40.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.916 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -92.82 110.8 22.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.858 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 39.4 t -104.64 127.55 58.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.111 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . 0.422 ' O ' ' N ' ' A' ' 158' ' ' LEU . . . -125.68 -152.22 8.13 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.505 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER 38.59 30.5 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.855 0.36 . . . . 0.0 110.87 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.422 ' N ' ' O ' ' A' ' 156' ' ' GLY . 61.4 mt -83.93 166.14 18.09 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.893 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -100.31 158.41 15.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.896 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 34.9 mttm -88.16 33.46 0.74 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.908 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -123.84 -52.22 1.79 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.907 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -51.54 155.54 1.53 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.905 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 4.3 m -131.03 174.79 9.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.862 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -50.37 -42.58 53.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.92 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -59.3 -54.58 45.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.898 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -48.73 -64.24 0.86 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.845 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.536 HG13 ' CD1' ' A' ' 171' ' ' PHE . 90.0 t -55.71 -50.41 67.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.099 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . 0.42 ' C ' ' O ' ' A' ' 167' ' ' VAL . 20.5 ttm-85 -36.88 -63.73 0.4 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.872 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 21.4 mtp85 -64.19 -51.48 63.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.907 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.51 ' O ' ' CB ' ' A' ' 173' ' ' ALA . 13.3 tp -43.72 -65.6 0.48 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.909 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . 0.536 ' CD1' HG13 ' A' ' 167' ' ' VAL . 6.2 m-85 -55.83 -68.1 0.23 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.853 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -45.3 -21.82 0.1 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.878 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.51 ' CB ' ' O ' ' A' ' 170' ' ' LEU . . . -49.21 -19.05 0.41 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.091 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -112.52 -73.93 0.65 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.875 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . 0.429 ' CA ' ' OE1' ' A' ' 203' ' ' GLU . . . -110.89 154.32 16.7 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.467 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -57.63 149.37 21.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.821 0.343 . . . . 0.0 110.895 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . 0.438 HG22 ' N ' ' A' ' 178' ' ' GLU . 46.1 mt -111.34 147.84 15.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.152 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . 0.459 ' N ' ' OE1' ' A' ' 178' ' ' GLU . 0.5 OUTLIER -102.89 -40.57 6.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.934 179.94 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -160.44 149.41 17.06 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.901 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 25.2 t -136.47 140.48 43.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.895 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 30.5 m -149.74 142.61 24.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.183 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 33.6 mm -107.29 121.95 60.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.157 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . 0.54 HD11 ' CE2' ' A' ' 195' ' ' PHE . 30.6 mt . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.887 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 18.1 p . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.971 0.415 . . . . 0.0 110.87 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 3.1 mmmm -94.19 33.59 1.35 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.867 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.402 ' C ' ' HB2' ' A' ' 158' ' ' LEU . . . 44.24 32.54 2.61 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.484 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 75.8 m -141.6 151.24 42.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.828 0.347 . . . . 0.0 110.881 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -158.88 161.32 36.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.145 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' PHE . . . . . 0.54 ' CE2' HD11 ' A' ' 183' ' ' LEU . 47.9 m-85 -118.05 135.92 53.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.9 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 64.7 t -133.2 145.96 33.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.122 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 42.6 mtpt -122.44 142.83 50.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.937 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -117.8 175.22 5.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.867 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 51.1 p -80.1 -44.25 20.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.815 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 2.7 m -133.95 -177.62 4.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.799 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 20.7 t60 -80.19 -57.1 3.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.879 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -37.99 -56.79 1.11 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.129 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . 0.429 ' OE1' ' CA ' ' A' ' 175' ' ' GLY . 31.3 mm-40 -54.63 -43.24 72.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.853 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -56.46 -55.78 29.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.079 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 53.1 tp60 -50.88 -41.95 58.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.92 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -57.7 -51.9 67.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.109 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -63.28 -26.49 68.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.072 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . 0.495 ' O ' ' N ' ' A' ' 212' ' ' HIS . 50.4 mt -69.15 -73.27 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.103 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' ASN . . . . . 0.459 ' N ' HG23 ' A' ' 208' ' ' ILE . 34.2 t30 -48.89 -42.72 37.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.843 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' ALA . . . . . 0.468 ' O ' ' CB ' ' A' ' 214' ' ' SER . . . -54.27 -45.31 72.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.101 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . 0.447 ' CB ' HD23 ' A' ' 224' ' ' LEU . 18.8 mt -100.51 -69.21 0.78 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.902 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' HIS . . . . . 0.495 ' N ' ' O ' ' A' ' 208' ' ' ILE . 27.2 t60 -53.95 124.24 14.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.878 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . 0.468 ' CA ' ' HB3' ' A' ' 223' ' ' SER . . . 81.24 -14.68 26.94 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.512 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' SER . . . . . 0.468 ' CB ' ' O ' ' A' ' 210' ' ' ALA . 1.9 m -85.94 -72.38 0.5 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.818 0.342 . . . . 0.0 110.838 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 59.7 mt-30 -99.13 169.54 9.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.898 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' THR . . . . . 0.423 HG23 ' C ' ' A' ' 222' ' ' SER . 3.0 m -118.78 97.61 5.8 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.148 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 13.2 mmt -38.74 138.81 0.76 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.556 0.693 . . . . 0.0 110.865 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -48.47 126.67 14.5 Favored 'Trans proline' 0 C--N 1.34 0.131 0 C-N-CA 122.685 2.256 . . . . 0.0 112.344 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 102.45 -53.42 0.78 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.503 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -70.65 150.08 46.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.781 0.324 . . . . 0.0 111.099 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 31.1 t -95.92 -18.19 20.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.826 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' SER . . . . . 0.423 ' C ' HG23 ' A' ' 216' ' ' THR . 3.5 m -99.91 151.22 21.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.874 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' SER . . . . . 0.468 ' HB3' ' CA ' ' A' ' 213' ' ' GLY . 17.4 m -59.58 145.36 44.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.844 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . 0.448 ' C ' ' O ' ' A' ' 223' ' ' SER . 48.2 tp -34.61 148.8 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.918 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 64.9 t -117.13 106.71 20.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.142 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 24.6 t -133.39 106.29 9.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.142 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 9.0 ptmt -125.03 174.39 8.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.906 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.884 179.961 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 3.6 ttmp? . . . . . 0 C--O 1.233 0.203 0 CA-C-O 120.817 0.341 . . . . 0.0 110.922 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.536 HD23 ' CD1' ' A' ' 228' ' ' PHE . 64.6 mt -123.47 124.01 41.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.902 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -94.24 110.47 22.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.885 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 21.2 t -104.19 120.62 54.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.112 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -120.64 -174.41 15.12 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.451 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 19.5 mmt 61.7 30.82 18.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.811 0.339 . . . . 0.0 110.902 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.406 ' HB2' ' C ' ' A' ' 192' ' ' GLY . 25.0 mt -88.04 162.31 16.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.912 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -102.39 160.27 14.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.892 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 14.9 mtpp -84.98 36.66 0.63 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.937 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 4.5 tp-100 -123.09 -51.08 1.9 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.905 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 66.1 mt-30 -54.23 154.32 4.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.888 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 90.3 p -130.77 -177.97 4.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.881 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . 0.493 ' O ' ' CB ' ' A' ' 168' ' ' ARG . 1.8 mp0 -55.31 -48.05 74.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.902 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -58.29 -55.17 38.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.866 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -45.64 -68.23 0.21 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.839 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.568 HG12 ' CD1' ' A' ' 171' ' ' PHE . 59.8 t -59.1 -55.51 23.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.155 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . 0.493 ' CB ' ' O ' ' A' ' 164' ' ' GLU . 70.9 ttt180 -34.3 -53.32 0.5 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.923 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 20.1 mmt85 -65.0 -54.3 32.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.931 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.514 ' O ' ' CB ' ' A' ' 173' ' ' ALA . 13.0 tp -44.21 -64.42 0.68 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.962 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . 0.568 ' CD1' HG12 ' A' ' 167' ' ' VAL . 6.8 m-85 -51.89 -67.53 0.24 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.904 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -48.41 -23.12 0.84 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.857 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.514 ' CB ' ' O ' ' A' ' 170' ' ' LEU . . . -51.95 -27.18 12.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.09 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -111.99 -62.84 1.5 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.846 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -118.76 137.17 12.62 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.48 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 48.8 m-80 -51.77 151.16 3.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.788 0.328 . . . . 0.0 110.897 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 97.6 mt -117.46 109.35 27.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.121 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -61.18 -36.99 81.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.883 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -159.44 137.22 10.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.898 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 5.7 t -124.32 143.42 50.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.888 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 55.7 m -154.37 137.04 15.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.161 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.401 HD13 ' CB ' ' A' ' 194' ' ' ALA . 10.6 mm -106.28 133.44 50.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.103 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . 0.5 HD12 ' CE2' ' A' ' 195' ' ' PHE . 84.8 mt . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.909 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 42.3 t . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.98 0.419 . . . . 0.0 110.851 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 25.2 mtmm -84.43 32.49 0.51 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.925 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.406 ' C ' ' HB2' ' A' ' 158' ' ' LEU . . . 58.12 39.21 91.86 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.506 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 7.2 p -157.85 149.39 21.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.83 0.348 . . . . 0.0 110.862 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . 0.401 ' CB ' HD13 ' A' ' 182' ' ' ILE . . . -160.13 156.5 26.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.156 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' PHE . . . . . 0.5 ' CE2' HD12 ' A' ' 183' ' ' LEU . 42.3 m-85 -114.12 126.96 55.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.866 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.56 HG23 ' CE2' ' A' ' 171' ' ' PHE . 98.8 t -117.23 139.36 44.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.072 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 31.4 tttt -116.37 118.38 32.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.86 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . 0.454 ' CD1' ' CD1' ' A' ' 153' ' ' LEU . 20.3 m-85 -95.58 172.28 8.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.918 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 8.3 t -79.2 -39.46 33.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.834 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 33.6 p -149.19 160.25 43.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.893 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . 0.448 ' O ' ' C ' ' A' ' 202' ' ' ALA . 13.3 t-80 -53.46 -58.93 5.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.873 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . 0.448 ' C ' ' O ' ' A' ' 201' ' ' HIS . . . -34.33 -62.93 0.31 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.085 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -54.21 -42.61 69.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.857 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . 0.4 ' N ' ' O ' ' A' ' 201' ' ' HIS . . . -58.53 -64.1 1.05 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.068 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 37.1 tp60 -43.15 -42.03 3.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.956 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -57.3 -57.47 12.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.065 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . 0.429 ' CB ' ' OH ' ' A' ' 198' ' ' TYR . . . -55.24 -33.56 63.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.088 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . 0.479 ' O ' ' N ' ' A' ' 212' ' ' HIS . 87.8 mt -62.72 -75.0 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.138 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -48.71 -42.09 33.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.892 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -56.32 -36.88 69.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.118 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . 0.465 ' HB3' ' CD2' ' A' ' 224' ' ' LEU . 50.7 mt -109.44 -72.6 0.72 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.898 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' HIS . . . . . 0.479 ' N ' ' O ' ' A' ' 208' ' ' ILE . 9.4 t60 -46.73 128.62 10.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.865 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 82.04 -22.91 5.56 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.514 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 7.9 t -91.45 -70.74 0.67 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.819 0.342 . . . . 0.0 110.818 -179.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 9.5 mm-40 -86.54 161.55 18.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.86 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' THR . . . . . 0.402 ' O ' ' C ' ' A' ' 217' ' ' MET . 39.1 m -129.01 108.65 10.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.157 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' MET . . . . . 0.402 ' C ' ' O ' ' A' ' 216' ' ' THR . 24.1 mmt -37.4 156.88 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.534 0.683 . . . . 0.0 110.884 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.16 113.29 3.55 Favored 'Trans proline' 0 C--N 1.341 0.133 0 C-N-CA 122.683 2.255 . . . . 0.0 112.307 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 113.94 -45.09 1.37 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.493 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -70.92 142.03 51.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.788 0.328 . . . . 0.0 111.103 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 68.3 m -91.53 -14.81 29.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.879 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 2.7 m -100.17 143.1 30.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.835 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 2.4 p -51.3 159.83 0.63 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.879 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . 0.465 ' CD2' ' HB3' ' A' ' 211' ' ' LEU . 41.6 tp -54.04 154.7 4.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.887 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 60.7 t -127.15 108.09 18.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.123 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 24.2 t -133.91 101.46 3.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.169 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 10.7 ptmt -131.75 143.21 50.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.925 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 228' ' ' PHE . . . . . 0.536 ' CD1' HD23 ' A' ' 153' ' ' LEU . 33.5 m-85 . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.889 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 6.5 ttpm? . . . . . 0 C--O 1.232 0.18 0 CA-C-O 120.782 0.325 . . . . 0.0 110.887 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.414 HD23 ' CE1' ' A' ' 228' ' ' PHE . 58.1 mt -129.29 127.09 40.45 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.934 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 18.8 t80 -101.04 113.14 25.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.844 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 48.1 t -104.07 124.01 58.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.094 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -124.45 -169.61 13.08 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.465 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 93.4 mmm 50.07 39.36 18.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.794 0.331 . . . . 0.0 110.919 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.407 ' HB2' ' C ' ' A' ' 192' ' ' GLY . 66.9 mt -94.04 162.36 13.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.906 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -100.3 158.08 16.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.883 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 52.4 mttp -83.5 39.47 0.67 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.922 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -124.9 -47.83 1.78 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.934 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 64.2 mt-30 -57.89 151.68 17.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.881 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 3.4 m -129.29 176.35 8.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.86 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -52.95 -44.13 66.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.883 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -59.38 -51.59 69.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.868 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -52.74 -61.74 2.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.892 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.57 HG11 ' CD1' ' A' ' 171' ' ' PHE . 25.4 t -58.64 -56.8 14.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.158 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . 0.415 ' C ' ' O ' ' A' ' 167' ' ' VAL . 15.5 ttt180 -36.3 -62.34 0.45 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.866 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 19.4 mmt85 -61.05 -54.11 48.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.915 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.504 ' O ' ' CB ' ' A' ' 173' ' ' ALA . 12.5 tp -43.14 -65.68 0.46 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.899 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . 0.57 ' CD1' HG11 ' A' ' 167' ' ' VAL . 8.5 m-85 -52.22 -70.86 0.08 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.888 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.408 ' C ' ' N ' ' A' ' 174' ' ' PHE . 5.3 pt-20 -43.3 -28.79 0.35 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.864 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.504 ' CB ' ' O ' ' A' ' 170' ' ' LEU . . . -44.49 -22.09 0.07 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.076 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . 0.408 ' N ' ' C ' ' A' ' 172' ' ' GLU . 97.7 m-85 -109.79 -74.91 0.64 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.878 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -108.08 148.12 16.62 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.495 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -52.35 145.77 10.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.791 0.329 . . . . 0.0 110.888 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 18.6 mt -108.96 136.1 45.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.137 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -93.49 -36.81 12.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.884 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . 0.431 ' HG3' ' N ' ' A' ' 180' ' ' CYS . 3.4 tp10 -163.73 144.55 8.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.919 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' CYS . . . . . 0.431 ' N ' ' HG3' ' A' ' 179' ' ' GLU . 35.7 t -135.12 142.99 46.33 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.902 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' THR . . . . . 0.457 HG23 ' N ' ' A' ' 182' ' ' ILE . 91.1 m -155.19 143.2 20.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.102 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.457 ' N ' HG23 ' A' ' 181' ' ' THR . 9.0 mm -105.35 138.5 30.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.131 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . 0.492 HD13 ' CE2' ' A' ' 195' ' ' PHE . 44.7 mt . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.896 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 36.2 t . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.931 0.396 . . . . 0.0 110.894 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 25.3 mttp -105.23 36.7 2.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.887 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.407 ' C ' ' HB2' ' A' ' 158' ' ' LEU . . . 46.02 44.53 14.02 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.539 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 3.5 p -155.32 155.07 33.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.838 0.352 . . . . 0.0 110.897 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -161.38 166.02 28.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.057 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' PHE . . . . . 0.492 ' CE2' HD13 ' A' ' 183' ' ' LEU . 39.4 m-85 -120.58 132.9 55.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.856 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 21.8 t -125.77 145.95 32.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.122 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 11.3 ttmm -123.29 141.53 51.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.935 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . 0.404 ' CD1' HD12 ' A' ' 153' ' ' LEU . 24.6 m-85 -118.59 174.94 5.97 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.886 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 10.5 t -81.66 -49.17 10.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.853 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 23.7 t -126.31 166.87 16.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.87 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 62.9 t-80 -66.51 -49.81 65.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.868 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -45.27 -59.07 2.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.101 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -47.8 -49.38 29.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.895 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -51.26 -61.62 2.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.064 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 44.9 tp60 -46.35 -43.65 16.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.918 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -55.8 -62.31 1.78 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.137 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -50.89 -35.03 30.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.083 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . 0.495 ' O ' ' N ' ' A' ' 212' ' ' HIS . 77.7 mt -61.44 -73.37 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.124 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -47.39 -42.98 23.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.915 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -57.72 -40.56 79.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.11 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . 0.422 ' O ' ' CB ' ' A' ' 214' ' ' SER . 61.1 mt -102.25 -72.05 0.7 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.972 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' HIS . . . . . 0.495 ' N ' ' O ' ' A' ' 208' ' ' ILE . 20.0 t60 -47.41 136.25 9.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.827 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 67.61 1.01 14.28 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.503 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' SER . . . . . 0.422 ' CB ' ' O ' ' A' ' 211' ' ' LEU . 1.0 OUTLIER -95.28 -71.09 0.68 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.912 0.386 . . . . 0.0 110.833 -179.683 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -99.96 -178.17 3.77 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.925 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 51.6 m -134.49 102.45 5.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.139 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 28.3 mmt -40.99 135.61 1.65 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.562 0.696 . . . . 0.0 110.847 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -48.62 119.18 3.94 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.686 2.258 . . . . 0.0 112.349 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 111.16 -46.19 1.21 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.467 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -76.45 148.79 37.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.802 0.334 . . . . 0.0 111.084 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 10.5 t -93.55 -18.9 21.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.916 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 1.1 t -100.05 147.62 25.43 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.859 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 58.4 m -59.43 156.51 12.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.855 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 38.9 tp -43.24 149.43 0.23 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.907 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 60.4 t -121.42 113.52 39.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.134 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 22.5 t -138.08 105.33 3.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.149 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 9.4 pttp -130.74 148.56 52.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.942 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 228' ' ' PHE . . . . . 0.414 ' CE1' HD23 ' A' ' 153' ' ' LEU . 91.8 m-85 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.859 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 25.4 tttp . . . . . 0 C--O 1.232 0.162 0 CA-C-O 120.775 0.322 . . . . 0.0 110.927 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.546 HD22 ' CD1' ' A' ' 228' ' ' PHE . 62.3 mt -105.29 132.68 51.18 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.914 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -92.24 135.06 34.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.887 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 23.0 t -124.27 114.85 42.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.098 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -116.59 -176.14 17.83 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.48 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 91.4 mmm 58.62 41.83 21.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.814 0.34 . . . . 0.0 110.873 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 46.5 mt -103.57 178.34 4.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.915 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -124.44 172.07 9.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.93 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 37.3 mttt -95.91 51.35 1.24 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.902 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -127.22 -52.19 1.4 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.883 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -64.56 164.32 11.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.872 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 31.8 p -133.55 177.77 7.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.877 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -52.16 -35.65 49.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.916 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -64.22 -57.43 9.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.836 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -47.04 -54.55 10.02 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.851 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.562 HG11 ' CE1' ' A' ' 171' ' ' PHE . 61.3 t -65.23 -40.56 89.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.174 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 4.3 mmm180 -48.0 -67.11 0.3 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.896 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 13.1 mmm-85 -60.78 -52.84 63.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.875 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.507 ' O ' ' CB ' ' A' ' 173' ' ' ALA . 12.6 tp -41.96 -66.27 0.37 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.892 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . 0.562 ' CE1' HG11 ' A' ' 167' ' ' VAL . 9.3 m-85 -55.92 -71.24 0.09 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.903 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.498 ' C ' ' CD ' ' A' ' 172' ' ' GLU . 0.5 OUTLIER -41.48 -24.91 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.873 -179.934 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.507 ' CB ' ' O ' ' A' ' 170' ' ' LEU . . . -45.58 -21.16 0.09 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.117 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -117.46 -66.45 1.08 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.875 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -114.63 134.24 11.56 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.471 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 40.2 m-20 -45.31 153.94 0.2 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.789 0.328 . . . . 0.0 110.899 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 38.1 mt -112.66 128.04 69.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.135 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -83.0 -37.98 23.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.859 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -164.67 129.6 2.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.948 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 51.4 t -113.8 142.76 45.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.912 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 40.7 m -155.0 144.95 21.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.165 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 31.5 mm -109.06 146.75 14.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.193 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 31.4 mt . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.943 179.89 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 4.9 t . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.966 0.412 . . . . 0.0 110.856 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 64.0 mttt -104.29 32.08 4.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.896 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 58.48 39.75 93.45 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.477 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 85.6 m -151.42 153.41 34.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.844 0.354 . . . . 0.0 110.852 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -162.44 167.05 24.19 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.132 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -125.53 133.72 52.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.854 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.463 HG23 ' CE2' ' A' ' 171' ' ' PHE . 29.1 t -127.92 118.84 49.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.122 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 22.5 ttmt -95.3 141.84 28.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.911 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . 0.439 ' OH ' ' CB ' ' A' ' 207' ' ' ALA . 10.3 m-85 -115.28 173.71 6.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.871 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 20.7 p -78.47 -46.24 20.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.817 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 3.0 t -137.32 156.32 48.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.869 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . 0.419 ' O ' ' C ' ' A' ' 202' ' ' ALA . 3.5 t-160 -52.29 -59.99 3.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.923 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 201' ' ' HIS . . . -35.89 -64.32 0.32 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.077 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -48.94 -47.29 43.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.845 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -54.94 -54.12 46.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.087 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 43.3 tp60 -49.72 -47.24 50.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.912 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . 0.436 ' O ' ' CB ' ' A' ' 210' ' ' ALA . . . -55.08 -48.73 73.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.14 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . 0.439 ' CB ' ' OH ' ' A' ' 198' ' ' TYR . . . -59.35 -41.31 88.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.082 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . 0.488 ' O ' ' N ' ' A' ' 212' ' ' HIS . 63.7 mt -58.66 -72.28 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.127 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 16.5 t30 -53.21 -40.08 64.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.914 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' ALA . . . . . 0.436 ' CB ' ' O ' ' A' ' 206' ' ' ALA . . . -57.78 -41.16 81.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.079 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 19.8 mt -101.47 -69.32 0.78 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.913 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' HIS . . . . . 0.488 ' N ' ' O ' ' A' ' 208' ' ' ILE . 14.4 t60 -48.28 133.26 15.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.877 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 73.92 -1.14 48.66 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.481 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 8.5 t -95.93 -70.99 0.69 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.794 0.331 . . . . 0.0 110.842 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -99.86 -175.78 3.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.898 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 35.1 m -137.13 109.3 7.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.146 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 23.8 mmt -38.17 158.18 0.09 OUTLIER Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.588 0.709 . . . . 0.0 110.872 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -71.62 107.15 2.11 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.644 2.23 . . . . 0.0 112.324 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 119.31 -48.04 0.98 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.476 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -68.46 148.23 50.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.765 0.317 . . . . 0.0 111.112 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 77.9 p -92.57 -18.17 23.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.882 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 2.4 m -100.04 149.66 23.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.862 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 66.3 m -59.88 157.23 12.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.861 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . 0.439 ' HG ' ' N ' ' A' ' 225' ' ' VAL . 16.0 tp -47.8 154.39 0.51 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.894 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . 0.439 ' N ' ' HG ' ' A' ' 224' ' ' LEU . 34.6 t -125.32 110.62 24.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.102 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 19.6 t -132.9 101.95 4.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.1 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 23.8 pttt -129.06 152.27 48.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.92 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 228' ' ' PHE . . . . . 0.546 ' CD1' HD22 ' A' ' 153' ' ' LEU . 52.2 m-85 . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.89 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.56 ' HD3' ' CD1' ' A' ' 195' ' ' PHE . 13.3 ttmt . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.832 0.349 . . . . 0.0 110.899 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.426 HD22 ' CD1' ' A' ' 228' ' ' PHE . 56.6 mt -117.84 123.6 46.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.956 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 56.3 t80 -91.13 121.81 33.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.859 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 58.9 t -109.1 128.79 64.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.151 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -124.6 -160.35 10.72 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.534 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 33.3 mtt 38.69 43.95 0.75 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.821 0.343 . . . . 0.0 110.867 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.422 ' HB2' ' C ' ' A' ' 192' ' ' GLY . 67.9 mt -99.88 175.55 5.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.885 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.496 ' N ' ' OD1' ' A' ' 159' ' ' ASN . 0.5 OUTLIER -115.35 154.9 28.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.894 179.904 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.74 20.64 1.41 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.922 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -107.83 -34.62 6.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.941 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . 0.466 ' HG3' ' ND2' ' A' ' 159' ' ' ASN . 25.8 mt-30 -59.12 158.42 8.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.917 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 85.2 p -132.53 163.96 27.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.86 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -47.8 -50.97 24.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.872 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -53.23 -47.78 68.72 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.839 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -53.93 -69.1 0.13 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.864 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.565 HG11 ' CD1' ' A' ' 171' ' ' PHE . 86.0 t -52.92 -54.39 16.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.164 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . 0.489 ' CD ' ' C ' ' A' ' 168' ' ' ARG . 0.0 OUTLIER -39.53 -63.18 0.59 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.891 -179.959 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 4.0 mtp-105 -60.85 -53.91 51.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.882 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.505 ' O ' ' CB ' ' A' ' 173' ' ' ALA . 11.9 tp -43.23 -65.93 0.43 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.901 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . 0.565 ' CD1' HG11 ' A' ' 167' ' ' VAL . 11.6 m-85 -52.2 -70.93 0.07 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.914 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.416 ' O ' ' N ' ' A' ' 174' ' ' PHE . 5.9 pt-20 -43.09 -29.36 0.35 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.947 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.505 ' CB ' ' O ' ' A' ' 170' ' ' LEU . . . -43.29 -23.05 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.082 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . 0.416 ' N ' ' O ' ' A' ' 172' ' ' GLU . 92.7 m-85 -114.56 -70.24 0.81 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.879 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -111.28 137.57 14.39 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.521 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -44.23 164.79 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.762 0.315 . . . . 0.0 110.896 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . 0.429 HG23 ' N ' ' A' ' 178' ' ' GLU . 51.1 mt -133.42 134.0 57.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.104 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . 0.429 ' N ' HG23 ' A' ' 177' ' ' ILE . 18.6 mt-10 -89.38 -41.31 12.19 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.918 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -150.75 151.2 32.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.831 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 49.4 t -146.0 138.2 25.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.854 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 26.2 m -154.89 151.2 28.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.155 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 48.6 mm -109.21 140.8 26.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.141 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 34.6 mt . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.919 179.877 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 8.3 t . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.947 0.404 . . . . 0.0 110.842 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 38.3 mttm -105.04 34.25 3.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.908 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.422 ' C ' ' HB2' ' A' ' 158' ' ' LEU . . . 49.92 39.47 32.9 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.521 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 80.8 m -151.03 157.61 43.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.772 0.32 . . . . 0.0 110.89 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -160.84 166.64 28.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.123 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' PHE . . . . . 0.56 ' CD1' ' HD3' ' A' ' 152' ' ' LYS . 40.0 m-85 -124.5 130.5 52.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.879 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 11.8 t -128.46 148.73 32.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.141 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 6.3 ttmm -126.93 138.39 53.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.92 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -114.68 175.44 5.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.915 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 41.2 t -81.6 -48.05 12.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.858 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 1.9 t -134.59 172.48 12.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.874 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . 0.404 ' O ' ' C ' ' A' ' 202' ' ' ALA . 18.2 t-160 -67.4 -55.96 11.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.85 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . 0.404 ' C ' ' O ' ' A' ' 201' ' ' HIS . . . -37.98 -64.51 0.4 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.098 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -49.37 -48.21 47.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.869 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -54.76 -58.37 7.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.137 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 6.1 tp60 -43.63 -50.57 7.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.897 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -52.8 -54.79 29.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.085 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -56.27 -32.66 64.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.138 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . 0.492 ' O ' ' N ' ' A' ' 212' ' ' HIS . 59.7 mt -65.07 -75.13 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.071 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -49.32 -42.61 42.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.861 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -54.97 -43.24 73.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.106 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 58.6 mt -102.23 -70.19 0.76 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.943 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' HIS . . . . . 0.492 ' N ' ' O ' ' A' ' 208' ' ' ILE . 5.4 t60 -50.74 129.88 23.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.866 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 75.61 -9.25 16.37 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.476 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 7.9 t -99.95 -70.23 0.74 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.877 0.37 . . . . 0.0 110.874 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' GLN . . . . . 0.415 ' HG3' ' N ' ' A' ' 216' ' ' THR . 1.7 tt0 -90.65 154.87 19.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.923 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' THR . . . . . 0.415 ' N ' ' HG3' ' A' ' 215' ' ' GLN . 30.5 m -118.17 101.62 8.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.156 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 19.4 mmt -39.13 134.84 1.09 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.626 0.727 . . . . 0.0 110.887 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -48.99 131.57 25.78 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.723 2.282 . . . . 0.0 112.356 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 99.29 -41.93 2.1 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.734 -0.745 . . . . 0.0 112.502 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -82.15 144.57 30.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.796 0.331 . . . . 0.0 111.129 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 8.3 m -93.4 -15.45 25.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.864 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 57.9 m -99.98 142.43 31.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.897 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 58.8 m -54.91 156.21 3.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.873 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . 0.435 ' HG ' ' N ' ' A' ' 225' ' ' VAL . 46.5 tp -52.37 159.63 0.96 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.954 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . 0.435 ' N ' ' HG ' ' A' ' 224' ' ' LEU . 99.2 t -130.5 113.11 24.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.114 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 40.2 t -138.83 113.52 8.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.113 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 11.4 pttm -130.98 167.31 19.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.909 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 228' ' ' PHE . . . . . 0.426 ' CD1' HD22 ' A' ' 153' ' ' LEU . 62.5 m-85 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.896 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 3.2 ttmp? . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.84 0.352 . . . . 0.0 110.893 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.508 HD23 ' CD1' ' A' ' 228' ' ' PHE . 38.7 mt -134.06 128.25 33.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.909 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -94.13 121.74 35.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.873 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.403 HG22 ' CG2' ' A' ' 226' ' ' VAL . 88.5 t -113.9 136.42 50.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.186 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -136.69 -159.93 8.52 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.515 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 14.7 mmt 46.8 28.56 0.84 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.84 0.352 . . . . 0.0 110.925 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 36.9 mt -85.35 167.46 15.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.912 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.529 HD22 ' N ' ' A' ' 218' ' ' PRO . 45.6 m-20 -105.26 158.43 16.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.897 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 60.4 mttt -85.59 37.2 0.68 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.894 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -116.9 -55.71 2.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.881 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -67.34 149.34 50.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.901 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 51.6 p -124.79 175.48 7.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.806 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 10.4 tm-20 -43.51 -30.45 0.57 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.9 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -67.67 -60.02 2.87 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.838 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -54.19 -44.78 71.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.801 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.557 HG13 ' CD1' ' A' ' 171' ' ' PHE . 89.7 t -66.1 -40.0 85.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.15 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 56.7 ttp180 -54.04 -63.37 1.17 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.904 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 17.4 mmt180 -59.0 -54.87 42.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.906 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.506 ' O ' ' CB ' ' A' ' 173' ' ' ALA . 11.3 tp -42.53 -66.11 0.4 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.91 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . 0.557 ' CD1' HG13 ' A' ' 167' ' ' VAL . 13.0 m-85 -51.73 -72.19 0.05 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.903 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.46 ' O ' ' N ' ' A' ' 174' ' ' PHE . 5.9 pt-20 -41.38 -31.51 0.25 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.897 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.506 ' CB ' ' O ' ' A' ' 170' ' ' LEU . . . -40.68 -24.82 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.133 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . 0.46 ' N ' ' O ' ' A' ' 172' ' ' GLU . 98.9 m-85 -112.21 -74.97 0.62 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.86 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -108.34 142.42 15.99 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.472 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -51.01 156.3 1.05 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.774 0.321 . . . . 0.0 110.907 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 81.7 mt -118.81 134.82 61.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.115 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 -90.87 -42.25 10.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.919 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -157.86 142.73 16.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.896 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 1.8 m -134.23 145.87 49.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.825 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 45.4 m -151.98 134.73 15.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.158 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 30.0 mm -87.94 128.29 40.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.098 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . 0.483 HD11 ' CD2' ' A' ' 195' ' ' PHE . 44.2 mt . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.922 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 27.2 p . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.938 0.399 . . . . 0.0 110.838 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 1.8 mmmp? -102.59 38.01 1.8 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.906 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 37.67 41.49 0.87 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.457 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 65.0 m -153.68 148.51 26.51 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.809 0.338 . . . . 0.0 110.904 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -162.56 148.6 12.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.104 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' PHE . . . . . 0.483 ' CD2' HD11 ' A' ' 183' ' ' LEU . 14.6 m-85 -98.49 143.1 29.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.891 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.554 HG21 ' CE2' ' A' ' 171' ' ' PHE . 16.1 t -143.03 132.73 21.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.14 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 14.0 mtpp -116.05 154.25 30.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.879 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -126.97 171.68 11.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.939 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 32.5 t -69.62 -47.9 61.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.813 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 17.0 m -137.33 170.49 16.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.899 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . 0.411 ' O ' ' C ' ' A' ' 202' ' ' ALA . 36.3 t-80 -60.95 -56.8 16.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.841 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . 0.411 ' C ' ' O ' ' A' ' 201' ' ' HIS . . . -37.12 -65.48 0.3 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.129 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 16.7 mp0 -48.38 -46.0 36.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.916 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -54.09 -54.98 32.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.093 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 4.3 tp60 -49.52 -54.62 16.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.853 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -46.31 -56.44 5.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.129 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -56.08 -36.19 67.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.154 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . 0.483 ' O ' ' N ' ' A' ' 212' ' ' HIS . 80.0 mt -64.25 -75.06 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.12 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -49.34 -41.49 38.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.842 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -52.01 -48.63 64.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.112 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 74.6 mt -100.97 -65.79 0.95 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.886 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' HIS . . . . . 0.483 ' N ' ' O ' ' A' ' 208' ' ' ILE . 6.3 t60 -51.62 129.19 25.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.87 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 73.62 -4.83 26.14 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.488 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 8.1 t -99.66 -67.91 0.83 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.81 0.338 . . . . 0.0 110.856 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 5.6 mm-40 -94.73 172.9 7.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.938 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' THR . . . . . 0.423 ' O ' ' C ' ' A' ' 217' ' ' MET . 54.1 m -133.08 92.85 3.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.198 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' MET . . . . . 0.423 ' C ' ' O ' ' A' ' 216' ' ' THR . 1.3 mmt -36.0 136.23 0.51 Allowed Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.591 0.71 . . . . 0.0 110.877 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . 0.529 ' N ' HD22 ' A' ' 159' ' ' ASN . 75.7 Cg_exo -48.52 125.56 12.64 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.701 2.267 . . . . 0.0 112.384 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 109.15 -50.46 0.77 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.498 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -77.03 149.38 35.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.762 0.315 . . . . 0.0 111.093 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 23.9 t -94.41 -18.26 21.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.88 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 2.2 m -99.98 147.45 25.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.833 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' SER . . . . . 0.417 ' O ' ' C ' ' A' ' 224' ' ' LEU . 53.8 m -61.16 147.25 44.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.888 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . 0.417 ' C ' ' O ' ' A' ' 223' ' ' SER . 19.1 tp -36.82 152.72 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.909 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . 0.402 ' N ' ' HG ' ' A' ' 224' ' ' LEU . 99.6 t -123.22 105.0 15.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.117 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . 0.403 ' CG2' HG22 ' A' ' 155' ' ' VAL . 22.1 t -132.67 101.84 4.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.118 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 45.8 pttt -119.47 167.69 11.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.873 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 228' ' ' PHE . . . . . 0.508 ' CD1' HD23 ' A' ' 153' ' ' LEU . 90.3 m-85 . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.91 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.441 ' HD3' ' CG ' ' A' ' 195' ' ' PHE . 2.7 ttmp? . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.859 0.362 . . . . 0.0 110.877 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 86.3 mt -117.91 133.66 55.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.914 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -102.64 114.37 28.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.885 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 37.8 t -108.55 111.45 36.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.139 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -111.4 -161.16 16.78 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.507 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 79.9 mmm 46.62 41.49 9.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.818 0.342 . . . . 0.0 110.913 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.417 ' HB2' ' C ' ' A' ' 192' ' ' GLY . 55.1 mt -99.54 171.03 8.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.933 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 30.2 m120 -113.6 171.38 7.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.892 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 43.6 mttm -92.79 42.59 1.1 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.917 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -124.28 -43.92 2.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.89 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 61.0 mt-30 -63.4 159.79 17.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.922 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 68.9 m -132.36 175.81 8.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.854 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -55.05 -47.02 75.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.88 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . 0.496 ' CG ' ' N ' ' A' ' 166' ' ' ASP . 0.6 OUTLIER -58.33 -53.71 55.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.809 -179.988 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . 0.496 ' N ' ' CG ' ' A' ' 165' ' ' ASP . 65.5 m-20 -45.34 -55.89 5.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.888 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.556 HG11 ' CD1' ' A' ' 171' ' ' PHE . 68.7 t -64.81 -44.43 96.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.131 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 33.9 mtp180 -48.6 -55.22 11.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.881 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 55.7 mtt180 -70.86 -50.28 36.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.866 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.511 ' O ' ' CB ' ' A' ' 173' ' ' ALA . 9.8 tp -48.18 -63.78 0.98 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.919 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . 0.556 ' CD1' HG11 ' A' ' 167' ' ' VAL . 7.3 m-85 -54.61 -58.48 7.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.905 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.446 ' N ' HD13 ' A' ' 177' ' ' ILE . 0.8 OUTLIER -59.82 -9.94 3.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.902 -179.915 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.511 ' CB ' ' O ' ' A' ' 170' ' ' LEU . . . -61.59 -10.75 8.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.131 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -120.43 -67.9 0.94 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.845 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -110.59 -173.93 20.25 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.46 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -83.79 151.23 25.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.785 0.326 . . . . 0.0 110.899 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . 0.446 HD13 ' N ' ' A' ' 172' ' ' GLU . 21.0 mt -121.27 129.62 75.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.143 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 35.0 mm-40 -79.3 -46.61 17.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.879 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 22.2 tp10 -165.29 143.86 6.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.875 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 13.0 t -118.81 143.0 47.2 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.923 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 30.1 m -153.11 116.05 4.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.113 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 44.6 mm -83.3 135.01 25.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.125 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 35.1 mt . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.911 179.931 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 40.7 t . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.937 0.398 . . . . 0.0 110.856 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 1.3 mmmp? -94.46 26.09 3.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.898 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.417 ' C ' ' HB2' ' A' ' 158' ' ' LEU . . . 59.93 34.65 84.04 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.453 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 84.3 m -154.12 154.82 34.27 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.806 0.336 . . . . 0.0 110.926 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -158.37 161.1 37.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.072 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' PHE . . . . . 0.441 ' CG ' ' HD3' ' A' ' 152' ' ' LYS . 27.8 m-85 -121.53 119.59 32.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.868 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 21.5 t -118.8 140.21 43.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.081 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 17.1 mtmt -114.65 145.88 41.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.859 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -119.42 174.87 6.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.929 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 81.0 p -78.19 -46.26 20.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.876 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 37.7 m -133.58 -179.3 5.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.838 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 53.8 t-80 -76.44 -52.77 9.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.892 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -39.6 -66.14 0.32 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.081 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 51.5 mm-40 -47.28 -43.8 22.59 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.885 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -51.77 -54.07 32.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.108 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 24.9 tp60 -56.57 -41.51 77.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.926 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -53.15 -50.1 65.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.119 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -68.25 -26.66 65.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.098 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . 0.497 ' O ' ' N ' ' A' ' 212' ' ' HIS . 63.4 mt -71.05 -65.11 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.083 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -60.92 -38.09 84.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.879 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -65.07 -26.77 68.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.113 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 89.9 mt -115.61 -75.0 0.59 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.94 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' HIS . . . . . 0.497 ' N ' ' O ' ' A' ' 208' ' ' ILE . 20.6 t60 -47.83 128.69 13.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.848 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 83.16 -22.03 7.55 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.514 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 4.8 m -90.18 -71.61 0.61 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.801 0.334 . . . . 0.0 110.893 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' GLN . . . . . 0.433 ' HG3' ' N ' ' A' ' 216' ' ' THR . 1.2 tt0 -88.71 156.05 19.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.865 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' THR . . . . . 0.433 ' N ' ' HG3' ' A' ' 215' ' ' GLN . 2.0 m -119.51 118.1 30.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.119 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 23.9 mmt -47.44 137.05 9.28 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.598 0.714 . . . . 0.0 110.87 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -48.89 113.82 1.03 Allowed 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.702 2.268 . . . . 0.0 112.379 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 112.7 -54.39 0.55 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.504 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -63.72 145.46 55.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.813 0.339 . . . . 0.0 111.15 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 48.2 t -93.23 -16.26 25.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.806 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 222' ' ' SER . . . . . 0.408 ' C ' HG22 ' A' ' 216' ' ' THR . 2.4 m -100.09 136.98 39.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.841 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 2.1 p -44.91 162.97 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.831 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . 0.414 ' O ' ' ND1' ' A' ' 212' ' ' HIS . 51.4 tp -56.98 157.04 6.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.895 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . 0.41 ' HA ' ' ND1' ' A' ' 212' ' ' HIS . 91.8 t -125.12 110.21 24.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.144 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 44.1 t -136.26 105.03 4.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.161 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 4.6 ptmt -132.69 145.77 51.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.909 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.914 179.933 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 23.1 ttpt . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.784 0.326 . . . . 0.0 110.913 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.471 HD23 ' CE1' ' A' ' 228' ' ' PHE . 87.4 mt -123.55 123.51 40.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.896 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -91.22 116.95 29.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.948 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 38.3 t -110.82 132.44 59.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.114 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -130.87 -158.84 9.39 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.473 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 45.52 31.86 1.0 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.793 0.33 . . . . 0.0 110.859 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 79.5 mt -85.24 -176.22 6.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.875 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.464 ' N ' ' OD1' ' A' ' 159' ' ' ASN . 0.5 OUTLIER -126.97 155.31 43.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.884 179.896 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 65.8 mttt -80.92 42.09 0.62 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.875 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 18.0 mp0 -130.96 -43.03 1.09 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.921 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 17.8 mm-40 -54.0 162.01 1.08 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.914 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 28.1 m -135.7 166.28 23.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.807 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . 0.465 ' O ' ' CB ' ' A' ' 168' ' ' ARG . 2.3 mp0 -49.28 -41.0 36.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.889 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -65.1 -48.34 74.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.867 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 -54.81 -56.61 17.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.817 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.504 HG13 ' CE1' ' A' ' 171' ' ' PHE . 54.3 t -66.98 -40.62 86.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.153 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . 0.465 ' CB ' ' O ' ' A' ' 164' ' ' GLU . 13.8 tpt180 -56.36 -56.28 23.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.865 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 10.0 mmt85 -63.25 -54.47 36.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.889 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.502 ' O ' ' CB ' ' A' ' 173' ' ' ALA . 9.9 tp -43.95 -64.94 0.57 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.925 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . 0.504 ' CE1' HG13 ' A' ' 167' ' ' VAL . 7.4 m-85 -51.33 -68.87 0.13 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.871 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -46.36 -26.4 0.82 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.888 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.502 ' CB ' ' O ' ' A' ' 170' ' ' LEU . . . -48.89 -21.13 0.59 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.126 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -114.21 -60.37 1.89 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.867 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -124.48 134.08 8.93 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.488 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -40.74 162.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.786 0.327 . . . . 0.0 110.93 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 32.3 mt -131.03 136.39 58.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.087 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -81.35 -48.76 11.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.92 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -155.49 151.21 27.44 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.882 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 42.1 t -129.38 135.76 49.12 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.856 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 89.5 m -148.1 134.17 19.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.152 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 48.5 mm -95.06 139.04 19.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.099 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . 0.54 HD12 ' CE2' ' A' ' 195' ' ' PHE . 41.0 mt . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.954 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 37.3 p . . . . . 0 N--CA 1.458 -0.065 0 CA-C-O 120.966 0.413 . . . . 0.0 110.871 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 30.1 mmtp -80.4 43.45 0.64 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.914 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 39.01 50.35 2.67 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.487 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 8.1 p -159.54 151.68 20.85 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.849 0.357 . . . . 0.0 110.835 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -160.04 168.02 26.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.111 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' PHE . . . . . 0.54 ' CE2' HD12 ' A' ' 183' ' ' LEU . 40.3 m-85 -120.18 135.83 54.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.864 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.431 HG13 ' N ' ' A' ' 197' ' ' LYS . 46.9 t -136.32 142.54 38.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.103 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . 0.431 ' N ' HG13 ' A' ' 196' ' ' VAL . 23.2 mttp -117.38 154.1 31.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.885 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -124.17 172.99 8.62 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.901 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 68.3 p -83.24 -33.4 26.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.874 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 11.2 t -141.65 165.1 28.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.851 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 4.8 t60 -67.69 -53.7 25.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.849 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -44.28 -60.28 1.99 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.126 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -46.86 -45.95 20.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.879 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -55.75 -58.43 7.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.111 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 16.5 tp60 -45.11 -49.64 11.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.888 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -53.54 -51.87 61.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.112 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -56.87 -45.12 82.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.107 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . 0.494 ' O ' ' N ' ' A' ' 212' ' ' HIS . 71.4 mt -57.97 -74.06 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.142 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -48.06 -42.54 28.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.883 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -58.31 -37.7 75.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.134 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . 0.419 ' O ' ' CB ' ' A' ' 214' ' ' SER . 41.4 mt -104.53 -72.0 0.72 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.945 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' HIS . . . . . 0.494 ' N ' ' O ' ' A' ' 208' ' ' ILE . 13.0 t60 -46.85 136.59 8.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.876 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 73.67 -6.41 18.18 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.479 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' SER . . . . . 0.419 ' CB ' ' O ' ' A' ' 211' ' ' LEU . 1.3 t -87.97 -71.03 0.6 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.825 0.345 . . . . 0.0 110.883 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.17 178.22 4.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.918 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' THR . . . . . 0.442 ' O ' ' C ' ' A' ' 217' ' ' MET . 56.4 m -134.97 95.29 3.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.132 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' MET . . . . . 0.442 ' C ' ' O ' ' A' ' 216' ' ' THR . 25.5 mmt -34.73 133.58 0.42 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.596 0.712 . . . . 0.0 110.887 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -48.91 117.73 2.98 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.723 2.282 . . . . 0.0 112.297 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 120.27 -54.17 0.66 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.52 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -72.04 159.86 33.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.769 0.319 . . . . 0.0 111.095 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 38.7 t -98.15 -23.9 15.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.881 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 1.9 m -99.98 147.48 25.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.841 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 73.4 m -60.02 156.41 14.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.852 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . 0.44 ' O ' ' ND1' ' A' ' 212' ' ' HIS . 38.2 tp -37.22 153.16 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.903 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . 0.414 ' HA ' ' ND1' ' A' ' 212' ' ' HIS . 61.4 t -124.66 111.04 26.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.136 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . 0.406 ' CG2' HD23 ' A' ' 224' ' ' LEU . 41.1 t -132.72 102.1 4.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.137 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 10.6 ptmt -129.48 151.65 49.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.898 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 228' ' ' PHE . . . . . 0.471 ' CE1' HD23 ' A' ' 153' ' ' LEU . 82.1 m-85 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.857 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 2.5 tptt . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.842 0.353 . . . . 0.0 110.876 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.434 HD11 ' CD1' ' A' ' 198' ' ' TYR . 41.6 mt -124.54 118.41 26.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.922 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -89.8 120.73 31.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.905 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 20.7 t -116.33 118.09 57.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.143 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -118.2 -155.8 10.09 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.499 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 16.5 mmt 47.42 34.59 3.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.786 0.327 . . . . 0.0 110.863 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 69.3 mt -95.51 165.87 12.14 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.941 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -102.27 162.21 13.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.895 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 40.4 mttp -85.48 32.89 0.56 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.897 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 3.5 tp60 -120.89 -50.51 2.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.913 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -44.31 159.82 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.893 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 4.9 m -139.06 168.5 19.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.866 -179.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -49.97 -48.73 52.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.885 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -53.31 -56.3 17.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.87 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -48.33 -67.59 0.26 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.87 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.555 HG12 ' CE1' ' A' ' 171' ' ' PHE . 65.3 t -49.99 -53.17 11.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.099 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . 0.429 ' C ' ' O ' ' A' ' 167' ' ' VAL . 1.5 tmm_? -36.25 -63.65 0.37 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.844 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 19.7 mtp180 -63.89 -51.89 62.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.915 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.506 ' O ' ' CB ' ' A' ' 173' ' ' ALA . 16.5 tp -43.29 -65.8 0.45 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.953 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . 0.555 ' CE1' HG12 ' A' ' 167' ' ' VAL . 9.3 m-85 -55.7 -68.33 0.21 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.884 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -44.81 -21.96 0.07 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.882 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.506 ' CB ' ' O ' ' A' ' 170' ' ' LEU . . . -50.11 -17.75 0.46 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.126 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -118.3 -71.74 0.72 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.916 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -109.51 145.83 16.83 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.463 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -55.84 145.59 24.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.836 0.35 . . . . 0.0 110.872 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 50.7 mt -109.26 135.06 49.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.127 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . 0.429 ' HB3' ' CE ' ' A' ' 197' ' ' LYS . 13.0 mt-10 -97.86 -39.09 9.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.897 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 23.2 tp10 -148.17 144.43 27.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.879 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 44.9 t -143.78 137.99 28.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.896 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' THR . . . . . 0.465 HG21 ' N ' ' A' ' 182' ' ' ILE . 22.4 m -154.53 137.29 15.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.096 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.465 ' N ' HG21 ' A' ' 181' ' ' THR . 26.4 mm -96.83 126.43 49.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.103 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . 0.664 ' CD1' ' CE2' ' A' ' 195' ' ' PHE . 28.7 mt . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.928 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 48.5 t . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.963 0.411 . . . . 0.0 110.904 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 52.5 mttm -100.68 34.53 2.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.875 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 41.11 39.54 2.13 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.463 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 65.1 m -154.6 149.03 26.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.833 0.349 . . . . 0.0 110.889 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -163.14 154.63 17.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.101 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 195' ' ' PHE . . . . . 0.664 ' CE2' ' CD1' ' A' ' 183' ' ' LEU . 69.7 m-85 -105.38 136.69 44.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.873 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 48.4 t -133.76 140.45 46.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.147 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . 0.429 ' CE ' ' HB3' ' A' ' 178' ' ' GLU . 22.0 ttpt -116.84 142.8 46.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.856 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . 0.434 ' CD1' HD11 ' A' ' 153' ' ' LEU . 9.5 m-85 -119.86 170.2 9.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.895 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 24.7 t -69.2 -48.24 62.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.866 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 59.5 p -145.81 173.05 12.45 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.9 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . 0.443 ' O ' ' C ' ' A' ' 202' ' ' ALA . 6.5 t60 -59.46 -56.48 21.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.823 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . 0.443 ' C ' ' O ' ' A' ' 201' ' ' HIS . . . -34.74 -69.81 0.09 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.122 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -47.1 -47.31 23.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.887 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -53.33 -58.06 8.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.061 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 3.2 tp60 -47.91 -40.03 20.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.929 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -59.81 -53.71 54.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.084 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -61.93 -25.66 67.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.127 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . 0.495 ' O ' ' N ' ' A' ' 212' ' ' HIS . 79.2 mt -71.15 -67.79 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.13 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -57.31 -38.88 74.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.877 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -63.5 -41.73 98.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.147 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 63.7 mt -100.73 -72.09 0.69 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.909 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 212' ' ' HIS . . . . . 0.495 ' N ' ' O ' ' A' ' 208' ' ' ILE . 1.4 t60 -52.15 130.48 30.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.872 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 72.54 -0.98 39.15 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.523 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 22.5 t -96.88 -71.89 0.66 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.782 0.325 . . . . 0.0 110.859 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -99.5 172.37 7.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.866 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 34.2 m -123.55 105.35 9.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.125 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 15.4 mmt -43.18 139.03 2.43 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.514 0.674 . . . . 0.0 110.929 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -48.31 120.74 5.33 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.681 2.254 . . . . 0.0 112.338 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 105.88 -53.97 0.62 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.485 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -66.68 146.93 53.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.845 0.355 . . . . 0.0 111.092 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 29.4 m -93.19 -17.29 23.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.826 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 9.8 p -100.01 151.29 21.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.861 -179.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 44.1 m -65.6 148.08 52.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.865 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . 0.435 ' O ' ' ND1' ' A' ' 212' ' ' HIS . 63.8 tp -39.56 149.83 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.914 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 61.9 t -121.89 106.52 18.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.129 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . 0.423 ' H ' ' CG ' ' A' ' 212' ' ' HIS . 28.7 t -126.17 104.99 13.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.137 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 46.2 pttt -120.31 176.36 5.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.924 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.927 179.952 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.423 ' HE3' ' CB ' ' A' ' 195' ' ' PHE . 20.6 tttp . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.85 0.357 . . . . 0.0 110.874 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.563 HD22 ' CE1' ' A' ' 228' ' ' PHE . 25.0 mt -96.63 154.35 17.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.923 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 79.1 t80 -125.0 114.14 18.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.892 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.501 HG23 ' CZ ' ' A' ' 171' ' ' PHE . 17.4 t -102.75 110.51 29.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.108 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -111.99 -171.6 18.82 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.471 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 10.5 mmt 59.66 28.08 17.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.795 0.331 . . . . 0.0 110.845 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 46.3 mt -91.17 165.99 13.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.933 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -108.64 166.56 10.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.904 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 33.0 mttt -84.6 51.7 2.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.91 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -134.88 -50.67 0.77 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.957 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -51.67 163.36 0.31 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.872 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 44.5 m -138.14 172.47 12.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.882 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -53.73 -45.13 70.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.898 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -57.43 -51.38 69.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.847 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -50.99 -65.73 0.51 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.876 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.419 HG11 ' CE1' ' A' ' 171' ' ' PHE . 58.3 t -57.8 -36.57 55.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.137 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 14.2 tpp85 -54.58 -62.72 1.47 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.868 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 68.3 mtp180 -64.87 -51.52 61.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.864 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.497 ' O ' ' CB ' ' A' ' 173' ' ' ALA . 13.0 tp -43.85 -65.51 0.49 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.912 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . 0.501 ' CZ ' HG23 ' A' ' 155' ' ' VAL . 6.6 m-85 -55.84 -67.95 0.25 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.858 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.509 ' C ' ' CD ' ' A' ' 172' ' ' GLU . 0.6 OUTLIER -45.43 -21.56 0.1 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.886 -179.91 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.497 ' CB ' ' O ' ' A' ' 170' ' ' LEU . . . -50.11 -18.97 0.64 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.098 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -110.27 -65.96 1.11 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.908 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -107.33 -165.53 21.98 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.478 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -100.01 132.84 45.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.778 0.323 . . . . 0.0 110.886 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . 0.401 HG23 ' N ' ' A' ' 178' ' ' GLU . 29.6 mt -101.89 138.32 26.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.089 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . 0.401 ' N ' HG23 ' A' ' 177' ' ' ILE . 12.2 mm-40 -98.96 -32.82 11.11 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.862 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -160.83 152.31 19.32 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.885 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 38.6 t -136.1 121.49 19.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.902 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 97.8 m -123.86 139.08 54.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.152 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 50.6 mm -115.57 114.54 46.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.134 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 18.8 mt . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.914 179.905 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 4.6 t . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.969 0.414 . . . . 0.0 110.816 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 2.6 mmmp? -105.56 15.51 26.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.91 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 62.47 32.24 82.42 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.497 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 11.1 m -148.04 142.96 26.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.794 0.331 . . . . 0.0 110.879 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -160.04 160.2 32.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.095 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 195' ' ' PHE . . . . . 0.423 ' CB ' ' HE3' ' A' ' 152' ' ' LYS . 77.4 m-85 -115.54 133.57 55.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.892 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 92.9 t -116.68 128.74 73.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.14 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 19.1 tttp -95.87 145.2 25.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.888 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . 0.477 ' CD1' HD11 ' A' ' 153' ' ' LEU . 7.6 m-85 -129.07 171.6 12.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.924 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 91.3 p -85.58 -20.91 28.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.885 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 2.2 m -162.01 176.42 10.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.772 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -77.16 -37.68 53.32 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.864 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -52.82 -65.31 0.58 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.102 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 18.2 mp0 -48.47 -41.29 29.25 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.88 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -58.85 -59.8 4.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.074 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 43.1 tp60 -45.64 -42.02 10.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.937 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -60.48 -52.74 63.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.101 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -62.74 -28.39 69.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.112 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . 0.501 ' O ' ' N ' ' A' ' 212' ' ' HIS . 93.2 mt -67.41 -75.11 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.121 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -46.25 -43.4 15.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.893 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -55.99 -41.93 75.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.095 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 71.6 mt -100.94 -69.57 0.77 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.873 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 212' ' ' HIS . . . . . 0.501 ' N ' ' O ' ' A' ' 208' ' ' ILE . 27.1 t60 -52.4 125.62 16.71 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.902 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 84.6 -10.22 62.66 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.507 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 51.7 m -97.71 -74.43 0.58 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.84 0.353 . . . . 0.0 110.845 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 19.9 mp0 -88.43 166.42 14.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.928 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 216' ' ' THR . . . . . 0.404 ' O ' ' C ' ' A' ' 217' ' ' MET . 32.4 m -135.79 106.39 6.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.141 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 217' ' ' MET . . . . . 0.404 ' C ' ' O ' ' A' ' 216' ' ' THR . 15.5 mmt -37.31 156.37 0.09 OUTLIER Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.547 0.689 . . . . 0.0 110.878 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.09 120.61 7.31 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.656 2.237 . . . . 0.0 112.323 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 109.36 -42.63 1.9 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.466 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -76.4 144.3 40.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.767 0.317 . . . . 0.0 111.089 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 3.5 t -93.57 -15.28 25.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.812 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 67.6 m -100.17 142.09 32.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.904 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 64.7 m -57.72 157.13 7.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.824 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 47.7 tp -48.35 148.81 1.77 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.916 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . 0.42 ' HA ' ' ND1' ' A' ' 212' ' ' HIS . 53.0 t -119.73 111.17 31.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.101 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 25.7 t -132.68 101.31 4.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.117 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.81 158.4 42.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.897 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 228' ' ' PHE . . . . . 0.563 ' CE1' HD22 ' A' ' 153' ' ' LEU . 28.6 m-85 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.887 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.566 ' HE2' ' CD1' ' A' ' 195' ' ' PHE . 3.8 ttpm? . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.869 0.366 . . . . 0.0 110.886 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 40.5 mt -129.65 123.97 32.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.886 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -90.19 119.33 30.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.9 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 5.1 t -107.22 124.7 63.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.121 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -124.85 -168.37 12.78 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.475 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 18.0 mmt 48.45 35.13 5.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.773 0.32 . . . . 0.0 110.896 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 38.3 mt -89.2 166.15 14.0 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.915 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -104.51 160.08 15.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.874 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 24.1 mttp -84.49 23.98 1.05 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.914 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -109.56 -55.21 2.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.909 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -53.4 146.05 13.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.88 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 57.7 m -126.38 166.37 17.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.864 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -44.13 -40.23 4.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.861 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -55.97 -66.08 0.49 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.872 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -52.81 -48.42 66.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.872 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.473 HG13 ' CD1' ' A' ' 171' ' ' PHE . 93.9 t -57.45 -35.24 48.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.099 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 51.4 ttt180 -63.81 -57.87 8.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.843 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 8.5 ptm180 -64.15 -53.24 52.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.85 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.515 ' O ' ' CB ' ' A' ' 173' ' ' ALA . 8.5 tp -43.72 -65.26 0.52 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.916 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . 0.495 ' CE2' HG23 ' A' ' 196' ' ' VAL . 10.9 m-85 -53.03 -68.9 0.13 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.884 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -45.75 -24.19 0.34 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.894 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.515 ' CB ' ' O ' ' A' ' 170' ' ' LEU . . . -49.4 -21.23 0.84 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.073 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -111.77 -71.37 0.76 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.879 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -112.21 146.83 18.16 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.462 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . 0.45 ' O ' ' CD2' ' A' ' 198' ' ' TYR . 32.6 m120 -51.57 160.3 0.64 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.816 0.341 . . . . 0.0 110.926 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . 0.411 ' CG2' ' N ' ' A' ' 178' ' ' GLU . 19.3 mt -124.73 152.37 30.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.128 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . 0.411 ' N ' ' CG2' ' A' ' 177' ' ' ILE . 9.1 mt-10 -120.49 -28.92 4.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.868 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -155.76 146.78 22.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.871 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 4.8 t -147.32 132.91 18.76 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.927 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 99.5 m -151.32 145.13 25.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.141 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 18.5 mm -97.25 137.48 24.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.14 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . 0.55 HD13 ' CE2' ' A' ' 195' ' ' PHE . 52.9 mt . . . . . 0 C--N 1.328 -0.352 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.914 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 10.8 t . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.914 0.388 . . . . 0.0 110.876 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 24.5 mmtt -90.82 36.16 0.9 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.918 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 43.28 37.61 3.41 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.468 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 193' ' ' CYS . . . . . 0.407 ' C ' ' HB2' ' A' ' 183' ' ' LEU . 72.1 m -150.49 150.4 31.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.799 0.333 . . . . 0.0 110.868 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -163.09 169.2 19.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.077 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 195' ' ' PHE . . . . . 0.566 ' CD1' ' HE2' ' A' ' 152' ' ' LYS . 18.2 m-85 -122.96 135.77 54.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.853 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.495 HG23 ' CE2' ' A' ' 171' ' ' PHE . 61.3 t -130.75 140.69 48.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.121 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 25.3 ttmt -117.44 146.49 43.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.856 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . 0.45 ' CD2' ' O ' ' A' ' 176' ' ' ASN . 24.6 m-85 -124.23 166.42 15.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.919 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 42.3 t -70.03 -48.74 56.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.828 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 7.3 t -136.82 168.69 19.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.859 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . 0.449 ' O ' ' C ' ' A' ' 202' ' ' ALA . 4.7 t60 -61.35 -57.34 12.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.85 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . 0.449 ' C ' ' O ' ' A' ' 201' ' ' HIS . . . -33.99 -67.03 0.14 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.093 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 19.4 mp0 -49.83 -39.59 39.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.879 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . 0.424 ' N ' ' O ' ' A' ' 201' ' ' HIS . . . -55.65 -51.82 65.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.092 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 59.6 tp60 -57.29 -45.18 84.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.876 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -51.93 -47.69 64.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.104 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -69.48 -29.88 67.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.136 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . 0.482 ' O ' ' N ' ' A' ' 212' ' ' HIS . 56.3 mt -66.94 -60.44 2.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.125 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -64.22 -36.95 85.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.869 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -66.6 -35.56 80.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.122 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . 0.439 ' HB3' ' CD2' ' A' ' 224' ' ' LEU . 84.5 mt -102.51 -69.33 0.79 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.902 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 212' ' ' HIS . . . . . 0.482 ' N ' ' O ' ' A' ' 208' ' ' ILE . 12.2 t60 -62.97 126.19 26.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.835 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 85.7 -4.28 86.0 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.495 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 2.1 m -94.43 -74.12 0.55 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.84 0.353 . . . . 0.0 110.854 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 17.2 pm0 -99.88 175.63 5.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.894 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 17.3 m -130.33 101.37 5.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.106 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 13.5 mmt -37.08 134.45 0.68 Allowed Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.608 0.718 . . . . 0.0 110.884 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -48.71 119.88 4.71 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.668 2.246 . . . . 0.0 112.342 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 112.89 -49.86 0.81 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.513 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -73.38 156.76 38.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.813 0.34 . . . . 0.0 111.081 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 94.7 p -98.88 -21.14 16.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.837 -179.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 1.8 m -100.15 143.31 30.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.855 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 15.1 m -56.88 153.49 10.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.921 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . 0.439 ' CD2' ' HB3' ' A' ' 211' ' ' LEU . 58.5 tp -40.17 149.62 0.07 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.865 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . 0.41 ' HA ' ' ND1' ' A' ' 212' ' ' HIS . 79.9 t -118.35 113.71 42.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.18 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 20.5 t -138.97 104.97 2.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.15 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 44.7 pttt -127.4 178.96 5.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.862 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.878 179.929 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 5.8 ttpm? . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.784 0.326 . . . . 0.0 110.904 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.446 HD11 ' CD1' ' A' ' 198' ' ' TYR . 59.5 mt -136.92 140.72 42.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.891 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 35.5 t80 -107.36 121.05 43.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.915 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 23.9 t -110.26 132.1 59.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.161 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -133.04 -161.5 9.87 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.512 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 19.5 mmt 49.04 30.55 2.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.819 0.342 . . . . 0.0 110.875 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 82.0 mt -91.05 166.69 12.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.924 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -108.94 155.82 20.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.882 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 36.2 mttp -81.38 44.73 0.81 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.868 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -127.93 -47.42 1.37 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.922 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 14.8 mm-40 -58.73 162.11 4.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.894 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 45.9 m -135.02 174.44 10.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.854 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . 0.451 ' O ' ' CB ' ' A' ' 168' ' ' ARG . 1.4 mp0 -51.35 -35.62 39.26 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.871 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -63.25 -65.89 0.62 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.904 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -42.21 -57.01 2.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.892 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.569 HG12 ' CD1' ' A' ' 171' ' ' PHE . 75.5 t -62.66 -59.89 3.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.12 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . 0.451 ' CB ' ' O ' ' A' ' 164' ' ' GLU . 29.9 ttm-85 -35.29 -63.91 0.31 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.874 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 83.7 mtm180 -59.16 -54.59 45.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.877 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.505 ' O ' ' CB ' ' A' ' 173' ' ' ALA . 16.2 tp -42.8 -66.02 0.41 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.896 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . 0.569 ' CD1' HG12 ' A' ' 167' ' ' VAL . 13.4 m-85 -51.7 -72.06 0.06 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.891 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -41.52 -31.79 0.29 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.915 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.505 ' CB ' ' O ' ' A' ' 170' ' ' LEU . . . -39.62 -30.16 0.07 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.06 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -107.85 -68.83 0.88 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.879 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -111.88 131.75 10.42 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.504 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -48.78 147.71 2.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.852 0.358 . . . . 0.0 110.849 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . 0.466 HG22 ' N ' ' A' ' 178' ' ' GLU . 67.2 mt -112.77 138.66 41.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.119 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . 0.466 ' N ' HG22 ' A' ' 177' ' ' ILE . 67.7 mm-40 -98.7 -36.23 9.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.842 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -148.6 139.23 22.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.845 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 47.9 t -145.12 138.47 26.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.855 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 18.1 m -152.83 148.94 27.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.199 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.417 HG22 ' N ' ' A' ' 183' ' ' LEU . 35.2 mm -102.26 134.91 41.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.152 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . 0.417 ' N ' HG22 ' A' ' 182' ' ' ILE . 29.4 mt . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.919 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 23.2 t . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.932 0.396 . . . . 0.0 110.826 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . 0.404 ' O ' ' C ' ' A' ' 192' ' ' GLY . 8.7 mtmp? -89.7 47.21 1.44 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.884 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.404 ' C ' ' O ' ' A' ' 191' ' ' LYS . . . 37.37 46.66 1.45 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.507 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 87.1 m -155.19 156.69 36.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.852 0.358 . . . . 0.0 110.881 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -160.61 166.86 28.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.085 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -119.73 119.6 34.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.905 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.531 HG23 ' CE2' ' A' ' 171' ' ' PHE . 21.9 t -114.04 152.34 15.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.138 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 23.0 tttp -135.61 137.3 41.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.913 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . 0.446 ' CD1' HD11 ' A' ' 153' ' ' LEU . 16.6 m-85 -113.31 162.43 16.06 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.876 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 11.8 t -65.95 -52.11 52.59 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.873 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 5.7 t -124.0 170.86 10.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.836 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 6.5 t60 -69.23 -51.03 41.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.854 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -42.74 -64.57 0.59 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.091 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -46.38 -43.07 15.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.88 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -53.07 -62.07 1.89 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.134 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 50.4 tp60 -46.61 -47.06 20.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.905 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -49.19 -57.88 5.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.118 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -54.72 -44.01 73.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.072 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . 0.502 ' O ' ' N ' ' A' ' 212' ' ' HIS . 75.7 mt -51.12 -72.83 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.141 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -54.83 -38.76 67.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.868 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -61.43 -31.4 71.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.111 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 98.5 mt -114.34 -73.85 0.64 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.873 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 212' ' ' HIS . . . . . 0.502 ' N ' ' O ' ' A' ' 208' ' ' ILE . 14.6 t60 -49.5 131.92 20.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.847 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 78.3 -10.24 29.74 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.515 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 25.6 t -99.22 -69.27 0.77 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.818 0.342 . . . . 0.0 110.87 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 7.1 mm-40 -88.11 159.39 18.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.931 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 216' ' ' THR . . . . . 0.409 ' O ' ' C ' ' A' ' 217' ' ' MET . 2.9 m -125.34 99.04 5.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.175 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 217' ' ' MET . . . . . 0.409 ' C ' ' O ' ' A' ' 216' ' ' THR . 12.1 mmt -35.96 135.07 0.53 Allowed Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.568 0.699 . . . . 0.0 110.879 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -48.21 121.31 5.93 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.719 2.28 . . . . 0.0 112.331 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 108.06 -48.57 0.93 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.483 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -75.15 144.6 42.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.792 0.33 . . . . 0.0 111.117 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 7.0 t -92.65 -16.0 26.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.872 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 67.9 m -99.99 138.37 37.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.846 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 66.2 m -52.83 155.71 2.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.857 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . 0.446 ' O ' ' ND1' ' A' ' 212' ' ' HIS . 50.8 tp -45.57 157.73 0.09 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.89 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 55.0 t -122.67 104.46 14.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.167 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 21.0 t -134.78 108.87 11.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.106 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.94 -179.54 4.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.852 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 228' ' ' PHE . . . . . 0.402 ' CD1' HD21 ' A' ' 153' ' ' LEU . 69.2 m-85 . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.865 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.549 ' HE3' ' CD1' ' A' ' 195' ' ' PHE . 19.1 ttpt . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.825 0.345 . . . . 0.0 110.93 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.444 ' CD1' ' CD1' ' A' ' 198' ' ' TYR . 37.9 mt -121.3 127.44 51.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.924 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -92.37 130.97 37.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.855 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 39.0 t -121.47 126.8 75.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.167 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -127.97 -172.3 13.19 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.513 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' MET . . . . . 0.43 ' CG ' HG23 ' A' ' 225' ' ' VAL . 82.2 mmm 51.38 39.54 24.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.773 0.32 . . . . 0.0 110.89 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 50.7 mt -93.39 171.43 8.92 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.936 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -100.44 160.73 14.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.891 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 24.2 mttp -89.87 34.59 0.84 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.91 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -127.92 -43.62 1.51 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.859 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -47.05 155.94 0.25 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.907 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 5.8 m -132.9 171.88 13.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.871 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . 0.464 ' O ' ' CB ' ' A' ' 168' ' ' ARG . 2.9 mp0 -55.24 -37.68 67.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.882 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -64.96 -44.98 87.62 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.874 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 -60.41 -59.39 5.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.874 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.571 HG12 ' CD1' ' A' ' 171' ' ' PHE . 96.2 t -62.17 -39.3 83.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.144 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . 0.464 ' CB ' ' O ' ' A' ' 164' ' ' GLU . 33.2 ttt180 -55.28 -63.13 1.26 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.832 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 74.7 mtt180 -60.91 -54.02 50.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.859 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.501 ' O ' ' CB ' ' A' ' 173' ' ' ALA . 10.0 tp -43.93 -65.64 0.48 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.866 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . 0.571 ' CD1' HG12 ' A' ' 167' ' ' VAL . 10.6 m-85 -51.07 -70.39 0.09 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.879 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -44.14 -30.44 0.77 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.89 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.501 ' CB ' ' O ' ' A' ' 170' ' ' LEU . . . -42.81 -28.05 0.22 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.127 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -106.46 -68.97 0.85 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.889 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -113.42 135.23 12.42 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.521 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -45.71 153.27 0.28 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.784 0.326 . . . . 0.0 110.897 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . 0.453 HG22 ' N ' ' A' ' 178' ' ' GLU . 58.2 mt -118.18 153.06 20.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.148 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . 0.453 ' N ' HG22 ' A' ' 177' ' ' ILE . 55.6 mt-10 -117.11 -37.72 3.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.885 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -144.7 140.36 28.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.931 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 10.1 t -140.01 134.14 31.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.854 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' THR . . . . . 0.466 HG21 ' N ' ' A' ' 182' ' ' ILE . 86.0 m -153.22 143.74 22.58 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.124 -179.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.466 ' N ' HG21 ' A' ' 181' ' ' THR . 9.7 mm -104.39 133.31 48.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.141 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 22.1 mt . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.944 179.885 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 13.4 t . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.915 0.388 . . . . 0.0 110.844 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 34.2 mtmm -84.12 38.12 0.64 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.914 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 43.11 43.38 5.61 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.493 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 80.7 m -154.62 159.55 40.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.826 0.346 . . . . 0.0 110.888 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -161.73 169.13 22.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.07 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 195' ' ' PHE . . . . . 0.549 ' CD1' ' HE3' ' A' ' 152' ' ' LYS . 38.2 m-85 -126.58 122.5 35.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.899 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 9.4 t -123.73 147.97 27.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.14 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -118.09 155.94 29.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.88 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . 0.444 ' CD1' ' CD1' ' A' ' 153' ' ' LEU . 20.8 m-85 -131.58 166.36 21.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.955 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 35.7 t -64.98 -51.54 61.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.858 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 4.8 m -140.51 -177.2 4.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.864 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . 0.441 ' O ' ' C ' ' A' ' 202' ' ' ALA . 13.1 t60 -68.15 -58.68 4.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.852 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . 0.441 ' C ' ' O ' ' A' ' 201' ' ' HIS . . . -34.93 -67.09 0.15 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.106 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -47.44 -47.36 26.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.89 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -52.36 -63.61 1.09 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.104 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 11.0 tp60 -43.36 -45.41 6.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.901 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -52.99 -55.34 24.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.107 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -58.41 -34.67 71.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.139 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . 0.496 ' O ' ' N ' ' A' ' 212' ' ' HIS . 82.5 mt -59.94 -72.6 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.078 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 -52.09 -41.69 62.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.901 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -57.04 -40.96 77.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.109 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 64.7 mt -101.92 -71.12 0.73 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.929 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 212' ' ' HIS . . . . . 0.496 ' N ' ' O ' ' A' ' 208' ' ' ILE . 31.0 t60 -54.54 128.78 33.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.903 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 80.21 -1.62 79.88 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.456 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 34.0 t -96.65 -74.34 0.57 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.821 0.343 . . . . 0.0 110.892 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -97.3 -177.46 3.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.911 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 60.4 m -133.65 100.99 4.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.125 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 33.0 mmt -39.27 135.08 1.12 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.607 0.718 . . . . 0.0 110.869 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -48.34 114.08 1.05 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.703 2.269 . . . . 0.0 112.343 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 119.07 -51.19 0.77 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.485 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -72.77 155.58 39.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.814 0.34 . . . . 0.0 111.069 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 28.7 t -98.16 -21.15 16.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.898 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 1.1 t -99.88 154.14 18.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.876 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 57.8 m -58.65 158.54 7.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.832 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . 0.432 ' O ' ' ND1' ' A' ' 212' ' ' HIS . 43.1 tp -47.81 152.51 0.73 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.94 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . 0.43 HG23 ' CG ' ' A' ' 157' ' ' MET . 98.0 t -118.48 111.46 34.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.139 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 23.7 t -138.37 105.36 3.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.098 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 34.3 pttt -129.13 169.73 14.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.897 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.917 179.978 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 12.4 tttt . . . . . 0 C--O 1.232 0.17 0 CA-C-O 120.805 0.336 . . . . 0.0 110.9 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.403 HD12 ' CD1' ' A' ' 198' ' ' TYR . 44.4 mt -120.53 129.2 53.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.904 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 29.6 t80 -98.01 119.92 37.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.912 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 21.6 t -110.27 129.1 65.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.102 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -127.69 -170.56 12.86 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.502 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 11.3 mmt 55.59 36.27 26.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.828 0.347 . . . . 0.0 110.937 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.409 ' HB2' ' C ' ' A' ' 192' ' ' GLY . 38.6 mt -95.55 168.93 10.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.872 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.478 ' ND2' ' O ' ' A' ' 218' ' ' PRO . 12.7 m120 -113.59 162.83 15.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.898 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 38.0 mttp -82.62 48.91 1.38 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.911 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -133.27 -49.49 0.85 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.886 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 16.0 mm-40 -56.65 155.52 7.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.899 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 17.1 m -135.51 176.13 8.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.884 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -47.57 -50.52 23.78 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.903 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -54.92 -58.62 6.86 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.839 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -41.84 -66.02 0.39 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.862 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.506 HG12 ' CE1' ' A' ' 171' ' ' PHE . 65.9 t -55.52 -54.77 21.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.113 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . 0.439 ' C ' ' O ' ' A' ' 167' ' ' VAL . 43.8 ttt180 -35.23 -70.11 0.09 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.875 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 44.3 mmm-85 -58.04 -53.57 56.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.909 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.499 ' O ' ' CB ' ' A' ' 173' ' ' ALA . 19.5 tp -41.37 -66.83 0.3 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.923 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . 0.506 ' CE1' HG12 ' A' ' 167' ' ' VAL . 9.9 m-85 -55.33 -72.84 0.06 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.858 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.45 ' O ' ' N ' ' A' ' 174' ' ' PHE . 0.5 OUTLIER -39.55 -28.26 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.907 -179.907 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.499 ' CB ' ' O ' ' A' ' 170' ' ' LEU . . . -41.41 -24.18 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.112 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . 0.45 ' N ' ' O ' ' A' ' 172' ' ' GLU . 93.7 m-85 -108.09 -69.92 0.83 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.931 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -100.94 -171.64 28.79 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.485 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 33.3 m-20 -98.86 131.67 44.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.771 0.319 . . . . 0.0 110.898 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . 0.417 ' CG2' ' N ' ' A' ' 178' ' ' GLU . 37.1 mt -96.39 151.94 3.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.136 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . 0.417 ' N ' ' CG2' ' A' ' 177' ' ' ILE . 6.8 mt-10 -121.27 -21.51 6.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.905 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -165.85 136.43 3.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.865 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 51.0 t -130.47 141.6 50.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.89 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 83.2 m -153.11 147.65 26.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.158 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.427 HD13 ' CB ' ' A' ' 194' ' ' ALA . 20.1 mm -115.22 137.51 48.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.132 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . 0.432 HD12 ' CE2' ' A' ' 195' ' ' PHE . 34.3 mt . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.932 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 17.1 t . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.916 0.389 . . . . 0.0 110.895 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 24.0 mtpt -89.68 31.55 0.93 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.952 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.409 ' C ' ' HB2' ' A' ' 158' ' ' LEU . . . 47.19 36.82 10.25 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.5 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 63.6 m -151.3 155.83 39.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.848 0.356 . . . . 0.0 110.843 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . 0.427 ' CB ' HD13 ' A' ' 182' ' ' ILE . . . -161.04 162.21 31.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.072 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 195' ' ' PHE . . . . . 0.432 ' CE2' HD12 ' A' ' 183' ' ' LEU . 58.2 m-85 -117.79 142.36 47.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.848 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 45.6 t -129.82 145.34 35.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.091 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 24.7 tttt -113.5 147.48 37.83 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.879 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . 0.403 ' CD1' HD12 ' A' ' 153' ' ' LEU . 7.6 m-85 -132.4 167.9 19.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.945 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 38.1 t -83.96 -40.08 18.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.856 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 3.5 m -138.26 176.61 8.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.854 -179.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . 0.431 ' O ' ' C ' ' A' ' 202' ' ' ALA . 5.3 t60 -74.24 -56.44 4.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.866 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . 0.431 ' C ' ' O ' ' A' ' 201' ' ' HIS . . . -35.56 -63.21 0.36 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.1 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 31.7 mm-40 -49.4 -49.83 43.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.871 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -51.45 -59.28 4.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.143 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 33.8 tp60 -48.27 -55.92 9.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.884 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -44.2 -61.38 1.51 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.067 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -49.05 -49.19 42.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.119 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . 0.498 ' O ' ' N ' ' A' ' 212' ' ' HIS . 66.4 mt -49.54 -74.95 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.123 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -44.47 -44.58 8.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.916 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -54.24 -43.31 70.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.126 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 7.9 mt -100.29 -68.93 0.79 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.934 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 212' ' ' HIS . . . . . 0.498 ' N ' ' O ' ' A' ' 208' ' ' ILE . 29.7 t60 -51.6 126.18 16.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.851 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . 0.45 ' HA2' ' CB ' ' A' ' 223' ' ' SER . . . 82.02 -19.23 10.35 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.518 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 2.5 m -85.5 -73.08 0.46 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.803 0.335 . . . . 0.0 110.872 -179.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 71.1 mt-30 -92.69 167.18 12.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.924 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 216' ' ' THR . . . . . 0.423 HG22 ' C ' ' A' ' 222' ' ' SER . 0.7 OUTLIER -126.95 104.07 7.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.119 -179.917 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 14.5 mmt -39.04 135.23 1.04 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.609 0.719 . . . . 0.0 110.836 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . 0.478 ' O ' ' ND2' ' A' ' 159' ' ' ASN . 76.1 Cg_exo -48.72 122.29 7.81 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.684 2.256 . . . . 0.0 112.375 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 105.03 -44.99 1.36 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.509 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -75.54 143.97 42.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.768 0.318 . . . . 0.0 111.091 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 29.9 t -92.59 -15.5 26.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.882 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 222' ' ' SER . . . . . 0.423 ' C ' HG22 ' A' ' 216' ' ' THR . 1.8 m -99.84 146.1 27.0 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.837 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 223' ' ' SER . . . . . 0.45 ' CB ' ' HA2' ' A' ' 213' ' ' GLY . 29.4 m -59.63 150.08 28.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.828 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 62.4 tp -41.78 151.62 0.09 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.935 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 60.1 t -118.34 113.83 43.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.171 179.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 46.0 t -136.92 105.2 3.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.153 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 8.3 ptmt -122.14 169.25 11.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.895 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.915 179.952 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.565 ' HD3' ' CD1' ' A' ' 195' ' ' PHE . 24.4 ttmt . . . . . 0 C--O 1.232 0.176 0 CA-C-O 120.798 0.332 . . . . 0.0 110.899 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.53 HD23 ' CE1' ' A' ' 228' ' ' PHE . 58.0 mt -127.2 121.81 32.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.882 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -95.13 127.03 40.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.864 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 59.1 t -114.47 133.81 59.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.149 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -128.97 -159.58 9.99 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.49 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 27.8 mtt 41.84 39.88 1.37 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.817 0.341 . . . . 0.0 110.86 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 42.8 mt -95.43 161.4 14.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.943 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.483 ' ND2' ' O ' ' A' ' 218' ' ' PRO . 69.2 m-20 -100.35 165.97 11.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.861 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 65.4 mttt -89.72 40.97 1.02 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.842 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 18.9 mm-40 -127.31 -53.17 1.38 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.858 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -55.13 148.82 13.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.926 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 1.6 t -133.81 176.42 8.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.84 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -47.93 -42.64 27.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.862 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -50.55 -57.66 7.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.89 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -61.21 -66.63 0.5 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.923 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 59.8 t -42.02 -35.32 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.094 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 25.0 ttm180 -63.88 -61.24 2.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.873 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 31.6 ptt180 -63.09 -52.13 63.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.887 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.507 ' O ' ' CB ' ' A' ' 173' ' ' ALA . 8.5 tp -44.23 -65.69 0.48 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.89 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . 0.569 ' CE2' HG22 ' A' ' 196' ' ' VAL . 14.0 m-85 -53.28 -69.41 0.12 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.888 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -44.32 -26.05 0.3 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.94 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.507 ' CB ' ' O ' ' A' ' 170' ' ' LEU . . . -46.74 -20.49 0.13 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.142 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -116.14 -73.61 0.64 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.909 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -109.45 147.22 16.96 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.536 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -52.5 157.58 1.47 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.823 0.344 . . . . 0.0 110.903 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . 0.417 HG21 ' N ' ' A' ' 178' ' ' GLU . 98.0 mt -122.37 147.55 26.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.143 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . 0.417 ' N ' HG21 ' A' ' 177' ' ' ILE . 14.9 mm-40 -102.4 -45.91 4.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.901 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -153.71 151.36 29.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.879 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 52.2 t -138.11 143.28 40.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.893 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 98.5 m -152.17 138.95 18.87 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.119 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 21.3 mm -93.72 127.86 45.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.158 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . 0.553 HD12 ' CE2' ' A' ' 195' ' ' PHE . 65.6 mt . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.899 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 9.3 p . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.947 0.404 . . . . 0.0 110.841 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 28.9 mmtt -94.71 39.87 1.1 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.927 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 39.21 42.79 1.79 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.435 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 71.5 m -154.85 150.01 27.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.834 0.349 . . . . 0.0 110.905 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -161.39 162.91 30.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.075 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 195' ' ' PHE . . . . . 0.565 ' CD1' ' HD3' ' A' ' 152' ' ' LYS . 28.0 m-85 -116.98 143.12 46.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.896 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.569 HG22 ' CE2' ' A' ' 171' ' ' PHE . 40.3 t -140.13 138.2 37.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.125 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 8.0 ttmm -118.91 148.29 43.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.879 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -122.82 172.22 8.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.93 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 1.2 t -76.14 -49.99 15.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.854 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 58.7 m -125.51 -178.19 4.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.854 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . 0.432 ' O ' ' C ' ' A' ' 202' ' ' ALA . 9.8 t60 -79.66 -63.14 1.48 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.885 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . 0.432 ' C ' ' O ' ' A' ' 201' ' ' HIS . . . -34.35 -60.65 0.41 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.085 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -48.02 -50.42 27.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.93 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -51.99 -59.05 4.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.072 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 13.1 tp60 -44.91 -49.34 11.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.881 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -51.29 -58.32 6.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.131 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -52.59 -37.54 58.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.126 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . 0.491 ' O ' ' N ' ' A' ' 212' ' ' HIS . 77.0 mt -59.23 -74.06 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.095 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -49.92 -42.52 48.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.898 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -53.31 -45.6 69.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.126 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 57.2 mt -99.99 -67.69 0.84 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.9 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 212' ' ' HIS . . . . . 0.491 ' N ' ' O ' ' A' ' 208' ' ' ILE . 9.2 t60 -51.46 127.79 20.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.846 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 77.63 -9.97 26.55 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.472 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 8.3 t -97.74 -66.55 0.89 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.84 0.352 . . . . 0.0 110.879 -179.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 7.3 mm-40 -92.31 163.66 13.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.919 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 216' ' ' THR . . . . . 0.436 ' O ' ' C ' ' A' ' 217' ' ' MET . 3.9 m -131.09 101.28 5.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.129 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 217' ' ' MET . . . . . 0.436 ' C ' ' O ' ' A' ' 216' ' ' THR . 0.0 OUTLIER -34.69 131.07 0.45 Allowed Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.548 0.69 . . . . 0.0 110.886 179.859 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . 0.483 ' O ' ' ND2' ' A' ' 159' ' ' ASN . 75.6 Cg_exo -48.89 120.29 5.25 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.699 2.266 . . . . 0.0 112.35 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 107.78 -45.03 1.36 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.499 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -73.48 142.11 46.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.812 0.339 . . . . 0.0 111.084 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 35.6 m -89.17 -16.55 31.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.836 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 3.9 m -99.87 143.24 30.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.841 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 95.8 p -63.32 152.46 37.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.873 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 27.0 tp -48.0 146.85 2.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.894 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 68.6 t -119.5 118.27 56.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.129 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 38.7 t -141.12 116.95 6.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.152 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 18.3 pttt -131.81 172.29 12.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.888 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 228' ' ' PHE . . . . . 0.53 ' CE1' HD23 ' A' ' 153' ' ' LEU . 54.8 m-85 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.89 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 9.4 tttp . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.829 0.347 . . . . 0.0 110.912 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.497 HD12 ' CD1' ' A' ' 198' ' ' TYR . 41.8 mt -133.92 121.05 21.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.89 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -93.86 118.37 31.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.841 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.462 HG12 ' CD2' ' A' ' 158' ' ' LEU . 16.5 t -106.35 131.9 54.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.098 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -130.41 -164.04 11.2 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.507 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 18.7 mmt 40.19 37.95 0.47 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.786 0.327 . . . . 0.0 110.846 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.462 ' CD2' HG12 ' A' ' 155' ' ' VAL . 83.8 mt -85.37 174.01 9.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.914 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.494 ' OD1' ' N ' ' A' ' 160' ' ' LYS . 60.1 t-20 -105.72 150.85 25.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.89 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . 0.494 ' N ' ' OD1' ' A' ' 159' ' ' ASN . 10.3 mptt -86.42 29.45 0.77 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.865 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 15.9 tm0? -111.48 -55.07 2.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.941 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -68.24 163.74 22.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.934 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 58.7 m -130.36 178.75 6.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.866 -179.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -46.9 -41.08 15.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.919 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -55.05 -61.93 1.99 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.826 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -46.8 -55.4 7.97 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.873 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.555 HG11 ' CD1' ' A' ' 171' ' ' PHE . 89.7 t -58.3 -40.27 77.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.104 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . 0.427 ' NH1' ' OE1' ' A' ' 172' ' ' GLU . 2.4 tmm_? -52.67 -62.92 1.34 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.866 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 9.7 mmm180 -59.39 -54.72 43.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.861 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.506 ' O ' ' CB ' ' A' ' 173' ' ' ALA . 9.4 tp -42.73 -66.24 0.39 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.883 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . 0.555 ' CD1' HG11 ' A' ' 167' ' ' VAL . 13.5 m-85 -51.32 -71.85 0.06 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.896 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.455 ' O ' ' N ' ' A' ' 174' ' ' PHE . 3.9 pt-20 -41.9 -31.53 0.34 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.927 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.506 ' CB ' ' O ' ' A' ' 170' ' ' LEU . . . -41.11 -24.44 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.057 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . 0.455 ' N ' ' O ' ' A' ' 172' ' ' GLU . 81.1 m-85 -113.96 -72.62 0.69 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.844 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -104.8 134.35 11.97 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.519 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 34.4 m-20 -49.4 149.16 2.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.791 0.329 . . . . 0.0 110.912 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 70.9 mt -114.07 150.02 16.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.162 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -117.27 -25.68 6.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.925 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -158.19 160.37 37.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.918 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 8.0 t -162.29 141.98 9.65 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.83 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 93.2 m -148.6 139.94 23.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.136 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 48.9 mm -102.18 119.3 50.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.119 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . 0.484 HD11 ' CE2' ' A' ' 195' ' ' PHE . 30.8 mt . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.922 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 4.8 t . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.963 0.411 . . . . 0.0 110.842 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 24.2 mmtt -116.88 34.42 5.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.95 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 47.76 35.9 12.61 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.444 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 75.0 m -148.18 150.48 33.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.765 0.316 . . . . 0.0 110.9 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -160.64 152.43 19.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.113 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 195' ' ' PHE . . . . . 0.484 ' CE2' HD11 ' A' ' 183' ' ' LEU . 25.6 m-85 -102.08 137.42 40.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.895 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 59.1 t -127.42 144.88 35.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.132 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 49.6 tttt -124.21 138.17 54.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.899 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . 0.497 ' CD1' HD12 ' A' ' 153' ' ' LEU . 19.4 m-85 -118.1 173.54 6.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.923 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 48.3 t -81.38 -47.65 12.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.869 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 2.9 t -132.84 153.97 50.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.874 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . 0.441 ' O ' ' C ' ' A' ' 202' ' ' ALA . 23.4 t-80 -52.75 -61.32 2.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.827 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . 0.441 ' C ' ' O ' ' A' ' 201' ' ' HIS . . . -34.06 -62.53 0.31 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.168 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -47.2 -43.42 21.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.849 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . 0.425 ' N ' ' O ' ' A' ' 201' ' ' HIS . . . -57.77 -55.14 38.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.095 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 3.8 tp60 -50.23 -43.35 52.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.907 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -56.59 -57.64 11.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.107 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -56.87 -35.44 68.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.144 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . 0.496 ' O ' ' N ' ' A' ' 212' ' ' HIS . 78.2 mt -59.72 -75.12 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.107 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -47.39 -42.49 22.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.862 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -56.05 -43.46 77.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.119 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 33.0 mt -99.96 -69.08 0.78 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.922 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 212' ' ' HIS . . . . . 0.496 ' N ' ' O ' ' A' ' 208' ' ' ILE . 1.7 t60 -49.7 131.15 21.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.854 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 72.31 1.95 52.48 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.475 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 6.2 t -94.53 -71.29 0.67 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.814 0.34 . . . . 0.0 110.863 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 17.3 pm0 -100.33 175.75 5.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.895 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 216' ' ' THR . . . . . 0.442 ' O ' ' C ' ' A' ' 217' ' ' MET . 4.6 m -134.97 97.87 3.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.159 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 217' ' ' MET . . . . . 0.442 ' C ' ' O ' ' A' ' 216' ' ' THR . 12.4 mmt -34.56 133.18 0.42 Allowed Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.6 0.715 . . . . 0.0 110.868 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -49.01 119.52 4.48 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.68 2.254 . . . . 0.0 112.383 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 112.27 -50.82 0.74 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.516 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -73.03 152.84 41.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.821 0.343 . . . . 0.0 111.093 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 3.6 t -96.69 -19.51 18.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.869 -179.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 1.3 p -99.47 134.85 41.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.865 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 223' ' ' SER . . . . . 0.436 ' O ' ' C ' ' A' ' 224' ' ' LEU . 3.5 m -58.02 151.23 18.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.859 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . 0.447 ' O ' ' ND1' ' A' ' 212' ' ' HIS . 21.7 tp -35.57 141.76 0.08 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.933 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 90.8 t -114.77 109.2 27.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.146 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 6.3 t -132.01 105.96 10.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.134 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 11.0 pttp -121.34 -179.1 3.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.871 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 228' ' ' PHE . . . . . 0.472 ' CD1' HD21 ' A' ' 153' ' ' LEU . 60.2 m-85 . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.826 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 11.4 tttp . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.829 0.347 . . . . 0.0 110.928 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 73.4 mt -133.75 129.82 37.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.861 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -97.38 116.44 29.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.902 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 47.8 t -110.27 135.46 49.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.134 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -134.31 -156.55 7.88 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.49 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 10.9 mmt 39.49 33.36 0.11 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.819 0.343 . . . . 0.0 110.852 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.408 ' HB2' ' C ' ' A' ' 192' ' ' GLY . 63.9 mt -85.03 169.4 14.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.935 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.459 ' ND2' ' HD2' ' A' ' 218' ' ' PRO . 7.4 p30 -103.44 163.55 12.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.892 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 29.4 mttt -97.96 23.08 8.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.907 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 2.3 tp-100 -109.85 -46.57 3.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.892 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 19.5 mt-30 -65.7 172.24 3.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.908 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 66.7 m -139.69 -177.44 4.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.905 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -59.07 -37.72 77.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.909 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -59.74 -50.82 72.33 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.868 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 39.6 m-20 -58.69 -56.55 20.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.876 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.558 HG11 ' CD1' ' A' ' 171' ' ' PHE . 19.5 t -63.09 -28.29 44.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.08 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 41.7 ttm-85 -63.76 -56.25 16.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.852 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 70.7 mtm180 -62.29 -55.11 31.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.912 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.506 ' O ' ' CB ' ' A' ' 173' ' ' ALA . 9.1 tp -43.38 -65.15 0.52 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.913 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . 0.558 ' CD1' HG11 ' A' ' 167' ' ' VAL . 8.5 m-85 -50.78 -69.29 0.12 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.874 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -46.3 -26.48 0.82 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.877 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.506 ' CB ' ' O ' ' A' ' 170' ' ' LEU . . . -49.36 -19.45 0.52 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.063 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -113.48 -74.68 0.62 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.883 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -107.5 151.56 16.92 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.492 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 46.6 m-80 -62.31 132.71 53.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.797 0.332 . . . . 0.0 110.927 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 84.2 mt -92.25 138.99 18.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.123 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -100.35 -30.48 11.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.915 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -164.54 142.0 6.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.888 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 1.8 m -137.21 138.24 39.96 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.911 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 60.4 m -151.12 132.82 14.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.146 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 44.5 mm -98.52 143.24 13.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.132 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . 0.512 HD11 ' CE2' ' A' ' 195' ' ' PHE . 52.7 mt . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.896 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 30.7 t . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.916 0.389 . . . . 0.0 110.858 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 63.6 mttt -94.04 37.59 1.09 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.913 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.408 ' C ' ' HB2' ' A' ' 158' ' ' LEU . . . 43.32 40.99 4.89 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.497 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 4.4 p -150.03 151.48 33.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.798 0.333 . . . . 0.0 110.941 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -160.62 150.96 18.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.069 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 195' ' ' PHE . . . . . 0.512 ' CE2' HD11 ' A' ' 183' ' ' LEU . 50.2 m-85 -108.72 116.3 31.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.914 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.432 HG12 ' CD2' ' A' ' 171' ' ' PHE . 38.8 t -110.04 146.97 14.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.122 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 34.4 tttp -127.1 160.26 31.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.876 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -137.65 164.79 27.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.909 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 41.2 t -71.61 -39.38 70.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.851 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 2.4 t -136.02 171.78 13.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.818 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . 0.408 ' O ' ' C ' ' A' ' 202' ' ' ALA . 40.1 t-80 -69.4 -57.05 5.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.855 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . 0.408 ' C ' ' O ' ' A' ' 201' ' ' HIS . . . -36.75 -61.39 0.54 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.148 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -47.53 -50.58 23.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.865 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -51.43 -57.59 8.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.073 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . 0.511 ' C ' ' CD ' ' A' ' 205' ' ' GLN . 0.0 OUTLIER -47.67 -68.13 0.21 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.887 -179.898 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . 0.407 ' C ' ' O ' ' A' ' 205' ' ' GLN . . . -37.02 -51.82 0.95 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.106 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -59.72 -43.23 94.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.105 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . 0.489 ' O ' ' N ' ' A' ' 212' ' ' HIS . 82.5 mt -56.23 -70.28 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.078 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -54.12 -40.29 67.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.827 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -56.03 -34.07 65.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.122 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 57.8 mt -112.35 -70.83 0.79 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.901 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 212' ' ' HIS . . . . . 0.489 ' N ' ' O ' ' A' ' 208' ' ' ILE . 2.9 t60 -44.28 126.77 5.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.868 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 82.15 -28.1 3.4 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.507 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 25.7 m -90.15 -67.26 0.86 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.819 0.342 . . . . 0.0 110.88 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 215' ' ' GLN . . . . . 0.411 ' HG3' ' N ' ' A' ' 216' ' ' THR . 1.2 tp-100 -83.3 143.43 30.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.921 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 216' ' ' THR . . . . . 0.411 ' N ' ' HG3' ' A' ' 215' ' ' GLN . 24.3 m -120.15 100.0 6.93 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.158 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 217' ' ' MET . . . . . 0.402 ' C ' ' O ' ' A' ' 216' ' ' THR . 13.6 mmt -37.37 132.65 0.78 Allowed Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.596 0.713 . . . . 0.0 110.907 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . 0.459 ' HD2' ' ND2' ' A' ' 159' ' ' ASN . 75.2 Cg_exo -48.55 122.42 7.83 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.65 2.233 . . . . 0.0 112.32 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 112.54 -52.29 0.65 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.51 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -68.79 150.49 47.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.826 0.346 . . . . 0.0 111.069 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 88.1 p -96.33 -18.36 20.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.903 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 1.4 t -100.08 146.96 26.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.852 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 73.0 m -58.9 155.83 12.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.887 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . 0.446 ' O ' ' ND1' ' A' ' 212' ' ' HIS . 32.4 tp -49.35 156.09 0.64 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.979 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . 0.403 ' N ' ' HG ' ' A' ' 224' ' ' LEU . 57.9 t -127.57 108.17 17.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.124 179.822 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 41.2 t -135.03 101.63 3.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.126 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 19.5 pttt -119.01 170.34 9.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.876 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.942 179.928 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.447 ' HD3' ' CD1' ' A' ' 195' ' ' PHE . 5.7 tttp . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.825 0.345 . . . . 0.0 110.898 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 36.6 mt -130.09 125.11 34.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.9 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -96.73 113.85 25.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.863 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 22.2 t -104.46 127.65 58.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.135 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . 0.474 ' O ' ' N ' ' A' ' 158' ' ' LEU . . . -128.63 -154.01 8.19 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.434 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' MET . . . . . 0.442 ' C ' ' O ' ' A' ' 156' ' ' GLY . 31.0 mtt 34.66 34.15 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.776 0.322 . . . . 0.0 110.868 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.474 ' N ' ' O ' ' A' ' 156' ' ' GLY . 58.5 mt -83.24 174.79 10.44 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.927 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.439 ' ND2' ' H ' ' A' ' 162' ' ' GLN . 3.2 p-10 -104.77 150.17 25.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.906 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 39.3 mttp -85.39 32.5 0.56 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.875 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -120.32 -54.38 2.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.925 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . 0.439 ' H ' ' ND2' ' A' ' 159' ' ' ASN . 3.6 pt20 -56.48 156.78 5.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.919 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 23.0 m -128.13 -177.1 4.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.864 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -51.54 -41.47 61.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.861 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -57.98 -59.29 5.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.863 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -48.73 -61.03 2.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.858 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.554 HG12 ' CD1' ' A' ' 171' ' ' PHE . 91.9 t -55.14 -45.06 77.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.136 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 33.3 mtp180 -51.62 -58.31 6.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.862 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 47.8 mtp180 -62.73 -54.56 37.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.886 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.518 ' O ' ' CB ' ' A' ' 173' ' ' ALA . 11.0 tp -44.14 -65.06 0.56 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.9 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . 0.554 ' CD1' HG12 ' A' ' 167' ' ' VAL . 13.2 m-85 -50.6 -68.36 0.18 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.845 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -47.31 -23.52 0.58 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.849 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.518 ' CB ' ' O ' ' A' ' 170' ' ' LEU . . . -54.19 -14.45 1.13 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.065 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -123.12 -69.01 0.85 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.872 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -113.57 148.05 18.64 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.499 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 35.4 m120 -55.96 153.86 8.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.801 0.334 . . . . 0.0 110.916 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . 0.454 HG23 ' N ' ' A' ' 178' ' ' GLU . 73.8 mt -118.31 151.51 20.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.162 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . 0.454 ' N ' HG23 ' A' ' 177' ' ' ILE . 6.3 mm-40 -108.85 -39.87 5.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.919 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -164.99 131.93 2.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.933 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 42.3 t -120.78 139.29 53.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.876 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 53.3 m -147.75 129.99 15.59 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.162 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 17.4 mm -93.48 130.32 42.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.146 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . 0.561 HD13 ' CE2' ' A' ' 195' ' ' PHE . 77.7 mt . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.945 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 3.3 t . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.987 0.423 . . . . 0.0 110.818 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 10.3 pttp -121.86 29.02 7.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.932 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 57.48 47.31 89.13 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.522 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 24.1 m -152.03 141.92 22.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.842 0.353 . . . . 0.0 110.896 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -162.06 157.9 24.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.095 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 195' ' ' PHE . . . . . 0.561 ' CE2' HD13 ' A' ' 183' ' ' LEU . 21.1 m-85 -110.82 124.8 52.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.882 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 94.3 t -122.24 139.29 49.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.125 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 41.3 mttm -116.2 144.76 43.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.898 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -119.28 174.72 6.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.91 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 46.6 p -74.5 -52.52 11.71 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.884 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 32.9 p -137.07 -175.72 4.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.874 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -71.46 -53.85 12.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.885 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -40.76 -62.53 0.78 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.136 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -47.42 -41.72 20.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.884 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -59.27 -56.23 24.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.102 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -47.85 -41.81 24.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.933 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -61.39 -51.91 66.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.118 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -61.84 -23.8 66.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.104 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . 0.499 ' O ' ' N ' ' A' ' 212' ' ' HIS . 53.5 mt -71.92 -71.57 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.15 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -54.89 -38.91 68.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.905 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -58.35 -50.74 72.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.12 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 30.7 mt -99.93 -67.56 0.85 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.93 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 212' ' ' HIS . . . . . 0.574 ' CE1' ' HA ' ' A' ' 225' ' ' VAL . 1.5 t60 -49.83 132.77 22.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.863 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 70.12 -2.12 15.27 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.5 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -96.38 -71.36 0.68 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.822 0.344 . . . . 0.0 110.876 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -100.27 166.98 10.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.934 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 216' ' ' THR . . . . . 0.415 ' O ' ' C ' ' A' ' 217' ' ' MET . 24.4 m -127.38 94.03 3.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.152 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 217' ' ' MET . . . . . 0.415 ' C ' ' O ' ' A' ' 216' ' ' THR . 17.8 mmt -36.39 136.18 0.55 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.579 0.704 . . . . 0.0 110.843 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -49.24 138.21 29.47 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.634 2.223 . . . . 0.0 112.366 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 100.07 -45.22 1.51 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.505 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -86.31 142.04 28.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.815 0.341 . . . . 0.0 111.095 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 13.9 m -93.49 -12.88 28.67 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.834 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 3.9 m -100.11 143.09 30.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.88 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 71.3 m -56.04 148.43 17.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.8 -179.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . 0.449 ' O ' ' ND1' ' A' ' 212' ' ' HIS . 51.3 tp -38.31 158.08 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.893 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . 0.574 ' HA ' ' CE1' ' A' ' 212' ' ' HIS . 61.7 t -130.4 105.76 11.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.114 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . 0.407 ' H ' ' CD2' ' A' ' 212' ' ' HIS . 21.5 t -134.04 101.46 3.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.146 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . 0.448 ' HE2' ' CG1' ' A' ' 225' ' ' VAL . 0.7 OUTLIER -130.38 145.29 51.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.896 179.883 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.929 179.958 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.363 0 N-CA-C 112.512 -0.235 . . . . 0.0 112.512 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 3.6 m 44.7 47.85 8.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.823 0.344 . . . . 0.0 110.838 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 7.3 t -107.12 127.98 53.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.902 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 96.98 99.27 1.95 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.475 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 71.4 p -86.96 -44.43 11.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.896 0.379 . . . . 0.0 110.862 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 81.1 p 45.08 36.95 2.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.898 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -153.97 92.22 0.13 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.494 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 8.5 t -108.04 108.37 19.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.898 0.38 . . . . 0.0 110.892 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.447 ' N ' ' CD2' ' A' ' 144' ' ' LEU . 1.5 pt? -153.03 149.55 28.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.905 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.414 ' C ' ' O ' ' A' ' 144' ' ' LEU . 23.7 mtp85 37.21 35.83 0.06 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.889 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 2.2 pm0 -48.59 143.91 7.29 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.65 0.738 . . . . 0.0 110.901 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -46.6 157.59 0.47 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.696 2.264 . . . . 0.0 112.359 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -77.31 -174.09 2.06 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.694 2.263 . . . . 0.0 112.371 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 94.5 p -124.97 96.36 4.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.873 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . 0.538 ' CD2' ' O ' ' A' ' 150' ' ' HIS . 7.8 p-80 -171.4 129.06 0.69 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.872 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 16.9 mtp180 -112.23 41.83 1.91 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.905 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.536 ' HD3' ' CD1' ' A' ' 195' ' ' PHE . 20.5 ttmt -128.81 156.63 43.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.886 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.541 HD23 ' CD1' ' A' ' 228' ' ' PHE . 24.6 mt -142.83 126.49 16.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.898 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -90.92 116.69 28.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.874 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 4.8 t -110.43 134.55 52.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.098 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -135.13 -156.27 7.63 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.511 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 10.1 mmt 45.31 35.44 1.83 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.785 0.326 . . . . 0.0 110.894 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 77.5 mt -93.67 167.94 11.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.897 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -101.38 154.77 18.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.892 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 86.7 mttt -84.13 41.34 0.81 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.875 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 -127.8 -48.81 1.37 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.897 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -55.33 163.91 1.08 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.879 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 3.8 t -131.33 165.8 22.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.905 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -45.08 -44.36 10.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.917 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.418 ' O ' ' N ' ' A' ' 168' ' ' ARG . 0.1 OUTLIER -57.71 -62.42 1.81 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.861 179.976 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -41.25 -52.29 3.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.889 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.556 HG13 ' CD1' ' A' ' 171' ' ' PHE . 30.0 t -66.95 -28.64 43.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.095 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . 0.418 ' N ' ' O ' ' A' ' 165' ' ' ASP . 18.9 ttt180 -61.88 -64.13 1.03 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.834 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 7.5 mmm180 -59.72 -54.22 48.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.875 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.501 ' O ' ' CB ' ' A' ' 173' ' ' ALA . 9.3 tp -42.08 -66.31 0.37 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.948 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.556 ' CD1' HG13 ' A' ' 167' ' ' VAL . 9.1 m-85 -53.37 -72.21 0.06 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.884 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -40.96 -30.29 0.13 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.842 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.501 ' CB ' ' O ' ' A' ' 170' ' ' LEU . . . -40.11 -30.4 0.09 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.128 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -105.42 -74.34 0.65 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.869 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -105.54 137.92 13.99 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.464 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -48.49 153.34 0.78 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.817 0.342 . . . . 0.0 110.857 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . 0.44 HG22 ' N ' ' A' ' 178' ' ' GLU . 81.5 mt -121.28 138.61 51.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.102 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . 0.44 ' N ' HG22 ' A' ' 177' ' ' ILE . 17.9 mm-40 -88.11 -49.01 7.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.943 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -150.97 160.08 44.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.949 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 41.9 t -145.68 135.16 23.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.851 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 95.4 m -146.99 110.38 4.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.139 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 21.3 mm -71.73 138.94 20.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.129 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 34.9 mt -90.35 132.82 35.36 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.876 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' ARG . . . . . 0.415 ' NH1' ' HB2' ' A' ' 184' ' ' ARG . 28.2 mtm105 -136.58 106.76 6.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.844 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -52.68 160.7 2.8 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.493 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -45.59 -38.95 17.23 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.659 2.24 . . . . 0.0 112.342 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -50.99 -40.98 59.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.861 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 121.52 -40.63 2.06 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.494 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . 0.407 ' O ' ' C ' ' A' ' 190' ' ' SER . 5.5 p30 -74.46 125.56 28.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.849 0.356 . . . . 0.0 110.877 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' SER . . . . . 0.407 ' C ' ' O ' ' A' ' 189' ' ' ASN . 18.7 t -36.59 137.75 0.27 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.84 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 39.0 mttt -92.57 16.56 11.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.893 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 65.69 43.53 94.1 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.451 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -154.67 155.74 35.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.809 0.338 . . . . 0.0 110.917 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -162.5 155.61 19.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.116 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . 0.536 ' CD1' ' HD3' ' A' ' 152' ' ' LYS . 38.5 m-85 -107.84 119.01 38.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.923 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 46.8 t -122.28 138.55 52.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.122 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.62 160.53 18.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.923 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -131.55 173.13 11.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.922 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 45.0 t -73.61 -44.83 56.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.895 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 1.4 t -143.15 179.92 6.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.835 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . 0.441 ' O ' ' C ' ' A' ' 202' ' ' ALA . 10.7 t-80 -67.18 -61.59 1.85 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.871 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . 0.441 ' C ' ' O ' ' A' ' 201' ' ' HIS . . . -34.24 -62.77 0.31 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.097 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -49.1 -46.88 45.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.905 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -51.64 -56.97 10.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.1 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 62.1 tp60 -53.21 -45.34 68.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.902 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -49.11 -53.32 21.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.064 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -64.29 -40.28 95.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.113 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . 0.499 ' O ' ' N ' ' A' ' 212' ' ' HIS . 71.5 mt -55.95 -66.08 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.137 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 12.9 t30 -59.77 -37.83 80.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.86 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -69.07 -21.7 64.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.128 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . 0.453 ' HB3' ' CD2' ' A' ' 224' ' ' LEU . 85.0 mt -113.88 -74.36 0.62 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.907 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' HIS . . . . . 0.499 ' N ' ' O ' ' A' ' 208' ' ' ILE . 17.8 t60 -51.82 126.55 18.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.835 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 84.11 -6.81 73.89 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.508 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 33.2 t -88.55 -73.82 0.48 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.8 0.333 . . . . 0.0 110.889 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -99.69 -178.31 3.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.896 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 25.3 m -134.31 102.7 5.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.192 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 30.2 mmt -39.99 137.66 1.17 Allowed Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.602 0.715 . . . . 0.0 110.865 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -48.75 124.94 11.88 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.679 2.253 . . . . 0.0 112.35 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 103.64 -47.46 1.1 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.48 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -75.64 145.9 40.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.779 0.323 . . . . 0.0 111.087 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 4.5 t -93.24 -16.34 24.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.856 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 5.5 m -100.05 141.15 33.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.81 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 73.1 m -54.95 155.19 4.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.823 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . 0.453 ' CD2' ' HB3' ' A' ' 211' ' ' LEU . 55.8 tp -43.24 148.57 0.28 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.919 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 0.41 ' HA ' ' ND1' ' A' ' 212' ' ' HIS . 88.2 t -118.81 113.05 40.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.099 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 22.0 t -136.25 110.28 9.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.161 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 19.2 pttp -130.25 162.45 28.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.86 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' PHE . . . . . 0.541 ' CD1' HD23 ' A' ' 153' ' ' LEU . 49.0 m-85 -62.51 116.16 4.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.899 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -66.87 134.2 51.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.12 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -88.71 163.2 15.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.879 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 43.7 m -118.57 -44.19 2.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.16 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -100.71 87.64 3.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.871 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -98.8 -59.42 1.74 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.922 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -63.99 -53.0 56.95 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.868 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 2.3 m -58.7 169.92 0.88 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.868 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 164.83 166.22 23.42 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.458 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . 0.441 ' O ' ' C ' ' A' ' 238' ' ' SER . 62.2 Cg_endo -76.99 7.35 3.67 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.674 2.25 . . . . 0.0 112.349 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' SER . . . . . 0.441 ' C ' ' O ' ' A' ' 237' ' ' PRO . 66.3 m -35.2 134.7 0.26 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.882 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 16.2 t -65.88 89.87 0.12 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.851 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.31 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.482 -179.997 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.418 ' O ' ' C ' ' A' ' 137' ' ' SER . . . . . . . . 0 N--CA 1.451 -0.321 0 N-CA-C 112.477 -0.249 . . . . 0.0 112.477 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.418 ' C ' ' O ' ' A' ' 136' ' ' GLY . 15.2 m 35.81 42.33 0.14 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.874 0.368 . . . . 0.0 110.827 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 6.2 t -82.4 -61.55 1.86 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.862 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 151.99 83.29 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.507 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 59.9 p -164.82 149.14 9.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.82 0.343 . . . . 0.0 110.887 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 58.7 m -42.46 -55.57 3.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.835 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 111.81 -140.5 16.19 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.485 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 86.3 m -108.83 122.01 46.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.837 0.351 . . . . 0.0 110.902 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -98.57 -44.57 6.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.899 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.425 ' C ' ' HD3' ' A' ' 145' ' ' ARG . 0.1 OUTLIER -43.65 155.03 0.08 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.889 179.928 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 45.0 mm-40 -110.56 97.09 30.73 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.607 0.718 . . . . 0.0 110.929 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -75.4 153.24 39.79 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.701 2.267 . . . . 0.0 112.321 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -76.57 168.96 22.76 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.7 2.267 . . . . 0.0 112.355 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 23.8 p -125.27 95.15 4.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.863 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -98.24 102.45 14.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.847 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 67.2 mmt-85 -61.77 -35.96 79.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.869 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 5.4 ttpm? -93.78 148.83 21.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.901 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 47.8 mt -128.59 136.16 50.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.919 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -94.5 131.5 40.14 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.898 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 92.9 t -123.7 129.5 74.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.169 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -125.78 -159.31 10.25 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.478 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER 44.16 30.23 0.42 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.816 0.341 . . . . 0.0 110.918 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 73.3 mt -88.75 157.19 18.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.905 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -101.05 160.46 14.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.843 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 47.2 mttt -83.97 37.54 0.61 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.895 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 55.9 tp60 -123.29 -46.47 2.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.921 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -55.71 151.11 11.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.922 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 3.7 t -126.5 166.26 17.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.879 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -44.37 -47.68 9.72 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.897 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -57.91 -57.04 14.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.876 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 -43.44 -57.04 3.27 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.884 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.57 HG11 ' CE1' ' A' ' 171' ' ' PHE . 61.7 t -61.73 -48.45 88.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.113 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 57.7 mtt180 -41.29 -68.55 0.18 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.87 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 87.6 mtt-85 -58.35 -53.66 55.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.84 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.5 ' O ' ' CB ' ' A' ' 173' ' ' ALA . 12.8 tp -41.07 -66.7 0.31 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.883 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.57 ' CE1' HG11 ' A' ' 167' ' ' VAL . 9.8 m-85 -56.02 -73.3 0.06 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.867 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.454 ' O ' ' N ' ' A' ' 174' ' ' PHE . 0.9 OUTLIER -39.18 -27.78 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.924 -179.94 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.5 ' CB ' ' O ' ' A' ' 170' ' ' LEU . . . -40.66 -25.18 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.1 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . 0.461 ' CZ ' ' HB2' ' A' ' 210' ' ' ALA . 95.6 m-85 -106.69 -70.73 0.78 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.877 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -102.14 -163.46 26.62 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.506 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 35.3 m120 -96.9 160.93 14.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.804 0.335 . . . . 0.0 110.865 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 13.0 mt -128.43 151.28 35.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.119 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 46.9 mm-40 -115.51 -42.54 3.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.915 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -155.18 149.61 26.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.899 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 40.6 t -137.98 143.98 40.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.879 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' THR . . . . . 0.405 HG21 ' N ' ' A' ' 182' ' ' ILE . 56.5 m -150.12 149.15 29.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.148 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.405 ' N ' HG21 ' A' ' 181' ' ' THR . 13.3 mm -115.45 126.13 72.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.128 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 78.6 mt -72.31 139.95 48.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.896 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' ARG . . . . . 0.413 ' NH1' ' HB2' ' A' ' 184' ' ' ARG . 28.0 mtm105 -146.46 125.91 13.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.865 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -58.76 -167.08 0.16 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.516 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -77.07 -47.07 0.13 Allowed 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.706 2.271 . . . . 0.0 112.33 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -45.81 -42.91 12.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.884 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 120.36 42.5 0.5 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.508 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -142.28 158.42 43.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.833 0.349 . . . . 0.0 110.891 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 53.3 p -75.21 126.72 31.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.871 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 26.5 mtpt -85.01 26.66 0.83 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.881 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 61.01 31.75 77.73 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.533 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 52.3 m -143.8 150.74 38.99 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.836 0.351 . . . . 0.0 110.894 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -155.52 172.09 18.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.087 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -128.43 130.4 47.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.879 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 48.6 t -127.8 132.96 68.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.126 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 29.2 mttp -104.53 150.03 24.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.869 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . 0.447 ' OH ' ' CB ' ' A' ' 207' ' ' ALA . 3.3 m-85 -123.03 175.36 6.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.949 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 58.0 m -86.36 -34.9 20.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.864 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 75.4 m -147.06 -179.86 7.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.867 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . 0.435 ' O ' ' C ' ' A' ' 202' ' ' ALA . 67.8 t60 -73.42 -63.96 1.09 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.896 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 201' ' ' HIS . . . -34.49 -61.44 0.39 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.05 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -48.47 -44.15 35.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.834 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . 0.411 ' N ' ' O ' ' A' ' 201' ' ' HIS . . . -60.16 -56.14 25.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.119 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 33.0 tp60 -50.66 -46.13 58.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.89 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -54.84 -49.6 70.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.055 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . 0.447 ' CB ' ' OH ' ' A' ' 198' ' ' TYR . . . -63.76 -26.59 68.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.106 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . 0.484 ' O ' ' N ' ' A' ' 212' ' ' HIS . 60.3 mt -70.74 -64.24 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.181 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -58.48 -39.16 79.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.895 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' ALA . . . . . 0.461 ' HB2' ' CZ ' ' A' ' 174' ' ' PHE . . . -66.99 -35.11 79.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.079 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 86.5 mt -102.5 -74.54 0.63 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.94 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' HIS . . . . . 0.484 ' N ' ' O ' ' A' ' 208' ' ' ILE . 33.9 t60 -49.18 134.07 18.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.861 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 70.06 -0.61 21.91 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.531 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -93.34 -71.01 0.67 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.747 0.308 . . . . 0.0 110.863 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -100.05 -178.44 3.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.916 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 7.6 m -136.97 110.3 7.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.139 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -39.26 160.05 0.1 OUTLIER Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.519 0.676 . . . . 0.0 110.915 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.32 103.0 1.54 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.637 2.224 . . . . 0.0 112.367 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 122.47 -49.77 0.87 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.501 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -65.24 150.38 48.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.796 0.331 . . . . 0.0 111.091 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 9.5 m -95.33 -17.38 21.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.848 -179.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 1.1 t -99.82 146.14 26.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.874 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -61.65 152.99 29.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.89 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 59.4 tp -38.71 152.92 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.907 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 0.409 ' HA ' ' ND1' ' A' ' 212' ' ' HIS . 86.5 t -125.1 104.4 13.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.124 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 8.8 t -128.4 103.06 9.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.121 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 7.6 ptmt -120.76 167.34 12.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.882 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -71.78 143.46 49.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.887 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -88.19 112.58 22.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.143 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . 0.436 ' O ' ' N ' ' A' ' 232' ' ' ASP . 5.8 t70 -82.41 46.07 1.01 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.88 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' THR . . . . . 0.422 ' C ' ' O ' ' A' ' 230' ' ' ASP . 9.2 t 36.3 32.81 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.119 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . 0.436 ' N ' ' O ' ' A' ' 230' ' ' ASP . 40.7 m-20 -110.06 42.57 1.5 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.862 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 21.4 tttm -44.17 -54.19 5.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.946 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . 0.49 ' C ' ' CD ' ' A' ' 234' ' ' GLU . 0.5 OUTLIER -82.74 161.95 21.9 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.874 179.933 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.8 t -111.06 -62.81 1.49 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.841 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -145.72 164.79 28.1 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.484 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -77.1 139.82 19.43 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.671 2.247 . . . . 0.0 112.328 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 4.7 t -63.52 -54.91 28.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.858 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 36.5 m -93.25 136.29 33.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.862 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.498 -179.975 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.372 0 N-CA-C 112.462 -0.255 . . . . 0.0 112.462 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 3.7 t -98.19 -62.13 1.29 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.884 0.373 . . . . 0.0 110.835 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 12.7 t -70.72 -50.21 38.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.841 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 88.89 73.08 1.28 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.472 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 32.1 p -60.77 109.89 1.17 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.851 0.358 . . . . 0.0 110.861 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 63.1 m -132.77 146.44 51.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.88 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 151.29 66.1 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.471 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 31.8 p -107.78 127.32 53.6 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.907 0.384 . . . . 0.0 110.826 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 11.4 mt -111.63 97.8 6.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.963 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 10.8 tpt180 -165.77 123.76 1.53 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.86 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -81.9 146.62 56.26 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.596 0.712 . . . . 0.0 110.925 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -77.42 152.42 30.17 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.694 2.263 . . . . 0.0 112.347 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -46.34 170.72 0.04 OUTLIER 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.676 2.251 . . . . 0.0 112.375 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 6.6 t -55.98 -54.0 50.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.87 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 28.0 p-80 -90.06 128.98 36.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.864 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 4.2 mpt_? -103.84 82.28 1.97 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.864 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 20.3 tttt -105.41 151.78 23.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.871 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 32.0 mt -127.08 124.99 40.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.916 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -92.82 110.8 22.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.858 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 39.4 t -104.64 127.55 58.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.111 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . 0.422 ' O ' ' N ' ' A' ' 158' ' ' LEU . . . -125.68 -152.22 8.13 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.505 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER 38.59 30.5 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.855 0.36 . . . . 0.0 110.87 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.422 ' N ' ' O ' ' A' ' 156' ' ' GLY . 61.4 mt -83.93 166.14 18.09 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.893 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -100.31 158.41 15.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.896 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 34.9 mttm -88.16 33.46 0.74 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.908 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -123.84 -52.22 1.79 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.907 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -51.54 155.54 1.53 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.905 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 4.3 m -131.03 174.79 9.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.862 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -50.37 -42.58 53.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.92 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -59.3 -54.58 45.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.898 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -48.73 -64.24 0.86 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.845 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.536 HG13 ' CD1' ' A' ' 171' ' ' PHE . 90.0 t -55.71 -50.41 67.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.099 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . 0.42 ' C ' ' O ' ' A' ' 167' ' ' VAL . 20.5 ttm-85 -36.88 -63.73 0.4 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.872 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 21.4 mtp85 -64.19 -51.48 63.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.907 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.51 ' O ' ' CB ' ' A' ' 173' ' ' ALA . 13.3 tp -43.72 -65.6 0.48 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.909 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.536 ' CD1' HG13 ' A' ' 167' ' ' VAL . 6.2 m-85 -55.83 -68.1 0.23 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.853 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -45.3 -21.82 0.1 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.878 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.51 ' CB ' ' O ' ' A' ' 170' ' ' LEU . . . -49.21 -19.05 0.41 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.091 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -112.52 -73.93 0.65 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.875 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . 0.429 ' CA ' ' OE1' ' A' ' 203' ' ' GLU . . . -110.89 154.32 16.7 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.467 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -57.63 149.37 21.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.821 0.343 . . . . 0.0 110.895 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . 0.438 HG22 ' N ' ' A' ' 178' ' ' GLU . 46.1 mt -111.34 147.84 15.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.152 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . 0.459 ' OE1' ' N ' ' A' ' 178' ' ' GLU . 0.5 OUTLIER -102.89 -40.57 6.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.934 179.94 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -160.44 149.41 17.06 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.901 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 25.2 t -136.47 140.48 43.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.895 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 30.5 m -149.74 142.61 24.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.183 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 33.6 mm -107.29 121.95 60.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.157 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.54 HD11 ' CE2' ' A' ' 195' ' ' PHE . 30.6 mt -72.36 140.11 48.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.887 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 46.7 mtt85 -141.81 147.32 37.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.882 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -83.0 -164.81 36.46 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.508 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -77.01 -40.9 0.42 Allowed 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.676 2.251 . . . . 0.0 112.313 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -57.24 -41.51 79.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.856 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 134.1 -44.25 1.2 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.755 -0.735 . . . . 0.0 112.46 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 64.2 m-20 -53.03 167.8 0.15 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.815 0.341 . . . . 0.0 110.918 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 18.1 p -82.78 142.93 31.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.87 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 3.1 mmmm -94.19 33.59 1.35 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.867 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.402 ' C ' ' HB2' ' A' ' 158' ' ' LEU . . . 44.24 32.54 2.61 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.484 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 75.8 m -141.6 151.24 42.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.828 0.347 . . . . 0.0 110.881 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -158.88 161.32 36.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.145 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . 0.54 ' CE2' HD11 ' A' ' 183' ' ' LEU . 47.9 m-85 -118.05 135.92 53.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.9 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 64.7 t -133.2 145.96 33.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.122 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 42.6 mtpt -122.44 142.83 50.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.937 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -117.8 175.22 5.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.867 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 51.1 p -80.1 -44.25 20.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.815 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 2.7 m -133.95 -177.62 4.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.799 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 20.7 t60 -80.19 -57.1 3.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.879 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -37.99 -56.79 1.11 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.129 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . 0.429 ' OE1' ' CA ' ' A' ' 175' ' ' GLY . 31.3 mm-40 -54.63 -43.24 72.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.853 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -56.46 -55.78 29.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.079 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 53.1 tp60 -50.88 -41.95 58.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.92 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -57.7 -51.9 67.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.109 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -63.28 -26.49 68.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.072 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . 0.495 ' O ' ' N ' ' A' ' 212' ' ' HIS . 50.4 mt -69.15 -73.27 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.103 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . 0.459 ' N ' HG23 ' A' ' 208' ' ' ILE . 34.2 t30 -48.89 -42.72 37.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.843 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' ALA . . . . . 0.468 ' O ' ' CB ' ' A' ' 214' ' ' SER . . . -54.27 -45.31 72.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.101 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . 0.447 ' CB ' HD23 ' A' ' 224' ' ' LEU . 18.8 mt -100.51 -69.21 0.78 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.902 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' HIS . . . . . 0.495 ' N ' ' O ' ' A' ' 208' ' ' ILE . 27.2 t60 -53.95 124.24 14.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.878 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . 0.468 ' CA ' ' HB3' ' A' ' 223' ' ' SER . . . 81.24 -14.68 26.94 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.512 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' SER . . . . . 0.468 ' CB ' ' O ' ' A' ' 210' ' ' ALA . 1.9 m -85.94 -72.38 0.5 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.818 0.342 . . . . 0.0 110.838 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 59.7 mt-30 -99.13 169.54 9.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.898 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' THR . . . . . 0.423 HG23 ' C ' ' A' ' 222' ' ' SER . 3.0 m -118.78 97.61 5.8 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.148 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 13.2 mmt -38.74 138.81 0.76 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.556 0.693 . . . . 0.0 110.865 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -48.47 126.67 14.5 Favored 'Trans proline' 0 C--N 1.34 0.131 0 C-N-CA 122.685 2.256 . . . . 0.0 112.344 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 102.45 -53.42 0.78 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.503 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -70.65 150.08 46.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.781 0.324 . . . . 0.0 111.099 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 31.1 t -95.92 -18.19 20.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.826 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' SER . . . . . 0.423 ' C ' HG23 ' A' ' 216' ' ' THR . 3.5 m -99.91 151.22 21.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.874 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' SER . . . . . 0.468 ' HB3' ' CA ' ' A' ' 213' ' ' GLY . 17.4 m -59.58 145.36 44.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.844 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . 0.448 ' C ' ' O ' ' A' ' 223' ' ' SER . 48.2 tp -34.61 148.8 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.918 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 64.9 t -117.13 106.71 20.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.142 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 24.6 t -133.39 106.29 9.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.142 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 9.0 ptmt -125.03 174.39 8.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.906 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -80.87 126.46 31.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.884 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . 0.409 ' C ' ' OD1' ' A' ' 230' ' ' ASP . . . -88.86 140.36 29.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.102 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . 0.409 ' OD1' ' C ' ' A' ' 229' ' ' ALA . 1.0 OUTLIER -144.15 143.83 31.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.867 179.999 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 77.1 m -89.9 120.11 30.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.144 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -62.74 143.51 57.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.894 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 2.9 tppp? -144.17 112.55 6.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.929 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -132.11 145.05 51.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.861 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 26.1 p -157.02 173.7 16.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.875 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 105.21 -173.44 20.55 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.461 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -77.01 -45.64 0.16 Allowed 'Trans proline' 0 C--O 1.231 0.135 0 C-N-CA 122.715 2.276 . . . . 0.0 112.387 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 1.8 t -141.35 171.31 14.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.862 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 30.7 m -57.3 112.91 1.53 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.847 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.297 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.464 -179.994 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.287 0 N-CA-C 112.481 -0.248 . . . . 0.0 112.481 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 42.7 t -153.9 114.65 4.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.889 0.376 . . . . 0.0 110.87 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 28.9 t -128.17 124.5 36.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.876 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -160.03 101.69 0.2 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.474 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 12.4 t -156.01 138.15 14.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.894 0.378 . . . . 0.0 110.842 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 7.6 t -132.47 165.55 24.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.839 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -156.99 73.84 0.23 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.495 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 51.5 m -97.21 167.49 11.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.814 0.34 . . . . 0.0 110.939 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 80.9 mt -94.97 -56.71 2.66 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.93 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 33.7 ptt-85 -48.42 132.17 16.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.875 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -116.1 91.96 33.77 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.591 0.71 . . . . 0.0 110.929 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -45.77 163.74 0.09 OUTLIER 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.659 2.24 . . . . 0.0 112.356 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -45.64 171.86 0.02 OUTLIER 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.655 2.237 . . . . 0.0 112.409 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 3.9 m -87.99 50.32 1.96 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.864 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 34.2 m80 -124.86 143.43 50.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.881 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 64.8 mtm-85 -124.05 44.17 2.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.878 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 3.6 ttmp? -129.85 149.51 51.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.922 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.536 HD23 ' CD1' ' A' ' 228' ' ' PHE . 64.6 mt -123.47 124.01 41.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.902 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -94.24 110.47 22.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.885 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 21.2 t -104.19 120.62 54.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.112 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -120.64 -174.41 15.12 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.451 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 19.5 mmt 61.7 30.82 18.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.811 0.339 . . . . 0.0 110.902 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.406 ' HB2' ' C ' ' A' ' 192' ' ' GLY . 25.0 mt -88.04 162.31 16.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.912 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -102.39 160.27 14.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.892 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 14.9 mtpp -84.98 36.66 0.63 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.937 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 4.5 tp-100 -123.09 -51.08 1.9 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.905 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 66.1 mt-30 -54.23 154.32 4.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.888 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 90.3 p -130.77 -177.97 4.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.881 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . 0.493 ' O ' ' CB ' ' A' ' 168' ' ' ARG . 1.8 mp0 -55.31 -48.05 74.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.902 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -58.29 -55.17 38.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.866 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -45.64 -68.23 0.21 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.839 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.568 HG12 ' CD1' ' A' ' 171' ' ' PHE . 59.8 t -59.1 -55.51 23.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.155 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . 0.493 ' CB ' ' O ' ' A' ' 164' ' ' GLU . 70.9 ttt180 -34.3 -53.32 0.5 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.923 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 20.1 mmt85 -65.0 -54.3 32.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.931 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.514 ' O ' ' CB ' ' A' ' 173' ' ' ALA . 13.0 tp -44.21 -64.42 0.68 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.962 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.568 ' CD1' HG12 ' A' ' 167' ' ' VAL . 6.8 m-85 -51.89 -67.53 0.24 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.904 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -48.41 -23.12 0.84 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.857 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.514 ' CB ' ' O ' ' A' ' 170' ' ' LEU . . . -51.95 -27.18 12.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.09 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -111.99 -62.84 1.5 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.846 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -118.76 137.17 12.62 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.48 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 48.8 m-80 -51.77 151.16 3.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.788 0.328 . . . . 0.0 110.897 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 97.6 mt -117.46 109.35 27.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.121 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -61.18 -36.99 81.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.883 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -159.44 137.22 10.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.898 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 5.7 t -124.32 143.42 50.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.888 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 55.7 m -154.37 137.04 15.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.161 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.401 HD13 ' CB ' ' A' ' 194' ' ' ALA . 10.6 mm -106.28 133.44 50.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.103 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.5 HD12 ' CE2' ' A' ' 195' ' ' PHE . 84.8 mt -83.08 123.76 29.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.909 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 68.8 mtm180 -130.93 152.55 50.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.873 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -106.27 179.59 23.01 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.489 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -45.46 -47.87 12.54 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.637 2.224 . . . . 0.0 112.346 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -43.35 -39.59 3.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.846 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 118.57 -36.83 3.44 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.465 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 22.8 m120 -75.21 177.18 6.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.857 0.361 . . . . 0.0 110.888 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 42.3 t -82.99 136.25 34.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.851 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 25.2 mtmm -84.43 32.49 0.51 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.925 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.406 ' C ' ' HB2' ' A' ' 158' ' ' LEU . . . 58.12 39.21 91.86 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.506 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 7.2 p -157.85 149.39 21.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.83 0.348 . . . . 0.0 110.862 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . 0.401 ' CB ' HD13 ' A' ' 182' ' ' ILE . . . -160.13 156.5 26.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.156 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . 0.5 ' CE2' HD12 ' A' ' 183' ' ' LEU . 42.3 m-85 -114.12 126.96 55.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.866 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.56 HG23 ' CE2' ' A' ' 171' ' ' PHE . 98.8 t -117.23 139.36 44.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.072 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 31.4 tttt -116.37 118.38 32.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.86 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . 0.454 ' CD1' ' CD1' ' A' ' 153' ' ' LEU . 20.3 m-85 -95.58 172.28 8.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.918 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 8.3 t -79.2 -39.46 33.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.834 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 33.6 p -149.19 160.25 43.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.893 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . 0.448 ' O ' ' C ' ' A' ' 202' ' ' ALA . 13.3 t-80 -53.46 -58.93 5.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.873 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . 0.448 ' C ' ' O ' ' A' ' 201' ' ' HIS . . . -34.33 -62.93 0.31 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.085 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -54.21 -42.61 69.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.857 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . 0.4 ' N ' ' O ' ' A' ' 201' ' ' HIS . . . -58.53 -64.1 1.05 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.068 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 37.1 tp60 -43.15 -42.03 3.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.956 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -57.3 -57.47 12.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.065 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . 0.429 ' CB ' ' OH ' ' A' ' 198' ' ' TYR . . . -55.24 -33.56 63.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.088 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . 0.479 ' O ' ' N ' ' A' ' 212' ' ' HIS . 87.8 mt -62.72 -75.0 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.138 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -48.71 -42.09 33.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.892 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -56.32 -36.88 69.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.118 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . 0.465 ' HB3' ' CD2' ' A' ' 224' ' ' LEU . 50.7 mt -109.44 -72.6 0.72 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.898 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' HIS . . . . . 0.479 ' N ' ' O ' ' A' ' 208' ' ' ILE . 9.4 t60 -46.73 128.62 10.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.865 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 82.04 -22.91 5.56 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.514 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 7.9 t -91.45 -70.74 0.67 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.819 0.342 . . . . 0.0 110.818 -179.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 9.5 mm-40 -86.54 161.55 18.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.86 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' THR . . . . . 0.402 ' O ' ' C ' ' A' ' 217' ' ' MET . 39.1 m -129.01 108.65 10.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.157 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' MET . . . . . 0.402 ' C ' ' O ' ' A' ' 216' ' ' THR . 24.1 mmt -37.4 156.88 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.534 0.683 . . . . 0.0 110.884 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.16 113.29 3.55 Favored 'Trans proline' 0 C--N 1.341 0.133 0 C-N-CA 122.683 2.255 . . . . 0.0 112.307 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 113.94 -45.09 1.37 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.493 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -70.92 142.03 51.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.788 0.328 . . . . 0.0 111.103 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 68.3 m -91.53 -14.81 29.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.879 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 2.7 m -100.17 143.1 30.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.835 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 2.4 p -51.3 159.83 0.63 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.879 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . 0.465 ' CD2' ' HB3' ' A' ' 211' ' ' LEU . 41.6 tp -54.04 154.7 4.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.887 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 60.7 t -127.15 108.09 18.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.123 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 24.2 t -133.91 101.46 3.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.169 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 10.7 ptmt -131.75 143.21 50.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.925 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' PHE . . . . . 0.536 ' CD1' HD23 ' A' ' 153' ' ' LEU . 33.5 m-85 -43.49 150.19 0.23 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.889 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -112.04 150.94 29.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.11 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -113.17 86.9 2.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.853 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 14.3 t -51.74 119.58 4.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.156 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -123.69 164.68 18.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.84 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 4.5 ptmm? -149.6 166.4 29.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.86 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -120.87 126.88 51.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.892 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 42.7 t -74.87 155.08 37.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.8 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -107.92 144.46 16.13 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.468 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -47.07 -46.15 19.73 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.682 2.255 . . . . 0.0 112.352 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 12.1 m -148.55 151.14 34.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.838 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 24.4 t -85.34 119.28 25.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.884 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.293 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.496 -179.956 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.383 0 N-CA-C 112.471 -0.252 . . . . 0.0 112.471 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 24.9 t -151.99 147.61 26.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.876 0.369 . . . . 0.0 110.866 -179.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 56.3 p -161.99 175.19 12.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.847 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 165.41 134.05 1.6 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.501 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 28.3 t -121.27 138.37 54.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.891 0.377 . . . . 0.0 110.824 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 88.0 p -123.12 43.97 2.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.883 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . 0.401 ' O ' ' C ' ' A' ' 143' ' ' CYS . . . 138.05 73.92 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.498 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' CYS . . . . . 0.401 ' C ' ' O ' ' A' ' 142' ' ' GLY . 41.7 t -37.86 -43.35 0.68 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.86 0.362 . . . . 0.0 110.912 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -134.84 153.74 51.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.918 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 5.1 tpp85 -145.9 144.61 30.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.838 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.58 92.91 47.19 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.579 0.704 . . . . 0.0 110.906 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -76.08 163.72 32.51 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.639 2.226 . . . . 0.0 112.318 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -76.18 176.87 9.49 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.64 2.227 . . . . 0.0 112.365 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 93.4 p -65.42 -45.14 85.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.866 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 5.8 m80 -57.22 123.1 14.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.904 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.463 ' CZ ' ' HB2' ' A' ' 151' ' ' ARG . 22.2 ttm105 -125.0 85.51 2.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.861 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 6.5 ttpm? -139.85 162.65 34.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.887 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.414 HD23 ' CE1' ' A' ' 228' ' ' PHE . 58.1 mt -129.29 127.09 40.45 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.934 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 18.8 t80 -101.04 113.14 25.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.844 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 48.1 t -104.07 124.01 58.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.094 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -124.45 -169.61 13.08 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.465 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 93.4 mmm 50.07 39.36 18.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.794 0.331 . . . . 0.0 110.919 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.407 ' HB2' ' C ' ' A' ' 192' ' ' GLY . 66.9 mt -94.04 162.36 13.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.906 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -100.3 158.08 16.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.883 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 52.4 mttp -83.5 39.47 0.67 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.922 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -124.9 -47.83 1.78 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.934 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 64.2 mt-30 -57.89 151.68 17.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.881 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 3.4 m -129.29 176.35 8.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.86 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -52.95 -44.13 66.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.883 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -59.38 -51.59 69.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.868 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -52.74 -61.74 2.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.892 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.57 HG11 ' CD1' ' A' ' 171' ' ' PHE . 25.4 t -58.64 -56.8 14.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.158 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . 0.415 ' C ' ' O ' ' A' ' 167' ' ' VAL . 15.5 ttt180 -36.3 -62.34 0.45 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.866 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 19.4 mmt85 -61.05 -54.11 48.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.915 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.504 ' O ' ' CB ' ' A' ' 173' ' ' ALA . 12.5 tp -43.14 -65.68 0.46 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.899 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.57 ' CD1' HG11 ' A' ' 167' ' ' VAL . 8.5 m-85 -52.22 -70.86 0.08 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.888 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.408 ' C ' ' N ' ' A' ' 174' ' ' PHE . 5.3 pt-20 -43.3 -28.79 0.35 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.864 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.504 ' CB ' ' O ' ' A' ' 170' ' ' LEU . . . -44.49 -22.09 0.07 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.076 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . 0.408 ' N ' ' C ' ' A' ' 172' ' ' GLU . 97.7 m-85 -109.79 -74.91 0.64 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.878 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -108.08 148.12 16.62 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.495 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -52.35 145.77 10.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.791 0.329 . . . . 0.0 110.888 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 18.6 mt -108.96 136.1 45.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.137 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -93.49 -36.81 12.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.884 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . 0.431 ' HG3' ' N ' ' A' ' 180' ' ' CYS . 3.4 tp10 -163.73 144.55 8.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.919 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . 0.431 ' N ' ' HG3' ' A' ' 179' ' ' GLU . 35.7 t -135.12 142.99 46.33 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.902 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' THR . . . . . 0.457 HG23 ' N ' ' A' ' 182' ' ' ILE . 91.1 m -155.19 143.2 20.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.102 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.457 ' N ' HG23 ' A' ' 181' ' ' THR . 9.0 mm -105.35 138.5 30.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.131 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.492 HD13 ' CE2' ' A' ' 195' ' ' PHE . 44.7 mt -86.24 136.06 33.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.896 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 67.0 mtt180 -146.7 115.82 6.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.886 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -51.19 163.91 1.05 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.513 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -45.52 -51.98 7.32 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.703 2.268 . . . . 0.0 112.343 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -43.87 -50.58 7.93 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.828 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 141.88 -45.36 0.94 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.507 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -57.1 145.84 29.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.795 0.331 . . . . 0.0 110.878 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 36.2 t -68.7 151.2 47.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.894 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 25.3 mttp -105.23 36.7 2.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.887 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.407 ' C ' ' HB2' ' A' ' 158' ' ' LEU . . . 46.02 44.53 14.02 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.539 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 3.5 p -155.32 155.07 33.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.838 0.352 . . . . 0.0 110.897 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -161.38 166.02 28.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.057 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . 0.492 ' CE2' HD13 ' A' ' 183' ' ' LEU . 39.4 m-85 -120.58 132.9 55.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.856 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 21.8 t -125.77 145.95 32.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.122 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 11.3 ttmm -123.29 141.53 51.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.935 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . 0.404 ' CD1' HD12 ' A' ' 153' ' ' LEU . 24.6 m-85 -118.59 174.94 5.97 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.886 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 10.5 t -81.66 -49.17 10.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.853 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 23.7 t -126.31 166.87 16.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.87 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 62.9 t-80 -66.51 -49.81 65.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.868 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -45.27 -59.07 2.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.101 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -47.8 -49.38 29.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.895 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -51.26 -61.62 2.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.064 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 44.9 tp60 -46.35 -43.65 16.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.918 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -55.8 -62.31 1.78 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.137 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -50.89 -35.03 30.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.083 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . 0.495 ' O ' ' N ' ' A' ' 212' ' ' HIS . 77.7 mt -61.44 -73.37 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.124 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -47.39 -42.98 23.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.915 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -57.72 -40.56 79.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.11 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . 0.422 ' O ' ' CB ' ' A' ' 214' ' ' SER . 61.1 mt -102.25 -72.05 0.7 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.972 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' HIS . . . . . 0.495 ' N ' ' O ' ' A' ' 208' ' ' ILE . 20.0 t60 -47.41 136.25 9.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.827 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 67.61 1.01 14.28 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.503 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' SER . . . . . 0.422 ' CB ' ' O ' ' A' ' 211' ' ' LEU . 1.0 OUTLIER -95.28 -71.09 0.68 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.912 0.386 . . . . 0.0 110.833 -179.683 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -99.96 -178.17 3.77 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.925 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 51.6 m -134.49 102.45 5.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.139 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 28.3 mmt -40.99 135.61 1.65 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.562 0.696 . . . . 0.0 110.847 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -48.62 119.18 3.94 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.686 2.258 . . . . 0.0 112.349 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 111.16 -46.19 1.21 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.467 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -76.45 148.79 37.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.802 0.334 . . . . 0.0 111.084 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 10.5 t -93.55 -18.9 21.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.916 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 1.1 t -100.05 147.62 25.43 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.859 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 58.4 m -59.43 156.51 12.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.855 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 38.9 tp -43.24 149.43 0.23 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.907 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 60.4 t -121.42 113.52 39.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.134 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 22.5 t -138.08 105.33 3.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.149 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 9.4 pttp -130.74 148.56 52.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.942 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' PHE . . . . . 0.414 ' CE1' HD23 ' A' ' 153' ' ' LEU . 91.8 m-85 -57.93 123.65 16.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.859 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -73.64 117.11 15.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.098 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -132.97 142.28 48.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.844 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 84.8 m -127.06 87.07 2.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.173 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -126.24 111.37 14.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.886 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 15.1 ptmt -77.72 127.83 33.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.896 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -136.65 141.01 43.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.844 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 34.1 t -80.48 -62.11 1.77 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.822 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -68.77 146.2 44.73 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.496 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . 0.445 ' O ' ' C ' ' A' ' 238' ' ' SER . 62.2 Cg_endo -77.03 -3.02 13.29 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.668 2.246 . . . . 0.0 112.366 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' SER . . . . . 0.445 ' C ' ' O ' ' A' ' 237' ' ' PRO . 96.9 p 34.86 42.13 0.07 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.88 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 29.2 t -108.66 103.51 12.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.865 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.307 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.53 179.991 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.365 0 N-CA-C 112.462 -0.255 . . . . 0.0 112.462 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.3 m -111.96 133.04 54.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.896 0.379 . . . . 0.0 110.89 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 69.5 p -121.03 166.7 13.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.878 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 60.07 82.18 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.476 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 85.4 p -130.98 145.17 51.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.87 0.367 . . . . 0.0 110.878 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 50.9 m -111.4 127.33 55.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.891 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -144.43 92.23 0.16 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.487 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 51.1 t -77.68 79.88 4.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.795 0.331 . . . . 0.0 110.874 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.7 mp -127.86 125.5 39.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.92 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 29.5 mmt85 -59.07 -58.3 9.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.895 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . 0.421 ' CD ' ' HD2' ' A' ' 147' ' ' PRO . 31.1 tp60 -154.26 138.52 11.2 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.618 0.723 . . . . 0.0 110.913 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . 0.421 ' HD2' ' CD ' ' A' ' 146' ' ' GLN . 72.4 Cg_exo -46.77 145.48 6.67 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.713 2.275 . . . . 0.0 112.334 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -46.94 141.84 11.59 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.701 2.267 . . . . 0.0 112.319 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 28.7 t -82.77 98.93 9.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.842 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 31.6 m80 -125.12 152.09 44.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.834 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 10.7 mmm-85 -103.77 -41.05 6.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.82 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 25.4 tttp -83.42 124.67 30.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.927 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.546 HD22 ' CD1' ' A' ' 228' ' ' PHE . 62.3 mt -105.29 132.68 51.18 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.914 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -92.24 135.06 34.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.887 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 23.0 t -124.27 114.85 42.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.098 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -116.59 -176.14 17.83 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.48 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 91.4 mmm 58.62 41.83 21.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.814 0.34 . . . . 0.0 110.873 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 46.5 mt -103.57 178.34 4.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.915 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -124.44 172.07 9.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.93 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 37.3 mttt -95.91 51.35 1.24 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.902 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -127.22 -52.19 1.4 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.883 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -64.56 164.32 11.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.872 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 31.8 p -133.55 177.77 7.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.877 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -52.16 -35.65 49.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.916 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -64.22 -57.43 9.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.836 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -47.04 -54.55 10.02 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.851 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.562 HG11 ' CE1' ' A' ' 171' ' ' PHE . 61.3 t -65.23 -40.56 89.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.174 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 4.3 mmm180 -48.0 -67.11 0.3 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.896 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 13.1 mmm-85 -60.78 -52.84 63.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.875 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.507 ' O ' ' CB ' ' A' ' 173' ' ' ALA . 12.6 tp -41.96 -66.27 0.37 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.892 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.562 ' CE1' HG11 ' A' ' 167' ' ' VAL . 9.3 m-85 -55.92 -71.24 0.09 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.903 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.498 ' C ' ' CD ' ' A' ' 172' ' ' GLU . 0.5 OUTLIER -41.48 -24.91 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.873 -179.934 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.507 ' CB ' ' O ' ' A' ' 170' ' ' LEU . . . -45.58 -21.16 0.09 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.117 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -117.46 -66.45 1.08 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.875 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -114.63 134.24 11.56 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.471 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 40.2 m-20 -45.31 153.94 0.2 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.789 0.328 . . . . 0.0 110.899 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 38.1 mt -112.66 128.04 69.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.135 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -83.0 -37.98 23.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.859 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -164.67 129.6 2.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.948 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 51.4 t -113.8 142.76 45.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.912 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 40.7 m -155.0 144.95 21.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.165 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 31.5 mm -109.06 146.75 14.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.193 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 31.4 mt -94.1 120.73 34.77 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.943 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 72.2 mtt180 -133.16 110.32 10.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.814 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -68.86 -149.27 0.25 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.501 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -45.54 156.61 0.36 Allowed 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.739 2.293 . . . . 0.0 112.326 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . 0.442 ' O ' ' C ' ' A' ' 188' ' ' GLY . 73.6 m-20 42.13 41.1 1.91 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.855 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.442 ' C ' ' O ' ' A' ' 187' ' ' ASP . . . 34.71 58.81 0.72 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.546 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -116.24 111.41 20.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.873 0.368 . . . . 0.0 110.865 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 4.9 t -42.59 131.73 3.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.856 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 64.0 mttt -104.29 32.08 4.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.896 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 58.48 39.75 93.45 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.477 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 85.6 m -151.42 153.41 34.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.844 0.354 . . . . 0.0 110.852 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -162.44 167.05 24.19 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.132 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -125.53 133.72 52.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.854 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.463 HG23 ' CE2' ' A' ' 171' ' ' PHE . 29.1 t -127.92 118.84 49.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.122 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 22.5 ttmt -95.3 141.84 28.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.911 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . 0.439 ' OH ' ' CB ' ' A' ' 207' ' ' ALA . 10.3 m-85 -115.28 173.71 6.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.871 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 20.7 p -78.47 -46.24 20.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.817 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 3.0 t -137.32 156.32 48.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.869 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . 0.419 ' O ' ' C ' ' A' ' 202' ' ' ALA . 3.5 t-160 -52.29 -59.99 3.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.923 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 201' ' ' HIS . . . -35.89 -64.32 0.32 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.077 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -48.94 -47.29 43.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.845 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -54.94 -54.12 46.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.087 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 43.3 tp60 -49.72 -47.24 50.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.912 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . 0.436 ' O ' ' CB ' ' A' ' 210' ' ' ALA . . . -55.08 -48.73 73.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.14 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . 0.439 ' CB ' ' OH ' ' A' ' 198' ' ' TYR . . . -59.35 -41.31 88.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.082 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . 0.488 ' O ' ' N ' ' A' ' 212' ' ' HIS . 63.7 mt -58.66 -72.28 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.127 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 16.5 t30 -53.21 -40.08 64.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.914 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' ALA . . . . . 0.436 ' CB ' ' O ' ' A' ' 206' ' ' ALA . . . -57.78 -41.16 81.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.079 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 19.8 mt -101.47 -69.32 0.78 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.913 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' HIS . . . . . 0.488 ' N ' ' O ' ' A' ' 208' ' ' ILE . 14.4 t60 -48.28 133.26 15.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.877 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 73.92 -1.14 48.66 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.481 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 8.5 t -95.93 -70.99 0.69 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.794 0.331 . . . . 0.0 110.842 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -99.86 -175.78 3.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.898 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 35.1 m -137.13 109.3 7.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.146 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 23.8 mmt -38.17 158.18 0.09 OUTLIER Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.588 0.709 . . . . 0.0 110.872 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -71.62 107.15 2.11 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.644 2.23 . . . . 0.0 112.324 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 119.31 -48.04 0.98 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.476 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -68.46 148.23 50.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.765 0.317 . . . . 0.0 111.112 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 77.9 p -92.57 -18.17 23.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.882 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 2.4 m -100.04 149.66 23.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.862 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 66.3 m -59.88 157.23 12.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.861 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . 0.439 ' HG ' ' N ' ' A' ' 225' ' ' VAL . 16.0 tp -47.8 154.39 0.51 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.894 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 0.439 ' N ' ' HG ' ' A' ' 224' ' ' LEU . 34.6 t -125.32 110.62 24.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.102 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 19.6 t -132.9 101.95 4.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.1 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 23.8 pttt -129.06 152.27 48.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.92 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' PHE . . . . . 0.546 ' CD1' HD22 ' A' ' 153' ' ' LEU . 52.2 m-85 -53.9 148.47 10.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.89 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -98.74 147.58 24.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.116 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -84.87 171.58 12.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.856 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 52.2 m -136.66 128.21 28.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.117 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -131.69 132.74 44.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.889 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -112.55 159.06 19.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.877 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -70.64 147.37 49.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.867 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 50.0 p -168.54 119.49 0.77 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.822 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -146.81 78.97 0.23 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.46 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -77.09 -41.28 0.38 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.701 2.267 . . . . 0.0 112.315 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 8.3 t 68.24 42.03 1.79 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.841 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 71.9 m -55.7 132.56 49.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.902 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.35 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.501 -179.954 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.313 0 N-CA-C 112.504 -0.238 . . . . 0.0 112.504 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 38.1 p -136.14 160.92 37.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.925 0.393 . . . . 0.0 110.801 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 12.9 t -97.8 -53.9 3.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.874 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 89.09 145.29 11.54 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.472 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 35.3 p -72.84 168.23 19.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.865 0.364 . . . . 0.0 110.822 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 2.4 t -162.47 138.81 7.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.825 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 107.14 62.14 0.58 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.506 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 2.4 t -136.17 152.58 50.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.866 0.365 . . . . 0.0 110.848 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -83.41 38.42 0.61 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.932 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 73.6 mtt-85 -81.59 112.81 19.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.902 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -127.33 79.6 72.98 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.612 0.72 . . . . 0.0 110.925 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -45.67 156.81 0.37 Allowed 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.749 2.299 . . . . 0.0 112.309 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -77.04 -174.73 2.31 Favored 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.704 2.27 . . . . 0.0 112.391 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 52.1 p -66.28 -58.86 4.43 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.9 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . 0.409 ' CD2' ' H ' ' A' ' 150' ' ' HIS . 6.9 p80 -67.68 102.36 1.18 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.896 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.465 ' CZ ' ' HB2' ' A' ' 151' ' ' ARG . 19.6 ttm105 -107.85 89.37 2.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.863 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.56 ' HD3' ' CD1' ' A' ' 195' ' ' PHE . 13.3 ttmt -104.16 144.01 32.15 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.899 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.426 HD22 ' CD1' ' A' ' 228' ' ' PHE . 56.6 mt -117.84 123.6 46.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.956 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 56.3 t80 -91.13 121.81 33.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.859 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 58.9 t -109.1 128.79 64.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.151 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -124.6 -160.35 10.72 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.534 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 33.3 mtt 38.69 43.95 0.75 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.821 0.343 . . . . 0.0 110.867 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.422 ' HB2' ' C ' ' A' ' 192' ' ' GLY . 67.9 mt -99.88 175.55 5.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.885 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.496 ' N ' ' OD1' ' A' ' 159' ' ' ASN . 0.5 OUTLIER -115.35 154.9 28.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.894 179.904 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.74 20.64 1.41 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.922 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -107.83 -34.62 6.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.941 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . 0.466 ' HG3' ' ND2' ' A' ' 159' ' ' ASN . 25.8 mt-30 -59.12 158.42 8.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.917 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 85.2 p -132.53 163.96 27.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.86 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -47.8 -50.97 24.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.872 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -53.23 -47.78 68.72 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.839 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -53.93 -69.1 0.13 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.864 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.565 HG11 ' CD1' ' A' ' 171' ' ' PHE . 86.0 t -52.92 -54.39 16.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.164 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . 0.489 ' CD ' ' C ' ' A' ' 168' ' ' ARG . 0.0 OUTLIER -39.53 -63.18 0.59 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.891 -179.959 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 4.0 mtp-105 -60.85 -53.91 51.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.882 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.505 ' O ' ' CB ' ' A' ' 173' ' ' ALA . 11.9 tp -43.23 -65.93 0.43 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.901 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.565 ' CD1' HG11 ' A' ' 167' ' ' VAL . 11.6 m-85 -52.2 -70.93 0.07 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.914 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.416 ' O ' ' N ' ' A' ' 174' ' ' PHE . 5.9 pt-20 -43.09 -29.36 0.35 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.947 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.505 ' CB ' ' O ' ' A' ' 170' ' ' LEU . . . -43.29 -23.05 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.082 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . 0.416 ' N ' ' O ' ' A' ' 172' ' ' GLU . 92.7 m-85 -114.56 -70.24 0.81 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.879 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -111.28 137.57 14.39 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.521 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -44.23 164.79 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.762 0.315 . . . . 0.0 110.896 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . 0.429 HG23 ' N ' ' A' ' 178' ' ' GLU . 51.1 mt -133.42 134.0 57.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.104 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . 0.429 ' N ' HG23 ' A' ' 177' ' ' ILE . 18.6 mt-10 -89.38 -41.31 12.19 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.918 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -150.75 151.2 32.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.831 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 49.4 t -146.0 138.2 25.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.854 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 26.2 m -154.89 151.2 28.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.155 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 48.6 mm -109.21 140.8 26.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.141 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 34.6 mt -89.24 108.45 19.62 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.919 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 47.4 mtt180 -133.09 112.2 11.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.873 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -72.64 -151.48 1.44 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.498 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -45.66 157.05 0.35 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.683 2.255 . . . . 0.0 112.34 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 6.7 t70 43.12 40.7 2.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.879 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 39.53 42.22 1.87 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.54 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -92.83 104.66 16.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.87 0.367 . . . . 0.0 110.906 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 8.3 t -50.83 139.26 17.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.842 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 38.3 mttm -105.04 34.25 3.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.908 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.422 ' C ' ' HB2' ' A' ' 158' ' ' LEU . . . 49.92 39.47 32.9 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.521 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 80.8 m -151.03 157.61 43.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.772 0.32 . . . . 0.0 110.89 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -160.84 166.64 28.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.123 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . 0.56 ' CD1' ' HD3' ' A' ' 152' ' ' LYS . 40.0 m-85 -124.5 130.5 52.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.879 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 11.8 t -128.46 148.73 32.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.141 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 6.3 ttmm -126.93 138.39 53.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.92 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -114.68 175.44 5.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.915 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 41.2 t -81.6 -48.05 12.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.858 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 1.9 t -134.59 172.48 12.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.874 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . 0.404 ' O ' ' C ' ' A' ' 202' ' ' ALA . 18.2 t-160 -67.4 -55.96 11.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.85 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . 0.404 ' C ' ' O ' ' A' ' 201' ' ' HIS . . . -37.98 -64.51 0.4 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.098 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -49.37 -48.21 47.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.869 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -54.76 -58.37 7.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.137 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 6.1 tp60 -43.63 -50.57 7.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.897 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -52.8 -54.79 29.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.085 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -56.27 -32.66 64.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.138 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . 0.492 ' O ' ' N ' ' A' ' 212' ' ' HIS . 59.7 mt -65.07 -75.13 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.071 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -49.32 -42.61 42.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.861 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -54.97 -43.24 73.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.106 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 58.6 mt -102.23 -70.19 0.76 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.943 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' HIS . . . . . 0.492 ' N ' ' O ' ' A' ' 208' ' ' ILE . 5.4 t60 -50.74 129.88 23.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.866 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 75.61 -9.25 16.37 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.476 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 7.9 t -99.95 -70.23 0.74 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.877 0.37 . . . . 0.0 110.874 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' GLN . . . . . 0.415 ' HG3' ' N ' ' A' ' 216' ' ' THR . 1.7 tt0 -90.65 154.87 19.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.923 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' THR . . . . . 0.415 ' N ' ' HG3' ' A' ' 215' ' ' GLN . 30.5 m -118.17 101.62 8.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.156 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 19.4 mmt -39.13 134.84 1.09 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.626 0.727 . . . . 0.0 110.887 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -48.99 131.57 25.78 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.723 2.282 . . . . 0.0 112.356 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 99.29 -41.93 2.1 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.734 -0.745 . . . . 0.0 112.502 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -82.15 144.57 30.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.796 0.331 . . . . 0.0 111.129 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 8.3 m -93.4 -15.45 25.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.864 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 57.9 m -99.98 142.43 31.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.897 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 58.8 m -54.91 156.21 3.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.873 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . 0.435 ' HG ' ' N ' ' A' ' 225' ' ' VAL . 46.5 tp -52.37 159.63 0.96 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.954 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 0.435 ' N ' ' HG ' ' A' ' 224' ' ' LEU . 99.2 t -130.5 113.11 24.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.114 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 40.2 t -138.83 113.52 8.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.113 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 11.4 pttm -130.98 167.31 19.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.909 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' PHE . . . . . 0.426 ' CD1' HD22 ' A' ' 153' ' ' LEU . 62.5 m-85 -71.29 107.95 4.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.896 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . 0.414 ' N ' ' O ' ' A' ' 152' ' ' LYS . . . -75.43 102.26 5.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.07 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -117.72 130.17 56.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.886 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 48.9 m -89.62 98.43 11.77 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.149 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -123.25 82.69 2.03 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.861 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 42.8 pttt -160.84 140.24 10.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.882 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -109.81 142.98 40.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.908 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 31.6 p -156.45 107.45 2.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.822 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -166.34 85.75 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.446 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -45.56 -50.09 9.78 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.68 2.253 . . . . 0.0 112.339 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 2.1 t -162.78 115.87 1.65 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.855 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 23.2 t -99.57 127.06 45.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.887 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.46 -179.999 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.353 0 N-CA-C 112.501 -0.239 . . . . 0.0 112.501 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 49.2 m -143.88 130.22 19.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.835 0.35 . . . . 0.0 110.925 -179.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 32.2 t -129.91 129.91 44.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.888 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 75.15 140.08 0.72 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.532 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 54.1 p -119.82 172.72 7.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.869 0.366 . . . . 0.0 110.886 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 4.7 m -124.38 108.93 12.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.915 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -121.14 136.29 11.16 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.498 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 39.4 m -122.08 -34.09 3.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.859 0.361 . . . . 0.0 110.881 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.461 HD22 ' N ' ' A' ' 144' ' ' LEU . 0.7 OUTLIER -78.7 155.15 29.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.933 -179.941 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 15.8 mtp85 -98.62 -53.67 3.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.852 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -138.5 138.58 22.55 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.56 0.695 . . . . 0.0 110.969 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . 0.511 ' HG2' ' CE1' ' A' ' 201' ' ' HIS . 63.1 Cg_endo -78.23 147.08 22.97 Favored 'Trans proline' 0 C--O 1.231 0.146 0 C-N-CA 122.69 2.26 . . . . 0.0 112.329 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -46.91 178.51 0.01 OUTLIER 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.691 2.261 . . . . 0.0 112.32 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 28.2 t -129.0 112.91 14.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.857 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 64.4 m80 -148.05 171.98 14.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.853 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 2.3 tpp85 -119.1 -33.65 4.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.873 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 3.2 ttmp? -91.33 152.36 20.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.893 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.508 HD23 ' CD1' ' A' ' 228' ' ' PHE . 38.7 mt -134.06 128.25 33.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.909 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -94.13 121.74 35.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.873 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.403 HG22 ' CG2' ' A' ' 226' ' ' VAL . 88.5 t -113.9 136.42 50.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.186 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -136.69 -159.93 8.52 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.515 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 14.7 mmt 46.8 28.56 0.84 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.84 0.352 . . . . 0.0 110.925 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 36.9 mt -85.35 167.46 15.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.912 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.529 HD22 ' N ' ' A' ' 218' ' ' PRO . 45.6 m-20 -105.26 158.43 16.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.897 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 60.4 mttt -85.59 37.2 0.68 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.894 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -116.9 -55.71 2.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.881 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -67.34 149.34 50.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.901 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 51.6 p -124.79 175.48 7.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.806 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 10.4 tm-20 -43.51 -30.45 0.57 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.9 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -67.67 -60.02 2.87 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.838 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -54.19 -44.78 71.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.801 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.557 HG13 ' CD1' ' A' ' 171' ' ' PHE . 89.7 t -66.1 -40.0 85.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.15 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 56.7 ttp180 -54.04 -63.37 1.17 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.904 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 17.4 mmt180 -59.0 -54.87 42.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.906 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.506 ' O ' ' CB ' ' A' ' 173' ' ' ALA . 11.3 tp -42.53 -66.11 0.4 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.91 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.557 ' CD1' HG13 ' A' ' 167' ' ' VAL . 13.0 m-85 -51.73 -72.19 0.05 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.903 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.46 ' O ' ' N ' ' A' ' 174' ' ' PHE . 5.9 pt-20 -41.38 -31.51 0.25 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.897 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.506 ' CB ' ' O ' ' A' ' 170' ' ' LEU . . . -40.68 -24.82 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.133 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . 0.46 ' N ' ' O ' ' A' ' 172' ' ' GLU . 98.9 m-85 -112.21 -74.97 0.62 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.86 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -108.34 142.42 15.99 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.472 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -51.01 156.3 1.05 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.774 0.321 . . . . 0.0 110.907 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 81.7 mt -118.81 134.82 61.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.115 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 -90.87 -42.25 10.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.919 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -157.86 142.73 16.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.896 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 1.8 m -134.23 145.87 49.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.825 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 45.4 m -151.98 134.73 15.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.158 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 30.0 mm -87.94 128.29 40.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.098 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.483 HD11 ' CD2' ' A' ' 195' ' ' PHE . 44.2 mt -95.53 115.29 27.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.922 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' ARG . . . . . 0.466 ' CB ' ' HA ' ' A' ' 190' ' ' SER . 15.2 ptp180 -166.95 145.82 5.21 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.891 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -64.0 155.68 45.3 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.473 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . 0.409 ' O ' ' C ' ' A' ' 187' ' ' ASP . 71.2 Cg_exo -45.63 -43.0 18.78 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.713 2.275 . . . . 0.0 112.307 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . 0.409 ' C ' ' O ' ' A' ' 186' ' ' PRO . 68.6 m-20 -37.57 -45.58 0.77 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.882 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 124.16 -35.6 3.19 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.481 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . 0.433 ' O ' ' C ' ' A' ' 190' ' ' SER . 6.9 m-20 -58.99 98.64 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.821 0.343 . . . . 0.0 110.91 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' SER . . . . . 0.466 ' HA ' ' CB ' ' A' ' 184' ' ' ARG . 27.2 p -35.3 145.49 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.838 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.414 ' CG ' ' HA ' ' A' ' 184' ' ' ARG . 1.8 mmmp? -102.59 38.01 1.8 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.906 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 37.67 41.49 0.87 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.457 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 65.0 m -153.68 148.51 26.51 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.809 0.338 . . . . 0.0 110.904 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -162.56 148.6 12.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.104 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . 0.483 ' CD2' HD11 ' A' ' 183' ' ' LEU . 14.6 m-85 -98.49 143.1 29.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.891 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.554 HG21 ' CE2' ' A' ' 171' ' ' PHE . 16.1 t -143.03 132.73 21.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.14 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 14.0 mtpp -116.05 154.25 30.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.879 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -126.97 171.68 11.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.939 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 32.5 t -69.62 -47.9 61.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.813 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 17.0 m -137.33 170.49 16.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.899 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . 0.511 ' CE1' ' HG2' ' A' ' 147' ' ' PRO . 36.3 t-80 -60.95 -56.8 16.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.841 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . 0.411 ' C ' ' O ' ' A' ' 201' ' ' HIS . . . -37.12 -65.48 0.3 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.129 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 16.7 mp0 -48.38 -46.0 36.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.916 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -54.09 -54.98 32.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.093 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 4.3 tp60 -49.52 -54.62 16.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.853 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -46.31 -56.44 5.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.129 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -56.08 -36.19 67.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.154 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . 0.483 ' O ' ' N ' ' A' ' 212' ' ' HIS . 80.0 mt -64.25 -75.06 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.12 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -49.34 -41.49 38.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.842 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -52.01 -48.63 64.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.112 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 74.6 mt -100.97 -65.79 0.95 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.886 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' HIS . . . . . 0.483 ' N ' ' O ' ' A' ' 208' ' ' ILE . 6.3 t60 -51.62 129.19 25.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.87 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 73.62 -4.83 26.14 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.488 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 8.1 t -99.66 -67.91 0.83 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.81 0.338 . . . . 0.0 110.856 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 5.6 mm-40 -94.73 172.9 7.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.938 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' THR . . . . . 0.423 ' O ' ' C ' ' A' ' 217' ' ' MET . 54.1 m -133.08 92.85 3.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.198 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' MET . . . . . 0.423 ' C ' ' O ' ' A' ' 216' ' ' THR . 1.3 mmt -36.0 136.23 0.51 Allowed Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.591 0.71 . . . . 0.0 110.877 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . 0.529 ' N ' HD22 ' A' ' 159' ' ' ASN . 75.7 Cg_exo -48.52 125.56 12.64 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.701 2.267 . . . . 0.0 112.384 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 109.15 -50.46 0.77 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.498 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -77.03 149.38 35.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.762 0.315 . . . . 0.0 111.093 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 23.9 t -94.41 -18.26 21.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.88 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 2.2 m -99.98 147.45 25.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.833 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' SER . . . . . 0.417 ' O ' ' C ' ' A' ' 224' ' ' LEU . 53.8 m -61.16 147.25 44.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.888 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . 0.417 ' C ' ' O ' ' A' ' 223' ' ' SER . 19.1 tp -36.82 152.72 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.909 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 0.402 ' N ' ' HG ' ' A' ' 224' ' ' LEU . 99.6 t -123.22 105.0 15.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.117 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . 0.403 ' CG2' HG22 ' A' ' 155' ' ' VAL . 22.1 t -132.67 101.84 4.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.118 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 45.8 pttt -119.47 167.69 11.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.873 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' PHE . . . . . 0.508 ' CD1' HD23 ' A' ' 153' ' ' LEU . 90.3 m-85 -72.34 115.75 11.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.91 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -43.55 143.96 0.86 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.121 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -104.63 -66.99 0.93 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.832 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 95.5 m -55.01 125.99 22.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.169 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -122.82 85.15 2.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.856 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 13.1 ttmm -58.12 139.66 54.31 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.889 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -142.67 171.79 13.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.913 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 96.2 p -170.03 113.77 0.48 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.836 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -71.59 146.18 39.98 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.472 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -78.0 -33.24 2.19 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.73 2.287 . . . . 0.0 112.35 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 1.1 t -54.97 143.55 26.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.881 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 75.6 m -89.73 -55.59 3.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.811 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.318 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.502 -179.974 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.313 0 N-CA-C 112.475 -0.25 . . . . 0.0 112.475 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 3.2 m -96.02 55.51 1.57 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.813 0.339 . . . . 0.0 110.865 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 32.2 t -101.64 41.69 1.19 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.863 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -171.54 -66.47 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.467 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 16.9 p -158.49 140.4 13.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.885 0.374 . . . . 0.0 110.842 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 6.9 t -97.26 -51.69 4.09 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.833 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 176.89 103.04 0.16 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.482 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 69.2 m -62.95 116.08 4.98 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.86 0.362 . . . . 0.0 110.876 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.0 mt -111.41 167.11 10.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.932 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 4.9 tpp85 -64.49 -44.59 90.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.889 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 86.7 mm-40 -52.6 149.61 10.64 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.588 0.708 . . . . 0.0 110.917 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -45.61 148.76 2.16 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.665 2.243 . . . . 0.0 112.349 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -77.98 106.49 2.18 Favored 'Trans proline' 0 N--CA 1.465 -0.161 0 C-N-CA 122.73 2.287 . . . . 0.0 112.364 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 22.9 t -136.99 105.29 5.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.859 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 56.7 m80 -100.83 88.74 3.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.848 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 15.5 ttm-85 -162.41 116.09 1.76 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.886 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.441 ' HD3' ' CG ' ' A' ' 195' ' ' PHE . 2.7 ttmp? -122.64 151.9 41.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.877 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 86.3 mt -117.91 133.66 55.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.914 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -102.64 114.37 28.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.885 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 37.8 t -108.55 111.45 36.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.139 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -111.4 -161.16 16.78 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.507 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 79.9 mmm 46.62 41.49 9.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.818 0.342 . . . . 0.0 110.913 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.417 ' HB2' ' C ' ' A' ' 192' ' ' GLY . 55.1 mt -99.54 171.03 8.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.933 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 30.2 m120 -113.6 171.38 7.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.892 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 43.6 mttm -92.79 42.59 1.1 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.917 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -124.28 -43.92 2.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.89 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 61.0 mt-30 -63.4 159.79 17.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.922 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 68.9 m -132.36 175.81 8.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.854 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -55.05 -47.02 75.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.88 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.496 ' CG ' ' N ' ' A' ' 166' ' ' ASP . 0.6 OUTLIER -58.33 -53.71 55.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.809 -179.988 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . 0.496 ' N ' ' CG ' ' A' ' 165' ' ' ASP . 65.5 m-20 -45.34 -55.89 5.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.888 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.556 HG11 ' CD1' ' A' ' 171' ' ' PHE . 68.7 t -64.81 -44.43 96.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.131 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 33.9 mtp180 -48.6 -55.22 11.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.881 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 55.7 mtt180 -70.86 -50.28 36.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.866 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.511 ' O ' ' CB ' ' A' ' 173' ' ' ALA . 9.8 tp -48.18 -63.78 0.98 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.919 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.556 ' CD1' HG11 ' A' ' 167' ' ' VAL . 7.3 m-85 -54.61 -58.48 7.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.905 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.446 ' N ' HD13 ' A' ' 177' ' ' ILE . 0.8 OUTLIER -59.82 -9.94 3.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.902 -179.915 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.511 ' CB ' ' O ' ' A' ' 170' ' ' LEU . . . -61.59 -10.75 8.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.131 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -120.43 -67.9 0.94 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.845 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -110.59 -173.93 20.25 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.46 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -83.79 151.23 25.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.785 0.326 . . . . 0.0 110.899 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . 0.446 HD13 ' N ' ' A' ' 172' ' ' GLU . 21.0 mt -121.27 129.62 75.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.143 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 35.0 mm-40 -79.3 -46.61 17.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.879 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 22.2 tp10 -165.29 143.86 6.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.875 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 13.0 t -118.81 143.0 47.2 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.923 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 30.1 m -153.11 116.05 4.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.113 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 44.6 mm -83.3 135.01 25.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.125 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 35.1 mt -84.39 102.53 12.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.911 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 61.6 mtp180 -118.06 137.58 52.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.923 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -53.99 -166.67 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.697 -0.764 . . . . 0.0 112.517 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -76.31 -46.51 0.18 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.644 2.229 . . . . 0.0 112.373 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -55.96 -40.14 72.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.905 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 124.68 35.22 0.65 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.475 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 37.1 p-10 -120.81 146.7 46.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.833 0.349 . . . . 0.0 110.876 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 40.7 t -69.23 132.1 45.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.856 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 1.3 mmmp? -94.46 26.09 3.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.898 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.417 ' C ' ' HB2' ' A' ' 158' ' ' LEU . . . 59.93 34.65 84.04 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.453 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 84.3 m -154.12 154.82 34.27 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.806 0.336 . . . . 0.0 110.926 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -158.37 161.1 37.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.072 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . 0.441 ' CG ' ' HD3' ' A' ' 152' ' ' LYS . 27.8 m-85 -121.53 119.59 32.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.868 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 21.5 t -118.8 140.21 43.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.081 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 17.1 mtmt -114.65 145.88 41.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.859 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -119.42 174.87 6.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.929 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 81.0 p -78.19 -46.26 20.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.876 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 37.7 m -133.58 -179.3 5.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.838 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 53.8 t-80 -76.44 -52.77 9.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.892 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -39.6 -66.14 0.32 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.081 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 51.5 mm-40 -47.28 -43.8 22.59 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.885 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -51.77 -54.07 32.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.108 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 24.9 tp60 -56.57 -41.51 77.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.926 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -53.15 -50.1 65.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.119 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -68.25 -26.66 65.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.098 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . 0.497 ' O ' ' N ' ' A' ' 212' ' ' HIS . 63.4 mt -71.05 -65.11 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.083 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -60.92 -38.09 84.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.879 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -65.07 -26.77 68.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.113 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 89.9 mt -115.61 -75.0 0.59 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.94 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' HIS . . . . . 0.497 ' N ' ' O ' ' A' ' 208' ' ' ILE . 20.6 t60 -47.83 128.69 13.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.848 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 83.16 -22.03 7.55 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.514 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 4.8 m -90.18 -71.61 0.61 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.801 0.334 . . . . 0.0 110.893 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' GLN . . . . . 0.433 ' HG3' ' N ' ' A' ' 216' ' ' THR . 1.2 tt0 -88.71 156.05 19.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.865 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' THR . . . . . 0.433 ' N ' ' HG3' ' A' ' 215' ' ' GLN . 2.0 m -119.51 118.1 30.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.119 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 23.9 mmt -47.44 137.05 9.28 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.598 0.714 . . . . 0.0 110.87 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -48.89 113.82 1.03 Allowed 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.702 2.268 . . . . 0.0 112.379 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 112.7 -54.39 0.55 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.504 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -63.72 145.46 55.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.813 0.339 . . . . 0.0 111.15 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 48.2 t -93.23 -16.26 25.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.806 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' SER . . . . . 0.408 ' C ' HG22 ' A' ' 216' ' ' THR . 2.4 m -100.09 136.98 39.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.841 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 2.1 p -44.91 162.97 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.831 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . 0.414 ' O ' ' ND1' ' A' ' 212' ' ' HIS . 51.4 tp -56.98 157.04 6.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.895 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 0.41 ' HA ' ' ND1' ' A' ' 212' ' ' HIS . 91.8 t -125.12 110.21 24.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.144 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 44.1 t -136.26 105.03 4.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.161 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 4.6 ptmt -132.69 145.77 51.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.909 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -51.45 144.43 10.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.914 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -78.46 -47.54 17.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.118 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -90.16 115.28 27.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.86 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 57.9 p -78.46 143.84 36.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.173 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -90.48 107.89 19.45 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.891 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 16.5 ptmt -158.22 159.84 36.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.886 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -160.44 159.47 30.98 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.875 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 24.2 t -73.46 -43.56 59.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.866 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -76.08 161.4 52.03 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.481 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . 0.426 ' O ' ' C ' ' A' ' 238' ' ' SER . 62.4 Cg_endo -79.18 19.98 0.87 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.656 2.237 . . . . 0.0 112.334 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' SER . . . . . 0.426 ' C ' ' O ' ' A' ' 237' ' ' PRO . 42.7 p -36.61 -46.44 0.58 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.869 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 75.5 p -164.25 136.71 4.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.84 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.446 -179.966 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.294 0 N-CA-C 112.478 -0.249 . . . . 0.0 112.478 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.437 ' CB ' ' HB2' ' A' ' 141' ' ' SER . 59.6 m 47.3 42.15 13.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.889 0.376 . . . . 0.0 110.901 -179.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 3.4 m 39.97 42.15 1.03 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.859 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 164.94 -95.69 0.12 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.503 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 61.6 p -162.06 110.53 1.43 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.853 0.358 . . . . 0.0 110.843 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.437 ' HB2' ' CB ' ' A' ' 137' ' ' SER . 3.3 m -164.79 148.3 8.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.869 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 171.67 -48.51 0.18 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.466 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 78.3 m -108.06 89.28 2.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.881 0.372 . . . . 0.0 110.881 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 17.1 tp -43.5 -52.48 6.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.882 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 31.7 ptt180 -113.7 112.99 24.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.905 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 74.6 mm-40 -71.35 142.31 86.72 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.664 0.745 . . . . 0.0 110.902 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -46.76 158.34 0.41 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.693 2.262 . . . . 0.0 112.295 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -45.17 171.93 0.02 OUTLIER 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.681 2.254 . . . . 0.0 112.329 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 65.6 m -118.25 105.36 11.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.827 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . 0.458 ' CD2' ' N ' ' A' ' 150' ' ' HIS . 0.2 OUTLIER -165.48 145.66 6.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.873 179.932 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 26.1 mtm180 -115.02 111.49 21.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.884 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 23.1 ttpt -122.6 152.03 40.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.913 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.471 HD23 ' CE1' ' A' ' 228' ' ' PHE . 87.4 mt -123.55 123.51 40.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.896 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -91.22 116.95 29.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.948 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 38.3 t -110.82 132.44 59.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.114 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -130.87 -158.84 9.39 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.473 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 45.52 31.86 1.0 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.793 0.33 . . . . 0.0 110.859 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 79.5 mt -85.24 -176.22 6.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.875 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.464 ' N ' ' OD1' ' A' ' 159' ' ' ASN . 0.5 OUTLIER -126.97 155.31 43.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.884 179.896 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 65.8 mttt -80.92 42.09 0.62 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.875 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 18.0 mp0 -130.96 -43.03 1.09 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.921 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 17.8 mm-40 -54.0 162.01 1.08 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.914 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 28.1 m -135.7 166.28 23.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.807 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . 0.465 ' O ' ' CB ' ' A' ' 168' ' ' ARG . 2.3 mp0 -49.28 -41.0 36.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.889 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -65.1 -48.34 74.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.867 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 -54.81 -56.61 17.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.817 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.504 HG13 ' CE1' ' A' ' 171' ' ' PHE . 54.3 t -66.98 -40.62 86.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.153 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . 0.465 ' CB ' ' O ' ' A' ' 164' ' ' GLU . 13.8 tpt180 -56.36 -56.28 23.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.865 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 10.0 mmt85 -63.25 -54.47 36.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.889 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.502 ' O ' ' CB ' ' A' ' 173' ' ' ALA . 9.9 tp -43.95 -64.94 0.57 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.925 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.504 ' CE1' HG13 ' A' ' 167' ' ' VAL . 7.4 m-85 -51.33 -68.87 0.13 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.871 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -46.36 -26.4 0.82 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.888 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.502 ' CB ' ' O ' ' A' ' 170' ' ' LEU . . . -48.89 -21.13 0.59 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.126 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -114.21 -60.37 1.89 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.867 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -124.48 134.08 8.93 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.488 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -40.74 162.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.786 0.327 . . . . 0.0 110.93 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 32.3 mt -131.03 136.39 58.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.087 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -81.35 -48.76 11.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.92 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -155.49 151.21 27.44 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.882 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 42.1 t -129.38 135.76 49.12 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.856 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 89.5 m -148.1 134.17 19.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.152 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 48.5 mm -95.06 139.04 19.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.099 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.54 HD12 ' CE2' ' A' ' 195' ' ' PHE . 41.0 mt -94.85 117.77 30.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.954 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 76.1 mtm180 -130.05 107.91 9.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.853 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -63.63 -148.76 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.452 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -45.46 153.51 0.66 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.649 2.233 . . . . 0.0 112.385 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 7.8 t0 41.05 42.04 1.46 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.854 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 40.14 44.94 3.01 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.502 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -92.29 107.65 19.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.861 0.362 . . . . 0.0 110.922 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 37.3 p -49.84 105.18 0.08 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.871 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 30.1 mmtp -80.4 43.45 0.64 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.914 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 39.01 50.35 2.67 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.487 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 8.1 p -159.54 151.68 20.85 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.849 0.357 . . . . 0.0 110.835 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -160.04 168.02 26.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.111 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . 0.54 ' CE2' HD12 ' A' ' 183' ' ' LEU . 40.3 m-85 -120.18 135.83 54.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.864 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.431 HG13 ' N ' ' A' ' 197' ' ' LYS . 46.9 t -136.32 142.54 38.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.103 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 0.431 ' N ' HG13 ' A' ' 196' ' ' VAL . 23.2 mttp -117.38 154.1 31.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.885 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -124.17 172.99 8.62 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.901 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 68.3 p -83.24 -33.4 26.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.874 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 11.2 t -141.65 165.1 28.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.851 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 4.8 t60 -67.69 -53.7 25.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.849 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -44.28 -60.28 1.99 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.126 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -46.86 -45.95 20.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.879 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -55.75 -58.43 7.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.111 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 16.5 tp60 -45.11 -49.64 11.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.888 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -53.54 -51.87 61.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.112 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -56.87 -45.12 82.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.107 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . 0.494 ' O ' ' N ' ' A' ' 212' ' ' HIS . 71.4 mt -57.97 -74.06 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.142 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -48.06 -42.54 28.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.883 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -58.31 -37.7 75.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.134 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . 0.419 ' O ' ' CB ' ' A' ' 214' ' ' SER . 41.4 mt -104.53 -72.0 0.72 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.945 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' HIS . . . . . 0.494 ' N ' ' O ' ' A' ' 208' ' ' ILE . 13.0 t60 -46.85 136.59 8.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.876 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 73.67 -6.41 18.18 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.479 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' SER . . . . . 0.419 ' CB ' ' O ' ' A' ' 211' ' ' LEU . 1.3 t -87.97 -71.03 0.6 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.825 0.345 . . . . 0.0 110.883 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.17 178.22 4.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.918 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' THR . . . . . 0.442 ' O ' ' C ' ' A' ' 217' ' ' MET . 56.4 m -134.97 95.29 3.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.132 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' MET . . . . . 0.442 ' C ' ' O ' ' A' ' 216' ' ' THR . 25.5 mmt -34.73 133.58 0.42 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.596 0.712 . . . . 0.0 110.887 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -48.91 117.73 2.98 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.723 2.282 . . . . 0.0 112.297 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 120.27 -54.17 0.66 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.52 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -72.04 159.86 33.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.769 0.319 . . . . 0.0 111.095 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 38.7 t -98.15 -23.9 15.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.881 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 1.9 m -99.98 147.48 25.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.841 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 73.4 m -60.02 156.41 14.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.852 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . 0.44 ' O ' ' ND1' ' A' ' 212' ' ' HIS . 38.2 tp -37.22 153.16 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.903 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 0.414 ' HA ' ' ND1' ' A' ' 212' ' ' HIS . 61.4 t -124.66 111.04 26.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.136 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . 0.406 ' CG2' HD23 ' A' ' 224' ' ' LEU . 41.1 t -132.72 102.1 4.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.137 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 10.6 ptmt -129.48 151.65 49.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.898 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' PHE . . . . . 0.471 ' CE1' HD23 ' A' ' 153' ' ' LEU . 82.1 m-85 -57.3 154.05 11.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.857 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -115.06 151.19 34.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.141 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 12.8 t70 65.0 42.99 3.94 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.882 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 59.8 p -129.19 161.0 31.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.164 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -130.76 134.22 46.68 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.871 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 23.5 pttm -55.44 141.52 36.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.9 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -161.73 164.03 29.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.916 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 40.0 t -88.38 95.08 10.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.854 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -124.86 78.51 0.37 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.505 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -78.61 37.4 0.65 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.664 2.243 . . . . 0.0 112.345 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 72.3 p -128.52 172.84 10.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.883 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 9.6 t -114.46 168.62 9.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.851 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.338 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.474 179.999 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.343 0 N-CA-C 112.515 -0.234 . . . . 0.0 112.515 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 23.3 t -60.79 90.23 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.829 0.347 . . . . 0.0 110.864 -179.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 8.0 m -50.85 107.2 0.16 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.864 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 120.15 -133.08 9.69 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.501 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 56.3 p -147.68 139.97 24.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.867 0.365 . . . . 0.0 110.831 -179.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 3.4 t -98.85 42.97 1.07 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.846 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 64.73 69.65 1.28 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.422 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 22.5 p -100.17 73.07 1.69 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.846 0.355 . . . . 0.0 110.862 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.404 HD22 ' N ' ' A' ' 144' ' ' LEU . 1.3 pt? -155.3 174.12 15.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.909 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.403 ' O ' ' C ' ' A' ' 146' ' ' GLN . 1.0 OUTLIER -99.35 161.74 13.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.854 179.926 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . 0.403 ' C ' ' O ' ' A' ' 145' ' ' ARG . 20.8 tt0 -37.47 99.5 0.19 Allowed Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.625 0.726 . . . . 0.0 110.93 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -44.3 147.27 1.58 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.73 2.287 . . . . 0.0 112.316 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -46.87 141.01 12.39 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.735 2.29 . . . . 0.0 112.33 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 2.4 m -72.07 -177.85 2.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.839 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 13.0 p80 38.83 45.97 1.0 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.895 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.708 ' H ' ' NE ' ' A' ' 151' ' ' ARG . 0.0 OUTLIER -77.53 154.91 31.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.858 -179.843 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.443 ' HB3' ' CB ' ' A' ' 229' ' ' ALA . 2.5 tptt -140.6 156.54 46.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.876 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.434 HD11 ' CD1' ' A' ' 198' ' ' TYR . 41.6 mt -124.54 118.41 26.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.922 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -89.8 120.73 31.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.905 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 20.7 t -116.33 118.09 57.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.143 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -118.2 -155.8 10.09 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.499 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 16.5 mmt 47.42 34.59 3.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.786 0.327 . . . . 0.0 110.863 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 69.3 mt -95.51 165.87 12.14 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.941 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -102.27 162.21 13.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.895 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 40.4 mttp -85.48 32.89 0.56 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.897 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 3.5 tp60 -120.89 -50.51 2.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.913 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -44.31 159.82 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.893 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 4.9 m -139.06 168.5 19.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.866 -179.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -49.97 -48.73 52.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.885 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -53.31 -56.3 17.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.87 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -48.33 -67.59 0.26 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.87 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.555 HG12 ' CE1' ' A' ' 171' ' ' PHE . 65.3 t -49.99 -53.17 11.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.099 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . 0.429 ' C ' ' O ' ' A' ' 167' ' ' VAL . 1.5 tmm_? -36.25 -63.65 0.37 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.844 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 19.7 mtp180 -63.89 -51.89 62.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.915 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.506 ' O ' ' CB ' ' A' ' 173' ' ' ALA . 16.5 tp -43.29 -65.8 0.45 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.953 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.555 ' CE1' HG12 ' A' ' 167' ' ' VAL . 9.3 m-85 -55.7 -68.33 0.21 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.884 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -44.81 -21.96 0.07 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.882 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.506 ' CB ' ' O ' ' A' ' 170' ' ' LEU . . . -50.11 -17.75 0.46 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.126 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -118.3 -71.74 0.72 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.916 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -109.51 145.83 16.83 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.463 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -55.84 145.59 24.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.836 0.35 . . . . 0.0 110.872 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 50.7 mt -109.26 135.06 49.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.127 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . 0.429 ' HB3' ' CE ' ' A' ' 197' ' ' LYS . 13.0 mt-10 -97.86 -39.09 9.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.897 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 23.2 tp10 -148.17 144.43 27.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.879 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 44.9 t -143.78 137.99 28.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.896 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' THR . . . . . 0.465 HG21 ' N ' ' A' ' 182' ' ' ILE . 22.4 m -154.53 137.29 15.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.096 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.465 ' N ' HG21 ' A' ' 181' ' ' THR . 26.4 mm -96.83 126.43 49.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.103 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.664 ' CD1' ' CE2' ' A' ' 195' ' ' PHE . 28.7 mt -81.73 108.88 15.64 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.928 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' ARG . . . . . 0.478 ' CB ' ' HA ' ' A' ' 190' ' ' SER . 5.6 ptp180 -169.08 142.91 2.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.885 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -78.25 -145.43 2.67 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.488 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -75.56 -167.32 0.42 Allowed 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.735 2.29 . . . . 0.0 112.336 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . 0.424 ' O ' ' C ' ' A' ' 188' ' ' GLY . 22.0 t0 40.32 34.44 0.22 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.845 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' A' ' 187' ' ' ASP . . . 36.41 45.16 0.92 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.454 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -91.39 75.92 5.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.821 0.343 . . . . 0.0 110.895 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' SER . . . . . 0.478 ' HA ' ' CB ' ' A' ' 184' ' ' ARG . 48.5 t -43.35 134.24 3.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.904 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 52.5 mttm -100.68 34.53 2.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.875 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 41.11 39.54 2.13 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.463 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 65.1 m -154.6 149.03 26.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.833 0.349 . . . . 0.0 110.889 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -163.14 154.63 17.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.101 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . 0.664 ' CE2' ' CD1' ' A' ' 183' ' ' LEU . 69.7 m-85 -105.38 136.69 44.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.873 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 48.4 t -133.76 140.45 46.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.147 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 0.429 ' CE ' ' HB3' ' A' ' 178' ' ' GLU . 22.0 ttpt -116.84 142.8 46.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.856 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . 0.434 ' CD1' HD11 ' A' ' 153' ' ' LEU . 9.5 m-85 -119.86 170.2 9.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.895 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 24.7 t -69.2 -48.24 62.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.866 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 59.5 p -145.81 173.05 12.45 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.9 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . 0.443 ' O ' ' C ' ' A' ' 202' ' ' ALA . 6.5 t60 -59.46 -56.48 21.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.823 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . 0.443 ' C ' ' O ' ' A' ' 201' ' ' HIS . . . -34.74 -69.81 0.09 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.122 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -47.1 -47.31 23.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.887 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -53.33 -58.06 8.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.061 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 3.2 tp60 -47.91 -40.03 20.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.929 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -59.81 -53.71 54.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.084 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -61.93 -25.66 67.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.127 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . 0.495 ' O ' ' N ' ' A' ' 212' ' ' HIS . 79.2 mt -71.15 -67.79 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.13 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -57.31 -38.88 74.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.877 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -63.5 -41.73 98.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.147 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 63.7 mt -100.73 -72.09 0.69 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.909 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' HIS . . . . . 0.495 ' N ' ' O ' ' A' ' 208' ' ' ILE . 1.4 t60 -52.15 130.48 30.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.872 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 72.54 -0.98 39.15 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.523 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 22.5 t -96.88 -71.89 0.66 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.782 0.325 . . . . 0.0 110.859 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -99.5 172.37 7.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.866 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 34.2 m -123.55 105.35 9.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.125 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 15.4 mmt -43.18 139.03 2.43 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.514 0.674 . . . . 0.0 110.929 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -48.31 120.74 5.33 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.681 2.254 . . . . 0.0 112.338 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 105.88 -53.97 0.62 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.485 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -66.68 146.93 53.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.845 0.355 . . . . 0.0 111.092 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 29.4 m -93.19 -17.29 23.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.826 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 9.8 p -100.01 151.29 21.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.861 -179.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 44.1 m -65.6 148.08 52.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.865 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . 0.435 ' O ' ' ND1' ' A' ' 212' ' ' HIS . 63.8 tp -39.56 149.83 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.914 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 61.9 t -121.89 106.52 18.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.129 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . 0.423 ' H ' ' CG ' ' A' ' 212' ' ' HIS . 28.7 t -126.17 104.99 13.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.137 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 46.2 pttt -120.31 176.36 5.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.924 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -83.61 114.65 21.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.927 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . 0.443 ' CB ' ' HB3' ' A' ' 152' ' ' LYS . . . -59.39 127.3 31.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.105 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -83.23 173.07 11.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.874 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 41.4 m -160.32 129.26 4.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.151 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . 0.488 ' OD1' ' N ' ' A' ' 233' ' ' LYS . 26.4 t0 -58.38 146.44 34.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.864 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . 0.488 ' N ' ' OD1' ' A' ' 232' ' ' ASP . 14.0 ttmm -171.45 145.17 2.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.885 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -148.25 125.4 11.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.885 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.5 t -169.75 158.1 7.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.908 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 54.96 -171.67 1.2 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.482 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -76.83 155.54 34.67 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.693 2.262 . . . . 0.0 112.321 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 56.6 m -84.26 151.22 24.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.845 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 3.0 m -109.94 129.03 55.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.837 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.33 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.463 179.995 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.319 0 N-CA-C 112.489 -0.245 . . . . 0.0 112.489 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 59.5 p -161.23 130.66 4.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.881 0.372 . . . . 0.0 110.886 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 2.5 t 59.39 42.23 18.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.81 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -78.7 -98.55 0.23 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.522 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 79.1 p -85.63 97.28 10.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.887 0.375 . . . . 0.0 110.892 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 7.0 t -172.53 134.28 0.65 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.857 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -154.22 73.55 0.25 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.478 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 19.3 p -162.92 148.74 12.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.877 0.37 . . . . 0.0 110.896 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -97.6 40.82 1.14 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.95 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -131.19 119.18 21.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.843 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 3.0 pm0 -52.93 143.92 29.07 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.621 0.724 . . . . 0.0 110.899 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -46.52 145.76 5.88 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.678 2.252 . . . . 0.0 112.333 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -47.0 -41.93 25.83 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.665 2.243 . . . . 0.0 112.357 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 66.3 m 46.17 37.5 4.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.858 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . 0.427 ' CB ' ' HB3' ' A' ' 228' ' ' PHE . 22.1 m80 -69.78 -176.66 1.1 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.899 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 20.3 mtt180 -133.2 -38.89 0.94 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.855 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.423 ' HE3' ' CB ' ' A' ' 195' ' ' PHE . 20.6 tttp -84.48 121.94 28.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.874 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.563 HD22 ' CE1' ' A' ' 228' ' ' PHE . 25.0 mt -96.63 154.35 17.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.923 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 79.1 t80 -125.0 114.14 18.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.892 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.501 HG23 ' CZ ' ' A' ' 171' ' ' PHE . 17.4 t -102.75 110.51 29.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.108 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -111.99 -171.6 18.82 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.471 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 10.5 mmt 59.66 28.08 17.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.795 0.331 . . . . 0.0 110.845 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 46.3 mt -91.17 165.99 13.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.933 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -108.64 166.56 10.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.904 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 33.0 mttt -84.6 51.7 2.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.91 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -134.88 -50.67 0.77 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.957 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -51.67 163.36 0.31 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.872 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 44.5 m -138.14 172.47 12.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.882 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -53.73 -45.13 70.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.898 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -57.43 -51.38 69.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.847 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -50.99 -65.73 0.51 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.876 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.419 HG11 ' CE1' ' A' ' 171' ' ' PHE . 58.3 t -57.8 -36.57 55.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.137 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 14.2 tpp85 -54.58 -62.72 1.47 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.868 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 68.3 mtp180 -64.87 -51.52 61.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.864 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.497 ' O ' ' CB ' ' A' ' 173' ' ' ALA . 13.0 tp -43.85 -65.51 0.49 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.912 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.501 ' CZ ' HG23 ' A' ' 155' ' ' VAL . 6.6 m-85 -55.84 -67.95 0.25 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.858 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.509 ' C ' ' CD ' ' A' ' 172' ' ' GLU . 0.6 OUTLIER -45.43 -21.56 0.1 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.886 -179.91 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.497 ' CB ' ' O ' ' A' ' 170' ' ' LEU . . . -50.11 -18.97 0.64 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.098 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -110.27 -65.96 1.11 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.908 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -107.33 -165.53 21.98 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.478 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -100.01 132.84 45.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.778 0.323 . . . . 0.0 110.886 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . 0.401 HG23 ' N ' ' A' ' 178' ' ' GLU . 29.6 mt -101.89 138.32 26.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.089 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . 0.401 ' N ' HG23 ' A' ' 177' ' ' ILE . 12.2 mm-40 -98.96 -32.82 11.11 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.862 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -160.83 152.31 19.32 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.885 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 38.6 t -136.1 121.49 19.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.902 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 97.8 m -123.86 139.08 54.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.152 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 50.6 mm -115.57 114.54 46.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.134 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 18.8 mt -77.75 98.92 5.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.914 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 9.6 mtm105 -109.83 25.35 11.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.868 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 58.92 148.6 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.504 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -47.27 -17.72 0.58 Allowed 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.66 2.24 . . . . 0.0 112.311 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -78.18 -44.45 25.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.894 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 125.48 -21.0 6.45 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.504 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 10.2 m-20 -76.17 127.87 33.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.854 0.359 . . . . 0.0 110.887 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 4.6 t -47.68 133.86 13.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.816 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 2.6 mmmp? -105.56 15.51 26.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.91 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 62.47 32.24 82.42 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.497 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 11.1 m -148.04 142.96 26.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.794 0.331 . . . . 0.0 110.879 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -160.04 160.2 32.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.095 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . 0.423 ' CB ' ' HE3' ' A' ' 152' ' ' LYS . 77.4 m-85 -115.54 133.57 55.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.892 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 92.9 t -116.68 128.74 73.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.14 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 19.1 tttp -95.87 145.2 25.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.888 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . 0.477 ' CD1' HD11 ' A' ' 153' ' ' LEU . 7.6 m-85 -129.07 171.6 12.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.924 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 91.3 p -85.58 -20.91 28.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.885 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 2.2 m -162.01 176.42 10.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.772 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -77.16 -37.68 53.32 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.864 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -52.82 -65.31 0.58 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.102 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 18.2 mp0 -48.47 -41.29 29.25 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.88 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -58.85 -59.8 4.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.074 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 43.1 tp60 -45.64 -42.02 10.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.937 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -60.48 -52.74 63.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.101 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -62.74 -28.39 69.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.112 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . 0.501 ' O ' ' N ' ' A' ' 212' ' ' HIS . 93.2 mt -67.41 -75.11 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.121 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -46.25 -43.4 15.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.893 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -55.99 -41.93 75.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.095 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 71.6 mt -100.94 -69.57 0.77 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.873 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' HIS . . . . . 0.501 ' N ' ' O ' ' A' ' 208' ' ' ILE . 27.1 t60 -52.4 125.62 16.71 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.902 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 84.6 -10.22 62.66 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.507 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 51.7 m -97.71 -74.43 0.58 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.84 0.353 . . . . 0.0 110.845 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 19.9 mp0 -88.43 166.42 14.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.928 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 216' ' ' THR . . . . . 0.404 ' O ' ' C ' ' A' ' 217' ' ' MET . 32.4 m -135.79 106.39 6.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.141 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 217' ' ' MET . . . . . 0.404 ' C ' ' O ' ' A' ' 216' ' ' THR . 15.5 mmt -37.31 156.37 0.09 OUTLIER Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.547 0.689 . . . . 0.0 110.878 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.09 120.61 7.31 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.656 2.237 . . . . 0.0 112.323 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 109.36 -42.63 1.9 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.466 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -76.4 144.3 40.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.767 0.317 . . . . 0.0 111.089 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 3.5 t -93.57 -15.28 25.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.812 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 67.6 m -100.17 142.09 32.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.904 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 64.7 m -57.72 157.13 7.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.824 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 47.7 tp -48.35 148.81 1.77 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.916 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 0.42 ' HA ' ' ND1' ' A' ' 212' ' ' HIS . 53.0 t -119.73 111.17 31.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.101 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 25.7 t -132.68 101.31 4.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.117 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.81 158.4 42.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.897 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 228' ' ' PHE . . . . . 0.563 ' CE1' HD22 ' A' ' 153' ' ' LEU . 28.6 m-85 -69.97 68.8 0.31 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.887 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . 0.472 ' C ' ' O ' ' A' ' 228' ' ' PHE . . . 32.0 44.22 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.048 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -78.69 155.38 29.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.894 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 231' ' ' THR . . . . . 0.465 ' O ' ' N ' ' A' ' 233' ' ' LYS . 1.7 m -161.97 105.17 1.18 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.161 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -40.2 93.64 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.842 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . 0.465 ' N ' ' O ' ' A' ' 231' ' ' THR . 44.1 tttp -138.32 110.49 7.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.914 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -117.66 131.53 56.63 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.878 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 83.8 p -121.16 39.45 3.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.877 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 108.31 149.41 14.26 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.494 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -76.78 118.35 4.79 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.698 2.265 . . . . 0.0 112.358 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 44.7 t -53.39 156.96 2.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.817 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 41.3 t -166.85 121.05 1.05 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.864 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.379 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.496 -179.978 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.306 0 N-CA-C 112.517 -0.233 . . . . 0.0 112.517 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 40.9 t -129.63 130.09 45.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.875 0.369 . . . . 0.0 110.894 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 38.8 m -111.77 -48.95 3.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.878 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -172.23 57.26 0.16 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.535 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 16.4 m -83.08 130.25 35.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.939 0.4 . . . . 0.0 110.858 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 79.2 p -88.96 165.72 14.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.839 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -129.2 -71.96 0.14 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.454 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 99.3 m -58.87 -49.23 78.56 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.834 0.35 . . . . 0.0 110.892 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -43.92 121.62 2.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.926 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.3 106.19 18.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.837 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 8.8 mm100 -78.91 160.48 71.44 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.617 0.722 . . . . 0.0 110.899 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -45.61 166.92 0.05 OUTLIER 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.65 2.234 . . . . 0.0 112.37 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -76.99 84.7 1.89 Allowed 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.642 2.228 . . . . 0.0 112.303 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' SER . . . . . 0.47 ' O ' ' CG ' ' A' ' 150' ' ' HIS . 54.9 p -110.95 159.93 17.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.872 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . 0.47 ' CG ' ' O ' ' A' ' 149' ' ' SER . 29.3 m80 -159.19 157.05 30.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.865 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 6.0 mmp_? 56.42 49.48 14.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.898 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.566 ' HE2' ' CD1' ' A' ' 195' ' ' PHE . 3.8 ttpm? -118.02 160.71 21.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.886 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 40.5 mt -129.65 123.97 32.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.886 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -90.19 119.33 30.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.9 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 5.1 t -107.22 124.7 63.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.121 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -124.85 -168.37 12.78 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.475 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 18.0 mmt 48.45 35.13 5.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.773 0.32 . . . . 0.0 110.896 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 38.3 mt -89.2 166.15 14.0 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.915 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -104.51 160.08 15.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.874 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 24.1 mttp -84.49 23.98 1.05 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.914 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -109.56 -55.21 2.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.909 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -53.4 146.05 13.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.88 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 57.7 m -126.38 166.37 17.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.864 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -44.13 -40.23 4.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.861 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -55.97 -66.08 0.49 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.872 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -52.81 -48.42 66.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.872 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.473 HG13 ' CD1' ' A' ' 171' ' ' PHE . 93.9 t -57.45 -35.24 48.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.099 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 51.4 ttt180 -63.81 -57.87 8.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.843 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 8.5 ptm180 -64.15 -53.24 52.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.85 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.515 ' O ' ' CB ' ' A' ' 173' ' ' ALA . 8.5 tp -43.72 -65.26 0.52 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.916 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.495 ' CE2' HG23 ' A' ' 196' ' ' VAL . 10.9 m-85 -53.03 -68.9 0.13 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.884 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -45.75 -24.19 0.34 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.894 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.515 ' CB ' ' O ' ' A' ' 170' ' ' LEU . . . -49.4 -21.23 0.84 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.073 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -111.77 -71.37 0.76 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.879 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -112.21 146.83 18.16 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.462 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . 0.45 ' O ' ' CD2' ' A' ' 198' ' ' TYR . 32.6 m120 -51.57 160.3 0.64 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.816 0.341 . . . . 0.0 110.926 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . 0.411 ' CG2' ' N ' ' A' ' 178' ' ' GLU . 19.3 mt -124.73 152.37 30.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.128 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . 0.411 ' N ' ' CG2' ' A' ' 177' ' ' ILE . 9.1 mt-10 -120.49 -28.92 4.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.868 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -155.76 146.78 22.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.871 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 4.8 t -147.32 132.91 18.76 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.927 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 99.5 m -151.32 145.13 25.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.141 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 18.5 mm -97.25 137.48 24.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.14 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.55 HD13 ' CE2' ' A' ' 195' ' ' PHE . 52.9 mt -100.36 98.75 9.36 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.914 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' ARG . . . . . 0.465 ' CB ' ' HA ' ' A' ' 190' ' ' SER . 24.4 ptt180 -154.27 163.4 40.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.853 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -87.47 -147.48 12.48 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.755 -0.735 . . . . 0.0 112.461 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -76.36 -175.72 2.71 Favored 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.688 2.259 . . . . 0.0 112.358 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . 0.431 ' HB3' ' ND2' ' A' ' 189' ' ' ASN . 5.2 t70 41.59 32.94 0.27 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.867 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 44.13 46.04 7.98 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.481 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . 0.431 ' ND2' ' HB3' ' A' ' 187' ' ' ASP . 19.2 m-80 -88.17 69.69 9.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.865 0.364 . . . . 0.0 110.89 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' SER . . . . . 0.465 ' HA ' ' CB ' ' A' ' 184' ' ' ARG . 10.8 t -35.91 119.6 0.57 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.876 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 24.5 mmtt -90.82 36.16 0.9 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.918 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 43.28 37.61 3.41 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.468 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . 0.407 ' C ' ' HB2' ' A' ' 183' ' ' LEU . 72.1 m -150.49 150.4 31.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.799 0.333 . . . . 0.0 110.868 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -163.09 169.2 19.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.077 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . 0.566 ' CD1' ' HE2' ' A' ' 152' ' ' LYS . 18.2 m-85 -122.96 135.77 54.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.853 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.495 HG23 ' CE2' ' A' ' 171' ' ' PHE . 61.3 t -130.75 140.69 48.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.121 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 25.3 ttmt -117.44 146.49 43.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.856 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . 0.45 ' CD2' ' O ' ' A' ' 176' ' ' ASN . 24.6 m-85 -124.23 166.42 15.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.919 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 42.3 t -70.03 -48.74 56.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.828 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 7.3 t -136.82 168.69 19.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.859 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . 0.449 ' O ' ' C ' ' A' ' 202' ' ' ALA . 4.7 t60 -61.35 -57.34 12.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.85 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . 0.449 ' C ' ' O ' ' A' ' 201' ' ' HIS . . . -33.99 -67.03 0.14 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.093 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 19.4 mp0 -49.83 -39.59 39.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.879 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . 0.424 ' N ' ' O ' ' A' ' 201' ' ' HIS . . . -55.65 -51.82 65.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.092 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 59.6 tp60 -57.29 -45.18 84.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.876 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -51.93 -47.69 64.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.104 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -69.48 -29.88 67.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.136 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . 0.482 ' O ' ' N ' ' A' ' 212' ' ' HIS . 56.3 mt -66.94 -60.44 2.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.125 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -64.22 -36.95 85.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.869 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -66.6 -35.56 80.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.122 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . 0.439 ' HB3' ' CD2' ' A' ' 224' ' ' LEU . 84.5 mt -102.51 -69.33 0.79 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.902 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 212' ' ' HIS . . . . . 0.482 ' N ' ' O ' ' A' ' 208' ' ' ILE . 12.2 t60 -62.97 126.19 26.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.835 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 85.7 -4.28 86.0 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.495 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 2.1 m -94.43 -74.12 0.55 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.84 0.353 . . . . 0.0 110.854 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 17.2 pm0 -99.88 175.63 5.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.894 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 17.3 m -130.33 101.37 5.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.106 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 13.5 mmt -37.08 134.45 0.68 Allowed Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.608 0.718 . . . . 0.0 110.884 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -48.71 119.88 4.71 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.668 2.246 . . . . 0.0 112.342 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 112.89 -49.86 0.81 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.513 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -73.38 156.76 38.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.813 0.34 . . . . 0.0 111.081 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 94.7 p -98.88 -21.14 16.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.837 -179.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 1.8 m -100.15 143.31 30.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.855 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 15.1 m -56.88 153.49 10.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.921 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . 0.439 ' CD2' ' HB3' ' A' ' 211' ' ' LEU . 58.5 tp -40.17 149.62 0.07 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.865 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 0.41 ' HA ' ' ND1' ' A' ' 212' ' ' HIS . 79.9 t -118.35 113.71 42.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.18 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 20.5 t -138.97 104.97 2.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.15 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 44.7 pttt -127.4 178.96 5.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.862 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -83.44 133.63 34.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.878 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -85.87 96.86 9.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.138 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -109.1 37.0 2.69 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.885 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 231' ' ' THR . . . . . 0.407 ' CG2' ' O ' ' A' ' 231' ' ' THR . 9.0 t -87.97 80.69 7.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.137 -179.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -170.92 129.38 0.77 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.824 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 16.5 tttt -88.48 103.8 16.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.939 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -107.88 137.14 46.41 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.889 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 32.8 p -124.0 146.8 48.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.865 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -136.17 95.21 0.24 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.451 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -76.99 44.1 1.4 Allowed 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.694 2.262 . . . . 0.0 112.389 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 9.0 m -43.03 -54.3 4.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.885 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 39.8 t -111.13 101.97 10.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.866 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.303 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.474 -179.988 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.34 0 N-CA-C 112.498 -0.241 . . . . 0.0 112.498 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 15.2 t -84.87 120.61 26.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.914 0.388 . . . . 0.0 110.861 -179.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 48.3 p -100.45 158.13 16.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.871 -179.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 117.58 119.91 3.03 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.475 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 32.9 t -107.57 -42.38 4.79 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.913 0.387 . . . . 0.0 110.863 -179.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 6.4 t 47.96 44.3 18.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.874 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -151.02 -38.45 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.476 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 10.1 t -91.77 52.92 2.11 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.873 0.368 . . . . 0.0 110.904 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.9 mp -80.18 -48.97 12.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.892 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.431 ' O ' ' C ' ' A' ' 146' ' ' GLN . 2.8 ptp85 -113.64 -44.06 3.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.892 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . 0.431 ' C ' ' O ' ' A' ' 145' ' ' ARG . 19.4 mt-30 -36.09 143.59 0.28 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.598 0.713 . . . . 0.0 110.897 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -78.58 112.13 3.11 Favored 'Trans proline' 0 C--O 1.231 0.142 0 C-N-CA 122.707 2.271 . . . . 0.0 112.324 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.438 ' O ' ' C ' ' A' ' 149' ' ' SER . 71.9 Cg_exo -44.58 -45.85 12.74 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.684 2.256 . . . . 0.0 112.308 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' SER . . . . . 0.438 ' C ' ' O ' ' A' ' 148' ' ' PRO . 2.3 t 35.05 46.63 0.22 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.877 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . 0.529 ' O ' ' CG ' ' A' ' 150' ' ' HIS . 12.5 p-80 -165.97 117.42 1.05 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.853 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 23.7 ptt180 -108.62 40.97 1.67 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.899 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 5.8 ttpm? -97.62 162.1 13.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.904 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.446 HD11 ' CD1' ' A' ' 198' ' ' TYR . 59.5 mt -136.92 140.72 42.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.891 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 35.5 t80 -107.36 121.05 43.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.915 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 23.9 t -110.26 132.1 59.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.161 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -133.04 -161.5 9.87 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.512 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 19.5 mmt 49.04 30.55 2.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.819 0.342 . . . . 0.0 110.875 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 82.0 mt -91.05 166.69 12.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.924 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -108.94 155.82 20.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.882 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 36.2 mttp -81.38 44.73 0.81 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.868 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -127.93 -47.42 1.37 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.922 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 14.8 mm-40 -58.73 162.11 4.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.894 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 45.9 m -135.02 174.44 10.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.854 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . 0.451 ' O ' ' CB ' ' A' ' 168' ' ' ARG . 1.4 mp0 -51.35 -35.62 39.26 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.871 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -63.25 -65.89 0.62 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.904 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -42.21 -57.01 2.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.892 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.569 HG12 ' CD1' ' A' ' 171' ' ' PHE . 75.5 t -62.66 -59.89 3.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.12 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . 0.451 ' CB ' ' O ' ' A' ' 164' ' ' GLU . 29.9 ttm-85 -35.29 -63.91 0.31 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.874 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 83.7 mtm180 -59.16 -54.59 45.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.877 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.505 ' O ' ' CB ' ' A' ' 173' ' ' ALA . 16.2 tp -42.8 -66.02 0.41 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.896 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.569 ' CD1' HG12 ' A' ' 167' ' ' VAL . 13.4 m-85 -51.7 -72.06 0.06 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.891 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -41.52 -31.79 0.29 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.915 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.505 ' CB ' ' O ' ' A' ' 170' ' ' LEU . . . -39.62 -30.16 0.07 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.06 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -107.85 -68.83 0.88 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.879 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -111.88 131.75 10.42 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.504 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -48.78 147.71 2.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.852 0.358 . . . . 0.0 110.849 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . 0.466 HG22 ' N ' ' A' ' 178' ' ' GLU . 67.2 mt -112.77 138.66 41.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.119 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . 0.466 ' N ' HG22 ' A' ' 177' ' ' ILE . 67.7 mm-40 -98.7 -36.23 9.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.842 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -148.6 139.23 22.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.845 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 47.9 t -145.12 138.47 26.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.855 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 18.1 m -152.83 148.94 27.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.199 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.417 HG22 ' N ' ' A' ' 183' ' ' LEU . 35.2 mm -102.26 134.91 41.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.152 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.417 ' N ' HG22 ' A' ' 182' ' ' ILE . 29.4 mt -80.81 117.05 21.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.919 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 64.4 mtp180 -132.17 121.14 23.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.843 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -69.48 171.55 40.37 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.513 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -45.57 -41.29 18.65 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.705 2.27 . . . . 0.0 112.332 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -59.92 -40.0 87.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.87 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 121.5 -45.02 1.26 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.484 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -54.07 112.43 0.96 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.812 0.339 . . . . 0.0 110.896 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 23.2 t -45.41 137.58 4.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.826 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.404 ' O ' ' C ' ' A' ' 192' ' ' GLY . 8.7 mtmp? -89.7 47.21 1.44 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.884 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.404 ' C ' ' O ' ' A' ' 191' ' ' LYS . . . 37.37 46.66 1.45 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.507 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 87.1 m -155.19 156.69 36.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.852 0.358 . . . . 0.0 110.881 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -160.61 166.86 28.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.085 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -119.73 119.6 34.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.905 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.531 HG23 ' CE2' ' A' ' 171' ' ' PHE . 21.9 t -114.04 152.34 15.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.138 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 23.0 tttp -135.61 137.3 41.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.913 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . 0.446 ' CD1' HD11 ' A' ' 153' ' ' LEU . 16.6 m-85 -113.31 162.43 16.06 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.876 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 11.8 t -65.95 -52.11 52.59 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.873 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 5.7 t -124.0 170.86 10.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.836 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 6.5 t60 -69.23 -51.03 41.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.854 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -42.74 -64.57 0.59 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.091 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -46.38 -43.07 15.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.88 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -53.07 -62.07 1.89 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.134 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 50.4 tp60 -46.61 -47.06 20.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.905 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -49.19 -57.88 5.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.118 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -54.72 -44.01 73.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.072 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . 0.502 ' O ' ' N ' ' A' ' 212' ' ' HIS . 75.7 mt -51.12 -72.83 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.141 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -54.83 -38.76 67.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.868 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -61.43 -31.4 71.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.111 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 98.5 mt -114.34 -73.85 0.64 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.873 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 212' ' ' HIS . . . . . 0.502 ' N ' ' O ' ' A' ' 208' ' ' ILE . 14.6 t60 -49.5 131.92 20.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.847 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 78.3 -10.24 29.74 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.515 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 25.6 t -99.22 -69.27 0.77 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.818 0.342 . . . . 0.0 110.87 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 7.1 mm-40 -88.11 159.39 18.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.931 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 216' ' ' THR . . . . . 0.409 ' O ' ' C ' ' A' ' 217' ' ' MET . 2.9 m -125.34 99.04 5.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.175 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 217' ' ' MET . . . . . 0.409 ' C ' ' O ' ' A' ' 216' ' ' THR . 12.1 mmt -35.96 135.07 0.53 Allowed Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.568 0.699 . . . . 0.0 110.879 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -48.21 121.31 5.93 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.719 2.28 . . . . 0.0 112.331 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 108.06 -48.57 0.93 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.483 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -75.15 144.6 42.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.792 0.33 . . . . 0.0 111.117 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 7.0 t -92.65 -16.0 26.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.872 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 67.9 m -99.99 138.37 37.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.846 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 66.2 m -52.83 155.71 2.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.857 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . 0.446 ' O ' ' ND1' ' A' ' 212' ' ' HIS . 50.8 tp -45.57 157.73 0.09 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.89 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 55.0 t -122.67 104.46 14.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.167 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 21.0 t -134.78 108.87 11.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.106 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.94 -179.54 4.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.852 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 228' ' ' PHE . . . . . 0.402 ' CD1' HD21 ' A' ' 153' ' ' LEU . 69.2 m-85 -80.5 96.9 6.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.865 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -50.39 124.86 11.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.096 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -105.33 130.48 53.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.898 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 14.0 t -52.08 156.32 1.62 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.175 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -115.67 -45.9 2.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.87 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -125.29 81.63 1.99 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.935 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -59.86 122.0 13.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.923 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 5.3 p -108.7 155.96 20.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.835 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 147.42 160.12 8.71 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.472 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -76.73 129.52 10.89 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.66 2.24 . . . . 0.0 112.344 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 6.1 t -68.41 150.7 47.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.881 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 90.4 p -106.68 135.49 48.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.859 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.333 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.513 -179.959 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.339 0 N-CA-C 112.497 -0.241 . . . . 0.0 112.497 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 63.6 p -80.63 80.78 7.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.924 0.392 . . . . 0.0 110.862 -179.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 3.7 t -118.64 141.72 48.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.838 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.42 ' O ' ' C ' ' A' ' 140' ' ' SER . . . 47.41 58.66 6.4 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.501 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.42 ' C ' ' O ' ' A' ' 139' ' ' GLY . 19.5 m -36.86 116.43 0.44 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.835 0.35 . . . . 0.0 110.827 -179.771 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 84.1 p -67.16 -46.13 74.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.847 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 138.97 87.94 0.17 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.473 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 68.8 m -104.19 94.29 5.29 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.82 0.343 . . . . 0.0 110.9 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.3 tt -112.72 110.0 19.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.947 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 17.3 ptt180 -143.17 167.05 23.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.914 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -121.2 83.7 39.39 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.604 0.716 . . . . 0.0 110.923 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -47.26 110.42 0.3 Allowed 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.642 2.228 . . . . 0.0 112.326 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.449 ' O ' ' C ' ' A' ' 149' ' ' SER . 72.3 Cg_exo -43.83 102.46 0.04 OUTLIER 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.705 2.27 . . . . 0.0 112.305 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' SER . . . . . 0.449 ' C ' ' O ' ' A' ' 148' ' ' PRO . 3.4 m -34.65 128.67 0.44 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.864 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . 0.46 ' CB ' ' HB3' ' A' ' 228' ' ' PHE . 12.0 m80 -162.77 146.61 11.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.836 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 11.2 tpp180 -103.36 -40.0 6.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.921 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.549 ' HE3' ' CD1' ' A' ' 195' ' ' PHE . 19.1 ttpt -88.71 147.04 24.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.93 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.444 ' CD1' ' CD1' ' A' ' 198' ' ' TYR . 37.9 mt -121.3 127.44 51.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.924 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -92.37 130.97 37.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.855 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 39.0 t -121.47 126.8 75.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.167 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -127.97 -172.3 13.19 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.513 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' MET . . . . . 0.43 ' CG ' HG23 ' A' ' 225' ' ' VAL . 82.2 mmm 51.38 39.54 24.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.773 0.32 . . . . 0.0 110.89 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 50.7 mt -93.39 171.43 8.92 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.936 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -100.44 160.73 14.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.891 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 24.2 mttp -89.87 34.59 0.84 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.91 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -127.92 -43.62 1.51 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.859 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -47.05 155.94 0.25 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.907 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 5.8 m -132.9 171.88 13.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.871 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . 0.464 ' O ' ' CB ' ' A' ' 168' ' ' ARG . 2.9 mp0 -55.24 -37.68 67.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.882 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -64.96 -44.98 87.62 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.874 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 -60.41 -59.39 5.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.874 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.571 HG12 ' CD1' ' A' ' 171' ' ' PHE . 96.2 t -62.17 -39.3 83.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.144 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . 0.464 ' CB ' ' O ' ' A' ' 164' ' ' GLU . 33.2 ttt180 -55.28 -63.13 1.26 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.832 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 74.7 mtt180 -60.91 -54.02 50.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.859 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.501 ' O ' ' CB ' ' A' ' 173' ' ' ALA . 10.0 tp -43.93 -65.64 0.48 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.866 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.571 ' CD1' HG12 ' A' ' 167' ' ' VAL . 10.6 m-85 -51.07 -70.39 0.09 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.879 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -44.14 -30.44 0.77 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.89 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.501 ' CB ' ' O ' ' A' ' 170' ' ' LEU . . . -42.81 -28.05 0.22 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.127 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -106.46 -68.97 0.85 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.889 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -113.42 135.23 12.42 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.521 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -45.71 153.27 0.28 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.784 0.326 . . . . 0.0 110.897 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . 0.453 HG22 ' N ' ' A' ' 178' ' ' GLU . 58.2 mt -118.18 153.06 20.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.148 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . 0.453 ' N ' HG22 ' A' ' 177' ' ' ILE . 55.6 mt-10 -117.11 -37.72 3.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.885 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -144.7 140.36 28.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.931 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 10.1 t -140.01 134.14 31.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.854 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' THR . . . . . 0.466 HG21 ' N ' ' A' ' 182' ' ' ILE . 86.0 m -153.22 143.74 22.58 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.124 -179.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.466 ' N ' HG21 ' A' ' 181' ' ' THR . 9.7 mm -104.39 133.31 48.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.141 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 22.1 mt -82.28 116.71 21.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.944 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 79.7 mtm180 -130.64 134.83 47.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.915 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -70.88 168.15 50.27 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.464 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -45.51 -51.02 8.55 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.7 2.266 . . . . 0.0 112.337 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -55.62 -43.23 75.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.843 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 137.55 -50.16 0.83 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.443 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 21.2 m-20 -42.82 125.96 3.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.811 0.339 . . . . 0.0 110.926 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 13.4 t -61.65 136.14 57.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.844 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 34.2 mtmm -84.12 38.12 0.64 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.914 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 43.11 43.38 5.61 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.493 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 80.7 m -154.62 159.55 40.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.826 0.346 . . . . 0.0 110.888 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -161.73 169.13 22.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.07 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . 0.549 ' CD1' ' HE3' ' A' ' 152' ' ' LYS . 38.2 m-85 -126.58 122.5 35.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.899 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 9.4 t -123.73 147.97 27.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.14 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -118.09 155.94 29.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.88 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . 0.444 ' CD1' ' CD1' ' A' ' 153' ' ' LEU . 20.8 m-85 -131.58 166.36 21.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.955 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 35.7 t -64.98 -51.54 61.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.858 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 4.8 m -140.51 -177.2 4.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.864 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . 0.441 ' O ' ' C ' ' A' ' 202' ' ' ALA . 13.1 t60 -68.15 -58.68 4.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.852 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . 0.441 ' C ' ' O ' ' A' ' 201' ' ' HIS . . . -34.93 -67.09 0.15 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.106 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -47.44 -47.36 26.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.89 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -52.36 -63.61 1.09 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.104 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 11.0 tp60 -43.36 -45.41 6.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.901 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -52.99 -55.34 24.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.107 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -58.41 -34.67 71.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.139 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . 0.496 ' O ' ' N ' ' A' ' 212' ' ' HIS . 82.5 mt -59.94 -72.6 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.078 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 -52.09 -41.69 62.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.901 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -57.04 -40.96 77.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.109 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 64.7 mt -101.92 -71.12 0.73 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.929 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 212' ' ' HIS . . . . . 0.496 ' N ' ' O ' ' A' ' 208' ' ' ILE . 31.0 t60 -54.54 128.78 33.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.903 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 80.21 -1.62 79.88 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.456 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 34.0 t -96.65 -74.34 0.57 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.821 0.343 . . . . 0.0 110.892 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -97.3 -177.46 3.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.911 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 60.4 m -133.65 100.99 4.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.125 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 33.0 mmt -39.27 135.08 1.12 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.607 0.718 . . . . 0.0 110.869 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -48.34 114.08 1.05 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.703 2.269 . . . . 0.0 112.343 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 119.07 -51.19 0.77 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.485 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -72.77 155.58 39.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.814 0.34 . . . . 0.0 111.069 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 28.7 t -98.16 -21.15 16.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.898 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 1.1 t -99.88 154.14 18.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.876 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 57.8 m -58.65 158.54 7.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.832 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . 0.432 ' O ' ' ND1' ' A' ' 212' ' ' HIS . 43.1 tp -47.81 152.51 0.73 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.94 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 0.43 HG23 ' CG ' ' A' ' 157' ' ' MET . 98.0 t -118.48 111.46 34.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.139 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 23.7 t -138.37 105.36 3.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.098 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 34.3 pttt -129.13 169.73 14.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.897 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 228' ' ' PHE . . . . . 0.46 ' HB3' ' CB ' ' A' ' 150' ' ' HIS . 59.4 m-85 -76.16 127.9 33.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.917 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -71.92 112.97 8.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.144 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . 0.408 ' O ' ' C ' ' A' ' 231' ' ' THR . 0.9 OUTLIER -92.63 92.12 7.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.878 179.981 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 231' ' ' THR . . . . . 0.408 ' C ' ' O ' ' A' ' 230' ' ' ASP . 55.4 m -37.35 121.84 0.86 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.119 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -98.07 155.31 17.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.869 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 32.0 pttt -149.45 135.67 19.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.871 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -114.51 96.98 6.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.872 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 41.4 t -97.45 154.67 17.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.835 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 101.98 90.97 2.14 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.508 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -77.88 15.76 1.25 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.668 2.245 . . . . 0.0 112.333 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 3.7 t 39.42 41.45 0.7 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.842 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 58.2 m -62.56 86.54 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.808 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.294 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.487 179.948 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.311 0 N-CA-C 112.492 -0.243 . . . . 0.0 112.492 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 11.1 t -139.93 139.72 36.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.875 0.369 . . . . 0.0 110.828 -179.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 94.1 p -51.03 140.22 16.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.884 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -170.43 -155.84 10.71 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.45 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 1.9 m -124.34 41.36 3.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.849 0.357 . . . . 0.0 110.85 -179.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 41.6 t -74.89 98.01 3.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.905 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 124.19 -86.86 0.37 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.518 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 4.6 m -88.06 135.72 33.3 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.868 0.366 . . . . 0.0 110.888 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 7.1 mp -127.32 94.01 3.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.919 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 17.9 ttm180 -91.91 121.93 33.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.897 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 -70.89 155.74 92.96 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.572 0.701 . . . . 0.0 110.923 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -77.25 112.06 3.31 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.653 2.235 . . . . 0.0 112.322 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -43.72 159.31 0.09 OUTLIER 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.686 2.257 . . . . 0.0 112.4 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 1.4 t -92.36 -70.51 0.69 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.859 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 46.1 p-80 -39.54 151.53 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.85 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.462 ' CZ ' ' HB2' ' A' ' 151' ' ' ARG . 17.6 ttm105 -125.6 91.16 3.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.905 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 12.4 tttt -105.13 151.08 24.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.9 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.403 HD12 ' CD1' ' A' ' 198' ' ' TYR . 44.4 mt -120.53 129.2 53.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.904 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 29.6 t80 -98.01 119.92 37.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.912 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 21.6 t -110.27 129.1 65.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.102 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -127.69 -170.56 12.86 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.502 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 11.3 mmt 55.59 36.27 26.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.828 0.347 . . . . 0.0 110.937 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.409 ' HB2' ' C ' ' A' ' 192' ' ' GLY . 38.6 mt -95.55 168.93 10.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.872 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.478 ' ND2' ' O ' ' A' ' 218' ' ' PRO . 12.7 m120 -113.59 162.83 15.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.898 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 38.0 mttp -82.62 48.91 1.38 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.911 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -133.27 -49.49 0.85 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.886 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 16.0 mm-40 -56.65 155.52 7.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.899 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 17.1 m -135.51 176.13 8.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.884 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -47.57 -50.52 23.78 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.903 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -54.92 -58.62 6.86 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.839 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -41.84 -66.02 0.39 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.862 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.506 HG12 ' CE1' ' A' ' 171' ' ' PHE . 65.9 t -55.52 -54.77 21.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.113 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . 0.439 ' C ' ' O ' ' A' ' 167' ' ' VAL . 43.8 ttt180 -35.23 -70.11 0.09 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.875 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 44.3 mmm-85 -58.04 -53.57 56.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.909 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.499 ' O ' ' CB ' ' A' ' 173' ' ' ALA . 19.5 tp -41.37 -66.83 0.3 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.923 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.506 ' CE1' HG12 ' A' ' 167' ' ' VAL . 9.9 m-85 -55.33 -72.84 0.06 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.858 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.45 ' O ' ' N ' ' A' ' 174' ' ' PHE . 0.5 OUTLIER -39.55 -28.26 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.907 -179.907 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.499 ' CB ' ' O ' ' A' ' 170' ' ' LEU . . . -41.41 -24.18 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.112 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . 0.45 ' N ' ' O ' ' A' ' 172' ' ' GLU . 93.7 m-85 -108.09 -69.92 0.83 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.931 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -100.94 -171.64 28.79 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.485 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 33.3 m-20 -98.86 131.67 44.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.771 0.319 . . . . 0.0 110.898 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . 0.417 ' CG2' ' N ' ' A' ' 178' ' ' GLU . 37.1 mt -96.39 151.94 3.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.136 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . 0.417 ' N ' ' CG2' ' A' ' 177' ' ' ILE . 6.8 mt-10 -121.27 -21.51 6.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.905 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -165.85 136.43 3.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.865 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 51.0 t -130.47 141.6 50.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.89 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 83.2 m -153.11 147.65 26.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.158 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.427 HD13 ' CB ' ' A' ' 194' ' ' ALA . 20.1 mm -115.22 137.51 48.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.132 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.432 HD12 ' CE2' ' A' ' 195' ' ' PHE . 34.3 mt -85.57 101.43 12.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.932 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 60.4 mtp180 -119.59 115.42 23.95 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.877 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -42.72 148.19 0.6 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.518 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -45.56 -29.06 4.77 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.678 2.252 . . . . 0.0 112.331 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -70.59 -41.38 72.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.866 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.404 ' O ' ' C ' ' A' ' 189' ' ' ASN . . . 145.16 -67.48 0.42 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.469 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . 0.404 ' C ' ' O ' ' A' ' 188' ' ' GLY . 3.5 p30 -37.14 135.67 0.48 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.847 0.356 . . . . 0.0 110.882 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 17.1 t -69.24 143.14 54.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.895 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 24.0 mtpt -89.68 31.55 0.93 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.952 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.409 ' C ' ' HB2' ' A' ' 158' ' ' LEU . . . 47.19 36.82 10.25 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.5 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 63.6 m -151.3 155.83 39.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.848 0.356 . . . . 0.0 110.843 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . 0.427 ' CB ' HD13 ' A' ' 182' ' ' ILE . . . -161.04 162.21 31.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.072 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . 0.432 ' CE2' HD12 ' A' ' 183' ' ' LEU . 58.2 m-85 -117.79 142.36 47.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.848 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 45.6 t -129.82 145.34 35.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.091 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 24.7 tttt -113.5 147.48 37.83 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.879 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . 0.403 ' CD1' HD12 ' A' ' 153' ' ' LEU . 7.6 m-85 -132.4 167.9 19.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.945 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 38.1 t -83.96 -40.08 18.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.856 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 3.5 m -138.26 176.61 8.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.854 -179.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . 0.431 ' O ' ' C ' ' A' ' 202' ' ' ALA . 5.3 t60 -74.24 -56.44 4.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.866 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . 0.431 ' C ' ' O ' ' A' ' 201' ' ' HIS . . . -35.56 -63.21 0.36 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.1 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 31.7 mm-40 -49.4 -49.83 43.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.871 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -51.45 -59.28 4.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.143 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 33.8 tp60 -48.27 -55.92 9.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.884 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -44.2 -61.38 1.51 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.067 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -49.05 -49.19 42.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.119 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . 0.498 ' O ' ' N ' ' A' ' 212' ' ' HIS . 66.4 mt -49.54 -74.95 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.123 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -44.47 -44.58 8.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.916 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -54.24 -43.31 70.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.126 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 7.9 mt -100.29 -68.93 0.79 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.934 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 212' ' ' HIS . . . . . 0.498 ' N ' ' O ' ' A' ' 208' ' ' ILE . 29.7 t60 -51.6 126.18 16.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.851 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . 0.45 ' HA2' ' CB ' ' A' ' 223' ' ' SER . . . 82.02 -19.23 10.35 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.518 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 2.5 m -85.5 -73.08 0.46 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.803 0.335 . . . . 0.0 110.872 -179.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 71.1 mt-30 -92.69 167.18 12.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.924 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 216' ' ' THR . . . . . 0.423 HG22 ' C ' ' A' ' 222' ' ' SER . 0.7 OUTLIER -126.95 104.07 7.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.119 -179.917 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 14.5 mmt -39.04 135.23 1.04 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.609 0.719 . . . . 0.0 110.836 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . 0.478 ' O ' ' ND2' ' A' ' 159' ' ' ASN . 76.1 Cg_exo -48.72 122.29 7.81 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.684 2.256 . . . . 0.0 112.375 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 105.03 -44.99 1.36 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.509 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -75.54 143.97 42.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.768 0.318 . . . . 0.0 111.091 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 29.9 t -92.59 -15.5 26.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.882 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 222' ' ' SER . . . . . 0.423 ' C ' HG22 ' A' ' 216' ' ' THR . 1.8 m -99.84 146.1 27.0 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.837 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 223' ' ' SER . . . . . 0.45 ' CB ' ' HA2' ' A' ' 213' ' ' GLY . 29.4 m -59.63 150.08 28.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.828 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 62.4 tp -41.78 151.62 0.09 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.935 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 60.1 t -118.34 113.83 43.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.171 179.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 46.0 t -136.92 105.2 3.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.153 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 8.3 ptmt -122.14 169.25 11.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.895 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -79.61 117.39 20.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.915 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -78.82 113.91 17.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.11 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -130.31 76.88 1.75 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.896 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 53.2 m -148.96 125.69 11.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.141 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -60.11 158.3 11.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.842 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . 0.406 ' HD2' ' C ' ' A' ' 233' ' ' LYS . 0.7 OUTLIER -111.28 -58.17 2.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.892 -179.992 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -40.48 142.23 0.44 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.852 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 36.4 p -108.9 96.89 6.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.836 -179.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 147.58 95.21 0.16 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.55 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -75.94 90.56 1.15 Allowed 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.707 2.271 . . . . 0.0 112.327 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 3.3 m -68.68 176.42 2.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.848 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 68.5 m -146.16 107.46 4.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.856 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.496 -180.0 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 N-CA-C 112.522 -0.231 . . . . 0.0 112.522 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 67.7 m -65.81 160.45 23.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.823 0.344 . . . . 0.0 110.909 -179.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 22.6 m -45.18 113.61 0.6 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.857 -179.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 86.45 96.5 0.82 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.53 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 1.4 t -121.28 147.05 46.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.877 0.37 . . . . 0.0 110.878 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 2.1 m -106.2 98.93 8.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.835 -179.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -132.38 -149.95 6.39 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.49 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 70.1 m -143.89 146.41 32.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.82 0.343 . . . . 0.0 110.875 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.402 HD13 ' C ' ' A' ' 144' ' ' LEU . 3.7 pp -169.08 140.44 2.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.906 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 10.8 ttp180 -155.78 151.3 27.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.872 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 33.4 mm-40 -106.96 93.46 9.07 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.587 0.708 . . . . 0.0 110.894 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -74.97 168.19 25.39 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.689 2.259 . . . . 0.0 112.375 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -75.72 170.2 20.68 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.681 2.254 . . . . 0.0 112.332 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 4.8 t -97.3 -45.53 6.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.843 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 8.0 p80 -86.59 94.38 9.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.906 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 12.8 ptt180 -117.09 103.61 10.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.868 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.565 ' HD3' ' CD1' ' A' ' 195' ' ' PHE . 24.4 ttmt -130.71 159.11 38.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.899 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.53 HD23 ' CE1' ' A' ' 228' ' ' PHE . 58.0 mt -127.2 121.81 32.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.882 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -95.13 127.03 40.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.864 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 59.1 t -114.47 133.81 59.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.149 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -128.97 -159.58 9.99 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.49 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 27.8 mtt 41.84 39.88 1.37 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.817 0.341 . . . . 0.0 110.86 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 42.8 mt -95.43 161.4 14.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.943 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.483 ' ND2' ' O ' ' A' ' 218' ' ' PRO . 69.2 m-20 -100.35 165.97 11.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.861 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 65.4 mttt -89.72 40.97 1.02 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.842 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 18.9 mm-40 -127.31 -53.17 1.38 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.858 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -55.13 148.82 13.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.926 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 1.6 t -133.81 176.42 8.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.84 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -47.93 -42.64 27.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.862 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -50.55 -57.66 7.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.89 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -61.21 -66.63 0.5 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.923 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 59.8 t -42.02 -35.32 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.094 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 25.0 ttm180 -63.88 -61.24 2.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.873 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 31.6 ptt180 -63.09 -52.13 63.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.887 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.507 ' O ' ' CB ' ' A' ' 173' ' ' ALA . 8.5 tp -44.23 -65.69 0.48 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.89 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.569 ' CE2' HG22 ' A' ' 196' ' ' VAL . 14.0 m-85 -53.28 -69.41 0.12 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.888 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -44.32 -26.05 0.3 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.94 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.507 ' CB ' ' O ' ' A' ' 170' ' ' LEU . . . -46.74 -20.49 0.13 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.142 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -116.14 -73.61 0.64 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.909 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -109.45 147.22 16.96 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.536 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -52.5 157.58 1.47 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.823 0.344 . . . . 0.0 110.903 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . 0.417 HG21 ' N ' ' A' ' 178' ' ' GLU . 98.0 mt -122.37 147.55 26.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.143 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . 0.417 ' N ' HG21 ' A' ' 177' ' ' ILE . 14.9 mm-40 -102.4 -45.91 4.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.901 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -153.71 151.36 29.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.879 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 52.2 t -138.11 143.28 40.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.893 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 98.5 m -152.17 138.95 18.87 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.119 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 21.3 mm -93.72 127.86 45.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.158 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.553 HD12 ' CE2' ' A' ' 195' ' ' PHE . 65.6 mt -90.12 104.61 17.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.899 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' ARG . . . . . 0.465 ' CB ' ' HA ' ' A' ' 190' ' ' SER . 16.7 ptt180 -162.29 150.12 14.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.896 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -61.02 -177.47 2.03 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.54 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -76.71 -14.78 17.42 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.709 2.273 . . . . 0.0 112.321 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -66.93 -47.13 72.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.903 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.447 ' O ' ' N ' ' A' ' 190' ' ' SER . . . 131.8 -45.96 1.1 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.502 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . 0.419 ' O ' ' C ' ' A' ' 190' ' ' SER . 24.3 m-80 -49.94 90.43 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.83 0.348 . . . . 0.0 110.932 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' SER . . . . . 0.465 ' HA ' ' CB ' ' A' ' 184' ' ' ARG . 9.3 p -36.14 141.93 0.09 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.841 -179.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.425 ' CG ' ' HA ' ' A' ' 184' ' ' ARG . 28.9 mmtt -94.71 39.87 1.1 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.927 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 39.21 42.79 1.79 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.435 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 71.5 m -154.85 150.01 27.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.834 0.349 . . . . 0.0 110.905 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -161.39 162.91 30.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.075 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . 0.565 ' CD1' ' HD3' ' A' ' 152' ' ' LYS . 28.0 m-85 -116.98 143.12 46.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.896 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.569 HG22 ' CE2' ' A' ' 171' ' ' PHE . 40.3 t -140.13 138.2 37.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.125 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 8.0 ttmm -118.91 148.29 43.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.879 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -122.82 172.22 8.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.93 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 1.2 t -76.14 -49.99 15.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.854 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 58.7 m -125.51 -178.19 4.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.854 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . 0.432 ' O ' ' C ' ' A' ' 202' ' ' ALA . 9.8 t60 -79.66 -63.14 1.48 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.885 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . 0.432 ' C ' ' O ' ' A' ' 201' ' ' HIS . . . -34.35 -60.65 0.41 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.085 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -48.02 -50.42 27.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.93 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -51.99 -59.05 4.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.072 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 13.1 tp60 -44.91 -49.34 11.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.881 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -51.29 -58.32 6.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.131 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -52.59 -37.54 58.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.126 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . 0.491 ' O ' ' N ' ' A' ' 212' ' ' HIS . 77.0 mt -59.23 -74.06 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.095 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -49.92 -42.52 48.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.898 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -53.31 -45.6 69.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.126 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 57.2 mt -99.99 -67.69 0.84 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.9 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 212' ' ' HIS . . . . . 0.491 ' N ' ' O ' ' A' ' 208' ' ' ILE . 9.2 t60 -51.46 127.79 20.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.846 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 77.63 -9.97 26.55 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.472 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 8.3 t -97.74 -66.55 0.89 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.84 0.352 . . . . 0.0 110.879 -179.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 7.3 mm-40 -92.31 163.66 13.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.919 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 216' ' ' THR . . . . . 0.436 ' O ' ' C ' ' A' ' 217' ' ' MET . 3.9 m -131.09 101.28 5.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.129 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 217' ' ' MET . . . . . 0.436 ' C ' ' O ' ' A' ' 216' ' ' THR . 0.0 OUTLIER -34.69 131.07 0.45 Allowed Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.548 0.69 . . . . 0.0 110.886 179.859 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . 0.483 ' O ' ' ND2' ' A' ' 159' ' ' ASN . 75.6 Cg_exo -48.89 120.29 5.25 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.699 2.266 . . . . 0.0 112.35 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 107.78 -45.03 1.36 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.499 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -73.48 142.11 46.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.812 0.339 . . . . 0.0 111.084 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 35.6 m -89.17 -16.55 31.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.836 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 3.9 m -99.87 143.24 30.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.841 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 95.8 p -63.32 152.46 37.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.873 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 27.0 tp -48.0 146.85 2.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.894 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 68.6 t -119.5 118.27 56.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.129 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 38.7 t -141.12 116.95 6.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.152 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 18.3 pttt -131.81 172.29 12.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.888 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 228' ' ' PHE . . . . . 0.53 ' CE1' HD23 ' A' ' 153' ' ' LEU . 54.8 m-85 -82.15 95.0 7.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.89 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . 0.426 ' C ' ' O ' ' A' ' 228' ' ' PHE . . . -34.75 122.13 0.53 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.071 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 -163.55 117.76 1.58 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.854 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 29.2 p -102.03 99.16 9.29 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.12 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -166.16 158.5 14.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.833 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 19.9 ttmt -86.86 -56.81 3.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.885 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . 0.439 ' HG2' ' N ' ' A' ' 235' ' ' SER . 18.6 tt0 -159.15 150.79 20.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.862 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 235' ' ' SER . . . . . 0.439 ' N ' ' HG2' ' A' ' 234' ' ' GLU . 55.7 m -108.34 175.91 5.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.905 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 156.44 146.68 4.53 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.494 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -77.08 136.59 16.48 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.697 2.265 . . . . 0.0 112.329 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 238' ' ' SER . . . . . 0.416 ' O ' ' C ' ' A' ' 239' ' ' SER . 13.6 t -62.17 101.79 0.25 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.886 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 239' ' ' SER . . . . . 0.416 ' C ' ' O ' ' A' ' 238' ' ' SER . 4.7 t -36.97 -49.56 0.83 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.864 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.345 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.508 -179.982 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.343 0 N-CA-C 112.477 -0.249 . . . . 0.0 112.477 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 12.7 m -128.32 41.77 3.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.905 0.383 . . . . 0.0 110.867 -179.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 28.8 p 45.06 42.06 6.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.841 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -159.28 179.6 34.77 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.481 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 88.1 p -81.38 136.02 35.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.859 0.361 . . . . 0.0 110.862 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 7.7 t -104.03 42.8 1.15 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.813 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -172.03 143.81 7.68 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.492 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 2.2 m -152.8 126.72 8.99 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.86 0.362 . . . . 0.0 110.924 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -43.83 158.65 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.938 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 34.6 mtt-85 -137.72 116.61 12.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.906 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 4.0 pp0? -70.78 143.79 89.93 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.574 0.702 . . . . 0.0 110.929 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -78.24 111.18 3.01 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.672 2.248 . . . . 0.0 112.319 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -74.33 94.01 0.91 Allowed 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.734 2.29 . . . . 0.0 112.381 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 67.4 p -83.61 38.4 0.62 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.888 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 34.1 p-80 -142.43 145.27 33.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.888 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 14.5 mtm-85 -130.95 68.41 1.49 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.875 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 9.4 tttp -134.51 159.44 41.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.912 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.497 HD12 ' CD1' ' A' ' 198' ' ' TYR . 41.8 mt -133.92 121.05 21.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.89 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -93.86 118.37 31.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.841 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.462 HG12 ' CD2' ' A' ' 158' ' ' LEU . 16.5 t -106.35 131.9 54.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.098 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -130.41 -164.04 11.2 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.507 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 18.7 mmt 40.19 37.95 0.47 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.786 0.327 . . . . 0.0 110.846 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.462 ' CD2' HG12 ' A' ' 155' ' ' VAL . 83.8 mt -85.37 174.01 9.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.914 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.494 ' OD1' ' N ' ' A' ' 160' ' ' LYS . 60.1 t-20 -105.72 150.85 25.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.89 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . 0.494 ' N ' ' OD1' ' A' ' 159' ' ' ASN . 10.3 mptt -86.42 29.45 0.77 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.865 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 15.9 tm0? -111.48 -55.07 2.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.941 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -68.24 163.74 22.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.934 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 58.7 m -130.36 178.75 6.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.866 -179.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -46.9 -41.08 15.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.919 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -55.05 -61.93 1.99 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.826 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -46.8 -55.4 7.97 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.873 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.555 HG11 ' CD1' ' A' ' 171' ' ' PHE . 89.7 t -58.3 -40.27 77.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.104 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . 0.427 ' NH1' ' OE1' ' A' ' 172' ' ' GLU . 2.4 tmm_? -52.67 -62.92 1.34 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.866 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 9.7 mmm180 -59.39 -54.72 43.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.861 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.506 ' O ' ' CB ' ' A' ' 173' ' ' ALA . 9.4 tp -42.73 -66.24 0.39 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.883 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.555 ' CD1' HG11 ' A' ' 167' ' ' VAL . 13.5 m-85 -51.32 -71.85 0.06 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.896 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.455 ' O ' ' N ' ' A' ' 174' ' ' PHE . 3.9 pt-20 -41.9 -31.53 0.34 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.927 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.506 ' CB ' ' O ' ' A' ' 170' ' ' LEU . . . -41.11 -24.44 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.057 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . 0.455 ' N ' ' O ' ' A' ' 172' ' ' GLU . 81.1 m-85 -113.96 -72.62 0.69 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.844 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -104.8 134.35 11.97 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.519 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 34.4 m-20 -49.4 149.16 2.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.791 0.329 . . . . 0.0 110.912 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 70.9 mt -114.07 150.02 16.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.162 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -117.27 -25.68 6.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.925 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -158.19 160.37 37.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.918 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 8.0 t -162.29 141.98 9.65 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.83 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 93.2 m -148.6 139.94 23.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.136 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 48.9 mm -102.18 119.3 50.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.119 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.484 HD11 ' CE2' ' A' ' 195' ' ' PHE . 30.8 mt -80.56 120.24 24.26 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.922 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' ARG . . . . . 0.482 ' O ' ' N ' ' A' ' 189' ' ' ASN . 98.4 mtt180 -119.74 30.21 7.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.893 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 56.88 157.34 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.437 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -48.83 -43.65 34.26 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.692 2.262 . . . . 0.0 112.333 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -54.18 -48.72 70.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.845 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 122.53 30.03 1.22 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.483 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . 0.482 ' N ' ' O ' ' A' ' 184' ' ' ARG . 47.4 m-20 -128.12 133.26 48.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.824 0.345 . . . . 0.0 110.853 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 4.8 t -39.04 131.76 1.38 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.842 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 24.2 mmtt -116.88 34.42 5.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.95 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 47.76 35.9 12.61 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.444 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 75.0 m -148.18 150.48 33.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.765 0.316 . . . . 0.0 110.9 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -160.64 152.43 19.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.113 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . 0.484 ' CE2' HD11 ' A' ' 183' ' ' LEU . 25.6 m-85 -102.08 137.42 40.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.895 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 59.1 t -127.42 144.88 35.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.132 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 49.6 tttt -124.21 138.17 54.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.899 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . 0.497 ' CD1' HD12 ' A' ' 153' ' ' LEU . 19.4 m-85 -118.1 173.54 6.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.923 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 48.3 t -81.38 -47.65 12.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.869 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 2.9 t -132.84 153.97 50.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.874 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . 0.441 ' O ' ' C ' ' A' ' 202' ' ' ALA . 23.4 t-80 -52.75 -61.32 2.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.827 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . 0.441 ' C ' ' O ' ' A' ' 201' ' ' HIS . . . -34.06 -62.53 0.31 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.168 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -47.2 -43.42 21.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.849 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . 0.425 ' N ' ' O ' ' A' ' 201' ' ' HIS . . . -57.77 -55.14 38.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.095 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 3.8 tp60 -50.23 -43.35 52.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.907 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -56.59 -57.64 11.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.107 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -56.87 -35.44 68.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.144 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . 0.496 ' O ' ' N ' ' A' ' 212' ' ' HIS . 78.2 mt -59.72 -75.12 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.107 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -47.39 -42.49 22.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.862 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -56.05 -43.46 77.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.119 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 33.0 mt -99.96 -69.08 0.78 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.922 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 212' ' ' HIS . . . . . 0.496 ' N ' ' O ' ' A' ' 208' ' ' ILE . 1.7 t60 -49.7 131.15 21.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.854 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 72.31 1.95 52.48 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.475 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 6.2 t -94.53 -71.29 0.67 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.814 0.34 . . . . 0.0 110.863 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 17.3 pm0 -100.33 175.75 5.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.895 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 216' ' ' THR . . . . . 0.442 ' O ' ' C ' ' A' ' 217' ' ' MET . 4.6 m -134.97 97.87 3.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.159 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 217' ' ' MET . . . . . 0.442 ' C ' ' O ' ' A' ' 216' ' ' THR . 12.4 mmt -34.56 133.18 0.42 Allowed Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.6 0.715 . . . . 0.0 110.868 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -49.01 119.52 4.48 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.68 2.254 . . . . 0.0 112.383 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 112.27 -50.82 0.74 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.516 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -73.03 152.84 41.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.821 0.343 . . . . 0.0 111.093 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 3.6 t -96.69 -19.51 18.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.869 -179.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 1.3 p -99.47 134.85 41.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.865 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 223' ' ' SER . . . . . 0.436 ' O ' ' C ' ' A' ' 224' ' ' LEU . 3.5 m -58.02 151.23 18.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.859 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . 0.447 ' O ' ' ND1' ' A' ' 212' ' ' HIS . 21.7 tp -35.57 141.76 0.08 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.933 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 90.8 t -114.77 109.2 27.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.146 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 6.3 t -132.01 105.96 10.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.134 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . 0.411 ' NZ ' ' OD2' ' A' ' 230' ' ' ASP . 11.0 pttp -121.34 -179.1 3.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.871 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 228' ' ' PHE . . . . . 0.472 ' CD1' HD21 ' A' ' 153' ' ' LEU . 60.2 m-85 -83.34 107.95 16.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.826 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -43.09 117.08 1.0 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.046 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . 0.411 ' OD2' ' NZ ' ' A' ' 227' ' ' LYS . 3.7 p30 -100.99 128.64 46.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.879 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 38.1 p -133.42 169.99 16.13 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.16 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -158.56 119.0 3.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.882 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 45.7 mtpt -76.4 157.54 32.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.911 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -57.49 -56.55 20.41 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.894 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 33.9 t -73.66 80.43 1.52 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.853 -179.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -67.67 -169.1 4.36 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.508 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -77.08 110.33 3.0 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.7 2.266 . . . . 0.0 112.336 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 2.2 m -70.31 100.48 1.73 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.853 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 29.9 m -73.39 128.07 34.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.847 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.302 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.519 -179.96 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 N-CA-C 112.524 -0.23 . . . . 0.0 112.524 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 41.0 t -112.89 114.34 26.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.907 0.384 . . . . 0.0 110.829 -179.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 1.8 m -95.76 112.56 24.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.839 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 144.46 91.2 0.12 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.502 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 20.8 t -103.1 108.86 20.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.863 0.363 . . . . 0.0 110.895 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 6.2 m -109.98 157.52 19.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.86 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -174.87 -168.66 35.82 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.499 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 27.2 p -69.67 89.8 0.55 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.835 0.35 . . . . 0.0 110.901 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.451 ' O ' ' C ' ' A' ' 145' ' ' ARG . 3.7 mm? -76.06 -43.55 43.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.887 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.451 ' C ' ' O ' ' A' ' 144' ' ' LEU . 0.0 OUTLIER -34.55 -39.28 0.08 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.877 179.964 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . 0.433 ' NE2' ' HG3' ' A' ' 145' ' ' ARG . 5.5 pm0 -172.05 143.7 1.38 Allowed Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.599 0.714 . . . . 0.0 110.944 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -78.27 147.57 23.29 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.66 2.24 . . . . 0.0 112.326 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -46.99 162.13 0.17 Allowed 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.658 2.239 . . . . 0.0 112.345 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 66.8 m -60.44 -68.02 0.34 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.869 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 38.0 p-80 -72.52 117.05 13.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.904 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 3.6 ptp85 -106.86 42.9 1.22 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.873 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 11.4 tttp -93.11 160.59 14.79 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.928 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 73.4 mt -133.75 129.82 37.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.861 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -97.38 116.44 29.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.902 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 47.8 t -110.27 135.46 49.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.134 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -134.31 -156.55 7.88 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.49 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 10.9 mmt 39.49 33.36 0.11 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.819 0.343 . . . . 0.0 110.852 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.408 ' HB2' ' C ' ' A' ' 192' ' ' GLY . 63.9 mt -85.03 169.4 14.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.935 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.459 ' ND2' ' HD2' ' A' ' 218' ' ' PRO . 7.4 p30 -103.44 163.55 12.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.892 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 29.4 mttt -97.96 23.08 8.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.907 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 2.3 tp-100 -109.85 -46.57 3.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.892 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 19.5 mt-30 -65.7 172.24 3.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.908 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 66.7 m -139.69 -177.44 4.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.905 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -59.07 -37.72 77.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.909 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -59.74 -50.82 72.33 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.868 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 39.6 m-20 -58.69 -56.55 20.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.876 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.558 HG11 ' CD1' ' A' ' 171' ' ' PHE . 19.5 t -63.09 -28.29 44.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.08 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 41.7 ttm-85 -63.76 -56.25 16.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.852 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 70.7 mtm180 -62.29 -55.11 31.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.912 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.506 ' O ' ' CB ' ' A' ' 173' ' ' ALA . 9.1 tp -43.38 -65.15 0.52 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.913 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.558 ' CD1' HG11 ' A' ' 167' ' ' VAL . 8.5 m-85 -50.78 -69.29 0.12 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.874 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -46.3 -26.48 0.82 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.877 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.506 ' CB ' ' O ' ' A' ' 170' ' ' LEU . . . -49.36 -19.45 0.52 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.063 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -113.48 -74.68 0.62 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.883 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -107.5 151.56 16.92 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.492 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 46.6 m-80 -62.31 132.71 53.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.797 0.332 . . . . 0.0 110.927 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 84.2 mt -92.25 138.99 18.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.123 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -100.35 -30.48 11.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.915 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -164.54 142.0 6.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.888 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 1.8 m -137.21 138.24 39.96 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.911 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 60.4 m -151.12 132.82 14.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.146 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 44.5 mm -98.52 143.24 13.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.132 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.512 HD11 ' CE2' ' A' ' 195' ' ' PHE . 52.7 mt -95.89 125.89 40.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.896 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' ARG . . . . . 0.45 ' CZ ' ' HB2' ' A' ' 184' ' ' ARG . 18.4 mtm105 -130.64 113.58 14.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.851 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -44.81 156.31 0.28 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.504 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -45.88 -39.78 19.44 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.681 2.254 . . . . 0.0 112.354 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -57.33 -44.1 83.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.881 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 140.02 -43.69 1.12 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.51 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 17.5 m-80 -60.85 147.88 41.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.814 0.34 . . . . 0.0 110.919 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 30.7 t -68.52 140.72 55.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.858 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 63.6 mttt -94.04 37.59 1.09 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.913 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.408 ' C ' ' HB2' ' A' ' 158' ' ' LEU . . . 43.32 40.99 4.89 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.497 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 4.4 p -150.03 151.48 33.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.798 0.333 . . . . 0.0 110.941 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -160.62 150.96 18.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.069 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . 0.512 ' CE2' HD11 ' A' ' 183' ' ' LEU . 50.2 m-85 -108.72 116.3 31.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.914 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.432 HG12 ' CD2' ' A' ' 171' ' ' PHE . 38.8 t -110.04 146.97 14.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.122 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 34.4 tttp -127.1 160.26 31.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.876 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -137.65 164.79 27.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.909 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 41.2 t -71.61 -39.38 70.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.851 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 2.4 t -136.02 171.78 13.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.818 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . 0.408 ' O ' ' C ' ' A' ' 202' ' ' ALA . 40.1 t-80 -69.4 -57.05 5.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.855 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . 0.408 ' C ' ' O ' ' A' ' 201' ' ' HIS . . . -36.75 -61.39 0.54 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.148 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -47.53 -50.58 23.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.865 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -51.43 -57.59 8.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.073 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . 0.511 ' C ' ' CD ' ' A' ' 205' ' ' GLN . 0.0 OUTLIER -47.67 -68.13 0.21 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.887 -179.898 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . 0.407 ' C ' ' O ' ' A' ' 205' ' ' GLN . . . -37.02 -51.82 0.95 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.106 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -59.72 -43.23 94.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.105 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . 0.489 ' O ' ' N ' ' A' ' 212' ' ' HIS . 82.5 mt -56.23 -70.28 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.078 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -54.12 -40.29 67.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.827 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -56.03 -34.07 65.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.122 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 57.8 mt -112.35 -70.83 0.79 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.901 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 212' ' ' HIS . . . . . 0.489 ' N ' ' O ' ' A' ' 208' ' ' ILE . 2.9 t60 -44.28 126.77 5.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.868 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 82.15 -28.1 3.4 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.507 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 25.7 m -90.15 -67.26 0.86 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.819 0.342 . . . . 0.0 110.88 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 215' ' ' GLN . . . . . 0.411 ' HG3' ' N ' ' A' ' 216' ' ' THR . 1.2 tp-100 -83.3 143.43 30.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.921 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 216' ' ' THR . . . . . 0.411 ' N ' ' HG3' ' A' ' 215' ' ' GLN . 24.3 m -120.15 100.0 6.93 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.158 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 217' ' ' MET . . . . . 0.402 ' C ' ' O ' ' A' ' 216' ' ' THR . 13.6 mmt -37.37 132.65 0.78 Allowed Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.596 0.713 . . . . 0.0 110.907 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . 0.459 ' HD2' ' ND2' ' A' ' 159' ' ' ASN . 75.2 Cg_exo -48.55 122.42 7.83 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.65 2.233 . . . . 0.0 112.32 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 112.54 -52.29 0.65 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.51 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -68.79 150.49 47.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.826 0.346 . . . . 0.0 111.069 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 88.1 p -96.33 -18.36 20.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.903 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 1.4 t -100.08 146.96 26.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.852 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 73.0 m -58.9 155.83 12.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.887 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . 0.446 ' O ' ' ND1' ' A' ' 212' ' ' HIS . 32.4 tp -49.35 156.09 0.64 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.979 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 0.403 ' N ' ' HG ' ' A' ' 224' ' ' LEU . 57.9 t -127.57 108.17 17.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.124 179.822 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 41.2 t -135.03 101.63 3.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.126 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 19.5 pttt -119.01 170.34 9.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.876 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -71.53 104.33 3.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.942 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -50.49 140.01 14.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.12 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -114.56 112.75 23.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.849 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 9.8 t -73.74 -23.03 59.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.135 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -137.77 168.26 20.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.863 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 16.7 ptmt -132.51 164.46 26.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.884 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -123.11 130.5 52.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.884 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 92.3 p -167.33 127.48 1.45 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.879 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -124.44 93.12 0.45 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.526 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -76.56 164.43 30.5 Favored 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.695 2.264 . . . . 0.0 112.313 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 238' ' ' SER . . . . . 0.441 ' O ' ' C ' ' A' ' 239' ' ' SER . 22.9 t -166.56 149.17 6.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.867 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 239' ' ' SER . . . . . 0.441 ' C ' ' O ' ' A' ' 238' ' ' SER . 47.4 m -34.52 -48.73 0.37 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.844 -179.801 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.293 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.477 -179.986 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.287 0 N-CA-C 112.438 -0.265 . . . . 0.0 112.438 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 2.2 m -104.26 -49.06 3.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.88 0.371 . . . . 0.0 110.892 -179.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 9.6 m -80.65 102.66 9.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.824 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 136.98 56.26 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.524 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 32.6 p -91.53 42.48 1.1 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.856 0.36 . . . . 0.0 110.838 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 52.8 p -78.95 135.51 36.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.823 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -169.08 143.33 7.95 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.481 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 86.8 m -119.01 143.27 47.16 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.811 0.338 . . . . 0.0 110.892 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.4 pp -117.31 141.19 48.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.937 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -104.29 162.32 13.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.907 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -65.54 141.39 97.91 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.612 0.72 . . . . 0.0 110.946 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -78.45 112.25 3.15 Favored 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.725 2.283 . . . . 0.0 112.325 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -45.19 173.11 0.02 OUTLIER 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.678 2.252 . . . . 0.0 112.323 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 59.9 p -94.4 41.16 1.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.854 -179.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 19.0 m80 -141.41 118.25 11.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.904 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 10.7 ttm180 -78.93 77.36 5.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.857 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.447 ' HD3' ' CD1' ' A' ' 195' ' ' PHE . 5.7 tttp -140.16 156.03 46.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.898 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 36.6 mt -130.09 125.11 34.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.9 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -96.73 113.85 25.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.863 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 22.2 t -104.46 127.65 58.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.135 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . 0.474 ' O ' ' N ' ' A' ' 158' ' ' LEU . . . -128.63 -154.01 8.19 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.434 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' MET . . . . . 0.442 ' C ' ' O ' ' A' ' 156' ' ' GLY . 31.0 mtt 34.66 34.15 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.776 0.322 . . . . 0.0 110.868 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.474 ' N ' ' O ' ' A' ' 156' ' ' GLY . 58.5 mt -83.24 174.79 10.44 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.927 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.439 ' ND2' ' H ' ' A' ' 162' ' ' GLN . 3.2 p-10 -104.77 150.17 25.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.906 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 39.3 mttp -85.39 32.5 0.56 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.875 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -120.32 -54.38 2.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.925 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . 0.439 ' H ' ' ND2' ' A' ' 159' ' ' ASN . 3.6 pt20 -56.48 156.78 5.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.919 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 23.0 m -128.13 -177.1 4.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.864 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -51.54 -41.47 61.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.861 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -57.98 -59.29 5.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.863 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -48.73 -61.03 2.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.858 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.554 HG12 ' CD1' ' A' ' 171' ' ' PHE . 91.9 t -55.14 -45.06 77.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.136 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 33.3 mtp180 -51.62 -58.31 6.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.862 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 47.8 mtp180 -62.73 -54.56 37.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.886 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.518 ' O ' ' CB ' ' A' ' 173' ' ' ALA . 11.0 tp -44.14 -65.06 0.56 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.9 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.554 ' CD1' HG12 ' A' ' 167' ' ' VAL . 13.2 m-85 -50.6 -68.36 0.18 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.845 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -47.31 -23.52 0.58 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.849 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.518 ' CB ' ' O ' ' A' ' 170' ' ' LEU . . . -54.19 -14.45 1.13 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.065 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -123.12 -69.01 0.85 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.872 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -113.57 148.05 18.64 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.499 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 35.4 m120 -55.96 153.86 8.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.801 0.334 . . . . 0.0 110.916 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . 0.454 HG23 ' N ' ' A' ' 178' ' ' GLU . 73.8 mt -118.31 151.51 20.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.162 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . 0.454 ' N ' HG23 ' A' ' 177' ' ' ILE . 6.3 mm-40 -108.85 -39.87 5.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.919 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -164.99 131.93 2.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.933 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 42.3 t -120.78 139.29 53.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.876 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 53.3 m -147.75 129.99 15.59 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.162 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 17.4 mm -93.48 130.32 42.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.146 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.561 HD13 ' CE2' ' A' ' 195' ' ' PHE . 77.7 mt -95.34 109.67 21.79 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.945 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' ARG . . . . . 0.438 ' HB3' ' N ' ' A' ' 190' ' ' SER . 20.5 mtp180 -126.01 26.86 6.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.9 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 62.23 149.89 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.498 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -45.61 -21.04 0.74 Allowed 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.702 2.268 . . . . 0.0 112.334 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -76.92 -41.73 42.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.871 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 119.05 -10.69 11.84 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.483 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -77.46 114.22 16.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.806 0.336 . . . . 0.0 110.912 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' SER . . . . . 0.438 ' N ' ' HB3' ' A' ' 184' ' ' ARG . 3.3 t -52.87 137.29 32.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.818 -179.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 10.3 pttp -121.86 29.02 7.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.932 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 57.48 47.31 89.13 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.522 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 24.1 m -152.03 141.92 22.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.842 0.353 . . . . 0.0 110.896 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -162.06 157.9 24.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.095 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . 0.561 ' CE2' HD13 ' A' ' 183' ' ' LEU . 21.1 m-85 -110.82 124.8 52.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.882 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 94.3 t -122.24 139.29 49.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.125 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 41.3 mttm -116.2 144.76 43.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.898 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -119.28 174.72 6.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.91 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 46.6 p -74.5 -52.52 11.71 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.884 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 32.9 p -137.07 -175.72 4.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.874 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -71.46 -53.85 12.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.885 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -40.76 -62.53 0.78 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.136 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -47.42 -41.72 20.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.884 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -59.27 -56.23 24.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.102 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -47.85 -41.81 24.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.933 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -61.39 -51.91 66.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.118 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -61.84 -23.8 66.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.104 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . 0.499 ' O ' ' N ' ' A' ' 212' ' ' HIS . 53.5 mt -71.92 -71.57 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.15 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -54.89 -38.91 68.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.905 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -58.35 -50.74 72.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.12 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 30.7 mt -99.93 -67.56 0.85 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.93 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 212' ' ' HIS . . . . . 0.574 ' CE1' ' HA ' ' A' ' 225' ' ' VAL . 1.5 t60 -49.83 132.77 22.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.863 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 70.12 -2.12 15.27 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.5 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -96.38 -71.36 0.68 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.822 0.344 . . . . 0.0 110.876 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -100.27 166.98 10.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.934 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 216' ' ' THR . . . . . 0.415 ' O ' ' C ' ' A' ' 217' ' ' MET . 24.4 m -127.38 94.03 3.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.152 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 217' ' ' MET . . . . . 0.415 ' C ' ' O ' ' A' ' 216' ' ' THR . 17.8 mmt -36.39 136.18 0.55 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.579 0.704 . . . . 0.0 110.843 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -49.24 138.21 29.47 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.634 2.223 . . . . 0.0 112.366 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 100.07 -45.22 1.51 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.505 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -86.31 142.04 28.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.815 0.341 . . . . 0.0 111.095 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 13.9 m -93.49 -12.88 28.67 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.834 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 3.9 m -100.11 143.09 30.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.88 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 71.3 m -56.04 148.43 17.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.8 -179.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . 0.449 ' O ' ' ND1' ' A' ' 212' ' ' HIS . 51.3 tp -38.31 158.08 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.893 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 0.574 ' HA ' ' CE1' ' A' ' 212' ' ' HIS . 61.7 t -130.4 105.76 11.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.114 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . 0.407 ' H ' ' CD2' ' A' ' 212' ' ' HIS . 21.5 t -134.04 101.46 3.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.146 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . 0.448 ' HE2' ' CG1' ' A' ' 225' ' ' VAL . 0.7 OUTLIER -130.38 145.29 51.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.896 179.883 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -49.04 137.0 13.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.929 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -79.74 157.69 27.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.103 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . 0.414 ' O ' ' C ' ' A' ' 231' ' ' THR . 1.6 p30 -147.35 175.32 10.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.889 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 231' ' ' THR . . . . . 0.414 ' C ' ' O ' ' A' ' 230' ' ' ASP . 1.6 m 36.1 47.85 0.48 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.16 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -124.2 113.73 18.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.88 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 34.9 mtmt -65.77 143.19 57.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.899 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 51.1 mm-40 -112.16 125.69 54.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.931 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 1.4 t -62.21 141.5 58.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.901 -179.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -76.67 146.15 32.3 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.516 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -46.61 144.43 7.54 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.695 2.263 . . . . 0.0 112.362 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 96.0 p -164.43 111.22 1.05 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.875 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 4.7 t -135.41 136.74 41.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.859 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.343 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.486 179.999 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.543 ' HD3' ' CD1' ' A' ' 195' ' ' PHE . 20.5 ttmt . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.869 0.366 . . . . 0.0 110.886 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.626 HD21 HD11 ' A' ' 208' ' ' ILE . 24.6 mt -142.83 126.49 16.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.898 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -90.92 116.69 28.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.874 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.867 HG13 HG22 ' A' ' 226' ' ' VAL . 4.8 t -110.43 134.55 52.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.098 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -135.13 -156.27 7.63 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.511 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 10.1 mmt 45.31 35.44 1.83 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.785 0.326 . . . . 0.0 110.894 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.526 HD23 ' SD ' ' A' ' 217' ' ' MET . 77.5 mt -93.67 167.94 11.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.897 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -101.38 154.77 18.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.892 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 86.7 mttt -84.13 41.34 0.81 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.875 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 -127.8 -48.81 1.37 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.897 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -55.33 163.91 1.08 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.879 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 3.8 t -131.33 165.8 22.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.905 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' GLU . . . . . 0.725 ' HA ' HD11 ' A' ' 182' ' ' ILE . 5.5 tt0 -45.08 -44.36 10.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.917 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 165' ' ' ASP . . . . . 0.418 ' O ' ' N ' ' A' ' 168' ' ' ARG . 0.1 OUTLIER -57.71 -62.42 1.81 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.861 179.976 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -41.25 -52.29 3.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.889 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.604 HG13 ' CE1' ' A' ' 171' ' ' PHE . 30.0 t -66.95 -28.64 43.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.095 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 168' ' ' ARG . . . . . 0.418 ' N ' ' O ' ' A' ' 165' ' ' ASP . 18.9 ttt180 -61.88 -64.13 1.03 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.834 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 7.5 mmm180 -59.72 -54.22 48.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.875 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.697 ' O ' ' HB3' ' A' ' 173' ' ' ALA . 9.3 tp -42.08 -66.31 0.37 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.948 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 171' ' ' PHE . . . . . 0.604 ' CE1' HG13 ' A' ' 167' ' ' VAL . 9.1 m-85 -53.37 -72.21 0.06 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.884 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -40.96 -30.29 0.13 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.842 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.697 ' HB3' ' O ' ' A' ' 170' ' ' LEU . . . -40.11 -30.4 0.09 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.128 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -105.42 -74.34 0.65 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.869 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -105.54 137.92 13.99 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.464 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -48.49 153.34 0.78 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.817 0.342 . . . . 0.0 110.857 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.541 HG23 ' O ' ' A' ' 197' ' ' LYS . 81.5 mt -121.28 138.61 51.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.102 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -88.11 -49.01 7.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.943 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -150.97 160.08 44.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.949 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 41.9 t -145.68 135.16 23.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.851 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 95.4 m -146.99 110.38 4.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.139 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.725 HD11 ' HA ' ' A' ' 164' ' ' GLU . 21.3 mm -71.73 138.94 20.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.129 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.592 HD11 ' CE2' ' A' ' 195' ' ' PHE . 34.9 mt . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.876 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 18.7 t . . . . . 0 C--O 1.23 0.054 0 CA-C-O 120.973 0.416 . . . . 0.0 110.84 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 39.0 mttt -92.57 16.56 11.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.893 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 65.69 43.53 94.1 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.451 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 193' ' ' CYS . . . . . 0.436 ' HB2' HD12 ' A' ' 183' ' ' LEU . 0.8 OUTLIER -154.67 155.74 35.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.809 0.338 . . . . 0.0 110.917 -179.897 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -162.5 155.61 19.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.116 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 195' ' ' PHE . . . . . 0.592 ' CE2' HD11 ' A' ' 183' ' ' LEU . 38.5 m-85 -107.84 119.01 38.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.923 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 46.8 t -122.28 138.55 52.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.122 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.541 ' O ' HG23 ' A' ' 177' ' ' ILE . 0.0 OUTLIER -113.62 160.53 18.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.923 179.892 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -131.55 173.13 11.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.922 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 45.0 t -73.61 -44.83 56.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.895 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 1.4 t -143.15 179.92 6.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.835 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 201' ' ' HIS . . . . . 0.441 ' O ' ' C ' ' A' ' 202' ' ' ALA . 10.7 t-80 -67.18 -61.59 1.85 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.871 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 202' ' ' ALA . . . . . 0.441 ' C ' ' O ' ' A' ' 201' ' ' HIS . . . -34.24 -62.77 0.31 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.097 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -49.1 -46.88 45.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.905 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 204' ' ' ALA . . . . . 0.438 ' HB1' HD11 ' A' ' 153' ' ' LEU . . . -51.64 -56.97 10.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.1 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 62.1 tp60 -53.21 -45.34 68.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.902 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -49.11 -53.32 21.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.064 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -64.29 -40.28 95.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.113 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 208' ' ' ILE . . . . . 0.626 HD11 HD21 ' A' ' 153' ' ' LEU . 71.5 mt -55.95 -66.08 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.137 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 12.9 t30 -59.77 -37.83 80.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.86 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -69.07 -21.7 64.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.128 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.736 ' HB3' HD23 ' A' ' 224' ' ' LEU . 85.0 mt -113.88 -74.36 0.62 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.907 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 212' ' ' HIS . . . . . 0.538 ' HD1' ' HA ' ' A' ' 225' ' ' VAL . 17.8 t60 -51.82 126.55 18.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.835 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 84.11 -6.81 73.89 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.508 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 33.2 t -88.55 -73.82 0.48 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.8 0.333 . . . . 0.0 110.889 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -99.69 -178.31 3.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.896 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 216' ' ' THR . . . . . 0.572 HG23 ' O ' ' A' ' 222' ' ' SER . 25.3 m -134.31 102.7 5.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.192 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 217' ' ' MET . . . . . 0.526 ' SD ' HD23 ' A' ' 158' ' ' LEU . 30.2 mmt -39.99 137.66 1.17 Allowed Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.602 0.715 . . . . 0.0 110.865 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -48.75 124.94 11.88 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.679 2.253 . . . . 0.0 112.35 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 103.64 -47.46 1.1 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.48 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 220' ' ' ALA . . . . . 0.416 ' O ' HG22 ' A' ' 216' ' ' THR . . . -75.64 145.9 40.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.779 0.323 . . . . 0.0 111.087 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 4.5 t -93.24 -16.34 24.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.856 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 222' ' ' SER . . . . . 0.572 ' O ' HG23 ' A' ' 216' ' ' THR . 5.5 m -100.05 141.15 33.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.81 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 73.1 m -54.95 155.19 4.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.823 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.736 HD23 ' HB3' ' A' ' 211' ' ' LEU . 55.8 tp -43.24 148.57 0.28 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.919 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 225' ' ' VAL . . . . . 0.538 ' HA ' ' HD1' ' A' ' 212' ' ' HIS . 88.2 t -118.81 113.05 40.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.099 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 226' ' ' VAL . . . . . 0.867 HG22 HG13 ' A' ' 155' ' ' VAL . 22.0 t -136.25 110.28 9.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.161 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 19.2 pttp -130.25 162.45 28.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.86 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 228' ' ' PHE . . . . . 0.572 ' HA ' HD23 ' A' ' 153' ' ' LEU . 49.0 m-85 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.899 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 5.4 ttpm? . . . . . 0 C--O 1.232 0.165 0 CA-C-O 120.806 0.336 . . . . 0.0 110.901 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.657 HD23 ' HA ' ' A' ' 228' ' ' PHE . 47.8 mt -128.59 136.16 50.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.919 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -94.5 131.5 40.14 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.898 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.567 HG22 HG13 ' A' ' 226' ' ' VAL . 92.9 t -123.7 129.5 74.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.169 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -125.78 -159.31 10.25 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.478 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.615 ' SD ' HG21 ' A' ' 225' ' ' VAL . 0.9 OUTLIER 44.16 30.23 0.42 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.816 0.341 . . . . 0.0 110.918 -179.957 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.402 ' HB2' ' C ' ' A' ' 192' ' ' GLY . 73.3 mt -88.75 157.19 18.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.905 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -101.05 160.46 14.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.843 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 47.2 mttt -83.97 37.54 0.61 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.895 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 55.9 tp60 -123.29 -46.47 2.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.921 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -55.71 151.11 11.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.922 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 3.7 t -126.5 166.26 17.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.879 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -44.37 -47.68 9.72 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.897 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -57.91 -57.04 14.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.876 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 -43.44 -57.04 3.27 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.884 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.728 HG13 ' CE1' ' A' ' 171' ' ' PHE . 61.7 t -61.73 -48.45 88.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.113 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 57.7 mtt180 -41.29 -68.55 0.18 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.87 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 87.6 mtt-85 -58.35 -53.66 55.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.84 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.64 ' O ' ' HB3' ' A' ' 173' ' ' ALA . 12.8 tp -41.07 -66.7 0.31 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.883 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 171' ' ' PHE . . . . . 0.728 ' CE1' HG13 ' A' ' 167' ' ' VAL . 9.8 m-85 -56.02 -73.3 0.06 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.867 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.454 ' O ' ' N ' ' A' ' 174' ' ' PHE . 0.9 OUTLIER -39.18 -27.78 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.924 -179.94 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.64 ' HB3' ' O ' ' A' ' 170' ' ' LEU . . . -40.66 -25.18 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.1 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 174' ' ' PHE . . . . . 0.454 ' N ' ' O ' ' A' ' 172' ' ' GLU . 95.6 m-85 -106.69 -70.73 0.78 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.877 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -102.14 -163.46 26.62 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.506 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 35.3 m120 -96.9 160.93 14.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.804 0.335 . . . . 0.0 110.865 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 13.0 mt -128.43 151.28 35.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.119 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 46.9 mm-40 -115.51 -42.54 3.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.915 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -155.18 149.61 26.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.899 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 40.6 t -137.98 143.98 40.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.879 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 56.5 m -150.12 149.15 29.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.148 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 13.3 mm -115.45 126.13 72.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.128 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.436 HD11 ' CE2' ' A' ' 195' ' ' PHE . 78.6 mt . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.896 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 53.3 p . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.941 0.4 . . . . 0.0 110.871 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 26.5 mtpt -85.01 26.66 0.83 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.881 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.402 ' C ' ' HB2' ' A' ' 158' ' ' LEU . . . 61.01 31.75 77.73 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.533 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 52.3 m -143.8 150.74 38.99 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.836 0.351 . . . . 0.0 110.894 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -155.52 172.09 18.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.087 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 195' ' ' PHE . . . . . 0.436 ' CE2' HD11 ' A' ' 183' ' ' LEU . 37.4 m-85 -128.43 130.4 47.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.879 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 48.6 t -127.8 132.96 68.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.126 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 29.2 mttp -104.53 150.03 24.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.869 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 198' ' ' TYR . . . . . 0.447 ' OH ' ' CB ' ' A' ' 207' ' ' ALA . 3.3 m-85 -123.03 175.36 6.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.949 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 58.0 m -86.36 -34.9 20.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.864 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 75.4 m -147.06 -179.86 7.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.867 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 201' ' ' HIS . . . . . 0.435 ' O ' ' C ' ' A' ' 202' ' ' ALA . 67.8 t60 -73.42 -63.96 1.09 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.896 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 202' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 201' ' ' HIS . . . -34.49 -61.44 0.39 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.05 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -48.47 -44.15 35.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.834 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 204' ' ' ALA . . . . . 0.411 ' N ' ' O ' ' A' ' 201' ' ' HIS . . . -60.16 -56.14 25.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.119 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 205' ' ' GLN . . . . . 0.439 ' HA ' HD12 ' A' ' 208' ' ' ILE . 33.0 tp60 -50.66 -46.13 58.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.89 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -54.84 -49.6 70.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.055 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 207' ' ' ALA . . . . . 0.447 ' CB ' ' OH ' ' A' ' 198' ' ' TYR . . . -63.76 -26.59 68.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.106 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 208' ' ' ILE . . . . . 0.484 ' O ' ' N ' ' A' ' 212' ' ' HIS . 60.3 mt -70.74 -64.24 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.181 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -58.48 -39.16 79.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.895 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 210' ' ' ALA . . . . . 0.413 ' HB1' ' CZ ' ' A' ' 174' ' ' PHE . . . -66.99 -35.11 79.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.079 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.451 ' HB3' HD23 ' A' ' 224' ' ' LEU . 86.5 mt -102.5 -74.54 0.63 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.94 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 212' ' ' HIS . . . . . 0.484 ' N ' ' O ' ' A' ' 208' ' ' ILE . 33.9 t60 -49.18 134.07 18.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.861 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 70.06 -0.61 21.91 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.531 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -93.34 -71.01 0.67 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.747 0.308 . . . . 0.0 110.863 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -100.05 -178.44 3.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.916 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 216' ' ' THR . . . . . 0.559 HG23 ' O ' ' A' ' 222' ' ' SER . 7.6 m -136.97 110.3 7.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.139 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 217' ' ' MET . . . . . 0.7 ' SD ' HD13 ' A' ' 224' ' ' LEU . 0.0 OUTLIER -39.26 160.05 0.1 OUTLIER Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.519 0.676 . . . . 0.0 110.915 179.883 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.32 103.0 1.54 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.637 2.224 . . . . 0.0 112.367 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 122.47 -49.77 0.87 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.501 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -65.24 150.38 48.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.796 0.331 . . . . 0.0 111.091 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 9.5 m -95.33 -17.38 21.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.848 -179.774 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 222' ' ' SER . . . . . 0.559 ' O ' HG23 ' A' ' 216' ' ' THR . 1.1 t -99.82 146.14 26.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.874 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -61.65 152.99 29.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.89 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.7 HD13 ' SD ' ' A' ' 217' ' ' MET . 59.4 tp -38.71 152.92 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.907 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 225' ' ' VAL . . . . . 0.615 HG21 ' SD ' ' A' ' 157' ' ' MET . 86.5 t -125.1 104.4 13.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.124 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 226' ' ' VAL . . . . . 0.567 HG13 HG22 ' A' ' 155' ' ' VAL . 8.8 t -128.4 103.06 9.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.121 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 7.6 ptmt -120.76 167.34 12.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.882 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 228' ' ' PHE . . . . . 0.657 ' HA ' HD23 ' A' ' 153' ' ' LEU . 73.4 m-85 . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.887 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 20.3 tttt . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.849 0.357 . . . . 0.0 110.871 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 32.0 mt -127.08 124.99 40.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.916 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -92.82 110.8 22.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.858 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.645 HG13 HG22 ' A' ' 226' ' ' VAL . 39.4 t -104.64 127.55 58.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.111 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.422 ' O ' ' N ' ' A' ' 158' ' ' LEU . . . -125.68 -152.22 8.13 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.505 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.485 ' SD ' HG21 ' A' ' 225' ' ' VAL . 0.4 OUTLIER 38.59 30.5 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.855 0.36 . . . . 0.0 110.87 179.976 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.422 ' N ' ' O ' ' A' ' 156' ' ' GLY . 61.4 mt -83.93 166.14 18.09 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.893 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -100.31 158.41 15.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.896 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 34.9 mttm -88.16 33.46 0.74 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.908 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -123.84 -52.22 1.79 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.907 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -51.54 155.54 1.53 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.905 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 4.3 m -131.03 174.79 9.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.862 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -50.37 -42.58 53.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.92 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -59.3 -54.58 45.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.898 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -48.73 -64.24 0.86 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.845 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.74 HG13 ' CE1' ' A' ' 171' ' ' PHE . 90.0 t -55.71 -50.41 67.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.099 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 168' ' ' ARG . . . . . 0.42 ' C ' ' O ' ' A' ' 167' ' ' VAL . 20.5 ttm-85 -36.88 -63.73 0.4 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.872 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 169' ' ' ARG . . . . . 0.403 ' O ' ' HG3' ' A' ' 172' ' ' GLU . 21.4 mtp85 -64.19 -51.48 63.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.907 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.684 ' O ' ' HB3' ' A' ' 173' ' ' ALA . 13.3 tp -43.72 -65.6 0.48 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.909 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 171' ' ' PHE . . . . . 0.74 ' CE1' HG13 ' A' ' 167' ' ' VAL . 6.2 m-85 -55.83 -68.1 0.23 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.853 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.403 ' HG3' ' O ' ' A' ' 169' ' ' ARG . 0.9 OUTLIER -45.3 -21.82 0.1 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.878 -179.915 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.684 ' HB3' ' O ' ' A' ' 170' ' ' LEU . . . -49.21 -19.05 0.41 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.091 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -112.52 -73.93 0.65 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.875 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' GLY . . . . . 0.429 ' CA ' ' OE1' ' A' ' 203' ' ' GLU . . . -110.89 154.32 16.7 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.467 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -57.63 149.37 21.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.821 0.343 . . . . 0.0 110.895 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 46.1 mt -111.34 147.84 15.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.152 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 178' ' ' GLU . . . . . 0.459 ' OE1' ' N ' ' A' ' 178' ' ' GLU . 0.5 OUTLIER -102.89 -40.57 6.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.934 179.94 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -160.44 149.41 17.06 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.901 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 25.2 t -136.47 140.48 43.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.895 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 30.5 m -149.74 142.61 24.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.183 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 33.6 mm -107.29 121.95 60.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.157 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.767 HD11 ' CE2' ' A' ' 195' ' ' PHE . 30.6 mt . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.887 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 18.1 p . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.971 0.415 . . . . 0.0 110.87 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 3.1 mmmm -94.19 33.59 1.35 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.867 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.412 ' C ' ' HB2' ' A' ' 158' ' ' LEU . . . 44.24 32.54 2.61 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.484 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 75.8 m -141.6 151.24 42.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.828 0.347 . . . . 0.0 110.881 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -158.88 161.32 36.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.145 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 195' ' ' PHE . . . . . 0.767 ' CE2' HD11 ' A' ' 183' ' ' LEU . 47.9 m-85 -118.05 135.92 53.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.9 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 64.7 t -133.2 145.96 33.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.122 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 42.6 mtpt -122.44 142.83 50.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.937 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -117.8 175.22 5.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.867 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 51.1 p -80.1 -44.25 20.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.815 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 2.7 m -133.95 -177.62 4.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.799 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 20.7 t60 -80.19 -57.1 3.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.879 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -37.99 -56.79 1.11 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.129 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 203' ' ' GLU . . . . . 0.429 ' OE1' ' CA ' ' A' ' 175' ' ' GLY . 31.3 mm-40 -54.63 -43.24 72.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.853 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -56.46 -55.78 29.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.079 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 53.1 tp60 -50.88 -41.95 58.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.92 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -57.7 -51.9 67.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.109 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -63.28 -26.49 68.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.072 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 208' ' ' ILE . . . . . 0.495 ' O ' ' N ' ' A' ' 212' ' ' HIS . 50.4 mt -69.15 -73.27 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.103 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 209' ' ' ASN . . . . . 0.464 ' N ' HG22 ' A' ' 208' ' ' ILE . 34.2 t30 -48.89 -42.72 37.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.843 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 210' ' ' ALA . . . . . 0.468 ' O ' ' CB ' ' A' ' 214' ' ' SER . . . -54.27 -45.31 72.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.101 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.454 ' CB ' HD23 ' A' ' 224' ' ' LEU . 18.8 mt -100.51 -69.21 0.78 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.902 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 212' ' ' HIS . . . . . 0.645 ' HD1' ' HA ' ' A' ' 225' ' ' VAL . 27.2 t60 -53.95 124.24 14.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.878 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 213' ' ' GLY . . . . . 0.488 ' CA ' ' HB3' ' A' ' 223' ' ' SER . . . 81.24 -14.68 26.94 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.512 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 214' ' ' SER . . . . . 0.468 ' CB ' ' O ' ' A' ' 210' ' ' ALA . 1.9 m -85.94 -72.38 0.5 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.818 0.342 . . . . 0.0 110.838 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 59.7 mt-30 -99.13 169.54 9.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.898 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 216' ' ' THR . . . . . 0.624 HG23 ' O ' ' A' ' 222' ' ' SER . 3.0 m -118.78 97.61 5.8 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.148 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 13.2 mmt -38.74 138.81 0.76 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.556 0.693 . . . . 0.0 110.865 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -48.47 126.67 14.5 Favored 'Trans proline' 0 C--N 1.34 0.131 0 C-N-CA 122.685 2.256 . . . . 0.0 112.344 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 102.45 -53.42 0.78 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.503 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -70.65 150.08 46.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.781 0.324 . . . . 0.0 111.099 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 31.1 t -95.92 -18.19 20.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.826 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 222' ' ' SER . . . . . 0.624 ' O ' HG23 ' A' ' 216' ' ' THR . 3.5 m -99.91 151.22 21.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.874 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 223' ' ' SER . . . . . 0.488 ' HB3' ' CA ' ' A' ' 213' ' ' GLY . 17.4 m -59.58 145.36 44.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.844 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.512 ' HG ' HG23 ' A' ' 226' ' ' VAL . 48.2 tp -34.61 148.8 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.918 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 225' ' ' VAL . . . . . 0.645 ' HA ' ' HD1' ' A' ' 212' ' ' HIS . 64.9 t -117.13 106.71 20.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.142 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 226' ' ' VAL . . . . . 0.645 HG22 HG13 ' A' ' 155' ' ' VAL . 24.6 t -133.39 106.29 9.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.142 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 9.0 ptmt -125.03 174.39 8.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.906 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.884 179.961 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 3.6 ttmp? . . . . . 0 C--O 1.233 0.203 0 CA-C-O 120.817 0.341 . . . . 0.0 110.922 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.612 HD12 ' CD1' ' A' ' 198' ' ' TYR . 64.6 mt -123.47 124.01 41.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.902 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -94.24 110.47 22.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.885 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.588 HG22 HG13 ' A' ' 226' ' ' VAL . 21.2 t -104.19 120.62 54.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.112 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -120.64 -174.41 15.12 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.451 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 19.5 mmt 61.7 30.82 18.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.811 0.339 . . . . 0.0 110.902 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.416 ' HB2' ' C ' ' A' ' 192' ' ' GLY . 25.0 mt -88.04 162.31 16.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.912 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -102.39 160.27 14.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.892 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 14.9 mtpp -84.98 36.66 0.63 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.937 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 4.5 tp-100 -123.09 -51.08 1.9 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.905 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 66.1 mt-30 -54.23 154.32 4.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.888 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 90.3 p -130.77 -177.97 4.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.881 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' GLU . . . . . 0.493 ' O ' ' CB ' ' A' ' 168' ' ' ARG . 1.8 mp0 -55.31 -48.05 74.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.902 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -58.29 -55.17 38.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.866 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -45.64 -68.23 0.21 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.839 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.527 HG13 ' CE1' ' A' ' 171' ' ' PHE . 59.8 t -59.1 -55.51 23.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.155 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 168' ' ' ARG . . . . . 0.493 ' CB ' ' O ' ' A' ' 164' ' ' GLU . 70.9 ttt180 -34.3 -53.32 0.5 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.923 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 20.1 mmt85 -65.0 -54.3 32.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.931 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.761 ' O ' ' HB3' ' A' ' 173' ' ' ALA . 13.0 tp -44.21 -64.42 0.68 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.962 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 171' ' ' PHE . . . . . 0.789 ' CB ' HD11 ' A' ' 177' ' ' ILE . 6.8 m-85 -51.89 -67.53 0.24 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.904 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -48.41 -23.12 0.84 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.857 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.761 ' HB3' ' O ' ' A' ' 170' ' ' LEU . . . -51.95 -27.18 12.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.09 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -111.99 -62.84 1.5 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.846 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -118.76 137.17 12.62 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.48 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 48.8 m-80 -51.77 151.16 3.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.788 0.328 . . . . 0.0 110.897 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.789 HD11 ' CB ' ' A' ' 171' ' ' PHE . 97.6 mt -117.46 109.35 27.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.121 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -61.18 -36.99 81.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.883 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -159.44 137.22 10.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.898 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 5.7 t -124.32 143.42 50.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.888 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 55.7 m -154.37 137.04 15.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.161 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 10.6 mm -106.28 133.44 50.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.103 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.801 HD11 ' CE2' ' A' ' 195' ' ' PHE . 84.8 mt . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.909 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 42.3 t . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.98 0.419 . . . . 0.0 110.851 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 25.2 mtmm -84.43 32.49 0.51 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.925 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.416 ' C ' ' HB2' ' A' ' 158' ' ' LEU . . . 58.12 39.21 91.86 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.506 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 7.2 p -157.85 149.39 21.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.83 0.348 . . . . 0.0 110.862 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -160.13 156.5 26.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.156 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 195' ' ' PHE . . . . . 0.801 ' CE2' HD11 ' A' ' 183' ' ' LEU . 42.3 m-85 -114.12 126.96 55.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.866 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.533 HG21 ' CE2' ' A' ' 171' ' ' PHE . 98.8 t -117.23 139.36 44.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.072 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 31.4 tttt -116.37 118.38 32.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.86 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 198' ' ' TYR . . . . . 0.612 ' CD1' HD12 ' A' ' 153' ' ' LEU . 20.3 m-85 -95.58 172.28 8.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.918 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 8.3 t -79.2 -39.46 33.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.834 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 33.6 p -149.19 160.25 43.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.893 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 201' ' ' HIS . . . . . 0.448 ' O ' ' C ' ' A' ' 202' ' ' ALA . 13.3 t-80 -53.46 -58.93 5.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.873 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 202' ' ' ALA . . . . . 0.448 ' C ' ' O ' ' A' ' 201' ' ' HIS . . . -34.33 -62.93 0.31 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.085 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -54.21 -42.61 69.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.857 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 204' ' ' ALA . . . . . 0.4 ' N ' ' O ' ' A' ' 201' ' ' HIS . . . -58.53 -64.1 1.05 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.068 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 205' ' ' GLN . . . . . 0.54 ' HA ' HD12 ' A' ' 208' ' ' ILE . 37.1 tp60 -43.15 -42.03 3.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.956 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -57.3 -57.47 12.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.065 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 207' ' ' ALA . . . . . 0.429 ' CB ' ' OH ' ' A' ' 198' ' ' TYR . . . -55.24 -33.56 63.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.088 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 208' ' ' ILE . . . . . 0.54 HD12 ' HA ' ' A' ' 205' ' ' GLN . 87.8 mt -62.72 -75.0 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.138 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -48.71 -42.09 33.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.892 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -56.32 -36.88 69.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.118 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.487 ' HB3' ' CD2' ' A' ' 224' ' ' LEU . 50.7 mt -109.44 -72.6 0.72 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.898 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 212' ' ' HIS . . . . . 0.479 ' N ' ' O ' ' A' ' 208' ' ' ILE . 9.4 t60 -46.73 128.62 10.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.865 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 82.04 -22.91 5.56 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.514 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 7.9 t -91.45 -70.74 0.67 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.819 0.342 . . . . 0.0 110.818 -179.699 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 9.5 mm-40 -86.54 161.55 18.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.86 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 216' ' ' THR . . . . . 0.549 HG23 ' O ' ' A' ' 222' ' ' SER . 39.1 m -129.01 108.65 10.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.157 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 217' ' ' MET . . . . . 0.402 ' C ' ' O ' ' A' ' 216' ' ' THR . 24.1 mmt -37.4 156.88 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.534 0.683 . . . . 0.0 110.884 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.16 113.29 3.55 Favored 'Trans proline' 0 C--N 1.341 0.133 0 C-N-CA 122.683 2.255 . . . . 0.0 112.307 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 113.94 -45.09 1.37 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.493 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -70.92 142.03 51.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.788 0.328 . . . . 0.0 111.103 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 68.3 m -91.53 -14.81 29.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.879 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 222' ' ' SER . . . . . 0.549 ' O ' HG23 ' A' ' 216' ' ' THR . 2.7 m -100.17 143.1 30.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.835 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 2.4 p -51.3 159.83 0.63 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.879 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.649 HD12 ' H ' ' A' ' 225' ' ' VAL . 41.6 tp -54.04 154.7 4.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.887 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 225' ' ' VAL . . . . . 0.649 ' H ' HD12 ' A' ' 224' ' ' LEU . 60.7 t -127.15 108.09 18.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.123 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 226' ' ' VAL . . . . . 0.588 HG13 HG22 ' A' ' 155' ' ' VAL . 24.2 t -133.91 101.46 3.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.169 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 10.7 ptmt -131.75 143.21 50.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.925 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.889 179.957 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 6.5 ttpm? . . . . . 0 C--O 1.232 0.18 0 CA-C-O 120.782 0.325 . . . . 0.0 110.887 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.417 HD12 ' CD1' ' A' ' 198' ' ' TYR . 58.1 mt -129.29 127.09 40.45 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.934 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 18.8 t80 -101.04 113.14 25.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.844 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.479 HG22 HG13 ' A' ' 226' ' ' VAL . 48.1 t -104.07 124.01 58.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.094 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -124.45 -169.61 13.08 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.465 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 93.4 mmm 50.07 39.36 18.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.794 0.331 . . . . 0.0 110.919 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.417 ' HB2' ' C ' ' A' ' 192' ' ' GLY . 66.9 mt -94.04 162.36 13.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.906 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -100.3 158.08 16.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.883 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 52.4 mttp -83.5 39.47 0.67 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.922 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -124.9 -47.83 1.78 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.934 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 64.2 mt-30 -57.89 151.68 17.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.881 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 3.4 m -129.29 176.35 8.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.86 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -52.95 -44.13 66.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.883 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -59.38 -51.59 69.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.868 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -52.74 -61.74 2.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.892 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.623 HG13 ' CD1' ' A' ' 171' ' ' PHE . 25.4 t -58.64 -56.8 14.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.158 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 168' ' ' ARG . . . . . 0.415 ' C ' ' O ' ' A' ' 167' ' ' VAL . 15.5 ttt180 -36.3 -62.34 0.45 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.866 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 19.4 mmt85 -61.05 -54.11 48.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.915 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.729 ' O ' ' HB3' ' A' ' 173' ' ' ALA . 12.5 tp -43.14 -65.68 0.46 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.899 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 171' ' ' PHE . . . . . 0.623 ' CD1' HG13 ' A' ' 167' ' ' VAL . 8.5 m-85 -52.22 -70.86 0.08 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.888 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.408 ' C ' ' N ' ' A' ' 174' ' ' PHE . 5.3 pt-20 -43.3 -28.79 0.35 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.864 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.729 ' HB3' ' O ' ' A' ' 170' ' ' LEU . . . -44.49 -22.09 0.07 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.076 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 174' ' ' PHE . . . . . 0.408 ' N ' ' C ' ' A' ' 172' ' ' GLU . 97.7 m-85 -109.79 -74.91 0.64 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.878 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -108.08 148.12 16.62 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.495 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -52.35 145.77 10.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.791 0.329 . . . . 0.0 110.888 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 18.6 mt -108.96 136.1 45.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.137 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -93.49 -36.81 12.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.884 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 179' ' ' GLU . . . . . 0.425 ' HG3' ' N ' ' A' ' 180' ' ' CYS . 3.4 tp10 -163.73 144.55 8.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.919 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 180' ' ' CYS . . . . . 0.425 ' N ' ' HG3' ' A' ' 179' ' ' GLU . 35.7 t -135.12 142.99 46.33 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.902 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 91.1 m -155.19 143.2 20.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.102 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 9.0 mm -105.35 138.5 30.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.131 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.562 HD11 ' CE2' ' A' ' 195' ' ' PHE . 44.7 mt . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.896 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 36.2 t . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.931 0.396 . . . . 0.0 110.894 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 25.3 mttp -105.23 36.7 2.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.887 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.417 ' C ' ' HB2' ' A' ' 158' ' ' LEU . . . 46.02 44.53 14.02 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.539 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 3.5 p -155.32 155.07 33.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.838 0.352 . . . . 0.0 110.897 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -161.38 166.02 28.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.057 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 195' ' ' PHE . . . . . 0.562 ' CE2' HD11 ' A' ' 183' ' ' LEU . 39.4 m-85 -120.58 132.9 55.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.856 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.455 HG21 ' CE2' ' A' ' 171' ' ' PHE . 21.8 t -125.77 145.95 32.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.122 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 11.3 ttmm -123.29 141.53 51.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.935 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 198' ' ' TYR . . . . . 0.417 ' CD1' HD12 ' A' ' 153' ' ' LEU . 24.6 m-85 -118.59 174.94 5.97 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.886 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 10.5 t -81.66 -49.17 10.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.853 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 23.7 t -126.31 166.87 16.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.87 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 62.9 t-80 -66.51 -49.81 65.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.868 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -45.27 -59.07 2.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.101 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -47.8 -49.38 29.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.895 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -51.26 -61.62 2.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.064 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 205' ' ' GLN . . . . . 0.775 ' HA ' HD12 ' A' ' 208' ' ' ILE . 44.9 tp60 -46.35 -43.65 16.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.918 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -55.8 -62.31 1.78 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.137 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -50.89 -35.03 30.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.083 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 208' ' ' ILE . . . . . 0.775 HD12 ' HA ' ' A' ' 205' ' ' GLN . 77.7 mt -61.44 -73.37 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.124 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -47.39 -42.98 23.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.915 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -57.72 -40.56 79.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.11 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.422 ' O ' ' CB ' ' A' ' 214' ' ' SER . 61.1 mt -102.25 -72.05 0.7 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.972 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 212' ' ' HIS . . . . . 0.495 ' N ' ' O ' ' A' ' 208' ' ' ILE . 20.0 t60 -47.41 136.25 9.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.827 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 67.61 1.01 14.28 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.503 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 214' ' ' SER . . . . . 0.422 ' CB ' ' O ' ' A' ' 211' ' ' LEU . 1.0 OUTLIER -95.28 -71.09 0.68 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.912 0.386 . . . . 0.0 110.833 -179.683 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -99.96 -178.17 3.77 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.925 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 216' ' ' THR . . . . . 0.547 HG23 ' O ' ' A' ' 222' ' ' SER . 51.6 m -134.49 102.45 5.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.139 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 28.3 mmt -40.99 135.61 1.65 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.562 0.696 . . . . 0.0 110.847 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -48.62 119.18 3.94 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.686 2.258 . . . . 0.0 112.349 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 111.16 -46.19 1.21 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.467 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -76.45 148.79 37.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.802 0.334 . . . . 0.0 111.084 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 10.5 t -93.55 -18.9 21.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.916 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 222' ' ' SER . . . . . 0.547 ' O ' HG23 ' A' ' 216' ' ' THR . 1.1 t -100.05 147.62 25.43 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.859 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 58.4 m -59.43 156.51 12.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.855 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.442 ' HG ' HG23 ' A' ' 226' ' ' VAL . 38.9 tp -43.24 149.43 0.23 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.907 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 225' ' ' VAL . . . . . 0.477 ' HA ' ' HD1' ' A' ' 212' ' ' HIS . 60.4 t -121.42 113.52 39.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.134 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 226' ' ' VAL . . . . . 0.479 HG13 HG22 ' A' ' 155' ' ' VAL . 22.5 t -138.08 105.33 3.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.149 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 9.4 pttp -130.74 148.56 52.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.942 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.859 179.986 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 25.4 tttp . . . . . 0 C--O 1.232 0.162 0 CA-C-O 120.775 0.322 . . . . 0.0 110.927 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.631 HD11 ' HB1' ' A' ' 204' ' ' ALA . 62.3 mt -105.29 132.68 51.18 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.914 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -92.24 135.06 34.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.887 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 23.0 t -124.27 114.85 42.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.098 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -116.59 -176.14 17.83 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.48 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 91.4 mmm 58.62 41.83 21.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.814 0.34 . . . . 0.0 110.873 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.645 HD23 ' HG3' ' A' ' 217' ' ' MET . 46.5 mt -103.57 178.34 4.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.915 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -124.44 172.07 9.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.93 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 37.3 mttt -95.91 51.35 1.24 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.902 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -127.22 -52.19 1.4 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.883 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -64.56 164.32 11.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.872 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 31.8 p -133.55 177.77 7.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.877 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -52.16 -35.65 49.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.916 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -64.22 -57.43 9.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.836 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -47.04 -54.55 10.02 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.851 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.816 HG13 ' CE1' ' A' ' 171' ' ' PHE . 61.3 t -65.23 -40.56 89.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.174 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 4.3 mmm180 -48.0 -67.11 0.3 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.896 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 13.1 mmm-85 -60.78 -52.84 63.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.875 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.67 ' O ' ' HB3' ' A' ' 173' ' ' ALA . 12.6 tp -41.96 -66.27 0.37 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.892 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 171' ' ' PHE . . . . . 0.816 ' CE1' HG13 ' A' ' 167' ' ' VAL . 9.3 m-85 -55.92 -71.24 0.09 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.903 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.498 ' CD ' ' C ' ' A' ' 172' ' ' GLU . 0.5 OUTLIER -41.48 -24.91 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.873 -179.934 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.67 ' HB3' ' O ' ' A' ' 170' ' ' LEU . . . -45.58 -21.16 0.09 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.117 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -117.46 -66.45 1.08 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.875 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -114.63 134.24 11.56 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.471 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 40.2 m-20 -45.31 153.94 0.2 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.789 0.328 . . . . 0.0 110.899 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 38.1 mt -112.66 128.04 69.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.135 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -83.0 -37.98 23.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.859 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -164.67 129.6 2.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.948 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 51.4 t -113.8 142.76 45.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.912 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 40.7 m -155.0 144.95 21.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.165 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 31.5 mm -109.06 146.75 14.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.193 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.742 HD11 ' CE2' ' A' ' 195' ' ' PHE . 31.4 mt . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.943 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 4.9 t . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.966 0.412 . . . . 0.0 110.856 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 64.0 mttt -104.29 32.08 4.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.896 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 58.48 39.75 93.45 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.477 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 193' ' ' CYS . . . . . 0.474 ' HB3' HD12 ' A' ' 183' ' ' LEU . 85.6 m -151.42 153.41 34.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.844 0.354 . . . . 0.0 110.852 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -162.44 167.05 24.19 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.132 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 195' ' ' PHE . . . . . 0.742 ' CE2' HD11 ' A' ' 183' ' ' LEU . 76.8 m-85 -125.53 133.72 52.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.854 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.411 HG21 ' CE2' ' A' ' 171' ' ' PHE . 29.1 t -127.92 118.84 49.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.122 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 22.5 ttmt -95.3 141.84 28.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.911 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 198' ' ' TYR . . . . . 0.439 ' OH ' ' CB ' ' A' ' 207' ' ' ALA . 10.3 m-85 -115.28 173.71 6.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.871 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 20.7 p -78.47 -46.24 20.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.817 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 3.0 t -137.32 156.32 48.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.869 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 201' ' ' HIS . . . . . 0.419 ' O ' ' C ' ' A' ' 202' ' ' ALA . 3.5 t-160 -52.29 -59.99 3.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.923 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 202' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 201' ' ' HIS . . . -35.89 -64.32 0.32 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.077 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -48.94 -47.29 43.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.845 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 204' ' ' ALA . . . . . 0.631 ' HB1' HD11 ' A' ' 153' ' ' LEU . . . -54.94 -54.12 46.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.087 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 43.3 tp60 -49.72 -47.24 50.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.912 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 206' ' ' ALA . . . . . 0.436 ' O ' ' CB ' ' A' ' 210' ' ' ALA . . . -55.08 -48.73 73.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.14 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 207' ' ' ALA . . . . . 0.439 ' CB ' ' OH ' ' A' ' 198' ' ' TYR . . . -59.35 -41.31 88.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.082 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 208' ' ' ILE . . . . . 0.542 HD11 ' CD2' ' A' ' 153' ' ' LEU . 63.7 mt -58.66 -72.28 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.127 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 16.5 t30 -53.21 -40.08 64.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.914 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 210' ' ' ALA . . . . . 0.436 ' CB ' ' O ' ' A' ' 206' ' ' ALA . . . -57.78 -41.16 81.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.079 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 19.8 mt -101.47 -69.32 0.78 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.913 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 212' ' ' HIS . . . . . 0.488 ' N ' ' O ' ' A' ' 208' ' ' ILE . 14.4 t60 -48.28 133.26 15.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.877 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 73.92 -1.14 48.66 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.481 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 8.5 t -95.93 -70.99 0.69 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.794 0.331 . . . . 0.0 110.842 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -99.86 -175.78 3.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.898 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 216' ' ' THR . . . . . 0.653 HG23 ' O ' ' A' ' 222' ' ' SER . 35.1 m -137.13 109.3 7.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.146 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 217' ' ' MET . . . . . 0.645 ' HG3' HD23 ' A' ' 158' ' ' LEU . 23.8 mmt -38.17 158.18 0.09 OUTLIER Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.588 0.709 . . . . 0.0 110.872 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -71.62 107.15 2.11 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.644 2.23 . . . . 0.0 112.324 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 119.31 -48.04 0.98 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.476 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -68.46 148.23 50.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.765 0.317 . . . . 0.0 111.112 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 77.9 p -92.57 -18.17 23.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.882 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 222' ' ' SER . . . . . 0.653 ' O ' HG23 ' A' ' 216' ' ' THR . 2.4 m -100.04 149.66 23.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.862 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 66.3 m -59.88 157.23 12.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.861 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.45 ' HG ' ' N ' ' A' ' 225' ' ' VAL . 16.0 tp -47.8 154.39 0.51 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.894 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 225' ' ' VAL . . . . . 0.45 ' N ' ' HG ' ' A' ' 224' ' ' LEU . 34.6 t -125.32 110.62 24.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.102 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 226' ' ' VAL . . . . . 0.436 ' O ' HG23 ' A' ' 208' ' ' ILE . 19.6 t -132.9 101.95 4.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.1 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 23.8 pttt -129.06 152.27 48.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.92 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 228' ' ' PHE . . . . . 0.453 ' HA ' HD23 ' A' ' 153' ' ' LEU . 52.2 m-85 . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.89 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.562 ' HD3' ' CD1' ' A' ' 195' ' ' PHE . 13.3 ttmt . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.832 0.349 . . . . 0.0 110.899 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.504 HD23 ' HA ' ' A' ' 228' ' ' PHE . 56.6 mt -117.84 123.6 46.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.956 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 56.3 t80 -91.13 121.81 33.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.859 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.444 ' CG1' HD11 ' A' ' 158' ' ' LEU . 58.9 t -109.1 128.79 64.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.151 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -124.6 -160.35 10.72 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.534 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.406 ' SD ' HG23 ' A' ' 225' ' ' VAL . 33.3 mtt 38.69 43.95 0.75 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.821 0.343 . . . . 0.0 110.867 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.451 HD23 ' HG3' ' A' ' 217' ' ' MET . 67.9 mt -99.88 175.55 5.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.885 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.496 ' N ' ' OD1' ' A' ' 159' ' ' ASN . 0.5 OUTLIER -115.35 154.9 28.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.894 179.904 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.74 20.64 1.41 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.922 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -107.83 -34.62 6.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.941 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' GLN . . . . . 0.49 ' HG3' ' ND2' ' A' ' 159' ' ' ASN . 25.8 mt-30 -59.12 158.42 8.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.917 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 85.2 p -132.53 163.96 27.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.86 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -47.8 -50.97 24.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.872 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -53.23 -47.78 68.72 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.839 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -53.93 -69.1 0.13 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.864 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.802 HG13 ' CE1' ' A' ' 171' ' ' PHE . 86.0 t -52.92 -54.39 16.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.164 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 168' ' ' ARG . . . . . 0.489 ' C ' ' CD ' ' A' ' 168' ' ' ARG . 0.0 OUTLIER -39.53 -63.18 0.59 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.891 -179.959 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 169' ' ' ARG . . . . . 0.406 ' CB ' HH11 ' A' ' 169' ' ' ARG . 4.0 mtp-105 -60.85 -53.91 51.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.882 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.714 ' O ' ' HB3' ' A' ' 173' ' ' ALA . 11.9 tp -43.23 -65.93 0.43 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.901 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 171' ' ' PHE . . . . . 0.802 ' CE1' HG13 ' A' ' 167' ' ' VAL . 11.6 m-85 -52.2 -70.93 0.07 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.914 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.416 ' O ' ' N ' ' A' ' 174' ' ' PHE . 5.9 pt-20 -43.09 -29.36 0.35 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.947 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.714 ' HB3' ' O ' ' A' ' 170' ' ' LEU . . . -43.29 -23.05 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.082 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 174' ' ' PHE . . . . . 0.416 ' N ' ' O ' ' A' ' 172' ' ' GLU . 92.7 m-85 -114.56 -70.24 0.81 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.879 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -111.28 137.57 14.39 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.521 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -44.23 164.79 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.762 0.315 . . . . 0.0 110.896 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.519 HD11 ' CB ' ' A' ' 171' ' ' PHE . 51.1 mt -133.42 134.0 57.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.104 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -89.38 -41.31 12.19 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.918 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -150.75 151.2 32.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.831 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 49.4 t -146.0 138.2 25.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.854 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 26.2 m -154.89 151.2 28.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.155 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 48.6 mm -109.21 140.8 26.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.141 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.471 HD11 ' CE2' ' A' ' 195' ' ' PHE . 34.6 mt . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.919 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 8.3 t . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.947 0.404 . . . . 0.0 110.842 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 38.3 mttm -105.04 34.25 3.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.908 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.431 ' C ' ' HB2' ' A' ' 158' ' ' LEU . . . 49.92 39.47 32.9 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.521 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 80.8 m -151.03 157.61 43.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.772 0.32 . . . . 0.0 110.89 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -160.84 166.64 28.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.123 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 195' ' ' PHE . . . . . 0.562 ' CD1' ' HD3' ' A' ' 152' ' ' LYS . 40.0 m-85 -124.5 130.5 52.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.879 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 11.8 t -128.46 148.73 32.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.141 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.424 ' O ' HG23 ' A' ' 177' ' ' ILE . 6.3 ttmm -126.93 138.39 53.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.92 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 198' ' ' TYR . . . . . 0.429 ' CD1' HD12 ' A' ' 153' ' ' LEU . 20.8 m-85 -114.68 175.44 5.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.915 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 41.2 t -81.6 -48.05 12.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.858 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 1.9 t -134.59 172.48 12.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.874 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 201' ' ' HIS . . . . . 0.404 ' O ' ' C ' ' A' ' 202' ' ' ALA . 18.2 t-160 -67.4 -55.96 11.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.85 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 202' ' ' ALA . . . . . 0.404 ' C ' ' O ' ' A' ' 201' ' ' HIS . . . -37.98 -64.51 0.4 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.098 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -49.37 -48.21 47.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.869 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -54.76 -58.37 7.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.137 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 205' ' ' GLN . . . . . 0.862 ' HA ' HD12 ' A' ' 208' ' ' ILE . 4.4 tp-100 -43.63 -50.57 7.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.897 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -52.8 -54.79 29.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.085 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -56.27 -32.66 64.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.138 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 208' ' ' ILE . . . . . 0.862 HD12 ' HA ' ' A' ' 205' ' ' GLN . 59.7 mt -65.07 -75.13 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.071 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -49.32 -42.61 42.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.861 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -54.97 -43.24 73.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.106 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 58.6 mt -102.23 -70.19 0.76 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.943 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 212' ' ' HIS . . . . . 0.492 ' N ' ' O ' ' A' ' 208' ' ' ILE . 5.4 t60 -50.74 129.88 23.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.866 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 75.61 -9.25 16.37 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.476 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 7.9 t -99.95 -70.23 0.74 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.877 0.37 . . . . 0.0 110.874 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 215' ' ' GLN . . . . . 0.432 ' HG3' ' N ' ' A' ' 216' ' ' THR . 1.7 tt0 -90.65 154.87 19.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.923 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 216' ' ' THR . . . . . 0.601 HG23 ' O ' ' A' ' 222' ' ' SER . 30.5 m -118.17 101.62 8.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.156 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 217' ' ' MET . . . . . 0.451 ' HG3' HD23 ' A' ' 158' ' ' LEU . 19.4 mmt -39.13 134.84 1.09 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.626 0.727 . . . . 0.0 110.887 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -48.99 131.57 25.78 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.723 2.282 . . . . 0.0 112.356 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 99.29 -41.93 2.1 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.734 -0.745 . . . . 0.0 112.502 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -82.15 144.57 30.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.796 0.331 . . . . 0.0 111.129 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 8.3 m -93.4 -15.45 25.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.864 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 222' ' ' SER . . . . . 0.601 ' O ' HG23 ' A' ' 216' ' ' THR . 57.9 m -99.98 142.43 31.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.897 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 58.8 m -54.91 156.21 3.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.873 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.446 ' HG ' ' N ' ' A' ' 225' ' ' VAL . 46.5 tp -52.37 159.63 0.96 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.954 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 225' ' ' VAL . . . . . 0.446 ' N ' ' HG ' ' A' ' 224' ' ' LEU . 99.2 t -130.5 113.11 24.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.114 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 40.2 t -138.83 113.52 8.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.113 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 11.4 pttm -130.98 167.31 19.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.909 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 228' ' ' PHE . . . . . 0.504 ' HA ' HD23 ' A' ' 153' ' ' LEU . 62.5 m-85 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.896 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 3.2 ttmp? . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.84 0.352 . . . . 0.0 110.893 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.476 HD23 ' HA ' ' A' ' 228' ' ' PHE . 38.7 mt -134.06 128.25 33.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.909 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -94.13 121.74 35.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.873 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.702 HG22 HG13 ' A' ' 226' ' ' VAL . 88.5 t -113.9 136.42 50.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.186 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -136.69 -159.93 8.52 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.515 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 14.7 mmt 46.8 28.56 0.84 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.84 0.352 . . . . 0.0 110.925 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 36.9 mt -85.35 167.46 15.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.912 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -105.26 158.43 16.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.897 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 60.4 mttt -85.59 37.2 0.68 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.894 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -116.9 -55.71 2.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.881 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -67.34 149.34 50.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.901 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 51.6 p -124.79 175.48 7.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.806 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 10.4 tm-20 -43.51 -30.45 0.57 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.9 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -67.67 -60.02 2.87 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.838 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -54.19 -44.78 71.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.801 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.792 HG13 ' CE1' ' A' ' 171' ' ' PHE . 89.7 t -66.1 -40.0 85.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.15 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 56.7 ttp180 -54.04 -63.37 1.17 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.904 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 17.4 mmt180 -59.0 -54.87 42.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.906 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.726 ' O ' ' HB3' ' A' ' 173' ' ' ALA . 11.3 tp -42.53 -66.11 0.4 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.91 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 171' ' ' PHE . . . . . 0.792 ' CE1' HG13 ' A' ' 167' ' ' VAL . 13.0 m-85 -51.73 -72.19 0.05 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.903 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.46 ' O ' ' N ' ' A' ' 174' ' ' PHE . 5.9 pt-20 -41.38 -31.51 0.25 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.897 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.726 ' HB3' ' O ' ' A' ' 170' ' ' LEU . . . -40.68 -24.82 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.133 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 174' ' ' PHE . . . . . 0.46 ' N ' ' O ' ' A' ' 172' ' ' GLU . 98.9 m-85 -112.21 -74.97 0.62 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.86 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -108.34 142.42 15.99 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.472 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -51.01 156.3 1.05 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.774 0.321 . . . . 0.0 110.907 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.461 HD11 ' CB ' ' A' ' 171' ' ' PHE . 81.7 mt -118.81 134.82 61.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.115 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 -90.87 -42.25 10.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.919 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -157.86 142.73 16.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.896 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 180' ' ' CYS . . . . . 0.622 ' SG ' HG13 ' A' ' 196' ' ' VAL . 1.8 m -134.23 145.87 49.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.825 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 45.4 m -151.98 134.73 15.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.158 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 30.0 mm -87.94 128.29 40.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.098 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.534 HD11 ' CE2' ' A' ' 195' ' ' PHE . 44.2 mt . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.922 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 27.2 p . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.938 0.399 . . . . 0.0 110.838 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 1.8 mmmp? -102.59 38.01 1.8 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.906 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 37.67 41.49 0.87 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.457 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 65.0 m -153.68 148.51 26.51 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.809 0.338 . . . . 0.0 110.904 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -162.56 148.6 12.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.104 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 195' ' ' PHE . . . . . 0.534 ' CE2' HD11 ' A' ' 183' ' ' LEU . 14.6 m-85 -98.49 143.1 29.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.891 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.639 HG11 ' CD2' ' A' ' 171' ' ' PHE . 16.1 t -143.03 132.73 21.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.14 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 14.0 mtpp -116.05 154.25 30.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.879 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -126.97 171.68 11.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.939 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 32.5 t -69.62 -47.9 61.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.813 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 17.0 m -137.33 170.49 16.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.899 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 201' ' ' HIS . . . . . 0.411 ' O ' ' C ' ' A' ' 202' ' ' ALA . 36.3 t-80 -60.95 -56.8 16.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.841 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 202' ' ' ALA . . . . . 0.411 ' C ' ' O ' ' A' ' 201' ' ' HIS . . . -37.12 -65.48 0.3 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.129 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 16.7 mp0 -48.38 -46.0 36.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.916 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 204' ' ' ALA . . . . . 0.407 ' HB3' ' O ' ' A' ' 201' ' ' HIS . . . -54.09 -54.98 32.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.093 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 205' ' ' GLN . . . . . 0.554 ' HA ' HD12 ' A' ' 208' ' ' ILE . 4.3 tp60 -49.52 -54.62 16.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.853 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -46.31 -56.44 5.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.129 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -56.08 -36.19 67.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.154 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 208' ' ' ILE . . . . . 0.554 HD12 ' HA ' ' A' ' 205' ' ' GLN . 80.0 mt -64.25 -75.06 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.12 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -49.34 -41.49 38.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.842 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -52.01 -48.63 64.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.112 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 74.6 mt -100.97 -65.79 0.95 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.886 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 212' ' ' HIS . . . . . 0.483 ' N ' ' O ' ' A' ' 208' ' ' ILE . 6.3 t60 -51.62 129.19 25.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.87 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 73.62 -4.83 26.14 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.488 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 8.1 t -99.66 -67.91 0.83 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.81 0.338 . . . . 0.0 110.856 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 5.6 mm-40 -94.73 172.9 7.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.938 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 216' ' ' THR . . . . . 0.522 HG23 ' O ' ' A' ' 222' ' ' SER . 54.1 m -133.08 92.85 3.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.198 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 217' ' ' MET . . . . . 0.442 ' HE2' HD13 ' A' ' 224' ' ' LEU . 1.3 mmt -36.0 136.23 0.51 Allowed Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.591 0.71 . . . . 0.0 110.877 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -48.52 125.56 12.64 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.701 2.267 . . . . 0.0 112.384 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 109.15 -50.46 0.77 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.498 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -77.03 149.38 35.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.762 0.315 . . . . 0.0 111.093 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 23.9 t -94.41 -18.26 21.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.88 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 222' ' ' SER . . . . . 0.522 ' O ' HG23 ' A' ' 216' ' ' THR . 2.2 m -99.98 147.45 25.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.833 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 223' ' ' SER . . . . . 0.417 ' O ' ' C ' ' A' ' 224' ' ' LEU . 53.8 m -61.16 147.25 44.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.888 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.442 HD13 ' HE2' ' A' ' 217' ' ' MET . 19.1 tp -36.82 152.72 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.909 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 225' ' ' VAL . . . . . 0.414 ' N ' ' HG ' ' A' ' 224' ' ' LEU . 99.6 t -123.22 105.0 15.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.117 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 226' ' ' VAL . . . . . 0.702 HG13 HG22 ' A' ' 155' ' ' VAL . 22.1 t -132.67 101.84 4.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.118 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 45.8 pttt -119.47 167.69 11.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.873 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 228' ' ' PHE . . . . . 0.476 ' HA ' HD23 ' A' ' 153' ' ' LEU . 90.3 m-85 . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.91 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.454 ' HD3' ' CG ' ' A' ' 195' ' ' PHE . 2.7 ttmp? . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.859 0.362 . . . . 0.0 110.877 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.405 ' N ' ' HG2' ' A' ' 152' ' ' LYS . 86.3 mt -117.91 133.66 55.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.914 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -102.64 114.37 28.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.885 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.636 HG21 ' CZ ' ' A' ' 171' ' ' PHE . 37.8 t -108.55 111.45 36.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.139 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -111.4 -161.16 16.78 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.507 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.419 ' CE ' ' HB1' ' A' ' 220' ' ' ALA . 79.9 mmm 46.62 41.49 9.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.818 0.342 . . . . 0.0 110.913 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.543 HD23 ' HG3' ' A' ' 217' ' ' MET . 55.1 mt -99.54 171.03 8.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.933 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 30.2 m120 -113.6 171.38 7.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.892 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 43.6 mttm -92.79 42.59 1.1 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.917 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -124.28 -43.92 2.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.89 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 61.0 mt-30 -63.4 159.79 17.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.922 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 68.9 m -132.36 175.81 8.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.854 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -55.05 -47.02 75.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.88 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' ASP . . . . . 0.496 ' CG ' ' N ' ' A' ' 166' ' ' ASP . 0.6 OUTLIER -58.33 -53.71 55.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.809 -179.988 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 166' ' ' ASP . . . . . 0.496 ' N ' ' CG ' ' A' ' 165' ' ' ASP . 65.5 m-20 -45.34 -55.89 5.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.888 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.784 HG13 ' CD1' ' A' ' 171' ' ' PHE . 68.7 t -64.81 -44.43 96.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.131 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 33.9 mtp180 -48.6 -55.22 11.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.881 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' ARG . . . . . 0.408 ' O ' ' HG3' ' A' ' 172' ' ' GLU . 55.7 mtt180 -70.86 -50.28 36.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.866 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.701 ' O ' ' HB3' ' A' ' 173' ' ' ALA . 9.8 tp -48.18 -63.78 0.98 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.919 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' PHE . . . . . 0.784 ' CD1' HG13 ' A' ' 167' ' ' VAL . 7.3 m-85 -54.61 -58.48 7.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.905 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.408 ' HG3' ' O ' ' A' ' 169' ' ' ARG . 0.8 OUTLIER -59.82 -9.94 3.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.902 -179.915 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.701 ' HB3' ' O ' ' A' ' 170' ' ' LEU . . . -61.59 -10.75 8.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.131 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -120.43 -67.9 0.94 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.845 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -110.59 -173.93 20.25 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.46 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -83.79 151.23 25.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.785 0.326 . . . . 0.0 110.899 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.467 HD11 ' CB ' ' A' ' 171' ' ' PHE . 21.0 mt -121.27 129.62 75.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.143 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 35.0 mm-40 -79.3 -46.61 17.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.879 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 22.2 tp10 -165.29 143.86 6.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.875 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 13.0 t -118.81 143.0 47.2 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.923 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 30.1 m -153.11 116.05 4.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.113 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 44.6 mm -83.3 135.01 25.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.125 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.861 HD11 ' CE2' ' A' ' 195' ' ' PHE . 35.1 mt . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.911 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 40.7 t . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.937 0.398 . . . . 0.0 110.856 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 1.3 mmmp? -94.46 26.09 3.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.898 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.425 ' C ' ' HB2' ' A' ' 158' ' ' LEU . . . 59.93 34.65 84.04 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.453 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 84.3 m -154.12 154.82 34.27 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.806 0.336 . . . . 0.0 110.926 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -158.37 161.1 37.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.072 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 195' ' ' PHE . . . . . 0.861 ' CE2' HD11 ' A' ' 183' ' ' LEU . 27.8 m-85 -121.53 119.59 32.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.868 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 21.5 t -118.8 140.21 43.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.081 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 17.1 mtmt -114.65 145.88 41.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.859 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -119.42 174.87 6.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.929 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 81.0 p -78.19 -46.26 20.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.876 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 37.7 m -133.58 -179.3 5.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.838 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 201' ' ' HIS . . . . . 0.513 ' O ' ' HB3' ' A' ' 204' ' ' ALA . 53.8 t-80 -76.44 -52.77 9.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.892 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -39.6 -66.14 0.32 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.081 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 51.5 mm-40 -47.28 -43.8 22.59 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.885 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 204' ' ' ALA . . . . . 0.513 ' HB3' ' O ' ' A' ' 201' ' ' HIS . . . -51.77 -54.07 32.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.108 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 205' ' ' GLN . . . . . 0.598 ' HA ' HD12 ' A' ' 208' ' ' ILE . 24.9 tp60 -56.57 -41.51 77.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.926 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -53.15 -50.1 65.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.119 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -68.25 -26.66 65.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.098 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 208' ' ' ILE . . . . . 0.598 HD12 ' HA ' ' A' ' 205' ' ' GLN . 63.4 mt -71.05 -65.11 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.083 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -60.92 -38.09 84.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.879 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -65.07 -26.77 68.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.113 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 89.9 mt -115.61 -75.0 0.59 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.94 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 212' ' ' HIS . . . . . 0.528 ' HD1' ' HA ' ' A' ' 225' ' ' VAL . 20.6 t60 -47.83 128.69 13.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.848 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 83.16 -22.03 7.55 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.514 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 4.8 m -90.18 -71.61 0.61 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.801 0.334 . . . . 0.0 110.893 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 215' ' ' GLN . . . . . 0.449 ' HG3' ' N ' ' A' ' 216' ' ' THR . 1.2 tt0 -88.71 156.05 19.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.865 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 216' ' ' THR . . . . . 0.594 HG23 ' O ' ' A' ' 222' ' ' SER . 2.0 m -119.51 118.1 30.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.119 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 217' ' ' MET . . . . . 0.543 ' HG3' HD23 ' A' ' 158' ' ' LEU . 23.9 mmt -47.44 137.05 9.28 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.598 0.714 . . . . 0.0 110.87 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -48.89 113.82 1.03 Allowed 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.702 2.268 . . . . 0.0 112.379 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 112.7 -54.39 0.55 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.504 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 220' ' ' ALA . . . . . 0.419 ' HB1' ' CE ' ' A' ' 157' ' ' MET . . . -63.72 145.46 55.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.813 0.339 . . . . 0.0 111.15 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 48.2 t -93.23 -16.26 25.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.806 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 222' ' ' SER . . . . . 0.594 ' O ' HG23 ' A' ' 216' ' ' THR . 2.4 m -100.09 136.98 39.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.841 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 2.1 p -44.91 162.97 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.831 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.462 ' HG ' HG23 ' A' ' 226' ' ' VAL . 51.4 tp -56.98 157.04 6.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.895 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 225' ' ' VAL . . . . . 0.528 ' HA ' ' HD1' ' A' ' 212' ' ' HIS . 91.8 t -125.12 110.21 24.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.144 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 226' ' ' VAL . . . . . 0.504 HG22 HG13 ' A' ' 155' ' ' VAL . 44.1 t -136.26 105.03 4.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.161 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 4.6 ptmt -132.69 145.77 51.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.909 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.914 179.933 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 23.1 ttpt . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.784 0.326 . . . . 0.0 110.913 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.438 HD21 ' CE1' ' A' ' 228' ' ' PHE . 87.4 mt -123.55 123.51 40.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.896 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -91.22 116.95 29.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.948 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.586 HG13 HG22 ' A' ' 226' ' ' VAL . 38.3 t -110.82 132.44 59.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.114 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -130.87 -158.84 9.39 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.473 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 45.52 31.86 1.0 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.793 0.33 . . . . 0.0 110.859 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 79.5 mt -85.24 -176.22 6.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.875 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.464 ' N ' ' OD1' ' A' ' 159' ' ' ASN . 0.5 OUTLIER -126.97 155.31 43.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.884 179.896 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 65.8 mttt -80.92 42.09 0.62 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.875 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 18.0 mp0 -130.96 -43.03 1.09 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.921 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 17.8 mm-40 -54.0 162.01 1.08 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.914 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 28.1 m -135.7 166.28 23.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.807 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' GLU . . . . . 0.465 ' O ' ' CB ' ' A' ' 168' ' ' ARG . 2.3 mp0 -49.28 -41.0 36.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.889 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -65.1 -48.34 74.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.867 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 -54.81 -56.61 17.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.817 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.528 HG13 ' CE1' ' A' ' 171' ' ' PHE . 54.3 t -66.98 -40.62 86.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.153 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 168' ' ' ARG . . . . . 0.465 ' CB ' ' O ' ' A' ' 164' ' ' GLU . 13.8 tpt180 -56.36 -56.28 23.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.865 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 10.0 mmt85 -63.25 -54.47 36.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.889 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.765 ' O ' ' HB3' ' A' ' 173' ' ' ALA . 9.9 tp -43.95 -64.94 0.57 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.925 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 171' ' ' PHE . . . . . 0.528 ' CE1' HG13 ' A' ' 167' ' ' VAL . 7.4 m-85 -51.33 -68.87 0.13 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.871 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -46.36 -26.4 0.82 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.888 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.765 ' HB3' ' O ' ' A' ' 170' ' ' LEU . . . -48.89 -21.13 0.59 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.126 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -114.21 -60.37 1.89 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.867 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -124.48 134.08 8.93 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.488 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -40.74 162.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.786 0.327 . . . . 0.0 110.93 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.663 HG23 ' O ' ' A' ' 197' ' ' LYS . 32.3 mt -131.03 136.39 58.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.087 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -81.35 -48.76 11.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.92 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -155.49 151.21 27.44 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.882 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 42.1 t -129.38 135.76 49.12 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.856 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 89.5 m -148.1 134.17 19.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.152 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 48.5 mm -95.06 139.04 19.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.099 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.769 HD11 ' CE2' ' A' ' 195' ' ' PHE . 41.0 mt . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.954 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 37.3 p . . . . . 0 N--CA 1.458 -0.065 0 CA-C-O 120.966 0.413 . . . . 0.0 110.871 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 30.1 mmtp -80.4 43.45 0.64 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.914 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 39.01 50.35 2.67 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.487 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 8.1 p -159.54 151.68 20.85 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.849 0.357 . . . . 0.0 110.835 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -160.04 168.02 26.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.111 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 195' ' ' PHE . . . . . 0.769 ' CE2' HD11 ' A' ' 183' ' ' LEU . 40.3 m-85 -120.18 135.83 54.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.864 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 46.9 t -136.32 142.54 38.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.103 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.663 ' O ' HG23 ' A' ' 177' ' ' ILE . 23.2 mttp -117.38 154.1 31.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.885 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -124.17 172.99 8.62 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.901 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 68.3 p -83.24 -33.4 26.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.874 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 11.2 t -141.65 165.1 28.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.851 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 4.8 t60 -67.69 -53.7 25.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.849 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -44.28 -60.28 1.99 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.126 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -46.86 -45.95 20.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.879 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -55.75 -58.43 7.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.111 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 16.5 tp60 -45.11 -49.64 11.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.888 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -53.54 -51.87 61.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.112 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -56.87 -45.12 82.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.107 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 208' ' ' ILE . . . . . 0.494 ' O ' ' N ' ' A' ' 212' ' ' HIS . 71.4 mt -57.97 -74.06 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.142 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -48.06 -42.54 28.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.883 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -58.31 -37.7 75.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.134 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.419 ' O ' ' CB ' ' A' ' 214' ' ' SER . 41.4 mt -104.53 -72.0 0.72 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.945 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 212' ' ' HIS . . . . . 0.494 ' N ' ' O ' ' A' ' 208' ' ' ILE . 13.0 t60 -46.85 136.59 8.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.876 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 73.67 -6.41 18.18 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.479 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 214' ' ' SER . . . . . 0.419 ' CB ' ' O ' ' A' ' 211' ' ' LEU . 1.3 t -87.97 -71.03 0.6 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.825 0.345 . . . . 0.0 110.883 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.17 178.22 4.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.918 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 216' ' ' THR . . . . . 0.616 HG23 ' O ' ' A' ' 222' ' ' SER . 56.4 m -134.97 95.29 3.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.132 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 217' ' ' MET . . . . . 0.442 ' C ' ' O ' ' A' ' 216' ' ' THR . 25.5 mmt -34.73 133.58 0.42 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.596 0.712 . . . . 0.0 110.887 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -48.91 117.73 2.98 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.723 2.282 . . . . 0.0 112.297 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 120.27 -54.17 0.66 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.52 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -72.04 159.86 33.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.769 0.319 . . . . 0.0 111.095 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 38.7 t -98.15 -23.9 15.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.881 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 222' ' ' SER . . . . . 0.616 ' O ' HG23 ' A' ' 216' ' ' THR . 1.9 m -99.98 147.48 25.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.841 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 73.4 m -60.02 156.41 14.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.852 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 38.2 tp -37.22 153.16 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.903 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 225' ' ' VAL . . . . . 0.428 ' HA ' ' ND1' ' A' ' 212' ' ' HIS . 61.4 t -124.66 111.04 26.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.136 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 226' ' ' VAL . . . . . 0.586 HG22 HG13 ' A' ' 155' ' ' VAL . 41.1 t -132.72 102.1 4.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.137 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 10.6 ptmt -129.48 151.65 49.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.898 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 228' ' ' PHE . . . . . 0.438 ' CE1' HD21 ' A' ' 153' ' ' LEU . 82.1 m-85 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.857 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 2.5 tptt . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.842 0.353 . . . . 0.0 110.876 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.483 HD12 ' CD1' ' A' ' 198' ' ' TYR . 41.6 mt -124.54 118.41 26.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.922 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -89.8 120.73 31.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.905 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.694 HG13 HG22 ' A' ' 226' ' ' VAL . 20.7 t -116.33 118.09 57.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.143 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -118.2 -155.8 10.09 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.499 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 16.5 mmt 47.42 34.59 3.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.786 0.327 . . . . 0.0 110.863 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.455 HD23 ' HG3' ' A' ' 217' ' ' MET . 69.3 mt -95.51 165.87 12.14 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.941 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.459 ' ND2' ' H ' ' A' ' 159' ' ' ASN . 0.5 OUTLIER -102.27 162.21 13.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.895 179.929 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 40.4 mttp -85.48 32.89 0.56 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.897 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 3.5 tp60 -120.89 -50.51 2.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.913 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -44.31 159.82 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.893 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 4.9 m -139.06 168.5 19.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.866 -179.814 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -49.97 -48.73 52.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.885 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -53.31 -56.3 17.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.87 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -48.33 -67.59 0.26 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.87 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.764 HG13 ' CE1' ' A' ' 171' ' ' PHE . 65.3 t -49.99 -53.17 11.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.099 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 168' ' ' ARG . . . . . 0.429 ' C ' ' O ' ' A' ' 167' ' ' VAL . 1.5 tmm_? -36.25 -63.65 0.37 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.844 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 19.7 mtp180 -63.89 -51.89 62.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.915 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.704 ' O ' ' HB3' ' A' ' 173' ' ' ALA . 16.5 tp -43.29 -65.8 0.45 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.953 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 171' ' ' PHE . . . . . 0.764 ' CE1' HG13 ' A' ' 167' ' ' VAL . 9.3 m-85 -55.7 -68.33 0.21 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.884 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -44.81 -21.96 0.07 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.882 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.704 ' HB3' ' O ' ' A' ' 170' ' ' LEU . . . -50.11 -17.75 0.46 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.126 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -118.3 -71.74 0.72 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.916 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -109.51 145.83 16.83 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.463 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -55.84 145.59 24.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.836 0.35 . . . . 0.0 110.872 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.482 HD11 ' CB ' ' A' ' 171' ' ' PHE . 50.7 mt -109.26 135.06 49.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.127 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 178' ' ' GLU . . . . . 0.45 ' HB3' ' CE ' ' A' ' 197' ' ' LYS . 13.0 mt-10 -97.86 -39.09 9.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.897 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 23.2 tp10 -148.17 144.43 27.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.879 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 44.9 t -143.78 137.99 28.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.896 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 22.4 m -154.53 137.29 15.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.096 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.699 HD13 ' CB ' ' A' ' 194' ' ' ALA . 26.4 mm -96.83 126.43 49.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.103 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 1.181 HD11 ' CE2' ' A' ' 195' ' ' PHE . 28.7 mt . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.928 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 48.5 t . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.963 0.411 . . . . 0.0 110.904 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 52.5 mttm -100.68 34.53 2.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.875 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 41.11 39.54 2.13 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.463 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 65.1 m -154.6 149.03 26.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.833 0.349 . . . . 0.0 110.889 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 194' ' ' ALA . . . . . 0.699 ' CB ' HD13 ' A' ' 182' ' ' ILE . . . -163.14 154.63 17.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.101 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 195' ' ' PHE . . . . . 1.181 ' CE2' HD11 ' A' ' 183' ' ' LEU . 69.7 m-85 -105.38 136.69 44.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.873 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 48.4 t -133.76 140.45 46.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.147 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.45 ' CE ' ' HB3' ' A' ' 178' ' ' GLU . 22.0 ttpt -116.84 142.8 46.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.856 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 198' ' ' TYR . . . . . 0.483 ' CD1' HD12 ' A' ' 153' ' ' LEU . 9.5 m-85 -119.86 170.2 9.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.895 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 24.7 t -69.2 -48.24 62.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.866 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 59.5 p -145.81 173.05 12.45 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.9 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 201' ' ' HIS . . . . . 0.443 ' O ' ' C ' ' A' ' 202' ' ' ALA . 13.5 t-80 -59.46 -56.48 21.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.823 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 202' ' ' ALA . . . . . 0.443 ' C ' ' O ' ' A' ' 201' ' ' HIS . . . -34.74 -69.81 0.09 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.122 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -47.1 -47.31 23.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.887 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -53.33 -58.06 8.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.061 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 3.2 tp60 -47.91 -40.03 20.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.929 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -59.81 -53.71 54.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.084 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -61.93 -25.66 67.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.127 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 208' ' ' ILE . . . . . 0.495 ' O ' ' N ' ' A' ' 212' ' ' HIS . 79.2 mt -71.15 -67.79 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.13 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -57.31 -38.88 74.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.877 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -63.5 -41.73 98.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.147 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.497 ' HB3' HD23 ' A' ' 224' ' ' LEU . 63.7 mt -100.73 -72.09 0.69 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.909 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 212' ' ' HIS . . . . . 0.495 ' N ' ' O ' ' A' ' 208' ' ' ILE . 1.4 t60 -52.15 130.48 30.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.872 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 72.54 -0.98 39.15 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.523 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 22.5 t -96.88 -71.89 0.66 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.782 0.325 . . . . 0.0 110.859 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -99.5 172.37 7.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.866 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 216' ' ' THR . . . . . 0.608 HG23 ' O ' ' A' ' 222' ' ' SER . 34.2 m -123.55 105.35 9.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.125 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 217' ' ' MET . . . . . 0.455 ' HG3' HD23 ' A' ' 158' ' ' LEU . 15.4 mmt -43.18 139.03 2.43 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.514 0.674 . . . . 0.0 110.929 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -48.31 120.74 5.33 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.681 2.254 . . . . 0.0 112.338 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 105.88 -53.97 0.62 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.485 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -66.68 146.93 53.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.845 0.355 . . . . 0.0 111.092 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 29.4 m -93.19 -17.29 23.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.826 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 222' ' ' SER . . . . . 0.608 ' O ' HG23 ' A' ' 216' ' ' THR . 9.8 p -100.01 151.29 21.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.861 -179.814 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 44.1 m -65.6 148.08 52.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.865 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.497 HD23 ' HB3' ' A' ' 211' ' ' LEU . 63.8 tp -39.56 149.83 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.914 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 61.9 t -121.89 106.52 18.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.129 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 226' ' ' VAL . . . . . 0.694 HG22 HG13 ' A' ' 155' ' ' VAL . 28.7 t -126.17 104.99 13.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.137 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 46.2 pttt -120.31 176.36 5.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.924 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.927 179.952 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.429 ' HE3' ' CB ' ' A' ' 195' ' ' PHE . 20.6 tttp . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.85 0.357 . . . . 0.0 110.874 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.663 HD21 HD11 ' A' ' 208' ' ' ILE . 25.0 mt -96.63 154.35 17.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.923 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 79.1 t80 -125.0 114.14 18.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.892 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.669 HG21 ' CZ ' ' A' ' 171' ' ' PHE . 17.4 t -102.75 110.51 29.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.108 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -111.99 -171.6 18.82 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.471 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 10.5 mmt 59.66 28.08 17.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.795 0.331 . . . . 0.0 110.845 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 46.3 mt -91.17 165.99 13.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.933 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -108.64 166.56 10.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.904 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 33.0 mttt -84.6 51.7 2.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.91 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -134.88 -50.67 0.77 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.957 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -51.67 163.36 0.31 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.872 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 44.5 m -138.14 172.47 12.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.882 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -53.73 -45.13 70.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.898 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -57.43 -51.38 69.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.847 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -50.99 -65.73 0.51 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.876 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.678 HG13 ' CE1' ' A' ' 171' ' ' PHE . 58.3 t -57.8 -36.57 55.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.137 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 14.2 tpp85 -54.58 -62.72 1.47 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.868 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 169' ' ' ARG . . . . . 0.401 ' O ' ' HG3' ' A' ' 172' ' ' GLU . 68.3 mtp180 -64.87 -51.52 61.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.864 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.694 ' O ' ' HB3' ' A' ' 173' ' ' ALA . 13.0 tp -43.85 -65.51 0.49 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.912 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 171' ' ' PHE . . . . . 0.678 ' CE1' HG13 ' A' ' 167' ' ' VAL . 6.6 m-85 -55.84 -67.95 0.25 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.858 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.509 ' CD ' ' C ' ' A' ' 172' ' ' GLU . 0.6 OUTLIER -45.43 -21.56 0.1 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.886 -179.91 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.694 ' HB3' ' O ' ' A' ' 170' ' ' LEU . . . -50.11 -18.97 0.64 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.098 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -110.27 -65.96 1.11 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.908 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -107.33 -165.53 21.98 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.478 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -100.01 132.84 45.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.778 0.323 . . . . 0.0 110.886 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 29.6 mt -101.89 138.32 26.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.089 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -98.96 -32.82 11.11 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.862 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -160.83 152.31 19.32 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.885 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 38.6 t -136.1 121.49 19.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.902 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 181' ' ' THR . . . . . 0.487 ' O ' ' HB1' ' A' ' 194' ' ' ALA . 97.8 m -123.86 139.08 54.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.152 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.43 HD13 ' HB1' ' A' ' 194' ' ' ALA . 50.6 mm -115.57 114.54 46.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.134 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.564 HD11 ' HE2' ' A' ' 195' ' ' PHE . 18.8 mt . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.914 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 4.6 t . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.969 0.414 . . . . 0.0 110.816 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 2.6 mmmp? -105.56 15.51 26.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.91 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 62.47 32.24 82.42 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.497 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 11.1 m -148.04 142.96 26.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.794 0.331 . . . . 0.0 110.879 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 194' ' ' ALA . . . . . 0.487 ' HB1' ' O ' ' A' ' 181' ' ' THR . . . -160.04 160.2 32.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.095 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 195' ' ' PHE . . . . . 0.564 ' HE2' HD11 ' A' ' 183' ' ' LEU . 77.4 m-85 -115.54 133.57 55.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.892 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.428 HG21 ' CE2' ' A' ' 171' ' ' PHE . 92.9 t -116.68 128.74 73.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.14 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 19.1 tttp -95.87 145.2 25.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.888 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 198' ' ' TYR . . . . . 0.44 ' CD1' HD12 ' A' ' 153' ' ' LEU . 7.6 m-85 -129.07 171.6 12.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.924 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 91.3 p -85.58 -20.91 28.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.885 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 2.2 m -162.01 176.42 10.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.772 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -77.16 -37.68 53.32 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.864 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -52.82 -65.31 0.58 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.102 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 18.2 mp0 -48.47 -41.29 29.25 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.88 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -58.85 -59.8 4.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.074 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 205' ' ' GLN . . . . . 0.61 ' HA ' HD12 ' A' ' 208' ' ' ILE . 43.1 tp60 -45.64 -42.02 10.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.937 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -60.48 -52.74 63.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.101 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -62.74 -28.39 69.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.112 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 208' ' ' ILE . . . . . 0.663 HD11 HD21 ' A' ' 153' ' ' LEU . 93.2 mt -67.41 -75.11 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.121 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -46.25 -43.4 15.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.893 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -55.99 -41.93 75.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.095 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 71.6 mt -100.94 -69.57 0.77 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.873 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 212' ' ' HIS . . . . . 0.637 ' HD1' ' HA ' ' A' ' 225' ' ' VAL . 27.1 t60 -52.4 125.62 16.71 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.902 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 84.6 -10.22 62.66 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.507 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 51.7 m -97.71 -74.43 0.58 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.84 0.353 . . . . 0.0 110.845 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 19.9 mp0 -88.43 166.42 14.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.928 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 216' ' ' THR . . . . . 0.664 HG23 ' O ' ' A' ' 222' ' ' SER . 32.4 m -135.79 106.39 6.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.141 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 217' ' ' MET . . . . . 0.404 ' C ' ' O ' ' A' ' 216' ' ' THR . 15.5 mmt -37.31 156.37 0.09 OUTLIER Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.547 0.689 . . . . 0.0 110.878 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.09 120.61 7.31 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.656 2.237 . . . . 0.0 112.323 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 109.36 -42.63 1.9 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.466 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -76.4 144.3 40.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.767 0.317 . . . . 0.0 111.089 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 3.5 t -93.57 -15.28 25.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.812 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 222' ' ' SER . . . . . 0.664 ' O ' HG23 ' A' ' 216' ' ' THR . 67.6 m -100.17 142.09 32.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.904 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 64.7 m -57.72 157.13 7.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.824 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 47.7 tp -48.35 148.81 1.77 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.916 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 225' ' ' VAL . . . . . 0.637 ' HA ' ' HD1' ' A' ' 212' ' ' HIS . 53.0 t -119.73 111.17 31.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.101 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 25.7 t -132.68 101.31 4.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.117 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.81 158.4 42.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.897 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 228' ' ' PHE . . . . . 0.632 ' CE1' HD21 ' A' ' 153' ' ' LEU . 28.6 m-85 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.887 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.577 ' HE2' ' CD1' ' A' ' 195' ' ' PHE . 3.8 ttpm? . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.869 0.366 . . . . 0.0 110.886 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 40.5 mt -129.65 123.97 32.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.886 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -90.19 119.33 30.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.9 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.737 HG13 HG22 ' A' ' 226' ' ' VAL . 5.1 t -107.22 124.7 63.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.121 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -124.85 -168.37 12.78 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.475 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 18.0 mmt 48.45 35.13 5.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.773 0.32 . . . . 0.0 110.896 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 38.3 mt -89.2 166.15 14.0 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.915 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -104.51 160.08 15.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.874 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 24.1 mttp -84.49 23.98 1.05 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.914 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -109.56 -55.21 2.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.909 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -53.4 146.05 13.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.88 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 57.7 m -126.38 166.37 17.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.864 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -44.13 -40.23 4.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.861 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -55.97 -66.08 0.49 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.872 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -52.81 -48.42 66.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.872 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.513 HG13 ' CE1' ' A' ' 171' ' ' PHE . 93.9 t -57.45 -35.24 48.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.099 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 51.4 ttt180 -63.81 -57.87 8.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.843 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 169' ' ' ARG . . . . . 0.401 ' O ' ' HG2' ' A' ' 172' ' ' GLU . 8.5 ptm180 -64.15 -53.24 52.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.85 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.741 ' O ' ' HB3' ' A' ' 173' ' ' ALA . 8.5 tp -43.72 -65.26 0.52 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.916 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 171' ' ' PHE . . . . . 0.513 ' CE1' HG13 ' A' ' 167' ' ' VAL . 10.9 m-85 -53.03 -68.9 0.13 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.884 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.401 ' HG2' ' O ' ' A' ' 169' ' ' ARG . 4.3 pt-20 -45.75 -24.19 0.34 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.894 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.741 ' HB3' ' O ' ' A' ' 170' ' ' LEU . . . -49.4 -21.23 0.84 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.073 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -111.77 -71.37 0.76 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.879 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -112.21 146.83 18.16 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.462 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 176' ' ' ASN . . . . . 0.45 ' O ' ' CD2' ' A' ' 198' ' ' TYR . 32.6 m120 -51.57 160.3 0.64 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.816 0.341 . . . . 0.0 110.926 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.411 ' CG2' ' N ' ' A' ' 178' ' ' GLU . 19.3 mt -124.73 152.37 30.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.128 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 178' ' ' GLU . . . . . 0.411 ' N ' ' CG2' ' A' ' 177' ' ' ILE . 9.1 mt-10 -120.49 -28.92 4.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.868 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -155.76 146.78 22.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.871 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 4.8 t -147.32 132.91 18.76 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.927 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 99.5 m -151.32 145.13 25.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.141 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 18.5 mm -97.25 137.48 24.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.14 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.934 HD11 ' CE2' ' A' ' 195' ' ' PHE . 52.9 mt . . . . . 0 C--N 1.328 -0.352 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.914 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 10.8 t . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.914 0.388 . . . . 0.0 110.876 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 24.5 mmtt -90.82 36.16 0.9 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.918 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 43.28 37.61 3.41 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.468 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 193' ' ' CYS . . . . . 0.416 ' C ' ' HB2' ' A' ' 183' ' ' LEU . 72.1 m -150.49 150.4 31.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.799 0.333 . . . . 0.0 110.868 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -163.09 169.2 19.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.077 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 195' ' ' PHE . . . . . 0.934 ' CE2' HD11 ' A' ' 183' ' ' LEU . 18.2 m-85 -122.96 135.77 54.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.853 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.511 HG21 ' CE2' ' A' ' 171' ' ' PHE . 61.3 t -130.75 140.69 48.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.121 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 25.3 ttmt -117.44 146.49 43.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.856 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 198' ' ' TYR . . . . . 0.45 ' CD2' ' O ' ' A' ' 176' ' ' ASN . 24.6 m-85 -124.23 166.42 15.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.919 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 42.3 t -70.03 -48.74 56.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.828 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 7.3 t -136.82 168.69 19.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.859 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 201' ' ' HIS . . . . . 0.533 ' O ' ' HB3' ' A' ' 204' ' ' ALA . 10.2 t-80 -61.35 -57.34 12.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.85 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 202' ' ' ALA . . . . . 0.449 ' C ' ' O ' ' A' ' 201' ' ' HIS . . . -33.99 -67.03 0.14 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.093 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 19.4 mp0 -49.83 -39.59 39.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.879 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 204' ' ' ALA . . . . . 0.533 ' HB3' ' O ' ' A' ' 201' ' ' HIS . . . -55.65 -51.82 65.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.092 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 59.6 tp60 -57.29 -45.18 84.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.876 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -51.93 -47.69 64.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.104 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -69.48 -29.88 67.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.136 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 208' ' ' ILE . . . . . 0.482 ' O ' ' N ' ' A' ' 212' ' ' HIS . 56.3 mt -66.94 -60.44 2.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.125 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -64.22 -36.95 85.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.869 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -66.6 -35.56 80.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.122 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.705 ' HB3' HD23 ' A' ' 224' ' ' LEU . 84.5 mt -102.51 -69.33 0.79 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.902 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 212' ' ' HIS . . . . . 0.482 ' N ' ' O ' ' A' ' 208' ' ' ILE . 12.2 t60 -62.97 126.19 26.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.835 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 85.7 -4.28 86.0 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.495 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 2.1 m -94.43 -74.12 0.55 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.84 0.353 . . . . 0.0 110.854 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 17.2 pm0 -99.88 175.63 5.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.894 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 216' ' ' THR . . . . . 0.673 HG23 ' O ' ' A' ' 222' ' ' SER . 17.3 m -130.33 101.37 5.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.106 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 13.5 mmt -37.08 134.45 0.68 Allowed Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.608 0.718 . . . . 0.0 110.884 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -48.71 119.88 4.71 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.668 2.246 . . . . 0.0 112.342 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 112.89 -49.86 0.81 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.513 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -73.38 156.76 38.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.813 0.34 . . . . 0.0 111.081 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 94.7 p -98.88 -21.14 16.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.837 -179.758 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 222' ' ' SER . . . . . 0.673 ' O ' HG23 ' A' ' 216' ' ' THR . 1.8 m -100.15 143.31 30.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.855 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 15.1 m -56.88 153.49 10.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.921 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.705 HD23 ' HB3' ' A' ' 211' ' ' LEU . 58.5 tp -40.17 149.62 0.07 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.865 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 225' ' ' VAL . . . . . 0.426 ' HA ' ' ND1' ' A' ' 212' ' ' HIS . 79.9 t -118.35 113.71 42.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.18 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 226' ' ' VAL . . . . . 0.737 HG22 HG13 ' A' ' 155' ' ' VAL . 20.5 t -138.97 104.97 2.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.15 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 44.7 pttt -127.4 178.96 5.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.862 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.878 179.929 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 5.8 ttpm? . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.784 0.326 . . . . 0.0 110.904 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 59.5 mt -136.92 140.72 42.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.891 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 35.5 t80 -107.36 121.05 43.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.915 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.566 HG13 HG22 ' A' ' 226' ' ' VAL . 23.9 t -110.26 132.1 59.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.161 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -133.04 -161.5 9.87 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.512 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 19.5 mmt 49.04 30.55 2.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.819 0.342 . . . . 0.0 110.875 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.401 ' HB2' ' C ' ' A' ' 192' ' ' GLY . 82.0 mt -91.05 166.69 12.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.924 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -108.94 155.82 20.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.882 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 36.2 mttp -81.38 44.73 0.81 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.868 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -127.93 -47.42 1.37 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.922 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 14.8 mm-40 -58.73 162.11 4.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.894 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 45.9 m -135.02 174.44 10.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.854 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 164' ' ' GLU . . . . . 0.451 ' O ' ' CB ' ' A' ' 168' ' ' ARG . 1.4 mp0 -51.35 -35.62 39.26 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.871 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -63.25 -65.89 0.62 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.904 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -42.21 -57.01 2.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.892 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.733 HG13 ' CE1' ' A' ' 171' ' ' PHE . 75.5 t -62.66 -59.89 3.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.12 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 168' ' ' ARG . . . . . 0.451 ' CB ' ' O ' ' A' ' 164' ' ' GLU . 29.9 ttm-85 -35.29 -63.91 0.31 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.874 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 83.7 mtm180 -59.16 -54.59 45.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.877 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.71 ' O ' ' HB3' ' A' ' 173' ' ' ALA . 16.2 tp -42.8 -66.02 0.41 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.896 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 171' ' ' PHE . . . . . 0.733 ' CE1' HG13 ' A' ' 167' ' ' VAL . 13.4 m-85 -51.7 -72.06 0.06 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.891 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -41.52 -31.79 0.29 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.915 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.71 ' HB3' ' O ' ' A' ' 170' ' ' LEU . . . -39.62 -30.16 0.07 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.06 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -107.85 -68.83 0.88 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.879 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -111.88 131.75 10.42 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.504 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -48.78 147.71 2.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.852 0.358 . . . . 0.0 110.849 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.639 HG23 ' O ' ' A' ' 197' ' ' LYS . 67.2 mt -112.77 138.66 41.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.119 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 67.7 mm-40 -98.7 -36.23 9.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.842 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -148.6 139.23 22.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.845 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 47.9 t -145.12 138.47 26.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.855 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 18.1 m -152.83 148.94 27.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.199 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 35.2 mm -102.26 134.91 41.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.152 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.597 HD12 ' HB3' ' A' ' 193' ' ' CYS . 29.4 mt . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.919 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 23.2 t . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.932 0.396 . . . . 0.0 110.826 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 191' ' ' LYS . . . . . 0.404 ' O ' ' C ' ' A' ' 192' ' ' GLY . 8.7 mtmp? -89.7 47.21 1.44 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.884 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.404 ' C ' ' O ' ' A' ' 191' ' ' LYS . . . 37.37 46.66 1.45 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.507 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 193' ' ' CYS . . . . . 0.597 ' HB3' HD12 ' A' ' 183' ' ' LEU . 87.1 m -155.19 156.69 36.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.852 0.358 . . . . 0.0 110.881 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -160.61 166.86 28.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.085 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 195' ' ' PHE . . . . . 0.459 ' CE2' HD21 ' A' ' 183' ' ' LEU . 26.6 m-85 -119.73 119.6 34.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.905 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.494 HG21 ' CE2' ' A' ' 171' ' ' PHE . 21.9 t -114.04 152.34 15.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.138 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.639 ' O ' HG23 ' A' ' 177' ' ' ILE . 23.0 tttp -135.61 137.3 41.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.913 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -113.31 162.43 16.06 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.876 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 11.8 t -65.95 -52.11 52.59 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.873 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 5.7 t -124.0 170.86 10.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.836 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 201' ' ' HIS . . . . . 0.49 ' O ' ' HB3' ' A' ' 204' ' ' ALA . 6.5 t60 -69.23 -51.03 41.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.854 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -42.74 -64.57 0.59 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.091 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -46.38 -43.07 15.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.88 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 204' ' ' ALA . . . . . 0.49 ' HB3' ' O ' ' A' ' 201' ' ' HIS . . . -53.07 -62.07 1.89 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.134 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 205' ' ' GLN . . . . . 0.556 ' HA ' HD12 ' A' ' 208' ' ' ILE . 50.4 tp60 -46.61 -47.06 20.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.905 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -49.19 -57.88 5.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.118 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -54.72 -44.01 73.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.072 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 208' ' ' ILE . . . . . 0.556 HD12 ' HA ' ' A' ' 205' ' ' GLN . 75.7 mt -51.12 -72.83 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.141 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -54.83 -38.76 67.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.868 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -61.43 -31.4 71.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.111 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 98.5 mt -114.34 -73.85 0.64 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.873 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 212' ' ' HIS . . . . . 0.502 ' N ' ' O ' ' A' ' 208' ' ' ILE . 14.6 t60 -49.5 131.92 20.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.847 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 78.3 -10.24 29.74 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.515 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 25.6 t -99.22 -69.27 0.77 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.818 0.342 . . . . 0.0 110.87 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 7.1 mm-40 -88.11 159.39 18.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.931 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 216' ' ' THR . . . . . 0.47 HG23 ' O ' ' A' ' 222' ' ' SER . 2.9 m -125.34 99.04 5.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.175 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 217' ' ' MET . . . . . 0.409 ' C ' ' O ' ' A' ' 216' ' ' THR . 12.1 mmt -35.96 135.07 0.53 Allowed Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.568 0.699 . . . . 0.0 110.879 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -48.21 121.31 5.93 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.719 2.28 . . . . 0.0 112.331 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 108.06 -48.57 0.93 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.483 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 220' ' ' ALA . . . . . 0.401 ' O ' HG22 ' A' ' 216' ' ' THR . . . -75.15 144.6 42.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.792 0.33 . . . . 0.0 111.117 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 7.0 t -92.65 -16.0 26.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.872 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 222' ' ' SER . . . . . 0.47 ' O ' HG23 ' A' ' 216' ' ' THR . 67.9 m -99.99 138.37 37.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.846 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 66.2 m -52.83 155.71 2.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.857 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.631 HD12 ' H ' ' A' ' 225' ' ' VAL . 50.8 tp -45.57 157.73 0.09 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.89 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 225' ' ' VAL . . . . . 0.631 ' H ' HD12 ' A' ' 224' ' ' LEU . 55.0 t -122.67 104.46 14.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.167 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 226' ' ' VAL . . . . . 0.624 HG23 ' HG ' ' A' ' 224' ' ' LEU . 21.0 t -134.78 108.87 11.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.106 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.94 -179.54 4.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.852 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.865 -179.998 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.552 ' HE3' ' CD1' ' A' ' 195' ' ' PHE . 19.1 ttpt . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.825 0.345 . . . . 0.0 110.93 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.572 HD12 ' CD1' ' A' ' 198' ' ' TYR . 37.9 mt -121.3 127.44 51.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.924 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -92.37 130.97 37.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.855 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.456 HG22 HG13 ' A' ' 226' ' ' VAL . 39.0 t -121.47 126.8 75.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.167 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -127.97 -172.3 13.19 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.513 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 82.2 mmm 51.38 39.54 24.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.773 0.32 . . . . 0.0 110.89 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.473 HD12 ' HA ' ' A' ' 193' ' ' CYS . 50.7 mt -93.39 171.43 8.92 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.936 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -100.44 160.73 14.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.891 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 24.2 mttp -89.87 34.59 0.84 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.91 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -127.92 -43.62 1.51 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.859 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -47.05 155.94 0.25 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.907 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 5.8 m -132.9 171.88 13.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.871 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 164' ' ' GLU . . . . . 0.464 ' O ' ' CB ' ' A' ' 168' ' ' ARG . 2.9 mp0 -55.24 -37.68 67.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.882 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -64.96 -44.98 87.62 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.874 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 -60.41 -59.39 5.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.874 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.894 HG13 ' CE1' ' A' ' 171' ' ' PHE . 96.2 t -62.17 -39.3 83.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.144 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 168' ' ' ARG . . . . . 0.464 ' CB ' ' O ' ' A' ' 164' ' ' GLU . 33.2 ttt180 -55.28 -63.13 1.26 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.832 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 74.7 mtt180 -60.91 -54.02 50.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.859 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.722 ' O ' ' HB3' ' A' ' 173' ' ' ALA . 10.0 tp -43.93 -65.64 0.48 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.866 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 171' ' ' PHE . . . . . 0.894 ' CE1' HG13 ' A' ' 167' ' ' VAL . 10.6 m-85 -51.07 -70.39 0.09 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.879 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -44.14 -30.44 0.77 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.89 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.722 ' HB3' ' O ' ' A' ' 170' ' ' LEU . . . -42.81 -28.05 0.22 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.127 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -106.46 -68.97 0.85 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.889 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -113.42 135.23 12.42 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.521 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -45.71 153.27 0.28 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.784 0.326 . . . . 0.0 110.897 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.416 ' CG2' ' N ' ' A' ' 178' ' ' GLU . 58.2 mt -118.18 153.06 20.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.148 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 178' ' ' GLU . . . . . 0.416 ' N ' ' CG2' ' A' ' 177' ' ' ILE . 55.6 mt-10 -117.11 -37.72 3.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.885 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -144.7 140.36 28.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.931 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 10.1 t -140.01 134.14 31.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.854 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 86.0 m -153.22 143.74 22.58 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.124 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.407 ' CG1' ' HG3' ' A' ' 164' ' ' GLU . 9.7 mm -104.39 133.31 48.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.141 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.674 HD11 ' CE2' ' A' ' 195' ' ' PHE . 22.1 mt . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.944 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 13.4 t . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.915 0.388 . . . . 0.0 110.844 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 34.2 mtmm -84.12 38.12 0.64 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.914 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 43.11 43.38 5.61 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.493 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 193' ' ' CYS . . . . . 0.473 ' HA ' HD12 ' A' ' 158' ' ' LEU . 80.7 m -154.62 159.55 40.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.826 0.346 . . . . 0.0 110.888 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -161.73 169.13 22.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.07 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 195' ' ' PHE . . . . . 0.674 ' CE2' HD11 ' A' ' 183' ' ' LEU . 38.2 m-85 -126.58 122.5 35.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.899 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 9.4 t -123.73 147.97 27.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.14 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -118.09 155.94 29.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.88 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 198' ' ' TYR . . . . . 0.572 ' CD1' HD12 ' A' ' 153' ' ' LEU . 20.8 m-85 -131.58 166.36 21.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.955 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 35.7 t -64.98 -51.54 61.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.858 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 4.8 m -140.51 -177.2 4.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.864 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 201' ' ' HIS . . . . . 0.441 ' O ' ' C ' ' A' ' 202' ' ' ALA . 13.1 t60 -68.15 -58.68 4.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.852 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 202' ' ' ALA . . . . . 0.441 ' C ' ' O ' ' A' ' 201' ' ' HIS . . . -34.93 -67.09 0.15 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.106 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -47.44 -47.36 26.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.89 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 204' ' ' ALA . . . . . 0.415 ' HB3' ' O ' ' A' ' 201' ' ' HIS . . . -52.36 -63.61 1.09 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.104 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 205' ' ' GLN . . . . . 0.878 ' HA ' HD12 ' A' ' 208' ' ' ILE . 11.0 tp60 -43.36 -45.41 6.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.901 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -52.99 -55.34 24.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.107 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -58.41 -34.67 71.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.139 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 208' ' ' ILE . . . . . 0.878 HD12 ' HA ' ' A' ' 205' ' ' GLN . 82.5 mt -59.94 -72.6 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.078 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 -52.09 -41.69 62.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.901 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -57.04 -40.96 77.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.109 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 64.7 mt -101.92 -71.12 0.73 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.929 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 212' ' ' HIS . . . . . 0.633 ' HD1' ' HA ' ' A' ' 225' ' ' VAL . 31.0 t60 -54.54 128.78 33.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.903 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 80.21 -1.62 79.88 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.456 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 34.0 t -96.65 -74.34 0.57 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.821 0.343 . . . . 0.0 110.892 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -97.3 -177.46 3.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.911 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 216' ' ' THR . . . . . 0.572 HG23 ' O ' ' A' ' 222' ' ' SER . 60.4 m -133.65 100.99 4.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.125 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 33.0 mmt -39.27 135.08 1.12 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.607 0.718 . . . . 0.0 110.869 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -48.34 114.08 1.05 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.703 2.269 . . . . 0.0 112.343 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 119.07 -51.19 0.77 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.485 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -72.77 155.58 39.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.814 0.34 . . . . 0.0 111.069 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 28.7 t -98.16 -21.15 16.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.898 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 222' ' ' SER . . . . . 0.572 ' O ' HG23 ' A' ' 216' ' ' THR . 1.1 t -99.88 154.14 18.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.876 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 57.8 m -58.65 158.54 7.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.832 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.458 ' HG ' HG23 ' A' ' 226' ' ' VAL . 43.1 tp -47.81 152.51 0.73 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.94 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 225' ' ' VAL . . . . . 0.633 ' HA ' ' HD1' ' A' ' 212' ' ' HIS . 98.0 t -118.48 111.46 34.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.139 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 226' ' ' VAL . . . . . 0.458 HG23 ' HG ' ' A' ' 224' ' ' LEU . 23.7 t -138.37 105.36 3.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.098 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 34.3 pttt -129.13 169.73 14.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.897 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.917 179.978 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 12.4 tttt . . . . . 0 C--O 1.232 0.17 0 CA-C-O 120.805 0.336 . . . . 0.0 110.9 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 44.4 mt -120.53 129.2 53.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.904 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 29.6 t80 -98.01 119.92 37.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.912 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.446 HG21 ' CZ ' ' A' ' 171' ' ' PHE . 21.6 t -110.27 129.1 65.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.102 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -127.69 -170.56 12.86 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.502 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 11.3 mmt 55.59 36.27 26.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.828 0.347 . . . . 0.0 110.937 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.422 ' HB2' ' C ' ' A' ' 192' ' ' GLY . 38.6 mt -95.55 168.93 10.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.872 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.478 ' ND2' ' O ' ' A' ' 218' ' ' PRO . 12.7 m120 -113.59 162.83 15.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.898 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 38.0 mttp -82.62 48.91 1.38 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.911 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -133.27 -49.49 0.85 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.886 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 16.0 mm-40 -56.65 155.52 7.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.899 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 17.1 m -135.51 176.13 8.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.884 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -47.57 -50.52 23.78 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.903 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -54.92 -58.62 6.86 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.839 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -41.84 -66.02 0.39 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.862 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.772 HG13 ' CE1' ' A' ' 171' ' ' PHE . 65.9 t -55.52 -54.77 21.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.113 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 168' ' ' ARG . . . . . 0.439 ' C ' ' O ' ' A' ' 167' ' ' VAL . 43.8 ttt180 -35.23 -70.11 0.09 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.875 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 44.3 mmm-85 -58.04 -53.57 56.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.909 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.664 ' O ' ' HB3' ' A' ' 173' ' ' ALA . 19.5 tp -41.37 -66.83 0.3 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.923 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 171' ' ' PHE . . . . . 0.772 ' CE1' HG13 ' A' ' 167' ' ' VAL . 9.9 m-85 -55.33 -72.84 0.06 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.858 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.45 ' O ' ' N ' ' A' ' 174' ' ' PHE . 0.5 OUTLIER -39.55 -28.26 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.907 -179.907 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.664 ' HB3' ' O ' ' A' ' 170' ' ' LEU . . . -41.41 -24.18 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.112 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 174' ' ' PHE . . . . . 0.45 ' N ' ' O ' ' A' ' 172' ' ' GLU . 93.7 m-85 -108.09 -69.92 0.83 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.931 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -100.94 -171.64 28.79 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.485 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 33.3 m-20 -98.86 131.67 44.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.771 0.319 . . . . 0.0 110.898 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.417 ' CG2' ' N ' ' A' ' 178' ' ' GLU . 37.1 mt -96.39 151.94 3.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.136 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 178' ' ' GLU . . . . . 0.417 ' N ' ' CG2' ' A' ' 177' ' ' ILE . 6.8 mt-10 -121.27 -21.51 6.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.905 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -165.85 136.43 3.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.865 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 51.0 t -130.47 141.6 50.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.89 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 83.2 m -153.11 147.65 26.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.158 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 20.1 mm -115.22 137.51 48.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.132 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.699 HD11 ' CE2' ' A' ' 195' ' ' PHE . 34.3 mt . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.932 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 17.1 t . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.916 0.389 . . . . 0.0 110.895 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 24.0 mtpt -89.68 31.55 0.93 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.952 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.422 ' C ' ' HB2' ' A' ' 158' ' ' LEU . . . 47.19 36.82 10.25 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.5 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 63.6 m -151.3 155.83 39.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.848 0.356 . . . . 0.0 110.843 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -161.04 162.21 31.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.072 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 195' ' ' PHE . . . . . 0.699 ' CE2' HD11 ' A' ' 183' ' ' LEU . 58.2 m-85 -117.79 142.36 47.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.848 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 45.6 t -129.82 145.34 35.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.091 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 24.7 tttt -113.5 147.48 37.83 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.879 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -132.4 167.9 19.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.945 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 38.1 t -83.96 -40.08 18.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.856 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 3.5 m -138.26 176.61 8.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.854 -179.771 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 201' ' ' HIS . . . . . 0.431 ' O ' ' C ' ' A' ' 202' ' ' ALA . 5.3 t60 -74.24 -56.44 4.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.866 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 202' ' ' ALA . . . . . 0.431 ' C ' ' O ' ' A' ' 201' ' ' HIS . . . -35.56 -63.21 0.36 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.1 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 31.7 mm-40 -49.4 -49.83 43.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.871 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -51.45 -59.28 4.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.143 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 205' ' ' GLN . . . . . 0.596 ' HA ' HD12 ' A' ' 208' ' ' ILE . 33.8 tp60 -48.27 -55.92 9.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.884 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -44.2 -61.38 1.51 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.067 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -49.05 -49.19 42.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.119 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 208' ' ' ILE . . . . . 0.596 HD12 ' HA ' ' A' ' 205' ' ' GLN . 66.4 mt -49.54 -74.95 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.123 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -44.47 -44.58 8.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.916 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 210' ' ' ALA . . . . . 0.416 ' HB1' ' CZ ' ' A' ' 174' ' ' PHE . . . -54.24 -43.31 70.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.126 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.428 ' CB ' HD23 ' A' ' 224' ' ' LEU . 7.9 mt -100.29 -68.93 0.79 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.934 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 212' ' ' HIS . . . . . 0.639 ' HD1' ' HA ' ' A' ' 225' ' ' VAL . 29.7 t60 -51.6 126.18 16.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.851 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 213' ' ' GLY . . . . . 0.442 ' HA2' ' CB ' ' A' ' 223' ' ' SER . . . 82.02 -19.23 10.35 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.518 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 2.5 m -85.5 -73.08 0.46 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.803 0.335 . . . . 0.0 110.872 -179.733 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 71.1 mt-30 -92.69 167.18 12.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.924 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 216' ' ' THR . . . . . 0.636 HG23 ' O ' ' A' ' 222' ' ' SER . 0.7 OUTLIER -126.95 104.07 7.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.119 -179.917 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 14.5 mmt -39.04 135.23 1.04 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.609 0.719 . . . . 0.0 110.836 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 218' ' ' PRO . . . . . 0.478 ' O ' ' ND2' ' A' ' 159' ' ' ASN . 76.1 Cg_exo -48.72 122.29 7.81 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.684 2.256 . . . . 0.0 112.375 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 105.03 -44.99 1.36 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.509 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -75.54 143.97 42.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.768 0.318 . . . . 0.0 111.091 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 29.9 t -92.59 -15.5 26.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.882 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 222' ' ' SER . . . . . 0.636 ' O ' HG23 ' A' ' 216' ' ' THR . 1.8 m -99.84 146.1 27.0 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.837 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 223' ' ' SER . . . . . 0.442 ' CB ' ' HA2' ' A' ' 213' ' ' GLY . 29.4 m -59.63 150.08 28.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.828 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.428 HD23 ' CB ' ' A' ' 211' ' ' LEU . 62.4 tp -41.78 151.62 0.09 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.935 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 225' ' ' VAL . . . . . 0.639 ' HA ' ' HD1' ' A' ' 212' ' ' HIS . 60.1 t -118.34 113.83 43.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.171 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 226' ' ' VAL . . . . . 0.595 HG12 HG12 ' A' ' 208' ' ' ILE . 46.0 t -136.92 105.2 3.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.153 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 8.3 ptmt -122.14 169.25 11.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.895 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.915 179.952 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.568 ' HD3' ' CD1' ' A' ' 195' ' ' PHE . 24.4 ttmt . . . . . 0 C--O 1.232 0.176 0 CA-C-O 120.798 0.332 . . . . 0.0 110.899 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.622 HD21 ' CE1' ' A' ' 228' ' ' PHE . 58.0 mt -127.2 121.81 32.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.882 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -95.13 127.03 40.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.864 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.634 HG21 ' HZ ' ' A' ' 171' ' ' PHE . 59.1 t -114.47 133.81 59.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.149 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -128.97 -159.58 9.99 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.49 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 27.8 mtt 41.84 39.88 1.37 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.817 0.341 . . . . 0.0 110.86 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 42.8 mt -95.43 161.4 14.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.943 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.483 ' ND2' ' O ' ' A' ' 218' ' ' PRO . 69.2 m-20 -100.35 165.97 11.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.861 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 65.4 mttt -89.72 40.97 1.02 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.842 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 18.9 mm-40 -127.31 -53.17 1.38 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.858 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -55.13 148.82 13.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.926 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 1.6 t -133.81 176.42 8.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.84 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -47.93 -42.64 27.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.862 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -50.55 -57.66 7.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.89 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 166' ' ' ASP . . . . . 0.404 ' O ' ' HG2' ' A' ' 169' ' ' ARG . 6.5 m-20 -61.21 -66.63 0.5 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.923 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.604 HG13 ' CE1' ' A' ' 171' ' ' PHE . 59.8 t -42.02 -35.32 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.094 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 25.0 ttm180 -63.88 -61.24 2.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.873 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 169' ' ' ARG . . . . . 0.404 ' HG2' ' O ' ' A' ' 166' ' ' ASP . 31.6 ptt180 -63.09 -52.13 63.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.887 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.729 ' O ' ' HB3' ' A' ' 173' ' ' ALA . 8.5 tp -44.23 -65.69 0.48 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.89 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 171' ' ' PHE . . . . . 0.634 ' HZ ' HG21 ' A' ' 155' ' ' VAL . 14.0 m-85 -53.28 -69.41 0.12 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.888 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -44.32 -26.05 0.3 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.94 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.729 ' HB3' ' O ' ' A' ' 170' ' ' LEU . . . -46.74 -20.49 0.13 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.142 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -116.14 -73.61 0.64 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.909 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -109.45 147.22 16.96 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.536 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -52.5 157.58 1.47 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.823 0.344 . . . . 0.0 110.903 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.451 HG23 ' O ' ' A' ' 197' ' ' LYS . 98.0 mt -122.37 147.55 26.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.143 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -102.4 -45.91 4.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.901 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -153.71 151.36 29.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.879 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 52.2 t -138.11 143.28 40.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.893 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 98.5 m -152.17 138.95 18.87 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.119 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 21.3 mm -93.72 127.86 45.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.158 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 1.0 HD11 ' CE2' ' A' ' 195' ' ' PHE . 65.6 mt . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.899 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 9.3 p . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.947 0.404 . . . . 0.0 110.841 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 28.9 mmtt -94.71 39.87 1.1 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.927 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 39.21 42.79 1.79 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.435 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 71.5 m -154.85 150.01 27.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.834 0.349 . . . . 0.0 110.905 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -161.39 162.91 30.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.075 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 195' ' ' PHE . . . . . 1.0 ' CE2' HD11 ' A' ' 183' ' ' LEU . 28.0 m-85 -116.98 143.12 46.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.896 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.53 HG11 ' CD2' ' A' ' 171' ' ' PHE . 40.3 t -140.13 138.2 37.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.125 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.451 ' O ' HG23 ' A' ' 177' ' ' ILE . 8.0 ttmm -118.91 148.29 43.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.879 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -122.82 172.22 8.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.93 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 1.2 t -76.14 -49.99 15.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.854 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 58.7 m -125.51 -178.19 4.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.854 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 201' ' ' HIS . . . . . 0.432 ' O ' ' C ' ' A' ' 202' ' ' ALA . 9.8 t60 -79.66 -63.14 1.48 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.885 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 202' ' ' ALA . . . . . 0.432 ' C ' ' O ' ' A' ' 201' ' ' HIS . . . -34.35 -60.65 0.41 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.085 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -48.02 -50.42 27.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.93 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -51.99 -59.05 4.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.072 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 205' ' ' GLN . . . . . 0.794 ' HA ' HD12 ' A' ' 208' ' ' ILE . 13.1 tp60 -44.91 -49.34 11.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.881 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -51.29 -58.32 6.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.131 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -52.59 -37.54 58.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.126 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 208' ' ' ILE . . . . . 0.794 HD12 ' HA ' ' A' ' 205' ' ' GLN . 77.0 mt -59.23 -74.06 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.095 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -49.92 -42.52 48.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.898 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -53.31 -45.6 69.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.126 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 57.2 mt -99.99 -67.69 0.84 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.9 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 212' ' ' HIS . . . . . 0.491 ' N ' ' O ' ' A' ' 208' ' ' ILE . 9.2 t60 -51.46 127.79 20.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.846 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 77.63 -9.97 26.55 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.472 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 8.3 t -97.74 -66.55 0.89 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.84 0.352 . . . . 0.0 110.879 -179.766 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 7.3 mm-40 -92.31 163.66 13.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.919 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 216' ' ' THR . . . . . 0.609 HG23 ' O ' ' A' ' 222' ' ' SER . 3.9 m -131.09 101.28 5.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.129 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 217' ' ' MET . . . . . 0.436 ' C ' ' O ' ' A' ' 216' ' ' THR . 0.0 OUTLIER -34.69 131.07 0.45 Allowed Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.548 0.69 . . . . 0.0 110.886 179.859 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 218' ' ' PRO . . . . . 0.483 ' O ' ' ND2' ' A' ' 159' ' ' ASN . 75.6 Cg_exo -48.89 120.29 5.25 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.699 2.266 . . . . 0.0 112.35 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 107.78 -45.03 1.36 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.499 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -73.48 142.11 46.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.812 0.339 . . . . 0.0 111.084 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 35.6 m -89.17 -16.55 31.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.836 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 222' ' ' SER . . . . . 0.609 ' O ' HG23 ' A' ' 216' ' ' THR . 3.9 m -99.87 143.24 30.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.841 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 95.8 p -63.32 152.46 37.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.873 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 27.0 tp -48.0 146.85 2.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.894 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 225' ' ' VAL . . . . . 0.417 ' HA ' ' HD1' ' A' ' 212' ' ' HIS . 68.6 t -119.5 118.27 56.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.129 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 226' ' ' VAL . . . . . 0.468 HG22 HG22 ' A' ' 155' ' ' VAL . 38.7 t -141.12 116.95 6.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.152 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 18.3 pttt -131.81 172.29 12.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.888 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 228' ' ' PHE . . . . . 0.622 ' CE1' HD21 ' A' ' 153' ' ' LEU . 54.8 m-85 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.89 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 9.4 tttp . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.829 0.347 . . . . 0.0 110.912 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.492 HD21 HD11 ' A' ' 208' ' ' ILE . 41.8 mt -133.92 121.05 21.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.89 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -93.86 118.37 31.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.841 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.715 HG22 HG13 ' A' ' 226' ' ' VAL . 16.5 t -106.35 131.9 54.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.098 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -130.41 -164.04 11.2 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.507 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 18.7 mmt 40.19 37.95 0.47 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.786 0.327 . . . . 0.0 110.846 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.466 HD21 ' CG1' ' A' ' 155' ' ' VAL . 83.8 mt -85.37 174.01 9.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.914 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.494 ' OD1' ' N ' ' A' ' 160' ' ' LYS . 60.1 t-20 -105.72 150.85 25.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.89 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 160' ' ' LYS . . . . . 0.494 ' N ' ' OD1' ' A' ' 159' ' ' ASN . 10.3 mptt -86.42 29.45 0.77 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.865 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 15.9 tm0? -111.48 -55.07 2.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.941 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -68.24 163.74 22.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.934 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 58.7 m -130.36 178.75 6.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.866 -179.754 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -46.9 -41.08 15.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.919 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -55.05 -61.93 1.99 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.826 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -46.8 -55.4 7.97 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.873 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.86 HG13 ' CE1' ' A' ' 171' ' ' PHE . 89.7 t -58.3 -40.27 77.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.104 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 168' ' ' ARG . . . . . 0.427 ' NH1' ' OE1' ' A' ' 172' ' ' GLU . 2.4 tmm_? -52.67 -62.92 1.34 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.866 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 9.7 mmm180 -59.39 -54.72 43.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.861 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.717 ' O ' ' HB3' ' A' ' 173' ' ' ALA . 9.4 tp -42.73 -66.24 0.39 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.883 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 171' ' ' PHE . . . . . 0.86 ' CE1' HG13 ' A' ' 167' ' ' VAL . 13.5 m-85 -51.32 -71.85 0.06 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.896 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.455 ' O ' ' N ' ' A' ' 174' ' ' PHE . 3.9 pt-20 -41.9 -31.53 0.34 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.927 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.717 ' HB3' ' O ' ' A' ' 170' ' ' LEU . . . -41.11 -24.44 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.057 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 174' ' ' PHE . . . . . 0.455 ' N ' ' O ' ' A' ' 172' ' ' GLU . 81.1 m-85 -113.96 -72.62 0.69 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.844 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -104.8 134.35 11.97 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.519 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 34.4 m-20 -49.4 149.16 2.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.791 0.329 . . . . 0.0 110.912 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.408 HD11 ' CB ' ' A' ' 171' ' ' PHE . 70.9 mt -114.07 150.02 16.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.162 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -117.27 -25.68 6.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.925 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -158.19 160.37 37.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.918 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 8.0 t -162.29 141.98 9.65 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.83 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 93.2 m -148.6 139.94 23.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.136 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.418 HD13 ' HB1' ' A' ' 194' ' ' ALA . 48.9 mm -102.18 119.3 50.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.119 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.472 HD11 ' CE2' ' A' ' 195' ' ' PHE . 30.8 mt . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.922 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 4.8 t . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.963 0.411 . . . . 0.0 110.842 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 24.2 mmtt -116.88 34.42 5.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.95 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 47.76 35.9 12.61 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.444 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 75.0 m -148.18 150.48 33.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.765 0.316 . . . . 0.0 110.9 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 194' ' ' ALA . . . . . 0.418 ' HB1' HD13 ' A' ' 182' ' ' ILE . . . -160.64 152.43 19.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.113 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 195' ' ' PHE . . . . . 0.472 ' CE2' HD11 ' A' ' 183' ' ' LEU . 25.6 m-85 -102.08 137.42 40.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.895 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.541 HG21 ' CE2' ' A' ' 171' ' ' PHE . 59.1 t -127.42 144.88 35.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.132 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 49.6 tttt -124.21 138.17 54.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.899 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 198' ' ' TYR . . . . . 0.453 ' CD1' HD12 ' A' ' 153' ' ' LEU . 19.4 m-85 -118.1 173.54 6.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.923 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 48.3 t -81.38 -47.65 12.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.869 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 2.9 t -132.84 153.97 50.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.874 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 201' ' ' HIS . . . . . 0.441 ' O ' ' C ' ' A' ' 202' ' ' ALA . 23.4 t-80 -52.75 -61.32 2.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.827 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 202' ' ' ALA . . . . . 0.441 ' C ' ' O ' ' A' ' 201' ' ' HIS . . . -34.06 -62.53 0.31 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.168 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -47.2 -43.42 21.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.849 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 204' ' ' ALA . . . . . 0.425 ' N ' ' O ' ' A' ' 201' ' ' HIS . . . -57.77 -55.14 38.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.095 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 205' ' ' GLN . . . . . 0.403 ' HA ' HD12 ' A' ' 208' ' ' ILE . 3.8 tp60 -50.23 -43.35 52.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.907 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -56.59 -57.64 11.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.107 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -56.87 -35.44 68.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.144 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 208' ' ' ILE . . . . . 0.496 ' O ' ' N ' ' A' ' 212' ' ' HIS . 78.2 mt -59.72 -75.12 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.107 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -47.39 -42.49 22.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.862 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -56.05 -43.46 77.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.119 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 33.0 mt -99.96 -69.08 0.78 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.922 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 212' ' ' HIS . . . . . 0.496 ' N ' ' O ' ' A' ' 208' ' ' ILE . 1.7 t60 -49.7 131.15 21.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.854 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 72.31 1.95 52.48 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.475 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 6.2 t -94.53 -71.29 0.67 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.814 0.34 . . . . 0.0 110.863 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 17.3 pm0 -100.33 175.75 5.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.895 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 216' ' ' THR . . . . . 0.442 ' O ' ' C ' ' A' ' 217' ' ' MET . 4.6 m -134.97 97.87 3.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.159 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 217' ' ' MET . . . . . 0.442 ' C ' ' O ' ' A' ' 216' ' ' THR . 12.4 mmt -34.56 133.18 0.42 Allowed Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.6 0.715 . . . . 0.0 110.868 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -49.01 119.52 4.48 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.68 2.254 . . . . 0.0 112.383 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 112.27 -50.82 0.74 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.516 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -73.03 152.84 41.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.821 0.343 . . . . 0.0 111.093 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 3.6 t -96.69 -19.51 18.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.869 -179.81 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 1.3 p -99.47 134.85 41.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.865 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 223' ' ' SER . . . . . 0.436 ' O ' ' C ' ' A' ' 224' ' ' LEU . 3.5 m -58.02 151.23 18.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.859 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.462 ' HG ' HG23 ' A' ' 226' ' ' VAL . 21.7 tp -35.57 141.76 0.08 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.933 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 90.8 t -114.77 109.2 27.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.146 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 226' ' ' VAL . . . . . 0.715 HG13 HG22 ' A' ' 155' ' ' VAL . 6.3 t -132.01 105.96 10.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.134 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 11.0 pttp -121.34 -179.1 3.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.871 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.826 179.98 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 11.4 tttp . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.829 0.347 . . . . 0.0 110.928 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 73.4 mt -133.75 129.82 37.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.861 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -97.38 116.44 29.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.902 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.469 HG22 HG13 ' A' ' 226' ' ' VAL . 47.8 t -110.27 135.46 49.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.134 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -134.31 -156.55 7.88 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.49 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 10.9 mmt 39.49 33.36 0.11 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.819 0.343 . . . . 0.0 110.852 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.418 ' HB2' ' C ' ' A' ' 192' ' ' GLY . 63.9 mt -85.03 169.4 14.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.935 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.461 ' ND2' ' HD2' ' A' ' 218' ' ' PRO . 7.4 p30 -103.44 163.55 12.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.892 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 29.4 mttt -97.96 23.08 8.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.907 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 2.3 tp-100 -109.85 -46.57 3.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.892 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 19.5 mt-30 -65.7 172.24 3.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.908 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 66.7 m -139.69 -177.44 4.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.905 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -59.07 -37.72 77.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.909 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -59.74 -50.82 72.33 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.868 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 39.6 m-20 -58.69 -56.55 20.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.876 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.615 HG13 ' CE1' ' A' ' 171' ' ' PHE . 19.5 t -63.09 -28.29 44.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.08 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 41.7 ttm-85 -63.76 -56.25 16.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.852 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 70.7 mtm180 -62.29 -55.11 31.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.912 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.765 ' O ' ' HB3' ' A' ' 173' ' ' ALA . 9.1 tp -43.38 -65.15 0.52 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.913 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 171' ' ' PHE . . . . . 0.615 ' CE1' HG13 ' A' ' 167' ' ' VAL . 8.5 m-85 -50.78 -69.29 0.12 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.874 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -46.3 -26.48 0.82 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.877 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.765 ' HB3' ' O ' ' A' ' 170' ' ' LEU . . . -49.36 -19.45 0.52 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.063 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -113.48 -74.68 0.62 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.883 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -107.5 151.56 16.92 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.492 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 46.6 m-80 -62.31 132.71 53.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.797 0.332 . . . . 0.0 110.927 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.421 HG21 ' SG ' ' A' ' 180' ' ' CYS . 84.2 mt -92.25 138.99 18.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.123 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -100.35 -30.48 11.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.915 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -164.54 142.0 6.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.888 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 180' ' ' CYS . . . . . 0.447 ' SG ' HG13 ' A' ' 196' ' ' VAL . 1.8 m -137.21 138.24 39.96 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.911 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 60.4 m -151.12 132.82 14.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.146 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 44.5 mm -98.52 143.24 13.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.132 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.747 HD11 ' CE2' ' A' ' 195' ' ' PHE . 52.7 mt . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.896 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 30.7 t . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.916 0.389 . . . . 0.0 110.858 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 63.6 mttt -94.04 37.59 1.09 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.913 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.418 ' C ' ' HB2' ' A' ' 158' ' ' LEU . . . 43.32 40.99 4.89 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.497 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 4.4 p -150.03 151.48 33.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.798 0.333 . . . . 0.0 110.941 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -160.62 150.96 18.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.069 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 195' ' ' PHE . . . . . 0.747 ' CE2' HD11 ' A' ' 183' ' ' LEU . 50.2 m-85 -108.72 116.3 31.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.914 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.609 HG11 ' CD2' ' A' ' 171' ' ' PHE . 38.8 t -110.04 146.97 14.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.122 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 34.4 tttp -127.1 160.26 31.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.876 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -137.65 164.79 27.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.909 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 41.2 t -71.61 -39.38 70.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.851 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 2.4 t -136.02 171.78 13.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.818 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 201' ' ' HIS . . . . . 0.408 ' O ' ' C ' ' A' ' 202' ' ' ALA . 40.1 t-80 -69.4 -57.05 5.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.855 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 202' ' ' ALA . . . . . 0.408 ' C ' ' O ' ' A' ' 201' ' ' HIS . . . -36.75 -61.39 0.54 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.148 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -47.53 -50.58 23.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.865 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -51.43 -57.59 8.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.073 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 205' ' ' GLN . . . . . 0.511 ' C ' ' CD ' ' A' ' 205' ' ' GLN . 0.0 OUTLIER -47.67 -68.13 0.21 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.887 -179.898 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 206' ' ' ALA . . . . . 0.407 ' C ' ' O ' ' A' ' 205' ' ' GLN . . . -37.02 -51.82 0.95 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.106 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -59.72 -43.23 94.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.105 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 208' ' ' ILE . . . . . 0.489 ' O ' ' N ' ' A' ' 212' ' ' HIS . 82.5 mt -56.23 -70.28 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.078 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -54.12 -40.29 67.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.827 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -56.03 -34.07 65.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.122 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 57.8 mt -112.35 -70.83 0.79 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.901 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 212' ' ' HIS . . . . . 0.489 ' N ' ' O ' ' A' ' 208' ' ' ILE . 2.9 t60 -44.28 126.77 5.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.868 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 213' ' ' GLY . . . . . 0.416 ' CA ' ' HB3' ' A' ' 223' ' ' SER . . . 82.15 -28.1 3.4 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.507 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 25.7 m -90.15 -67.26 0.86 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.819 0.342 . . . . 0.0 110.88 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 -83.3 143.43 30.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.921 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 216' ' ' THR . . . . . 0.684 HG23 ' O ' ' A' ' 222' ' ' SER . 24.3 m -120.15 100.0 6.93 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.158 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 217' ' ' MET . . . . . 0.402 ' C ' ' O ' ' A' ' 216' ' ' THR . 13.6 mmt -37.37 132.65 0.78 Allowed Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.596 0.713 . . . . 0.0 110.907 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 218' ' ' PRO . . . . . 0.461 ' HD2' ' ND2' ' A' ' 159' ' ' ASN . 75.2 Cg_exo -48.55 122.42 7.83 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.65 2.233 . . . . 0.0 112.32 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 112.54 -52.29 0.65 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.51 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -68.79 150.49 47.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.826 0.346 . . . . 0.0 111.069 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 88.1 p -96.33 -18.36 20.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.903 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 222' ' ' SER . . . . . 0.684 ' O ' HG23 ' A' ' 216' ' ' THR . 1.4 t -100.08 146.96 26.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.852 -179.8 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 223' ' ' SER . . . . . 0.416 ' HB3' ' CA ' ' A' ' 213' ' ' GLY . 73.0 m -58.9 155.83 12.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.887 -179.799 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.441 HD23 ' N ' ' A' ' 212' ' ' HIS . 32.4 tp -49.35 156.09 0.64 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.979 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 225' ' ' VAL . . . . . 0.416 ' N ' ' HG ' ' A' ' 224' ' ' LEU . 57.9 t -127.57 108.17 17.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.124 179.822 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 226' ' ' VAL . . . . . 0.469 HG13 HG22 ' A' ' 155' ' ' VAL . 41.2 t -135.03 101.63 3.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.126 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 19.5 pttt -119.01 170.34 9.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.876 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.942 179.928 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.461 ' HE2' ' CG ' ' A' ' 195' ' ' PHE . 5.7 tttp . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.825 0.345 . . . . 0.0 110.898 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.589 HD12 ' CD1' ' A' ' 198' ' ' TYR . 36.6 mt -130.09 125.11 34.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.9 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -96.73 113.85 25.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.863 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.551 HG13 HG22 ' A' ' 226' ' ' VAL . 22.2 t -104.46 127.65 58.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.135 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.474 ' O ' ' N ' ' A' ' 158' ' ' LEU . . . -128.63 -154.01 8.19 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.434 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.442 ' C ' ' O ' ' A' ' 156' ' ' GLY . 31.0 mtt 34.66 34.15 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.776 0.322 . . . . 0.0 110.868 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.474 ' N ' ' O ' ' A' ' 156' ' ' GLY . 58.5 mt -83.24 174.79 10.44 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.927 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.484 ' ND2' ' H ' ' A' ' 162' ' ' GLN . 3.2 p-10 -104.77 150.17 25.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.906 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 39.3 mttp -85.39 32.5 0.56 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.875 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -120.32 -54.38 2.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.925 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 162' ' ' GLN . . . . . 0.484 ' H ' ' ND2' ' A' ' 159' ' ' ASN . 3.6 pt20 -56.48 156.78 5.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.919 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 23.0 m -128.13 -177.1 4.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.864 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -51.54 -41.47 61.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.861 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -57.98 -59.29 5.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.863 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -48.73 -61.03 2.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.858 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.827 HG13 ' CE1' ' A' ' 171' ' ' PHE . 91.9 t -55.14 -45.06 77.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.136 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 33.3 mtp180 -51.62 -58.31 6.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.862 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 47.8 mtp180 -62.73 -54.56 37.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.886 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.794 ' O ' ' HB3' ' A' ' 173' ' ' ALA . 11.0 tp -44.14 -65.06 0.56 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.9 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 171' ' ' PHE . . . . . 0.827 ' CE1' HG13 ' A' ' 167' ' ' VAL . 13.2 m-85 -50.6 -68.36 0.18 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.845 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -47.31 -23.52 0.58 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.849 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.794 ' HB3' ' O ' ' A' ' 170' ' ' LEU . . . -54.19 -14.45 1.13 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.065 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -123.12 -69.01 0.85 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.872 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -113.57 148.05 18.64 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.499 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 35.4 m120 -55.96 153.86 8.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.801 0.334 . . . . 0.0 110.916 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.512 HD11 ' CB ' ' A' ' 171' ' ' PHE . 73.8 mt -118.31 151.51 20.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.162 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -108.85 -39.87 5.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.919 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -164.99 131.93 2.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.933 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 42.3 t -120.78 139.29 53.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.876 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 53.3 m -147.75 129.99 15.59 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.162 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 17.4 mm -93.48 130.32 42.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.146 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.592 HD11 ' CE2' ' A' ' 195' ' ' PHE . 77.7 mt . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.945 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 3.3 t . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.987 0.423 . . . . 0.0 110.818 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 10.3 pttp -121.86 29.02 7.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.932 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 57.48 47.31 89.13 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.522 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 24.1 m -152.03 141.92 22.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.842 0.353 . . . . 0.0 110.896 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -162.06 157.9 24.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.095 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 195' ' ' PHE . . . . . 0.592 ' CE2' HD11 ' A' ' 183' ' ' LEU . 21.1 m-85 -110.82 124.8 52.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.882 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.575 HG11 ' CD2' ' A' ' 171' ' ' PHE . 94.3 t -122.24 139.29 49.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.125 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 41.3 mttm -116.2 144.76 43.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.898 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 198' ' ' TYR . . . . . 0.589 ' CD1' HD12 ' A' ' 153' ' ' LEU . 19.7 m-85 -119.28 174.72 6.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.91 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 46.6 p -74.5 -52.52 11.71 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.884 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 32.9 p -137.07 -175.72 4.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.874 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 201' ' ' HIS . . . . . 0.435 ' O ' ' HB3' ' A' ' 204' ' ' ALA . 3.4 t-160 -71.46 -53.85 12.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.885 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -40.76 -62.53 0.78 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.136 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -47.42 -41.72 20.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.884 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 204' ' ' ALA . . . . . 0.435 ' HB3' ' O ' ' A' ' 201' ' ' HIS . . . -59.27 -56.23 24.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.102 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -47.85 -41.81 24.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.933 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -61.39 -51.91 66.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.118 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -61.84 -23.8 66.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.104 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 208' ' ' ILE . . . . . 0.499 ' O ' ' N ' ' A' ' 212' ' ' HIS . 53.5 mt -71.92 -71.57 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.15 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 209' ' ' ASN . . . . . 0.403 ' N ' HG22 ' A' ' 208' ' ' ILE . 5.3 t30 -54.89 -38.91 68.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.905 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -58.35 -50.74 72.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.12 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 30.7 mt -99.93 -67.56 0.85 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.93 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 212' ' ' HIS . . . . . 0.587 ' CE1' ' HA ' ' A' ' 225' ' ' VAL . 1.5 t60 -49.83 132.77 22.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.863 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 70.12 -2.12 15.27 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.5 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -96.38 -71.36 0.68 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.822 0.344 . . . . 0.0 110.876 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -100.27 166.98 10.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.934 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 216' ' ' THR . . . . . 0.636 HG23 ' O ' ' A' ' 222' ' ' SER . 24.4 m -127.38 94.03 3.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.152 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 217' ' ' MET . . . . . 0.415 ' C ' ' O ' ' A' ' 216' ' ' THR . 17.8 mmt -36.39 136.18 0.55 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.579 0.704 . . . . 0.0 110.843 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -49.24 138.21 29.47 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.634 2.223 . . . . 0.0 112.366 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 100.07 -45.22 1.51 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.505 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -86.31 142.04 28.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.815 0.341 . . . . 0.0 111.095 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 13.9 m -93.49 -12.88 28.67 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.834 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 222' ' ' SER . . . . . 0.636 ' O ' HG23 ' A' ' 216' ' ' THR . 3.9 m -100.11 143.09 30.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.88 -179.817 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 71.3 m -56.04 148.43 17.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.8 -179.772 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.612 HD12 ' H ' ' A' ' 225' ' ' VAL . 51.3 tp -38.31 158.08 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.893 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 225' ' ' VAL . . . . . 0.612 ' H ' HD12 ' A' ' 224' ' ' LEU . 61.7 t -130.4 105.76 11.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.114 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 226' ' ' VAL . . . . . 0.551 HG22 HG13 ' A' ' 155' ' ' VAL . 21.5 t -134.04 101.46 3.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.146 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 227' ' ' LYS . . . . . 0.469 ' HE2' ' CG1' ' A' ' 225' ' ' VAL . 0.7 OUTLIER -130.38 145.29 51.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.896 179.883 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.929 179.958 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.363 0 N-CA-C 112.512 -0.235 . . . . 0.0 112.512 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 3.6 m 44.7 47.85 8.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.823 0.344 . . . . 0.0 110.838 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 7.3 t -107.12 127.98 53.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.902 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 96.98 99.27 1.95 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.475 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 71.4 p -86.96 -44.43 11.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.896 0.379 . . . . 0.0 110.862 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 81.1 p 45.08 36.95 2.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.898 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -153.97 92.22 0.13 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.494 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 8.5 t -108.04 108.37 19.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.898 0.38 . . . . 0.0 110.892 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.637 HD23 ' N ' ' A' ' 144' ' ' LEU . 1.5 pt? -153.03 149.55 28.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.905 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.414 ' C ' ' O ' ' A' ' 144' ' ' LEU . 23.7 mtp85 37.21 35.83 0.06 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.889 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 2.2 pm0 -48.59 143.91 7.29 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.65 0.738 . . . . 0.0 110.901 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -46.6 157.59 0.47 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.696 2.264 . . . . 0.0 112.359 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -77.31 -174.09 2.06 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.694 2.263 . . . . 0.0 112.371 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 94.5 p -124.97 96.36 4.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.873 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' HIS . . . . . 0.538 ' CD2' ' O ' ' A' ' 150' ' ' HIS . 7.8 p-80 -171.4 129.06 0.69 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.872 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 16.9 mtp180 -112.23 41.83 1.91 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.905 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.543 ' HD3' ' CD1' ' A' ' 195' ' ' PHE . 20.5 ttmt -128.81 156.63 43.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.886 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.626 HD21 HD11 ' A' ' 208' ' ' ILE . 24.6 mt -142.83 126.49 16.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.898 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -90.92 116.69 28.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.874 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.867 HG13 HG22 ' A' ' 226' ' ' VAL . 4.8 t -110.43 134.55 52.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.098 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -135.13 -156.27 7.63 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.511 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 10.1 mmt 45.31 35.44 1.83 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.785 0.326 . . . . 0.0 110.894 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.526 HD23 ' SD ' ' A' ' 217' ' ' MET . 77.5 mt -93.67 167.94 11.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.897 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -101.38 154.77 18.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.892 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 86.7 mttt -84.13 41.34 0.81 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.875 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 -127.8 -48.81 1.37 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.897 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -55.33 163.91 1.08 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.879 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 3.8 t -131.33 165.8 22.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.905 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.725 ' HA ' HD11 ' A' ' 182' ' ' ILE . 5.5 tt0 -45.08 -44.36 10.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.917 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.418 ' O ' ' N ' ' A' ' 168' ' ' ARG . 0.1 OUTLIER -57.71 -62.42 1.81 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.861 179.976 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -41.25 -52.29 3.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.889 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.604 HG13 ' CE1' ' A' ' 171' ' ' PHE . 30.0 t -66.95 -28.64 43.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.095 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' ARG . . . . . 0.418 ' N ' ' O ' ' A' ' 165' ' ' ASP . 18.9 ttt180 -61.88 -64.13 1.03 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.834 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 7.5 mmm180 -59.72 -54.22 48.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.875 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.697 ' O ' ' HB3' ' A' ' 173' ' ' ALA . 9.3 tp -42.08 -66.31 0.37 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.948 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.604 ' CE1' HG13 ' A' ' 167' ' ' VAL . 9.1 m-85 -53.37 -72.21 0.06 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.884 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -40.96 -30.29 0.13 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.842 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.697 ' HB3' ' O ' ' A' ' 170' ' ' LEU . . . -40.11 -30.4 0.09 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.128 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -105.42 -74.34 0.65 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.869 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -105.54 137.92 13.99 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.464 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -48.49 153.34 0.78 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.817 0.342 . . . . 0.0 110.857 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.541 HG23 ' O ' ' A' ' 197' ' ' LYS . 81.5 mt -121.28 138.61 51.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.102 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -88.11 -49.01 7.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.943 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -150.97 160.08 44.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.949 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 41.9 t -145.68 135.16 23.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.851 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 95.4 m -146.99 110.38 4.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.139 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.725 HD11 ' HA ' ' A' ' 164' ' ' GLU . 21.3 mm -71.73 138.94 20.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.129 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.592 HD11 ' CE2' ' A' ' 195' ' ' PHE . 34.9 mt -90.35 132.82 35.36 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.876 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 184' ' ' ARG . . . . . 0.426 ' NH1' ' HB2' ' A' ' 184' ' ' ARG . 28.2 mtm105 -136.58 106.76 6.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.844 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -52.68 160.7 2.8 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.493 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -45.59 -38.95 17.23 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.659 2.24 . . . . 0.0 112.342 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -50.99 -40.98 59.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.861 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 121.52 -40.63 2.06 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.494 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' ASN . . . . . 0.407 ' O ' ' C ' ' A' ' 190' ' ' SER . 0.4 OUTLIER -74.46 125.56 28.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.849 0.356 . . . . 0.0 110.877 -179.875 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 190' ' ' SER . . . . . 0.407 ' C ' ' O ' ' A' ' 189' ' ' ASN . 18.7 t -36.59 137.75 0.27 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.84 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 39.0 mttt -92.57 16.56 11.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.893 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 65.69 43.53 94.1 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.451 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' CYS . . . . . 0.436 ' HB2' HD12 ' A' ' 183' ' ' LEU . 0.8 OUTLIER -154.67 155.74 35.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.809 0.338 . . . . 0.0 110.917 -179.897 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -162.5 155.61 19.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.116 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' PHE . . . . . 0.592 ' CE2' HD11 ' A' ' 183' ' ' LEU . 38.5 m-85 -107.84 119.01 38.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.923 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 46.8 t -122.28 138.55 52.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.122 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.541 ' O ' HG23 ' A' ' 177' ' ' ILE . 0.0 OUTLIER -113.62 160.53 18.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.923 179.892 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -131.55 173.13 11.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.922 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 45.0 t -73.61 -44.83 56.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.895 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 1.4 t -143.15 179.92 6.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.835 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' HIS . . . . . 0.441 ' O ' ' C ' ' A' ' 202' ' ' ALA . 10.7 t-80 -67.18 -61.59 1.85 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.871 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 202' ' ' ALA . . . . . 0.441 ' C ' ' O ' ' A' ' 201' ' ' HIS . . . -34.24 -62.77 0.31 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.097 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -49.1 -46.88 45.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.905 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 204' ' ' ALA . . . . . 0.438 ' HB1' HD11 ' A' ' 153' ' ' LEU . . . -51.64 -56.97 10.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.1 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 62.1 tp60 -53.21 -45.34 68.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.902 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -49.11 -53.32 21.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.064 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -64.29 -40.28 95.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.113 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 208' ' ' ILE . . . . . 0.626 HD11 HD21 ' A' ' 153' ' ' LEU . 71.5 mt -55.95 -66.08 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.137 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 12.9 t30 -59.77 -37.83 80.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.86 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -69.07 -21.7 64.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.128 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.736 ' HB3' HD23 ' A' ' 224' ' ' LEU . 85.0 mt -113.88 -74.36 0.62 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.907 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 212' ' ' HIS . . . . . 0.538 ' HD1' ' HA ' ' A' ' 225' ' ' VAL . 17.8 t60 -51.82 126.55 18.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.835 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 84.11 -6.81 73.89 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.508 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 33.2 t -88.55 -73.82 0.48 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.8 0.333 . . . . 0.0 110.889 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -99.69 -178.31 3.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.896 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 216' ' ' THR . . . . . 0.572 HG23 ' O ' ' A' ' 222' ' ' SER . 25.3 m -134.31 102.7 5.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.192 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 217' ' ' MET . . . . . 0.526 ' SD ' HD23 ' A' ' 158' ' ' LEU . 30.2 mmt -39.99 137.66 1.17 Allowed Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.602 0.715 . . . . 0.0 110.865 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -48.75 124.94 11.88 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.679 2.253 . . . . 0.0 112.35 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 103.64 -47.46 1.1 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.48 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 220' ' ' ALA . . . . . 0.416 ' O ' HG22 ' A' ' 216' ' ' THR . . . -75.64 145.9 40.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.779 0.323 . . . . 0.0 111.087 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 4.5 t -93.24 -16.34 24.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.856 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 222' ' ' SER . . . . . 0.572 ' O ' HG23 ' A' ' 216' ' ' THR . 5.5 m -100.05 141.15 33.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.81 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 73.1 m -54.95 155.19 4.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.823 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.736 HD23 ' HB3' ' A' ' 211' ' ' LEU . 55.8 tp -43.24 148.57 0.28 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.919 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 0.538 ' HA ' ' HD1' ' A' ' 212' ' ' HIS . 88.2 t -118.81 113.05 40.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.099 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 226' ' ' VAL . . . . . 0.867 HG22 HG13 ' A' ' 155' ' ' VAL . 22.0 t -136.25 110.28 9.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.161 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 19.2 pttp -130.25 162.45 28.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.86 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 228' ' ' PHE . . . . . 0.572 ' HA ' HD23 ' A' ' 153' ' ' LEU . 49.0 m-85 -62.51 116.16 4.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.899 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -66.87 134.2 51.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.12 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -88.71 163.2 15.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.879 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 43.7 m -118.57 -44.19 2.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.16 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -100.71 87.64 3.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.871 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -98.8 -59.42 1.74 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.922 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -63.99 -53.0 56.95 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.868 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 2.3 m -58.7 169.92 0.88 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.868 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 164.83 166.22 23.42 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.458 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 237' ' ' PRO . . . . . 0.441 ' O ' ' C ' ' A' ' 238' ' ' SER . 62.2 Cg_endo -76.99 7.35 3.67 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.674 2.25 . . . . 0.0 112.349 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 238' ' ' SER . . . . . 0.441 ' C ' ' O ' ' A' ' 237' ' ' PRO . 66.3 m -35.2 134.7 0.26 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.882 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 16.2 t -65.88 89.87 0.12 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.851 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.31 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.482 -179.997 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.418 ' O ' ' C ' ' A' ' 137' ' ' SER . . . . . . . . 0 N--CA 1.451 -0.321 0 N-CA-C 112.477 -0.249 . . . . 0.0 112.477 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.418 ' C ' ' O ' ' A' ' 136' ' ' GLY . 15.2 m 35.81 42.33 0.14 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.874 0.368 . . . . 0.0 110.827 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 6.2 t -82.4 -61.55 1.86 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.862 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 151.99 83.29 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.507 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 59.9 p -164.82 149.14 9.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.82 0.343 . . . . 0.0 110.887 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 58.7 m -42.46 -55.57 3.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.835 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 111.81 -140.5 16.19 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.485 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 86.3 m -108.83 122.01 46.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.837 0.351 . . . . 0.0 110.902 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -98.57 -44.57 6.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.899 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.416 ' HD3' ' C ' ' A' ' 145' ' ' ARG . 0.1 OUTLIER -43.65 155.03 0.08 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.889 179.928 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 45.0 mm-40 -110.56 97.09 30.73 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.607 0.718 . . . . 0.0 110.929 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -75.4 153.24 39.79 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.701 2.267 . . . . 0.0 112.321 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -76.57 168.96 22.76 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.7 2.267 . . . . 0.0 112.355 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 23.8 p -125.27 95.15 4.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.863 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -98.24 102.45 14.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.847 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 67.2 mmt-85 -61.77 -35.96 79.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.869 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 5.4 ttpm? -93.78 148.83 21.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.901 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.657 HD23 ' HA ' ' A' ' 228' ' ' PHE . 47.8 mt -128.59 136.16 50.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.919 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -94.5 131.5 40.14 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.898 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.567 HG22 HG13 ' A' ' 226' ' ' VAL . 92.9 t -123.7 129.5 74.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.169 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -125.78 -159.31 10.25 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.478 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.615 ' SD ' HG21 ' A' ' 225' ' ' VAL . 0.9 OUTLIER 44.16 30.23 0.42 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.816 0.341 . . . . 0.0 110.918 -179.957 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.402 ' HB2' ' C ' ' A' ' 192' ' ' GLY . 73.3 mt -88.75 157.19 18.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.905 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -101.05 160.46 14.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.843 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 47.2 mttt -83.97 37.54 0.61 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.895 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 55.9 tp60 -123.29 -46.47 2.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.921 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -55.71 151.11 11.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.922 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 3.7 t -126.5 166.26 17.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.879 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -44.37 -47.68 9.72 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.897 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -57.91 -57.04 14.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.876 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 -43.44 -57.04 3.27 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.884 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.728 HG13 ' CE1' ' A' ' 171' ' ' PHE . 61.7 t -61.73 -48.45 88.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.113 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 57.7 mtt180 -41.29 -68.55 0.18 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.87 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 87.6 mtt-85 -58.35 -53.66 55.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.84 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.64 ' O ' ' HB3' ' A' ' 173' ' ' ALA . 12.8 tp -41.07 -66.7 0.31 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.883 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.728 ' CE1' HG13 ' A' ' 167' ' ' VAL . 9.8 m-85 -56.02 -73.3 0.06 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.867 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.454 ' O ' ' N ' ' A' ' 174' ' ' PHE . 0.9 OUTLIER -39.18 -27.78 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.924 -179.94 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.64 ' HB3' ' O ' ' A' ' 170' ' ' LEU . . . -40.66 -25.18 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.1 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 174' ' ' PHE . . . . . 0.454 ' N ' ' O ' ' A' ' 172' ' ' GLU . 95.6 m-85 -106.69 -70.73 0.78 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.877 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -102.14 -163.46 26.62 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.506 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 35.3 m120 -96.9 160.93 14.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.804 0.335 . . . . 0.0 110.865 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 13.0 mt -128.43 151.28 35.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.119 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 46.9 mm-40 -115.51 -42.54 3.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.915 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -155.18 149.61 26.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.899 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 40.6 t -137.98 143.98 40.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.879 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 56.5 m -150.12 149.15 29.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.148 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 13.3 mm -115.45 126.13 72.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.128 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.436 HD11 ' CE2' ' A' ' 195' ' ' PHE . 78.6 mt -72.31 139.95 48.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.896 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 184' ' ' ARG . . . . . 0.426 ' NH1' ' HB2' ' A' ' 184' ' ' ARG . 28.0 mtm105 -146.46 125.91 13.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.865 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -58.76 -167.08 0.16 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.516 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -77.07 -47.07 0.13 Allowed 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.706 2.271 . . . . 0.0 112.33 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -45.81 -42.91 12.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.884 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 120.36 42.5 0.5 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.508 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -142.28 158.42 43.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.833 0.349 . . . . 0.0 110.891 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 53.3 p -75.21 126.72 31.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.871 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 26.5 mtpt -85.01 26.66 0.83 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.881 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.402 ' C ' ' HB2' ' A' ' 158' ' ' LEU . . . 61.01 31.75 77.73 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.533 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 52.3 m -143.8 150.74 38.99 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.836 0.351 . . . . 0.0 110.894 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -155.52 172.09 18.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.087 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 195' ' ' PHE . . . . . 0.436 ' CE2' HD11 ' A' ' 183' ' ' LEU . 37.4 m-85 -128.43 130.4 47.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.879 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 48.6 t -127.8 132.96 68.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.126 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 29.2 mttp -104.53 150.03 24.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.869 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 198' ' ' TYR . . . . . 0.447 ' OH ' ' CB ' ' A' ' 207' ' ' ALA . 3.3 m-85 -123.03 175.36 6.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.949 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 58.0 m -86.36 -34.9 20.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.864 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 75.4 m -147.06 -179.86 7.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.867 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 201' ' ' HIS . . . . . 0.435 ' O ' ' C ' ' A' ' 202' ' ' ALA . 67.8 t60 -73.42 -63.96 1.09 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.896 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 202' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 201' ' ' HIS . . . -34.49 -61.44 0.39 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.05 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -48.47 -44.15 35.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.834 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 204' ' ' ALA . . . . . 0.411 ' N ' ' O ' ' A' ' 201' ' ' HIS . . . -60.16 -56.14 25.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.119 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 205' ' ' GLN . . . . . 0.439 ' HA ' HD12 ' A' ' 208' ' ' ILE . 33.0 tp60 -50.66 -46.13 58.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.89 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -54.84 -49.6 70.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.055 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 207' ' ' ALA . . . . . 0.447 ' CB ' ' OH ' ' A' ' 198' ' ' TYR . . . -63.76 -26.59 68.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.106 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 208' ' ' ILE . . . . . 0.484 ' O ' ' N ' ' A' ' 212' ' ' HIS . 60.3 mt -70.74 -64.24 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.181 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -58.48 -39.16 79.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.895 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 210' ' ' ALA . . . . . 0.413 ' HB1' ' CZ ' ' A' ' 174' ' ' PHE . . . -66.99 -35.11 79.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.079 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.451 ' HB3' HD23 ' A' ' 224' ' ' LEU . 86.5 mt -102.5 -74.54 0.63 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.94 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 212' ' ' HIS . . . . . 0.484 ' N ' ' O ' ' A' ' 208' ' ' ILE . 33.9 t60 -49.18 134.07 18.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.861 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 70.06 -0.61 21.91 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.531 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -93.34 -71.01 0.67 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.747 0.308 . . . . 0.0 110.863 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -100.05 -178.44 3.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.916 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 216' ' ' THR . . . . . 0.559 HG23 ' O ' ' A' ' 222' ' ' SER . 7.6 m -136.97 110.3 7.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.139 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 217' ' ' MET . . . . . 0.7 ' SD ' HD13 ' A' ' 224' ' ' LEU . 0.0 OUTLIER -39.26 160.05 0.1 OUTLIER Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.519 0.676 . . . . 0.0 110.915 179.883 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.32 103.0 1.54 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.637 2.224 . . . . 0.0 112.367 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 122.47 -49.77 0.87 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.501 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -65.24 150.38 48.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.796 0.331 . . . . 0.0 111.091 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 9.5 m -95.33 -17.38 21.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.848 -179.774 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 222' ' ' SER . . . . . 0.559 ' O ' HG23 ' A' ' 216' ' ' THR . 1.1 t -99.82 146.14 26.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.874 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -61.65 152.99 29.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.89 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.7 HD13 ' SD ' ' A' ' 217' ' ' MET . 59.4 tp -38.71 152.92 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.907 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 0.615 HG21 ' SD ' ' A' ' 157' ' ' MET . 86.5 t -125.1 104.4 13.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.124 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 226' ' ' VAL . . . . . 0.567 HG13 HG22 ' A' ' 155' ' ' VAL . 8.8 t -128.4 103.06 9.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.121 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 7.6 ptmt -120.76 167.34 12.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.882 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 228' ' ' PHE . . . . . 0.657 ' HA ' HD23 ' A' ' 153' ' ' LEU . 73.4 m-85 -71.78 143.46 49.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.887 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -88.19 112.58 22.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.143 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 230' ' ' ASP . . . . . 0.436 ' O ' ' N ' ' A' ' 232' ' ' ASP . 5.8 t70 -82.41 46.07 1.01 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.88 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 231' ' ' THR . . . . . 0.422 ' C ' ' O ' ' A' ' 230' ' ' ASP . 9.2 t 36.3 32.81 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.119 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 232' ' ' ASP . . . . . 0.436 ' N ' ' O ' ' A' ' 230' ' ' ASP . 40.7 m-20 -110.06 42.57 1.5 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.862 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 21.4 tttm -44.17 -54.19 5.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.946 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 234' ' ' GLU . . . . . 0.49 ' C ' ' CD ' ' A' ' 234' ' ' GLU . 0.5 OUTLIER -82.74 161.95 21.9 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.874 179.933 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.8 t -111.06 -62.81 1.49 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.841 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -145.72 164.79 28.1 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.484 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -77.1 139.82 19.43 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.671 2.247 . . . . 0.0 112.328 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 4.7 t -63.52 -54.91 28.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.858 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 36.5 m -93.25 136.29 33.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.862 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.498 -179.975 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.372 0 N-CA-C 112.462 -0.255 . . . . 0.0 112.462 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 3.7 t -98.19 -62.13 1.29 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.884 0.373 . . . . 0.0 110.835 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 12.7 t -70.72 -50.21 38.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.841 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 88.89 73.08 1.28 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.472 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 32.1 p -60.77 109.89 1.17 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.851 0.358 . . . . 0.0 110.861 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 63.1 m -132.77 146.44 51.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.88 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 151.29 66.1 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.471 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 31.8 p -107.78 127.32 53.6 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.907 0.384 . . . . 0.0 110.826 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 11.4 mt -111.63 97.8 6.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.963 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 10.8 tpt180 -165.77 123.76 1.53 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.86 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -81.9 146.62 56.26 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.596 0.712 . . . . 0.0 110.925 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -77.42 152.42 30.17 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.694 2.263 . . . . 0.0 112.347 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -46.34 170.72 0.04 OUTLIER 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.676 2.251 . . . . 0.0 112.375 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 6.6 t -55.98 -54.0 50.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.87 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 28.0 p-80 -90.06 128.98 36.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.864 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 4.2 mpt_? -103.84 82.28 1.97 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.864 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 20.3 tttt -105.41 151.78 23.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.871 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 32.0 mt -127.08 124.99 40.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.916 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -92.82 110.8 22.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.858 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.645 HG13 HG22 ' A' ' 226' ' ' VAL . 39.4 t -104.64 127.55 58.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.111 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.422 ' O ' ' N ' ' A' ' 158' ' ' LEU . . . -125.68 -152.22 8.13 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.505 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.485 ' SD ' HG21 ' A' ' 225' ' ' VAL . 0.4 OUTLIER 38.59 30.5 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.855 0.36 . . . . 0.0 110.87 179.976 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.422 ' N ' ' O ' ' A' ' 156' ' ' GLY . 61.4 mt -83.93 166.14 18.09 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.893 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -100.31 158.41 15.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.896 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 34.9 mttm -88.16 33.46 0.74 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.908 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -123.84 -52.22 1.79 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.907 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -51.54 155.54 1.53 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.905 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 4.3 m -131.03 174.79 9.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.862 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -50.37 -42.58 53.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.92 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -59.3 -54.58 45.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.898 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -48.73 -64.24 0.86 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.845 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.74 HG13 ' CE1' ' A' ' 171' ' ' PHE . 90.0 t -55.71 -50.41 67.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.099 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 168' ' ' ARG . . . . . 0.42 ' C ' ' O ' ' A' ' 167' ' ' VAL . 20.5 ttm-85 -36.88 -63.73 0.4 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.872 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' ARG . . . . . 0.403 ' O ' ' HG3' ' A' ' 172' ' ' GLU . 21.4 mtp85 -64.19 -51.48 63.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.907 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.684 ' O ' ' HB3' ' A' ' 173' ' ' ALA . 13.3 tp -43.72 -65.6 0.48 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.909 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.74 ' CE1' HG13 ' A' ' 167' ' ' VAL . 6.2 m-85 -55.83 -68.1 0.23 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.853 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.403 ' HG3' ' O ' ' A' ' 169' ' ' ARG . 0.9 OUTLIER -45.3 -21.82 0.1 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.878 -179.915 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.684 ' HB3' ' O ' ' A' ' 170' ' ' LEU . . . -49.21 -19.05 0.41 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.091 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -112.52 -73.93 0.65 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.875 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' GLY . . . . . 0.429 ' CA ' ' OE1' ' A' ' 203' ' ' GLU . . . -110.89 154.32 16.7 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.467 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -57.63 149.37 21.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.821 0.343 . . . . 0.0 110.895 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 46.1 mt -111.34 147.84 15.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.152 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.459 ' OE1' ' N ' ' A' ' 178' ' ' GLU . 0.5 OUTLIER -102.89 -40.57 6.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.934 179.94 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -160.44 149.41 17.06 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.901 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 25.2 t -136.47 140.48 43.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.895 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 30.5 m -149.74 142.61 24.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.183 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 33.6 mm -107.29 121.95 60.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.157 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.767 HD11 ' CE2' ' A' ' 195' ' ' PHE . 30.6 mt -72.36 140.11 48.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.887 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 46.7 mtt85 -141.81 147.32 37.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.882 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -83.0 -164.81 36.46 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.508 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -77.01 -40.9 0.42 Allowed 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.676 2.251 . . . . 0.0 112.313 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -57.24 -41.51 79.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.856 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 134.1 -44.25 1.2 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.755 -0.735 . . . . 0.0 112.46 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 64.2 m-20 -53.03 167.8 0.15 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.815 0.341 . . . . 0.0 110.918 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 18.1 p -82.78 142.93 31.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.87 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 3.1 mmmm -94.19 33.59 1.35 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.867 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.412 ' C ' ' HB2' ' A' ' 158' ' ' LEU . . . 44.24 32.54 2.61 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.484 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 75.8 m -141.6 151.24 42.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.828 0.347 . . . . 0.0 110.881 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -158.88 161.32 36.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.145 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 195' ' ' PHE . . . . . 0.767 ' CE2' HD11 ' A' ' 183' ' ' LEU . 47.9 m-85 -118.05 135.92 53.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.9 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 64.7 t -133.2 145.96 33.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.122 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 42.6 mtpt -122.44 142.83 50.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.937 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -117.8 175.22 5.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.867 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 51.1 p -80.1 -44.25 20.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.815 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 2.7 m -133.95 -177.62 4.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.799 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 20.7 t60 -80.19 -57.1 3.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.879 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -37.99 -56.79 1.11 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.129 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 203' ' ' GLU . . . . . 0.429 ' OE1' ' CA ' ' A' ' 175' ' ' GLY . 31.3 mm-40 -54.63 -43.24 72.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.853 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -56.46 -55.78 29.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.079 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 53.1 tp60 -50.88 -41.95 58.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.92 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -57.7 -51.9 67.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.109 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -63.28 -26.49 68.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.072 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 208' ' ' ILE . . . . . 0.495 ' O ' ' N ' ' A' ' 212' ' ' HIS . 50.4 mt -69.15 -73.27 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.103 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 209' ' ' ASN . . . . . 0.464 ' N ' HG22 ' A' ' 208' ' ' ILE . 34.2 t30 -48.89 -42.72 37.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.843 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 210' ' ' ALA . . . . . 0.468 ' O ' ' CB ' ' A' ' 214' ' ' SER . . . -54.27 -45.31 72.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.101 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.454 ' CB ' HD23 ' A' ' 224' ' ' LEU . 18.8 mt -100.51 -69.21 0.78 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.902 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 212' ' ' HIS . . . . . 0.645 ' HD1' ' HA ' ' A' ' 225' ' ' VAL . 27.2 t60 -53.95 124.24 14.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.878 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 213' ' ' GLY . . . . . 0.488 ' CA ' ' HB3' ' A' ' 223' ' ' SER . . . 81.24 -14.68 26.94 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.512 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 214' ' ' SER . . . . . 0.468 ' CB ' ' O ' ' A' ' 210' ' ' ALA . 1.9 m -85.94 -72.38 0.5 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.818 0.342 . . . . 0.0 110.838 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 59.7 mt-30 -99.13 169.54 9.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.898 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 216' ' ' THR . . . . . 0.624 HG23 ' O ' ' A' ' 222' ' ' SER . 3.0 m -118.78 97.61 5.8 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.148 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 13.2 mmt -38.74 138.81 0.76 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.556 0.693 . . . . 0.0 110.865 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -48.47 126.67 14.5 Favored 'Trans proline' 0 C--N 1.34 0.131 0 C-N-CA 122.685 2.256 . . . . 0.0 112.344 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 102.45 -53.42 0.78 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.503 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -70.65 150.08 46.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.781 0.324 . . . . 0.0 111.099 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 31.1 t -95.92 -18.19 20.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.826 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 222' ' ' SER . . . . . 0.624 ' O ' HG23 ' A' ' 216' ' ' THR . 3.5 m -99.91 151.22 21.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.874 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 223' ' ' SER . . . . . 0.488 ' HB3' ' CA ' ' A' ' 213' ' ' GLY . 17.4 m -59.58 145.36 44.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.844 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.512 ' HG ' HG23 ' A' ' 226' ' ' VAL . 48.2 tp -34.61 148.8 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.918 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 0.645 ' HA ' ' HD1' ' A' ' 212' ' ' HIS . 64.9 t -117.13 106.71 20.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.142 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 226' ' ' VAL . . . . . 0.645 HG22 HG13 ' A' ' 155' ' ' VAL . 24.6 t -133.39 106.29 9.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.142 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 9.0 ptmt -125.03 174.39 8.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.906 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -80.87 126.46 31.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.884 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 229' ' ' ALA . . . . . 0.409 ' C ' ' OD1' ' A' ' 230' ' ' ASP . . . -88.86 140.36 29.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.102 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 230' ' ' ASP . . . . . 0.409 ' OD1' ' C ' ' A' ' 229' ' ' ALA . 1.0 OUTLIER -144.15 143.83 31.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.867 179.999 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 77.1 m -89.9 120.11 30.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.144 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -62.74 143.51 57.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.894 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 2.9 tppp? -144.17 112.55 6.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.929 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -132.11 145.05 51.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.861 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 26.1 p -157.02 173.7 16.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.875 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 105.21 -173.44 20.55 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.461 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -77.01 -45.64 0.16 Allowed 'Trans proline' 0 C--O 1.231 0.135 0 C-N-CA 122.715 2.276 . . . . 0.0 112.387 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 1.8 t -141.35 171.31 14.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.862 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 30.7 m -57.3 112.91 1.53 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.847 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.297 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.464 -179.994 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.287 0 N-CA-C 112.481 -0.248 . . . . 0.0 112.481 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 42.7 t -153.9 114.65 4.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.889 0.376 . . . . 0.0 110.87 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 28.9 t -128.17 124.5 36.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.876 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -160.03 101.69 0.2 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.474 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 12.4 t -156.01 138.15 14.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.894 0.378 . . . . 0.0 110.842 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 7.6 t -132.47 165.55 24.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.839 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -156.99 73.84 0.23 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.495 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 51.5 m -97.21 167.49 11.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.814 0.34 . . . . 0.0 110.939 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 80.9 mt -94.97 -56.71 2.66 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.93 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 33.7 ptt-85 -48.42 132.17 16.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.875 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -116.1 91.96 33.77 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.591 0.71 . . . . 0.0 110.929 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -45.77 163.74 0.09 OUTLIER 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.659 2.24 . . . . 0.0 112.356 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -45.64 171.86 0.02 OUTLIER 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.655 2.237 . . . . 0.0 112.409 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 3.9 m -87.99 50.32 1.96 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.864 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 34.2 m80 -124.86 143.43 50.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.881 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 64.8 mtm-85 -124.05 44.17 2.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.878 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 3.6 ttmp? -129.85 149.51 51.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.922 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.612 HD12 ' CD1' ' A' ' 198' ' ' TYR . 64.6 mt -123.47 124.01 41.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.902 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.49 ' HB2' ' HB2' ' A' ' 229' ' ' ALA . 32.0 t80 -94.24 110.47 22.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.885 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.588 HG22 HG13 ' A' ' 226' ' ' VAL . 21.2 t -104.19 120.62 54.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.112 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -120.64 -174.41 15.12 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.451 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 19.5 mmt 61.7 30.82 18.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.811 0.339 . . . . 0.0 110.902 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.416 ' HB2' ' C ' ' A' ' 192' ' ' GLY . 25.0 mt -88.04 162.31 16.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.912 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -102.39 160.27 14.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.892 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 14.9 mtpp -84.98 36.66 0.63 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.937 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 4.5 tp-100 -123.09 -51.08 1.9 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.905 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 66.1 mt-30 -54.23 154.32 4.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.888 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 90.3 p -130.77 -177.97 4.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.881 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.493 ' O ' ' CB ' ' A' ' 168' ' ' ARG . 1.8 mp0 -55.31 -48.05 74.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.902 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -58.29 -55.17 38.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.866 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -45.64 -68.23 0.21 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.839 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.527 HG13 ' CE1' ' A' ' 171' ' ' PHE . 59.8 t -59.1 -55.51 23.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.155 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' ARG . . . . . 0.493 ' CB ' ' O ' ' A' ' 164' ' ' GLU . 70.9 ttt180 -34.3 -53.32 0.5 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.923 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 20.1 mmt85 -65.0 -54.3 32.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.931 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.761 ' O ' ' HB3' ' A' ' 173' ' ' ALA . 13.0 tp -44.21 -64.42 0.68 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.962 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.789 ' CB ' HD11 ' A' ' 177' ' ' ILE . 6.8 m-85 -51.89 -67.53 0.24 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.904 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -48.41 -23.12 0.84 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.857 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.761 ' HB3' ' O ' ' A' ' 170' ' ' LEU . . . -51.95 -27.18 12.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.09 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -111.99 -62.84 1.5 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.846 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -118.76 137.17 12.62 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.48 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 48.8 m-80 -51.77 151.16 3.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.788 0.328 . . . . 0.0 110.897 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.789 HD11 ' CB ' ' A' ' 171' ' ' PHE . 97.6 mt -117.46 109.35 27.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.121 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -61.18 -36.99 81.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.883 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -159.44 137.22 10.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.898 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 5.7 t -124.32 143.42 50.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.888 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 55.7 m -154.37 137.04 15.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.161 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 10.6 mm -106.28 133.44 50.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.103 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.801 HD11 ' CE2' ' A' ' 195' ' ' PHE . 84.8 mt -83.08 123.76 29.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.909 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 68.8 mtm180 -130.93 152.55 50.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.873 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -106.27 179.59 23.01 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.489 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -45.46 -47.87 12.54 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.637 2.224 . . . . 0.0 112.346 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -43.35 -39.59 3.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.846 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 118.57 -36.83 3.44 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.465 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 22.8 m120 -75.21 177.18 6.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.857 0.361 . . . . 0.0 110.888 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 42.3 t -82.99 136.25 34.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.851 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 25.2 mtmm -84.43 32.49 0.51 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.925 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.416 ' C ' ' HB2' ' A' ' 158' ' ' LEU . . . 58.12 39.21 91.86 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.506 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 7.2 p -157.85 149.39 21.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.83 0.348 . . . . 0.0 110.862 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -160.13 156.5 26.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.156 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 195' ' ' PHE . . . . . 0.801 ' CE2' HD11 ' A' ' 183' ' ' LEU . 42.3 m-85 -114.12 126.96 55.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.866 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.533 HG21 ' CE2' ' A' ' 171' ' ' PHE . 98.8 t -117.23 139.36 44.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.072 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 31.4 tttt -116.37 118.38 32.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.86 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 198' ' ' TYR . . . . . 0.612 ' CD1' HD12 ' A' ' 153' ' ' LEU . 20.3 m-85 -95.58 172.28 8.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.918 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 8.3 t -79.2 -39.46 33.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.834 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 33.6 p -149.19 160.25 43.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.893 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 201' ' ' HIS . . . . . 0.448 ' O ' ' C ' ' A' ' 202' ' ' ALA . 13.3 t-80 -53.46 -58.93 5.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.873 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 202' ' ' ALA . . . . . 0.448 ' C ' ' O ' ' A' ' 201' ' ' HIS . . . -34.33 -62.93 0.31 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.085 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -54.21 -42.61 69.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.857 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 204' ' ' ALA . . . . . 0.4 ' N ' ' O ' ' A' ' 201' ' ' HIS . . . -58.53 -64.1 1.05 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.068 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 205' ' ' GLN . . . . . 0.54 ' HA ' HD12 ' A' ' 208' ' ' ILE . 37.1 tp60 -43.15 -42.03 3.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.956 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -57.3 -57.47 12.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.065 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 207' ' ' ALA . . . . . 0.429 ' CB ' ' OH ' ' A' ' 198' ' ' TYR . . . -55.24 -33.56 63.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.088 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 208' ' ' ILE . . . . . 0.54 HD12 ' HA ' ' A' ' 205' ' ' GLN . 87.8 mt -62.72 -75.0 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.138 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -48.71 -42.09 33.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.892 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -56.32 -36.88 69.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.118 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.487 ' HB3' ' CD2' ' A' ' 224' ' ' LEU . 50.7 mt -109.44 -72.6 0.72 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.898 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 212' ' ' HIS . . . . . 0.479 ' N ' ' O ' ' A' ' 208' ' ' ILE . 9.4 t60 -46.73 128.62 10.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.865 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 82.04 -22.91 5.56 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.514 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 7.9 t -91.45 -70.74 0.67 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.819 0.342 . . . . 0.0 110.818 -179.699 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 9.5 mm-40 -86.54 161.55 18.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.86 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 216' ' ' THR . . . . . 0.549 HG23 ' O ' ' A' ' 222' ' ' SER . 39.1 m -129.01 108.65 10.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.157 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 217' ' ' MET . . . . . 0.402 ' C ' ' O ' ' A' ' 216' ' ' THR . 24.1 mmt -37.4 156.88 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.534 0.683 . . . . 0.0 110.884 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.16 113.29 3.55 Favored 'Trans proline' 0 C--N 1.341 0.133 0 C-N-CA 122.683 2.255 . . . . 0.0 112.307 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 113.94 -45.09 1.37 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.493 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -70.92 142.03 51.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.788 0.328 . . . . 0.0 111.103 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 68.3 m -91.53 -14.81 29.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.879 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 222' ' ' SER . . . . . 0.549 ' O ' HG23 ' A' ' 216' ' ' THR . 2.7 m -100.17 143.1 30.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.835 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 2.4 p -51.3 159.83 0.63 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.879 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.649 HD12 ' H ' ' A' ' 225' ' ' VAL . 41.6 tp -54.04 154.7 4.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.887 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 0.649 ' H ' HD12 ' A' ' 224' ' ' LEU . 60.7 t -127.15 108.09 18.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.123 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 226' ' ' VAL . . . . . 0.588 HG13 HG22 ' A' ' 155' ' ' VAL . 24.2 t -133.91 101.46 3.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.169 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 10.7 ptmt -131.75 143.21 50.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.925 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -43.49 150.19 0.23 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.889 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 229' ' ' ALA . . . . . 0.49 ' HB2' ' HB2' ' A' ' 154' ' ' PHE . . . -112.04 150.94 29.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.11 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -113.17 86.9 2.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.853 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 231' ' ' THR . . . . . 0.551 HG23 ' O ' ' A' ' 231' ' ' THR . 14.3 t -51.74 119.58 4.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.156 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -123.69 164.68 18.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.84 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 4.5 ptmm? -149.6 166.4 29.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.86 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -120.87 126.88 51.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.892 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 42.7 t -74.87 155.08 37.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.8 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -107.92 144.46 16.13 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.468 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -47.07 -46.15 19.73 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.682 2.255 . . . . 0.0 112.352 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 12.1 m -148.55 151.14 34.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.838 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 24.4 t -85.34 119.28 25.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.884 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.293 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.496 -179.956 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.383 0 N-CA-C 112.471 -0.252 . . . . 0.0 112.471 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 24.9 t -151.99 147.61 26.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.876 0.369 . . . . 0.0 110.866 -179.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 56.3 p -161.99 175.19 12.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.847 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 165.41 134.05 1.6 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.501 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 28.3 t -121.27 138.37 54.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.891 0.377 . . . . 0.0 110.824 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 88.0 p -123.12 43.97 2.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.883 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' GLY . . . . . 0.401 ' O ' ' C ' ' A' ' 143' ' ' CYS . . . 138.05 73.92 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.498 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' CYS . . . . . 0.401 ' C ' ' O ' ' A' ' 142' ' ' GLY . 41.7 t -37.86 -43.35 0.68 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.86 0.362 . . . . 0.0 110.912 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.55 ' H ' HD23 ' A' ' 144' ' ' LEU . 2.4 pt? -134.84 153.74 51.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.918 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 5.1 tpp85 -145.9 144.61 30.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.838 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.58 92.91 47.19 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.579 0.704 . . . . 0.0 110.906 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -76.08 163.72 32.51 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.639 2.226 . . . . 0.0 112.318 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -76.18 176.87 9.49 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.64 2.227 . . . . 0.0 112.365 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 93.4 p -65.42 -45.14 85.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.866 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 5.8 m80 -57.22 123.1 14.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.904 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.47 ' CZ ' ' HB2' ' A' ' 151' ' ' ARG . 22.2 ttm105 -125.0 85.51 2.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.861 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 6.5 ttpm? -139.85 162.65 34.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.887 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.417 HD12 ' CD1' ' A' ' 198' ' ' TYR . 58.1 mt -129.29 127.09 40.45 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.934 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.407 ' HB2' ' HB2' ' A' ' 229' ' ' ALA . 18.8 t80 -101.04 113.14 25.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.844 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.479 HG22 HG13 ' A' ' 226' ' ' VAL . 48.1 t -104.07 124.01 58.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.094 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -124.45 -169.61 13.08 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.465 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 93.4 mmm 50.07 39.36 18.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.794 0.331 . . . . 0.0 110.919 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.417 ' HB2' ' C ' ' A' ' 192' ' ' GLY . 66.9 mt -94.04 162.36 13.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.906 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -100.3 158.08 16.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.883 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 52.4 mttp -83.5 39.47 0.67 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.922 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -124.9 -47.83 1.78 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.934 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 64.2 mt-30 -57.89 151.68 17.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.881 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 3.4 m -129.29 176.35 8.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.86 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -52.95 -44.13 66.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.883 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -59.38 -51.59 69.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.868 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -52.74 -61.74 2.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.892 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.623 HG13 ' CD1' ' A' ' 171' ' ' PHE . 25.4 t -58.64 -56.8 14.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.158 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 168' ' ' ARG . . . . . 0.415 ' C ' ' O ' ' A' ' 167' ' ' VAL . 15.5 ttt180 -36.3 -62.34 0.45 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.866 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 19.4 mmt85 -61.05 -54.11 48.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.915 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.729 ' O ' ' HB3' ' A' ' 173' ' ' ALA . 12.5 tp -43.14 -65.68 0.46 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.899 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.623 ' CD1' HG13 ' A' ' 167' ' ' VAL . 8.5 m-85 -52.22 -70.86 0.08 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.888 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.408 ' C ' ' N ' ' A' ' 174' ' ' PHE . 5.3 pt-20 -43.3 -28.79 0.35 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.864 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.729 ' HB3' ' O ' ' A' ' 170' ' ' LEU . . . -44.49 -22.09 0.07 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.076 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 174' ' ' PHE . . . . . 0.408 ' N ' ' C ' ' A' ' 172' ' ' GLU . 97.7 m-85 -109.79 -74.91 0.64 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.878 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -108.08 148.12 16.62 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.495 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -52.35 145.77 10.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.791 0.329 . . . . 0.0 110.888 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 18.6 mt -108.96 136.1 45.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.137 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -93.49 -36.81 12.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.884 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' GLU . . . . . 0.425 ' HG3' ' N ' ' A' ' 180' ' ' CYS . 3.4 tp10 -163.73 144.55 8.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.919 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 180' ' ' CYS . . . . . 0.425 ' N ' ' HG3' ' A' ' 179' ' ' GLU . 35.7 t -135.12 142.99 46.33 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.902 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 91.1 m -155.19 143.2 20.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.102 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 9.0 mm -105.35 138.5 30.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.131 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.562 HD11 ' CE2' ' A' ' 195' ' ' PHE . 44.7 mt -86.24 136.06 33.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.896 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 67.0 mtt180 -146.7 115.82 6.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.886 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -51.19 163.91 1.05 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.513 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -45.52 -51.98 7.32 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.703 2.268 . . . . 0.0 112.343 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -43.87 -50.58 7.93 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.828 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 141.88 -45.36 0.94 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.507 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -57.1 145.84 29.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.795 0.331 . . . . 0.0 110.878 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 36.2 t -68.7 151.2 47.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.894 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 25.3 mttp -105.23 36.7 2.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.887 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.417 ' C ' ' HB2' ' A' ' 158' ' ' LEU . . . 46.02 44.53 14.02 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.539 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 3.5 p -155.32 155.07 33.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.838 0.352 . . . . 0.0 110.897 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -161.38 166.02 28.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.057 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 195' ' ' PHE . . . . . 0.562 ' CE2' HD11 ' A' ' 183' ' ' LEU . 39.4 m-85 -120.58 132.9 55.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.856 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.455 HG21 ' CE2' ' A' ' 171' ' ' PHE . 21.8 t -125.77 145.95 32.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.122 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 11.3 ttmm -123.29 141.53 51.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.935 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 198' ' ' TYR . . . . . 0.417 ' CD1' HD12 ' A' ' 153' ' ' LEU . 24.6 m-85 -118.59 174.94 5.97 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.886 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 10.5 t -81.66 -49.17 10.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.853 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 23.7 t -126.31 166.87 16.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.87 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 62.9 t-80 -66.51 -49.81 65.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.868 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -45.27 -59.07 2.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.101 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -47.8 -49.38 29.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.895 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -51.26 -61.62 2.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.064 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 205' ' ' GLN . . . . . 0.775 ' HA ' HD12 ' A' ' 208' ' ' ILE . 44.9 tp60 -46.35 -43.65 16.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.918 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -55.8 -62.31 1.78 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.137 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -50.89 -35.03 30.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.083 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 208' ' ' ILE . . . . . 0.775 HD12 ' HA ' ' A' ' 205' ' ' GLN . 77.7 mt -61.44 -73.37 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.124 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -47.39 -42.98 23.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.915 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -57.72 -40.56 79.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.11 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.422 ' O ' ' CB ' ' A' ' 214' ' ' SER . 61.1 mt -102.25 -72.05 0.7 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.972 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 212' ' ' HIS . . . . . 0.495 ' N ' ' O ' ' A' ' 208' ' ' ILE . 20.0 t60 -47.41 136.25 9.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.827 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 67.61 1.01 14.28 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.503 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 214' ' ' SER . . . . . 0.422 ' CB ' ' O ' ' A' ' 211' ' ' LEU . 1.0 OUTLIER -95.28 -71.09 0.68 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.912 0.386 . . . . 0.0 110.833 -179.683 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -99.96 -178.17 3.77 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.925 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 216' ' ' THR . . . . . 0.547 HG23 ' O ' ' A' ' 222' ' ' SER . 51.6 m -134.49 102.45 5.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.139 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 28.3 mmt -40.99 135.61 1.65 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.562 0.696 . . . . 0.0 110.847 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -48.62 119.18 3.94 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.686 2.258 . . . . 0.0 112.349 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 111.16 -46.19 1.21 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.467 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -76.45 148.79 37.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.802 0.334 . . . . 0.0 111.084 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 10.5 t -93.55 -18.9 21.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.916 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 222' ' ' SER . . . . . 0.547 ' O ' HG23 ' A' ' 216' ' ' THR . 1.1 t -100.05 147.62 25.43 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.859 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 58.4 m -59.43 156.51 12.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.855 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.442 ' HG ' HG23 ' A' ' 226' ' ' VAL . 38.9 tp -43.24 149.43 0.23 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.907 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 0.477 ' HA ' ' HD1' ' A' ' 212' ' ' HIS . 60.4 t -121.42 113.52 39.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.134 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 226' ' ' VAL . . . . . 0.479 HG13 HG22 ' A' ' 155' ' ' VAL . 22.5 t -138.08 105.33 3.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.149 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 9.4 pttp -130.74 148.56 52.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.942 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -57.93 123.65 16.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.859 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 229' ' ' ALA . . . . . 0.407 ' HB2' ' HB2' ' A' ' 154' ' ' PHE . . . -73.64 117.11 15.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.098 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -132.97 142.28 48.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.844 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 84.8 m -127.06 87.07 2.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.173 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -126.24 111.37 14.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.886 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 15.1 ptmt -77.72 127.83 33.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.896 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -136.65 141.01 43.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.844 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 34.1 t -80.48 -62.11 1.77 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.822 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -68.77 146.2 44.73 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.496 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 237' ' ' PRO . . . . . 0.445 ' O ' ' C ' ' A' ' 238' ' ' SER . 62.2 Cg_endo -77.03 -3.02 13.29 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.668 2.246 . . . . 0.0 112.366 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 238' ' ' SER . . . . . 0.445 ' C ' ' O ' ' A' ' 237' ' ' PRO . 96.9 p 34.86 42.13 0.07 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.88 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 29.2 t -108.66 103.51 12.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.865 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.307 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.53 179.991 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.365 0 N-CA-C 112.462 -0.255 . . . . 0.0 112.462 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.3 m -111.96 133.04 54.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.896 0.379 . . . . 0.0 110.89 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 69.5 p -121.03 166.7 13.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.878 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 60.07 82.18 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.476 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 85.4 p -130.98 145.17 51.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.87 0.367 . . . . 0.0 110.878 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 50.9 m -111.4 127.33 55.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.891 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -144.43 92.23 0.16 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.487 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 51.1 t -77.68 79.88 4.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.795 0.331 . . . . 0.0 110.874 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.7 mp -127.86 125.5 39.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.92 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 29.5 mmt85 -59.07 -58.3 9.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.895 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' GLN . . . . . 0.444 ' CD ' ' HD2' ' A' ' 147' ' ' PRO . 31.1 tp60 -154.26 138.52 11.2 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.618 0.723 . . . . 0.0 110.913 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.444 ' HD2' ' CD ' ' A' ' 146' ' ' GLN . 72.4 Cg_exo -46.77 145.48 6.67 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.713 2.275 . . . . 0.0 112.334 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 147' ' ' PRO . 72.4 Cg_exo -46.94 141.84 11.59 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.701 2.267 . . . . 0.0 112.319 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 28.7 t -82.77 98.93 9.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.842 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 31.6 m80 -125.12 152.09 44.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.834 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 10.7 mmm-85 -103.77 -41.05 6.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.82 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 25.4 tttp -83.42 124.67 30.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.927 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.631 HD11 ' HB1' ' A' ' 204' ' ' ALA . 62.3 mt -105.29 132.68 51.18 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.914 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -92.24 135.06 34.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.887 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 23.0 t -124.27 114.85 42.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.098 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -116.59 -176.14 17.83 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.48 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 91.4 mmm 58.62 41.83 21.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.814 0.34 . . . . 0.0 110.873 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.645 HD23 ' HG3' ' A' ' 217' ' ' MET . 46.5 mt -103.57 178.34 4.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.915 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -124.44 172.07 9.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.93 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 37.3 mttt -95.91 51.35 1.24 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.902 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -127.22 -52.19 1.4 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.883 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -64.56 164.32 11.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.872 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 31.8 p -133.55 177.77 7.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.877 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -52.16 -35.65 49.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.916 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -64.22 -57.43 9.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.836 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -47.04 -54.55 10.02 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.851 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.816 HG13 ' CE1' ' A' ' 171' ' ' PHE . 61.3 t -65.23 -40.56 89.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.174 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 4.3 mmm180 -48.0 -67.11 0.3 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.896 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 13.1 mmm-85 -60.78 -52.84 63.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.875 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.67 ' O ' ' HB3' ' A' ' 173' ' ' ALA . 12.6 tp -41.96 -66.27 0.37 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.892 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.816 ' CE1' HG13 ' A' ' 167' ' ' VAL . 9.3 m-85 -55.92 -71.24 0.09 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.903 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.498 ' CD ' ' C ' ' A' ' 172' ' ' GLU . 0.5 OUTLIER -41.48 -24.91 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.873 -179.934 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.67 ' HB3' ' O ' ' A' ' 170' ' ' LEU . . . -45.58 -21.16 0.09 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.117 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -117.46 -66.45 1.08 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.875 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -114.63 134.24 11.56 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.471 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 40.2 m-20 -45.31 153.94 0.2 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.789 0.328 . . . . 0.0 110.899 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 38.1 mt -112.66 128.04 69.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.135 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -83.0 -37.98 23.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.859 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -164.67 129.6 2.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.948 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 51.4 t -113.8 142.76 45.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.912 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 40.7 m -155.0 144.95 21.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.165 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 31.5 mm -109.06 146.75 14.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.193 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.742 HD11 ' CE2' ' A' ' 195' ' ' PHE . 31.4 mt -94.1 120.73 34.77 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.943 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 72.2 mtt180 -133.16 110.32 10.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.814 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -68.86 -149.27 0.25 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.501 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -45.54 156.61 0.36 Allowed 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.739 2.293 . . . . 0.0 112.326 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' ASP . . . . . 0.442 ' O ' ' C ' ' A' ' 188' ' ' GLY . 73.6 m-20 42.13 41.1 1.91 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.855 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.442 ' C ' ' O ' ' A' ' 187' ' ' ASP . . . 34.71 58.81 0.72 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.546 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -116.24 111.41 20.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.873 0.368 . . . . 0.0 110.865 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 4.9 t -42.59 131.73 3.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.856 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 64.0 mttt -104.29 32.08 4.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.896 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 58.48 39.75 93.45 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.477 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' CYS . . . . . 0.474 ' HB3' HD12 ' A' ' 183' ' ' LEU . 85.6 m -151.42 153.41 34.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.844 0.354 . . . . 0.0 110.852 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -162.44 167.05 24.19 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.132 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 195' ' ' PHE . . . . . 0.742 ' CE2' HD11 ' A' ' 183' ' ' LEU . 76.8 m-85 -125.53 133.72 52.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.854 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.411 HG21 ' CE2' ' A' ' 171' ' ' PHE . 29.1 t -127.92 118.84 49.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.122 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 22.5 ttmt -95.3 141.84 28.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.911 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 198' ' ' TYR . . . . . 0.439 ' OH ' ' CB ' ' A' ' 207' ' ' ALA . 10.3 m-85 -115.28 173.71 6.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.871 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 20.7 p -78.47 -46.24 20.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.817 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 3.0 t -137.32 156.32 48.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.869 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 201' ' ' HIS . . . . . 0.419 ' O ' ' C ' ' A' ' 202' ' ' ALA . 3.5 t-160 -52.29 -59.99 3.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.923 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 202' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 201' ' ' HIS . . . -35.89 -64.32 0.32 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.077 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -48.94 -47.29 43.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.845 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 204' ' ' ALA . . . . . 0.631 ' HB1' HD11 ' A' ' 153' ' ' LEU . . . -54.94 -54.12 46.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.087 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 43.3 tp60 -49.72 -47.24 50.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.912 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 206' ' ' ALA . . . . . 0.436 ' O ' ' CB ' ' A' ' 210' ' ' ALA . . . -55.08 -48.73 73.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.14 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 207' ' ' ALA . . . . . 0.439 ' CB ' ' OH ' ' A' ' 198' ' ' TYR . . . -59.35 -41.31 88.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.082 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 208' ' ' ILE . . . . . 0.542 HD11 ' CD2' ' A' ' 153' ' ' LEU . 63.7 mt -58.66 -72.28 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.127 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 16.5 t30 -53.21 -40.08 64.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.914 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 210' ' ' ALA . . . . . 0.436 ' CB ' ' O ' ' A' ' 206' ' ' ALA . . . -57.78 -41.16 81.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.079 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 19.8 mt -101.47 -69.32 0.78 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.913 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 212' ' ' HIS . . . . . 0.488 ' N ' ' O ' ' A' ' 208' ' ' ILE . 14.4 t60 -48.28 133.26 15.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.877 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 73.92 -1.14 48.66 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.481 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 8.5 t -95.93 -70.99 0.69 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.794 0.331 . . . . 0.0 110.842 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -99.86 -175.78 3.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.898 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 216' ' ' THR . . . . . 0.653 HG23 ' O ' ' A' ' 222' ' ' SER . 35.1 m -137.13 109.3 7.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.146 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 217' ' ' MET . . . . . 0.645 ' HG3' HD23 ' A' ' 158' ' ' LEU . 23.8 mmt -38.17 158.18 0.09 OUTLIER Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.588 0.709 . . . . 0.0 110.872 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -71.62 107.15 2.11 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.644 2.23 . . . . 0.0 112.324 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 119.31 -48.04 0.98 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.476 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -68.46 148.23 50.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.765 0.317 . . . . 0.0 111.112 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 77.9 p -92.57 -18.17 23.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.882 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 222' ' ' SER . . . . . 0.653 ' O ' HG23 ' A' ' 216' ' ' THR . 2.4 m -100.04 149.66 23.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.862 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 66.3 m -59.88 157.23 12.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.861 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.45 ' HG ' ' N ' ' A' ' 225' ' ' VAL . 16.0 tp -47.8 154.39 0.51 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.894 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 0.45 ' N ' ' HG ' ' A' ' 224' ' ' LEU . 34.6 t -125.32 110.62 24.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.102 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 226' ' ' VAL . . . . . 0.436 ' O ' HG23 ' A' ' 208' ' ' ILE . 19.6 t -132.9 101.95 4.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.1 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 23.8 pttt -129.06 152.27 48.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.92 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 228' ' ' PHE . . . . . 0.453 ' HA ' HD23 ' A' ' 153' ' ' LEU . 52.2 m-85 -53.9 148.47 10.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.89 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -98.74 147.58 24.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.116 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -84.87 171.58 12.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.856 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 52.2 m -136.66 128.21 28.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.117 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -131.69 132.74 44.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.889 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -112.55 159.06 19.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.877 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -70.64 147.37 49.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.867 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 50.0 p -168.54 119.49 0.77 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.822 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -146.81 78.97 0.23 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.46 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -77.09 -41.28 0.38 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.701 2.267 . . . . 0.0 112.315 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 8.3 t 68.24 42.03 1.79 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.841 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 71.9 m -55.7 132.56 49.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.902 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.35 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.501 -179.954 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.313 0 N-CA-C 112.504 -0.238 . . . . 0.0 112.504 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 38.1 p -136.14 160.92 37.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.925 0.393 . . . . 0.0 110.801 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 12.9 t -97.8 -53.9 3.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.874 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 89.09 145.29 11.54 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.472 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 35.3 p -72.84 168.23 19.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.865 0.364 . . . . 0.0 110.822 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 2.4 t -162.47 138.81 7.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.825 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 107.14 62.14 0.58 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.506 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 2.4 t -136.17 152.58 50.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.866 0.365 . . . . 0.0 110.848 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.698 ' H ' HD23 ' A' ' 144' ' ' LEU . 1.7 pt? -83.41 38.42 0.61 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.932 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 73.6 mtt-85 -81.59 112.81 19.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.902 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -127.33 79.6 72.98 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.612 0.72 . . . . 0.0 110.925 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -45.67 156.81 0.37 Allowed 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.749 2.299 . . . . 0.0 112.309 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -77.04 -174.73 2.31 Favored 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.704 2.27 . . . . 0.0 112.391 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 52.1 p -66.28 -58.86 4.43 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.9 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 17.2 p-80 -67.68 102.36 1.18 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.896 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.47 ' CZ ' ' HB2' ' A' ' 151' ' ' ARG . 19.6 ttm105 -107.85 89.37 2.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.863 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.562 ' HD3' ' CD1' ' A' ' 195' ' ' PHE . 13.3 ttmt -104.16 144.01 32.15 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.899 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.504 HD23 ' HA ' ' A' ' 228' ' ' PHE . 56.6 mt -117.84 123.6 46.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.956 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.641 ' HB2' ' HB2' ' A' ' 229' ' ' ALA . 56.3 t80 -91.13 121.81 33.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.859 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.444 ' CG1' HD11 ' A' ' 158' ' ' LEU . 58.9 t -109.1 128.79 64.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.151 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -124.6 -160.35 10.72 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.534 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.406 ' SD ' HG23 ' A' ' 225' ' ' VAL . 33.3 mtt 38.69 43.95 0.75 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.821 0.343 . . . . 0.0 110.867 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.451 HD23 ' HG3' ' A' ' 217' ' ' MET . 67.9 mt -99.88 175.55 5.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.885 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.496 ' N ' ' OD1' ' A' ' 159' ' ' ASN . 0.5 OUTLIER -115.35 154.9 28.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.894 179.904 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.74 20.64 1.41 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.922 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -107.83 -34.62 6.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.941 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.49 ' HG3' ' ND2' ' A' ' 159' ' ' ASN . 25.8 mt-30 -59.12 158.42 8.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.917 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 85.2 p -132.53 163.96 27.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.86 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -47.8 -50.97 24.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.872 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -53.23 -47.78 68.72 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.839 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -53.93 -69.1 0.13 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.864 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.802 HG13 ' CE1' ' A' ' 171' ' ' PHE . 86.0 t -52.92 -54.39 16.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.164 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 168' ' ' ARG . . . . . 0.489 ' C ' ' CD ' ' A' ' 168' ' ' ARG . 0.0 OUTLIER -39.53 -63.18 0.59 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.891 -179.959 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 169' ' ' ARG . . . . . 0.406 ' CB ' HH11 ' A' ' 169' ' ' ARG . 4.0 mtp-105 -60.85 -53.91 51.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.882 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.714 ' O ' ' HB3' ' A' ' 173' ' ' ALA . 11.9 tp -43.23 -65.93 0.43 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.901 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.802 ' CE1' HG13 ' A' ' 167' ' ' VAL . 11.6 m-85 -52.2 -70.93 0.07 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.914 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.416 ' O ' ' N ' ' A' ' 174' ' ' PHE . 5.9 pt-20 -43.09 -29.36 0.35 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.947 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.714 ' HB3' ' O ' ' A' ' 170' ' ' LEU . . . -43.29 -23.05 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.082 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 174' ' ' PHE . . . . . 0.416 ' N ' ' O ' ' A' ' 172' ' ' GLU . 92.7 m-85 -114.56 -70.24 0.81 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.879 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -111.28 137.57 14.39 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.521 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -44.23 164.79 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.762 0.315 . . . . 0.0 110.896 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.519 HD11 ' CB ' ' A' ' 171' ' ' PHE . 51.1 mt -133.42 134.0 57.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.104 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -89.38 -41.31 12.19 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.918 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -150.75 151.2 32.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.831 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 49.4 t -146.0 138.2 25.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.854 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 26.2 m -154.89 151.2 28.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.155 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 48.6 mm -109.21 140.8 26.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.141 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.471 HD11 ' CE2' ' A' ' 195' ' ' PHE . 34.6 mt -89.24 108.45 19.62 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.919 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 47.4 mtt180 -133.09 112.2 11.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.873 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -72.64 -151.48 1.44 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.498 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -45.66 157.05 0.35 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.683 2.255 . . . . 0.0 112.34 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 6.7 t70 43.12 40.7 2.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.879 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 39.53 42.22 1.87 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.54 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -92.83 104.66 16.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.87 0.367 . . . . 0.0 110.906 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 8.3 t -50.83 139.26 17.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.842 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 38.3 mttm -105.04 34.25 3.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.908 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.431 ' C ' ' HB2' ' A' ' 158' ' ' LEU . . . 49.92 39.47 32.9 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.521 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 80.8 m -151.03 157.61 43.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.772 0.32 . . . . 0.0 110.89 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -160.84 166.64 28.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.123 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 195' ' ' PHE . . . . . 0.562 ' CD1' ' HD3' ' A' ' 152' ' ' LYS . 40.0 m-85 -124.5 130.5 52.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.879 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 11.8 t -128.46 148.73 32.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.141 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.424 ' O ' HG23 ' A' ' 177' ' ' ILE . 6.3 ttmm -126.93 138.39 53.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.92 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 198' ' ' TYR . . . . . 0.429 ' CD1' HD12 ' A' ' 153' ' ' LEU . 20.8 m-85 -114.68 175.44 5.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.915 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 41.2 t -81.6 -48.05 12.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.858 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 1.9 t -134.59 172.48 12.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.874 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 201' ' ' HIS . . . . . 0.404 ' O ' ' C ' ' A' ' 202' ' ' ALA . 18.2 t-160 -67.4 -55.96 11.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.85 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 202' ' ' ALA . . . . . 0.404 ' C ' ' O ' ' A' ' 201' ' ' HIS . . . -37.98 -64.51 0.4 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.098 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -49.37 -48.21 47.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.869 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -54.76 -58.37 7.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.137 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 205' ' ' GLN . . . . . 0.862 ' HA ' HD12 ' A' ' 208' ' ' ILE . 4.4 tp-100 -43.63 -50.57 7.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.897 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -52.8 -54.79 29.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.085 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -56.27 -32.66 64.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.138 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 208' ' ' ILE . . . . . 0.862 HD12 ' HA ' ' A' ' 205' ' ' GLN . 59.7 mt -65.07 -75.13 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.071 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -49.32 -42.61 42.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.861 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -54.97 -43.24 73.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.106 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 58.6 mt -102.23 -70.19 0.76 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.943 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 212' ' ' HIS . . . . . 0.492 ' N ' ' O ' ' A' ' 208' ' ' ILE . 5.4 t60 -50.74 129.88 23.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.866 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 75.61 -9.25 16.37 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.476 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 7.9 t -99.95 -70.23 0.74 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.877 0.37 . . . . 0.0 110.874 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 215' ' ' GLN . . . . . 0.432 ' HG3' ' N ' ' A' ' 216' ' ' THR . 1.7 tt0 -90.65 154.87 19.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.923 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 216' ' ' THR . . . . . 0.601 HG23 ' O ' ' A' ' 222' ' ' SER . 30.5 m -118.17 101.62 8.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.156 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 217' ' ' MET . . . . . 0.451 ' HG3' HD23 ' A' ' 158' ' ' LEU . 19.4 mmt -39.13 134.84 1.09 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.626 0.727 . . . . 0.0 110.887 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -48.99 131.57 25.78 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.723 2.282 . . . . 0.0 112.356 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 99.29 -41.93 2.1 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.734 -0.745 . . . . 0.0 112.502 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -82.15 144.57 30.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.796 0.331 . . . . 0.0 111.129 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 8.3 m -93.4 -15.45 25.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.864 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 222' ' ' SER . . . . . 0.601 ' O ' HG23 ' A' ' 216' ' ' THR . 57.9 m -99.98 142.43 31.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.897 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 58.8 m -54.91 156.21 3.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.873 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.446 ' HG ' ' N ' ' A' ' 225' ' ' VAL . 46.5 tp -52.37 159.63 0.96 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.954 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 0.446 ' N ' ' HG ' ' A' ' 224' ' ' LEU . 99.2 t -130.5 113.11 24.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.114 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 40.2 t -138.83 113.52 8.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.113 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 11.4 pttm -130.98 167.31 19.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.909 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 228' ' ' PHE . . . . . 0.504 ' HA ' HD23 ' A' ' 153' ' ' LEU . 62.5 m-85 -71.29 107.95 4.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.896 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 229' ' ' ALA . . . . . 0.641 ' HB2' ' HB2' ' A' ' 154' ' ' PHE . . . -75.43 102.26 5.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.07 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -117.72 130.17 56.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.886 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 48.9 m -89.62 98.43 11.77 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.149 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -123.25 82.69 2.03 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.861 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 42.8 pttt -160.84 140.24 10.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.882 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -109.81 142.98 40.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.908 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 31.6 p -156.45 107.45 2.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.822 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -166.34 85.75 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.446 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -45.56 -50.09 9.78 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.68 2.253 . . . . 0.0 112.339 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 2.1 t -162.78 115.87 1.65 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.855 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 23.2 t -99.57 127.06 45.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.887 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.46 -179.999 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.353 0 N-CA-C 112.501 -0.239 . . . . 0.0 112.501 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 49.2 m -143.88 130.22 19.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.835 0.35 . . . . 0.0 110.925 -179.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 32.2 t -129.91 129.91 44.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.888 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 75.15 140.08 0.72 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.532 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 54.1 p -119.82 172.72 7.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.869 0.366 . . . . 0.0 110.886 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 4.7 m -124.38 108.93 12.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.915 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -121.14 136.29 11.16 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.498 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 39.4 m -122.08 -34.09 3.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.859 0.361 . . . . 0.0 110.881 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -78.7 155.15 29.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.933 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 15.8 mtp85 -98.62 -53.67 3.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.852 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -138.5 138.58 22.55 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.56 0.695 . . . . 0.0 110.969 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.54 ' HG2' ' CE1' ' A' ' 201' ' ' HIS . 63.1 Cg_endo -78.23 147.08 22.97 Favored 'Trans proline' 0 C--O 1.231 0.146 0 C-N-CA 122.69 2.26 . . . . 0.0 112.329 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -46.91 178.51 0.01 OUTLIER 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.691 2.261 . . . . 0.0 112.32 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 28.2 t -129.0 112.91 14.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.857 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 64.4 m80 -148.05 171.98 14.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.853 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 2.3 tpp85 -119.1 -33.65 4.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.873 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 3.2 ttmp? -91.33 152.36 20.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.893 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.476 HD23 ' HA ' ' A' ' 228' ' ' PHE . 38.7 mt -134.06 128.25 33.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.909 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -94.13 121.74 35.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.873 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.702 HG22 HG13 ' A' ' 226' ' ' VAL . 88.5 t -113.9 136.42 50.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.186 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -136.69 -159.93 8.52 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.515 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 14.7 mmt 46.8 28.56 0.84 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.84 0.352 . . . . 0.0 110.925 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 36.9 mt -85.35 167.46 15.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.912 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -105.26 158.43 16.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.897 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 60.4 mttt -85.59 37.2 0.68 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.894 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -116.9 -55.71 2.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.881 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -67.34 149.34 50.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.901 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 51.6 p -124.79 175.48 7.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.806 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 10.4 tm-20 -43.51 -30.45 0.57 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.9 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -67.67 -60.02 2.87 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.838 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -54.19 -44.78 71.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.801 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.792 HG13 ' CE1' ' A' ' 171' ' ' PHE . 89.7 t -66.1 -40.0 85.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.15 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 56.7 ttp180 -54.04 -63.37 1.17 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.904 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 17.4 mmt180 -59.0 -54.87 42.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.906 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.726 ' O ' ' HB3' ' A' ' 173' ' ' ALA . 11.3 tp -42.53 -66.11 0.4 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.91 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.792 ' CE1' HG13 ' A' ' 167' ' ' VAL . 13.0 m-85 -51.73 -72.19 0.05 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.903 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.46 ' O ' ' N ' ' A' ' 174' ' ' PHE . 5.9 pt-20 -41.38 -31.51 0.25 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.897 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.726 ' HB3' ' O ' ' A' ' 170' ' ' LEU . . . -40.68 -24.82 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.133 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 174' ' ' PHE . . . . . 0.46 ' N ' ' O ' ' A' ' 172' ' ' GLU . 98.9 m-85 -112.21 -74.97 0.62 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.86 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -108.34 142.42 15.99 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.472 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -51.01 156.3 1.05 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.774 0.321 . . . . 0.0 110.907 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.461 HD11 ' CB ' ' A' ' 171' ' ' PHE . 81.7 mt -118.81 134.82 61.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.115 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 -90.87 -42.25 10.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.919 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -157.86 142.73 16.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.896 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' CYS . . . . . 0.622 ' SG ' HG13 ' A' ' 196' ' ' VAL . 1.8 m -134.23 145.87 49.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.825 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 45.4 m -151.98 134.73 15.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.158 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 30.0 mm -87.94 128.29 40.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.098 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.534 HD11 ' CE2' ' A' ' 195' ' ' PHE . 44.2 mt -95.53 115.29 27.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.922 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 184' ' ' ARG . . . . . 0.476 ' CB ' ' HA ' ' A' ' 190' ' ' SER . 15.2 ptp180 -166.95 145.82 5.21 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.891 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -64.0 155.68 45.3 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.473 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.409 ' O ' ' C ' ' A' ' 187' ' ' ASP . 71.2 Cg_exo -45.63 -43.0 18.78 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.713 2.275 . . . . 0.0 112.307 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 187' ' ' ASP . . . . . 0.409 ' C ' ' O ' ' A' ' 186' ' ' PRO . 68.6 m-20 -37.57 -45.58 0.77 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.882 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 124.16 -35.6 3.19 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.481 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 189' ' ' ASN . . . . . 0.433 ' O ' ' C ' ' A' ' 190' ' ' SER . 6.9 m-20 -58.99 98.64 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.821 0.343 . . . . 0.0 110.91 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 190' ' ' SER . . . . . 0.476 ' HA ' ' CB ' ' A' ' 184' ' ' ARG . 27.2 p -35.3 145.49 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.838 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.426 ' CG ' ' HA ' ' A' ' 184' ' ' ARG . 1.8 mmmp? -102.59 38.01 1.8 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.906 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 37.67 41.49 0.87 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.457 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 65.0 m -153.68 148.51 26.51 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.809 0.338 . . . . 0.0 110.904 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -162.56 148.6 12.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.104 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 195' ' ' PHE . . . . . 0.534 ' CE2' HD11 ' A' ' 183' ' ' LEU . 14.6 m-85 -98.49 143.1 29.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.891 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.639 HG11 ' CD2' ' A' ' 171' ' ' PHE . 16.1 t -143.03 132.73 21.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.14 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 14.0 mtpp -116.05 154.25 30.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.879 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -126.97 171.68 11.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.939 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 32.5 t -69.62 -47.9 61.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.813 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 17.0 m -137.33 170.49 16.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.899 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 201' ' ' HIS . . . . . 0.54 ' CE1' ' HG2' ' A' ' 147' ' ' PRO . 36.3 t-80 -60.95 -56.8 16.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.841 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 202' ' ' ALA . . . . . 0.411 ' C ' ' O ' ' A' ' 201' ' ' HIS . . . -37.12 -65.48 0.3 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.129 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 16.7 mp0 -48.38 -46.0 36.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.916 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 204' ' ' ALA . . . . . 0.407 ' HB3' ' O ' ' A' ' 201' ' ' HIS . . . -54.09 -54.98 32.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.093 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 205' ' ' GLN . . . . . 0.554 ' HA ' HD12 ' A' ' 208' ' ' ILE . 4.3 tp60 -49.52 -54.62 16.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.853 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -46.31 -56.44 5.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.129 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -56.08 -36.19 67.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.154 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 208' ' ' ILE . . . . . 0.554 HD12 ' HA ' ' A' ' 205' ' ' GLN . 80.0 mt -64.25 -75.06 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.12 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -49.34 -41.49 38.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.842 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -52.01 -48.63 64.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.112 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 74.6 mt -100.97 -65.79 0.95 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.886 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 212' ' ' HIS . . . . . 0.483 ' N ' ' O ' ' A' ' 208' ' ' ILE . 6.3 t60 -51.62 129.19 25.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.87 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 73.62 -4.83 26.14 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.488 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 8.1 t -99.66 -67.91 0.83 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.81 0.338 . . . . 0.0 110.856 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 5.6 mm-40 -94.73 172.9 7.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.938 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 216' ' ' THR . . . . . 0.522 HG23 ' O ' ' A' ' 222' ' ' SER . 54.1 m -133.08 92.85 3.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.198 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 217' ' ' MET . . . . . 0.442 ' HE2' HD13 ' A' ' 224' ' ' LEU . 1.3 mmt -36.0 136.23 0.51 Allowed Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.591 0.71 . . . . 0.0 110.877 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -48.52 125.56 12.64 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.701 2.267 . . . . 0.0 112.384 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 109.15 -50.46 0.77 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.498 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -77.03 149.38 35.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.762 0.315 . . . . 0.0 111.093 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 23.9 t -94.41 -18.26 21.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.88 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 222' ' ' SER . . . . . 0.522 ' O ' HG23 ' A' ' 216' ' ' THR . 2.2 m -99.98 147.45 25.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.833 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 223' ' ' SER . . . . . 0.417 ' O ' ' C ' ' A' ' 224' ' ' LEU . 53.8 m -61.16 147.25 44.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.888 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.442 HD13 ' HE2' ' A' ' 217' ' ' MET . 19.1 tp -36.82 152.72 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.909 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 0.414 ' N ' ' HG ' ' A' ' 224' ' ' LEU . 99.6 t -123.22 105.0 15.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.117 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 226' ' ' VAL . . . . . 0.702 HG13 HG22 ' A' ' 155' ' ' VAL . 22.1 t -132.67 101.84 4.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.118 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 45.8 pttt -119.47 167.69 11.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.873 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 228' ' ' PHE . . . . . 0.476 ' HA ' HD23 ' A' ' 153' ' ' LEU . 90.3 m-85 -72.34 115.75 11.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.91 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -43.55 143.96 0.86 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.121 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -104.63 -66.99 0.93 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.832 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 95.5 m -55.01 125.99 22.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.169 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -122.82 85.15 2.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.856 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 13.1 ttmm -58.12 139.66 54.31 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.889 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -142.67 171.79 13.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.913 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 96.2 p -170.03 113.77 0.48 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.836 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -71.59 146.18 39.98 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.472 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -78.0 -33.24 2.19 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.73 2.287 . . . . 0.0 112.35 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 1.1 t -54.97 143.55 26.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.881 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 75.6 m -89.73 -55.59 3.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.811 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.318 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.502 -179.974 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.313 0 N-CA-C 112.475 -0.25 . . . . 0.0 112.475 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 3.2 m -96.02 55.51 1.57 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.813 0.339 . . . . 0.0 110.865 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 32.2 t -101.64 41.69 1.19 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.863 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -171.54 -66.47 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.467 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 16.9 p -158.49 140.4 13.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.885 0.374 . . . . 0.0 110.842 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 6.9 t -97.26 -51.69 4.09 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.833 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 176.89 103.04 0.16 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.482 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 69.2 m -62.95 116.08 4.98 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.86 0.362 . . . . 0.0 110.876 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.0 mt -111.41 167.11 10.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.932 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 4.9 tpp85 -64.49 -44.59 90.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.889 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 86.7 mm-40 -52.6 149.61 10.64 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.588 0.708 . . . . 0.0 110.917 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -45.61 148.76 2.16 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.665 2.243 . . . . 0.0 112.349 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -77.98 106.49 2.18 Favored 'Trans proline' 0 N--CA 1.465 -0.161 0 C-N-CA 122.73 2.287 . . . . 0.0 112.364 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 22.9 t -136.99 105.29 5.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.859 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 56.7 m80 -100.83 88.74 3.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.848 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 15.5 ttm-85 -162.41 116.09 1.76 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.886 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.454 ' HD3' ' CG ' ' A' ' 195' ' ' PHE . 2.7 ttmp? -122.64 151.9 41.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.877 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.405 ' N ' ' HG2' ' A' ' 152' ' ' LYS . 86.3 mt -117.91 133.66 55.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.914 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -102.64 114.37 28.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.885 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.636 HG21 ' CZ ' ' A' ' 171' ' ' PHE . 37.8 t -108.55 111.45 36.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.139 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -111.4 -161.16 16.78 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.507 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.419 ' CE ' ' HB1' ' A' ' 220' ' ' ALA . 79.9 mmm 46.62 41.49 9.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.818 0.342 . . . . 0.0 110.913 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.543 HD23 ' HG3' ' A' ' 217' ' ' MET . 55.1 mt -99.54 171.03 8.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.933 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 30.2 m120 -113.6 171.38 7.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.892 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 43.6 mttm -92.79 42.59 1.1 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.917 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -124.28 -43.92 2.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.89 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 61.0 mt-30 -63.4 159.79 17.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.922 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 68.9 m -132.36 175.81 8.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.854 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -55.05 -47.02 75.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.88 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.496 ' CG ' ' N ' ' A' ' 166' ' ' ASP . 0.6 OUTLIER -58.33 -53.71 55.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.809 -179.988 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 166' ' ' ASP . . . . . 0.496 ' N ' ' CG ' ' A' ' 165' ' ' ASP . 65.5 m-20 -45.34 -55.89 5.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.888 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.784 HG13 ' CD1' ' A' ' 171' ' ' PHE . 68.7 t -64.81 -44.43 96.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.131 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 33.9 mtp180 -48.6 -55.22 11.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.881 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' ARG . . . . . 0.408 ' O ' ' HG3' ' A' ' 172' ' ' GLU . 55.7 mtt180 -70.86 -50.28 36.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.866 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.701 ' O ' ' HB3' ' A' ' 173' ' ' ALA . 9.8 tp -48.18 -63.78 0.98 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.919 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.784 ' CD1' HG13 ' A' ' 167' ' ' VAL . 7.3 m-85 -54.61 -58.48 7.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.905 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.408 ' HG3' ' O ' ' A' ' 169' ' ' ARG . 0.8 OUTLIER -59.82 -9.94 3.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.902 -179.915 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.701 ' HB3' ' O ' ' A' ' 170' ' ' LEU . . . -61.59 -10.75 8.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.131 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -120.43 -67.9 0.94 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.845 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -110.59 -173.93 20.25 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.46 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -83.79 151.23 25.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.785 0.326 . . . . 0.0 110.899 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.467 HD11 ' CB ' ' A' ' 171' ' ' PHE . 21.0 mt -121.27 129.62 75.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.143 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 35.0 mm-40 -79.3 -46.61 17.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.879 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 22.2 tp10 -165.29 143.86 6.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.875 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 13.0 t -118.81 143.0 47.2 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.923 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 30.1 m -153.11 116.05 4.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.113 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 44.6 mm -83.3 135.01 25.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.125 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.861 HD11 ' CE2' ' A' ' 195' ' ' PHE . 35.1 mt -84.39 102.53 12.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.911 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 61.6 mtp180 -118.06 137.58 52.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.923 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -53.99 -166.67 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.697 -0.764 . . . . 0.0 112.517 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -76.31 -46.51 0.18 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.644 2.229 . . . . 0.0 112.373 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -55.96 -40.14 72.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.905 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 124.68 35.22 0.65 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.475 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 37.1 p-10 -120.81 146.7 46.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.833 0.349 . . . . 0.0 110.876 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 40.7 t -69.23 132.1 45.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.856 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 1.3 mmmp? -94.46 26.09 3.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.898 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.425 ' C ' ' HB2' ' A' ' 158' ' ' LEU . . . 59.93 34.65 84.04 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.453 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 84.3 m -154.12 154.82 34.27 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.806 0.336 . . . . 0.0 110.926 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -158.37 161.1 37.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.072 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 195' ' ' PHE . . . . . 0.861 ' CE2' HD11 ' A' ' 183' ' ' LEU . 27.8 m-85 -121.53 119.59 32.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.868 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 21.5 t -118.8 140.21 43.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.081 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 17.1 mtmt -114.65 145.88 41.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.859 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -119.42 174.87 6.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.929 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 81.0 p -78.19 -46.26 20.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.876 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 37.7 m -133.58 -179.3 5.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.838 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 201' ' ' HIS . . . . . 0.513 ' O ' ' HB3' ' A' ' 204' ' ' ALA . 53.8 t-80 -76.44 -52.77 9.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.892 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -39.6 -66.14 0.32 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.081 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 51.5 mm-40 -47.28 -43.8 22.59 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.885 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 204' ' ' ALA . . . . . 0.513 ' HB3' ' O ' ' A' ' 201' ' ' HIS . . . -51.77 -54.07 32.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.108 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 205' ' ' GLN . . . . . 0.598 ' HA ' HD12 ' A' ' 208' ' ' ILE . 24.9 tp60 -56.57 -41.51 77.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.926 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -53.15 -50.1 65.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.119 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -68.25 -26.66 65.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.098 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 208' ' ' ILE . . . . . 0.598 HD12 ' HA ' ' A' ' 205' ' ' GLN . 63.4 mt -71.05 -65.11 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.083 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -60.92 -38.09 84.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.879 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -65.07 -26.77 68.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.113 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 89.9 mt -115.61 -75.0 0.59 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.94 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 212' ' ' HIS . . . . . 0.528 ' HD1' ' HA ' ' A' ' 225' ' ' VAL . 20.6 t60 -47.83 128.69 13.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.848 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 83.16 -22.03 7.55 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.514 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 4.8 m -90.18 -71.61 0.61 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.801 0.334 . . . . 0.0 110.893 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 215' ' ' GLN . . . . . 0.449 ' HG3' ' N ' ' A' ' 216' ' ' THR . 1.2 tt0 -88.71 156.05 19.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.865 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 216' ' ' THR . . . . . 0.594 HG23 ' O ' ' A' ' 222' ' ' SER . 2.0 m -119.51 118.1 30.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.119 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 217' ' ' MET . . . . . 0.543 ' HG3' HD23 ' A' ' 158' ' ' LEU . 23.9 mmt -47.44 137.05 9.28 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.598 0.714 . . . . 0.0 110.87 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -48.89 113.82 1.03 Allowed 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.702 2.268 . . . . 0.0 112.379 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 112.7 -54.39 0.55 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.504 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 220' ' ' ALA . . . . . 0.419 ' HB1' ' CE ' ' A' ' 157' ' ' MET . . . -63.72 145.46 55.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.813 0.339 . . . . 0.0 111.15 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 48.2 t -93.23 -16.26 25.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.806 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 222' ' ' SER . . . . . 0.594 ' O ' HG23 ' A' ' 216' ' ' THR . 2.4 m -100.09 136.98 39.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.841 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 2.1 p -44.91 162.97 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.831 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.462 ' HG ' HG23 ' A' ' 226' ' ' VAL . 51.4 tp -56.98 157.04 6.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.895 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 0.528 ' HA ' ' HD1' ' A' ' 212' ' ' HIS . 91.8 t -125.12 110.21 24.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.144 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 226' ' ' VAL . . . . . 0.504 HG22 HG13 ' A' ' 155' ' ' VAL . 44.1 t -136.26 105.03 4.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.161 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 4.6 ptmt -132.69 145.77 51.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.909 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -51.45 144.43 10.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.914 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -78.46 -47.54 17.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.118 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -90.16 115.28 27.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.86 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 57.9 p -78.46 143.84 36.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.173 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -90.48 107.89 19.45 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.891 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 16.5 ptmt -158.22 159.84 36.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.886 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -160.44 159.47 30.98 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.875 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 24.2 t -73.46 -43.56 59.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.866 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -76.08 161.4 52.03 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.481 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 237' ' ' PRO . . . . . 0.426 ' O ' ' C ' ' A' ' 238' ' ' SER . 62.4 Cg_endo -79.18 19.98 0.87 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.656 2.237 . . . . 0.0 112.334 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 238' ' ' SER . . . . . 0.426 ' C ' ' O ' ' A' ' 237' ' ' PRO . 42.7 p -36.61 -46.44 0.58 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.869 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 75.5 p -164.25 136.71 4.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.84 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.446 -179.966 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.294 0 N-CA-C 112.478 -0.249 . . . . 0.0 112.478 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.452 ' CB ' ' HB2' ' A' ' 141' ' ' SER . 59.6 m 47.3 42.15 13.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.889 0.376 . . . . 0.0 110.901 -179.707 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 3.4 m 39.97 42.15 1.03 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.859 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 164.94 -95.69 0.12 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.503 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 61.6 p -162.06 110.53 1.43 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.853 0.358 . . . . 0.0 110.843 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.452 ' HB2' ' CB ' ' A' ' 137' ' ' SER . 3.3 m -164.79 148.3 8.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.869 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 171.67 -48.51 0.18 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.466 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 78.3 m -108.06 89.28 2.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.881 0.372 . . . . 0.0 110.881 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 17.1 tp -43.5 -52.48 6.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.882 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 31.7 ptt180 -113.7 112.99 24.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.905 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 74.6 mm-40 -71.35 142.31 86.72 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.664 0.745 . . . . 0.0 110.902 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -46.76 158.34 0.41 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.693 2.262 . . . . 0.0 112.295 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -45.17 171.93 0.02 OUTLIER 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.681 2.254 . . . . 0.0 112.329 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 65.6 m -118.25 105.36 11.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.827 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' HIS . . . . . 0.458 ' CD2' ' N ' ' A' ' 150' ' ' HIS . 0.2 OUTLIER -165.48 145.66 6.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.873 179.932 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 26.1 mtm180 -115.02 111.49 21.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.884 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 23.1 ttpt -122.6 152.03 40.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.913 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.438 HD21 ' CE1' ' A' ' 228' ' ' PHE . 87.4 mt -123.55 123.51 40.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.896 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -91.22 116.95 29.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.948 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.586 HG13 HG22 ' A' ' 226' ' ' VAL . 38.3 t -110.82 132.44 59.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.114 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -130.87 -158.84 9.39 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.473 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 45.52 31.86 1.0 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.793 0.33 . . . . 0.0 110.859 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 79.5 mt -85.24 -176.22 6.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.875 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.464 ' N ' ' OD1' ' A' ' 159' ' ' ASN . 0.5 OUTLIER -126.97 155.31 43.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.884 179.896 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 65.8 mttt -80.92 42.09 0.62 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.875 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 18.0 mp0 -130.96 -43.03 1.09 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.921 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 17.8 mm-40 -54.0 162.01 1.08 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.914 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 28.1 m -135.7 166.28 23.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.807 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.465 ' O ' ' CB ' ' A' ' 168' ' ' ARG . 2.3 mp0 -49.28 -41.0 36.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.889 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -65.1 -48.34 74.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.867 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 -54.81 -56.61 17.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.817 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.528 HG13 ' CE1' ' A' ' 171' ' ' PHE . 54.3 t -66.98 -40.62 86.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.153 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' ARG . . . . . 0.465 ' CB ' ' O ' ' A' ' 164' ' ' GLU . 13.8 tpt180 -56.36 -56.28 23.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.865 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 10.0 mmt85 -63.25 -54.47 36.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.889 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.765 ' O ' ' HB3' ' A' ' 173' ' ' ALA . 9.9 tp -43.95 -64.94 0.57 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.925 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.528 ' CE1' HG13 ' A' ' 167' ' ' VAL . 7.4 m-85 -51.33 -68.87 0.13 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.871 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -46.36 -26.4 0.82 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.888 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.765 ' HB3' ' O ' ' A' ' 170' ' ' LEU . . . -48.89 -21.13 0.59 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.126 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -114.21 -60.37 1.89 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.867 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -124.48 134.08 8.93 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.488 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -40.74 162.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.786 0.327 . . . . 0.0 110.93 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.663 HG23 ' O ' ' A' ' 197' ' ' LYS . 32.3 mt -131.03 136.39 58.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.087 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -81.35 -48.76 11.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.92 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -155.49 151.21 27.44 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.882 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 42.1 t -129.38 135.76 49.12 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.856 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 89.5 m -148.1 134.17 19.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.152 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 48.5 mm -95.06 139.04 19.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.099 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.769 HD11 ' CE2' ' A' ' 195' ' ' PHE . 41.0 mt -94.85 117.77 30.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.954 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 76.1 mtm180 -130.05 107.91 9.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.853 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -63.63 -148.76 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.452 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -45.46 153.51 0.66 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.649 2.233 . . . . 0.0 112.385 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 7.8 t0 41.05 42.04 1.46 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.854 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 40.14 44.94 3.01 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.502 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -92.29 107.65 19.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.861 0.362 . . . . 0.0 110.922 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 37.3 p -49.84 105.18 0.08 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.871 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 30.1 mmtp -80.4 43.45 0.64 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.914 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 39.01 50.35 2.67 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.487 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 8.1 p -159.54 151.68 20.85 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.849 0.357 . . . . 0.0 110.835 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -160.04 168.02 26.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.111 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 195' ' ' PHE . . . . . 0.769 ' CE2' HD11 ' A' ' 183' ' ' LEU . 40.3 m-85 -120.18 135.83 54.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.864 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 46.9 t -136.32 142.54 38.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.103 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.663 ' O ' HG23 ' A' ' 177' ' ' ILE . 23.2 mttp -117.38 154.1 31.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.885 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -124.17 172.99 8.62 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.901 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 68.3 p -83.24 -33.4 26.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.874 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 11.2 t -141.65 165.1 28.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.851 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 4.8 t60 -67.69 -53.7 25.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.849 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -44.28 -60.28 1.99 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.126 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -46.86 -45.95 20.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.879 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -55.75 -58.43 7.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.111 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 16.5 tp60 -45.11 -49.64 11.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.888 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -53.54 -51.87 61.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.112 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -56.87 -45.12 82.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.107 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 208' ' ' ILE . . . . . 0.494 ' O ' ' N ' ' A' ' 212' ' ' HIS . 71.4 mt -57.97 -74.06 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.142 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -48.06 -42.54 28.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.883 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -58.31 -37.7 75.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.134 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.419 ' O ' ' CB ' ' A' ' 214' ' ' SER . 41.4 mt -104.53 -72.0 0.72 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.945 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 212' ' ' HIS . . . . . 0.494 ' N ' ' O ' ' A' ' 208' ' ' ILE . 13.0 t60 -46.85 136.59 8.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.876 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 73.67 -6.41 18.18 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.479 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 214' ' ' SER . . . . . 0.419 ' CB ' ' O ' ' A' ' 211' ' ' LEU . 1.3 t -87.97 -71.03 0.6 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.825 0.345 . . . . 0.0 110.883 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.17 178.22 4.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.918 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 216' ' ' THR . . . . . 0.616 HG23 ' O ' ' A' ' 222' ' ' SER . 56.4 m -134.97 95.29 3.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.132 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 217' ' ' MET . . . . . 0.442 ' C ' ' O ' ' A' ' 216' ' ' THR . 25.5 mmt -34.73 133.58 0.42 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.596 0.712 . . . . 0.0 110.887 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -48.91 117.73 2.98 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.723 2.282 . . . . 0.0 112.297 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 120.27 -54.17 0.66 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.52 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -72.04 159.86 33.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.769 0.319 . . . . 0.0 111.095 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 38.7 t -98.15 -23.9 15.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.881 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 222' ' ' SER . . . . . 0.616 ' O ' HG23 ' A' ' 216' ' ' THR . 1.9 m -99.98 147.48 25.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.841 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 73.4 m -60.02 156.41 14.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.852 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 38.2 tp -37.22 153.16 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.903 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 0.428 ' HA ' ' ND1' ' A' ' 212' ' ' HIS . 61.4 t -124.66 111.04 26.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.136 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 226' ' ' VAL . . . . . 0.586 HG22 HG13 ' A' ' 155' ' ' VAL . 41.1 t -132.72 102.1 4.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.137 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 10.6 ptmt -129.48 151.65 49.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.898 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 228' ' ' PHE . . . . . 0.438 ' CE1' HD21 ' A' ' 153' ' ' LEU . 82.1 m-85 -57.3 154.05 11.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.857 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -115.06 151.19 34.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.141 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 12.8 t70 65.0 42.99 3.94 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.882 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 59.8 p -129.19 161.0 31.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.164 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -130.76 134.22 46.68 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.871 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 23.5 pttm -55.44 141.52 36.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.9 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -161.73 164.03 29.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.916 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 40.0 t -88.38 95.08 10.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.854 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -124.86 78.51 0.37 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.505 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -78.61 37.4 0.65 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.664 2.243 . . . . 0.0 112.345 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 72.3 p -128.52 172.84 10.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.883 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 9.6 t -114.46 168.62 9.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.851 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.338 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.474 179.999 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.343 0 N-CA-C 112.515 -0.234 . . . . 0.0 112.515 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 23.3 t -60.79 90.23 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.829 0.347 . . . . 0.0 110.864 -179.743 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 8.0 m -50.85 107.2 0.16 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.864 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 120.15 -133.08 9.69 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.501 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 56.3 p -147.68 139.97 24.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.867 0.365 . . . . 0.0 110.831 -179.728 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 3.4 t -98.85 42.97 1.07 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.846 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 64.73 69.65 1.28 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.422 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 22.5 p -100.17 73.07 1.69 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.846 0.355 . . . . 0.0 110.862 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.531 HD23 ' N ' ' A' ' 144' ' ' LEU . 1.3 pt? -155.3 174.12 15.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.909 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.403 ' O ' ' C ' ' A' ' 146' ' ' GLN . 1.0 OUTLIER -99.35 161.74 13.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.854 179.926 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 146' ' ' GLN . . . . . 0.403 ' C ' ' O ' ' A' ' 145' ' ' ARG . 20.8 tt0 -37.47 99.5 0.19 Allowed Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.625 0.726 . . . . 0.0 110.93 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -44.3 147.27 1.58 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.73 2.287 . . . . 0.0 112.316 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -46.87 141.01 12.39 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.735 2.29 . . . . 0.0 112.33 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 2.4 m -72.07 -177.85 2.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.839 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 13.0 p80 38.83 45.97 1.0 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.895 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.767 ' H ' ' NE ' ' A' ' 151' ' ' ARG . 0.0 OUTLIER -77.53 154.91 31.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.858 -179.843 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.971 ' HB3' ' HB3' ' A' ' 229' ' ' ALA . 2.5 tptt -140.6 156.54 46.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.876 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.483 HD12 ' CD1' ' A' ' 198' ' ' TYR . 41.6 mt -124.54 118.41 26.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.922 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -89.8 120.73 31.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.905 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.694 HG13 HG22 ' A' ' 226' ' ' VAL . 20.7 t -116.33 118.09 57.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.143 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -118.2 -155.8 10.09 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.499 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 16.5 mmt 47.42 34.59 3.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.786 0.327 . . . . 0.0 110.863 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.455 HD23 ' HG3' ' A' ' 217' ' ' MET . 69.3 mt -95.51 165.87 12.14 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.941 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.459 ' ND2' ' H ' ' A' ' 159' ' ' ASN . 0.5 OUTLIER -102.27 162.21 13.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.895 179.929 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 40.4 mttp -85.48 32.89 0.56 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.897 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 3.5 tp60 -120.89 -50.51 2.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.913 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -44.31 159.82 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.893 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 4.9 m -139.06 168.5 19.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.866 -179.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -49.97 -48.73 52.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.885 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -53.31 -56.3 17.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.87 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -48.33 -67.59 0.26 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.87 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.764 HG13 ' CE1' ' A' ' 171' ' ' PHE . 65.3 t -49.99 -53.17 11.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.099 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 168' ' ' ARG . . . . . 0.429 ' C ' ' O ' ' A' ' 167' ' ' VAL . 1.5 tmm_? -36.25 -63.65 0.37 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.844 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 19.7 mtp180 -63.89 -51.89 62.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.915 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.704 ' O ' ' HB3' ' A' ' 173' ' ' ALA . 16.5 tp -43.29 -65.8 0.45 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.953 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.764 ' CE1' HG13 ' A' ' 167' ' ' VAL . 9.3 m-85 -55.7 -68.33 0.21 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.884 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -44.81 -21.96 0.07 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.882 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.704 ' HB3' ' O ' ' A' ' 170' ' ' LEU . . . -50.11 -17.75 0.46 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.126 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -118.3 -71.74 0.72 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.916 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -109.51 145.83 16.83 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.463 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -55.84 145.59 24.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.836 0.35 . . . . 0.0 110.872 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.482 HD11 ' CB ' ' A' ' 171' ' ' PHE . 50.7 mt -109.26 135.06 49.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.127 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.45 ' HB3' ' CE ' ' A' ' 197' ' ' LYS . 13.0 mt-10 -97.86 -39.09 9.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.897 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 23.2 tp10 -148.17 144.43 27.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.879 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 44.9 t -143.78 137.99 28.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.896 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 22.4 m -154.53 137.29 15.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.096 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.699 HD13 ' CB ' ' A' ' 194' ' ' ALA . 26.4 mm -96.83 126.43 49.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.103 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 1.181 HD11 ' CE2' ' A' ' 195' ' ' PHE . 28.7 mt -81.73 108.88 15.64 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.928 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 184' ' ' ARG . . . . . 0.487 ' CB ' ' HA ' ' A' ' 190' ' ' SER . 5.6 ptp180 -169.08 142.91 2.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.885 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -78.25 -145.43 2.67 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.488 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -75.56 -167.32 0.42 Allowed 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.735 2.29 . . . . 0.0 112.336 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 187' ' ' ASP . . . . . 0.424 ' O ' ' C ' ' A' ' 188' ' ' GLY . 22.0 t0 40.32 34.44 0.22 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.845 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' A' ' 187' ' ' ASP . . . 36.41 45.16 0.92 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.454 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -91.39 75.92 5.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.821 0.343 . . . . 0.0 110.895 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 190' ' ' SER . . . . . 0.487 ' HA ' ' CB ' ' A' ' 184' ' ' ARG . 48.5 t -43.35 134.24 3.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.904 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 52.5 mttm -100.68 34.53 2.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.875 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 41.11 39.54 2.13 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.463 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 65.1 m -154.6 149.03 26.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.833 0.349 . . . . 0.0 110.889 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.699 ' CB ' HD13 ' A' ' 182' ' ' ILE . . . -163.14 154.63 17.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.101 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 195' ' ' PHE . . . . . 1.181 ' CE2' HD11 ' A' ' 183' ' ' LEU . 69.7 m-85 -105.38 136.69 44.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.873 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 48.4 t -133.76 140.45 46.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.147 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.45 ' CE ' ' HB3' ' A' ' 178' ' ' GLU . 22.0 ttpt -116.84 142.8 46.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.856 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 198' ' ' TYR . . . . . 0.483 ' CD1' HD12 ' A' ' 153' ' ' LEU . 9.5 m-85 -119.86 170.2 9.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.895 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 24.7 t -69.2 -48.24 62.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.866 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 59.5 p -145.81 173.05 12.45 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.9 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 201' ' ' HIS . . . . . 0.443 ' O ' ' C ' ' A' ' 202' ' ' ALA . 13.5 t-80 -59.46 -56.48 21.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.823 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 202' ' ' ALA . . . . . 0.443 ' C ' ' O ' ' A' ' 201' ' ' HIS . . . -34.74 -69.81 0.09 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.122 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -47.1 -47.31 23.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.887 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -53.33 -58.06 8.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.061 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 3.2 tp60 -47.91 -40.03 20.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.929 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -59.81 -53.71 54.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.084 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -61.93 -25.66 67.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.127 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 208' ' ' ILE . . . . . 0.495 ' O ' ' N ' ' A' ' 212' ' ' HIS . 79.2 mt -71.15 -67.79 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.13 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -57.31 -38.88 74.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.877 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -63.5 -41.73 98.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.147 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.497 ' HB3' HD23 ' A' ' 224' ' ' LEU . 63.7 mt -100.73 -72.09 0.69 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.909 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 212' ' ' HIS . . . . . 0.495 ' N ' ' O ' ' A' ' 208' ' ' ILE . 1.4 t60 -52.15 130.48 30.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.872 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 72.54 -0.98 39.15 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.523 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 22.5 t -96.88 -71.89 0.66 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.782 0.325 . . . . 0.0 110.859 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -99.5 172.37 7.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.866 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 216' ' ' THR . . . . . 0.608 HG23 ' O ' ' A' ' 222' ' ' SER . 34.2 m -123.55 105.35 9.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.125 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 217' ' ' MET . . . . . 0.455 ' HG3' HD23 ' A' ' 158' ' ' LEU . 15.4 mmt -43.18 139.03 2.43 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.514 0.674 . . . . 0.0 110.929 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -48.31 120.74 5.33 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.681 2.254 . . . . 0.0 112.338 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 105.88 -53.97 0.62 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.485 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -66.68 146.93 53.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.845 0.355 . . . . 0.0 111.092 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 29.4 m -93.19 -17.29 23.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.826 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 222' ' ' SER . . . . . 0.608 ' O ' HG23 ' A' ' 216' ' ' THR . 9.8 p -100.01 151.29 21.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.861 -179.814 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 44.1 m -65.6 148.08 52.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.865 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.497 HD23 ' HB3' ' A' ' 211' ' ' LEU . 63.8 tp -39.56 149.83 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.914 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 61.9 t -121.89 106.52 18.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.129 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 226' ' ' VAL . . . . . 0.694 HG22 HG13 ' A' ' 155' ' ' VAL . 28.7 t -126.17 104.99 13.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.137 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 46.2 pttt -120.31 176.36 5.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.924 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -83.61 114.65 21.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.927 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 229' ' ' ALA . . . . . 0.971 ' HB3' ' HB3' ' A' ' 152' ' ' LYS . . . -59.39 127.3 31.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.105 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -83.23 173.07 11.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.874 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 41.4 m -160.32 129.26 4.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.151 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 232' ' ' ASP . . . . . 0.488 ' OD1' ' N ' ' A' ' 233' ' ' LYS . 26.4 t0 -58.38 146.44 34.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.864 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 233' ' ' LYS . . . . . 0.488 ' N ' ' OD1' ' A' ' 232' ' ' ASP . 14.0 ttmm -171.45 145.17 2.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.885 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -148.25 125.4 11.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.885 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.5 t -169.75 158.1 7.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.908 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 54.96 -171.67 1.2 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.482 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -76.83 155.54 34.67 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.693 2.262 . . . . 0.0 112.321 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 56.6 m -84.26 151.22 24.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.845 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 3.0 m -109.94 129.03 55.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.837 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.33 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.463 179.995 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.319 0 N-CA-C 112.489 -0.245 . . . . 0.0 112.489 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 59.5 p -161.23 130.66 4.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.881 0.372 . . . . 0.0 110.886 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 2.5 t 59.39 42.23 18.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.81 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -78.7 -98.55 0.23 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.522 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 79.1 p -85.63 97.28 10.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.887 0.375 . . . . 0.0 110.892 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 7.0 t -172.53 134.28 0.65 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.857 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -154.22 73.55 0.25 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.478 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 19.3 p -162.92 148.74 12.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.877 0.37 . . . . 0.0 110.896 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -97.6 40.82 1.14 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.95 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -131.19 119.18 21.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.843 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' GLN . . . . . 0.413 ' H ' ' CD ' ' A' ' 146' ' ' GLN . 3.0 pm0 -52.93 143.92 29.07 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.621 0.724 . . . . 0.0 110.899 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -46.52 145.76 5.88 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.678 2.252 . . . . 0.0 112.333 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -47.0 -41.93 25.83 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.665 2.243 . . . . 0.0 112.357 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 66.3 m 46.17 37.5 4.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.858 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' HIS . . . . . 0.429 ' CB ' ' HB3' ' A' ' 228' ' ' PHE . 22.1 m80 -69.78 -176.66 1.1 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.899 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 20.3 mtt180 -133.2 -38.89 0.94 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.855 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.429 ' HE3' ' CB ' ' A' ' 195' ' ' PHE . 20.6 tttp -84.48 121.94 28.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.874 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.663 HD21 HD11 ' A' ' 208' ' ' ILE . 25.0 mt -96.63 154.35 17.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.923 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 79.1 t80 -125.0 114.14 18.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.892 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.669 HG21 ' CZ ' ' A' ' 171' ' ' PHE . 17.4 t -102.75 110.51 29.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.108 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -111.99 -171.6 18.82 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.471 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 10.5 mmt 59.66 28.08 17.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.795 0.331 . . . . 0.0 110.845 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 46.3 mt -91.17 165.99 13.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.933 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -108.64 166.56 10.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.904 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 33.0 mttt -84.6 51.7 2.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.91 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -134.88 -50.67 0.77 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.957 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -51.67 163.36 0.31 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.872 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 44.5 m -138.14 172.47 12.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.882 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -53.73 -45.13 70.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.898 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -57.43 -51.38 69.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.847 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -50.99 -65.73 0.51 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.876 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.678 HG13 ' CE1' ' A' ' 171' ' ' PHE . 58.3 t -57.8 -36.57 55.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.137 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 14.2 tpp85 -54.58 -62.72 1.47 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.868 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' ARG . . . . . 0.401 ' O ' ' HG3' ' A' ' 172' ' ' GLU . 68.3 mtp180 -64.87 -51.52 61.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.864 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.694 ' O ' ' HB3' ' A' ' 173' ' ' ALA . 13.0 tp -43.85 -65.51 0.49 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.912 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.678 ' CE1' HG13 ' A' ' 167' ' ' VAL . 6.6 m-85 -55.84 -67.95 0.25 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.858 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.509 ' CD ' ' C ' ' A' ' 172' ' ' GLU . 0.6 OUTLIER -45.43 -21.56 0.1 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.886 -179.91 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.694 ' HB3' ' O ' ' A' ' 170' ' ' LEU . . . -50.11 -18.97 0.64 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.098 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -110.27 -65.96 1.11 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.908 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -107.33 -165.53 21.98 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.478 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -100.01 132.84 45.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.778 0.323 . . . . 0.0 110.886 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 29.6 mt -101.89 138.32 26.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.089 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -98.96 -32.82 11.11 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.862 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -160.83 152.31 19.32 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.885 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 38.6 t -136.1 121.49 19.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.902 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' THR . . . . . 0.487 ' O ' ' HB1' ' A' ' 194' ' ' ALA . 97.8 m -123.86 139.08 54.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.152 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.43 HD13 ' HB1' ' A' ' 194' ' ' ALA . 50.6 mm -115.57 114.54 46.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.134 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.564 HD11 ' HE2' ' A' ' 195' ' ' PHE . 18.8 mt -77.75 98.92 5.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.914 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 184' ' ' ARG . . . . . 0.403 ' HB2' ' NH1' ' A' ' 184' ' ' ARG . 9.6 mtm105 -109.83 25.35 11.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.868 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 58.92 148.6 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.504 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -47.27 -17.72 0.58 Allowed 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.66 2.24 . . . . 0.0 112.311 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -78.18 -44.45 25.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.894 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 125.48 -21.0 6.45 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.504 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 10.2 m-20 -76.17 127.87 33.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.854 0.359 . . . . 0.0 110.887 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 4.6 t -47.68 133.86 13.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.816 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 2.6 mmmp? -105.56 15.51 26.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.91 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 62.47 32.24 82.42 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.497 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 11.1 m -148.04 142.96 26.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.794 0.331 . . . . 0.0 110.879 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.487 ' HB1' ' O ' ' A' ' 181' ' ' THR . . . -160.04 160.2 32.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.095 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 195' ' ' PHE . . . . . 0.564 ' HE2' HD11 ' A' ' 183' ' ' LEU . 77.4 m-85 -115.54 133.57 55.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.892 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.428 HG21 ' CE2' ' A' ' 171' ' ' PHE . 92.9 t -116.68 128.74 73.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.14 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 19.1 tttp -95.87 145.2 25.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.888 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 198' ' ' TYR . . . . . 0.44 ' CD1' HD12 ' A' ' 153' ' ' LEU . 7.6 m-85 -129.07 171.6 12.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.924 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 91.3 p -85.58 -20.91 28.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.885 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 2.2 m -162.01 176.42 10.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.772 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -77.16 -37.68 53.32 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.864 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -52.82 -65.31 0.58 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.102 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 18.2 mp0 -48.47 -41.29 29.25 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.88 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -58.85 -59.8 4.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.074 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 205' ' ' GLN . . . . . 0.61 ' HA ' HD12 ' A' ' 208' ' ' ILE . 43.1 tp60 -45.64 -42.02 10.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.937 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -60.48 -52.74 63.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.101 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -62.74 -28.39 69.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.112 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 208' ' ' ILE . . . . . 0.663 HD11 HD21 ' A' ' 153' ' ' LEU . 93.2 mt -67.41 -75.11 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.121 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -46.25 -43.4 15.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.893 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -55.99 -41.93 75.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.095 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 71.6 mt -100.94 -69.57 0.77 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.873 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 212' ' ' HIS . . . . . 0.637 ' HD1' ' HA ' ' A' ' 225' ' ' VAL . 27.1 t60 -52.4 125.62 16.71 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.902 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 84.6 -10.22 62.66 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.507 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 51.7 m -97.71 -74.43 0.58 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.84 0.353 . . . . 0.0 110.845 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 19.9 mp0 -88.43 166.42 14.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.928 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 216' ' ' THR . . . . . 0.664 HG23 ' O ' ' A' ' 222' ' ' SER . 32.4 m -135.79 106.39 6.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.141 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 217' ' ' MET . . . . . 0.404 ' C ' ' O ' ' A' ' 216' ' ' THR . 15.5 mmt -37.31 156.37 0.09 OUTLIER Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.547 0.689 . . . . 0.0 110.878 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.09 120.61 7.31 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.656 2.237 . . . . 0.0 112.323 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 109.36 -42.63 1.9 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.466 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -76.4 144.3 40.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.767 0.317 . . . . 0.0 111.089 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 3.5 t -93.57 -15.28 25.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.812 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 222' ' ' SER . . . . . 0.664 ' O ' HG23 ' A' ' 216' ' ' THR . 67.6 m -100.17 142.09 32.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.904 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 64.7 m -57.72 157.13 7.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.824 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 47.7 tp -48.35 148.81 1.77 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.916 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 0.637 ' HA ' ' HD1' ' A' ' 212' ' ' HIS . 53.0 t -119.73 111.17 31.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.101 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 25.7 t -132.68 101.31 4.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.117 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.81 158.4 42.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.897 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 228' ' ' PHE . . . . . 0.632 ' CE1' HD21 ' A' ' 153' ' ' LEU . 28.6 m-85 -69.97 68.8 0.31 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.887 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 229' ' ' ALA . . . . . 0.472 ' C ' ' O ' ' A' ' 228' ' ' PHE . . . 32.0 44.22 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.048 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -78.69 155.38 29.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.894 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 231' ' ' THR . . . . . 0.465 ' O ' ' N ' ' A' ' 233' ' ' LYS . 1.7 m -161.97 105.17 1.18 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.161 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -40.2 93.64 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.842 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 233' ' ' LYS . . . . . 0.465 ' N ' ' O ' ' A' ' 231' ' ' THR . 44.1 tttp -138.32 110.49 7.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.914 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -117.66 131.53 56.63 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.878 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 83.8 p -121.16 39.45 3.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.877 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 108.31 149.41 14.26 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.494 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -76.78 118.35 4.79 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.698 2.265 . . . . 0.0 112.358 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 44.7 t -53.39 156.96 2.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.817 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 41.3 t -166.85 121.05 1.05 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.864 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.379 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.496 -179.978 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.306 0 N-CA-C 112.517 -0.233 . . . . 0.0 112.517 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 40.9 t -129.63 130.09 45.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.875 0.369 . . . . 0.0 110.894 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 38.8 m -111.77 -48.95 3.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.878 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -172.23 57.26 0.16 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.535 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 16.4 m -83.08 130.25 35.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.939 0.4 . . . . 0.0 110.858 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 79.2 p -88.96 165.72 14.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.839 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -129.2 -71.96 0.14 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.454 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 99.3 m -58.87 -49.23 78.56 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.834 0.35 . . . . 0.0 110.892 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -43.92 121.62 2.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.926 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.3 106.19 18.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.837 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 8.8 mm100 -78.91 160.48 71.44 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.617 0.722 . . . . 0.0 110.899 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -45.61 166.92 0.05 OUTLIER 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.65 2.234 . . . . 0.0 112.37 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -76.99 84.7 1.89 Allowed 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.642 2.228 . . . . 0.0 112.303 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' SER . . . . . 0.47 ' O ' ' CG ' ' A' ' 150' ' ' HIS . 54.9 p -110.95 159.93 17.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.872 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' HIS . . . . . 0.47 ' CG ' ' O ' ' A' ' 149' ' ' SER . 29.3 m80 -159.19 157.05 30.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.865 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 6.0 mmp_? 56.42 49.48 14.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.898 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.577 ' HE2' ' CD1' ' A' ' 195' ' ' PHE . 3.8 ttpm? -118.02 160.71 21.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.886 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 40.5 mt -129.65 123.97 32.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.886 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -90.19 119.33 30.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.9 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.737 HG13 HG22 ' A' ' 226' ' ' VAL . 5.1 t -107.22 124.7 63.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.121 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -124.85 -168.37 12.78 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.475 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 18.0 mmt 48.45 35.13 5.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.773 0.32 . . . . 0.0 110.896 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 38.3 mt -89.2 166.15 14.0 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.915 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -104.51 160.08 15.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.874 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 24.1 mttp -84.49 23.98 1.05 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.914 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -109.56 -55.21 2.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.909 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -53.4 146.05 13.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.88 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 57.7 m -126.38 166.37 17.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.864 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -44.13 -40.23 4.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.861 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -55.97 -66.08 0.49 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.872 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -52.81 -48.42 66.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.872 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.513 HG13 ' CE1' ' A' ' 171' ' ' PHE . 93.9 t -57.45 -35.24 48.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.099 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 51.4 ttt180 -63.81 -57.87 8.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.843 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' ARG . . . . . 0.401 ' O ' ' HG2' ' A' ' 172' ' ' GLU . 8.5 ptm180 -64.15 -53.24 52.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.85 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.741 ' O ' ' HB3' ' A' ' 173' ' ' ALA . 8.5 tp -43.72 -65.26 0.52 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.916 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.513 ' CE1' HG13 ' A' ' 167' ' ' VAL . 10.9 m-85 -53.03 -68.9 0.13 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.884 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.401 ' HG2' ' O ' ' A' ' 169' ' ' ARG . 4.3 pt-20 -45.75 -24.19 0.34 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.894 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.741 ' HB3' ' O ' ' A' ' 170' ' ' LEU . . . -49.4 -21.23 0.84 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.073 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -111.77 -71.37 0.76 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.879 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -112.21 146.83 18.16 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.462 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' ASN . . . . . 0.45 ' O ' ' CD2' ' A' ' 198' ' ' TYR . 32.6 m120 -51.57 160.3 0.64 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.816 0.341 . . . . 0.0 110.926 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.411 ' CG2' ' N ' ' A' ' 178' ' ' GLU . 19.3 mt -124.73 152.37 30.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.128 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.411 ' N ' ' CG2' ' A' ' 177' ' ' ILE . 9.1 mt-10 -120.49 -28.92 4.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.868 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -155.76 146.78 22.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.871 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 4.8 t -147.32 132.91 18.76 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.927 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 99.5 m -151.32 145.13 25.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.141 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 18.5 mm -97.25 137.48 24.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.14 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.934 HD11 ' CE2' ' A' ' 195' ' ' PHE . 52.9 mt -100.36 98.75 9.36 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.914 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 184' ' ' ARG . . . . . 0.473 ' CB ' ' HA ' ' A' ' 190' ' ' SER . 24.4 ptt180 -154.27 163.4 40.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.853 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -87.47 -147.48 12.48 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.755 -0.735 . . . . 0.0 112.461 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -76.36 -175.72 2.71 Favored 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.688 2.259 . . . . 0.0 112.358 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 5.2 t70 41.59 32.94 0.27 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.867 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 44.13 46.04 7.98 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.481 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 189' ' ' ASN . . . . . 0.426 ' O ' ' C ' ' A' ' 190' ' ' SER . 6.1 m120 -88.17 69.69 9.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.865 0.364 . . . . 0.0 110.89 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 190' ' ' SER . . . . . 0.473 ' HA ' ' CB ' ' A' ' 184' ' ' ARG . 10.8 t -35.91 119.6 0.57 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.876 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 24.5 mmtt -90.82 36.16 0.9 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.918 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 43.28 37.61 3.41 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.468 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 193' ' ' CYS . . . . . 0.416 ' C ' ' HB2' ' A' ' 183' ' ' LEU . 72.1 m -150.49 150.4 31.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.799 0.333 . . . . 0.0 110.868 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -163.09 169.2 19.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.077 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 195' ' ' PHE . . . . . 0.934 ' CE2' HD11 ' A' ' 183' ' ' LEU . 18.2 m-85 -122.96 135.77 54.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.853 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.511 HG21 ' CE2' ' A' ' 171' ' ' PHE . 61.3 t -130.75 140.69 48.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.121 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 25.3 ttmt -117.44 146.49 43.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.856 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 198' ' ' TYR . . . . . 0.45 ' CD2' ' O ' ' A' ' 176' ' ' ASN . 24.6 m-85 -124.23 166.42 15.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.919 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 42.3 t -70.03 -48.74 56.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.828 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 7.3 t -136.82 168.69 19.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.859 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 201' ' ' HIS . . . . . 0.533 ' O ' ' HB3' ' A' ' 204' ' ' ALA . 10.2 t-80 -61.35 -57.34 12.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.85 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 202' ' ' ALA . . . . . 0.449 ' C ' ' O ' ' A' ' 201' ' ' HIS . . . -33.99 -67.03 0.14 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.093 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 19.4 mp0 -49.83 -39.59 39.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.879 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 204' ' ' ALA . . . . . 0.533 ' HB3' ' O ' ' A' ' 201' ' ' HIS . . . -55.65 -51.82 65.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.092 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 59.6 tp60 -57.29 -45.18 84.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.876 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -51.93 -47.69 64.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.104 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -69.48 -29.88 67.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.136 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 208' ' ' ILE . . . . . 0.482 ' O ' ' N ' ' A' ' 212' ' ' HIS . 56.3 mt -66.94 -60.44 2.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.125 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -64.22 -36.95 85.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.869 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -66.6 -35.56 80.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.122 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.705 ' HB3' HD23 ' A' ' 224' ' ' LEU . 84.5 mt -102.51 -69.33 0.79 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.902 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 212' ' ' HIS . . . . . 0.482 ' N ' ' O ' ' A' ' 208' ' ' ILE . 12.2 t60 -62.97 126.19 26.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.835 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 85.7 -4.28 86.0 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.495 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 2.1 m -94.43 -74.12 0.55 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.84 0.353 . . . . 0.0 110.854 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 17.2 pm0 -99.88 175.63 5.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.894 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 216' ' ' THR . . . . . 0.673 HG23 ' O ' ' A' ' 222' ' ' SER . 17.3 m -130.33 101.37 5.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.106 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 13.5 mmt -37.08 134.45 0.68 Allowed Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.608 0.718 . . . . 0.0 110.884 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -48.71 119.88 4.71 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.668 2.246 . . . . 0.0 112.342 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 112.89 -49.86 0.81 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.513 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -73.38 156.76 38.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.813 0.34 . . . . 0.0 111.081 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 94.7 p -98.88 -21.14 16.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.837 -179.758 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 222' ' ' SER . . . . . 0.673 ' O ' HG23 ' A' ' 216' ' ' THR . 1.8 m -100.15 143.31 30.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.855 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 15.1 m -56.88 153.49 10.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.921 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.705 HD23 ' HB3' ' A' ' 211' ' ' LEU . 58.5 tp -40.17 149.62 0.07 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.865 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 0.426 ' HA ' ' ND1' ' A' ' 212' ' ' HIS . 79.9 t -118.35 113.71 42.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.18 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 226' ' ' VAL . . . . . 0.737 HG22 HG13 ' A' ' 155' ' ' VAL . 20.5 t -138.97 104.97 2.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.15 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 44.7 pttt -127.4 178.96 5.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.862 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -83.44 133.63 34.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.878 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -85.87 96.86 9.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.138 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -109.1 37.0 2.69 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.885 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 231' ' ' THR . . . . . 0.631 HG23 ' O ' ' A' ' 231' ' ' THR . 9.0 t -87.97 80.69 7.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.137 -179.852 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -170.92 129.38 0.77 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.824 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 16.5 tttt -88.48 103.8 16.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.939 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -107.88 137.14 46.41 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.889 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 32.8 p -124.0 146.8 48.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.865 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -136.17 95.21 0.24 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.451 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -76.99 44.1 1.4 Allowed 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.694 2.262 . . . . 0.0 112.389 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 9.0 m -43.03 -54.3 4.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.885 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 39.8 t -111.13 101.97 10.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.866 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.303 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.474 -179.988 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.34 0 N-CA-C 112.498 -0.241 . . . . 0.0 112.498 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 15.2 t -84.87 120.61 26.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.914 0.388 . . . . 0.0 110.861 -179.792 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 48.3 p -100.45 158.13 16.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.871 -179.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 117.58 119.91 3.03 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.475 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 32.9 t -107.57 -42.38 4.79 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.913 0.387 . . . . 0.0 110.863 -179.734 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 6.4 t 47.96 44.3 18.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.874 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -151.02 -38.45 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.476 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 10.1 t -91.77 52.92 2.11 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.873 0.368 . . . . 0.0 110.904 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.405 ' N ' HD12 ' A' ' 144' ' ' LEU . 5.9 mp -80.18 -48.97 12.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.892 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.431 ' O ' ' C ' ' A' ' 146' ' ' GLN . 2.8 ptp85 -113.64 -44.06 3.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.892 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' GLN . . . . . 0.431 ' C ' ' O ' ' A' ' 145' ' ' ARG . 19.4 mt-30 -36.09 143.59 0.28 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.598 0.713 . . . . 0.0 110.897 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -78.58 112.13 3.11 Favored 'Trans proline' 0 C--O 1.231 0.142 0 C-N-CA 122.707 2.271 . . . . 0.0 112.324 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.438 ' O ' ' C ' ' A' ' 149' ' ' SER . 71.9 Cg_exo -44.58 -45.85 12.74 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.684 2.256 . . . . 0.0 112.308 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' SER . . . . . 0.438 ' C ' ' O ' ' A' ' 148' ' ' PRO . 2.3 t 35.05 46.63 0.22 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.877 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' HIS . . . . . 0.529 ' O ' ' CG ' ' A' ' 150' ' ' HIS . 12.5 p-80 -165.97 117.42 1.05 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.853 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 23.7 ptt180 -108.62 40.97 1.67 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.899 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 5.8 ttpm? -97.62 162.1 13.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.904 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 59.5 mt -136.92 140.72 42.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.891 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.524 ' HB2' ' HB2' ' A' ' 229' ' ' ALA . 35.5 t80 -107.36 121.05 43.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.915 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.566 HG13 HG22 ' A' ' 226' ' ' VAL . 23.9 t -110.26 132.1 59.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.161 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -133.04 -161.5 9.87 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.512 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 19.5 mmt 49.04 30.55 2.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.819 0.342 . . . . 0.0 110.875 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.401 ' HB2' ' C ' ' A' ' 192' ' ' GLY . 82.0 mt -91.05 166.69 12.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.924 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -108.94 155.82 20.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.882 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 36.2 mttp -81.38 44.73 0.81 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.868 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -127.93 -47.42 1.37 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.922 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 14.8 mm-40 -58.73 162.11 4.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.894 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 45.9 m -135.02 174.44 10.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.854 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.451 ' O ' ' CB ' ' A' ' 168' ' ' ARG . 1.4 mp0 -51.35 -35.62 39.26 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.871 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -63.25 -65.89 0.62 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.904 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -42.21 -57.01 2.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.892 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.733 HG13 ' CE1' ' A' ' 171' ' ' PHE . 75.5 t -62.66 -59.89 3.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.12 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 168' ' ' ARG . . . . . 0.451 ' CB ' ' O ' ' A' ' 164' ' ' GLU . 29.9 ttm-85 -35.29 -63.91 0.31 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.874 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 83.7 mtm180 -59.16 -54.59 45.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.877 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.71 ' O ' ' HB3' ' A' ' 173' ' ' ALA . 16.2 tp -42.8 -66.02 0.41 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.896 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.733 ' CE1' HG13 ' A' ' 167' ' ' VAL . 13.4 m-85 -51.7 -72.06 0.06 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.891 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -41.52 -31.79 0.29 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.915 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.71 ' HB3' ' O ' ' A' ' 170' ' ' LEU . . . -39.62 -30.16 0.07 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.06 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -107.85 -68.83 0.88 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.879 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -111.88 131.75 10.42 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.504 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -48.78 147.71 2.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.852 0.358 . . . . 0.0 110.849 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.639 HG23 ' O ' ' A' ' 197' ' ' LYS . 67.2 mt -112.77 138.66 41.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.119 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 67.7 mm-40 -98.7 -36.23 9.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.842 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -148.6 139.23 22.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.845 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 47.9 t -145.12 138.47 26.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.855 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 18.1 m -152.83 148.94 27.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.199 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 35.2 mm -102.26 134.91 41.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.152 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.597 HD12 ' HB3' ' A' ' 193' ' ' CYS . 29.4 mt -80.81 117.05 21.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.919 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 64.4 mtp180 -132.17 121.14 23.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.843 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -69.48 171.55 40.37 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.513 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -45.57 -41.29 18.65 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.705 2.27 . . . . 0.0 112.332 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -59.92 -40.0 87.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.87 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 121.5 -45.02 1.26 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.484 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -54.07 112.43 0.96 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.812 0.339 . . . . 0.0 110.896 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 23.2 t -45.41 137.58 4.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.826 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.404 ' O ' ' C ' ' A' ' 192' ' ' GLY . 8.7 mtmp? -89.7 47.21 1.44 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.884 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.404 ' C ' ' O ' ' A' ' 191' ' ' LYS . . . 37.37 46.66 1.45 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.507 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 193' ' ' CYS . . . . . 0.597 ' HB3' HD12 ' A' ' 183' ' ' LEU . 87.1 m -155.19 156.69 36.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.852 0.358 . . . . 0.0 110.881 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -160.61 166.86 28.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.085 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 195' ' ' PHE . . . . . 0.459 ' CE2' HD21 ' A' ' 183' ' ' LEU . 26.6 m-85 -119.73 119.6 34.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.905 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.494 HG21 ' CE2' ' A' ' 171' ' ' PHE . 21.9 t -114.04 152.34 15.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.138 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.639 ' O ' HG23 ' A' ' 177' ' ' ILE . 23.0 tttp -135.61 137.3 41.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.913 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -113.31 162.43 16.06 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.876 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 11.8 t -65.95 -52.11 52.59 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.873 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 5.7 t -124.0 170.86 10.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.836 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 201' ' ' HIS . . . . . 0.49 ' O ' ' HB3' ' A' ' 204' ' ' ALA . 6.5 t60 -69.23 -51.03 41.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.854 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -42.74 -64.57 0.59 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.091 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -46.38 -43.07 15.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.88 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 204' ' ' ALA . . . . . 0.49 ' HB3' ' O ' ' A' ' 201' ' ' HIS . . . -53.07 -62.07 1.89 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.134 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 205' ' ' GLN . . . . . 0.556 ' HA ' HD12 ' A' ' 208' ' ' ILE . 50.4 tp60 -46.61 -47.06 20.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.905 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -49.19 -57.88 5.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.118 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -54.72 -44.01 73.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.072 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 208' ' ' ILE . . . . . 0.556 HD12 ' HA ' ' A' ' 205' ' ' GLN . 75.7 mt -51.12 -72.83 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.141 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -54.83 -38.76 67.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.868 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -61.43 -31.4 71.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.111 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 98.5 mt -114.34 -73.85 0.64 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.873 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 212' ' ' HIS . . . . . 0.502 ' N ' ' O ' ' A' ' 208' ' ' ILE . 14.6 t60 -49.5 131.92 20.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.847 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 78.3 -10.24 29.74 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.515 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 25.6 t -99.22 -69.27 0.77 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.818 0.342 . . . . 0.0 110.87 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 7.1 mm-40 -88.11 159.39 18.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.931 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 216' ' ' THR . . . . . 0.47 HG23 ' O ' ' A' ' 222' ' ' SER . 2.9 m -125.34 99.04 5.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.175 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 217' ' ' MET . . . . . 0.409 ' C ' ' O ' ' A' ' 216' ' ' THR . 12.1 mmt -35.96 135.07 0.53 Allowed Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.568 0.699 . . . . 0.0 110.879 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -48.21 121.31 5.93 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.719 2.28 . . . . 0.0 112.331 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 108.06 -48.57 0.93 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.483 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 220' ' ' ALA . . . . . 0.401 ' O ' HG22 ' A' ' 216' ' ' THR . . . -75.15 144.6 42.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.792 0.33 . . . . 0.0 111.117 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 7.0 t -92.65 -16.0 26.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.872 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 222' ' ' SER . . . . . 0.47 ' O ' HG23 ' A' ' 216' ' ' THR . 67.9 m -99.99 138.37 37.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.846 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 66.2 m -52.83 155.71 2.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.857 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.631 HD12 ' H ' ' A' ' 225' ' ' VAL . 50.8 tp -45.57 157.73 0.09 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.89 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 0.631 ' H ' HD12 ' A' ' 224' ' ' LEU . 55.0 t -122.67 104.46 14.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.167 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 226' ' ' VAL . . . . . 0.624 HG23 ' HG ' ' A' ' 224' ' ' LEU . 21.0 t -134.78 108.87 11.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.106 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.94 -179.54 4.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.852 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -80.5 96.9 6.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.865 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 229' ' ' ALA . . . . . 0.524 ' HB2' ' HB2' ' A' ' 154' ' ' PHE . . . -50.39 124.86 11.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.096 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -105.33 130.48 53.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.898 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 14.0 t -52.08 156.32 1.62 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.175 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -115.67 -45.9 2.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.87 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -125.29 81.63 1.99 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.935 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -59.86 122.0 13.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.923 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 5.3 p -108.7 155.96 20.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.835 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 147.42 160.12 8.71 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.472 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -76.73 129.52 10.89 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.66 2.24 . . . . 0.0 112.344 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 6.1 t -68.41 150.7 47.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.881 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 90.4 p -106.68 135.49 48.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.859 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.333 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.513 -179.959 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.339 0 N-CA-C 112.497 -0.241 . . . . 0.0 112.497 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 63.6 p -80.63 80.78 7.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.924 0.392 . . . . 0.0 110.862 -179.752 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 3.7 t -118.64 141.72 48.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.838 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.42 ' O ' ' C ' ' A' ' 140' ' ' SER . . . 47.41 58.66 6.4 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.501 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.42 ' C ' ' O ' ' A' ' 139' ' ' GLY . 19.5 m -36.86 116.43 0.44 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.835 0.35 . . . . 0.0 110.827 -179.771 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 84.1 p -67.16 -46.13 74.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.847 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 138.97 87.94 0.17 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.473 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 68.8 m -104.19 94.29 5.29 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.82 0.343 . . . . 0.0 110.9 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.3 tt -112.72 110.0 19.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.947 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 17.3 ptt180 -143.17 167.05 23.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.914 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -121.2 83.7 39.39 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.604 0.716 . . . . 0.0 110.923 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.415 ' HG2' ' CE1' ' A' ' 201' ' ' HIS . 72.5 Cg_exo -47.26 110.42 0.3 Allowed 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.642 2.228 . . . . 0.0 112.326 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.449 ' O ' ' C ' ' A' ' 149' ' ' SER . 72.3 Cg_exo -43.83 102.46 0.04 OUTLIER 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.705 2.27 . . . . 0.0 112.305 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' SER . . . . . 0.449 ' C ' ' O ' ' A' ' 148' ' ' PRO . 3.4 m -34.65 128.67 0.44 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.864 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' HIS . . . . . 0.463 ' CB ' ' HB3' ' A' ' 228' ' ' PHE . 12.0 m80 -162.77 146.61 11.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.836 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 11.2 tpp180 -103.36 -40.0 6.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.921 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.552 ' HE3' ' CD1' ' A' ' 195' ' ' PHE . 19.1 ttpt -88.71 147.04 24.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.93 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.572 HD12 ' CD1' ' A' ' 198' ' ' TYR . 37.9 mt -121.3 127.44 51.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.924 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -92.37 130.97 37.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.855 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.456 HG22 HG13 ' A' ' 226' ' ' VAL . 39.0 t -121.47 126.8 75.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.167 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -127.97 -172.3 13.19 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.513 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 82.2 mmm 51.38 39.54 24.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.773 0.32 . . . . 0.0 110.89 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.473 HD12 ' HA ' ' A' ' 193' ' ' CYS . 50.7 mt -93.39 171.43 8.92 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.936 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -100.44 160.73 14.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.891 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 24.2 mttp -89.87 34.59 0.84 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.91 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -127.92 -43.62 1.51 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.859 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -47.05 155.94 0.25 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.907 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 5.8 m -132.9 171.88 13.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.871 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.464 ' O ' ' CB ' ' A' ' 168' ' ' ARG . 2.9 mp0 -55.24 -37.68 67.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.882 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -64.96 -44.98 87.62 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.874 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 -60.41 -59.39 5.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.874 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.894 HG13 ' CE1' ' A' ' 171' ' ' PHE . 96.2 t -62.17 -39.3 83.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.144 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 168' ' ' ARG . . . . . 0.464 ' CB ' ' O ' ' A' ' 164' ' ' GLU . 33.2 ttt180 -55.28 -63.13 1.26 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.832 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 74.7 mtt180 -60.91 -54.02 50.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.859 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.722 ' O ' ' HB3' ' A' ' 173' ' ' ALA . 10.0 tp -43.93 -65.64 0.48 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.866 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.894 ' CE1' HG13 ' A' ' 167' ' ' VAL . 10.6 m-85 -51.07 -70.39 0.09 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.879 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -44.14 -30.44 0.77 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.89 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.722 ' HB3' ' O ' ' A' ' 170' ' ' LEU . . . -42.81 -28.05 0.22 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.127 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -106.46 -68.97 0.85 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.889 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -113.42 135.23 12.42 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.521 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -45.71 153.27 0.28 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.784 0.326 . . . . 0.0 110.897 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.416 ' CG2' ' N ' ' A' ' 178' ' ' GLU . 58.2 mt -118.18 153.06 20.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.148 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.416 ' N ' ' CG2' ' A' ' 177' ' ' ILE . 55.6 mt-10 -117.11 -37.72 3.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.885 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -144.7 140.36 28.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.931 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 10.1 t -140.01 134.14 31.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.854 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 86.0 m -153.22 143.74 22.58 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.124 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.407 ' CG1' ' HG3' ' A' ' 164' ' ' GLU . 9.7 mm -104.39 133.31 48.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.141 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.674 HD11 ' CE2' ' A' ' 195' ' ' PHE . 22.1 mt -82.28 116.71 21.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.944 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 79.7 mtm180 -130.64 134.83 47.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.915 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -70.88 168.15 50.27 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.464 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -45.51 -51.02 8.55 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.7 2.266 . . . . 0.0 112.337 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -55.62 -43.23 75.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.843 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 137.55 -50.16 0.83 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.443 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 21.2 m-20 -42.82 125.96 3.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.811 0.339 . . . . 0.0 110.926 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 13.4 t -61.65 136.14 57.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.844 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 34.2 mtmm -84.12 38.12 0.64 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.914 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 43.11 43.38 5.61 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.493 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 193' ' ' CYS . . . . . 0.473 ' HA ' HD12 ' A' ' 158' ' ' LEU . 80.7 m -154.62 159.55 40.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.826 0.346 . . . . 0.0 110.888 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -161.73 169.13 22.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.07 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 195' ' ' PHE . . . . . 0.674 ' CE2' HD11 ' A' ' 183' ' ' LEU . 38.2 m-85 -126.58 122.5 35.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.899 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 9.4 t -123.73 147.97 27.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.14 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -118.09 155.94 29.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.88 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 198' ' ' TYR . . . . . 0.572 ' CD1' HD12 ' A' ' 153' ' ' LEU . 20.8 m-85 -131.58 166.36 21.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.955 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 35.7 t -64.98 -51.54 61.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.858 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 4.8 m -140.51 -177.2 4.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.864 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 201' ' ' HIS . . . . . 0.441 ' O ' ' C ' ' A' ' 202' ' ' ALA . 3.6 t-80 -68.15 -58.68 4.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.852 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 202' ' ' ALA . . . . . 0.441 ' C ' ' O ' ' A' ' 201' ' ' HIS . . . -34.93 -67.09 0.15 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.106 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -47.44 -47.36 26.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.89 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 204' ' ' ALA . . . . . 0.415 ' HB3' ' O ' ' A' ' 201' ' ' HIS . . . -52.36 -63.61 1.09 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.104 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 205' ' ' GLN . . . . . 0.878 ' HA ' HD12 ' A' ' 208' ' ' ILE . 11.0 tp60 -43.36 -45.41 6.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.901 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -52.99 -55.34 24.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.107 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -58.41 -34.67 71.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.139 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 208' ' ' ILE . . . . . 0.878 HD12 ' HA ' ' A' ' 205' ' ' GLN . 82.5 mt -59.94 -72.6 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.078 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 -52.09 -41.69 62.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.901 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -57.04 -40.96 77.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.109 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 64.7 mt -101.92 -71.12 0.73 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.929 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 212' ' ' HIS . . . . . 0.633 ' HD1' ' HA ' ' A' ' 225' ' ' VAL . 31.0 t60 -54.54 128.78 33.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.903 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 80.21 -1.62 79.88 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.456 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 34.0 t -96.65 -74.34 0.57 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.821 0.343 . . . . 0.0 110.892 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -97.3 -177.46 3.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.911 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 216' ' ' THR . . . . . 0.572 HG23 ' O ' ' A' ' 222' ' ' SER . 60.4 m -133.65 100.99 4.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.125 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 33.0 mmt -39.27 135.08 1.12 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.607 0.718 . . . . 0.0 110.869 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -48.34 114.08 1.05 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.703 2.269 . . . . 0.0 112.343 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 119.07 -51.19 0.77 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.485 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -72.77 155.58 39.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.814 0.34 . . . . 0.0 111.069 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 28.7 t -98.16 -21.15 16.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.898 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 222' ' ' SER . . . . . 0.572 ' O ' HG23 ' A' ' 216' ' ' THR . 1.1 t -99.88 154.14 18.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.876 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 57.8 m -58.65 158.54 7.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.832 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.458 ' HG ' HG23 ' A' ' 226' ' ' VAL . 43.1 tp -47.81 152.51 0.73 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.94 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 0.633 ' HA ' ' HD1' ' A' ' 212' ' ' HIS . 98.0 t -118.48 111.46 34.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.139 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 226' ' ' VAL . . . . . 0.458 HG23 ' HG ' ' A' ' 224' ' ' LEU . 23.7 t -138.37 105.36 3.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.098 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 34.3 pttt -129.13 169.73 14.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.897 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 228' ' ' PHE . . . . . 0.463 ' HB3' ' CB ' ' A' ' 150' ' ' HIS . 59.4 m-85 -76.16 127.9 33.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.917 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -71.92 112.97 8.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.144 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 230' ' ' ASP . . . . . 0.408 ' O ' ' C ' ' A' ' 231' ' ' THR . 0.9 OUTLIER -92.63 92.12 7.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.878 179.981 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 231' ' ' THR . . . . . 0.408 ' C ' ' O ' ' A' ' 230' ' ' ASP . 55.4 m -37.35 121.84 0.86 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.119 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -98.07 155.31 17.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.869 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 32.0 pttt -149.45 135.67 19.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.871 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -114.51 96.98 6.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.872 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 41.4 t -97.45 154.67 17.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.835 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 101.98 90.97 2.14 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.508 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -77.88 15.76 1.25 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.668 2.245 . . . . 0.0 112.333 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 3.7 t 39.42 41.45 0.7 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.842 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 58.2 m -62.56 86.54 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.808 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.294 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.487 179.948 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.311 0 N-CA-C 112.492 -0.243 . . . . 0.0 112.492 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 11.1 t -139.93 139.72 36.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.875 0.369 . . . . 0.0 110.828 -179.718 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 94.1 p -51.03 140.22 16.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.884 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -170.43 -155.84 10.71 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.45 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 1.9 m -124.34 41.36 3.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.849 0.357 . . . . 0.0 110.85 -179.73 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 41.6 t -74.89 98.01 3.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.905 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 124.19 -86.86 0.37 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.518 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' CYS . . . . . 0.404 ' C ' HD12 ' A' ' 144' ' ' LEU . 4.6 m -88.06 135.72 33.3 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.868 0.366 . . . . 0.0 110.888 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.404 HD12 ' C ' ' A' ' 143' ' ' CYS . 7.1 mp -127.32 94.01 3.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.919 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 17.9 ttm180 -91.91 121.93 33.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.897 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 -70.89 155.74 92.96 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.572 0.701 . . . . 0.0 110.923 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -77.25 112.06 3.31 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.653 2.235 . . . . 0.0 112.322 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -43.72 159.31 0.09 OUTLIER 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.686 2.257 . . . . 0.0 112.4 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 1.4 t -92.36 -70.51 0.69 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.859 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 46.1 p-80 -39.54 151.53 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.85 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.467 ' CZ ' ' HB2' ' A' ' 151' ' ' ARG . 17.6 ttm105 -125.6 91.16 3.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.905 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.61 ' HB3' ' HB3' ' A' ' 229' ' ' ALA . 12.4 tttt -105.13 151.08 24.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.9 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 44.4 mt -120.53 129.2 53.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.904 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 29.6 t80 -98.01 119.92 37.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.912 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.446 HG21 ' CZ ' ' A' ' 171' ' ' PHE . 21.6 t -110.27 129.1 65.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.102 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -127.69 -170.56 12.86 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.502 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 11.3 mmt 55.59 36.27 26.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.828 0.347 . . . . 0.0 110.937 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.422 ' HB2' ' C ' ' A' ' 192' ' ' GLY . 38.6 mt -95.55 168.93 10.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.872 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.478 ' ND2' ' O ' ' A' ' 218' ' ' PRO . 12.7 m120 -113.59 162.83 15.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.898 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 38.0 mttp -82.62 48.91 1.38 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.911 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -133.27 -49.49 0.85 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.886 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 16.0 mm-40 -56.65 155.52 7.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.899 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 17.1 m -135.51 176.13 8.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.884 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -47.57 -50.52 23.78 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.903 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -54.92 -58.62 6.86 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.839 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -41.84 -66.02 0.39 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.862 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.772 HG13 ' CE1' ' A' ' 171' ' ' PHE . 65.9 t -55.52 -54.77 21.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.113 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 168' ' ' ARG . . . . . 0.439 ' C ' ' O ' ' A' ' 167' ' ' VAL . 43.8 ttt180 -35.23 -70.11 0.09 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.875 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 44.3 mmm-85 -58.04 -53.57 56.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.909 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.664 ' O ' ' HB3' ' A' ' 173' ' ' ALA . 19.5 tp -41.37 -66.83 0.3 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.923 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.772 ' CE1' HG13 ' A' ' 167' ' ' VAL . 9.9 m-85 -55.33 -72.84 0.06 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.858 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.45 ' O ' ' N ' ' A' ' 174' ' ' PHE . 0.5 OUTLIER -39.55 -28.26 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.907 -179.907 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.664 ' HB3' ' O ' ' A' ' 170' ' ' LEU . . . -41.41 -24.18 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.112 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 174' ' ' PHE . . . . . 0.45 ' N ' ' O ' ' A' ' 172' ' ' GLU . 93.7 m-85 -108.09 -69.92 0.83 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.931 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -100.94 -171.64 28.79 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.485 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 33.3 m-20 -98.86 131.67 44.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.771 0.319 . . . . 0.0 110.898 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.417 ' CG2' ' N ' ' A' ' 178' ' ' GLU . 37.1 mt -96.39 151.94 3.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.136 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.417 ' N ' ' CG2' ' A' ' 177' ' ' ILE . 6.8 mt-10 -121.27 -21.51 6.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.905 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -165.85 136.43 3.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.865 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 51.0 t -130.47 141.6 50.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.89 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 83.2 m -153.11 147.65 26.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.158 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 20.1 mm -115.22 137.51 48.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.132 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.699 HD11 ' CE2' ' A' ' 195' ' ' PHE . 34.3 mt -85.57 101.43 12.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.932 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 60.4 mtp180 -119.59 115.42 23.95 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.877 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -42.72 148.19 0.6 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.518 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -45.56 -29.06 4.77 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.678 2.252 . . . . 0.0 112.331 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -70.59 -41.38 72.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.866 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.404 ' O ' ' C ' ' A' ' 189' ' ' ASN . . . 145.16 -67.48 0.42 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.469 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 189' ' ' ASN . . . . . 0.404 ' C ' ' O ' ' A' ' 188' ' ' GLY . 3.5 p30 -37.14 135.67 0.48 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.847 0.356 . . . . 0.0 110.882 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 17.1 t -69.24 143.14 54.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.895 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 24.0 mtpt -89.68 31.55 0.93 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.952 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.422 ' C ' ' HB2' ' A' ' 158' ' ' LEU . . . 47.19 36.82 10.25 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.5 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 63.6 m -151.3 155.83 39.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.848 0.356 . . . . 0.0 110.843 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -161.04 162.21 31.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.072 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 195' ' ' PHE . . . . . 0.699 ' CE2' HD11 ' A' ' 183' ' ' LEU . 58.2 m-85 -117.79 142.36 47.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.848 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 45.6 t -129.82 145.34 35.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.091 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 24.7 tttt -113.5 147.48 37.83 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.879 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -132.4 167.9 19.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.945 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 38.1 t -83.96 -40.08 18.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.856 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 3.5 m -138.26 176.61 8.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.854 -179.771 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 201' ' ' HIS . . . . . 0.431 ' O ' ' C ' ' A' ' 202' ' ' ALA . 5.3 t60 -74.24 -56.44 4.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.866 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 202' ' ' ALA . . . . . 0.431 ' C ' ' O ' ' A' ' 201' ' ' HIS . . . -35.56 -63.21 0.36 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.1 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 31.7 mm-40 -49.4 -49.83 43.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.871 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -51.45 -59.28 4.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.143 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 205' ' ' GLN . . . . . 0.596 ' HA ' HD12 ' A' ' 208' ' ' ILE . 33.8 tp60 -48.27 -55.92 9.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.884 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -44.2 -61.38 1.51 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.067 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -49.05 -49.19 42.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.119 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 208' ' ' ILE . . . . . 0.596 HD12 ' HA ' ' A' ' 205' ' ' GLN . 66.4 mt -49.54 -74.95 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.123 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -44.47 -44.58 8.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.916 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 210' ' ' ALA . . . . . 0.416 ' HB1' ' CZ ' ' A' ' 174' ' ' PHE . . . -54.24 -43.31 70.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.126 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.428 ' CB ' HD23 ' A' ' 224' ' ' LEU . 7.9 mt -100.29 -68.93 0.79 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.934 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 212' ' ' HIS . . . . . 0.639 ' HD1' ' HA ' ' A' ' 225' ' ' VAL . 29.7 t60 -51.6 126.18 16.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.851 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 213' ' ' GLY . . . . . 0.442 ' HA2' ' CB ' ' A' ' 223' ' ' SER . . . 82.02 -19.23 10.35 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.518 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 2.5 m -85.5 -73.08 0.46 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.803 0.335 . . . . 0.0 110.872 -179.733 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 71.1 mt-30 -92.69 167.18 12.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.924 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 216' ' ' THR . . . . . 0.636 HG23 ' O ' ' A' ' 222' ' ' SER . 0.7 OUTLIER -126.95 104.07 7.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.119 -179.917 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 14.5 mmt -39.04 135.23 1.04 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.609 0.719 . . . . 0.0 110.836 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 218' ' ' PRO . . . . . 0.478 ' O ' ' ND2' ' A' ' 159' ' ' ASN . 76.1 Cg_exo -48.72 122.29 7.81 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.684 2.256 . . . . 0.0 112.375 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 105.03 -44.99 1.36 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.509 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -75.54 143.97 42.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.768 0.318 . . . . 0.0 111.091 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 29.9 t -92.59 -15.5 26.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.882 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 222' ' ' SER . . . . . 0.636 ' O ' HG23 ' A' ' 216' ' ' THR . 1.8 m -99.84 146.1 27.0 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.837 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 223' ' ' SER . . . . . 0.442 ' CB ' ' HA2' ' A' ' 213' ' ' GLY . 29.4 m -59.63 150.08 28.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.828 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.428 HD23 ' CB ' ' A' ' 211' ' ' LEU . 62.4 tp -41.78 151.62 0.09 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.935 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 0.639 ' HA ' ' HD1' ' A' ' 212' ' ' HIS . 60.1 t -118.34 113.83 43.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.171 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 226' ' ' VAL . . . . . 0.595 HG12 HG12 ' A' ' 208' ' ' ILE . 46.0 t -136.92 105.2 3.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.153 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 8.3 ptmt -122.14 169.25 11.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.895 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -79.61 117.39 20.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.915 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 229' ' ' ALA . . . . . 0.61 ' HB3' ' HB3' ' A' ' 152' ' ' LYS . . . -78.82 113.91 17.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.11 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -130.31 76.88 1.75 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.896 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 53.2 m -148.96 125.69 11.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.141 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -60.11 158.3 11.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.842 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 233' ' ' LYS . . . . . 0.402 ' HD2' ' C ' ' A' ' 233' ' ' LYS . 0.7 OUTLIER -111.28 -58.17 2.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.892 -179.992 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -40.48 142.23 0.44 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.852 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 36.4 p -108.9 96.89 6.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.836 -179.798 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 147.58 95.21 0.16 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.55 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -75.94 90.56 1.15 Allowed 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.707 2.271 . . . . 0.0 112.327 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 3.3 m -68.68 176.42 2.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.848 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 68.5 m -146.16 107.46 4.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.856 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.496 -180.0 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 N-CA-C 112.522 -0.231 . . . . 0.0 112.522 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 67.7 m -65.81 160.45 23.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.823 0.344 . . . . 0.0 110.909 -179.72 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 22.6 m -45.18 113.61 0.6 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.857 -179.791 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 86.45 96.5 0.82 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.53 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 1.4 t -121.28 147.05 46.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.877 0.37 . . . . 0.0 110.878 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 2.1 m -106.2 98.93 8.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.835 -179.811 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -132.38 -149.95 6.39 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.49 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 70.1 m -143.89 146.41 32.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.82 0.343 . . . . 0.0 110.875 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.7 pp -169.08 140.44 2.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.906 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 10.8 ttp180 -155.78 151.3 27.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.872 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 33.4 mm-40 -106.96 93.46 9.07 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.587 0.708 . . . . 0.0 110.894 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -74.97 168.19 25.39 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.689 2.259 . . . . 0.0 112.375 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -75.72 170.2 20.68 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.681 2.254 . . . . 0.0 112.332 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 4.8 t -97.3 -45.53 6.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.843 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 8.0 p80 -86.59 94.38 9.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.906 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 12.8 ptt180 -117.09 103.61 10.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.868 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.568 ' HD3' ' CD1' ' A' ' 195' ' ' PHE . 24.4 ttmt -130.71 159.11 38.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.899 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.622 HD21 ' CE1' ' A' ' 228' ' ' PHE . 58.0 mt -127.2 121.81 32.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.882 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -95.13 127.03 40.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.864 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.634 HG21 ' HZ ' ' A' ' 171' ' ' PHE . 59.1 t -114.47 133.81 59.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.149 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -128.97 -159.58 9.99 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.49 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 27.8 mtt 41.84 39.88 1.37 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.817 0.341 . . . . 0.0 110.86 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 42.8 mt -95.43 161.4 14.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.943 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.483 ' ND2' ' O ' ' A' ' 218' ' ' PRO . 69.2 m-20 -100.35 165.97 11.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.861 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 65.4 mttt -89.72 40.97 1.02 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.842 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 18.9 mm-40 -127.31 -53.17 1.38 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.858 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -55.13 148.82 13.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.926 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 1.6 t -133.81 176.42 8.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.84 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -47.93 -42.64 27.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.862 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -50.55 -57.66 7.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.89 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 166' ' ' ASP . . . . . 0.404 ' O ' ' HG2' ' A' ' 169' ' ' ARG . 6.5 m-20 -61.21 -66.63 0.5 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.923 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.604 HG13 ' CE1' ' A' ' 171' ' ' PHE . 59.8 t -42.02 -35.32 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.094 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 25.0 ttm180 -63.88 -61.24 2.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.873 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' ARG . . . . . 0.404 ' HG2' ' O ' ' A' ' 166' ' ' ASP . 31.6 ptt180 -63.09 -52.13 63.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.887 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.729 ' O ' ' HB3' ' A' ' 173' ' ' ALA . 8.5 tp -44.23 -65.69 0.48 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.89 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.634 ' HZ ' HG21 ' A' ' 155' ' ' VAL . 14.0 m-85 -53.28 -69.41 0.12 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.888 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -44.32 -26.05 0.3 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.94 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.729 ' HB3' ' O ' ' A' ' 170' ' ' LEU . . . -46.74 -20.49 0.13 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.142 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -116.14 -73.61 0.64 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.909 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -109.45 147.22 16.96 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.536 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -52.5 157.58 1.47 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.823 0.344 . . . . 0.0 110.903 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.451 HG23 ' O ' ' A' ' 197' ' ' LYS . 98.0 mt -122.37 147.55 26.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.143 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -102.4 -45.91 4.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.901 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -153.71 151.36 29.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.879 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 52.2 t -138.11 143.28 40.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.893 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 98.5 m -152.17 138.95 18.87 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.119 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 21.3 mm -93.72 127.86 45.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.158 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 1.0 HD11 ' CE2' ' A' ' 195' ' ' PHE . 65.6 mt -90.12 104.61 17.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.899 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 184' ' ' ARG . . . . . 0.476 ' CB ' ' HA ' ' A' ' 190' ' ' SER . 16.7 ptt180 -162.29 150.12 14.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.896 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -61.02 -177.47 2.03 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.54 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -76.71 -14.78 17.42 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.709 2.273 . . . . 0.0 112.321 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -66.93 -47.13 72.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.903 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.447 ' O ' ' N ' ' A' ' 190' ' ' SER . . . 131.8 -45.96 1.1 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.502 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 189' ' ' ASN . . . . . 0.419 ' O ' ' C ' ' A' ' 190' ' ' SER . 24.3 m-80 -49.94 90.43 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.83 0.348 . . . . 0.0 110.932 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 190' ' ' SER . . . . . 0.476 ' HA ' ' CB ' ' A' ' 184' ' ' ARG . 9.3 p -36.14 141.93 0.09 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.841 -179.868 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.437 ' CG ' ' HA ' ' A' ' 184' ' ' ARG . 28.9 mmtt -94.71 39.87 1.1 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.927 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 39.21 42.79 1.79 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.435 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 71.5 m -154.85 150.01 27.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.834 0.349 . . . . 0.0 110.905 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -161.39 162.91 30.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.075 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 195' ' ' PHE . . . . . 1.0 ' CE2' HD11 ' A' ' 183' ' ' LEU . 28.0 m-85 -116.98 143.12 46.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.896 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.53 HG11 ' CD2' ' A' ' 171' ' ' PHE . 40.3 t -140.13 138.2 37.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.125 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.451 ' O ' HG23 ' A' ' 177' ' ' ILE . 8.0 ttmm -118.91 148.29 43.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.879 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -122.82 172.22 8.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.93 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 1.2 t -76.14 -49.99 15.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.854 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 58.7 m -125.51 -178.19 4.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.854 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 201' ' ' HIS . . . . . 0.432 ' O ' ' C ' ' A' ' 202' ' ' ALA . 9.8 t60 -79.66 -63.14 1.48 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.885 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 202' ' ' ALA . . . . . 0.432 ' C ' ' O ' ' A' ' 201' ' ' HIS . . . -34.35 -60.65 0.41 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.085 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -48.02 -50.42 27.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.93 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -51.99 -59.05 4.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.072 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 205' ' ' GLN . . . . . 0.794 ' HA ' HD12 ' A' ' 208' ' ' ILE . 13.1 tp60 -44.91 -49.34 11.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.881 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -51.29 -58.32 6.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.131 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -52.59 -37.54 58.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.126 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 208' ' ' ILE . . . . . 0.794 HD12 ' HA ' ' A' ' 205' ' ' GLN . 77.0 mt -59.23 -74.06 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.095 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -49.92 -42.52 48.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.898 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -53.31 -45.6 69.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.126 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 57.2 mt -99.99 -67.69 0.84 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.9 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 212' ' ' HIS . . . . . 0.491 ' N ' ' O ' ' A' ' 208' ' ' ILE . 9.2 t60 -51.46 127.79 20.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.846 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 77.63 -9.97 26.55 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.472 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 8.3 t -97.74 -66.55 0.89 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.84 0.352 . . . . 0.0 110.879 -179.766 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 7.3 mm-40 -92.31 163.66 13.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.919 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 216' ' ' THR . . . . . 0.609 HG23 ' O ' ' A' ' 222' ' ' SER . 3.9 m -131.09 101.28 5.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.129 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 217' ' ' MET . . . . . 0.436 ' C ' ' O ' ' A' ' 216' ' ' THR . 0.0 OUTLIER -34.69 131.07 0.45 Allowed Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.548 0.69 . . . . 0.0 110.886 179.859 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 218' ' ' PRO . . . . . 0.483 ' O ' ' ND2' ' A' ' 159' ' ' ASN . 75.6 Cg_exo -48.89 120.29 5.25 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.699 2.266 . . . . 0.0 112.35 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 107.78 -45.03 1.36 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.499 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -73.48 142.11 46.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.812 0.339 . . . . 0.0 111.084 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 35.6 m -89.17 -16.55 31.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.836 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 222' ' ' SER . . . . . 0.609 ' O ' HG23 ' A' ' 216' ' ' THR . 3.9 m -99.87 143.24 30.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.841 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 95.8 p -63.32 152.46 37.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.873 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 27.0 tp -48.0 146.85 2.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.894 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 0.417 ' HA ' ' HD1' ' A' ' 212' ' ' HIS . 68.6 t -119.5 118.27 56.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.129 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 226' ' ' VAL . . . . . 0.468 HG22 HG22 ' A' ' 155' ' ' VAL . 38.7 t -141.12 116.95 6.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.152 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 18.3 pttt -131.81 172.29 12.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.888 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 228' ' ' PHE . . . . . 0.622 ' CE1' HD21 ' A' ' 153' ' ' LEU . 54.8 m-85 -82.15 95.0 7.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.89 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 229' ' ' ALA . . . . . 0.426 ' C ' ' O ' ' A' ' 228' ' ' PHE . . . -34.75 122.13 0.53 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.071 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 -163.55 117.76 1.58 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.854 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 29.2 p -102.03 99.16 9.29 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.12 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -166.16 158.5 14.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.833 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 19.9 ttmt -86.86 -56.81 3.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.885 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 234' ' ' GLU . . . . . 0.446 ' HG2' ' N ' ' A' ' 235' ' ' SER . 18.6 tt0 -159.15 150.79 20.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.862 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 235' ' ' SER . . . . . 0.446 ' N ' ' HG2' ' A' ' 234' ' ' GLU . 55.7 m -108.34 175.91 5.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.905 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 156.44 146.68 4.53 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.494 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -77.08 136.59 16.48 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.697 2.265 . . . . 0.0 112.329 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 238' ' ' SER . . . . . 0.416 ' O ' ' C ' ' A' ' 239' ' ' SER . 13.6 t -62.17 101.79 0.25 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.886 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 239' ' ' SER . . . . . 0.416 ' C ' ' O ' ' A' ' 238' ' ' SER . 4.7 t -36.97 -49.56 0.83 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.864 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.345 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.508 -179.982 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.343 0 N-CA-C 112.477 -0.249 . . . . 0.0 112.477 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 12.7 m -128.32 41.77 3.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.905 0.383 . . . . 0.0 110.867 -179.728 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 28.8 p 45.06 42.06 6.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.841 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -159.28 179.6 34.77 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.481 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 88.1 p -81.38 136.02 35.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.859 0.361 . . . . 0.0 110.862 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 7.7 t -104.03 42.8 1.15 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.813 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -172.03 143.81 7.68 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.492 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 2.2 m -152.8 126.72 8.99 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.86 0.362 . . . . 0.0 110.924 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -43.83 158.65 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.938 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 34.6 mtt-85 -137.72 116.61 12.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.906 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 4.0 pp0? -70.78 143.79 89.93 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.574 0.702 . . . . 0.0 110.929 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -78.24 111.18 3.01 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.672 2.248 . . . . 0.0 112.319 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -74.33 94.01 0.91 Allowed 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.734 2.29 . . . . 0.0 112.381 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 67.4 p -83.61 38.4 0.62 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.888 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 34.1 p-80 -142.43 145.27 33.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.888 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 14.5 mtm-85 -130.95 68.41 1.49 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.875 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.901 ' HB3' ' HB3' ' A' ' 229' ' ' ALA . 9.4 tttp -134.51 159.44 41.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.912 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.492 HD21 HD11 ' A' ' 208' ' ' ILE . 41.8 mt -133.92 121.05 21.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.89 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -93.86 118.37 31.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.841 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.715 HG22 HG13 ' A' ' 226' ' ' VAL . 16.5 t -106.35 131.9 54.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.098 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -130.41 -164.04 11.2 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.507 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 18.7 mmt 40.19 37.95 0.47 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.786 0.327 . . . . 0.0 110.846 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.466 HD21 ' CG1' ' A' ' 155' ' ' VAL . 83.8 mt -85.37 174.01 9.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.914 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.494 ' OD1' ' N ' ' A' ' 160' ' ' LYS . 60.1 t-20 -105.72 150.85 25.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.89 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 160' ' ' LYS . . . . . 0.494 ' N ' ' OD1' ' A' ' 159' ' ' ASN . 10.3 mptt -86.42 29.45 0.77 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.865 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 15.9 tm0? -111.48 -55.07 2.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.941 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -68.24 163.74 22.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.934 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 58.7 m -130.36 178.75 6.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.866 -179.754 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -46.9 -41.08 15.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.919 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -55.05 -61.93 1.99 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.826 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -46.8 -55.4 7.97 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.873 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.86 HG13 ' CE1' ' A' ' 171' ' ' PHE . 89.7 t -58.3 -40.27 77.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.104 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 168' ' ' ARG . . . . . 0.427 ' NH1' ' OE1' ' A' ' 172' ' ' GLU . 2.4 tmm_? -52.67 -62.92 1.34 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.866 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 9.7 mmm180 -59.39 -54.72 43.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.861 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.717 ' O ' ' HB3' ' A' ' 173' ' ' ALA . 9.4 tp -42.73 -66.24 0.39 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.883 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.86 ' CE1' HG13 ' A' ' 167' ' ' VAL . 13.5 m-85 -51.32 -71.85 0.06 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.896 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.455 ' O ' ' N ' ' A' ' 174' ' ' PHE . 3.9 pt-20 -41.9 -31.53 0.34 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.927 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.717 ' HB3' ' O ' ' A' ' 170' ' ' LEU . . . -41.11 -24.44 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.057 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 174' ' ' PHE . . . . . 0.455 ' N ' ' O ' ' A' ' 172' ' ' GLU . 81.1 m-85 -113.96 -72.62 0.69 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.844 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -104.8 134.35 11.97 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.519 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 34.4 m-20 -49.4 149.16 2.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.791 0.329 . . . . 0.0 110.912 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.408 HD11 ' CB ' ' A' ' 171' ' ' PHE . 70.9 mt -114.07 150.02 16.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.162 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -117.27 -25.68 6.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.925 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -158.19 160.37 37.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.918 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 8.0 t -162.29 141.98 9.65 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.83 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 93.2 m -148.6 139.94 23.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.136 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.418 HD13 ' HB1' ' A' ' 194' ' ' ALA . 48.9 mm -102.18 119.3 50.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.119 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.472 HD11 ' CE2' ' A' ' 195' ' ' PHE . 30.8 mt -80.56 120.24 24.26 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.922 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 184' ' ' ARG . . . . . 0.482 ' O ' ' N ' ' A' ' 189' ' ' ASN . 98.4 mtt180 -119.74 30.21 7.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.893 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 56.88 157.34 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.437 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -48.83 -43.65 34.26 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.692 2.262 . . . . 0.0 112.333 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -54.18 -48.72 70.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.845 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 122.53 30.03 1.22 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.483 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 189' ' ' ASN . . . . . 0.482 ' N ' ' O ' ' A' ' 184' ' ' ARG . 47.4 m-20 -128.12 133.26 48.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.824 0.345 . . . . 0.0 110.853 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 4.8 t -39.04 131.76 1.38 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.842 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 24.2 mmtt -116.88 34.42 5.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.95 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 47.76 35.9 12.61 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.444 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 75.0 m -148.18 150.48 33.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.765 0.316 . . . . 0.0 110.9 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.418 ' HB1' HD13 ' A' ' 182' ' ' ILE . . . -160.64 152.43 19.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.113 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 195' ' ' PHE . . . . . 0.472 ' CE2' HD11 ' A' ' 183' ' ' LEU . 25.6 m-85 -102.08 137.42 40.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.895 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.541 HG21 ' CE2' ' A' ' 171' ' ' PHE . 59.1 t -127.42 144.88 35.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.132 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 49.6 tttt -124.21 138.17 54.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.899 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 198' ' ' TYR . . . . . 0.453 ' CD1' HD12 ' A' ' 153' ' ' LEU . 19.4 m-85 -118.1 173.54 6.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.923 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 48.3 t -81.38 -47.65 12.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.869 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 2.9 t -132.84 153.97 50.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.874 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 201' ' ' HIS . . . . . 0.441 ' O ' ' C ' ' A' ' 202' ' ' ALA . 23.4 t-80 -52.75 -61.32 2.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.827 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 202' ' ' ALA . . . . . 0.441 ' C ' ' O ' ' A' ' 201' ' ' HIS . . . -34.06 -62.53 0.31 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.168 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -47.2 -43.42 21.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.849 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 204' ' ' ALA . . . . . 0.425 ' N ' ' O ' ' A' ' 201' ' ' HIS . . . -57.77 -55.14 38.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.095 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 205' ' ' GLN . . . . . 0.403 ' HA ' HD12 ' A' ' 208' ' ' ILE . 3.8 tp60 -50.23 -43.35 52.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.907 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -56.59 -57.64 11.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.107 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -56.87 -35.44 68.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.144 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 208' ' ' ILE . . . . . 0.496 ' O ' ' N ' ' A' ' 212' ' ' HIS . 78.2 mt -59.72 -75.12 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.107 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -47.39 -42.49 22.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.862 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -56.05 -43.46 77.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.119 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 33.0 mt -99.96 -69.08 0.78 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.922 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 212' ' ' HIS . . . . . 0.496 ' N ' ' O ' ' A' ' 208' ' ' ILE . 1.7 t60 -49.7 131.15 21.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.854 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 72.31 1.95 52.48 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.475 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 6.2 t -94.53 -71.29 0.67 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.814 0.34 . . . . 0.0 110.863 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 17.3 pm0 -100.33 175.75 5.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.895 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 216' ' ' THR . . . . . 0.442 ' O ' ' C ' ' A' ' 217' ' ' MET . 4.6 m -134.97 97.87 3.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.159 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 217' ' ' MET . . . . . 0.442 ' C ' ' O ' ' A' ' 216' ' ' THR . 12.4 mmt -34.56 133.18 0.42 Allowed Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.6 0.715 . . . . 0.0 110.868 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -49.01 119.52 4.48 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.68 2.254 . . . . 0.0 112.383 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 112.27 -50.82 0.74 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.516 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -73.03 152.84 41.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.821 0.343 . . . . 0.0 111.093 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 3.6 t -96.69 -19.51 18.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.869 -179.81 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 1.3 p -99.47 134.85 41.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.865 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 223' ' ' SER . . . . . 0.436 ' O ' ' C ' ' A' ' 224' ' ' LEU . 3.5 m -58.02 151.23 18.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.859 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.462 ' HG ' HG23 ' A' ' 226' ' ' VAL . 21.7 tp -35.57 141.76 0.08 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.933 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 90.8 t -114.77 109.2 27.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.146 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 226' ' ' VAL . . . . . 0.715 HG13 HG22 ' A' ' 155' ' ' VAL . 6.3 t -132.01 105.96 10.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.134 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 227' ' ' LYS . . . . . 0.411 ' NZ ' ' OD2' ' A' ' 230' ' ' ASP . 11.0 pttp -121.34 -179.1 3.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.871 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -83.34 107.95 16.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.826 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 229' ' ' ALA . . . . . 0.901 ' HB3' ' HB3' ' A' ' 152' ' ' LYS . . . -43.09 117.08 1.0 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.046 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 230' ' ' ASP . . . . . 0.411 ' OD2' ' NZ ' ' A' ' 227' ' ' LYS . 3.7 p30 -100.99 128.64 46.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.879 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 38.1 p -133.42 169.99 16.13 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.16 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -158.56 119.0 3.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.882 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 45.7 mtpt -76.4 157.54 32.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.911 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -57.49 -56.55 20.41 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.894 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 33.9 t -73.66 80.43 1.52 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.853 -179.792 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -67.67 -169.1 4.36 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.508 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -77.08 110.33 3.0 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.7 2.266 . . . . 0.0 112.336 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 2.2 m -70.31 100.48 1.73 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.853 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 29.9 m -73.39 128.07 34.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.847 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.302 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.519 -179.96 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 N-CA-C 112.524 -0.23 . . . . 0.0 112.524 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 41.0 t -112.89 114.34 26.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.907 0.384 . . . . 0.0 110.829 -179.718 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 1.8 m -95.76 112.56 24.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.839 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 144.46 91.2 0.12 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.502 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 20.8 t -103.1 108.86 20.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.863 0.363 . . . . 0.0 110.895 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 6.2 m -109.98 157.52 19.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.86 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -174.87 -168.66 35.82 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.499 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 27.2 p -69.67 89.8 0.55 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.835 0.35 . . . . 0.0 110.901 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.451 ' O ' ' C ' ' A' ' 145' ' ' ARG . 3.7 mm? -76.06 -43.55 43.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.887 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.456 ' HG3' ' NE2' ' A' ' 146' ' ' GLN . 0.0 OUTLIER -34.55 -39.28 0.08 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.877 179.964 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 146' ' ' GLN . . . . . 0.456 ' NE2' ' HG3' ' A' ' 145' ' ' ARG . 5.5 pm0 -172.05 143.7 1.38 Allowed Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.599 0.714 . . . . 0.0 110.944 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -78.27 147.57 23.29 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.66 2.24 . . . . 0.0 112.326 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -46.99 162.13 0.17 Allowed 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.658 2.239 . . . . 0.0 112.345 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 66.8 m -60.44 -68.02 0.34 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.869 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 38.0 p-80 -72.52 117.05 13.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.904 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 3.6 ptp85 -106.86 42.9 1.22 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.873 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 11.4 tttp -93.11 160.59 14.79 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.928 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 73.4 mt -133.75 129.82 37.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.861 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -97.38 116.44 29.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.902 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.469 HG22 HG13 ' A' ' 226' ' ' VAL . 47.8 t -110.27 135.46 49.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.134 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -134.31 -156.55 7.88 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.49 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 10.9 mmt 39.49 33.36 0.11 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.819 0.343 . . . . 0.0 110.852 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.418 ' HB2' ' C ' ' A' ' 192' ' ' GLY . 63.9 mt -85.03 169.4 14.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.935 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.461 ' ND2' ' HD2' ' A' ' 218' ' ' PRO . 7.4 p30 -103.44 163.55 12.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.892 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 29.4 mttt -97.96 23.08 8.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.907 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 2.3 tp-100 -109.85 -46.57 3.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.892 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 19.5 mt-30 -65.7 172.24 3.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.908 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 66.7 m -139.69 -177.44 4.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.905 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -59.07 -37.72 77.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.909 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -59.74 -50.82 72.33 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.868 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 39.6 m-20 -58.69 -56.55 20.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.876 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.615 HG13 ' CE1' ' A' ' 171' ' ' PHE . 19.5 t -63.09 -28.29 44.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.08 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 41.7 ttm-85 -63.76 -56.25 16.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.852 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 70.7 mtm180 -62.29 -55.11 31.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.912 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.765 ' O ' ' HB3' ' A' ' 173' ' ' ALA . 9.1 tp -43.38 -65.15 0.52 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.913 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.615 ' CE1' HG13 ' A' ' 167' ' ' VAL . 8.5 m-85 -50.78 -69.29 0.12 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.874 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -46.3 -26.48 0.82 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.877 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.765 ' HB3' ' O ' ' A' ' 170' ' ' LEU . . . -49.36 -19.45 0.52 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.063 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -113.48 -74.68 0.62 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.883 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -107.5 151.56 16.92 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.492 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 46.6 m-80 -62.31 132.71 53.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.797 0.332 . . . . 0.0 110.927 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.421 HG21 ' SG ' ' A' ' 180' ' ' CYS . 84.2 mt -92.25 138.99 18.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.123 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -100.35 -30.48 11.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.915 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -164.54 142.0 6.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.888 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 180' ' ' CYS . . . . . 0.447 ' SG ' HG13 ' A' ' 196' ' ' VAL . 1.8 m -137.21 138.24 39.96 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.911 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 60.4 m -151.12 132.82 14.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.146 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 44.5 mm -98.52 143.24 13.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.132 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.747 HD11 ' CE2' ' A' ' 195' ' ' PHE . 52.7 mt -95.89 125.89 40.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.896 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 184' ' ' ARG . . . . . 0.457 ' CZ ' ' HB2' ' A' ' 184' ' ' ARG . 18.4 mtm105 -130.64 113.58 14.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.851 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -44.81 156.31 0.28 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.504 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -45.88 -39.78 19.44 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.681 2.254 . . . . 0.0 112.354 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -57.33 -44.1 83.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.881 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 140.02 -43.69 1.12 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.51 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 17.5 m-80 -60.85 147.88 41.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.814 0.34 . . . . 0.0 110.919 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 30.7 t -68.52 140.72 55.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.858 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 63.6 mttt -94.04 37.59 1.09 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.913 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.418 ' C ' ' HB2' ' A' ' 158' ' ' LEU . . . 43.32 40.99 4.89 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.497 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 4.4 p -150.03 151.48 33.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.798 0.333 . . . . 0.0 110.941 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -160.62 150.96 18.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.069 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 195' ' ' PHE . . . . . 0.747 ' CE2' HD11 ' A' ' 183' ' ' LEU . 50.2 m-85 -108.72 116.3 31.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.914 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.609 HG11 ' CD2' ' A' ' 171' ' ' PHE . 38.8 t -110.04 146.97 14.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.122 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 34.4 tttp -127.1 160.26 31.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.876 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -137.65 164.79 27.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.909 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 41.2 t -71.61 -39.38 70.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.851 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 2.4 t -136.02 171.78 13.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.818 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 201' ' ' HIS . . . . . 0.408 ' O ' ' C ' ' A' ' 202' ' ' ALA . 40.1 t-80 -69.4 -57.05 5.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.855 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 202' ' ' ALA . . . . . 0.408 ' C ' ' O ' ' A' ' 201' ' ' HIS . . . -36.75 -61.39 0.54 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.148 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -47.53 -50.58 23.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.865 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -51.43 -57.59 8.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.073 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 205' ' ' GLN . . . . . 0.511 ' C ' ' CD ' ' A' ' 205' ' ' GLN . 0.0 OUTLIER -47.67 -68.13 0.21 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.887 -179.898 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 206' ' ' ALA . . . . . 0.407 ' C ' ' O ' ' A' ' 205' ' ' GLN . . . -37.02 -51.82 0.95 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.106 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -59.72 -43.23 94.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.105 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 208' ' ' ILE . . . . . 0.489 ' O ' ' N ' ' A' ' 212' ' ' HIS . 82.5 mt -56.23 -70.28 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.078 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -54.12 -40.29 67.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.827 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -56.03 -34.07 65.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.122 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 57.8 mt -112.35 -70.83 0.79 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.901 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 212' ' ' HIS . . . . . 0.489 ' N ' ' O ' ' A' ' 208' ' ' ILE . 2.9 t60 -44.28 126.77 5.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.868 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 213' ' ' GLY . . . . . 0.416 ' CA ' ' HB3' ' A' ' 223' ' ' SER . . . 82.15 -28.1 3.4 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.507 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 25.7 m -90.15 -67.26 0.86 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.819 0.342 . . . . 0.0 110.88 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 -83.3 143.43 30.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.921 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 216' ' ' THR . . . . . 0.684 HG23 ' O ' ' A' ' 222' ' ' SER . 24.3 m -120.15 100.0 6.93 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.158 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 217' ' ' MET . . . . . 0.402 ' C ' ' O ' ' A' ' 216' ' ' THR . 13.6 mmt -37.37 132.65 0.78 Allowed Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.596 0.713 . . . . 0.0 110.907 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 218' ' ' PRO . . . . . 0.461 ' HD2' ' ND2' ' A' ' 159' ' ' ASN . 75.2 Cg_exo -48.55 122.42 7.83 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.65 2.233 . . . . 0.0 112.32 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 112.54 -52.29 0.65 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.51 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -68.79 150.49 47.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.826 0.346 . . . . 0.0 111.069 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 88.1 p -96.33 -18.36 20.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.903 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 222' ' ' SER . . . . . 0.684 ' O ' HG23 ' A' ' 216' ' ' THR . 1.4 t -100.08 146.96 26.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.852 -179.8 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 223' ' ' SER . . . . . 0.416 ' HB3' ' CA ' ' A' ' 213' ' ' GLY . 73.0 m -58.9 155.83 12.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.887 -179.799 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.441 HD23 ' N ' ' A' ' 212' ' ' HIS . 32.4 tp -49.35 156.09 0.64 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.979 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 0.416 ' N ' ' HG ' ' A' ' 224' ' ' LEU . 57.9 t -127.57 108.17 17.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.124 179.822 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 226' ' ' VAL . . . . . 0.469 HG13 HG22 ' A' ' 155' ' ' VAL . 41.2 t -135.03 101.63 3.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.126 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 19.5 pttt -119.01 170.34 9.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.876 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -71.53 104.33 3.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.942 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -50.49 140.01 14.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.12 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -114.56 112.75 23.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.849 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 9.8 t -73.74 -23.03 59.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.135 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -137.77 168.26 20.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.863 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 16.7 ptmt -132.51 164.46 26.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.884 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -123.11 130.5 52.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.884 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 92.3 p -167.33 127.48 1.45 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.879 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -124.44 93.12 0.45 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.526 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -76.56 164.43 30.5 Favored 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.695 2.264 . . . . 0.0 112.313 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 238' ' ' SER . . . . . 0.441 ' O ' ' C ' ' A' ' 239' ' ' SER . 22.9 t -166.56 149.17 6.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.867 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 239' ' ' SER . . . . . 0.441 ' C ' ' O ' ' A' ' 238' ' ' SER . 47.4 m -34.52 -48.73 0.37 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.844 -179.801 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.293 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.477 -179.986 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.287 0 N-CA-C 112.438 -0.265 . . . . 0.0 112.438 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 2.2 m -104.26 -49.06 3.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.88 0.371 . . . . 0.0 110.892 -179.724 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 9.6 m -80.65 102.66 9.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.824 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 136.98 56.26 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.524 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 32.6 p -91.53 42.48 1.1 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.856 0.36 . . . . 0.0 110.838 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 52.8 p -78.95 135.51 36.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.823 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -169.08 143.33 7.95 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.481 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 86.8 m -119.01 143.27 47.16 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.811 0.338 . . . . 0.0 110.892 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.532 ' C ' HD12 ' A' ' 144' ' ' LEU . 3.4 pp -117.31 141.19 48.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.937 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -104.29 162.32 13.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.907 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -65.54 141.39 97.91 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.612 0.72 . . . . 0.0 110.946 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -78.45 112.25 3.15 Favored 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.725 2.283 . . . . 0.0 112.325 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -45.19 173.11 0.02 OUTLIER 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.678 2.252 . . . . 0.0 112.323 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 59.9 p -94.4 41.16 1.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.854 -179.825 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 19.0 m80 -141.41 118.25 11.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.904 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 10.7 ttm180 -78.93 77.36 5.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.857 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.647 ' HB3' ' HB3' ' A' ' 229' ' ' ALA . 5.7 tttp -140.16 156.03 46.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.898 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.589 HD12 ' CD1' ' A' ' 198' ' ' TYR . 36.6 mt -130.09 125.11 34.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.9 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -96.73 113.85 25.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.863 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.551 HG13 HG22 ' A' ' 226' ' ' VAL . 22.2 t -104.46 127.65 58.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.135 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.474 ' O ' ' N ' ' A' ' 158' ' ' LEU . . . -128.63 -154.01 8.19 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.434 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.442 ' C ' ' O ' ' A' ' 156' ' ' GLY . 31.0 mtt 34.66 34.15 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.776 0.322 . . . . 0.0 110.868 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.474 ' N ' ' O ' ' A' ' 156' ' ' GLY . 58.5 mt -83.24 174.79 10.44 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.927 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.484 ' ND2' ' H ' ' A' ' 162' ' ' GLN . 3.2 p-10 -104.77 150.17 25.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.906 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 39.3 mttp -85.39 32.5 0.56 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.875 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -120.32 -54.38 2.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.925 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.484 ' H ' ' ND2' ' A' ' 159' ' ' ASN . 3.6 pt20 -56.48 156.78 5.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.919 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 23.0 m -128.13 -177.1 4.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.864 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -51.54 -41.47 61.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.861 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -57.98 -59.29 5.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.863 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -48.73 -61.03 2.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.858 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.827 HG13 ' CE1' ' A' ' 171' ' ' PHE . 91.9 t -55.14 -45.06 77.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.136 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 33.3 mtp180 -51.62 -58.31 6.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.862 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 47.8 mtp180 -62.73 -54.56 37.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.886 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.794 ' O ' ' HB3' ' A' ' 173' ' ' ALA . 11.0 tp -44.14 -65.06 0.56 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.9 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.827 ' CE1' HG13 ' A' ' 167' ' ' VAL . 13.2 m-85 -50.6 -68.36 0.18 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.845 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -47.31 -23.52 0.58 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.849 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.794 ' HB3' ' O ' ' A' ' 170' ' ' LEU . . . -54.19 -14.45 1.13 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.065 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -123.12 -69.01 0.85 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.872 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -113.57 148.05 18.64 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.499 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 35.4 m120 -55.96 153.86 8.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.801 0.334 . . . . 0.0 110.916 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.512 HD11 ' CB ' ' A' ' 171' ' ' PHE . 73.8 mt -118.31 151.51 20.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.162 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -108.85 -39.87 5.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.919 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -164.99 131.93 2.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.933 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 42.3 t -120.78 139.29 53.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.876 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 53.3 m -147.75 129.99 15.59 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.162 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 17.4 mm -93.48 130.32 42.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.146 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.592 HD11 ' CE2' ' A' ' 195' ' ' PHE . 77.7 mt -95.34 109.67 21.79 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.945 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 184' ' ' ARG . . . . . 0.443 ' HB3' ' N ' ' A' ' 190' ' ' SER . 20.5 mtp180 -126.01 26.86 6.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.9 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 62.23 149.89 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.498 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -45.61 -21.04 0.74 Allowed 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.702 2.268 . . . . 0.0 112.334 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -76.92 -41.73 42.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.871 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 119.05 -10.69 11.84 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.483 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -77.46 114.22 16.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.806 0.336 . . . . 0.0 110.912 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 190' ' ' SER . . . . . 0.443 ' N ' ' HB3' ' A' ' 184' ' ' ARG . 3.3 t -52.87 137.29 32.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.818 -179.841 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 10.3 pttp -121.86 29.02 7.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.932 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 57.48 47.31 89.13 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.522 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 24.1 m -152.03 141.92 22.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.842 0.353 . . . . 0.0 110.896 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -162.06 157.9 24.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.095 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 195' ' ' PHE . . . . . 0.592 ' CE2' HD11 ' A' ' 183' ' ' LEU . 21.1 m-85 -110.82 124.8 52.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.882 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.575 HG11 ' CD2' ' A' ' 171' ' ' PHE . 94.3 t -122.24 139.29 49.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.125 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 41.3 mttm -116.2 144.76 43.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.898 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 198' ' ' TYR . . . . . 0.589 ' CD1' HD12 ' A' ' 153' ' ' LEU . 19.7 m-85 -119.28 174.72 6.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.91 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 46.6 p -74.5 -52.52 11.71 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.884 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 32.9 p -137.07 -175.72 4.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.874 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 201' ' ' HIS . . . . . 0.435 ' O ' ' HB3' ' A' ' 204' ' ' ALA . 3.4 t-160 -71.46 -53.85 12.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.885 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -40.76 -62.53 0.78 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.136 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -47.42 -41.72 20.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.884 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 204' ' ' ALA . . . . . 0.435 ' HB3' ' O ' ' A' ' 201' ' ' HIS . . . -59.27 -56.23 24.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.102 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -47.85 -41.81 24.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.933 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -61.39 -51.91 66.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.118 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -61.84 -23.8 66.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.104 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 208' ' ' ILE . . . . . 0.499 ' O ' ' N ' ' A' ' 212' ' ' HIS . 53.5 mt -71.92 -71.57 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.15 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 209' ' ' ASN . . . . . 0.403 ' N ' HG22 ' A' ' 208' ' ' ILE . 5.3 t30 -54.89 -38.91 68.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.905 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -58.35 -50.74 72.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.12 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 30.7 mt -99.93 -67.56 0.85 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.93 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 212' ' ' HIS . . . . . 0.587 ' CE1' ' HA ' ' A' ' 225' ' ' VAL . 1.5 t60 -49.83 132.77 22.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.863 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 70.12 -2.12 15.27 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.5 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -96.38 -71.36 0.68 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.822 0.344 . . . . 0.0 110.876 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -100.27 166.98 10.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.934 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 216' ' ' THR . . . . . 0.636 HG23 ' O ' ' A' ' 222' ' ' SER . 24.4 m -127.38 94.03 3.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.152 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 217' ' ' MET . . . . . 0.415 ' C ' ' O ' ' A' ' 216' ' ' THR . 17.8 mmt -36.39 136.18 0.55 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.579 0.704 . . . . 0.0 110.843 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -49.24 138.21 29.47 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.634 2.223 . . . . 0.0 112.366 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 100.07 -45.22 1.51 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.505 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -86.31 142.04 28.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.815 0.341 . . . . 0.0 111.095 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 13.9 m -93.49 -12.88 28.67 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.834 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 222' ' ' SER . . . . . 0.636 ' O ' HG23 ' A' ' 216' ' ' THR . 3.9 m -100.11 143.09 30.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.88 -179.817 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 71.3 m -56.04 148.43 17.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.8 -179.772 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.612 HD12 ' H ' ' A' ' 225' ' ' VAL . 51.3 tp -38.31 158.08 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.893 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 0.612 ' H ' HD12 ' A' ' 224' ' ' LEU . 61.7 t -130.4 105.76 11.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.114 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 226' ' ' VAL . . . . . 0.551 HG22 HG13 ' A' ' 155' ' ' VAL . 21.5 t -134.04 101.46 3.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.146 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 227' ' ' LYS . . . . . 0.469 ' HE2' ' CG1' ' A' ' 225' ' ' VAL . 0.7 OUTLIER -130.38 145.29 51.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.896 179.883 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -49.04 137.0 13.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.929 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 229' ' ' ALA . . . . . 0.647 ' HB3' ' HB3' ' A' ' 152' ' ' LYS . . . -79.74 157.69 27.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.103 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 230' ' ' ASP . . . . . 0.414 ' O ' ' C ' ' A' ' 231' ' ' THR . 1.6 p30 -147.35 175.32 10.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.889 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 231' ' ' THR . . . . . 0.414 ' C ' ' O ' ' A' ' 230' ' ' ASP . 1.6 m 36.1 47.85 0.48 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.16 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -124.2 113.73 18.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.88 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 34.9 mtmt -65.77 143.19 57.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.899 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 51.1 mm-40 -112.16 125.69 54.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.931 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 1.4 t -62.21 141.5 58.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.901 -179.788 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -76.67 146.15 32.3 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.516 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -46.61 144.43 7.54 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.695 2.263 . . . . 0.0 112.362 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 96.0 p -164.43 111.22 1.05 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.875 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 4.7 t -135.41 136.74 41.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.859 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.343 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.486 179.999 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.543 ' HD3' ' CD1' ' A' ' 195' ' ' PHE . 20.5 ttmt . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.869 0.366 . . . . 0.0 110.886 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.626 HD21 HD11 ' A' ' 208' ' ' ILE . 24.6 mt -142.83 126.49 16.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.898 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -90.92 116.69 28.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.874 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.867 HG13 HG22 ' A' ' 226' ' ' VAL . 4.8 t -110.43 134.55 52.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.098 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -135.13 -156.27 7.63 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.511 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 10.1 mmt 45.31 35.44 1.83 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.785 0.326 . . . . 0.0 110.894 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.526 HD23 ' SD ' ' A' ' 217' ' ' MET . 77.5 mt -93.67 167.94 11.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.897 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -101.38 154.77 18.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.892 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 86.7 mttt -84.13 41.34 0.81 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.875 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 -127.8 -48.81 1.37 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.897 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -55.33 163.91 1.08 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.879 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 3.8 t -131.33 165.8 22.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.905 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . 0.725 ' HA ' HD11 ' A' ' 182' ' ' ILE . 5.5 tt0 -45.08 -44.36 10.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.917 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . 0.418 ' O ' ' N ' ' A' ' 168' ' ' ARG . 0.1 OUTLIER -57.71 -62.42 1.81 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.861 179.976 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -41.25 -52.29 3.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.889 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.604 HG13 ' CE1' ' A' ' 171' ' ' PHE . 30.0 t -66.95 -28.64 43.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.095 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . 0.418 ' N ' ' O ' ' A' ' 165' ' ' ASP . 18.9 ttt180 -61.88 -64.13 1.03 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.834 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 7.5 mmm180 -59.72 -54.22 48.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.875 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.697 ' O ' ' HB3' ' A' ' 173' ' ' ALA . 9.3 tp -42.08 -66.31 0.37 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.948 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . 0.604 ' CE1' HG13 ' A' ' 167' ' ' VAL . 9.1 m-85 -53.37 -72.21 0.06 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.884 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -40.96 -30.29 0.13 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.842 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.697 ' HB3' ' O ' ' A' ' 170' ' ' LEU . . . -40.11 -30.4 0.09 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.128 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -105.42 -74.34 0.65 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.869 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -105.54 137.92 13.99 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.464 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -48.49 153.34 0.78 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.817 0.342 . . . . 0.0 110.857 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.541 HG23 ' O ' ' A' ' 197' ' ' LYS . 81.5 mt -121.28 138.61 51.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.102 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -88.11 -49.01 7.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.943 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -150.97 160.08 44.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.949 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 41.9 t -145.68 135.16 23.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.851 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 95.4 m -146.99 110.38 4.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.139 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.725 HD11 ' HA ' ' A' ' 164' ' ' GLU . 21.3 mm -71.73 138.94 20.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.129 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.592 HD11 ' CE2' ' A' ' 195' ' ' PHE . 34.9 mt . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.876 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 18.7 t . . . . . 0 C--O 1.23 0.054 0 CA-C-O 120.973 0.416 . . . . 0.0 110.84 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 39.0 mttt -92.57 16.56 11.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.893 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 65.69 43.53 94.1 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.451 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' CYS . . . . . 0.436 ' HB2' HD12 ' A' ' 183' ' ' LEU . 0.8 OUTLIER -154.67 155.74 35.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.809 0.338 . . . . 0.0 110.917 -179.897 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -162.5 155.61 19.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.116 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' PHE . . . . . 0.592 ' CE2' HD11 ' A' ' 183' ' ' LEU . 38.5 m-85 -107.84 119.01 38.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.923 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 46.8 t -122.28 138.55 52.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.122 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.541 ' O ' HG23 ' A' ' 177' ' ' ILE . 0.0 OUTLIER -113.62 160.53 18.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.923 179.892 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -131.55 173.13 11.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.922 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 45.0 t -73.61 -44.83 56.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.895 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 1.4 t -143.15 179.92 6.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.835 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . 0.441 ' O ' ' C ' ' A' ' 202' ' ' ALA . 10.7 t-80 -67.18 -61.59 1.85 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.871 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . 0.441 ' C ' ' O ' ' A' ' 201' ' ' HIS . . . -34.24 -62.77 0.31 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.097 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -49.1 -46.88 45.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.905 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . 0.438 ' HB1' HD11 ' A' ' 153' ' ' LEU . . . -51.64 -56.97 10.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.1 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 62.1 tp60 -53.21 -45.34 68.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.902 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -49.11 -53.32 21.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.064 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -64.29 -40.28 95.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.113 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . 0.626 HD11 HD21 ' A' ' 153' ' ' LEU . 71.5 mt -55.95 -66.08 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.137 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 12.9 t30 -59.77 -37.83 80.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.86 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -69.07 -21.7 64.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.128 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.736 ' HB3' HD23 ' A' ' 224' ' ' LEU . 85.0 mt -113.88 -74.36 0.62 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.907 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' HIS . . . . . 0.538 ' HD1' ' HA ' ' A' ' 225' ' ' VAL . 17.8 t60 -51.82 126.55 18.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.835 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 84.11 -6.81 73.89 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.508 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 33.2 t -88.55 -73.82 0.48 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.8 0.333 . . . . 0.0 110.889 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -99.69 -178.31 3.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.896 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' THR . . . . . 0.572 HG23 ' O ' ' A' ' 222' ' ' SER . 25.3 m -134.31 102.7 5.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.192 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' MET . . . . . 0.526 ' SD ' HD23 ' A' ' 158' ' ' LEU . 30.2 mmt -39.99 137.66 1.17 Allowed Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.602 0.715 . . . . 0.0 110.865 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -48.75 124.94 11.88 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.679 2.253 . . . . 0.0 112.35 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 103.64 -47.46 1.1 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.48 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' ALA . . . . . 0.416 ' O ' HG22 ' A' ' 216' ' ' THR . . . -75.64 145.9 40.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.779 0.323 . . . . 0.0 111.087 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 4.5 t -93.24 -16.34 24.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.856 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' SER . . . . . 0.572 ' O ' HG23 ' A' ' 216' ' ' THR . 5.5 m -100.05 141.15 33.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.81 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 73.1 m -54.95 155.19 4.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.823 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.736 HD23 ' HB3' ' A' ' 211' ' ' LEU . 55.8 tp -43.24 148.57 0.28 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.919 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . 0.538 ' HA ' ' HD1' ' A' ' 212' ' ' HIS . 88.2 t -118.81 113.05 40.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.099 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . 0.867 HG22 HG13 ' A' ' 155' ' ' VAL . 22.0 t -136.25 110.28 9.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.161 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 19.2 pttp -130.25 162.45 28.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.86 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 228' ' ' PHE . . . . . 0.572 ' HA ' HD23 ' A' ' 153' ' ' LEU . 49.0 m-85 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.899 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 5.4 ttpm? . . . . . 0 C--O 1.232 0.165 0 CA-C-O 120.806 0.336 . . . . 0.0 110.901 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.657 HD23 ' HA ' ' A' ' 228' ' ' PHE . 47.8 mt -128.59 136.16 50.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.919 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -94.5 131.5 40.14 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.898 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.567 HG22 HG13 ' A' ' 226' ' ' VAL . 92.9 t -123.7 129.5 74.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.169 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -125.78 -159.31 10.25 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.478 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.615 ' SD ' HG21 ' A' ' 225' ' ' VAL . 0.9 OUTLIER 44.16 30.23 0.42 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.816 0.341 . . . . 0.0 110.918 -179.957 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.402 ' HB2' ' C ' ' A' ' 192' ' ' GLY . 73.3 mt -88.75 157.19 18.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.905 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -101.05 160.46 14.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.843 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 47.2 mttt -83.97 37.54 0.61 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.895 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 55.9 tp60 -123.29 -46.47 2.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.921 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -55.71 151.11 11.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.922 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 3.7 t -126.5 166.26 17.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.879 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -44.37 -47.68 9.72 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.897 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -57.91 -57.04 14.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.876 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 -43.44 -57.04 3.27 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.884 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.728 HG13 ' CE1' ' A' ' 171' ' ' PHE . 61.7 t -61.73 -48.45 88.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.113 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 57.7 mtt180 -41.29 -68.55 0.18 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.87 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 87.6 mtt-85 -58.35 -53.66 55.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.84 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.64 ' O ' ' HB3' ' A' ' 173' ' ' ALA . 12.8 tp -41.07 -66.7 0.31 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.883 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . 0.728 ' CE1' HG13 ' A' ' 167' ' ' VAL . 9.8 m-85 -56.02 -73.3 0.06 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.867 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.454 ' O ' ' N ' ' A' ' 174' ' ' PHE . 0.9 OUTLIER -39.18 -27.78 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.924 -179.94 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.64 ' HB3' ' O ' ' A' ' 170' ' ' LEU . . . -40.66 -25.18 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.1 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . 0.454 ' N ' ' O ' ' A' ' 172' ' ' GLU . 95.6 m-85 -106.69 -70.73 0.78 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.877 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -102.14 -163.46 26.62 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.506 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 35.3 m120 -96.9 160.93 14.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.804 0.335 . . . . 0.0 110.865 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 13.0 mt -128.43 151.28 35.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.119 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 46.9 mm-40 -115.51 -42.54 3.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.915 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -155.18 149.61 26.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.899 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 40.6 t -137.98 143.98 40.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.879 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 56.5 m -150.12 149.15 29.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.148 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 13.3 mm -115.45 126.13 72.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.128 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.436 HD11 ' CE2' ' A' ' 195' ' ' PHE . 78.6 mt . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.896 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 53.3 p . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.941 0.4 . . . . 0.0 110.871 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 26.5 mtpt -85.01 26.66 0.83 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.881 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.402 ' C ' ' HB2' ' A' ' 158' ' ' LEU . . . 61.01 31.75 77.73 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.533 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 52.3 m -143.8 150.74 38.99 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.836 0.351 . . . . 0.0 110.894 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -155.52 172.09 18.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.087 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' PHE . . . . . 0.436 ' CE2' HD11 ' A' ' 183' ' ' LEU . 37.4 m-85 -128.43 130.4 47.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.879 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 48.6 t -127.8 132.96 68.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.126 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 29.2 mttp -104.53 150.03 24.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.869 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . 0.447 ' OH ' ' CB ' ' A' ' 207' ' ' ALA . 3.3 m-85 -123.03 175.36 6.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.949 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 58.0 m -86.36 -34.9 20.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.864 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 75.4 m -147.06 -179.86 7.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.867 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . 0.435 ' O ' ' C ' ' A' ' 202' ' ' ALA . 67.8 t60 -73.42 -63.96 1.09 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.896 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 201' ' ' HIS . . . -34.49 -61.44 0.39 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.05 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -48.47 -44.15 35.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.834 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . 0.411 ' N ' ' O ' ' A' ' 201' ' ' HIS . . . -60.16 -56.14 25.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.119 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . 0.439 ' HA ' HD12 ' A' ' 208' ' ' ILE . 33.0 tp60 -50.66 -46.13 58.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.89 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -54.84 -49.6 70.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.055 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . 0.447 ' CB ' ' OH ' ' A' ' 198' ' ' TYR . . . -63.76 -26.59 68.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.106 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . 0.484 ' O ' ' N ' ' A' ' 212' ' ' HIS . 60.3 mt -70.74 -64.24 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.181 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -58.48 -39.16 79.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.895 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' ALA . . . . . 0.413 ' HB1' ' CZ ' ' A' ' 174' ' ' PHE . . . -66.99 -35.11 79.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.079 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.451 ' HB3' HD23 ' A' ' 224' ' ' LEU . 86.5 mt -102.5 -74.54 0.63 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.94 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' HIS . . . . . 0.484 ' N ' ' O ' ' A' ' 208' ' ' ILE . 33.9 t60 -49.18 134.07 18.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.861 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 70.06 -0.61 21.91 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.531 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -93.34 -71.01 0.67 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.747 0.308 . . . . 0.0 110.863 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -100.05 -178.44 3.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.916 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' THR . . . . . 0.559 HG23 ' O ' ' A' ' 222' ' ' SER . 7.6 m -136.97 110.3 7.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.139 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' MET . . . . . 0.7 ' SD ' HD13 ' A' ' 224' ' ' LEU . 0.0 OUTLIER -39.26 160.05 0.1 OUTLIER Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.519 0.676 . . . . 0.0 110.915 179.883 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.32 103.0 1.54 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.637 2.224 . . . . 0.0 112.367 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 122.47 -49.77 0.87 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.501 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -65.24 150.38 48.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.796 0.331 . . . . 0.0 111.091 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 9.5 m -95.33 -17.38 21.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.848 -179.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' SER . . . . . 0.559 ' O ' HG23 ' A' ' 216' ' ' THR . 1.1 t -99.82 146.14 26.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.874 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -61.65 152.99 29.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.89 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.7 HD13 ' SD ' ' A' ' 217' ' ' MET . 59.4 tp -38.71 152.92 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.907 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . 0.615 HG21 ' SD ' ' A' ' 157' ' ' MET . 86.5 t -125.1 104.4 13.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.124 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . 0.567 HG13 HG22 ' A' ' 155' ' ' VAL . 8.8 t -128.4 103.06 9.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.121 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 7.6 ptmt -120.76 167.34 12.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.882 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 228' ' ' PHE . . . . . 0.657 ' HA ' HD23 ' A' ' 153' ' ' LEU . 73.4 m-85 . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.887 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 20.3 tttt . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.849 0.357 . . . . 0.0 110.871 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 32.0 mt -127.08 124.99 40.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.916 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -92.82 110.8 22.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.858 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.645 HG13 HG22 ' A' ' 226' ' ' VAL . 39.4 t -104.64 127.55 58.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.111 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.422 ' O ' ' N ' ' A' ' 158' ' ' LEU . . . -125.68 -152.22 8.13 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.505 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.485 ' SD ' HG21 ' A' ' 225' ' ' VAL . 0.4 OUTLIER 38.59 30.5 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.855 0.36 . . . . 0.0 110.87 179.976 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.422 ' N ' ' O ' ' A' ' 156' ' ' GLY . 61.4 mt -83.93 166.14 18.09 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.893 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -100.31 158.41 15.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.896 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 34.9 mttm -88.16 33.46 0.74 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.908 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -123.84 -52.22 1.79 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.907 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -51.54 155.54 1.53 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.905 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 4.3 m -131.03 174.79 9.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.862 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -50.37 -42.58 53.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.92 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -59.3 -54.58 45.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.898 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -48.73 -64.24 0.86 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.845 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.74 HG13 ' CE1' ' A' ' 171' ' ' PHE . 90.0 t -55.71 -50.41 67.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.099 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . 0.42 ' C ' ' O ' ' A' ' 167' ' ' VAL . 20.5 ttm-85 -36.88 -63.73 0.4 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.872 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . 0.403 ' O ' ' HG3' ' A' ' 172' ' ' GLU . 21.4 mtp85 -64.19 -51.48 63.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.907 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.684 ' O ' ' HB3' ' A' ' 173' ' ' ALA . 13.3 tp -43.72 -65.6 0.48 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.909 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . 0.74 ' CE1' HG13 ' A' ' 167' ' ' VAL . 6.2 m-85 -55.83 -68.1 0.23 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.853 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.403 ' HG3' ' O ' ' A' ' 169' ' ' ARG . 0.9 OUTLIER -45.3 -21.82 0.1 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.878 -179.915 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.684 ' HB3' ' O ' ' A' ' 170' ' ' LEU . . . -49.21 -19.05 0.41 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.091 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -112.52 -73.93 0.65 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.875 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . 0.429 ' CA ' ' OE1' ' A' ' 203' ' ' GLU . . . -110.89 154.32 16.7 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.467 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -57.63 149.37 21.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.821 0.343 . . . . 0.0 110.895 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 46.1 mt -111.34 147.84 15.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.152 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . 0.459 ' OE1' ' N ' ' A' ' 178' ' ' GLU . 0.5 OUTLIER -102.89 -40.57 6.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.934 179.94 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -160.44 149.41 17.06 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.901 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 25.2 t -136.47 140.48 43.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.895 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 30.5 m -149.74 142.61 24.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.183 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 33.6 mm -107.29 121.95 60.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.157 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.767 HD11 ' CE2' ' A' ' 195' ' ' PHE . 30.6 mt . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.887 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 18.1 p . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.971 0.415 . . . . 0.0 110.87 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 3.1 mmmm -94.19 33.59 1.35 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.867 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.412 ' C ' ' HB2' ' A' ' 158' ' ' LEU . . . 44.24 32.54 2.61 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.484 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 75.8 m -141.6 151.24 42.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.828 0.347 . . . . 0.0 110.881 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -158.88 161.32 36.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.145 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' PHE . . . . . 0.767 ' CE2' HD11 ' A' ' 183' ' ' LEU . 47.9 m-85 -118.05 135.92 53.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.9 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 64.7 t -133.2 145.96 33.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.122 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 42.6 mtpt -122.44 142.83 50.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.937 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -117.8 175.22 5.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.867 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 51.1 p -80.1 -44.25 20.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.815 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 2.7 m -133.95 -177.62 4.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.799 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 20.7 t60 -80.19 -57.1 3.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.879 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -37.99 -56.79 1.11 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.129 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . 0.429 ' OE1' ' CA ' ' A' ' 175' ' ' GLY . 31.3 mm-40 -54.63 -43.24 72.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.853 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -56.46 -55.78 29.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.079 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 53.1 tp60 -50.88 -41.95 58.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.92 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -57.7 -51.9 67.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.109 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -63.28 -26.49 68.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.072 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . 0.495 ' O ' ' N ' ' A' ' 212' ' ' HIS . 50.4 mt -69.15 -73.27 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.103 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' ASN . . . . . 0.464 ' N ' HG22 ' A' ' 208' ' ' ILE . 34.2 t30 -48.89 -42.72 37.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.843 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' ALA . . . . . 0.468 ' O ' ' CB ' ' A' ' 214' ' ' SER . . . -54.27 -45.31 72.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.101 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.454 ' CB ' HD23 ' A' ' 224' ' ' LEU . 18.8 mt -100.51 -69.21 0.78 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.902 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' HIS . . . . . 0.645 ' HD1' ' HA ' ' A' ' 225' ' ' VAL . 27.2 t60 -53.95 124.24 14.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.878 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . 0.488 ' CA ' ' HB3' ' A' ' 223' ' ' SER . . . 81.24 -14.68 26.94 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.512 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' SER . . . . . 0.468 ' CB ' ' O ' ' A' ' 210' ' ' ALA . 1.9 m -85.94 -72.38 0.5 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.818 0.342 . . . . 0.0 110.838 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 59.7 mt-30 -99.13 169.54 9.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.898 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' THR . . . . . 0.624 HG23 ' O ' ' A' ' 222' ' ' SER . 3.0 m -118.78 97.61 5.8 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.148 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 13.2 mmt -38.74 138.81 0.76 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.556 0.693 . . . . 0.0 110.865 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -48.47 126.67 14.5 Favored 'Trans proline' 0 C--N 1.34 0.131 0 C-N-CA 122.685 2.256 . . . . 0.0 112.344 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 102.45 -53.42 0.78 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.503 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -70.65 150.08 46.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.781 0.324 . . . . 0.0 111.099 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 31.1 t -95.92 -18.19 20.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.826 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' SER . . . . . 0.624 ' O ' HG23 ' A' ' 216' ' ' THR . 3.5 m -99.91 151.22 21.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.874 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . 0.488 ' HB3' ' CA ' ' A' ' 213' ' ' GLY . 17.4 m -59.58 145.36 44.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.844 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.512 ' HG ' HG23 ' A' ' 226' ' ' VAL . 48.2 tp -34.61 148.8 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.918 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . 0.645 ' HA ' ' HD1' ' A' ' 212' ' ' HIS . 64.9 t -117.13 106.71 20.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.142 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . 0.645 HG22 HG13 ' A' ' 155' ' ' VAL . 24.6 t -133.39 106.29 9.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.142 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 9.0 ptmt -125.03 174.39 8.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.906 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.884 179.961 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 3.6 ttmp? . . . . . 0 C--O 1.233 0.203 0 CA-C-O 120.817 0.341 . . . . 0.0 110.922 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.612 HD12 ' CD1' ' A' ' 198' ' ' TYR . 64.6 mt -123.47 124.01 41.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.902 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -94.24 110.47 22.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.885 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.588 HG22 HG13 ' A' ' 226' ' ' VAL . 21.2 t -104.19 120.62 54.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.112 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -120.64 -174.41 15.12 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.451 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 19.5 mmt 61.7 30.82 18.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.811 0.339 . . . . 0.0 110.902 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.416 ' HB2' ' C ' ' A' ' 192' ' ' GLY . 25.0 mt -88.04 162.31 16.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.912 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -102.39 160.27 14.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.892 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 14.9 mtpp -84.98 36.66 0.63 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.937 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 4.5 tp-100 -123.09 -51.08 1.9 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.905 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 66.1 mt-30 -54.23 154.32 4.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.888 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 90.3 p -130.77 -177.97 4.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.881 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . 0.493 ' O ' ' CB ' ' A' ' 168' ' ' ARG . 1.8 mp0 -55.31 -48.05 74.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.902 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -58.29 -55.17 38.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.866 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -45.64 -68.23 0.21 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.839 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.527 HG13 ' CE1' ' A' ' 171' ' ' PHE . 59.8 t -59.1 -55.51 23.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.155 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . 0.493 ' CB ' ' O ' ' A' ' 164' ' ' GLU . 70.9 ttt180 -34.3 -53.32 0.5 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.923 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 20.1 mmt85 -65.0 -54.3 32.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.931 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.761 ' O ' ' HB3' ' A' ' 173' ' ' ALA . 13.0 tp -44.21 -64.42 0.68 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.962 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . 0.789 ' CB ' HD11 ' A' ' 177' ' ' ILE . 6.8 m-85 -51.89 -67.53 0.24 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.904 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -48.41 -23.12 0.84 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.857 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.761 ' HB3' ' O ' ' A' ' 170' ' ' LEU . . . -51.95 -27.18 12.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.09 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -111.99 -62.84 1.5 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.846 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -118.76 137.17 12.62 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.48 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 48.8 m-80 -51.77 151.16 3.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.788 0.328 . . . . 0.0 110.897 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.789 HD11 ' CB ' ' A' ' 171' ' ' PHE . 97.6 mt -117.46 109.35 27.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.121 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -61.18 -36.99 81.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.883 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -159.44 137.22 10.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.898 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 5.7 t -124.32 143.42 50.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.888 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 55.7 m -154.37 137.04 15.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.161 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 10.6 mm -106.28 133.44 50.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.103 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.801 HD11 ' CE2' ' A' ' 195' ' ' PHE . 84.8 mt . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.909 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 42.3 t . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.98 0.419 . . . . 0.0 110.851 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 25.2 mtmm -84.43 32.49 0.51 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.925 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.416 ' C ' ' HB2' ' A' ' 158' ' ' LEU . . . 58.12 39.21 91.86 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.506 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 7.2 p -157.85 149.39 21.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.83 0.348 . . . . 0.0 110.862 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -160.13 156.5 26.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.156 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' PHE . . . . . 0.801 ' CE2' HD11 ' A' ' 183' ' ' LEU . 42.3 m-85 -114.12 126.96 55.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.866 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.533 HG21 ' CE2' ' A' ' 171' ' ' PHE . 98.8 t -117.23 139.36 44.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.072 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 31.4 tttt -116.37 118.38 32.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.86 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . 0.612 ' CD1' HD12 ' A' ' 153' ' ' LEU . 20.3 m-85 -95.58 172.28 8.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.918 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 8.3 t -79.2 -39.46 33.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.834 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 33.6 p -149.19 160.25 43.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.893 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . 0.448 ' O ' ' C ' ' A' ' 202' ' ' ALA . 13.3 t-80 -53.46 -58.93 5.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.873 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . 0.448 ' C ' ' O ' ' A' ' 201' ' ' HIS . . . -34.33 -62.93 0.31 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.085 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -54.21 -42.61 69.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.857 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . 0.4 ' N ' ' O ' ' A' ' 201' ' ' HIS . . . -58.53 -64.1 1.05 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.068 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . 0.54 ' HA ' HD12 ' A' ' 208' ' ' ILE . 37.1 tp60 -43.15 -42.03 3.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.956 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -57.3 -57.47 12.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.065 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . 0.429 ' CB ' ' OH ' ' A' ' 198' ' ' TYR . . . -55.24 -33.56 63.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.088 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . 0.54 HD12 ' HA ' ' A' ' 205' ' ' GLN . 87.8 mt -62.72 -75.0 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.138 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -48.71 -42.09 33.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.892 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -56.32 -36.88 69.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.118 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.487 ' HB3' ' CD2' ' A' ' 224' ' ' LEU . 50.7 mt -109.44 -72.6 0.72 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.898 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' HIS . . . . . 0.479 ' N ' ' O ' ' A' ' 208' ' ' ILE . 9.4 t60 -46.73 128.62 10.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.865 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 82.04 -22.91 5.56 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.514 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 7.9 t -91.45 -70.74 0.67 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.819 0.342 . . . . 0.0 110.818 -179.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 9.5 mm-40 -86.54 161.55 18.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.86 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' THR . . . . . 0.549 HG23 ' O ' ' A' ' 222' ' ' SER . 39.1 m -129.01 108.65 10.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.157 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' MET . . . . . 0.402 ' C ' ' O ' ' A' ' 216' ' ' THR . 24.1 mmt -37.4 156.88 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.534 0.683 . . . . 0.0 110.884 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.16 113.29 3.55 Favored 'Trans proline' 0 C--N 1.341 0.133 0 C-N-CA 122.683 2.255 . . . . 0.0 112.307 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 113.94 -45.09 1.37 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.493 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -70.92 142.03 51.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.788 0.328 . . . . 0.0 111.103 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 68.3 m -91.53 -14.81 29.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.879 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' SER . . . . . 0.549 ' O ' HG23 ' A' ' 216' ' ' THR . 2.7 m -100.17 143.1 30.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.835 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 2.4 p -51.3 159.83 0.63 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.879 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.649 HD12 ' H ' ' A' ' 225' ' ' VAL . 41.6 tp -54.04 154.7 4.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.887 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . 0.649 ' H ' HD12 ' A' ' 224' ' ' LEU . 60.7 t -127.15 108.09 18.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.123 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . 0.588 HG13 HG22 ' A' ' 155' ' ' VAL . 24.2 t -133.91 101.46 3.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.169 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 10.7 ptmt -131.75 143.21 50.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.925 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.889 179.957 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 6.5 ttpm? . . . . . 0 C--O 1.232 0.18 0 CA-C-O 120.782 0.325 . . . . 0.0 110.887 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.417 HD12 ' CD1' ' A' ' 198' ' ' TYR . 58.1 mt -129.29 127.09 40.45 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.934 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 18.8 t80 -101.04 113.14 25.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.844 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.479 HG22 HG13 ' A' ' 226' ' ' VAL . 48.1 t -104.07 124.01 58.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.094 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -124.45 -169.61 13.08 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.465 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 93.4 mmm 50.07 39.36 18.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.794 0.331 . . . . 0.0 110.919 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.417 ' HB2' ' C ' ' A' ' 192' ' ' GLY . 66.9 mt -94.04 162.36 13.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.906 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -100.3 158.08 16.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.883 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 52.4 mttp -83.5 39.47 0.67 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.922 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -124.9 -47.83 1.78 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.934 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 64.2 mt-30 -57.89 151.68 17.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.881 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 3.4 m -129.29 176.35 8.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.86 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -52.95 -44.13 66.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.883 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -59.38 -51.59 69.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.868 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -52.74 -61.74 2.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.892 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.623 HG13 ' CD1' ' A' ' 171' ' ' PHE . 25.4 t -58.64 -56.8 14.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.158 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . 0.415 ' C ' ' O ' ' A' ' 167' ' ' VAL . 15.5 ttt180 -36.3 -62.34 0.45 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.866 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 19.4 mmt85 -61.05 -54.11 48.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.915 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.729 ' O ' ' HB3' ' A' ' 173' ' ' ALA . 12.5 tp -43.14 -65.68 0.46 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.899 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . 0.623 ' CD1' HG13 ' A' ' 167' ' ' VAL . 8.5 m-85 -52.22 -70.86 0.08 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.888 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.408 ' C ' ' N ' ' A' ' 174' ' ' PHE . 5.3 pt-20 -43.3 -28.79 0.35 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.864 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.729 ' HB3' ' O ' ' A' ' 170' ' ' LEU . . . -44.49 -22.09 0.07 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.076 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . 0.408 ' N ' ' C ' ' A' ' 172' ' ' GLU . 97.7 m-85 -109.79 -74.91 0.64 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.878 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -108.08 148.12 16.62 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.495 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -52.35 145.77 10.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.791 0.329 . . . . 0.0 110.888 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 18.6 mt -108.96 136.1 45.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.137 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -93.49 -36.81 12.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.884 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . 0.425 ' HG3' ' N ' ' A' ' 180' ' ' CYS . 3.4 tp10 -163.73 144.55 8.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.919 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' CYS . . . . . 0.425 ' N ' ' HG3' ' A' ' 179' ' ' GLU . 35.7 t -135.12 142.99 46.33 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.902 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 91.1 m -155.19 143.2 20.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.102 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 9.0 mm -105.35 138.5 30.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.131 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.562 HD11 ' CE2' ' A' ' 195' ' ' PHE . 44.7 mt . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.896 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 36.2 t . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.931 0.396 . . . . 0.0 110.894 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 25.3 mttp -105.23 36.7 2.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.887 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.417 ' C ' ' HB2' ' A' ' 158' ' ' LEU . . . 46.02 44.53 14.02 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.539 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 3.5 p -155.32 155.07 33.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.838 0.352 . . . . 0.0 110.897 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -161.38 166.02 28.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.057 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' PHE . . . . . 0.562 ' CE2' HD11 ' A' ' 183' ' ' LEU . 39.4 m-85 -120.58 132.9 55.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.856 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.455 HG21 ' CE2' ' A' ' 171' ' ' PHE . 21.8 t -125.77 145.95 32.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.122 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 11.3 ttmm -123.29 141.53 51.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.935 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . 0.417 ' CD1' HD12 ' A' ' 153' ' ' LEU . 24.6 m-85 -118.59 174.94 5.97 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.886 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 10.5 t -81.66 -49.17 10.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.853 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 23.7 t -126.31 166.87 16.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.87 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 62.9 t-80 -66.51 -49.81 65.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.868 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -45.27 -59.07 2.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.101 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -47.8 -49.38 29.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.895 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -51.26 -61.62 2.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.064 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . 0.775 ' HA ' HD12 ' A' ' 208' ' ' ILE . 44.9 tp60 -46.35 -43.65 16.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.918 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -55.8 -62.31 1.78 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.137 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -50.89 -35.03 30.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.083 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . 0.775 HD12 ' HA ' ' A' ' 205' ' ' GLN . 77.7 mt -61.44 -73.37 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.124 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -47.39 -42.98 23.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.915 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -57.72 -40.56 79.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.11 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.422 ' O ' ' CB ' ' A' ' 214' ' ' SER . 61.1 mt -102.25 -72.05 0.7 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.972 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' HIS . . . . . 0.495 ' N ' ' O ' ' A' ' 208' ' ' ILE . 20.0 t60 -47.41 136.25 9.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.827 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 67.61 1.01 14.28 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.503 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' SER . . . . . 0.422 ' CB ' ' O ' ' A' ' 211' ' ' LEU . 1.0 OUTLIER -95.28 -71.09 0.68 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.912 0.386 . . . . 0.0 110.833 -179.683 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -99.96 -178.17 3.77 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.925 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' THR . . . . . 0.547 HG23 ' O ' ' A' ' 222' ' ' SER . 51.6 m -134.49 102.45 5.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.139 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 28.3 mmt -40.99 135.61 1.65 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.562 0.696 . . . . 0.0 110.847 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -48.62 119.18 3.94 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.686 2.258 . . . . 0.0 112.349 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 111.16 -46.19 1.21 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.467 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -76.45 148.79 37.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.802 0.334 . . . . 0.0 111.084 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 10.5 t -93.55 -18.9 21.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.916 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' SER . . . . . 0.547 ' O ' HG23 ' A' ' 216' ' ' THR . 1.1 t -100.05 147.62 25.43 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.859 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 58.4 m -59.43 156.51 12.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.855 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.442 ' HG ' HG23 ' A' ' 226' ' ' VAL . 38.9 tp -43.24 149.43 0.23 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.907 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . 0.477 ' HA ' ' HD1' ' A' ' 212' ' ' HIS . 60.4 t -121.42 113.52 39.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.134 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . 0.479 HG13 HG22 ' A' ' 155' ' ' VAL . 22.5 t -138.08 105.33 3.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.149 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 9.4 pttp -130.74 148.56 52.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.942 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.859 179.986 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 25.4 tttp . . . . . 0 C--O 1.232 0.162 0 CA-C-O 120.775 0.322 . . . . 0.0 110.927 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.631 HD11 ' HB1' ' A' ' 204' ' ' ALA . 62.3 mt -105.29 132.68 51.18 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.914 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -92.24 135.06 34.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.887 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 23.0 t -124.27 114.85 42.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.098 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -116.59 -176.14 17.83 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.48 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 91.4 mmm 58.62 41.83 21.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.814 0.34 . . . . 0.0 110.873 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.645 HD23 ' HG3' ' A' ' 217' ' ' MET . 46.5 mt -103.57 178.34 4.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.915 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -124.44 172.07 9.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.93 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 37.3 mttt -95.91 51.35 1.24 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.902 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -127.22 -52.19 1.4 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.883 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -64.56 164.32 11.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.872 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 31.8 p -133.55 177.77 7.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.877 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -52.16 -35.65 49.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.916 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -64.22 -57.43 9.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.836 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -47.04 -54.55 10.02 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.851 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.816 HG13 ' CE1' ' A' ' 171' ' ' PHE . 61.3 t -65.23 -40.56 89.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.174 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 4.3 mmm180 -48.0 -67.11 0.3 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.896 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 13.1 mmm-85 -60.78 -52.84 63.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.875 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.67 ' O ' ' HB3' ' A' ' 173' ' ' ALA . 12.6 tp -41.96 -66.27 0.37 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.892 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . 0.816 ' CE1' HG13 ' A' ' 167' ' ' VAL . 9.3 m-85 -55.92 -71.24 0.09 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.903 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.498 ' C ' ' CD ' ' A' ' 172' ' ' GLU . 0.5 OUTLIER -41.48 -24.91 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.873 -179.934 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.67 ' HB3' ' O ' ' A' ' 170' ' ' LEU . . . -45.58 -21.16 0.09 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.117 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -117.46 -66.45 1.08 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.875 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -114.63 134.24 11.56 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.471 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 40.2 m-20 -45.31 153.94 0.2 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.789 0.328 . . . . 0.0 110.899 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 38.1 mt -112.66 128.04 69.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.135 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -83.0 -37.98 23.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.859 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -164.67 129.6 2.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.948 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 51.4 t -113.8 142.76 45.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.912 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 40.7 m -155.0 144.95 21.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.165 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 31.5 mm -109.06 146.75 14.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.193 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.742 HD11 ' CE2' ' A' ' 195' ' ' PHE . 31.4 mt . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.943 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 4.9 t . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.966 0.412 . . . . 0.0 110.856 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 64.0 mttt -104.29 32.08 4.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.896 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 58.48 39.75 93.45 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.477 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' CYS . . . . . 0.474 ' HB3' HD12 ' A' ' 183' ' ' LEU . 85.6 m -151.42 153.41 34.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.844 0.354 . . . . 0.0 110.852 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -162.44 167.05 24.19 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.132 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' PHE . . . . . 0.742 ' CE2' HD11 ' A' ' 183' ' ' LEU . 76.8 m-85 -125.53 133.72 52.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.854 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.411 HG21 ' CE2' ' A' ' 171' ' ' PHE . 29.1 t -127.92 118.84 49.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.122 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 22.5 ttmt -95.3 141.84 28.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.911 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . 0.439 ' OH ' ' CB ' ' A' ' 207' ' ' ALA . 10.3 m-85 -115.28 173.71 6.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.871 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 20.7 p -78.47 -46.24 20.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.817 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 3.0 t -137.32 156.32 48.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.869 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . 0.419 ' O ' ' C ' ' A' ' 202' ' ' ALA . 3.5 t-160 -52.29 -59.99 3.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.923 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 201' ' ' HIS . . . -35.89 -64.32 0.32 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.077 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -48.94 -47.29 43.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.845 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . 0.631 ' HB1' HD11 ' A' ' 153' ' ' LEU . . . -54.94 -54.12 46.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.087 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 43.3 tp60 -49.72 -47.24 50.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.912 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . 0.436 ' O ' ' CB ' ' A' ' 210' ' ' ALA . . . -55.08 -48.73 73.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.14 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . 0.439 ' CB ' ' OH ' ' A' ' 198' ' ' TYR . . . -59.35 -41.31 88.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.082 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . 0.542 HD11 ' CD2' ' A' ' 153' ' ' LEU . 63.7 mt -58.66 -72.28 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.127 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 16.5 t30 -53.21 -40.08 64.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.914 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' ALA . . . . . 0.436 ' CB ' ' O ' ' A' ' 206' ' ' ALA . . . -57.78 -41.16 81.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.079 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 19.8 mt -101.47 -69.32 0.78 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.913 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' HIS . . . . . 0.488 ' N ' ' O ' ' A' ' 208' ' ' ILE . 14.4 t60 -48.28 133.26 15.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.877 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 73.92 -1.14 48.66 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.481 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 8.5 t -95.93 -70.99 0.69 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.794 0.331 . . . . 0.0 110.842 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -99.86 -175.78 3.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.898 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' THR . . . . . 0.653 HG23 ' O ' ' A' ' 222' ' ' SER . 35.1 m -137.13 109.3 7.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.146 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' MET . . . . . 0.645 ' HG3' HD23 ' A' ' 158' ' ' LEU . 23.8 mmt -38.17 158.18 0.09 OUTLIER Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.588 0.709 . . . . 0.0 110.872 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -71.62 107.15 2.11 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.644 2.23 . . . . 0.0 112.324 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 119.31 -48.04 0.98 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.476 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -68.46 148.23 50.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.765 0.317 . . . . 0.0 111.112 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 77.9 p -92.57 -18.17 23.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.882 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 222' ' ' SER . . . . . 0.653 ' O ' HG23 ' A' ' 216' ' ' THR . 2.4 m -100.04 149.66 23.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.862 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 66.3 m -59.88 157.23 12.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.861 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.45 ' HG ' ' N ' ' A' ' 225' ' ' VAL . 16.0 tp -47.8 154.39 0.51 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.894 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . 0.45 ' N ' ' HG ' ' A' ' 224' ' ' LEU . 34.6 t -125.32 110.62 24.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.102 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . 0.436 ' O ' HG23 ' A' ' 208' ' ' ILE . 19.6 t -132.9 101.95 4.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.1 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 23.8 pttt -129.06 152.27 48.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.92 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 228' ' ' PHE . . . . . 0.453 ' HA ' HD23 ' A' ' 153' ' ' LEU . 52.2 m-85 . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.89 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.562 ' HD3' ' CD1' ' A' ' 195' ' ' PHE . 13.3 ttmt . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.832 0.349 . . . . 0.0 110.899 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.504 HD23 ' HA ' ' A' ' 228' ' ' PHE . 56.6 mt -117.84 123.6 46.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.956 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 56.3 t80 -91.13 121.81 33.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.859 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.444 ' CG1' HD11 ' A' ' 158' ' ' LEU . 58.9 t -109.1 128.79 64.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.151 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -124.6 -160.35 10.72 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.534 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.406 ' SD ' HG23 ' A' ' 225' ' ' VAL . 33.3 mtt 38.69 43.95 0.75 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.821 0.343 . . . . 0.0 110.867 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.451 HD23 ' HG3' ' A' ' 217' ' ' MET . 67.9 mt -99.88 175.55 5.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.885 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.496 ' N ' ' OD1' ' A' ' 159' ' ' ASN . 0.5 OUTLIER -115.35 154.9 28.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.894 179.904 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.74 20.64 1.41 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.922 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -107.83 -34.62 6.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.941 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . 0.49 ' HG3' ' ND2' ' A' ' 159' ' ' ASN . 25.8 mt-30 -59.12 158.42 8.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.917 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 85.2 p -132.53 163.96 27.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.86 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -47.8 -50.97 24.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.872 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -53.23 -47.78 68.72 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.839 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -53.93 -69.1 0.13 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.864 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.802 HG13 ' CE1' ' A' ' 171' ' ' PHE . 86.0 t -52.92 -54.39 16.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.164 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . 0.489 ' C ' ' CD ' ' A' ' 168' ' ' ARG . 0.0 OUTLIER -39.53 -63.18 0.59 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.891 -179.959 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . 0.406 HH11 ' CB ' ' A' ' 169' ' ' ARG . 4.0 mtp-105 -60.85 -53.91 51.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.882 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.714 ' O ' ' HB3' ' A' ' 173' ' ' ALA . 11.9 tp -43.23 -65.93 0.43 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.901 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . 0.802 ' CE1' HG13 ' A' ' 167' ' ' VAL . 11.6 m-85 -52.2 -70.93 0.07 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.914 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.416 ' O ' ' N ' ' A' ' 174' ' ' PHE . 5.9 pt-20 -43.09 -29.36 0.35 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.947 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.714 ' HB3' ' O ' ' A' ' 170' ' ' LEU . . . -43.29 -23.05 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.082 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . 0.416 ' N ' ' O ' ' A' ' 172' ' ' GLU . 92.7 m-85 -114.56 -70.24 0.81 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.879 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -111.28 137.57 14.39 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.521 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -44.23 164.79 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.762 0.315 . . . . 0.0 110.896 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.519 HD11 ' CB ' ' A' ' 171' ' ' PHE . 51.1 mt -133.42 134.0 57.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.104 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -89.38 -41.31 12.19 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.918 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -150.75 151.2 32.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.831 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 49.4 t -146.0 138.2 25.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.854 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 26.2 m -154.89 151.2 28.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.155 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 48.6 mm -109.21 140.8 26.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.141 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.471 HD11 ' CE2' ' A' ' 195' ' ' PHE . 34.6 mt . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.919 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 8.3 t . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.947 0.404 . . . . 0.0 110.842 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 38.3 mttm -105.04 34.25 3.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.908 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.431 ' C ' ' HB2' ' A' ' 158' ' ' LEU . . . 49.92 39.47 32.9 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.521 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 80.8 m -151.03 157.61 43.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.772 0.32 . . . . 0.0 110.89 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -160.84 166.64 28.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.123 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' PHE . . . . . 0.562 ' CD1' ' HD3' ' A' ' 152' ' ' LYS . 40.0 m-85 -124.5 130.5 52.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.879 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 11.8 t -128.46 148.73 32.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.141 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.424 ' O ' HG23 ' A' ' 177' ' ' ILE . 6.3 ttmm -126.93 138.39 53.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.92 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . 0.429 ' CD1' HD12 ' A' ' 153' ' ' LEU . 20.8 m-85 -114.68 175.44 5.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.915 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 41.2 t -81.6 -48.05 12.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.858 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 1.9 t -134.59 172.48 12.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.874 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . 0.404 ' O ' ' C ' ' A' ' 202' ' ' ALA . 18.2 t-160 -67.4 -55.96 11.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.85 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . 0.404 ' C ' ' O ' ' A' ' 201' ' ' HIS . . . -37.98 -64.51 0.4 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.098 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -49.37 -48.21 47.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.869 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -54.76 -58.37 7.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.137 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . 0.862 ' HA ' HD12 ' A' ' 208' ' ' ILE . 6.1 tp60 -43.63 -50.57 7.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.897 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -52.8 -54.79 29.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.085 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -56.27 -32.66 64.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.138 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . 0.862 HD12 ' HA ' ' A' ' 205' ' ' GLN . 59.7 mt -65.07 -75.13 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.071 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -49.32 -42.61 42.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.861 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -54.97 -43.24 73.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.106 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 58.6 mt -102.23 -70.19 0.76 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.943 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' HIS . . . . . 0.492 ' N ' ' O ' ' A' ' 208' ' ' ILE . 5.4 t60 -50.74 129.88 23.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.866 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 75.61 -9.25 16.37 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.476 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 7.9 t -99.95 -70.23 0.74 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.877 0.37 . . . . 0.0 110.874 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' GLN . . . . . 0.432 ' HG3' ' N ' ' A' ' 216' ' ' THR . 1.7 tt0 -90.65 154.87 19.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.923 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' THR . . . . . 0.601 HG23 ' O ' ' A' ' 222' ' ' SER . 30.5 m -118.17 101.62 8.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.156 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' MET . . . . . 0.451 ' HG3' HD23 ' A' ' 158' ' ' LEU . 19.4 mmt -39.13 134.84 1.09 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.626 0.727 . . . . 0.0 110.887 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -48.99 131.57 25.78 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.723 2.282 . . . . 0.0 112.356 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 99.29 -41.93 2.1 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.734 -0.745 . . . . 0.0 112.502 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -82.15 144.57 30.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.796 0.331 . . . . 0.0 111.129 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 8.3 m -93.4 -15.45 25.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.864 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 222' ' ' SER . . . . . 0.601 ' O ' HG23 ' A' ' 216' ' ' THR . 57.9 m -99.98 142.43 31.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.897 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 58.8 m -54.91 156.21 3.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.873 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.446 ' HG ' ' N ' ' A' ' 225' ' ' VAL . 46.5 tp -52.37 159.63 0.96 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.954 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . 0.446 ' N ' ' HG ' ' A' ' 224' ' ' LEU . 99.2 t -130.5 113.11 24.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.114 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 40.2 t -138.83 113.52 8.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.113 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 11.4 pttm -130.98 167.31 19.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.909 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 228' ' ' PHE . . . . . 0.504 ' HA ' HD23 ' A' ' 153' ' ' LEU . 62.5 m-85 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.896 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 3.2 ttmp? . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.84 0.352 . . . . 0.0 110.893 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.476 HD23 ' HA ' ' A' ' 228' ' ' PHE . 38.7 mt -134.06 128.25 33.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.909 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -94.13 121.74 35.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.873 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.702 HG22 HG13 ' A' ' 226' ' ' VAL . 88.5 t -113.9 136.42 50.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.186 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -136.69 -159.93 8.52 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.515 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 14.7 mmt 46.8 28.56 0.84 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.84 0.352 . . . . 0.0 110.925 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 36.9 mt -85.35 167.46 15.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.912 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.573 HD21 ' N ' ' A' ' 218' ' ' PRO . 45.6 m-20 -105.26 158.43 16.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.897 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 60.4 mttt -85.59 37.2 0.68 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.894 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -116.9 -55.71 2.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.881 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -67.34 149.34 50.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.901 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 51.6 p -124.79 175.48 7.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.806 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 10.4 tm-20 -43.51 -30.45 0.57 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.9 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -67.67 -60.02 2.87 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.838 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -54.19 -44.78 71.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.801 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.792 HG13 ' CE1' ' A' ' 171' ' ' PHE . 89.7 t -66.1 -40.0 85.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.15 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 56.7 ttp180 -54.04 -63.37 1.17 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.904 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 17.4 mmt180 -59.0 -54.87 42.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.906 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.726 ' O ' ' HB3' ' A' ' 173' ' ' ALA . 11.3 tp -42.53 -66.11 0.4 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.91 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . 0.792 ' CE1' HG13 ' A' ' 167' ' ' VAL . 13.0 m-85 -51.73 -72.19 0.05 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.903 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.46 ' O ' ' N ' ' A' ' 174' ' ' PHE . 5.9 pt-20 -41.38 -31.51 0.25 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.897 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.726 ' HB3' ' O ' ' A' ' 170' ' ' LEU . . . -40.68 -24.82 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.133 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . 0.46 ' N ' ' O ' ' A' ' 172' ' ' GLU . 98.9 m-85 -112.21 -74.97 0.62 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.86 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -108.34 142.42 15.99 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.472 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -51.01 156.3 1.05 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.774 0.321 . . . . 0.0 110.907 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.461 HD11 ' CB ' ' A' ' 171' ' ' PHE . 81.7 mt -118.81 134.82 61.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.115 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 -90.87 -42.25 10.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.919 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -157.86 142.73 16.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.896 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' CYS . . . . . 0.622 ' SG ' HG13 ' A' ' 196' ' ' VAL . 1.8 m -134.23 145.87 49.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.825 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 45.4 m -151.98 134.73 15.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.158 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 30.0 mm -87.94 128.29 40.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.098 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.534 HD11 ' CE2' ' A' ' 195' ' ' PHE . 44.2 mt . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.922 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 27.2 p . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.938 0.399 . . . . 0.0 110.838 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 1.8 mmmp? -102.59 38.01 1.8 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.906 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 37.67 41.49 0.87 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.457 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 65.0 m -153.68 148.51 26.51 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.809 0.338 . . . . 0.0 110.904 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -162.56 148.6 12.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.104 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' PHE . . . . . 0.534 ' CE2' HD11 ' A' ' 183' ' ' LEU . 14.6 m-85 -98.49 143.1 29.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.891 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.639 HG11 ' CD2' ' A' ' 171' ' ' PHE . 16.1 t -143.03 132.73 21.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.14 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 14.0 mtpp -116.05 154.25 30.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.879 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -126.97 171.68 11.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.939 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 32.5 t -69.62 -47.9 61.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.813 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 17.0 m -137.33 170.49 16.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.899 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . 0.411 ' O ' ' C ' ' A' ' 202' ' ' ALA . 36.3 t-80 -60.95 -56.8 16.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.841 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . 0.411 ' C ' ' O ' ' A' ' 201' ' ' HIS . . . -37.12 -65.48 0.3 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.129 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 16.7 mp0 -48.38 -46.0 36.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.916 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . 0.407 ' HB3' ' O ' ' A' ' 201' ' ' HIS . . . -54.09 -54.98 32.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.093 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . 0.554 ' HA ' HD12 ' A' ' 208' ' ' ILE . 4.3 tp60 -49.52 -54.62 16.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.853 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -46.31 -56.44 5.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.129 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -56.08 -36.19 67.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.154 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . 0.554 HD12 ' HA ' ' A' ' 205' ' ' GLN . 80.0 mt -64.25 -75.06 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.12 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -49.34 -41.49 38.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.842 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -52.01 -48.63 64.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.112 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 74.6 mt -100.97 -65.79 0.95 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.886 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' HIS . . . . . 0.483 ' N ' ' O ' ' A' ' 208' ' ' ILE . 6.3 t60 -51.62 129.19 25.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.87 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 73.62 -4.83 26.14 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.488 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 8.1 t -99.66 -67.91 0.83 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.81 0.338 . . . . 0.0 110.856 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 5.6 mm-40 -94.73 172.9 7.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.938 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' THR . . . . . 0.522 HG23 ' O ' ' A' ' 222' ' ' SER . 54.1 m -133.08 92.85 3.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.198 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' MET . . . . . 0.483 ' HE2' HD13 ' A' ' 224' ' ' LEU . 1.3 mmt -36.0 136.23 0.51 Allowed Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.591 0.71 . . . . 0.0 110.877 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . 0.573 ' N ' HD21 ' A' ' 159' ' ' ASN . 75.7 Cg_exo -48.52 125.56 12.64 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.701 2.267 . . . . 0.0 112.384 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 109.15 -50.46 0.77 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.498 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -77.03 149.38 35.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.762 0.315 . . . . 0.0 111.093 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 23.9 t -94.41 -18.26 21.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.88 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 222' ' ' SER . . . . . 0.522 ' O ' HG23 ' A' ' 216' ' ' THR . 2.2 m -99.98 147.45 25.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.833 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . 0.417 ' O ' ' C ' ' A' ' 224' ' ' LEU . 53.8 m -61.16 147.25 44.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.888 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.483 HD13 ' HE2' ' A' ' 217' ' ' MET . 19.1 tp -36.82 152.72 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.909 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . 0.414 ' N ' ' HG ' ' A' ' 224' ' ' LEU . 99.6 t -123.22 105.0 15.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.117 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . 0.702 HG13 HG22 ' A' ' 155' ' ' VAL . 22.1 t -132.67 101.84 4.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.118 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 45.8 pttt -119.47 167.69 11.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.873 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 228' ' ' PHE . . . . . 0.476 ' HA ' HD23 ' A' ' 153' ' ' LEU . 90.3 m-85 . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.91 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.454 ' HD3' ' CG ' ' A' ' 195' ' ' PHE . 2.7 ttmp? . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.859 0.362 . . . . 0.0 110.877 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.405 ' N ' ' HG2' ' A' ' 152' ' ' LYS . 86.3 mt -117.91 133.66 55.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.914 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -102.64 114.37 28.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.885 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.636 HG21 ' CZ ' ' A' ' 171' ' ' PHE . 37.8 t -108.55 111.45 36.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.139 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -111.4 -161.16 16.78 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.507 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.419 ' CE ' ' HB1' ' A' ' 220' ' ' ALA . 79.9 mmm 46.62 41.49 9.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.818 0.342 . . . . 0.0 110.913 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.543 HD23 ' HG3' ' A' ' 217' ' ' MET . 55.1 mt -99.54 171.03 8.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.933 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 30.2 m120 -113.6 171.38 7.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.892 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 43.6 mttm -92.79 42.59 1.1 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.917 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -124.28 -43.92 2.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.89 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 61.0 mt-30 -63.4 159.79 17.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.922 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 68.9 m -132.36 175.81 8.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.854 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -55.05 -47.02 75.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.88 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . 0.496 ' CG ' ' N ' ' A' ' 166' ' ' ASP . 0.6 OUTLIER -58.33 -53.71 55.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.809 -179.988 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . 0.496 ' N ' ' CG ' ' A' ' 165' ' ' ASP . 65.5 m-20 -45.34 -55.89 5.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.888 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.784 HG13 ' CD1' ' A' ' 171' ' ' PHE . 68.7 t -64.81 -44.43 96.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.131 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 33.9 mtp180 -48.6 -55.22 11.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.881 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . 0.408 ' O ' ' HG3' ' A' ' 172' ' ' GLU . 55.7 mtt180 -70.86 -50.28 36.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.866 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.701 ' O ' ' HB3' ' A' ' 173' ' ' ALA . 9.8 tp -48.18 -63.78 0.98 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.919 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . 0.784 ' CD1' HG13 ' A' ' 167' ' ' VAL . 7.3 m-85 -54.61 -58.48 7.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.905 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.408 ' HG3' ' O ' ' A' ' 169' ' ' ARG . 0.8 OUTLIER -59.82 -9.94 3.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.902 -179.915 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.701 ' HB3' ' O ' ' A' ' 170' ' ' LEU . . . -61.59 -10.75 8.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.131 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -120.43 -67.9 0.94 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.845 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -110.59 -173.93 20.25 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.46 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -83.79 151.23 25.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.785 0.326 . . . . 0.0 110.899 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.467 HD11 ' CB ' ' A' ' 171' ' ' PHE . 21.0 mt -121.27 129.62 75.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.143 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 35.0 mm-40 -79.3 -46.61 17.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.879 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 22.2 tp10 -165.29 143.86 6.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.875 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 13.0 t -118.81 143.0 47.2 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.923 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 30.1 m -153.11 116.05 4.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.113 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 44.6 mm -83.3 135.01 25.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.125 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.861 HD11 ' CE2' ' A' ' 195' ' ' PHE . 35.1 mt . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.911 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 40.7 t . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.937 0.398 . . . . 0.0 110.856 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 1.3 mmmp? -94.46 26.09 3.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.898 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.425 ' C ' ' HB2' ' A' ' 158' ' ' LEU . . . 59.93 34.65 84.04 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.453 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 84.3 m -154.12 154.82 34.27 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.806 0.336 . . . . 0.0 110.926 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -158.37 161.1 37.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.072 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' PHE . . . . . 0.861 ' CE2' HD11 ' A' ' 183' ' ' LEU . 27.8 m-85 -121.53 119.59 32.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.868 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 21.5 t -118.8 140.21 43.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.081 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 17.1 mtmt -114.65 145.88 41.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.859 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -119.42 174.87 6.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.929 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 81.0 p -78.19 -46.26 20.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.876 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 37.7 m -133.58 -179.3 5.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.838 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . 0.513 ' O ' ' HB3' ' A' ' 204' ' ' ALA . 53.8 t-80 -76.44 -52.77 9.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.892 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -39.6 -66.14 0.32 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.081 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 51.5 mm-40 -47.28 -43.8 22.59 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.885 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . 0.513 ' HB3' ' O ' ' A' ' 201' ' ' HIS . . . -51.77 -54.07 32.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.108 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . 0.598 ' HA ' HD12 ' A' ' 208' ' ' ILE . 24.9 tp60 -56.57 -41.51 77.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.926 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -53.15 -50.1 65.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.119 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -68.25 -26.66 65.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.098 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . 0.598 HD12 ' HA ' ' A' ' 205' ' ' GLN . 63.4 mt -71.05 -65.11 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.083 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -60.92 -38.09 84.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.879 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -65.07 -26.77 68.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.113 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 89.9 mt -115.61 -75.0 0.59 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.94 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' HIS . . . . . 0.528 ' HD1' ' HA ' ' A' ' 225' ' ' VAL . 20.6 t60 -47.83 128.69 13.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.848 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 83.16 -22.03 7.55 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.514 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 4.8 m -90.18 -71.61 0.61 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.801 0.334 . . . . 0.0 110.893 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' GLN . . . . . 0.449 ' HG3' ' N ' ' A' ' 216' ' ' THR . 1.2 tt0 -88.71 156.05 19.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.865 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' THR . . . . . 0.594 HG23 ' O ' ' A' ' 222' ' ' SER . 2.0 m -119.51 118.1 30.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.119 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' MET . . . . . 0.543 ' HG3' HD23 ' A' ' 158' ' ' LEU . 23.9 mmt -47.44 137.05 9.28 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.598 0.714 . . . . 0.0 110.87 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -48.89 113.82 1.03 Allowed 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.702 2.268 . . . . 0.0 112.379 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 112.7 -54.39 0.55 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.504 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' ALA . . . . . 0.419 ' HB1' ' CE ' ' A' ' 157' ' ' MET . . . -63.72 145.46 55.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.813 0.339 . . . . 0.0 111.15 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 48.2 t -93.23 -16.26 25.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.806 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 222' ' ' SER . . . . . 0.594 ' O ' HG23 ' A' ' 216' ' ' THR . 2.4 m -100.09 136.98 39.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.841 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 2.1 p -44.91 162.97 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.831 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.462 ' HG ' HG23 ' A' ' 226' ' ' VAL . 51.4 tp -56.98 157.04 6.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.895 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . 0.528 ' HA ' ' HD1' ' A' ' 212' ' ' HIS . 91.8 t -125.12 110.21 24.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.144 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . 0.504 HG22 HG13 ' A' ' 155' ' ' VAL . 44.1 t -136.26 105.03 4.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.161 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 4.6 ptmt -132.69 145.77 51.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.909 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.914 179.933 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 23.1 ttpt . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.784 0.326 . . . . 0.0 110.913 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.438 HD21 ' CE1' ' A' ' 228' ' ' PHE . 87.4 mt -123.55 123.51 40.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.896 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -91.22 116.95 29.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.948 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.586 HG13 HG22 ' A' ' 226' ' ' VAL . 38.3 t -110.82 132.44 59.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.114 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -130.87 -158.84 9.39 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.473 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 45.52 31.86 1.0 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.793 0.33 . . . . 0.0 110.859 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 79.5 mt -85.24 -176.22 6.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.875 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.464 ' N ' ' OD1' ' A' ' 159' ' ' ASN . 0.5 OUTLIER -126.97 155.31 43.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.884 179.896 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 65.8 mttt -80.92 42.09 0.62 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.875 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 18.0 mp0 -130.96 -43.03 1.09 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.921 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 17.8 mm-40 -54.0 162.01 1.08 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.914 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 28.1 m -135.7 166.28 23.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.807 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . 0.465 ' O ' ' CB ' ' A' ' 168' ' ' ARG . 2.3 mp0 -49.28 -41.0 36.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.889 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -65.1 -48.34 74.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.867 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 -54.81 -56.61 17.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.817 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.528 HG13 ' CE1' ' A' ' 171' ' ' PHE . 54.3 t -66.98 -40.62 86.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.153 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . 0.465 ' CB ' ' O ' ' A' ' 164' ' ' GLU . 13.8 tpt180 -56.36 -56.28 23.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.865 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 10.0 mmt85 -63.25 -54.47 36.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.889 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.765 ' O ' ' HB3' ' A' ' 173' ' ' ALA . 9.9 tp -43.95 -64.94 0.57 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.925 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . 0.528 ' CE1' HG13 ' A' ' 167' ' ' VAL . 7.4 m-85 -51.33 -68.87 0.13 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.871 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -46.36 -26.4 0.82 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.888 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.765 ' HB3' ' O ' ' A' ' 170' ' ' LEU . . . -48.89 -21.13 0.59 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.126 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -114.21 -60.37 1.89 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.867 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -124.48 134.08 8.93 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.488 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -40.74 162.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.786 0.327 . . . . 0.0 110.93 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.663 HG23 ' O ' ' A' ' 197' ' ' LYS . 32.3 mt -131.03 136.39 58.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.087 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -81.35 -48.76 11.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.92 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -155.49 151.21 27.44 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.882 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 42.1 t -129.38 135.76 49.12 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.856 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 89.5 m -148.1 134.17 19.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.152 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 48.5 mm -95.06 139.04 19.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.099 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.769 HD11 ' CE2' ' A' ' 195' ' ' PHE . 41.0 mt . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.954 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 37.3 p . . . . . 0 N--CA 1.458 -0.065 0 CA-C-O 120.966 0.413 . . . . 0.0 110.871 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 30.1 mmtp -80.4 43.45 0.64 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.914 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 39.01 50.35 2.67 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.487 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 8.1 p -159.54 151.68 20.85 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.849 0.357 . . . . 0.0 110.835 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -160.04 168.02 26.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.111 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' PHE . . . . . 0.769 ' CE2' HD11 ' A' ' 183' ' ' LEU . 40.3 m-85 -120.18 135.83 54.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.864 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 46.9 t -136.32 142.54 38.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.103 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.663 ' O ' HG23 ' A' ' 177' ' ' ILE . 23.2 mttp -117.38 154.1 31.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.885 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -124.17 172.99 8.62 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.901 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 68.3 p -83.24 -33.4 26.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.874 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 11.2 t -141.65 165.1 28.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.851 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 4.8 t60 -67.69 -53.7 25.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.849 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -44.28 -60.28 1.99 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.126 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -46.86 -45.95 20.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.879 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -55.75 -58.43 7.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.111 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 16.5 tp60 -45.11 -49.64 11.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.888 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -53.54 -51.87 61.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.112 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -56.87 -45.12 82.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.107 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . 0.494 ' O ' ' N ' ' A' ' 212' ' ' HIS . 71.4 mt -57.97 -74.06 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.142 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -48.06 -42.54 28.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.883 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -58.31 -37.7 75.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.134 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.419 ' O ' ' CB ' ' A' ' 214' ' ' SER . 41.4 mt -104.53 -72.0 0.72 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.945 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' HIS . . . . . 0.494 ' N ' ' O ' ' A' ' 208' ' ' ILE . 13.0 t60 -46.85 136.59 8.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.876 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 73.67 -6.41 18.18 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.479 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' SER . . . . . 0.419 ' CB ' ' O ' ' A' ' 211' ' ' LEU . 1.3 t -87.97 -71.03 0.6 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.825 0.345 . . . . 0.0 110.883 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.17 178.22 4.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.918 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' THR . . . . . 0.616 HG23 ' O ' ' A' ' 222' ' ' SER . 56.4 m -134.97 95.29 3.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.132 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' MET . . . . . 0.442 ' C ' ' O ' ' A' ' 216' ' ' THR . 25.5 mmt -34.73 133.58 0.42 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.596 0.712 . . . . 0.0 110.887 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -48.91 117.73 2.98 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.723 2.282 . . . . 0.0 112.297 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 120.27 -54.17 0.66 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.52 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -72.04 159.86 33.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.769 0.319 . . . . 0.0 111.095 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 38.7 t -98.15 -23.9 15.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.881 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 222' ' ' SER . . . . . 0.616 ' O ' HG23 ' A' ' 216' ' ' THR . 1.9 m -99.98 147.48 25.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.841 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 73.4 m -60.02 156.41 14.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.852 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 38.2 tp -37.22 153.16 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.903 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . 0.428 ' HA ' ' ND1' ' A' ' 212' ' ' HIS . 61.4 t -124.66 111.04 26.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.136 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . 0.586 HG22 HG13 ' A' ' 155' ' ' VAL . 41.1 t -132.72 102.1 4.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.137 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 10.6 ptmt -129.48 151.65 49.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.898 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 228' ' ' PHE . . . . . 0.438 ' CE1' HD21 ' A' ' 153' ' ' LEU . 82.1 m-85 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.857 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 2.5 tptt . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.842 0.353 . . . . 0.0 110.876 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.483 HD12 ' CD1' ' A' ' 198' ' ' TYR . 41.6 mt -124.54 118.41 26.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.922 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -89.8 120.73 31.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.905 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.694 HG13 HG22 ' A' ' 226' ' ' VAL . 20.7 t -116.33 118.09 57.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.143 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -118.2 -155.8 10.09 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.499 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 16.5 mmt 47.42 34.59 3.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.786 0.327 . . . . 0.0 110.863 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.455 HD23 ' HG3' ' A' ' 217' ' ' MET . 69.3 mt -95.51 165.87 12.14 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.941 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.459 ' H ' ' ND2' ' A' ' 159' ' ' ASN . 0.5 OUTLIER -102.27 162.21 13.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.895 179.929 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 40.4 mttp -85.48 32.89 0.56 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.897 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 3.5 tp60 -120.89 -50.51 2.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.913 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -44.31 159.82 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.893 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 4.9 m -139.06 168.5 19.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.866 -179.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -49.97 -48.73 52.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.885 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -53.31 -56.3 17.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.87 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -48.33 -67.59 0.26 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.87 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.764 HG13 ' CE1' ' A' ' 171' ' ' PHE . 65.3 t -49.99 -53.17 11.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.099 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . 0.429 ' C ' ' O ' ' A' ' 167' ' ' VAL . 1.5 tmm_? -36.25 -63.65 0.37 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.844 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 19.7 mtp180 -63.89 -51.89 62.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.915 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.704 ' O ' ' HB3' ' A' ' 173' ' ' ALA . 16.5 tp -43.29 -65.8 0.45 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.953 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . 0.764 ' CE1' HG13 ' A' ' 167' ' ' VAL . 9.3 m-85 -55.7 -68.33 0.21 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.884 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -44.81 -21.96 0.07 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.882 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.704 ' HB3' ' O ' ' A' ' 170' ' ' LEU . . . -50.11 -17.75 0.46 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.126 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -118.3 -71.74 0.72 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.916 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -109.51 145.83 16.83 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.463 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -55.84 145.59 24.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.836 0.35 . . . . 0.0 110.872 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.482 HD11 ' CB ' ' A' ' 171' ' ' PHE . 50.7 mt -109.26 135.06 49.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.127 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . 0.45 ' HB3' ' CE ' ' A' ' 197' ' ' LYS . 13.0 mt-10 -97.86 -39.09 9.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.897 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 23.2 tp10 -148.17 144.43 27.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.879 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 44.9 t -143.78 137.99 28.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.896 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 22.4 m -154.53 137.29 15.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.096 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.699 HD13 ' CB ' ' A' ' 194' ' ' ALA . 26.4 mm -96.83 126.43 49.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.103 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 1.181 HD11 ' CE2' ' A' ' 195' ' ' PHE . 28.7 mt . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.928 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 48.5 t . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.963 0.411 . . . . 0.0 110.904 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 52.5 mttm -100.68 34.53 2.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.875 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 41.11 39.54 2.13 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.463 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 65.1 m -154.6 149.03 26.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.833 0.349 . . . . 0.0 110.889 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . 0.699 ' CB ' HD13 ' A' ' 182' ' ' ILE . . . -163.14 154.63 17.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.101 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 195' ' ' PHE . . . . . 1.181 ' CE2' HD11 ' A' ' 183' ' ' LEU . 69.7 m-85 -105.38 136.69 44.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.873 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 48.4 t -133.76 140.45 46.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.147 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.45 ' CE ' ' HB3' ' A' ' 178' ' ' GLU . 22.0 ttpt -116.84 142.8 46.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.856 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . 0.483 ' CD1' HD12 ' A' ' 153' ' ' LEU . 9.5 m-85 -119.86 170.2 9.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.895 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 24.7 t -69.2 -48.24 62.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.866 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 59.5 p -145.81 173.05 12.45 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.9 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . 0.443 ' O ' ' C ' ' A' ' 202' ' ' ALA . 6.5 t60 -59.46 -56.48 21.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.823 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . 0.443 ' C ' ' O ' ' A' ' 201' ' ' HIS . . . -34.74 -69.81 0.09 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.122 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -47.1 -47.31 23.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.887 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -53.33 -58.06 8.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.061 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 3.2 tp60 -47.91 -40.03 20.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.929 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -59.81 -53.71 54.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.084 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -61.93 -25.66 67.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.127 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . 0.495 ' O ' ' N ' ' A' ' 212' ' ' HIS . 79.2 mt -71.15 -67.79 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.13 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -57.31 -38.88 74.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.877 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -63.5 -41.73 98.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.147 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.497 ' HB3' HD23 ' A' ' 224' ' ' LEU . 63.7 mt -100.73 -72.09 0.69 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.909 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 212' ' ' HIS . . . . . 0.495 ' N ' ' O ' ' A' ' 208' ' ' ILE . 1.4 t60 -52.15 130.48 30.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.872 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 72.54 -0.98 39.15 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.523 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 22.5 t -96.88 -71.89 0.66 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.782 0.325 . . . . 0.0 110.859 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -99.5 172.37 7.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.866 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 216' ' ' THR . . . . . 0.608 HG23 ' O ' ' A' ' 222' ' ' SER . 34.2 m -123.55 105.35 9.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.125 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 217' ' ' MET . . . . . 0.455 ' HG3' HD23 ' A' ' 158' ' ' LEU . 15.4 mmt -43.18 139.03 2.43 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.514 0.674 . . . . 0.0 110.929 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -48.31 120.74 5.33 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.681 2.254 . . . . 0.0 112.338 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 105.88 -53.97 0.62 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.485 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -66.68 146.93 53.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.845 0.355 . . . . 0.0 111.092 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 29.4 m -93.19 -17.29 23.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.826 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 222' ' ' SER . . . . . 0.608 ' O ' HG23 ' A' ' 216' ' ' THR . 9.8 p -100.01 151.29 21.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.861 -179.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 44.1 m -65.6 148.08 52.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.865 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.497 HD23 ' HB3' ' A' ' 211' ' ' LEU . 63.8 tp -39.56 149.83 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.914 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 61.9 t -121.89 106.52 18.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.129 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . 0.694 HG22 HG13 ' A' ' 155' ' ' VAL . 28.7 t -126.17 104.99 13.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.137 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 46.2 pttt -120.31 176.36 5.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.924 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.927 179.952 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.429 ' HE3' ' CB ' ' A' ' 195' ' ' PHE . 20.6 tttp . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.85 0.357 . . . . 0.0 110.874 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.663 HD21 HD11 ' A' ' 208' ' ' ILE . 25.0 mt -96.63 154.35 17.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.923 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 79.1 t80 -125.0 114.14 18.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.892 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.669 HG21 ' CZ ' ' A' ' 171' ' ' PHE . 17.4 t -102.75 110.51 29.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.108 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -111.99 -171.6 18.82 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.471 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 10.5 mmt 59.66 28.08 17.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.795 0.331 . . . . 0.0 110.845 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 46.3 mt -91.17 165.99 13.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.933 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -108.64 166.56 10.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.904 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 33.0 mttt -84.6 51.7 2.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.91 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -134.88 -50.67 0.77 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.957 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -51.67 163.36 0.31 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.872 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 44.5 m -138.14 172.47 12.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.882 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -53.73 -45.13 70.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.898 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -57.43 -51.38 69.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.847 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -50.99 -65.73 0.51 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.876 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.678 HG13 ' CE1' ' A' ' 171' ' ' PHE . 58.3 t -57.8 -36.57 55.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.137 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 14.2 tpp85 -54.58 -62.72 1.47 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.868 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . 0.401 ' O ' ' HG3' ' A' ' 172' ' ' GLU . 68.3 mtp180 -64.87 -51.52 61.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.864 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.694 ' O ' ' HB3' ' A' ' 173' ' ' ALA . 13.0 tp -43.85 -65.51 0.49 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.912 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . 0.678 ' CE1' HG13 ' A' ' 167' ' ' VAL . 6.6 m-85 -55.84 -67.95 0.25 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.858 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.509 ' C ' ' CD ' ' A' ' 172' ' ' GLU . 0.6 OUTLIER -45.43 -21.56 0.1 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.886 -179.91 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.694 ' HB3' ' O ' ' A' ' 170' ' ' LEU . . . -50.11 -18.97 0.64 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.098 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -110.27 -65.96 1.11 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.908 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -107.33 -165.53 21.98 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.478 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -100.01 132.84 45.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.778 0.323 . . . . 0.0 110.886 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 29.6 mt -101.89 138.32 26.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.089 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -98.96 -32.82 11.11 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.862 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -160.83 152.31 19.32 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.885 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 38.6 t -136.1 121.49 19.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.902 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . 0.487 ' O ' ' HB1' ' A' ' 194' ' ' ALA . 97.8 m -123.86 139.08 54.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.152 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.43 HD13 ' HB1' ' A' ' 194' ' ' ALA . 50.6 mm -115.57 114.54 46.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.134 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.564 HD11 ' HE2' ' A' ' 195' ' ' PHE . 18.8 mt . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.914 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 4.6 t . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.969 0.414 . . . . 0.0 110.816 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 2.6 mmmp? -105.56 15.51 26.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.91 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 62.47 32.24 82.42 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.497 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 11.1 m -148.04 142.96 26.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.794 0.331 . . . . 0.0 110.879 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . 0.487 ' HB1' ' O ' ' A' ' 181' ' ' THR . . . -160.04 160.2 32.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.095 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 195' ' ' PHE . . . . . 0.564 ' HE2' HD11 ' A' ' 183' ' ' LEU . 77.4 m-85 -115.54 133.57 55.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.892 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.428 HG21 ' CE2' ' A' ' 171' ' ' PHE . 92.9 t -116.68 128.74 73.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.14 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 19.1 tttp -95.87 145.2 25.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.888 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . 0.44 ' CD1' HD12 ' A' ' 153' ' ' LEU . 7.6 m-85 -129.07 171.6 12.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.924 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 91.3 p -85.58 -20.91 28.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.885 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 2.2 m -162.01 176.42 10.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.772 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -77.16 -37.68 53.32 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.864 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -52.82 -65.31 0.58 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.102 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 18.2 mp0 -48.47 -41.29 29.25 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.88 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -58.85 -59.8 4.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.074 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . 0.61 ' HA ' HD12 ' A' ' 208' ' ' ILE . 43.1 tp60 -45.64 -42.02 10.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.937 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -60.48 -52.74 63.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.101 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -62.74 -28.39 69.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.112 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . 0.663 HD11 HD21 ' A' ' 153' ' ' LEU . 93.2 mt -67.41 -75.11 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.121 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -46.25 -43.4 15.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.893 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -55.99 -41.93 75.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.095 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 71.6 mt -100.94 -69.57 0.77 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.873 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 212' ' ' HIS . . . . . 0.637 ' HD1' ' HA ' ' A' ' 225' ' ' VAL . 27.1 t60 -52.4 125.62 16.71 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.902 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 84.6 -10.22 62.66 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.507 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 51.7 m -97.71 -74.43 0.58 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.84 0.353 . . . . 0.0 110.845 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 19.9 mp0 -88.43 166.42 14.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.928 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 216' ' ' THR . . . . . 0.664 HG23 ' O ' ' A' ' 222' ' ' SER . 32.4 m -135.79 106.39 6.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.141 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 217' ' ' MET . . . . . 0.404 ' C ' ' O ' ' A' ' 216' ' ' THR . 15.5 mmt -37.31 156.37 0.09 OUTLIER Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.547 0.689 . . . . 0.0 110.878 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.09 120.61 7.31 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.656 2.237 . . . . 0.0 112.323 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 109.36 -42.63 1.9 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.466 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -76.4 144.3 40.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.767 0.317 . . . . 0.0 111.089 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 3.5 t -93.57 -15.28 25.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.812 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 222' ' ' SER . . . . . 0.664 ' O ' HG23 ' A' ' 216' ' ' THR . 67.6 m -100.17 142.09 32.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.904 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 64.7 m -57.72 157.13 7.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.824 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 47.7 tp -48.35 148.81 1.77 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.916 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . 0.637 ' HA ' ' HD1' ' A' ' 212' ' ' HIS . 53.0 t -119.73 111.17 31.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.101 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 25.7 t -132.68 101.31 4.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.117 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.81 158.4 42.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.897 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 228' ' ' PHE . . . . . 0.632 ' CE1' HD21 ' A' ' 153' ' ' LEU . 28.6 m-85 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.887 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.577 ' HE2' ' CD1' ' A' ' 195' ' ' PHE . 3.8 ttpm? . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.869 0.366 . . . . 0.0 110.886 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 40.5 mt -129.65 123.97 32.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.886 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -90.19 119.33 30.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.9 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.737 HG13 HG22 ' A' ' 226' ' ' VAL . 5.1 t -107.22 124.7 63.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.121 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -124.85 -168.37 12.78 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.475 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 18.0 mmt 48.45 35.13 5.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.773 0.32 . . . . 0.0 110.896 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 38.3 mt -89.2 166.15 14.0 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.915 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -104.51 160.08 15.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.874 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 24.1 mttp -84.49 23.98 1.05 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.914 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -109.56 -55.21 2.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.909 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -53.4 146.05 13.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.88 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 57.7 m -126.38 166.37 17.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.864 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -44.13 -40.23 4.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.861 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -55.97 -66.08 0.49 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.872 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -52.81 -48.42 66.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.872 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.513 HG13 ' CE1' ' A' ' 171' ' ' PHE . 93.9 t -57.45 -35.24 48.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.099 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 51.4 ttt180 -63.81 -57.87 8.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.843 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . 0.401 ' O ' ' HG2' ' A' ' 172' ' ' GLU . 8.5 ptm180 -64.15 -53.24 52.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.85 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.741 ' O ' ' HB3' ' A' ' 173' ' ' ALA . 8.5 tp -43.72 -65.26 0.52 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.916 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . 0.513 ' CE1' HG13 ' A' ' 167' ' ' VAL . 10.9 m-85 -53.03 -68.9 0.13 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.884 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.401 ' HG2' ' O ' ' A' ' 169' ' ' ARG . 4.3 pt-20 -45.75 -24.19 0.34 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.894 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.741 ' HB3' ' O ' ' A' ' 170' ' ' LEU . . . -49.4 -21.23 0.84 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.073 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -111.77 -71.37 0.76 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.879 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -112.21 146.83 18.16 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.462 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . 0.45 ' O ' ' CD2' ' A' ' 198' ' ' TYR . 32.6 m120 -51.57 160.3 0.64 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.816 0.341 . . . . 0.0 110.926 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.411 ' CG2' ' N ' ' A' ' 178' ' ' GLU . 19.3 mt -124.73 152.37 30.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.128 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . 0.411 ' N ' ' CG2' ' A' ' 177' ' ' ILE . 9.1 mt-10 -120.49 -28.92 4.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.868 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -155.76 146.78 22.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.871 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 4.8 t -147.32 132.91 18.76 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.927 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 99.5 m -151.32 145.13 25.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.141 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 18.5 mm -97.25 137.48 24.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.14 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.934 HD11 ' CE2' ' A' ' 195' ' ' PHE . 52.9 mt . . . . . 0 C--N 1.328 -0.352 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.914 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 10.8 t . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.914 0.388 . . . . 0.0 110.876 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 24.5 mmtt -90.82 36.16 0.9 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.918 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 43.28 37.61 3.41 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.468 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 193' ' ' CYS . . . . . 0.416 ' C ' ' HB2' ' A' ' 183' ' ' LEU . 72.1 m -150.49 150.4 31.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.799 0.333 . . . . 0.0 110.868 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -163.09 169.2 19.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.077 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 195' ' ' PHE . . . . . 0.934 ' CE2' HD11 ' A' ' 183' ' ' LEU . 18.2 m-85 -122.96 135.77 54.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.853 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.511 HG21 ' CE2' ' A' ' 171' ' ' PHE . 61.3 t -130.75 140.69 48.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.121 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 25.3 ttmt -117.44 146.49 43.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.856 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . 0.45 ' CD2' ' O ' ' A' ' 176' ' ' ASN . 24.6 m-85 -124.23 166.42 15.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.919 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 42.3 t -70.03 -48.74 56.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.828 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 7.3 t -136.82 168.69 19.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.859 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . 0.533 ' O ' ' HB3' ' A' ' 204' ' ' ALA . 4.7 t60 -61.35 -57.34 12.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.85 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . 0.449 ' C ' ' O ' ' A' ' 201' ' ' HIS . . . -33.99 -67.03 0.14 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.093 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 19.4 mp0 -49.83 -39.59 39.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.879 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . 0.533 ' HB3' ' O ' ' A' ' 201' ' ' HIS . . . -55.65 -51.82 65.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.092 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 59.6 tp60 -57.29 -45.18 84.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.876 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -51.93 -47.69 64.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.104 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -69.48 -29.88 67.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.136 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . 0.482 ' O ' ' N ' ' A' ' 212' ' ' HIS . 56.3 mt -66.94 -60.44 2.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.125 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -64.22 -36.95 85.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.869 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -66.6 -35.56 80.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.122 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.705 ' HB3' HD23 ' A' ' 224' ' ' LEU . 84.5 mt -102.51 -69.33 0.79 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.902 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 212' ' ' HIS . . . . . 0.482 ' N ' ' O ' ' A' ' 208' ' ' ILE . 12.2 t60 -62.97 126.19 26.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.835 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 85.7 -4.28 86.0 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.495 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 2.1 m -94.43 -74.12 0.55 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.84 0.353 . . . . 0.0 110.854 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 17.2 pm0 -99.88 175.63 5.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.894 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 216' ' ' THR . . . . . 0.673 HG23 ' O ' ' A' ' 222' ' ' SER . 17.3 m -130.33 101.37 5.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.106 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 13.5 mmt -37.08 134.45 0.68 Allowed Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.608 0.718 . . . . 0.0 110.884 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -48.71 119.88 4.71 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.668 2.246 . . . . 0.0 112.342 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 112.89 -49.86 0.81 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.513 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -73.38 156.76 38.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.813 0.34 . . . . 0.0 111.081 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 94.7 p -98.88 -21.14 16.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.837 -179.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 222' ' ' SER . . . . . 0.673 ' O ' HG23 ' A' ' 216' ' ' THR . 1.8 m -100.15 143.31 30.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.855 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 15.1 m -56.88 153.49 10.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.921 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.705 HD23 ' HB3' ' A' ' 211' ' ' LEU . 58.5 tp -40.17 149.62 0.07 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.865 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . 0.426 ' HA ' ' ND1' ' A' ' 212' ' ' HIS . 79.9 t -118.35 113.71 42.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.18 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . 0.737 HG22 HG13 ' A' ' 155' ' ' VAL . 20.5 t -138.97 104.97 2.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.15 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 44.7 pttt -127.4 178.96 5.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.862 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.878 179.929 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 5.8 ttpm? . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.784 0.326 . . . . 0.0 110.904 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 59.5 mt -136.92 140.72 42.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.891 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 35.5 t80 -107.36 121.05 43.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.915 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.566 HG13 HG22 ' A' ' 226' ' ' VAL . 23.9 t -110.26 132.1 59.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.161 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -133.04 -161.5 9.87 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.512 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 19.5 mmt 49.04 30.55 2.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.819 0.342 . . . . 0.0 110.875 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.401 ' HB2' ' C ' ' A' ' 192' ' ' GLY . 82.0 mt -91.05 166.69 12.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.924 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -108.94 155.82 20.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.882 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 36.2 mttp -81.38 44.73 0.81 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.868 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -127.93 -47.42 1.37 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.922 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 14.8 mm-40 -58.73 162.11 4.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.894 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 45.9 m -135.02 174.44 10.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.854 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . 0.451 ' O ' ' CB ' ' A' ' 168' ' ' ARG . 1.4 mp0 -51.35 -35.62 39.26 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.871 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -63.25 -65.89 0.62 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.904 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -42.21 -57.01 2.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.892 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.733 HG13 ' CE1' ' A' ' 171' ' ' PHE . 75.5 t -62.66 -59.89 3.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.12 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . 0.451 ' CB ' ' O ' ' A' ' 164' ' ' GLU . 29.9 ttm-85 -35.29 -63.91 0.31 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.874 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 83.7 mtm180 -59.16 -54.59 45.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.877 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.71 ' O ' ' HB3' ' A' ' 173' ' ' ALA . 16.2 tp -42.8 -66.02 0.41 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.896 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . 0.733 ' CE1' HG13 ' A' ' 167' ' ' VAL . 13.4 m-85 -51.7 -72.06 0.06 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.891 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -41.52 -31.79 0.29 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.915 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.71 ' HB3' ' O ' ' A' ' 170' ' ' LEU . . . -39.62 -30.16 0.07 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.06 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -107.85 -68.83 0.88 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.879 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -111.88 131.75 10.42 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.504 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -48.78 147.71 2.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.852 0.358 . . . . 0.0 110.849 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.639 HG23 ' O ' ' A' ' 197' ' ' LYS . 67.2 mt -112.77 138.66 41.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.119 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 67.7 mm-40 -98.7 -36.23 9.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.842 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -148.6 139.23 22.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.845 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 47.9 t -145.12 138.47 26.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.855 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 18.1 m -152.83 148.94 27.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.199 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 35.2 mm -102.26 134.91 41.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.152 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.597 HD12 ' HB3' ' A' ' 193' ' ' CYS . 29.4 mt . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.919 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 23.2 t . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.932 0.396 . . . . 0.0 110.826 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . 0.404 ' O ' ' C ' ' A' ' 192' ' ' GLY . 8.7 mtmp? -89.7 47.21 1.44 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.884 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.404 ' C ' ' O ' ' A' ' 191' ' ' LYS . . . 37.37 46.66 1.45 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.507 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 193' ' ' CYS . . . . . 0.597 ' HB3' HD12 ' A' ' 183' ' ' LEU . 87.1 m -155.19 156.69 36.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.852 0.358 . . . . 0.0 110.881 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -160.61 166.86 28.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.085 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 195' ' ' PHE . . . . . 0.459 ' CE2' HD21 ' A' ' 183' ' ' LEU . 26.6 m-85 -119.73 119.6 34.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.905 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.494 HG21 ' CE2' ' A' ' 171' ' ' PHE . 21.9 t -114.04 152.34 15.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.138 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.639 ' O ' HG23 ' A' ' 177' ' ' ILE . 23.0 tttp -135.61 137.3 41.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.913 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -113.31 162.43 16.06 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.876 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 11.8 t -65.95 -52.11 52.59 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.873 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 5.7 t -124.0 170.86 10.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.836 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . 0.49 ' O ' ' HB3' ' A' ' 204' ' ' ALA . 6.5 t60 -69.23 -51.03 41.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.854 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -42.74 -64.57 0.59 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.091 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -46.38 -43.07 15.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.88 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . 0.49 ' HB3' ' O ' ' A' ' 201' ' ' HIS . . . -53.07 -62.07 1.89 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.134 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . 0.556 ' HA ' HD12 ' A' ' 208' ' ' ILE . 50.4 tp60 -46.61 -47.06 20.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.905 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -49.19 -57.88 5.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.118 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -54.72 -44.01 73.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.072 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . 0.556 HD12 ' HA ' ' A' ' 205' ' ' GLN . 75.7 mt -51.12 -72.83 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.141 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -54.83 -38.76 67.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.868 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -61.43 -31.4 71.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.111 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 98.5 mt -114.34 -73.85 0.64 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.873 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 212' ' ' HIS . . . . . 0.502 ' N ' ' O ' ' A' ' 208' ' ' ILE . 14.6 t60 -49.5 131.92 20.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.847 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 78.3 -10.24 29.74 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.515 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 25.6 t -99.22 -69.27 0.77 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.818 0.342 . . . . 0.0 110.87 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 7.1 mm-40 -88.11 159.39 18.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.931 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 216' ' ' THR . . . . . 0.47 HG23 ' O ' ' A' ' 222' ' ' SER . 2.9 m -125.34 99.04 5.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.175 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 217' ' ' MET . . . . . 0.409 ' C ' ' O ' ' A' ' 216' ' ' THR . 12.1 mmt -35.96 135.07 0.53 Allowed Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.568 0.699 . . . . 0.0 110.879 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -48.21 121.31 5.93 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.719 2.28 . . . . 0.0 112.331 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 108.06 -48.57 0.93 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.483 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 220' ' ' ALA . . . . . 0.401 ' O ' HG22 ' A' ' 216' ' ' THR . . . -75.15 144.6 42.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.792 0.33 . . . . 0.0 111.117 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 7.0 t -92.65 -16.0 26.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.872 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 222' ' ' SER . . . . . 0.47 ' O ' HG23 ' A' ' 216' ' ' THR . 67.9 m -99.99 138.37 37.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.846 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 66.2 m -52.83 155.71 2.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.857 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.631 HD12 ' H ' ' A' ' 225' ' ' VAL . 50.8 tp -45.57 157.73 0.09 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.89 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . 0.631 ' H ' HD12 ' A' ' 224' ' ' LEU . 55.0 t -122.67 104.46 14.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.167 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . 0.624 HG23 ' HG ' ' A' ' 224' ' ' LEU . 21.0 t -134.78 108.87 11.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.106 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.94 -179.54 4.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.852 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.865 -179.998 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.552 ' HE3' ' CD1' ' A' ' 195' ' ' PHE . 19.1 ttpt . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.825 0.345 . . . . 0.0 110.93 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.572 HD12 ' CD1' ' A' ' 198' ' ' TYR . 37.9 mt -121.3 127.44 51.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.924 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -92.37 130.97 37.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.855 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.456 HG22 HG13 ' A' ' 226' ' ' VAL . 39.0 t -121.47 126.8 75.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.167 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -127.97 -172.3 13.19 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.513 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 82.2 mmm 51.38 39.54 24.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.773 0.32 . . . . 0.0 110.89 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.473 HD12 ' HA ' ' A' ' 193' ' ' CYS . 50.7 mt -93.39 171.43 8.92 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.936 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -100.44 160.73 14.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.891 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 24.2 mttp -89.87 34.59 0.84 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.91 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -127.92 -43.62 1.51 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.859 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -47.05 155.94 0.25 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.907 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 5.8 m -132.9 171.88 13.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.871 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . 0.464 ' O ' ' CB ' ' A' ' 168' ' ' ARG . 2.9 mp0 -55.24 -37.68 67.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.882 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -64.96 -44.98 87.62 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.874 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 -60.41 -59.39 5.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.874 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.894 HG13 ' CE1' ' A' ' 171' ' ' PHE . 96.2 t -62.17 -39.3 83.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.144 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . 0.464 ' CB ' ' O ' ' A' ' 164' ' ' GLU . 33.2 ttt180 -55.28 -63.13 1.26 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.832 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 74.7 mtt180 -60.91 -54.02 50.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.859 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.722 ' O ' ' HB3' ' A' ' 173' ' ' ALA . 10.0 tp -43.93 -65.64 0.48 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.866 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . 0.894 ' CE1' HG13 ' A' ' 167' ' ' VAL . 10.6 m-85 -51.07 -70.39 0.09 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.879 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -44.14 -30.44 0.77 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.89 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.722 ' HB3' ' O ' ' A' ' 170' ' ' LEU . . . -42.81 -28.05 0.22 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.127 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -106.46 -68.97 0.85 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.889 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -113.42 135.23 12.42 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.521 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -45.71 153.27 0.28 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.784 0.326 . . . . 0.0 110.897 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.416 ' CG2' ' N ' ' A' ' 178' ' ' GLU . 58.2 mt -118.18 153.06 20.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.148 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . 0.416 ' N ' ' CG2' ' A' ' 177' ' ' ILE . 55.6 mt-10 -117.11 -37.72 3.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.885 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -144.7 140.36 28.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.931 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 10.1 t -140.01 134.14 31.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.854 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 86.0 m -153.22 143.74 22.58 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.124 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.407 ' CG1' ' HG3' ' A' ' 164' ' ' GLU . 9.7 mm -104.39 133.31 48.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.141 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.674 HD11 ' CE2' ' A' ' 195' ' ' PHE . 22.1 mt . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.944 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 13.4 t . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.915 0.388 . . . . 0.0 110.844 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 34.2 mtmm -84.12 38.12 0.64 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.914 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 43.11 43.38 5.61 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.493 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 193' ' ' CYS . . . . . 0.473 ' HA ' HD12 ' A' ' 158' ' ' LEU . 80.7 m -154.62 159.55 40.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.826 0.346 . . . . 0.0 110.888 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -161.73 169.13 22.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.07 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 195' ' ' PHE . . . . . 0.674 ' CE2' HD11 ' A' ' 183' ' ' LEU . 38.2 m-85 -126.58 122.5 35.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.899 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 9.4 t -123.73 147.97 27.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.14 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -118.09 155.94 29.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.88 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . 0.572 ' CD1' HD12 ' A' ' 153' ' ' LEU . 20.8 m-85 -131.58 166.36 21.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.955 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 35.7 t -64.98 -51.54 61.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.858 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 4.8 m -140.51 -177.2 4.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.864 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . 0.441 ' O ' ' C ' ' A' ' 202' ' ' ALA . 13.1 t60 -68.15 -58.68 4.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.852 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . 0.441 ' C ' ' O ' ' A' ' 201' ' ' HIS . . . -34.93 -67.09 0.15 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.106 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -47.44 -47.36 26.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.89 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . 0.415 ' HB3' ' O ' ' A' ' 201' ' ' HIS . . . -52.36 -63.61 1.09 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.104 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . 0.878 ' HA ' HD12 ' A' ' 208' ' ' ILE . 11.0 tp60 -43.36 -45.41 6.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.901 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -52.99 -55.34 24.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.107 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -58.41 -34.67 71.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.139 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . 0.878 HD12 ' HA ' ' A' ' 205' ' ' GLN . 82.5 mt -59.94 -72.6 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.078 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 -52.09 -41.69 62.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.901 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -57.04 -40.96 77.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.109 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 64.7 mt -101.92 -71.12 0.73 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.929 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 212' ' ' HIS . . . . . 0.633 ' HD1' ' HA ' ' A' ' 225' ' ' VAL . 31.0 t60 -54.54 128.78 33.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.903 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 80.21 -1.62 79.88 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.456 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 34.0 t -96.65 -74.34 0.57 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.821 0.343 . . . . 0.0 110.892 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -97.3 -177.46 3.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.911 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 216' ' ' THR . . . . . 0.572 HG23 ' O ' ' A' ' 222' ' ' SER . 60.4 m -133.65 100.99 4.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.125 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 33.0 mmt -39.27 135.08 1.12 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.607 0.718 . . . . 0.0 110.869 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -48.34 114.08 1.05 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.703 2.269 . . . . 0.0 112.343 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 119.07 -51.19 0.77 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.485 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -72.77 155.58 39.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.814 0.34 . . . . 0.0 111.069 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 28.7 t -98.16 -21.15 16.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.898 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 222' ' ' SER . . . . . 0.572 ' O ' HG23 ' A' ' 216' ' ' THR . 1.1 t -99.88 154.14 18.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.876 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 57.8 m -58.65 158.54 7.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.832 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.458 ' HG ' HG23 ' A' ' 226' ' ' VAL . 43.1 tp -47.81 152.51 0.73 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.94 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . 0.633 ' HA ' ' HD1' ' A' ' 212' ' ' HIS . 98.0 t -118.48 111.46 34.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.139 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . 0.458 HG23 ' HG ' ' A' ' 224' ' ' LEU . 23.7 t -138.37 105.36 3.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.098 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 34.3 pttt -129.13 169.73 14.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.897 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.917 179.978 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 12.4 tttt . . . . . 0 C--O 1.232 0.17 0 CA-C-O 120.805 0.336 . . . . 0.0 110.9 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 44.4 mt -120.53 129.2 53.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.904 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 29.6 t80 -98.01 119.92 37.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.912 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.446 HG21 ' CZ ' ' A' ' 171' ' ' PHE . 21.6 t -110.27 129.1 65.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.102 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -127.69 -170.56 12.86 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.502 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 11.3 mmt 55.59 36.27 26.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.828 0.347 . . . . 0.0 110.937 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.422 ' HB2' ' C ' ' A' ' 192' ' ' GLY . 38.6 mt -95.55 168.93 10.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.872 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.478 ' ND2' ' O ' ' A' ' 218' ' ' PRO . 12.7 m120 -113.59 162.83 15.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.898 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 38.0 mttp -82.62 48.91 1.38 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.911 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -133.27 -49.49 0.85 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.886 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 16.0 mm-40 -56.65 155.52 7.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.899 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 17.1 m -135.51 176.13 8.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.884 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -47.57 -50.52 23.78 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.903 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -54.92 -58.62 6.86 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.839 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -41.84 -66.02 0.39 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.862 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.772 HG13 ' CE1' ' A' ' 171' ' ' PHE . 65.9 t -55.52 -54.77 21.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.113 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . 0.439 ' C ' ' O ' ' A' ' 167' ' ' VAL . 43.8 ttt180 -35.23 -70.11 0.09 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.875 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 44.3 mmm-85 -58.04 -53.57 56.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.909 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.664 ' O ' ' HB3' ' A' ' 173' ' ' ALA . 19.5 tp -41.37 -66.83 0.3 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.923 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . 0.772 ' CE1' HG13 ' A' ' 167' ' ' VAL . 9.9 m-85 -55.33 -72.84 0.06 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.858 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.45 ' O ' ' N ' ' A' ' 174' ' ' PHE . 0.5 OUTLIER -39.55 -28.26 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.907 -179.907 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.664 ' HB3' ' O ' ' A' ' 170' ' ' LEU . . . -41.41 -24.18 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.112 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . 0.45 ' N ' ' O ' ' A' ' 172' ' ' GLU . 93.7 m-85 -108.09 -69.92 0.83 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.931 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -100.94 -171.64 28.79 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.485 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 33.3 m-20 -98.86 131.67 44.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.771 0.319 . . . . 0.0 110.898 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.417 ' CG2' ' N ' ' A' ' 178' ' ' GLU . 37.1 mt -96.39 151.94 3.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.136 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . 0.417 ' N ' ' CG2' ' A' ' 177' ' ' ILE . 6.8 mt-10 -121.27 -21.51 6.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.905 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -165.85 136.43 3.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.865 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 51.0 t -130.47 141.6 50.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.89 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 83.2 m -153.11 147.65 26.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.158 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 20.1 mm -115.22 137.51 48.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.132 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.699 HD11 ' CE2' ' A' ' 195' ' ' PHE . 34.3 mt . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.932 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 17.1 t . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.916 0.389 . . . . 0.0 110.895 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 24.0 mtpt -89.68 31.55 0.93 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.952 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.422 ' C ' ' HB2' ' A' ' 158' ' ' LEU . . . 47.19 36.82 10.25 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.5 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 63.6 m -151.3 155.83 39.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.848 0.356 . . . . 0.0 110.843 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -161.04 162.21 31.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.072 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 195' ' ' PHE . . . . . 0.699 ' CE2' HD11 ' A' ' 183' ' ' LEU . 58.2 m-85 -117.79 142.36 47.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.848 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 45.6 t -129.82 145.34 35.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.091 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 24.7 tttt -113.5 147.48 37.83 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.879 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -132.4 167.9 19.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.945 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 38.1 t -83.96 -40.08 18.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.856 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 3.5 m -138.26 176.61 8.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.854 -179.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . 0.431 ' O ' ' C ' ' A' ' 202' ' ' ALA . 5.3 t60 -74.24 -56.44 4.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.866 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . 0.431 ' C ' ' O ' ' A' ' 201' ' ' HIS . . . -35.56 -63.21 0.36 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.1 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 31.7 mm-40 -49.4 -49.83 43.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.871 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -51.45 -59.28 4.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.143 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . 0.596 ' HA ' HD12 ' A' ' 208' ' ' ILE . 33.8 tp60 -48.27 -55.92 9.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.884 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -44.2 -61.38 1.51 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.067 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -49.05 -49.19 42.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.119 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . 0.596 HD12 ' HA ' ' A' ' 205' ' ' GLN . 66.4 mt -49.54 -74.95 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.123 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -44.47 -44.58 8.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.916 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 210' ' ' ALA . . . . . 0.416 ' HB1' ' CZ ' ' A' ' 174' ' ' PHE . . . -54.24 -43.31 70.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.126 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.428 ' CB ' HD23 ' A' ' 224' ' ' LEU . 7.9 mt -100.29 -68.93 0.79 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.934 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 212' ' ' HIS . . . . . 0.639 ' HD1' ' HA ' ' A' ' 225' ' ' VAL . 29.7 t60 -51.6 126.18 16.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.851 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . 0.442 ' HA2' ' CB ' ' A' ' 223' ' ' SER . . . 82.02 -19.23 10.35 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.518 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 2.5 m -85.5 -73.08 0.46 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.803 0.335 . . . . 0.0 110.872 -179.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 71.1 mt-30 -92.69 167.18 12.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.924 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 216' ' ' THR . . . . . 0.636 HG23 ' O ' ' A' ' 222' ' ' SER . 0.7 OUTLIER -126.95 104.07 7.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.119 -179.917 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 14.5 mmt -39.04 135.23 1.04 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.609 0.719 . . . . 0.0 110.836 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . 0.478 ' O ' ' ND2' ' A' ' 159' ' ' ASN . 76.1 Cg_exo -48.72 122.29 7.81 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.684 2.256 . . . . 0.0 112.375 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 105.03 -44.99 1.36 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.509 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -75.54 143.97 42.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.768 0.318 . . . . 0.0 111.091 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 29.9 t -92.59 -15.5 26.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.882 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 222' ' ' SER . . . . . 0.636 ' O ' HG23 ' A' ' 216' ' ' THR . 1.8 m -99.84 146.1 27.0 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.837 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . 0.442 ' CB ' ' HA2' ' A' ' 213' ' ' GLY . 29.4 m -59.63 150.08 28.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.828 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.428 HD23 ' CB ' ' A' ' 211' ' ' LEU . 62.4 tp -41.78 151.62 0.09 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.935 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . 0.639 ' HA ' ' HD1' ' A' ' 212' ' ' HIS . 60.1 t -118.34 113.83 43.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.171 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . 0.595 HG12 HG12 ' A' ' 208' ' ' ILE . 46.0 t -136.92 105.2 3.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.153 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 8.3 ptmt -122.14 169.25 11.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.895 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.915 179.952 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.568 ' HD3' ' CD1' ' A' ' 195' ' ' PHE . 24.4 ttmt . . . . . 0 C--O 1.232 0.176 0 CA-C-O 120.798 0.332 . . . . 0.0 110.899 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.622 HD21 ' CE1' ' A' ' 228' ' ' PHE . 58.0 mt -127.2 121.81 32.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.882 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -95.13 127.03 40.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.864 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.634 HG21 ' HZ ' ' A' ' 171' ' ' PHE . 59.1 t -114.47 133.81 59.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.149 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -128.97 -159.58 9.99 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.49 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 27.8 mtt 41.84 39.88 1.37 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.817 0.341 . . . . 0.0 110.86 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 42.8 mt -95.43 161.4 14.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.943 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.483 ' ND2' ' O ' ' A' ' 218' ' ' PRO . 69.2 m-20 -100.35 165.97 11.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.861 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 65.4 mttt -89.72 40.97 1.02 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.842 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 18.9 mm-40 -127.31 -53.17 1.38 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.858 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -55.13 148.82 13.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.926 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 1.6 t -133.81 176.42 8.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.84 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -47.93 -42.64 27.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.862 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -50.55 -57.66 7.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.89 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . 0.404 ' O ' ' HG2' ' A' ' 169' ' ' ARG . 6.5 m-20 -61.21 -66.63 0.5 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.923 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.604 HG13 ' CE1' ' A' ' 171' ' ' PHE . 59.8 t -42.02 -35.32 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.094 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 25.0 ttm180 -63.88 -61.24 2.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.873 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . 0.404 ' HG2' ' O ' ' A' ' 166' ' ' ASP . 31.6 ptt180 -63.09 -52.13 63.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.887 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.729 ' O ' ' HB3' ' A' ' 173' ' ' ALA . 8.5 tp -44.23 -65.69 0.48 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.89 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . 0.634 ' HZ ' HG21 ' A' ' 155' ' ' VAL . 14.0 m-85 -53.28 -69.41 0.12 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.888 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -44.32 -26.05 0.3 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.94 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.729 ' HB3' ' O ' ' A' ' 170' ' ' LEU . . . -46.74 -20.49 0.13 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.142 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -116.14 -73.61 0.64 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.909 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -109.45 147.22 16.96 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.536 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -52.5 157.58 1.47 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.823 0.344 . . . . 0.0 110.903 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.451 HG23 ' O ' ' A' ' 197' ' ' LYS . 98.0 mt -122.37 147.55 26.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.143 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -102.4 -45.91 4.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.901 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -153.71 151.36 29.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.879 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 52.2 t -138.11 143.28 40.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.893 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 98.5 m -152.17 138.95 18.87 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.119 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 21.3 mm -93.72 127.86 45.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.158 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 1.0 HD11 ' CE2' ' A' ' 195' ' ' PHE . 65.6 mt . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.899 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 9.3 p . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.947 0.404 . . . . 0.0 110.841 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 28.9 mmtt -94.71 39.87 1.1 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.927 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 39.21 42.79 1.79 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.435 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 71.5 m -154.85 150.01 27.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.834 0.349 . . . . 0.0 110.905 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -161.39 162.91 30.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.075 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 195' ' ' PHE . . . . . 1.0 ' CE2' HD11 ' A' ' 183' ' ' LEU . 28.0 m-85 -116.98 143.12 46.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.896 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.53 HG11 ' CD2' ' A' ' 171' ' ' PHE . 40.3 t -140.13 138.2 37.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.125 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.451 ' O ' HG23 ' A' ' 177' ' ' ILE . 8.0 ttmm -118.91 148.29 43.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.879 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -122.82 172.22 8.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.93 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 1.2 t -76.14 -49.99 15.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.854 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 58.7 m -125.51 -178.19 4.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.854 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . 0.432 ' O ' ' C ' ' A' ' 202' ' ' ALA . 9.8 t60 -79.66 -63.14 1.48 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.885 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . 0.432 ' C ' ' O ' ' A' ' 201' ' ' HIS . . . -34.35 -60.65 0.41 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.085 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -48.02 -50.42 27.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.93 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -51.99 -59.05 4.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.072 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . 0.794 ' HA ' HD12 ' A' ' 208' ' ' ILE . 13.1 tp60 -44.91 -49.34 11.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.881 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -51.29 -58.32 6.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.131 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -52.59 -37.54 58.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.126 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . 0.794 HD12 ' HA ' ' A' ' 205' ' ' GLN . 77.0 mt -59.23 -74.06 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.095 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -49.92 -42.52 48.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.898 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -53.31 -45.6 69.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.126 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 57.2 mt -99.99 -67.69 0.84 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.9 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 212' ' ' HIS . . . . . 0.491 ' N ' ' O ' ' A' ' 208' ' ' ILE . 9.2 t60 -51.46 127.79 20.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.846 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 77.63 -9.97 26.55 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.472 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 8.3 t -97.74 -66.55 0.89 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.84 0.352 . . . . 0.0 110.879 -179.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 7.3 mm-40 -92.31 163.66 13.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.919 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 216' ' ' THR . . . . . 0.609 HG23 ' O ' ' A' ' 222' ' ' SER . 3.9 m -131.09 101.28 5.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.129 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 217' ' ' MET . . . . . 0.436 ' C ' ' O ' ' A' ' 216' ' ' THR . 0.0 OUTLIER -34.69 131.07 0.45 Allowed Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.548 0.69 . . . . 0.0 110.886 179.859 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . 0.483 ' O ' ' ND2' ' A' ' 159' ' ' ASN . 75.6 Cg_exo -48.89 120.29 5.25 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.699 2.266 . . . . 0.0 112.35 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 107.78 -45.03 1.36 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.499 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -73.48 142.11 46.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.812 0.339 . . . . 0.0 111.084 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 35.6 m -89.17 -16.55 31.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.836 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 222' ' ' SER . . . . . 0.609 ' O ' HG23 ' A' ' 216' ' ' THR . 3.9 m -99.87 143.24 30.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.841 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 95.8 p -63.32 152.46 37.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.873 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 27.0 tp -48.0 146.85 2.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.894 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . 0.417 ' HA ' ' HD1' ' A' ' 212' ' ' HIS . 68.6 t -119.5 118.27 56.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.129 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . 0.468 HG22 HG22 ' A' ' 155' ' ' VAL . 38.7 t -141.12 116.95 6.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.152 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 18.3 pttt -131.81 172.29 12.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.888 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 228' ' ' PHE . . . . . 0.622 ' CE1' HD21 ' A' ' 153' ' ' LEU . 54.8 m-85 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.89 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 9.4 tttp . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.829 0.347 . . . . 0.0 110.912 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.492 HD21 HD11 ' A' ' 208' ' ' ILE . 41.8 mt -133.92 121.05 21.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.89 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -93.86 118.37 31.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.841 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.715 HG22 HG13 ' A' ' 226' ' ' VAL . 16.5 t -106.35 131.9 54.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.098 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -130.41 -164.04 11.2 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.507 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 18.7 mmt 40.19 37.95 0.47 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.786 0.327 . . . . 0.0 110.846 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.466 HD21 ' CG1' ' A' ' 155' ' ' VAL . 83.8 mt -85.37 174.01 9.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.914 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.494 ' OD1' ' N ' ' A' ' 160' ' ' LYS . 60.1 t-20 -105.72 150.85 25.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.89 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . 0.494 ' N ' ' OD1' ' A' ' 159' ' ' ASN . 10.3 mptt -86.42 29.45 0.77 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.865 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 15.9 tm0? -111.48 -55.07 2.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.941 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -68.24 163.74 22.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.934 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 58.7 m -130.36 178.75 6.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.866 -179.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -46.9 -41.08 15.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.919 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -55.05 -61.93 1.99 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.826 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -46.8 -55.4 7.97 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.873 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.86 HG13 ' CE1' ' A' ' 171' ' ' PHE . 89.7 t -58.3 -40.27 77.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.104 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . 0.427 ' NH1' ' OE1' ' A' ' 172' ' ' GLU . 2.4 tmm_? -52.67 -62.92 1.34 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.866 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 9.7 mmm180 -59.39 -54.72 43.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.861 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.717 ' O ' ' HB3' ' A' ' 173' ' ' ALA . 9.4 tp -42.73 -66.24 0.39 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.883 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . 0.86 ' CE1' HG13 ' A' ' 167' ' ' VAL . 13.5 m-85 -51.32 -71.85 0.06 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.896 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.455 ' O ' ' N ' ' A' ' 174' ' ' PHE . 3.9 pt-20 -41.9 -31.53 0.34 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.927 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.717 ' HB3' ' O ' ' A' ' 170' ' ' LEU . . . -41.11 -24.44 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.057 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . 0.455 ' N ' ' O ' ' A' ' 172' ' ' GLU . 81.1 m-85 -113.96 -72.62 0.69 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.844 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -104.8 134.35 11.97 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.519 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 34.4 m-20 -49.4 149.16 2.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.791 0.329 . . . . 0.0 110.912 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.408 HD11 ' CB ' ' A' ' 171' ' ' PHE . 70.9 mt -114.07 150.02 16.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.162 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -117.27 -25.68 6.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.925 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -158.19 160.37 37.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.918 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 8.0 t -162.29 141.98 9.65 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.83 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 93.2 m -148.6 139.94 23.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.136 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.418 HD13 ' HB1' ' A' ' 194' ' ' ALA . 48.9 mm -102.18 119.3 50.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.119 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.472 HD11 ' CE2' ' A' ' 195' ' ' PHE . 30.8 mt . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.922 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 4.8 t . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.963 0.411 . . . . 0.0 110.842 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 24.2 mmtt -116.88 34.42 5.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.95 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 47.76 35.9 12.61 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.444 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 75.0 m -148.18 150.48 33.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.765 0.316 . . . . 0.0 110.9 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . 0.418 ' HB1' HD13 ' A' ' 182' ' ' ILE . . . -160.64 152.43 19.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.113 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 195' ' ' PHE . . . . . 0.472 ' CE2' HD11 ' A' ' 183' ' ' LEU . 25.6 m-85 -102.08 137.42 40.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.895 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.541 HG21 ' CE2' ' A' ' 171' ' ' PHE . 59.1 t -127.42 144.88 35.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.132 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 49.6 tttt -124.21 138.17 54.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.899 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . 0.453 ' CD1' HD12 ' A' ' 153' ' ' LEU . 19.4 m-85 -118.1 173.54 6.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.923 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 48.3 t -81.38 -47.65 12.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.869 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 2.9 t -132.84 153.97 50.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.874 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . 0.441 ' O ' ' C ' ' A' ' 202' ' ' ALA . 23.4 t-80 -52.75 -61.32 2.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.827 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . 0.441 ' C ' ' O ' ' A' ' 201' ' ' HIS . . . -34.06 -62.53 0.31 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.168 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -47.2 -43.42 21.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.849 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . 0.425 ' N ' ' O ' ' A' ' 201' ' ' HIS . . . -57.77 -55.14 38.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.095 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . 0.403 ' HA ' HD12 ' A' ' 208' ' ' ILE . 3.8 tp60 -50.23 -43.35 52.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.907 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -56.59 -57.64 11.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.107 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -56.87 -35.44 68.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.144 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . 0.496 ' O ' ' N ' ' A' ' 212' ' ' HIS . 78.2 mt -59.72 -75.12 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.107 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -47.39 -42.49 22.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.862 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -56.05 -43.46 77.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.119 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 33.0 mt -99.96 -69.08 0.78 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.922 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 212' ' ' HIS . . . . . 0.496 ' N ' ' O ' ' A' ' 208' ' ' ILE . 1.7 t60 -49.7 131.15 21.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.854 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 72.31 1.95 52.48 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.475 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 6.2 t -94.53 -71.29 0.67 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.814 0.34 . . . . 0.0 110.863 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 17.3 pm0 -100.33 175.75 5.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.895 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 216' ' ' THR . . . . . 0.442 ' O ' ' C ' ' A' ' 217' ' ' MET . 4.6 m -134.97 97.87 3.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.159 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 217' ' ' MET . . . . . 0.442 ' C ' ' O ' ' A' ' 216' ' ' THR . 12.4 mmt -34.56 133.18 0.42 Allowed Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.6 0.715 . . . . 0.0 110.868 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -49.01 119.52 4.48 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.68 2.254 . . . . 0.0 112.383 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 112.27 -50.82 0.74 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.516 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -73.03 152.84 41.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.821 0.343 . . . . 0.0 111.093 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 3.6 t -96.69 -19.51 18.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.869 -179.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 1.3 p -99.47 134.85 41.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.865 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . 0.436 ' O ' ' C ' ' A' ' 224' ' ' LEU . 3.5 m -58.02 151.23 18.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.859 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.462 ' HG ' HG23 ' A' ' 226' ' ' VAL . 21.7 tp -35.57 141.76 0.08 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.933 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 90.8 t -114.77 109.2 27.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.146 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . 0.715 HG13 HG22 ' A' ' 155' ' ' VAL . 6.3 t -132.01 105.96 10.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.134 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 11.0 pttp -121.34 -179.1 3.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.871 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.826 179.98 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 11.4 tttp . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.829 0.347 . . . . 0.0 110.928 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 73.4 mt -133.75 129.82 37.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.861 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -97.38 116.44 29.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.902 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.469 HG22 HG13 ' A' ' 226' ' ' VAL . 47.8 t -110.27 135.46 49.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.134 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -134.31 -156.55 7.88 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.49 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 10.9 mmt 39.49 33.36 0.11 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.819 0.343 . . . . 0.0 110.852 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.418 ' HB2' ' C ' ' A' ' 192' ' ' GLY . 63.9 mt -85.03 169.4 14.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.935 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.461 ' ND2' ' HD2' ' A' ' 218' ' ' PRO . 7.4 p30 -103.44 163.55 12.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.892 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 29.4 mttt -97.96 23.08 8.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.907 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 2.3 tp-100 -109.85 -46.57 3.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.892 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 19.5 mt-30 -65.7 172.24 3.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.908 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 66.7 m -139.69 -177.44 4.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.905 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -59.07 -37.72 77.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.909 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -59.74 -50.82 72.33 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.868 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 39.6 m-20 -58.69 -56.55 20.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.876 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.615 HG13 ' CE1' ' A' ' 171' ' ' PHE . 19.5 t -63.09 -28.29 44.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.08 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 41.7 ttm-85 -63.76 -56.25 16.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.852 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 70.7 mtm180 -62.29 -55.11 31.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.912 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.765 ' O ' ' HB3' ' A' ' 173' ' ' ALA . 9.1 tp -43.38 -65.15 0.52 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.913 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . 0.615 ' CE1' HG13 ' A' ' 167' ' ' VAL . 8.5 m-85 -50.78 -69.29 0.12 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.874 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -46.3 -26.48 0.82 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.877 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.765 ' HB3' ' O ' ' A' ' 170' ' ' LEU . . . -49.36 -19.45 0.52 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.063 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -113.48 -74.68 0.62 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.883 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -107.5 151.56 16.92 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.492 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 46.6 m-80 -62.31 132.71 53.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.797 0.332 . . . . 0.0 110.927 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.421 HG21 ' SG ' ' A' ' 180' ' ' CYS . 84.2 mt -92.25 138.99 18.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.123 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -100.35 -30.48 11.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.915 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -164.54 142.0 6.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.888 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' CYS . . . . . 0.447 ' SG ' HG13 ' A' ' 196' ' ' VAL . 1.8 m -137.21 138.24 39.96 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.911 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 60.4 m -151.12 132.82 14.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.146 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 44.5 mm -98.52 143.24 13.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.132 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.747 HD11 ' CE2' ' A' ' 195' ' ' PHE . 52.7 mt . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.896 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 30.7 t . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.916 0.389 . . . . 0.0 110.858 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 63.6 mttt -94.04 37.59 1.09 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.913 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.418 ' C ' ' HB2' ' A' ' 158' ' ' LEU . . . 43.32 40.99 4.89 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.497 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 4.4 p -150.03 151.48 33.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.798 0.333 . . . . 0.0 110.941 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -160.62 150.96 18.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.069 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 195' ' ' PHE . . . . . 0.747 ' CE2' HD11 ' A' ' 183' ' ' LEU . 50.2 m-85 -108.72 116.3 31.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.914 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.609 HG11 ' CD2' ' A' ' 171' ' ' PHE . 38.8 t -110.04 146.97 14.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.122 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 34.4 tttp -127.1 160.26 31.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.876 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -137.65 164.79 27.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.909 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 41.2 t -71.61 -39.38 70.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.851 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 2.4 t -136.02 171.78 13.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.818 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . 0.408 ' O ' ' C ' ' A' ' 202' ' ' ALA . 40.1 t-80 -69.4 -57.05 5.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.855 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . 0.408 ' C ' ' O ' ' A' ' 201' ' ' HIS . . . -36.75 -61.39 0.54 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.148 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -47.53 -50.58 23.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.865 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -51.43 -57.59 8.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.073 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . 0.511 ' C ' ' CD ' ' A' ' 205' ' ' GLN . 0.0 OUTLIER -47.67 -68.13 0.21 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.887 -179.898 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . 0.407 ' C ' ' O ' ' A' ' 205' ' ' GLN . . . -37.02 -51.82 0.95 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.106 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -59.72 -43.23 94.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.105 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . 0.489 ' O ' ' N ' ' A' ' 212' ' ' HIS . 82.5 mt -56.23 -70.28 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.078 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -54.12 -40.29 67.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.827 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -56.03 -34.07 65.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.122 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 57.8 mt -112.35 -70.83 0.79 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.901 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 212' ' ' HIS . . . . . 0.489 ' N ' ' O ' ' A' ' 208' ' ' ILE . 2.9 t60 -44.28 126.77 5.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.868 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . 0.416 ' CA ' ' HB3' ' A' ' 223' ' ' SER . . . 82.15 -28.1 3.4 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.507 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 25.7 m -90.15 -67.26 0.86 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.819 0.342 . . . . 0.0 110.88 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 -83.3 143.43 30.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.921 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 216' ' ' THR . . . . . 0.684 HG23 ' O ' ' A' ' 222' ' ' SER . 24.3 m -120.15 100.0 6.93 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.158 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 217' ' ' MET . . . . . 0.402 ' C ' ' O ' ' A' ' 216' ' ' THR . 13.6 mmt -37.37 132.65 0.78 Allowed Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.596 0.713 . . . . 0.0 110.907 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . 0.461 ' HD2' ' ND2' ' A' ' 159' ' ' ASN . 75.2 Cg_exo -48.55 122.42 7.83 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.65 2.233 . . . . 0.0 112.32 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 112.54 -52.29 0.65 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.51 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -68.79 150.49 47.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.826 0.346 . . . . 0.0 111.069 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 88.1 p -96.33 -18.36 20.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.903 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 222' ' ' SER . . . . . 0.684 ' O ' HG23 ' A' ' 216' ' ' THR . 1.4 t -100.08 146.96 26.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.852 -179.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . 0.416 ' HB3' ' CA ' ' A' ' 213' ' ' GLY . 73.0 m -58.9 155.83 12.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.887 -179.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.441 HD23 ' N ' ' A' ' 212' ' ' HIS . 32.4 tp -49.35 156.09 0.64 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.979 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . 0.416 ' N ' ' HG ' ' A' ' 224' ' ' LEU . 57.9 t -127.57 108.17 17.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.124 179.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . 0.469 HG13 HG22 ' A' ' 155' ' ' VAL . 41.2 t -135.03 101.63 3.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.126 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 19.5 pttt -119.01 170.34 9.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.876 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.942 179.928 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.461 ' HE2' ' CG ' ' A' ' 195' ' ' PHE . 5.7 tttp . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.825 0.345 . . . . 0.0 110.898 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.589 HD12 ' CD1' ' A' ' 198' ' ' TYR . 36.6 mt -130.09 125.11 34.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.9 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -96.73 113.85 25.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.863 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.551 HG13 HG22 ' A' ' 226' ' ' VAL . 22.2 t -104.46 127.65 58.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.135 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.474 ' O ' ' N ' ' A' ' 158' ' ' LEU . . . -128.63 -154.01 8.19 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.434 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.442 ' C ' ' O ' ' A' ' 156' ' ' GLY . 31.0 mtt 34.66 34.15 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.776 0.322 . . . . 0.0 110.868 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.474 ' N ' ' O ' ' A' ' 156' ' ' GLY . 58.5 mt -83.24 174.79 10.44 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.927 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.484 ' ND2' ' H ' ' A' ' 162' ' ' GLN . 3.2 p-10 -104.77 150.17 25.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.906 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 39.3 mttp -85.39 32.5 0.56 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.875 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -120.32 -54.38 2.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.925 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . 0.484 ' H ' ' ND2' ' A' ' 159' ' ' ASN . 3.6 pt20 -56.48 156.78 5.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.919 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 23.0 m -128.13 -177.1 4.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.864 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -51.54 -41.47 61.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.861 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -57.98 -59.29 5.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.863 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -48.73 -61.03 2.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.858 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.827 HG13 ' CE1' ' A' ' 171' ' ' PHE . 91.9 t -55.14 -45.06 77.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.136 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 33.3 mtp180 -51.62 -58.31 6.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.862 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 47.8 mtp180 -62.73 -54.56 37.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.886 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.794 ' O ' ' HB3' ' A' ' 173' ' ' ALA . 11.0 tp -44.14 -65.06 0.56 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.9 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . 0.827 ' CE1' HG13 ' A' ' 167' ' ' VAL . 13.2 m-85 -50.6 -68.36 0.18 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.845 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -47.31 -23.52 0.58 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.849 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.794 ' HB3' ' O ' ' A' ' 170' ' ' LEU . . . -54.19 -14.45 1.13 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.065 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -123.12 -69.01 0.85 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.872 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -113.57 148.05 18.64 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.499 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 35.4 m120 -55.96 153.86 8.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.801 0.334 . . . . 0.0 110.916 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.512 HD11 ' CB ' ' A' ' 171' ' ' PHE . 73.8 mt -118.31 151.51 20.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.162 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -108.85 -39.87 5.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.919 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -164.99 131.93 2.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.933 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 42.3 t -120.78 139.29 53.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.876 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 53.3 m -147.75 129.99 15.59 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.162 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 17.4 mm -93.48 130.32 42.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.146 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.592 HD11 ' CE2' ' A' ' 195' ' ' PHE . 77.7 mt . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.945 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 3.3 t . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.987 0.423 . . . . 0.0 110.818 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 10.3 pttp -121.86 29.02 7.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.932 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 57.48 47.31 89.13 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.522 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 24.1 m -152.03 141.92 22.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.842 0.353 . . . . 0.0 110.896 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -162.06 157.9 24.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.095 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 195' ' ' PHE . . . . . 0.592 ' CE2' HD11 ' A' ' 183' ' ' LEU . 21.1 m-85 -110.82 124.8 52.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.882 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.575 HG11 ' CD2' ' A' ' 171' ' ' PHE . 94.3 t -122.24 139.29 49.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.125 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 41.3 mttm -116.2 144.76 43.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.898 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . 0.589 ' CD1' HD12 ' A' ' 153' ' ' LEU . 19.7 m-85 -119.28 174.72 6.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.91 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 46.6 p -74.5 -52.52 11.71 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.884 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 32.9 p -137.07 -175.72 4.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.874 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . 0.435 ' O ' ' HB3' ' A' ' 204' ' ' ALA . 3.4 t-160 -71.46 -53.85 12.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.885 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -40.76 -62.53 0.78 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.136 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -47.42 -41.72 20.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.884 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . 0.435 ' HB3' ' O ' ' A' ' 201' ' ' HIS . . . -59.27 -56.23 24.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.102 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -47.85 -41.81 24.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.933 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -61.39 -51.91 66.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.118 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -61.84 -23.8 66.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.104 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . 0.499 ' O ' ' N ' ' A' ' 212' ' ' HIS . 53.5 mt -71.92 -71.57 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.15 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 209' ' ' ASN . . . . . 0.403 ' N ' HG22 ' A' ' 208' ' ' ILE . 5.3 t30 -54.89 -38.91 68.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.905 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -58.35 -50.74 72.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.12 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 30.7 mt -99.93 -67.56 0.85 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.93 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 212' ' ' HIS . . . . . 0.587 ' CE1' ' HA ' ' A' ' 225' ' ' VAL . 1.5 t60 -49.83 132.77 22.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.863 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 70.12 -2.12 15.27 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.5 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -96.38 -71.36 0.68 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.822 0.344 . . . . 0.0 110.876 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -100.27 166.98 10.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.934 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 216' ' ' THR . . . . . 0.636 HG23 ' O ' ' A' ' 222' ' ' SER . 24.4 m -127.38 94.03 3.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.152 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 217' ' ' MET . . . . . 0.415 ' C ' ' O ' ' A' ' 216' ' ' THR . 17.8 mmt -36.39 136.18 0.55 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.579 0.704 . . . . 0.0 110.843 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -49.24 138.21 29.47 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.634 2.223 . . . . 0.0 112.366 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 100.07 -45.22 1.51 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.505 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -86.31 142.04 28.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.815 0.341 . . . . 0.0 111.095 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 13.9 m -93.49 -12.88 28.67 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.834 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 222' ' ' SER . . . . . 0.636 ' O ' HG23 ' A' ' 216' ' ' THR . 3.9 m -100.11 143.09 30.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.88 -179.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 71.3 m -56.04 148.43 17.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.8 -179.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.612 HD12 ' H ' ' A' ' 225' ' ' VAL . 51.3 tp -38.31 158.08 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.893 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . 0.612 ' H ' HD12 ' A' ' 224' ' ' LEU . 61.7 t -130.4 105.76 11.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.114 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . 0.551 HG22 HG13 ' A' ' 155' ' ' VAL . 21.5 t -134.04 101.46 3.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.146 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . 0.469 ' HE2' ' CG1' ' A' ' 225' ' ' VAL . 0.7 OUTLIER -130.38 145.29 51.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.896 179.883 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.929 179.958 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.363 0 N-CA-C 112.512 -0.235 . . . . 0.0 112.512 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 3.6 m 44.7 47.85 8.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.823 0.344 . . . . 0.0 110.838 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 7.3 t -107.12 127.98 53.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.902 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 96.98 99.27 1.95 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.475 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 71.4 p -86.96 -44.43 11.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.896 0.379 . . . . 0.0 110.862 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 81.1 p 45.08 36.95 2.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.898 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -153.97 92.22 0.13 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.494 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 8.5 t -108.04 108.37 19.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.898 0.38 . . . . 0.0 110.892 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.637 ' N ' HD23 ' A' ' 144' ' ' LEU . 1.5 pt? -153.03 149.55 28.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.905 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.414 ' C ' ' O ' ' A' ' 144' ' ' LEU . 23.7 mtp85 37.21 35.83 0.06 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.889 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 2.2 pm0 -48.59 143.91 7.29 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.65 0.738 . . . . 0.0 110.901 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -46.6 157.59 0.47 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.696 2.264 . . . . 0.0 112.359 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -77.31 -174.09 2.06 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.694 2.263 . . . . 0.0 112.371 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 94.5 p -124.97 96.36 4.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.873 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . 0.538 ' O ' ' CD2' ' A' ' 150' ' ' HIS . 7.8 p-80 -171.4 129.06 0.69 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.872 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 16.9 mtp180 -112.23 41.83 1.91 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.905 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.543 ' HD3' ' CD1' ' A' ' 195' ' ' PHE . 20.5 ttmt -128.81 156.63 43.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.886 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.626 HD21 HD11 ' A' ' 208' ' ' ILE . 24.6 mt -142.83 126.49 16.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.898 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -90.92 116.69 28.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.874 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.867 HG13 HG22 ' A' ' 226' ' ' VAL . 4.8 t -110.43 134.55 52.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.098 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -135.13 -156.27 7.63 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.511 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 10.1 mmt 45.31 35.44 1.83 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.785 0.326 . . . . 0.0 110.894 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.526 HD23 ' SD ' ' A' ' 217' ' ' MET . 77.5 mt -93.67 167.94 11.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.897 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -101.38 154.77 18.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.892 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 86.7 mttt -84.13 41.34 0.81 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.875 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 -127.8 -48.81 1.37 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.897 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -55.33 163.91 1.08 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.879 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 3.8 t -131.33 165.8 22.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.905 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.725 ' HA ' HD11 ' A' ' 182' ' ' ILE . 5.5 tt0 -45.08 -44.36 10.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.917 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.418 ' O ' ' N ' ' A' ' 168' ' ' ARG . 0.1 OUTLIER -57.71 -62.42 1.81 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.861 179.976 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -41.25 -52.29 3.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.889 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.604 HG13 ' CE1' ' A' ' 171' ' ' PHE . 30.0 t -66.95 -28.64 43.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.095 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . 0.418 ' N ' ' O ' ' A' ' 165' ' ' ASP . 18.9 ttt180 -61.88 -64.13 1.03 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.834 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 7.5 mmm180 -59.72 -54.22 48.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.875 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.697 ' O ' ' HB3' ' A' ' 173' ' ' ALA . 9.3 tp -42.08 -66.31 0.37 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.948 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.604 ' CE1' HG13 ' A' ' 167' ' ' VAL . 9.1 m-85 -53.37 -72.21 0.06 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.884 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -40.96 -30.29 0.13 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.842 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.697 ' HB3' ' O ' ' A' ' 170' ' ' LEU . . . -40.11 -30.4 0.09 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.128 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -105.42 -74.34 0.65 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.869 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -105.54 137.92 13.99 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.464 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -48.49 153.34 0.78 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.817 0.342 . . . . 0.0 110.857 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.541 HG23 ' O ' ' A' ' 197' ' ' LYS . 81.5 mt -121.28 138.61 51.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.102 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -88.11 -49.01 7.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.943 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -150.97 160.08 44.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.949 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 41.9 t -145.68 135.16 23.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.851 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 95.4 m -146.99 110.38 4.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.139 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.725 HD11 ' HA ' ' A' ' 164' ' ' GLU . 21.3 mm -71.73 138.94 20.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.129 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.592 HD11 ' CE2' ' A' ' 195' ' ' PHE . 34.9 mt -90.35 132.82 35.36 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.876 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' ARG . . . . . 0.426 ' HB2' ' NH1' ' A' ' 184' ' ' ARG . 28.2 mtm105 -136.58 106.76 6.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.844 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -52.68 160.7 2.8 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.493 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -45.59 -38.95 17.23 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.659 2.24 . . . . 0.0 112.342 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -50.99 -40.98 59.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.861 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 121.52 -40.63 2.06 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.494 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . 0.407 ' O ' ' C ' ' A' ' 190' ' ' SER . 5.5 p30 -74.46 125.56 28.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.849 0.356 . . . . 0.0 110.877 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . 0.407 ' C ' ' O ' ' A' ' 189' ' ' ASN . 18.7 t -36.59 137.75 0.27 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.84 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 39.0 mttt -92.57 16.56 11.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.893 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 65.69 43.53 94.1 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.451 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . 0.436 ' HB2' HD12 ' A' ' 183' ' ' LEU . 0.8 OUTLIER -154.67 155.74 35.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.809 0.338 . . . . 0.0 110.917 -179.897 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -162.5 155.61 19.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.116 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . 0.592 ' CE2' HD11 ' A' ' 183' ' ' LEU . 38.5 m-85 -107.84 119.01 38.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.923 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 46.8 t -122.28 138.55 52.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.122 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.541 ' O ' HG23 ' A' ' 177' ' ' ILE . 0.0 OUTLIER -113.62 160.53 18.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.923 179.892 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -131.55 173.13 11.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.922 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 45.0 t -73.61 -44.83 56.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.895 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 1.4 t -143.15 179.92 6.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.835 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . 0.441 ' O ' ' C ' ' A' ' 202' ' ' ALA . 10.7 t-80 -67.18 -61.59 1.85 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.871 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . 0.441 ' C ' ' O ' ' A' ' 201' ' ' HIS . . . -34.24 -62.77 0.31 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.097 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -49.1 -46.88 45.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.905 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . 0.438 ' HB1' HD11 ' A' ' 153' ' ' LEU . . . -51.64 -56.97 10.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.1 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 62.1 tp60 -53.21 -45.34 68.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.902 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -49.11 -53.32 21.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.064 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -64.29 -40.28 95.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.113 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . 0.626 HD11 HD21 ' A' ' 153' ' ' LEU . 71.5 mt -55.95 -66.08 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.137 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 12.9 t30 -59.77 -37.83 80.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.86 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -69.07 -21.7 64.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.128 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.736 ' HB3' HD23 ' A' ' 224' ' ' LEU . 85.0 mt -113.88 -74.36 0.62 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.907 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' HIS . . . . . 0.538 ' HD1' ' HA ' ' A' ' 225' ' ' VAL . 17.8 t60 -51.82 126.55 18.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.835 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 84.11 -6.81 73.89 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.508 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 33.2 t -88.55 -73.82 0.48 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.8 0.333 . . . . 0.0 110.889 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -99.69 -178.31 3.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.896 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' THR . . . . . 0.572 HG23 ' O ' ' A' ' 222' ' ' SER . 25.3 m -134.31 102.7 5.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.192 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' MET . . . . . 0.526 ' SD ' HD23 ' A' ' 158' ' ' LEU . 30.2 mmt -39.99 137.66 1.17 Allowed Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.602 0.715 . . . . 0.0 110.865 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -48.75 124.94 11.88 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.679 2.253 . . . . 0.0 112.35 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 103.64 -47.46 1.1 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.48 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . 0.416 ' O ' HG22 ' A' ' 216' ' ' THR . . . -75.64 145.9 40.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.779 0.323 . . . . 0.0 111.087 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 4.5 t -93.24 -16.34 24.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.856 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . 0.572 ' O ' HG23 ' A' ' 216' ' ' THR . 5.5 m -100.05 141.15 33.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.81 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 73.1 m -54.95 155.19 4.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.823 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.736 HD23 ' HB3' ' A' ' 211' ' ' LEU . 55.8 tp -43.24 148.57 0.28 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.919 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 0.538 ' HA ' ' HD1' ' A' ' 212' ' ' HIS . 88.2 t -118.81 113.05 40.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.099 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . 0.867 HG22 HG13 ' A' ' 155' ' ' VAL . 22.0 t -136.25 110.28 9.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.161 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 19.2 pttp -130.25 162.45 28.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.86 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' PHE . . . . . 0.572 ' HA ' HD23 ' A' ' 153' ' ' LEU . 49.0 m-85 -62.51 116.16 4.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.899 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -66.87 134.2 51.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.12 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -88.71 163.2 15.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.879 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 43.7 m -118.57 -44.19 2.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.16 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -100.71 87.64 3.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.871 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -98.8 -59.42 1.74 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.922 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -63.99 -53.0 56.95 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.868 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 2.3 m -58.7 169.92 0.88 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.868 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 164.83 166.22 23.42 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.458 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . 0.441 ' O ' ' C ' ' A' ' 238' ' ' SER . 62.2 Cg_endo -76.99 7.35 3.67 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.674 2.25 . . . . 0.0 112.349 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' SER . . . . . 0.441 ' C ' ' O ' ' A' ' 237' ' ' PRO . 66.3 m -35.2 134.7 0.26 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.882 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 16.2 t -65.88 89.87 0.12 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.851 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.31 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.482 -179.997 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.418 ' O ' ' C ' ' A' ' 137' ' ' SER . . . . . . . . 0 N--CA 1.451 -0.321 0 N-CA-C 112.477 -0.249 . . . . 0.0 112.477 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.418 ' C ' ' O ' ' A' ' 136' ' ' GLY . 15.2 m 35.81 42.33 0.14 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.874 0.368 . . . . 0.0 110.827 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 6.2 t -82.4 -61.55 1.86 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.862 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 151.99 83.29 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.507 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 59.9 p -164.82 149.14 9.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.82 0.343 . . . . 0.0 110.887 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 58.7 m -42.46 -55.57 3.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.835 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 111.81 -140.5 16.19 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.485 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 86.3 m -108.83 122.01 46.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.837 0.351 . . . . 0.0 110.902 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -98.57 -44.57 6.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.899 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.416 ' C ' ' HD3' ' A' ' 145' ' ' ARG . 0.1 OUTLIER -43.65 155.03 0.08 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.889 179.928 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 45.0 mm-40 -110.56 97.09 30.73 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.607 0.718 . . . . 0.0 110.929 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -75.4 153.24 39.79 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.701 2.267 . . . . 0.0 112.321 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -76.57 168.96 22.76 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.7 2.267 . . . . 0.0 112.355 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 23.8 p -125.27 95.15 4.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.863 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -98.24 102.45 14.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.847 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 67.2 mmt-85 -61.77 -35.96 79.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.869 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 5.4 ttpm? -93.78 148.83 21.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.901 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.657 HD23 ' HA ' ' A' ' 228' ' ' PHE . 47.8 mt -128.59 136.16 50.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.919 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -94.5 131.5 40.14 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.898 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.567 HG22 HG13 ' A' ' 226' ' ' VAL . 92.9 t -123.7 129.5 74.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.169 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -125.78 -159.31 10.25 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.478 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.615 ' SD ' HG21 ' A' ' 225' ' ' VAL . 0.9 OUTLIER 44.16 30.23 0.42 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.816 0.341 . . . . 0.0 110.918 -179.957 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.402 ' HB2' ' C ' ' A' ' 192' ' ' GLY . 73.3 mt -88.75 157.19 18.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.905 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -101.05 160.46 14.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.843 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 47.2 mttt -83.97 37.54 0.61 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.895 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 55.9 tp60 -123.29 -46.47 2.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.921 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -55.71 151.11 11.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.922 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 3.7 t -126.5 166.26 17.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.879 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -44.37 -47.68 9.72 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.897 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -57.91 -57.04 14.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.876 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 -43.44 -57.04 3.27 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.884 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.728 HG13 ' CE1' ' A' ' 171' ' ' PHE . 61.7 t -61.73 -48.45 88.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.113 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 57.7 mtt180 -41.29 -68.55 0.18 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.87 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 87.6 mtt-85 -58.35 -53.66 55.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.84 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.64 ' O ' ' HB3' ' A' ' 173' ' ' ALA . 12.8 tp -41.07 -66.7 0.31 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.883 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.728 ' CE1' HG13 ' A' ' 167' ' ' VAL . 9.8 m-85 -56.02 -73.3 0.06 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.867 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.454 ' O ' ' N ' ' A' ' 174' ' ' PHE . 0.9 OUTLIER -39.18 -27.78 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.924 -179.94 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.64 ' HB3' ' O ' ' A' ' 170' ' ' LEU . . . -40.66 -25.18 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.1 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . 0.454 ' N ' ' O ' ' A' ' 172' ' ' GLU . 95.6 m-85 -106.69 -70.73 0.78 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.877 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -102.14 -163.46 26.62 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.506 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 35.3 m120 -96.9 160.93 14.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.804 0.335 . . . . 0.0 110.865 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 13.0 mt -128.43 151.28 35.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.119 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 46.9 mm-40 -115.51 -42.54 3.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.915 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -155.18 149.61 26.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.899 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 40.6 t -137.98 143.98 40.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.879 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 56.5 m -150.12 149.15 29.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.148 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 13.3 mm -115.45 126.13 72.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.128 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.436 HD11 ' CE2' ' A' ' 195' ' ' PHE . 78.6 mt -72.31 139.95 48.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.896 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' ARG . . . . . 0.426 ' HB2' ' NH1' ' A' ' 184' ' ' ARG . 28.0 mtm105 -146.46 125.91 13.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.865 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -58.76 -167.08 0.16 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.516 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -77.07 -47.07 0.13 Allowed 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.706 2.271 . . . . 0.0 112.33 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -45.81 -42.91 12.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.884 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 120.36 42.5 0.5 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.508 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -142.28 158.42 43.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.833 0.349 . . . . 0.0 110.891 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 53.3 p -75.21 126.72 31.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.871 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 26.5 mtpt -85.01 26.66 0.83 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.881 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.402 ' C ' ' HB2' ' A' ' 158' ' ' LEU . . . 61.01 31.75 77.73 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.533 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 52.3 m -143.8 150.74 38.99 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.836 0.351 . . . . 0.0 110.894 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -155.52 172.09 18.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.087 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . 0.436 ' CE2' HD11 ' A' ' 183' ' ' LEU . 37.4 m-85 -128.43 130.4 47.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.879 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 48.6 t -127.8 132.96 68.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.126 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 29.2 mttp -104.53 150.03 24.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.869 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . 0.447 ' OH ' ' CB ' ' A' ' 207' ' ' ALA . 3.3 m-85 -123.03 175.36 6.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.949 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 58.0 m -86.36 -34.9 20.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.864 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 75.4 m -147.06 -179.86 7.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.867 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . 0.435 ' O ' ' C ' ' A' ' 202' ' ' ALA . 67.8 t60 -73.42 -63.96 1.09 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.896 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 201' ' ' HIS . . . -34.49 -61.44 0.39 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.05 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -48.47 -44.15 35.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.834 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . 0.411 ' N ' ' O ' ' A' ' 201' ' ' HIS . . . -60.16 -56.14 25.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.119 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . 0.439 ' HA ' HD12 ' A' ' 208' ' ' ILE . 33.0 tp60 -50.66 -46.13 58.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.89 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -54.84 -49.6 70.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.055 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . 0.447 ' CB ' ' OH ' ' A' ' 198' ' ' TYR . . . -63.76 -26.59 68.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.106 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . 0.484 ' O ' ' N ' ' A' ' 212' ' ' HIS . 60.3 mt -70.74 -64.24 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.181 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -58.48 -39.16 79.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.895 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' ALA . . . . . 0.413 ' HB1' ' CZ ' ' A' ' 174' ' ' PHE . . . -66.99 -35.11 79.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.079 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.451 ' HB3' HD23 ' A' ' 224' ' ' LEU . 86.5 mt -102.5 -74.54 0.63 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.94 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' HIS . . . . . 0.484 ' N ' ' O ' ' A' ' 208' ' ' ILE . 33.9 t60 -49.18 134.07 18.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.861 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 70.06 -0.61 21.91 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.531 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -93.34 -71.01 0.67 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.747 0.308 . . . . 0.0 110.863 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -100.05 -178.44 3.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.916 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' THR . . . . . 0.559 HG23 ' O ' ' A' ' 222' ' ' SER . 7.6 m -136.97 110.3 7.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.139 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' MET . . . . . 0.7 ' SD ' HD13 ' A' ' 224' ' ' LEU . 0.0 OUTLIER -39.26 160.05 0.1 OUTLIER Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.519 0.676 . . . . 0.0 110.915 179.883 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.32 103.0 1.54 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.637 2.224 . . . . 0.0 112.367 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 122.47 -49.77 0.87 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.501 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -65.24 150.38 48.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.796 0.331 . . . . 0.0 111.091 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 9.5 m -95.33 -17.38 21.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.848 -179.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . 0.559 ' O ' HG23 ' A' ' 216' ' ' THR . 1.1 t -99.82 146.14 26.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.874 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -61.65 152.99 29.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.89 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.7 HD13 ' SD ' ' A' ' 217' ' ' MET . 59.4 tp -38.71 152.92 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.907 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 0.615 HG21 ' SD ' ' A' ' 157' ' ' MET . 86.5 t -125.1 104.4 13.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.124 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . 0.567 HG13 HG22 ' A' ' 155' ' ' VAL . 8.8 t -128.4 103.06 9.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.121 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 7.6 ptmt -120.76 167.34 12.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.882 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' PHE . . . . . 0.657 ' HA ' HD23 ' A' ' 153' ' ' LEU . 73.4 m-85 -71.78 143.46 49.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.887 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -88.19 112.58 22.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.143 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . 0.436 ' O ' ' N ' ' A' ' 232' ' ' ASP . 5.8 t70 -82.41 46.07 1.01 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.88 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' THR . . . . . 0.422 ' C ' ' O ' ' A' ' 230' ' ' ASP . 9.2 t 36.3 32.81 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.119 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . 0.436 ' N ' ' O ' ' A' ' 230' ' ' ASP . 40.7 m-20 -110.06 42.57 1.5 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.862 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 21.4 tttm -44.17 -54.19 5.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.946 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . 0.49 ' C ' ' CD ' ' A' ' 234' ' ' GLU . 0.5 OUTLIER -82.74 161.95 21.9 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.874 179.933 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.8 t -111.06 -62.81 1.49 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.841 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -145.72 164.79 28.1 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.484 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -77.1 139.82 19.43 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.671 2.247 . . . . 0.0 112.328 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 4.7 t -63.52 -54.91 28.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.858 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 36.5 m -93.25 136.29 33.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.862 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.498 -179.975 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.372 0 N-CA-C 112.462 -0.255 . . . . 0.0 112.462 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 3.7 t -98.19 -62.13 1.29 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.884 0.373 . . . . 0.0 110.835 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 12.7 t -70.72 -50.21 38.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.841 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 88.89 73.08 1.28 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.472 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 32.1 p -60.77 109.89 1.17 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.851 0.358 . . . . 0.0 110.861 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 63.1 m -132.77 146.44 51.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.88 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 151.29 66.1 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.471 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 31.8 p -107.78 127.32 53.6 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.907 0.384 . . . . 0.0 110.826 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 11.4 mt -111.63 97.8 6.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.963 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 10.8 tpt180 -165.77 123.76 1.53 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.86 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -81.9 146.62 56.26 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.596 0.712 . . . . 0.0 110.925 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -77.42 152.42 30.17 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.694 2.263 . . . . 0.0 112.347 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -46.34 170.72 0.04 OUTLIER 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.676 2.251 . . . . 0.0 112.375 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 6.6 t -55.98 -54.0 50.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.87 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 28.0 p-80 -90.06 128.98 36.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.864 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 4.2 mpt_? -103.84 82.28 1.97 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.864 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 20.3 tttt -105.41 151.78 23.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.871 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 32.0 mt -127.08 124.99 40.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.916 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -92.82 110.8 22.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.858 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.645 HG13 HG22 ' A' ' 226' ' ' VAL . 39.4 t -104.64 127.55 58.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.111 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.422 ' O ' ' N ' ' A' ' 158' ' ' LEU . . . -125.68 -152.22 8.13 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.505 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.485 ' SD ' HG21 ' A' ' 225' ' ' VAL . 0.4 OUTLIER 38.59 30.5 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.855 0.36 . . . . 0.0 110.87 179.976 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.422 ' N ' ' O ' ' A' ' 156' ' ' GLY . 61.4 mt -83.93 166.14 18.09 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.893 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -100.31 158.41 15.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.896 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 34.9 mttm -88.16 33.46 0.74 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.908 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -123.84 -52.22 1.79 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.907 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -51.54 155.54 1.53 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.905 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 4.3 m -131.03 174.79 9.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.862 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -50.37 -42.58 53.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.92 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -59.3 -54.58 45.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.898 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -48.73 -64.24 0.86 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.845 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.74 HG13 ' CE1' ' A' ' 171' ' ' PHE . 90.0 t -55.71 -50.41 67.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.099 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . 0.42 ' C ' ' O ' ' A' ' 167' ' ' VAL . 20.5 ttm-85 -36.88 -63.73 0.4 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.872 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . 0.403 ' O ' ' HG3' ' A' ' 172' ' ' GLU . 21.4 mtp85 -64.19 -51.48 63.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.907 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.684 ' O ' ' HB3' ' A' ' 173' ' ' ALA . 13.3 tp -43.72 -65.6 0.48 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.909 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.74 ' CE1' HG13 ' A' ' 167' ' ' VAL . 6.2 m-85 -55.83 -68.1 0.23 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.853 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.403 ' HG3' ' O ' ' A' ' 169' ' ' ARG . 0.9 OUTLIER -45.3 -21.82 0.1 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.878 -179.915 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.684 ' HB3' ' O ' ' A' ' 170' ' ' LEU . . . -49.21 -19.05 0.41 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.091 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -112.52 -73.93 0.65 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.875 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . 0.429 ' CA ' ' OE1' ' A' ' 203' ' ' GLU . . . -110.89 154.32 16.7 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.467 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -57.63 149.37 21.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.821 0.343 . . . . 0.0 110.895 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 46.1 mt -111.34 147.84 15.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.152 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.459 ' OE1' ' N ' ' A' ' 178' ' ' GLU . 0.5 OUTLIER -102.89 -40.57 6.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.934 179.94 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -160.44 149.41 17.06 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.901 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 25.2 t -136.47 140.48 43.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.895 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 30.5 m -149.74 142.61 24.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.183 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 33.6 mm -107.29 121.95 60.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.157 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.767 HD11 ' CE2' ' A' ' 195' ' ' PHE . 30.6 mt -72.36 140.11 48.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.887 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 46.7 mtt85 -141.81 147.32 37.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.882 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -83.0 -164.81 36.46 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.508 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -77.01 -40.9 0.42 Allowed 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.676 2.251 . . . . 0.0 112.313 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -57.24 -41.51 79.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.856 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 134.1 -44.25 1.2 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.755 -0.735 . . . . 0.0 112.46 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 64.2 m-20 -53.03 167.8 0.15 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.815 0.341 . . . . 0.0 110.918 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 18.1 p -82.78 142.93 31.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.87 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 3.1 mmmm -94.19 33.59 1.35 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.867 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.412 ' C ' ' HB2' ' A' ' 158' ' ' LEU . . . 44.24 32.54 2.61 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.484 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 75.8 m -141.6 151.24 42.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.828 0.347 . . . . 0.0 110.881 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -158.88 161.32 36.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.145 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . 0.767 ' CE2' HD11 ' A' ' 183' ' ' LEU . 47.9 m-85 -118.05 135.92 53.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.9 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 64.7 t -133.2 145.96 33.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.122 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 42.6 mtpt -122.44 142.83 50.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.937 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -117.8 175.22 5.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.867 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 51.1 p -80.1 -44.25 20.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.815 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 2.7 m -133.95 -177.62 4.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.799 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 20.7 t60 -80.19 -57.1 3.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.879 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -37.99 -56.79 1.11 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.129 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . 0.429 ' OE1' ' CA ' ' A' ' 175' ' ' GLY . 31.3 mm-40 -54.63 -43.24 72.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.853 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -56.46 -55.78 29.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.079 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 53.1 tp60 -50.88 -41.95 58.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.92 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -57.7 -51.9 67.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.109 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -63.28 -26.49 68.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.072 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . 0.495 ' O ' ' N ' ' A' ' 212' ' ' HIS . 50.4 mt -69.15 -73.27 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.103 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . 0.464 ' N ' HG22 ' A' ' 208' ' ' ILE . 34.2 t30 -48.89 -42.72 37.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.843 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' ALA . . . . . 0.468 ' O ' ' CB ' ' A' ' 214' ' ' SER . . . -54.27 -45.31 72.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.101 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.454 ' CB ' HD23 ' A' ' 224' ' ' LEU . 18.8 mt -100.51 -69.21 0.78 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.902 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' HIS . . . . . 0.645 ' HD1' ' HA ' ' A' ' 225' ' ' VAL . 27.2 t60 -53.95 124.24 14.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.878 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . 0.488 ' CA ' ' HB3' ' A' ' 223' ' ' SER . . . 81.24 -14.68 26.94 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.512 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' SER . . . . . 0.468 ' CB ' ' O ' ' A' ' 210' ' ' ALA . 1.9 m -85.94 -72.38 0.5 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.818 0.342 . . . . 0.0 110.838 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 59.7 mt-30 -99.13 169.54 9.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.898 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' THR . . . . . 0.624 HG23 ' O ' ' A' ' 222' ' ' SER . 3.0 m -118.78 97.61 5.8 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.148 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 13.2 mmt -38.74 138.81 0.76 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.556 0.693 . . . . 0.0 110.865 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -48.47 126.67 14.5 Favored 'Trans proline' 0 C--N 1.34 0.131 0 C-N-CA 122.685 2.256 . . . . 0.0 112.344 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 102.45 -53.42 0.78 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.503 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -70.65 150.08 46.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.781 0.324 . . . . 0.0 111.099 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 31.1 t -95.92 -18.19 20.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.826 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . 0.624 ' O ' HG23 ' A' ' 216' ' ' THR . 3.5 m -99.91 151.22 21.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.874 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . 0.488 ' HB3' ' CA ' ' A' ' 213' ' ' GLY . 17.4 m -59.58 145.36 44.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.844 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.512 ' HG ' HG23 ' A' ' 226' ' ' VAL . 48.2 tp -34.61 148.8 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.918 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 0.645 ' HA ' ' HD1' ' A' ' 212' ' ' HIS . 64.9 t -117.13 106.71 20.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.142 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . 0.645 HG22 HG13 ' A' ' 155' ' ' VAL . 24.6 t -133.39 106.29 9.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.142 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 9.0 ptmt -125.03 174.39 8.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.906 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -80.87 126.46 31.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.884 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . 0.409 ' C ' ' OD1' ' A' ' 230' ' ' ASP . . . -88.86 140.36 29.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.102 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . 0.409 ' OD1' ' C ' ' A' ' 229' ' ' ALA . 1.0 OUTLIER -144.15 143.83 31.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.867 179.999 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 77.1 m -89.9 120.11 30.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.144 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -62.74 143.51 57.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.894 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 2.9 tppp? -144.17 112.55 6.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.929 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -132.11 145.05 51.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.861 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 26.1 p -157.02 173.7 16.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.875 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 105.21 -173.44 20.55 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.461 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -77.01 -45.64 0.16 Allowed 'Trans proline' 0 C--O 1.231 0.135 0 C-N-CA 122.715 2.276 . . . . 0.0 112.387 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 1.8 t -141.35 171.31 14.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.862 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 30.7 m -57.3 112.91 1.53 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.847 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.297 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.464 -179.994 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.287 0 N-CA-C 112.481 -0.248 . . . . 0.0 112.481 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 42.7 t -153.9 114.65 4.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.889 0.376 . . . . 0.0 110.87 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 28.9 t -128.17 124.5 36.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.876 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -160.03 101.69 0.2 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.474 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 12.4 t -156.01 138.15 14.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.894 0.378 . . . . 0.0 110.842 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 7.6 t -132.47 165.55 24.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.839 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -156.99 73.84 0.23 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.495 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 51.5 m -97.21 167.49 11.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.814 0.34 . . . . 0.0 110.939 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 80.9 mt -94.97 -56.71 2.66 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.93 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 33.7 ptt-85 -48.42 132.17 16.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.875 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -116.1 91.96 33.77 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.591 0.71 . . . . 0.0 110.929 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -45.77 163.74 0.09 OUTLIER 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.659 2.24 . . . . 0.0 112.356 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -45.64 171.86 0.02 OUTLIER 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.655 2.237 . . . . 0.0 112.409 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 3.9 m -87.99 50.32 1.96 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.864 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 34.2 m80 -124.86 143.43 50.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.881 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 64.8 mtm-85 -124.05 44.17 2.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.878 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 3.6 ttmp? -129.85 149.51 51.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.922 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.612 HD12 ' CD1' ' A' ' 198' ' ' TYR . 64.6 mt -123.47 124.01 41.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.902 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.49 ' HB2' ' HB2' ' A' ' 229' ' ' ALA . 32.0 t80 -94.24 110.47 22.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.885 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.588 HG22 HG13 ' A' ' 226' ' ' VAL . 21.2 t -104.19 120.62 54.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.112 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -120.64 -174.41 15.12 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.451 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 19.5 mmt 61.7 30.82 18.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.811 0.339 . . . . 0.0 110.902 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.416 ' HB2' ' C ' ' A' ' 192' ' ' GLY . 25.0 mt -88.04 162.31 16.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.912 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -102.39 160.27 14.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.892 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 14.9 mtpp -84.98 36.66 0.63 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.937 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 4.5 tp-100 -123.09 -51.08 1.9 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.905 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 66.1 mt-30 -54.23 154.32 4.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.888 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 90.3 p -130.77 -177.97 4.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.881 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.493 ' O ' ' CB ' ' A' ' 168' ' ' ARG . 1.8 mp0 -55.31 -48.05 74.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.902 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -58.29 -55.17 38.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.866 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -45.64 -68.23 0.21 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.839 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.527 HG13 ' CE1' ' A' ' 171' ' ' PHE . 59.8 t -59.1 -55.51 23.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.155 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . 0.493 ' CB ' ' O ' ' A' ' 164' ' ' GLU . 70.9 ttt180 -34.3 -53.32 0.5 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.923 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 20.1 mmt85 -65.0 -54.3 32.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.931 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.761 ' O ' ' HB3' ' A' ' 173' ' ' ALA . 13.0 tp -44.21 -64.42 0.68 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.962 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.789 ' CB ' HD11 ' A' ' 177' ' ' ILE . 6.8 m-85 -51.89 -67.53 0.24 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.904 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -48.41 -23.12 0.84 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.857 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.761 ' HB3' ' O ' ' A' ' 170' ' ' LEU . . . -51.95 -27.18 12.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.09 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -111.99 -62.84 1.5 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.846 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -118.76 137.17 12.62 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.48 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 48.8 m-80 -51.77 151.16 3.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.788 0.328 . . . . 0.0 110.897 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.789 HD11 ' CB ' ' A' ' 171' ' ' PHE . 97.6 mt -117.46 109.35 27.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.121 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -61.18 -36.99 81.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.883 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -159.44 137.22 10.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.898 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 5.7 t -124.32 143.42 50.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.888 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 55.7 m -154.37 137.04 15.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.161 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 10.6 mm -106.28 133.44 50.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.103 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.801 HD11 ' CE2' ' A' ' 195' ' ' PHE . 84.8 mt -83.08 123.76 29.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.909 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 68.8 mtm180 -130.93 152.55 50.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.873 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -106.27 179.59 23.01 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.489 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -45.46 -47.87 12.54 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.637 2.224 . . . . 0.0 112.346 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -43.35 -39.59 3.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.846 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 118.57 -36.83 3.44 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.465 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 22.8 m120 -75.21 177.18 6.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.857 0.361 . . . . 0.0 110.888 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 42.3 t -82.99 136.25 34.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.851 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 25.2 mtmm -84.43 32.49 0.51 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.925 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.416 ' C ' ' HB2' ' A' ' 158' ' ' LEU . . . 58.12 39.21 91.86 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.506 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 7.2 p -157.85 149.39 21.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.83 0.348 . . . . 0.0 110.862 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -160.13 156.5 26.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.156 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . 0.801 ' CE2' HD11 ' A' ' 183' ' ' LEU . 42.3 m-85 -114.12 126.96 55.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.866 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.533 HG21 ' CE2' ' A' ' 171' ' ' PHE . 98.8 t -117.23 139.36 44.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.072 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 31.4 tttt -116.37 118.38 32.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.86 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . 0.612 ' CD1' HD12 ' A' ' 153' ' ' LEU . 20.3 m-85 -95.58 172.28 8.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.918 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 8.3 t -79.2 -39.46 33.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.834 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 33.6 p -149.19 160.25 43.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.893 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . 0.448 ' O ' ' C ' ' A' ' 202' ' ' ALA . 13.3 t-80 -53.46 -58.93 5.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.873 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . 0.448 ' C ' ' O ' ' A' ' 201' ' ' HIS . . . -34.33 -62.93 0.31 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.085 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -54.21 -42.61 69.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.857 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . 0.4 ' N ' ' O ' ' A' ' 201' ' ' HIS . . . -58.53 -64.1 1.05 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.068 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . 0.54 ' HA ' HD12 ' A' ' 208' ' ' ILE . 37.1 tp60 -43.15 -42.03 3.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.956 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -57.3 -57.47 12.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.065 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . 0.429 ' CB ' ' OH ' ' A' ' 198' ' ' TYR . . . -55.24 -33.56 63.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.088 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . 0.54 HD12 ' HA ' ' A' ' 205' ' ' GLN . 87.8 mt -62.72 -75.0 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.138 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -48.71 -42.09 33.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.892 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -56.32 -36.88 69.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.118 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.487 ' HB3' ' CD2' ' A' ' 224' ' ' LEU . 50.7 mt -109.44 -72.6 0.72 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.898 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' HIS . . . . . 0.479 ' N ' ' O ' ' A' ' 208' ' ' ILE . 9.4 t60 -46.73 128.62 10.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.865 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 82.04 -22.91 5.56 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.514 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 7.9 t -91.45 -70.74 0.67 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.819 0.342 . . . . 0.0 110.818 -179.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 9.5 mm-40 -86.54 161.55 18.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.86 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' THR . . . . . 0.549 HG23 ' O ' ' A' ' 222' ' ' SER . 39.1 m -129.01 108.65 10.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.157 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' MET . . . . . 0.402 ' C ' ' O ' ' A' ' 216' ' ' THR . 24.1 mmt -37.4 156.88 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.534 0.683 . . . . 0.0 110.884 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.16 113.29 3.55 Favored 'Trans proline' 0 C--N 1.341 0.133 0 C-N-CA 122.683 2.255 . . . . 0.0 112.307 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 113.94 -45.09 1.37 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.493 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -70.92 142.03 51.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.788 0.328 . . . . 0.0 111.103 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 68.3 m -91.53 -14.81 29.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.879 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . 0.549 ' O ' HG23 ' A' ' 216' ' ' THR . 2.7 m -100.17 143.1 30.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.835 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 2.4 p -51.3 159.83 0.63 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.879 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.649 HD12 ' H ' ' A' ' 225' ' ' VAL . 41.6 tp -54.04 154.7 4.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.887 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 0.649 ' H ' HD12 ' A' ' 224' ' ' LEU . 60.7 t -127.15 108.09 18.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.123 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . 0.588 HG13 HG22 ' A' ' 155' ' ' VAL . 24.2 t -133.91 101.46 3.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.169 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 10.7 ptmt -131.75 143.21 50.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.925 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -43.49 150.19 0.23 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.889 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . 0.49 ' HB2' ' HB2' ' A' ' 154' ' ' PHE . . . -112.04 150.94 29.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.11 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -113.17 86.9 2.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.853 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' THR . . . . . 0.551 HG23 ' O ' ' A' ' 231' ' ' THR . 14.3 t -51.74 119.58 4.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.156 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -123.69 164.68 18.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.84 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 4.5 ptmm? -149.6 166.4 29.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.86 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -120.87 126.88 51.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.892 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 42.7 t -74.87 155.08 37.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.8 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -107.92 144.46 16.13 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.468 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -47.07 -46.15 19.73 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.682 2.255 . . . . 0.0 112.352 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 12.1 m -148.55 151.14 34.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.838 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 24.4 t -85.34 119.28 25.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.884 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.293 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.496 -179.956 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.383 0 N-CA-C 112.471 -0.252 . . . . 0.0 112.471 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 24.9 t -151.99 147.61 26.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.876 0.369 . . . . 0.0 110.866 -179.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 56.3 p -161.99 175.19 12.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.847 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 165.41 134.05 1.6 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.501 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 28.3 t -121.27 138.37 54.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.891 0.377 . . . . 0.0 110.824 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 88.0 p -123.12 43.97 2.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.883 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . 0.401 ' O ' ' C ' ' A' ' 143' ' ' CYS . . . 138.05 73.92 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.498 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' CYS . . . . . 0.401 ' C ' ' O ' ' A' ' 142' ' ' GLY . 41.7 t -37.86 -43.35 0.68 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.86 0.362 . . . . 0.0 110.912 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.55 ' H ' HD23 ' A' ' 144' ' ' LEU . 2.4 pt? -134.84 153.74 51.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.918 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 5.1 tpp85 -145.9 144.61 30.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.838 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.58 92.91 47.19 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.579 0.704 . . . . 0.0 110.906 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -76.08 163.72 32.51 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.639 2.226 . . . . 0.0 112.318 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -76.18 176.87 9.49 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.64 2.227 . . . . 0.0 112.365 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 93.4 p -65.42 -45.14 85.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.866 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 5.8 m80 -57.22 123.1 14.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.904 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.47 ' HB2' ' CZ ' ' A' ' 151' ' ' ARG . 22.2 ttm105 -125.0 85.51 2.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.861 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 6.5 ttpm? -139.85 162.65 34.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.887 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.417 HD12 ' CD1' ' A' ' 198' ' ' TYR . 58.1 mt -129.29 127.09 40.45 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.934 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.407 ' HB2' ' HB2' ' A' ' 229' ' ' ALA . 18.8 t80 -101.04 113.14 25.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.844 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.479 HG22 HG13 ' A' ' 226' ' ' VAL . 48.1 t -104.07 124.01 58.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.094 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -124.45 -169.61 13.08 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.465 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 93.4 mmm 50.07 39.36 18.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.794 0.331 . . . . 0.0 110.919 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.417 ' HB2' ' C ' ' A' ' 192' ' ' GLY . 66.9 mt -94.04 162.36 13.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.906 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -100.3 158.08 16.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.883 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 52.4 mttp -83.5 39.47 0.67 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.922 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -124.9 -47.83 1.78 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.934 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 64.2 mt-30 -57.89 151.68 17.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.881 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 3.4 m -129.29 176.35 8.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.86 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -52.95 -44.13 66.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.883 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -59.38 -51.59 69.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.868 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -52.74 -61.74 2.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.892 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.623 HG13 ' CD1' ' A' ' 171' ' ' PHE . 25.4 t -58.64 -56.8 14.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.158 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . 0.415 ' C ' ' O ' ' A' ' 167' ' ' VAL . 15.5 ttt180 -36.3 -62.34 0.45 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.866 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 19.4 mmt85 -61.05 -54.11 48.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.915 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.729 ' O ' ' HB3' ' A' ' 173' ' ' ALA . 12.5 tp -43.14 -65.68 0.46 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.899 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.623 ' CD1' HG13 ' A' ' 167' ' ' VAL . 8.5 m-85 -52.22 -70.86 0.08 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.888 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.408 ' C ' ' N ' ' A' ' 174' ' ' PHE . 5.3 pt-20 -43.3 -28.79 0.35 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.864 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.729 ' HB3' ' O ' ' A' ' 170' ' ' LEU . . . -44.49 -22.09 0.07 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.076 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . 0.408 ' N ' ' C ' ' A' ' 172' ' ' GLU . 97.7 m-85 -109.79 -74.91 0.64 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.878 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -108.08 148.12 16.62 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.495 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -52.35 145.77 10.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.791 0.329 . . . . 0.0 110.888 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 18.6 mt -108.96 136.1 45.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.137 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -93.49 -36.81 12.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.884 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . 0.425 ' HG3' ' N ' ' A' ' 180' ' ' CYS . 3.4 tp10 -163.73 144.55 8.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.919 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . 0.425 ' N ' ' HG3' ' A' ' 179' ' ' GLU . 35.7 t -135.12 142.99 46.33 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.902 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 91.1 m -155.19 143.2 20.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.102 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 9.0 mm -105.35 138.5 30.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.131 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.562 HD11 ' CE2' ' A' ' 195' ' ' PHE . 44.7 mt -86.24 136.06 33.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.896 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 67.0 mtt180 -146.7 115.82 6.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.886 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -51.19 163.91 1.05 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.513 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -45.52 -51.98 7.32 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.703 2.268 . . . . 0.0 112.343 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -43.87 -50.58 7.93 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.828 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 141.88 -45.36 0.94 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.507 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -57.1 145.84 29.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.795 0.331 . . . . 0.0 110.878 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 36.2 t -68.7 151.2 47.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.894 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 25.3 mttp -105.23 36.7 2.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.887 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.417 ' C ' ' HB2' ' A' ' 158' ' ' LEU . . . 46.02 44.53 14.02 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.539 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 3.5 p -155.32 155.07 33.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.838 0.352 . . . . 0.0 110.897 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -161.38 166.02 28.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.057 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . 0.562 ' CE2' HD11 ' A' ' 183' ' ' LEU . 39.4 m-85 -120.58 132.9 55.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.856 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.455 HG21 ' CE2' ' A' ' 171' ' ' PHE . 21.8 t -125.77 145.95 32.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.122 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 11.3 ttmm -123.29 141.53 51.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.935 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . 0.417 ' CD1' HD12 ' A' ' 153' ' ' LEU . 24.6 m-85 -118.59 174.94 5.97 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.886 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 10.5 t -81.66 -49.17 10.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.853 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 23.7 t -126.31 166.87 16.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.87 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 62.9 t-80 -66.51 -49.81 65.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.868 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -45.27 -59.07 2.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.101 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -47.8 -49.38 29.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.895 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -51.26 -61.62 2.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.064 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . 0.775 ' HA ' HD12 ' A' ' 208' ' ' ILE . 44.9 tp60 -46.35 -43.65 16.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.918 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -55.8 -62.31 1.78 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.137 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -50.89 -35.03 30.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.083 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . 0.775 HD12 ' HA ' ' A' ' 205' ' ' GLN . 77.7 mt -61.44 -73.37 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.124 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -47.39 -42.98 23.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.915 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -57.72 -40.56 79.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.11 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.422 ' O ' ' CB ' ' A' ' 214' ' ' SER . 61.1 mt -102.25 -72.05 0.7 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.972 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' HIS . . . . . 0.495 ' N ' ' O ' ' A' ' 208' ' ' ILE . 20.0 t60 -47.41 136.25 9.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.827 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 67.61 1.01 14.28 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.503 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' SER . . . . . 0.422 ' CB ' ' O ' ' A' ' 211' ' ' LEU . 1.0 OUTLIER -95.28 -71.09 0.68 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.912 0.386 . . . . 0.0 110.833 -179.683 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -99.96 -178.17 3.77 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.925 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' THR . . . . . 0.547 HG23 ' O ' ' A' ' 222' ' ' SER . 51.6 m -134.49 102.45 5.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.139 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 28.3 mmt -40.99 135.61 1.65 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.562 0.696 . . . . 0.0 110.847 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -48.62 119.18 3.94 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.686 2.258 . . . . 0.0 112.349 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 111.16 -46.19 1.21 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.467 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -76.45 148.79 37.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.802 0.334 . . . . 0.0 111.084 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 10.5 t -93.55 -18.9 21.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.916 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . 0.547 ' O ' HG23 ' A' ' 216' ' ' THR . 1.1 t -100.05 147.62 25.43 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.859 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 58.4 m -59.43 156.51 12.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.855 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.442 ' HG ' HG23 ' A' ' 226' ' ' VAL . 38.9 tp -43.24 149.43 0.23 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.907 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 0.477 ' HA ' ' HD1' ' A' ' 212' ' ' HIS . 60.4 t -121.42 113.52 39.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.134 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . 0.479 HG13 HG22 ' A' ' 155' ' ' VAL . 22.5 t -138.08 105.33 3.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.149 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 9.4 pttp -130.74 148.56 52.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.942 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -57.93 123.65 16.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.859 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . 0.407 ' HB2' ' HB2' ' A' ' 154' ' ' PHE . . . -73.64 117.11 15.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.098 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -132.97 142.28 48.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.844 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 84.8 m -127.06 87.07 2.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.173 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -126.24 111.37 14.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.886 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 15.1 ptmt -77.72 127.83 33.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.896 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -136.65 141.01 43.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.844 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 34.1 t -80.48 -62.11 1.77 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.822 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -68.77 146.2 44.73 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.496 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . 0.445 ' O ' ' C ' ' A' ' 238' ' ' SER . 62.2 Cg_endo -77.03 -3.02 13.29 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.668 2.246 . . . . 0.0 112.366 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' SER . . . . . 0.445 ' C ' ' O ' ' A' ' 237' ' ' PRO . 96.9 p 34.86 42.13 0.07 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.88 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 29.2 t -108.66 103.51 12.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.865 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.307 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.53 179.991 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.365 0 N-CA-C 112.462 -0.255 . . . . 0.0 112.462 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.3 m -111.96 133.04 54.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.896 0.379 . . . . 0.0 110.89 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 69.5 p -121.03 166.7 13.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.878 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 60.07 82.18 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.476 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 85.4 p -130.98 145.17 51.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.87 0.367 . . . . 0.0 110.878 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 50.9 m -111.4 127.33 55.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.891 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -144.43 92.23 0.16 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.487 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 51.1 t -77.68 79.88 4.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.795 0.331 . . . . 0.0 110.874 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.7 mp -127.86 125.5 39.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.92 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 29.5 mmt85 -59.07 -58.3 9.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.895 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . 0.444 ' CD ' ' HD2' ' A' ' 147' ' ' PRO . 31.1 tp60 -154.26 138.52 11.2 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.618 0.723 . . . . 0.0 110.913 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.444 ' HD2' ' CD ' ' A' ' 146' ' ' GLN . 72.4 Cg_exo -46.77 145.48 6.67 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.713 2.275 . . . . 0.0 112.334 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 147' ' ' PRO . 72.4 Cg_exo -46.94 141.84 11.59 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.701 2.267 . . . . 0.0 112.319 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 28.7 t -82.77 98.93 9.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.842 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 31.6 m80 -125.12 152.09 44.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.834 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 10.7 mmm-85 -103.77 -41.05 6.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.82 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 25.4 tttp -83.42 124.67 30.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.927 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.631 HD11 ' HB1' ' A' ' 204' ' ' ALA . 62.3 mt -105.29 132.68 51.18 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.914 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -92.24 135.06 34.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.887 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 23.0 t -124.27 114.85 42.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.098 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -116.59 -176.14 17.83 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.48 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 91.4 mmm 58.62 41.83 21.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.814 0.34 . . . . 0.0 110.873 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.645 HD23 ' HG3' ' A' ' 217' ' ' MET . 46.5 mt -103.57 178.34 4.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.915 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -124.44 172.07 9.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.93 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 37.3 mttt -95.91 51.35 1.24 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.902 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -127.22 -52.19 1.4 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.883 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -64.56 164.32 11.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.872 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 31.8 p -133.55 177.77 7.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.877 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -52.16 -35.65 49.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.916 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -64.22 -57.43 9.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.836 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -47.04 -54.55 10.02 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.851 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.816 HG13 ' CE1' ' A' ' 171' ' ' PHE . 61.3 t -65.23 -40.56 89.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.174 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 4.3 mmm180 -48.0 -67.11 0.3 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.896 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 13.1 mmm-85 -60.78 -52.84 63.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.875 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.67 ' O ' ' HB3' ' A' ' 173' ' ' ALA . 12.6 tp -41.96 -66.27 0.37 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.892 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.816 ' CE1' HG13 ' A' ' 167' ' ' VAL . 9.3 m-85 -55.92 -71.24 0.09 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.903 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.498 ' C ' ' CD ' ' A' ' 172' ' ' GLU . 0.5 OUTLIER -41.48 -24.91 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.873 -179.934 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.67 ' HB3' ' O ' ' A' ' 170' ' ' LEU . . . -45.58 -21.16 0.09 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.117 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -117.46 -66.45 1.08 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.875 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -114.63 134.24 11.56 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.471 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 40.2 m-20 -45.31 153.94 0.2 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.789 0.328 . . . . 0.0 110.899 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 38.1 mt -112.66 128.04 69.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.135 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -83.0 -37.98 23.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.859 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -164.67 129.6 2.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.948 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 51.4 t -113.8 142.76 45.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.912 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 40.7 m -155.0 144.95 21.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.165 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 31.5 mm -109.06 146.75 14.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.193 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.742 HD11 ' CE2' ' A' ' 195' ' ' PHE . 31.4 mt -94.1 120.73 34.77 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.943 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 72.2 mtt180 -133.16 110.32 10.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.814 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -68.86 -149.27 0.25 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.501 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -45.54 156.61 0.36 Allowed 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.739 2.293 . . . . 0.0 112.326 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . 0.442 ' O ' ' C ' ' A' ' 188' ' ' GLY . 73.6 m-20 42.13 41.1 1.91 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.855 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.442 ' C ' ' O ' ' A' ' 187' ' ' ASP . . . 34.71 58.81 0.72 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.546 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -116.24 111.41 20.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.873 0.368 . . . . 0.0 110.865 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 4.9 t -42.59 131.73 3.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.856 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 64.0 mttt -104.29 32.08 4.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.896 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 58.48 39.75 93.45 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.477 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . 0.474 ' HB3' HD12 ' A' ' 183' ' ' LEU . 85.6 m -151.42 153.41 34.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.844 0.354 . . . . 0.0 110.852 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -162.44 167.05 24.19 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.132 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . 0.742 ' CE2' HD11 ' A' ' 183' ' ' LEU . 76.8 m-85 -125.53 133.72 52.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.854 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.411 HG21 ' CE2' ' A' ' 171' ' ' PHE . 29.1 t -127.92 118.84 49.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.122 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 22.5 ttmt -95.3 141.84 28.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.911 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . 0.439 ' OH ' ' CB ' ' A' ' 207' ' ' ALA . 10.3 m-85 -115.28 173.71 6.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.871 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 20.7 p -78.47 -46.24 20.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.817 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 3.0 t -137.32 156.32 48.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.869 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . 0.419 ' O ' ' C ' ' A' ' 202' ' ' ALA . 3.5 t-160 -52.29 -59.99 3.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.923 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 201' ' ' HIS . . . -35.89 -64.32 0.32 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.077 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -48.94 -47.29 43.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.845 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . 0.631 ' HB1' HD11 ' A' ' 153' ' ' LEU . . . -54.94 -54.12 46.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.087 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 43.3 tp60 -49.72 -47.24 50.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.912 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . 0.436 ' O ' ' CB ' ' A' ' 210' ' ' ALA . . . -55.08 -48.73 73.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.14 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . 0.439 ' CB ' ' OH ' ' A' ' 198' ' ' TYR . . . -59.35 -41.31 88.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.082 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . 0.542 HD11 ' CD2' ' A' ' 153' ' ' LEU . 63.7 mt -58.66 -72.28 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.127 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 16.5 t30 -53.21 -40.08 64.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.914 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' ALA . . . . . 0.436 ' CB ' ' O ' ' A' ' 206' ' ' ALA . . . -57.78 -41.16 81.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.079 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 19.8 mt -101.47 -69.32 0.78 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.913 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' HIS . . . . . 0.488 ' N ' ' O ' ' A' ' 208' ' ' ILE . 14.4 t60 -48.28 133.26 15.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.877 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 73.92 -1.14 48.66 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.481 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 8.5 t -95.93 -70.99 0.69 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.794 0.331 . . . . 0.0 110.842 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -99.86 -175.78 3.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.898 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' THR . . . . . 0.653 HG23 ' O ' ' A' ' 222' ' ' SER . 35.1 m -137.13 109.3 7.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.146 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' MET . . . . . 0.645 ' HG3' HD23 ' A' ' 158' ' ' LEU . 23.8 mmt -38.17 158.18 0.09 OUTLIER Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.588 0.709 . . . . 0.0 110.872 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -71.62 107.15 2.11 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.644 2.23 . . . . 0.0 112.324 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 119.31 -48.04 0.98 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.476 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -68.46 148.23 50.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.765 0.317 . . . . 0.0 111.112 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 77.9 p -92.57 -18.17 23.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.882 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . 0.653 ' O ' HG23 ' A' ' 216' ' ' THR . 2.4 m -100.04 149.66 23.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.862 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 66.3 m -59.88 157.23 12.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.861 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.45 ' HG ' ' N ' ' A' ' 225' ' ' VAL . 16.0 tp -47.8 154.39 0.51 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.894 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 0.45 ' N ' ' HG ' ' A' ' 224' ' ' LEU . 34.6 t -125.32 110.62 24.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.102 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . 0.436 ' O ' HG23 ' A' ' 208' ' ' ILE . 19.6 t -132.9 101.95 4.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.1 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 23.8 pttt -129.06 152.27 48.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.92 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' PHE . . . . . 0.453 ' HA ' HD23 ' A' ' 153' ' ' LEU . 52.2 m-85 -53.9 148.47 10.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.89 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -98.74 147.58 24.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.116 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -84.87 171.58 12.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.856 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 52.2 m -136.66 128.21 28.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.117 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -131.69 132.74 44.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.889 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -112.55 159.06 19.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.877 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -70.64 147.37 49.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.867 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 50.0 p -168.54 119.49 0.77 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.822 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -146.81 78.97 0.23 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.46 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -77.09 -41.28 0.38 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.701 2.267 . . . . 0.0 112.315 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 8.3 t 68.24 42.03 1.79 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.841 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 71.9 m -55.7 132.56 49.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.902 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.35 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.501 -179.954 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.313 0 N-CA-C 112.504 -0.238 . . . . 0.0 112.504 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 38.1 p -136.14 160.92 37.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.925 0.393 . . . . 0.0 110.801 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 12.9 t -97.8 -53.9 3.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.874 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 89.09 145.29 11.54 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.472 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 35.3 p -72.84 168.23 19.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.865 0.364 . . . . 0.0 110.822 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 2.4 t -162.47 138.81 7.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.825 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 107.14 62.14 0.58 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.506 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 2.4 t -136.17 152.58 50.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.866 0.365 . . . . 0.0 110.848 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.698 ' H ' HD23 ' A' ' 144' ' ' LEU . 1.7 pt? -83.41 38.42 0.61 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.932 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 73.6 mtt-85 -81.59 112.81 19.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.902 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -127.33 79.6 72.98 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.612 0.72 . . . . 0.0 110.925 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -45.67 156.81 0.37 Allowed 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.749 2.299 . . . . 0.0 112.309 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -77.04 -174.73 2.31 Favored 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.704 2.27 . . . . 0.0 112.391 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 52.1 p -66.28 -58.86 4.43 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.9 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . 0.489 ' CD2' ' H ' ' A' ' 150' ' ' HIS . 6.9 p80 -67.68 102.36 1.18 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.896 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.47 ' HB2' ' CZ ' ' A' ' 151' ' ' ARG . 19.6 ttm105 -107.85 89.37 2.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.863 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.562 ' HD3' ' CD1' ' A' ' 195' ' ' PHE . 13.3 ttmt -104.16 144.01 32.15 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.899 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.504 HD23 ' HA ' ' A' ' 228' ' ' PHE . 56.6 mt -117.84 123.6 46.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.956 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.641 ' HB2' ' HB2' ' A' ' 229' ' ' ALA . 56.3 t80 -91.13 121.81 33.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.859 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.444 ' CG1' HD11 ' A' ' 158' ' ' LEU . 58.9 t -109.1 128.79 64.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.151 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -124.6 -160.35 10.72 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.534 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.406 ' SD ' HG23 ' A' ' 225' ' ' VAL . 33.3 mtt 38.69 43.95 0.75 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.821 0.343 . . . . 0.0 110.867 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.451 HD23 ' HG3' ' A' ' 217' ' ' MET . 67.9 mt -99.88 175.55 5.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.885 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.496 ' N ' ' OD1' ' A' ' 159' ' ' ASN . 0.5 OUTLIER -115.35 154.9 28.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.894 179.904 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.74 20.64 1.41 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.922 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -107.83 -34.62 6.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.941 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.49 ' HG3' ' ND2' ' A' ' 159' ' ' ASN . 25.8 mt-30 -59.12 158.42 8.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.917 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 85.2 p -132.53 163.96 27.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.86 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -47.8 -50.97 24.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.872 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -53.23 -47.78 68.72 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.839 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -53.93 -69.1 0.13 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.864 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.802 HG13 ' CE1' ' A' ' 171' ' ' PHE . 86.0 t -52.92 -54.39 16.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.164 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . 0.489 ' C ' ' CD ' ' A' ' 168' ' ' ARG . 0.0 OUTLIER -39.53 -63.18 0.59 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.891 -179.959 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . 0.406 HH11 ' CB ' ' A' ' 169' ' ' ARG . 4.0 mtp-105 -60.85 -53.91 51.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.882 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.714 ' O ' ' HB3' ' A' ' 173' ' ' ALA . 11.9 tp -43.23 -65.93 0.43 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.901 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.802 ' CE1' HG13 ' A' ' 167' ' ' VAL . 11.6 m-85 -52.2 -70.93 0.07 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.914 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.416 ' O ' ' N ' ' A' ' 174' ' ' PHE . 5.9 pt-20 -43.09 -29.36 0.35 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.947 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.714 ' HB3' ' O ' ' A' ' 170' ' ' LEU . . . -43.29 -23.05 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.082 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . 0.416 ' N ' ' O ' ' A' ' 172' ' ' GLU . 92.7 m-85 -114.56 -70.24 0.81 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.879 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -111.28 137.57 14.39 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.521 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -44.23 164.79 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.762 0.315 . . . . 0.0 110.896 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.519 HD11 ' CB ' ' A' ' 171' ' ' PHE . 51.1 mt -133.42 134.0 57.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.104 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -89.38 -41.31 12.19 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.918 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -150.75 151.2 32.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.831 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 49.4 t -146.0 138.2 25.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.854 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 26.2 m -154.89 151.2 28.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.155 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 48.6 mm -109.21 140.8 26.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.141 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.471 HD11 ' CE2' ' A' ' 195' ' ' PHE . 34.6 mt -89.24 108.45 19.62 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.919 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 47.4 mtt180 -133.09 112.2 11.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.873 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -72.64 -151.48 1.44 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.498 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -45.66 157.05 0.35 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.683 2.255 . . . . 0.0 112.34 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 6.7 t70 43.12 40.7 2.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.879 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 39.53 42.22 1.87 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.54 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -92.83 104.66 16.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.87 0.367 . . . . 0.0 110.906 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 8.3 t -50.83 139.26 17.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.842 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 38.3 mttm -105.04 34.25 3.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.908 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.431 ' C ' ' HB2' ' A' ' 158' ' ' LEU . . . 49.92 39.47 32.9 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.521 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 80.8 m -151.03 157.61 43.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.772 0.32 . . . . 0.0 110.89 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -160.84 166.64 28.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.123 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . 0.562 ' CD1' ' HD3' ' A' ' 152' ' ' LYS . 40.0 m-85 -124.5 130.5 52.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.879 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 11.8 t -128.46 148.73 32.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.141 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.424 ' O ' HG23 ' A' ' 177' ' ' ILE . 6.3 ttmm -126.93 138.39 53.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.92 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . 0.429 ' CD1' HD12 ' A' ' 153' ' ' LEU . 20.8 m-85 -114.68 175.44 5.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.915 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 41.2 t -81.6 -48.05 12.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.858 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 1.9 t -134.59 172.48 12.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.874 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . 0.404 ' O ' ' C ' ' A' ' 202' ' ' ALA . 18.2 t-160 -67.4 -55.96 11.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.85 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . 0.404 ' C ' ' O ' ' A' ' 201' ' ' HIS . . . -37.98 -64.51 0.4 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.098 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -49.37 -48.21 47.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.869 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -54.76 -58.37 7.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.137 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . 0.862 ' HA ' HD12 ' A' ' 208' ' ' ILE . 6.1 tp60 -43.63 -50.57 7.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.897 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -52.8 -54.79 29.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.085 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -56.27 -32.66 64.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.138 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . 0.862 HD12 ' HA ' ' A' ' 205' ' ' GLN . 59.7 mt -65.07 -75.13 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.071 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -49.32 -42.61 42.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.861 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -54.97 -43.24 73.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.106 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 58.6 mt -102.23 -70.19 0.76 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.943 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' HIS . . . . . 0.492 ' N ' ' O ' ' A' ' 208' ' ' ILE . 5.4 t60 -50.74 129.88 23.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.866 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 75.61 -9.25 16.37 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.476 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 7.9 t -99.95 -70.23 0.74 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.877 0.37 . . . . 0.0 110.874 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' GLN . . . . . 0.432 ' HG3' ' N ' ' A' ' 216' ' ' THR . 1.7 tt0 -90.65 154.87 19.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.923 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' THR . . . . . 0.601 HG23 ' O ' ' A' ' 222' ' ' SER . 30.5 m -118.17 101.62 8.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.156 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' MET . . . . . 0.451 ' HG3' HD23 ' A' ' 158' ' ' LEU . 19.4 mmt -39.13 134.84 1.09 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.626 0.727 . . . . 0.0 110.887 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -48.99 131.57 25.78 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.723 2.282 . . . . 0.0 112.356 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 99.29 -41.93 2.1 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.734 -0.745 . . . . 0.0 112.502 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -82.15 144.57 30.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.796 0.331 . . . . 0.0 111.129 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 8.3 m -93.4 -15.45 25.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.864 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . 0.601 ' O ' HG23 ' A' ' 216' ' ' THR . 57.9 m -99.98 142.43 31.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.897 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 58.8 m -54.91 156.21 3.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.873 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.446 ' HG ' ' N ' ' A' ' 225' ' ' VAL . 46.5 tp -52.37 159.63 0.96 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.954 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 0.446 ' N ' ' HG ' ' A' ' 224' ' ' LEU . 99.2 t -130.5 113.11 24.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.114 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 40.2 t -138.83 113.52 8.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.113 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 11.4 pttm -130.98 167.31 19.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.909 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' PHE . . . . . 0.504 ' HA ' HD23 ' A' ' 153' ' ' LEU . 62.5 m-85 -71.29 107.95 4.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.896 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . 0.641 ' HB2' ' HB2' ' A' ' 154' ' ' PHE . . . -75.43 102.26 5.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.07 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -117.72 130.17 56.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.886 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 48.9 m -89.62 98.43 11.77 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.149 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -123.25 82.69 2.03 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.861 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 42.8 pttt -160.84 140.24 10.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.882 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -109.81 142.98 40.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.908 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 31.6 p -156.45 107.45 2.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.822 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -166.34 85.75 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.446 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -45.56 -50.09 9.78 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.68 2.253 . . . . 0.0 112.339 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 2.1 t -162.78 115.87 1.65 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.855 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 23.2 t -99.57 127.06 45.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.887 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.46 -179.999 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.353 0 N-CA-C 112.501 -0.239 . . . . 0.0 112.501 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 49.2 m -143.88 130.22 19.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.835 0.35 . . . . 0.0 110.925 -179.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 32.2 t -129.91 129.91 44.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.888 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 75.15 140.08 0.72 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.532 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 54.1 p -119.82 172.72 7.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.869 0.366 . . . . 0.0 110.886 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 4.7 m -124.38 108.93 12.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.915 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -121.14 136.29 11.16 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.498 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 39.4 m -122.08 -34.09 3.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.859 0.361 . . . . 0.0 110.881 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -78.7 155.15 29.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.933 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 15.8 mtp85 -98.62 -53.67 3.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.852 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -138.5 138.58 22.55 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.56 0.695 . . . . 0.0 110.969 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.54 ' HG2' ' CE1' ' A' ' 201' ' ' HIS . 63.1 Cg_endo -78.23 147.08 22.97 Favored 'Trans proline' 0 C--O 1.231 0.146 0 C-N-CA 122.69 2.26 . . . . 0.0 112.329 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -46.91 178.51 0.01 OUTLIER 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.691 2.261 . . . . 0.0 112.32 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 28.2 t -129.0 112.91 14.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.857 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 64.4 m80 -148.05 171.98 14.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.853 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 2.3 tpp85 -119.1 -33.65 4.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.873 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 3.2 ttmp? -91.33 152.36 20.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.893 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.476 HD23 ' HA ' ' A' ' 228' ' ' PHE . 38.7 mt -134.06 128.25 33.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.909 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -94.13 121.74 35.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.873 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.702 HG22 HG13 ' A' ' 226' ' ' VAL . 88.5 t -113.9 136.42 50.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.186 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -136.69 -159.93 8.52 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.515 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 14.7 mmt 46.8 28.56 0.84 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.84 0.352 . . . . 0.0 110.925 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 36.9 mt -85.35 167.46 15.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.912 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.573 HD21 ' N ' ' A' ' 218' ' ' PRO . 45.6 m-20 -105.26 158.43 16.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.897 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 60.4 mttt -85.59 37.2 0.68 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.894 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -116.9 -55.71 2.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.881 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -67.34 149.34 50.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.901 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 51.6 p -124.79 175.48 7.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.806 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 10.4 tm-20 -43.51 -30.45 0.57 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.9 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -67.67 -60.02 2.87 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.838 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -54.19 -44.78 71.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.801 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.792 HG13 ' CE1' ' A' ' 171' ' ' PHE . 89.7 t -66.1 -40.0 85.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.15 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 56.7 ttp180 -54.04 -63.37 1.17 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.904 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 17.4 mmt180 -59.0 -54.87 42.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.906 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.726 ' O ' ' HB3' ' A' ' 173' ' ' ALA . 11.3 tp -42.53 -66.11 0.4 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.91 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.792 ' CE1' HG13 ' A' ' 167' ' ' VAL . 13.0 m-85 -51.73 -72.19 0.05 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.903 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.46 ' O ' ' N ' ' A' ' 174' ' ' PHE . 5.9 pt-20 -41.38 -31.51 0.25 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.897 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.726 ' HB3' ' O ' ' A' ' 170' ' ' LEU . . . -40.68 -24.82 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.133 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . 0.46 ' N ' ' O ' ' A' ' 172' ' ' GLU . 98.9 m-85 -112.21 -74.97 0.62 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.86 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -108.34 142.42 15.99 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.472 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -51.01 156.3 1.05 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.774 0.321 . . . . 0.0 110.907 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.461 HD11 ' CB ' ' A' ' 171' ' ' PHE . 81.7 mt -118.81 134.82 61.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.115 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 -90.87 -42.25 10.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.919 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -157.86 142.73 16.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.896 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . 0.622 ' SG ' HG13 ' A' ' 196' ' ' VAL . 1.8 m -134.23 145.87 49.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.825 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 45.4 m -151.98 134.73 15.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.158 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 30.0 mm -87.94 128.29 40.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.098 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.534 HD11 ' CE2' ' A' ' 195' ' ' PHE . 44.2 mt -95.53 115.29 27.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.922 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' ARG . . . . . 0.476 ' CB ' ' HA ' ' A' ' 190' ' ' SER . 15.2 ptp180 -166.95 145.82 5.21 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.891 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -64.0 155.68 45.3 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.473 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.409 ' O ' ' C ' ' A' ' 187' ' ' ASP . 71.2 Cg_exo -45.63 -43.0 18.78 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.713 2.275 . . . . 0.0 112.307 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . 0.409 ' C ' ' O ' ' A' ' 186' ' ' PRO . 68.6 m-20 -37.57 -45.58 0.77 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.882 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 124.16 -35.6 3.19 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.481 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . 0.433 ' O ' ' C ' ' A' ' 190' ' ' SER . 6.9 m-20 -58.99 98.64 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.821 0.343 . . . . 0.0 110.91 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . 0.476 ' HA ' ' CB ' ' A' ' 184' ' ' ARG . 27.2 p -35.3 145.49 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.838 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.426 ' CG ' ' HA ' ' A' ' 184' ' ' ARG . 1.8 mmmp? -102.59 38.01 1.8 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.906 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 37.67 41.49 0.87 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.457 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 65.0 m -153.68 148.51 26.51 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.809 0.338 . . . . 0.0 110.904 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -162.56 148.6 12.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.104 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . 0.534 ' CE2' HD11 ' A' ' 183' ' ' LEU . 14.6 m-85 -98.49 143.1 29.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.891 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.639 HG11 ' CD2' ' A' ' 171' ' ' PHE . 16.1 t -143.03 132.73 21.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.14 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 14.0 mtpp -116.05 154.25 30.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.879 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -126.97 171.68 11.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.939 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 32.5 t -69.62 -47.9 61.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.813 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 17.0 m -137.33 170.49 16.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.899 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . 0.54 ' CE1' ' HG2' ' A' ' 147' ' ' PRO . 36.3 t-80 -60.95 -56.8 16.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.841 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . 0.411 ' C ' ' O ' ' A' ' 201' ' ' HIS . . . -37.12 -65.48 0.3 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.129 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 16.7 mp0 -48.38 -46.0 36.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.916 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . 0.407 ' HB3' ' O ' ' A' ' 201' ' ' HIS . . . -54.09 -54.98 32.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.093 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . 0.554 ' HA ' HD12 ' A' ' 208' ' ' ILE . 4.3 tp60 -49.52 -54.62 16.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.853 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -46.31 -56.44 5.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.129 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -56.08 -36.19 67.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.154 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . 0.554 HD12 ' HA ' ' A' ' 205' ' ' GLN . 80.0 mt -64.25 -75.06 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.12 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -49.34 -41.49 38.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.842 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -52.01 -48.63 64.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.112 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 74.6 mt -100.97 -65.79 0.95 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.886 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' HIS . . . . . 0.483 ' N ' ' O ' ' A' ' 208' ' ' ILE . 6.3 t60 -51.62 129.19 25.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.87 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 73.62 -4.83 26.14 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.488 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 8.1 t -99.66 -67.91 0.83 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.81 0.338 . . . . 0.0 110.856 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 5.6 mm-40 -94.73 172.9 7.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.938 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' THR . . . . . 0.522 HG23 ' O ' ' A' ' 222' ' ' SER . 54.1 m -133.08 92.85 3.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.198 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' MET . . . . . 0.483 ' HE2' HD13 ' A' ' 224' ' ' LEU . 1.3 mmt -36.0 136.23 0.51 Allowed Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.591 0.71 . . . . 0.0 110.877 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . 0.573 ' N ' HD21 ' A' ' 159' ' ' ASN . 75.7 Cg_exo -48.52 125.56 12.64 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.701 2.267 . . . . 0.0 112.384 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 109.15 -50.46 0.77 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.498 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -77.03 149.38 35.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.762 0.315 . . . . 0.0 111.093 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 23.9 t -94.41 -18.26 21.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.88 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . 0.522 ' O ' HG23 ' A' ' 216' ' ' THR . 2.2 m -99.98 147.45 25.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.833 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . 0.417 ' O ' ' C ' ' A' ' 224' ' ' LEU . 53.8 m -61.16 147.25 44.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.888 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.483 HD13 ' HE2' ' A' ' 217' ' ' MET . 19.1 tp -36.82 152.72 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.909 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 0.414 ' N ' ' HG ' ' A' ' 224' ' ' LEU . 99.6 t -123.22 105.0 15.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.117 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . 0.702 HG13 HG22 ' A' ' 155' ' ' VAL . 22.1 t -132.67 101.84 4.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.118 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 45.8 pttt -119.47 167.69 11.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.873 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' PHE . . . . . 0.476 ' HA ' HD23 ' A' ' 153' ' ' LEU . 90.3 m-85 -72.34 115.75 11.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.91 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -43.55 143.96 0.86 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.121 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -104.63 -66.99 0.93 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.832 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 95.5 m -55.01 125.99 22.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.169 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -122.82 85.15 2.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.856 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 13.1 ttmm -58.12 139.66 54.31 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.889 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -142.67 171.79 13.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.913 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 96.2 p -170.03 113.77 0.48 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.836 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -71.59 146.18 39.98 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.472 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -78.0 -33.24 2.19 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.73 2.287 . . . . 0.0 112.35 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 1.1 t -54.97 143.55 26.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.881 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 75.6 m -89.73 -55.59 3.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.811 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.318 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.502 -179.974 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.313 0 N-CA-C 112.475 -0.25 . . . . 0.0 112.475 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 3.2 m -96.02 55.51 1.57 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.813 0.339 . . . . 0.0 110.865 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 32.2 t -101.64 41.69 1.19 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.863 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -171.54 -66.47 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.467 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 16.9 p -158.49 140.4 13.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.885 0.374 . . . . 0.0 110.842 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 6.9 t -97.26 -51.69 4.09 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.833 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 176.89 103.04 0.16 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.482 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 69.2 m -62.95 116.08 4.98 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.86 0.362 . . . . 0.0 110.876 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.0 mt -111.41 167.11 10.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.932 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 4.9 tpp85 -64.49 -44.59 90.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.889 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 86.7 mm-40 -52.6 149.61 10.64 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.588 0.708 . . . . 0.0 110.917 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -45.61 148.76 2.16 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.665 2.243 . . . . 0.0 112.349 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -77.98 106.49 2.18 Favored 'Trans proline' 0 N--CA 1.465 -0.161 0 C-N-CA 122.73 2.287 . . . . 0.0 112.364 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 22.9 t -136.99 105.29 5.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.859 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 56.7 m80 -100.83 88.74 3.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.848 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 15.5 ttm-85 -162.41 116.09 1.76 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.886 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.454 ' HD3' ' CG ' ' A' ' 195' ' ' PHE . 2.7 ttmp? -122.64 151.9 41.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.877 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.405 ' N ' ' HG2' ' A' ' 152' ' ' LYS . 86.3 mt -117.91 133.66 55.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.914 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -102.64 114.37 28.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.885 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.636 HG21 ' CZ ' ' A' ' 171' ' ' PHE . 37.8 t -108.55 111.45 36.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.139 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -111.4 -161.16 16.78 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.507 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.419 ' CE ' ' HB1' ' A' ' 220' ' ' ALA . 79.9 mmm 46.62 41.49 9.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.818 0.342 . . . . 0.0 110.913 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.543 HD23 ' HG3' ' A' ' 217' ' ' MET . 55.1 mt -99.54 171.03 8.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.933 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 30.2 m120 -113.6 171.38 7.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.892 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 43.6 mttm -92.79 42.59 1.1 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.917 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -124.28 -43.92 2.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.89 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 61.0 mt-30 -63.4 159.79 17.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.922 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 68.9 m -132.36 175.81 8.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.854 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -55.05 -47.02 75.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.88 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.496 ' CG ' ' N ' ' A' ' 166' ' ' ASP . 0.6 OUTLIER -58.33 -53.71 55.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.809 -179.988 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . 0.496 ' N ' ' CG ' ' A' ' 165' ' ' ASP . 65.5 m-20 -45.34 -55.89 5.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.888 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.784 HG13 ' CD1' ' A' ' 171' ' ' PHE . 68.7 t -64.81 -44.43 96.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.131 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 33.9 mtp180 -48.6 -55.22 11.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.881 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . 0.408 ' O ' ' HG3' ' A' ' 172' ' ' GLU . 55.7 mtt180 -70.86 -50.28 36.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.866 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.701 ' O ' ' HB3' ' A' ' 173' ' ' ALA . 9.8 tp -48.18 -63.78 0.98 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.919 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.784 ' CD1' HG13 ' A' ' 167' ' ' VAL . 7.3 m-85 -54.61 -58.48 7.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.905 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.408 ' HG3' ' O ' ' A' ' 169' ' ' ARG . 0.8 OUTLIER -59.82 -9.94 3.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.902 -179.915 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.701 ' HB3' ' O ' ' A' ' 170' ' ' LEU . . . -61.59 -10.75 8.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.131 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -120.43 -67.9 0.94 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.845 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -110.59 -173.93 20.25 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.46 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -83.79 151.23 25.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.785 0.326 . . . . 0.0 110.899 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.467 HD11 ' CB ' ' A' ' 171' ' ' PHE . 21.0 mt -121.27 129.62 75.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.143 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 35.0 mm-40 -79.3 -46.61 17.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.879 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 22.2 tp10 -165.29 143.86 6.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.875 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 13.0 t -118.81 143.0 47.2 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.923 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 30.1 m -153.11 116.05 4.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.113 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 44.6 mm -83.3 135.01 25.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.125 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.861 HD11 ' CE2' ' A' ' 195' ' ' PHE . 35.1 mt -84.39 102.53 12.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.911 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 61.6 mtp180 -118.06 137.58 52.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.923 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -53.99 -166.67 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.697 -0.764 . . . . 0.0 112.517 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -76.31 -46.51 0.18 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.644 2.229 . . . . 0.0 112.373 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -55.96 -40.14 72.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.905 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 124.68 35.22 0.65 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.475 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 37.1 p-10 -120.81 146.7 46.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.833 0.349 . . . . 0.0 110.876 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 40.7 t -69.23 132.1 45.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.856 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 1.3 mmmp? -94.46 26.09 3.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.898 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.425 ' C ' ' HB2' ' A' ' 158' ' ' LEU . . . 59.93 34.65 84.04 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.453 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 84.3 m -154.12 154.82 34.27 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.806 0.336 . . . . 0.0 110.926 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -158.37 161.1 37.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.072 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . 0.861 ' CE2' HD11 ' A' ' 183' ' ' LEU . 27.8 m-85 -121.53 119.59 32.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.868 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 21.5 t -118.8 140.21 43.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.081 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 17.1 mtmt -114.65 145.88 41.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.859 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -119.42 174.87 6.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.929 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 81.0 p -78.19 -46.26 20.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.876 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 37.7 m -133.58 -179.3 5.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.838 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . 0.513 ' O ' ' HB3' ' A' ' 204' ' ' ALA . 53.8 t-80 -76.44 -52.77 9.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.892 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -39.6 -66.14 0.32 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.081 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 51.5 mm-40 -47.28 -43.8 22.59 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.885 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . 0.513 ' HB3' ' O ' ' A' ' 201' ' ' HIS . . . -51.77 -54.07 32.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.108 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . 0.598 ' HA ' HD12 ' A' ' 208' ' ' ILE . 24.9 tp60 -56.57 -41.51 77.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.926 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -53.15 -50.1 65.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.119 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -68.25 -26.66 65.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.098 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . 0.598 HD12 ' HA ' ' A' ' 205' ' ' GLN . 63.4 mt -71.05 -65.11 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.083 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -60.92 -38.09 84.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.879 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -65.07 -26.77 68.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.113 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 89.9 mt -115.61 -75.0 0.59 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.94 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' HIS . . . . . 0.528 ' HD1' ' HA ' ' A' ' 225' ' ' VAL . 20.6 t60 -47.83 128.69 13.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.848 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 83.16 -22.03 7.55 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.514 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 4.8 m -90.18 -71.61 0.61 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.801 0.334 . . . . 0.0 110.893 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' GLN . . . . . 0.449 ' HG3' ' N ' ' A' ' 216' ' ' THR . 1.2 tt0 -88.71 156.05 19.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.865 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' THR . . . . . 0.594 HG23 ' O ' ' A' ' 222' ' ' SER . 2.0 m -119.51 118.1 30.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.119 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' MET . . . . . 0.543 ' HG3' HD23 ' A' ' 158' ' ' LEU . 23.9 mmt -47.44 137.05 9.28 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.598 0.714 . . . . 0.0 110.87 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -48.89 113.82 1.03 Allowed 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.702 2.268 . . . . 0.0 112.379 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 112.7 -54.39 0.55 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.504 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . 0.419 ' HB1' ' CE ' ' A' ' 157' ' ' MET . . . -63.72 145.46 55.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.813 0.339 . . . . 0.0 111.15 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 48.2 t -93.23 -16.26 25.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.806 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . 0.594 ' O ' HG23 ' A' ' 216' ' ' THR . 2.4 m -100.09 136.98 39.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.841 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 2.1 p -44.91 162.97 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.831 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.462 ' HG ' HG23 ' A' ' 226' ' ' VAL . 51.4 tp -56.98 157.04 6.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.895 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 0.528 ' HA ' ' HD1' ' A' ' 212' ' ' HIS . 91.8 t -125.12 110.21 24.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.144 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . 0.504 HG22 HG13 ' A' ' 155' ' ' VAL . 44.1 t -136.26 105.03 4.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.161 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 4.6 ptmt -132.69 145.77 51.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.909 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -51.45 144.43 10.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.914 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -78.46 -47.54 17.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.118 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -90.16 115.28 27.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.86 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 57.9 p -78.46 143.84 36.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.173 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -90.48 107.89 19.45 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.891 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 16.5 ptmt -158.22 159.84 36.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.886 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -160.44 159.47 30.98 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.875 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 24.2 t -73.46 -43.56 59.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.866 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -76.08 161.4 52.03 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.481 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . 0.426 ' O ' ' C ' ' A' ' 238' ' ' SER . 62.4 Cg_endo -79.18 19.98 0.87 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.656 2.237 . . . . 0.0 112.334 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' SER . . . . . 0.426 ' C ' ' O ' ' A' ' 237' ' ' PRO . 42.7 p -36.61 -46.44 0.58 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.869 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 75.5 p -164.25 136.71 4.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.84 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.446 -179.966 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.294 0 N-CA-C 112.478 -0.249 . . . . 0.0 112.478 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.452 ' CB ' ' HB2' ' A' ' 141' ' ' SER . 59.6 m 47.3 42.15 13.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.889 0.376 . . . . 0.0 110.901 -179.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 3.4 m 39.97 42.15 1.03 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.859 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 164.94 -95.69 0.12 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.503 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 61.6 p -162.06 110.53 1.43 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.853 0.358 . . . . 0.0 110.843 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.452 ' HB2' ' CB ' ' A' ' 137' ' ' SER . 3.3 m -164.79 148.3 8.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.869 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 171.67 -48.51 0.18 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.466 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 78.3 m -108.06 89.28 2.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.881 0.372 . . . . 0.0 110.881 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 17.1 tp -43.5 -52.48 6.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.882 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 31.7 ptt180 -113.7 112.99 24.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.905 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 74.6 mm-40 -71.35 142.31 86.72 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.664 0.745 . . . . 0.0 110.902 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -46.76 158.34 0.41 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.693 2.262 . . . . 0.0 112.295 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -45.17 171.93 0.02 OUTLIER 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.681 2.254 . . . . 0.0 112.329 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 65.6 m -118.25 105.36 11.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.827 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . 0.458 ' CD2' ' N ' ' A' ' 150' ' ' HIS . 0.2 OUTLIER -165.48 145.66 6.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.873 179.932 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 26.1 mtm180 -115.02 111.49 21.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.884 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 23.1 ttpt -122.6 152.03 40.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.913 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.438 HD21 ' CE1' ' A' ' 228' ' ' PHE . 87.4 mt -123.55 123.51 40.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.896 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -91.22 116.95 29.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.948 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.586 HG13 HG22 ' A' ' 226' ' ' VAL . 38.3 t -110.82 132.44 59.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.114 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -130.87 -158.84 9.39 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.473 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 45.52 31.86 1.0 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.793 0.33 . . . . 0.0 110.859 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 79.5 mt -85.24 -176.22 6.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.875 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.464 ' N ' ' OD1' ' A' ' 159' ' ' ASN . 0.5 OUTLIER -126.97 155.31 43.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.884 179.896 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 65.8 mttt -80.92 42.09 0.62 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.875 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 18.0 mp0 -130.96 -43.03 1.09 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.921 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 17.8 mm-40 -54.0 162.01 1.08 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.914 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 28.1 m -135.7 166.28 23.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.807 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.465 ' O ' ' CB ' ' A' ' 168' ' ' ARG . 2.3 mp0 -49.28 -41.0 36.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.889 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -65.1 -48.34 74.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.867 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 -54.81 -56.61 17.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.817 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.528 HG13 ' CE1' ' A' ' 171' ' ' PHE . 54.3 t -66.98 -40.62 86.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.153 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . 0.465 ' CB ' ' O ' ' A' ' 164' ' ' GLU . 13.8 tpt180 -56.36 -56.28 23.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.865 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 10.0 mmt85 -63.25 -54.47 36.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.889 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.765 ' O ' ' HB3' ' A' ' 173' ' ' ALA . 9.9 tp -43.95 -64.94 0.57 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.925 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.528 ' CE1' HG13 ' A' ' 167' ' ' VAL . 7.4 m-85 -51.33 -68.87 0.13 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.871 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -46.36 -26.4 0.82 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.888 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.765 ' HB3' ' O ' ' A' ' 170' ' ' LEU . . . -48.89 -21.13 0.59 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.126 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -114.21 -60.37 1.89 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.867 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -124.48 134.08 8.93 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.488 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -40.74 162.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.786 0.327 . . . . 0.0 110.93 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.663 HG23 ' O ' ' A' ' 197' ' ' LYS . 32.3 mt -131.03 136.39 58.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.087 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -81.35 -48.76 11.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.92 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -155.49 151.21 27.44 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.882 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 42.1 t -129.38 135.76 49.12 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.856 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 89.5 m -148.1 134.17 19.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.152 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 48.5 mm -95.06 139.04 19.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.099 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.769 HD11 ' CE2' ' A' ' 195' ' ' PHE . 41.0 mt -94.85 117.77 30.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.954 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 76.1 mtm180 -130.05 107.91 9.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.853 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -63.63 -148.76 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.452 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -45.46 153.51 0.66 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.649 2.233 . . . . 0.0 112.385 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 7.8 t0 41.05 42.04 1.46 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.854 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 40.14 44.94 3.01 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.502 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -92.29 107.65 19.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.861 0.362 . . . . 0.0 110.922 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 37.3 p -49.84 105.18 0.08 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.871 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 30.1 mmtp -80.4 43.45 0.64 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.914 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 39.01 50.35 2.67 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.487 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 8.1 p -159.54 151.68 20.85 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.849 0.357 . . . . 0.0 110.835 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -160.04 168.02 26.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.111 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . 0.769 ' CE2' HD11 ' A' ' 183' ' ' LEU . 40.3 m-85 -120.18 135.83 54.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.864 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 46.9 t -136.32 142.54 38.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.103 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.663 ' O ' HG23 ' A' ' 177' ' ' ILE . 23.2 mttp -117.38 154.1 31.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.885 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -124.17 172.99 8.62 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.901 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 68.3 p -83.24 -33.4 26.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.874 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 11.2 t -141.65 165.1 28.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.851 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 4.8 t60 -67.69 -53.7 25.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.849 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -44.28 -60.28 1.99 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.126 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -46.86 -45.95 20.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.879 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -55.75 -58.43 7.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.111 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 16.5 tp60 -45.11 -49.64 11.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.888 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -53.54 -51.87 61.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.112 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -56.87 -45.12 82.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.107 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . 0.494 ' O ' ' N ' ' A' ' 212' ' ' HIS . 71.4 mt -57.97 -74.06 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.142 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -48.06 -42.54 28.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.883 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -58.31 -37.7 75.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.134 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.419 ' O ' ' CB ' ' A' ' 214' ' ' SER . 41.4 mt -104.53 -72.0 0.72 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.945 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' HIS . . . . . 0.494 ' N ' ' O ' ' A' ' 208' ' ' ILE . 13.0 t60 -46.85 136.59 8.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.876 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 73.67 -6.41 18.18 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.479 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' SER . . . . . 0.419 ' CB ' ' O ' ' A' ' 211' ' ' LEU . 1.3 t -87.97 -71.03 0.6 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.825 0.345 . . . . 0.0 110.883 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.17 178.22 4.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.918 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' THR . . . . . 0.616 HG23 ' O ' ' A' ' 222' ' ' SER . 56.4 m -134.97 95.29 3.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.132 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' MET . . . . . 0.442 ' C ' ' O ' ' A' ' 216' ' ' THR . 25.5 mmt -34.73 133.58 0.42 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.596 0.712 . . . . 0.0 110.887 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -48.91 117.73 2.98 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.723 2.282 . . . . 0.0 112.297 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 120.27 -54.17 0.66 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.52 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -72.04 159.86 33.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.769 0.319 . . . . 0.0 111.095 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 38.7 t -98.15 -23.9 15.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.881 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . 0.616 ' O ' HG23 ' A' ' 216' ' ' THR . 1.9 m -99.98 147.48 25.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.841 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 73.4 m -60.02 156.41 14.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.852 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 38.2 tp -37.22 153.16 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.903 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 0.428 ' HA ' ' ND1' ' A' ' 212' ' ' HIS . 61.4 t -124.66 111.04 26.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.136 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . 0.586 HG22 HG13 ' A' ' 155' ' ' VAL . 41.1 t -132.72 102.1 4.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.137 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 10.6 ptmt -129.48 151.65 49.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.898 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' PHE . . . . . 0.438 ' CE1' HD21 ' A' ' 153' ' ' LEU . 82.1 m-85 -57.3 154.05 11.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.857 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -115.06 151.19 34.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.141 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 12.8 t70 65.0 42.99 3.94 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.882 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 59.8 p -129.19 161.0 31.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.164 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -130.76 134.22 46.68 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.871 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 23.5 pttm -55.44 141.52 36.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.9 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -161.73 164.03 29.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.916 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 40.0 t -88.38 95.08 10.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.854 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -124.86 78.51 0.37 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.505 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -78.61 37.4 0.65 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.664 2.243 . . . . 0.0 112.345 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 72.3 p -128.52 172.84 10.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.883 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 9.6 t -114.46 168.62 9.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.851 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.338 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.474 179.999 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.343 0 N-CA-C 112.515 -0.234 . . . . 0.0 112.515 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 23.3 t -60.79 90.23 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.829 0.347 . . . . 0.0 110.864 -179.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 8.0 m -50.85 107.2 0.16 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.864 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 120.15 -133.08 9.69 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.501 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 56.3 p -147.68 139.97 24.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.867 0.365 . . . . 0.0 110.831 -179.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 3.4 t -98.85 42.97 1.07 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.846 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 64.73 69.65 1.28 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.422 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 22.5 p -100.17 73.07 1.69 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.846 0.355 . . . . 0.0 110.862 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.531 ' N ' HD23 ' A' ' 144' ' ' LEU . 1.3 pt? -155.3 174.12 15.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.909 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.403 ' O ' ' C ' ' A' ' 146' ' ' GLN . 1.0 OUTLIER -99.35 161.74 13.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.854 179.926 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . 0.403 ' C ' ' O ' ' A' ' 145' ' ' ARG . 20.8 tt0 -37.47 99.5 0.19 Allowed Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.625 0.726 . . . . 0.0 110.93 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -44.3 147.27 1.58 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.73 2.287 . . . . 0.0 112.316 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -46.87 141.01 12.39 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.735 2.29 . . . . 0.0 112.33 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 2.4 m -72.07 -177.85 2.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.839 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 13.0 p80 38.83 45.97 1.0 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.895 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.767 ' H ' ' NE ' ' A' ' 151' ' ' ARG . 0.0 OUTLIER -77.53 154.91 31.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.858 -179.843 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.971 ' HB3' ' HB3' ' A' ' 229' ' ' ALA . 2.5 tptt -140.6 156.54 46.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.876 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.483 HD12 ' CD1' ' A' ' 198' ' ' TYR . 41.6 mt -124.54 118.41 26.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.922 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -89.8 120.73 31.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.905 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.694 HG13 HG22 ' A' ' 226' ' ' VAL . 20.7 t -116.33 118.09 57.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.143 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -118.2 -155.8 10.09 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.499 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 16.5 mmt 47.42 34.59 3.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.786 0.327 . . . . 0.0 110.863 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.455 HD23 ' HG3' ' A' ' 217' ' ' MET . 69.3 mt -95.51 165.87 12.14 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.941 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.459 ' H ' ' ND2' ' A' ' 159' ' ' ASN . 0.5 OUTLIER -102.27 162.21 13.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.895 179.929 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 40.4 mttp -85.48 32.89 0.56 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.897 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 3.5 tp60 -120.89 -50.51 2.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.913 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -44.31 159.82 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.893 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 4.9 m -139.06 168.5 19.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.866 -179.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -49.97 -48.73 52.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.885 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -53.31 -56.3 17.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.87 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -48.33 -67.59 0.26 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.87 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.764 HG13 ' CE1' ' A' ' 171' ' ' PHE . 65.3 t -49.99 -53.17 11.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.099 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . 0.429 ' C ' ' O ' ' A' ' 167' ' ' VAL . 1.5 tmm_? -36.25 -63.65 0.37 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.844 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 19.7 mtp180 -63.89 -51.89 62.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.915 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.704 ' O ' ' HB3' ' A' ' 173' ' ' ALA . 16.5 tp -43.29 -65.8 0.45 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.953 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.764 ' CE1' HG13 ' A' ' 167' ' ' VAL . 9.3 m-85 -55.7 -68.33 0.21 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.884 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -44.81 -21.96 0.07 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.882 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.704 ' HB3' ' O ' ' A' ' 170' ' ' LEU . . . -50.11 -17.75 0.46 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.126 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -118.3 -71.74 0.72 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.916 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -109.51 145.83 16.83 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.463 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -55.84 145.59 24.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.836 0.35 . . . . 0.0 110.872 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.482 HD11 ' CB ' ' A' ' 171' ' ' PHE . 50.7 mt -109.26 135.06 49.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.127 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.45 ' HB3' ' CE ' ' A' ' 197' ' ' LYS . 13.0 mt-10 -97.86 -39.09 9.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.897 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 23.2 tp10 -148.17 144.43 27.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.879 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 44.9 t -143.78 137.99 28.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.896 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 22.4 m -154.53 137.29 15.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.096 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.699 HD13 ' CB ' ' A' ' 194' ' ' ALA . 26.4 mm -96.83 126.43 49.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.103 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 1.181 HD11 ' CE2' ' A' ' 195' ' ' PHE . 28.7 mt -81.73 108.88 15.64 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.928 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' ARG . . . . . 0.487 ' CB ' ' HA ' ' A' ' 190' ' ' SER . 5.6 ptp180 -169.08 142.91 2.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.885 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -78.25 -145.43 2.67 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.488 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -75.56 -167.32 0.42 Allowed 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.735 2.29 . . . . 0.0 112.336 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . 0.424 ' O ' ' C ' ' A' ' 188' ' ' GLY . 22.0 t0 40.32 34.44 0.22 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.845 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' A' ' 187' ' ' ASP . . . 36.41 45.16 0.92 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.454 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -91.39 75.92 5.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.821 0.343 . . . . 0.0 110.895 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . 0.487 ' HA ' ' CB ' ' A' ' 184' ' ' ARG . 48.5 t -43.35 134.24 3.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.904 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 52.5 mttm -100.68 34.53 2.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.875 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 41.11 39.54 2.13 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.463 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 65.1 m -154.6 149.03 26.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.833 0.349 . . . . 0.0 110.889 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.699 ' CB ' HD13 ' A' ' 182' ' ' ILE . . . -163.14 154.63 17.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.101 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . 1.181 ' CE2' HD11 ' A' ' 183' ' ' LEU . 69.7 m-85 -105.38 136.69 44.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.873 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 48.4 t -133.76 140.45 46.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.147 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.45 ' CE ' ' HB3' ' A' ' 178' ' ' GLU . 22.0 ttpt -116.84 142.8 46.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.856 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . 0.483 ' CD1' HD12 ' A' ' 153' ' ' LEU . 9.5 m-85 -119.86 170.2 9.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.895 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 24.7 t -69.2 -48.24 62.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.866 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 59.5 p -145.81 173.05 12.45 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.9 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . 0.443 ' O ' ' C ' ' A' ' 202' ' ' ALA . 6.5 t60 -59.46 -56.48 21.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.823 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . 0.443 ' C ' ' O ' ' A' ' 201' ' ' HIS . . . -34.74 -69.81 0.09 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.122 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -47.1 -47.31 23.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.887 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -53.33 -58.06 8.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.061 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 3.2 tp60 -47.91 -40.03 20.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.929 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -59.81 -53.71 54.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.084 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -61.93 -25.66 67.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.127 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . 0.495 ' O ' ' N ' ' A' ' 212' ' ' HIS . 79.2 mt -71.15 -67.79 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.13 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -57.31 -38.88 74.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.877 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -63.5 -41.73 98.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.147 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.497 ' HB3' HD23 ' A' ' 224' ' ' LEU . 63.7 mt -100.73 -72.09 0.69 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.909 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' HIS . . . . . 0.495 ' N ' ' O ' ' A' ' 208' ' ' ILE . 1.4 t60 -52.15 130.48 30.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.872 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 72.54 -0.98 39.15 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.523 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 22.5 t -96.88 -71.89 0.66 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.782 0.325 . . . . 0.0 110.859 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -99.5 172.37 7.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.866 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 216' ' ' THR . . . . . 0.608 HG23 ' O ' ' A' ' 222' ' ' SER . 34.2 m -123.55 105.35 9.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.125 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 217' ' ' MET . . . . . 0.455 ' HG3' HD23 ' A' ' 158' ' ' LEU . 15.4 mmt -43.18 139.03 2.43 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.514 0.674 . . . . 0.0 110.929 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -48.31 120.74 5.33 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.681 2.254 . . . . 0.0 112.338 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 105.88 -53.97 0.62 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.485 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -66.68 146.93 53.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.845 0.355 . . . . 0.0 111.092 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 29.4 m -93.19 -17.29 23.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.826 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . 0.608 ' O ' HG23 ' A' ' 216' ' ' THR . 9.8 p -100.01 151.29 21.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.861 -179.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 44.1 m -65.6 148.08 52.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.865 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.497 HD23 ' HB3' ' A' ' 211' ' ' LEU . 63.8 tp -39.56 149.83 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.914 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 61.9 t -121.89 106.52 18.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.129 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . 0.694 HG22 HG13 ' A' ' 155' ' ' VAL . 28.7 t -126.17 104.99 13.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.137 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 46.2 pttt -120.31 176.36 5.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.924 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -83.61 114.65 21.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.927 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . 0.971 ' HB3' ' HB3' ' A' ' 152' ' ' LYS . . . -59.39 127.3 31.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.105 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -83.23 173.07 11.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.874 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 41.4 m -160.32 129.26 4.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.151 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . 0.488 ' OD1' ' N ' ' A' ' 233' ' ' LYS . 26.4 t0 -58.38 146.44 34.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.864 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . 0.488 ' N ' ' OD1' ' A' ' 232' ' ' ASP . 14.0 ttmm -171.45 145.17 2.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.885 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -148.25 125.4 11.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.885 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.5 t -169.75 158.1 7.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.908 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 54.96 -171.67 1.2 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.482 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -76.83 155.54 34.67 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.693 2.262 . . . . 0.0 112.321 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 56.6 m -84.26 151.22 24.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.845 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 3.0 m -109.94 129.03 55.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.837 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.33 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.463 179.995 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.319 0 N-CA-C 112.489 -0.245 . . . . 0.0 112.489 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 59.5 p -161.23 130.66 4.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.881 0.372 . . . . 0.0 110.886 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 2.5 t 59.39 42.23 18.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.81 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -78.7 -98.55 0.23 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.522 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 79.1 p -85.63 97.28 10.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.887 0.375 . . . . 0.0 110.892 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 7.0 t -172.53 134.28 0.65 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.857 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -154.22 73.55 0.25 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.478 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 19.3 p -162.92 148.74 12.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.877 0.37 . . . . 0.0 110.896 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -97.6 40.82 1.14 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.95 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -131.19 119.18 21.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.843 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . 0.413 ' CD ' ' H ' ' A' ' 146' ' ' GLN . 3.0 pm0 -52.93 143.92 29.07 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.621 0.724 . . . . 0.0 110.899 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -46.52 145.76 5.88 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.678 2.252 . . . . 0.0 112.333 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -47.0 -41.93 25.83 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.665 2.243 . . . . 0.0 112.357 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 66.3 m 46.17 37.5 4.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.858 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . 0.429 ' CB ' ' HB3' ' A' ' 228' ' ' PHE . 22.1 m80 -69.78 -176.66 1.1 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.899 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 20.3 mtt180 -133.2 -38.89 0.94 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.855 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.429 ' HE3' ' CB ' ' A' ' 195' ' ' PHE . 20.6 tttp -84.48 121.94 28.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.874 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.663 HD21 HD11 ' A' ' 208' ' ' ILE . 25.0 mt -96.63 154.35 17.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.923 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 79.1 t80 -125.0 114.14 18.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.892 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.669 HG21 ' CZ ' ' A' ' 171' ' ' PHE . 17.4 t -102.75 110.51 29.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.108 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -111.99 -171.6 18.82 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.471 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 10.5 mmt 59.66 28.08 17.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.795 0.331 . . . . 0.0 110.845 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 46.3 mt -91.17 165.99 13.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.933 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -108.64 166.56 10.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.904 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 33.0 mttt -84.6 51.7 2.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.91 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -134.88 -50.67 0.77 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.957 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -51.67 163.36 0.31 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.872 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 44.5 m -138.14 172.47 12.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.882 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -53.73 -45.13 70.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.898 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -57.43 -51.38 69.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.847 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -50.99 -65.73 0.51 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.876 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.678 HG13 ' CE1' ' A' ' 171' ' ' PHE . 58.3 t -57.8 -36.57 55.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.137 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 14.2 tpp85 -54.58 -62.72 1.47 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.868 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . 0.401 ' O ' ' HG3' ' A' ' 172' ' ' GLU . 68.3 mtp180 -64.87 -51.52 61.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.864 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.694 ' O ' ' HB3' ' A' ' 173' ' ' ALA . 13.0 tp -43.85 -65.51 0.49 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.912 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.678 ' CE1' HG13 ' A' ' 167' ' ' VAL . 6.6 m-85 -55.84 -67.95 0.25 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.858 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.509 ' C ' ' CD ' ' A' ' 172' ' ' GLU . 0.6 OUTLIER -45.43 -21.56 0.1 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.886 -179.91 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.694 ' HB3' ' O ' ' A' ' 170' ' ' LEU . . . -50.11 -18.97 0.64 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.098 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -110.27 -65.96 1.11 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.908 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -107.33 -165.53 21.98 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.478 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -100.01 132.84 45.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.778 0.323 . . . . 0.0 110.886 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 29.6 mt -101.89 138.32 26.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.089 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -98.96 -32.82 11.11 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.862 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -160.83 152.31 19.32 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.885 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 38.6 t -136.1 121.49 19.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.902 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . 0.487 ' O ' ' HB1' ' A' ' 194' ' ' ALA . 97.8 m -123.86 139.08 54.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.152 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.43 HD13 ' HB1' ' A' ' 194' ' ' ALA . 50.6 mm -115.57 114.54 46.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.134 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.564 HD11 ' HE2' ' A' ' 195' ' ' PHE . 18.8 mt -77.75 98.92 5.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.914 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' ARG . . . . . 0.403 ' HB2' ' NH1' ' A' ' 184' ' ' ARG . 9.6 mtm105 -109.83 25.35 11.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.868 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 58.92 148.6 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.504 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -47.27 -17.72 0.58 Allowed 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.66 2.24 . . . . 0.0 112.311 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -78.18 -44.45 25.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.894 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 125.48 -21.0 6.45 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.504 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 10.2 m-20 -76.17 127.87 33.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.854 0.359 . . . . 0.0 110.887 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 4.6 t -47.68 133.86 13.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.816 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 2.6 mmmp? -105.56 15.51 26.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.91 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 62.47 32.24 82.42 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.497 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 11.1 m -148.04 142.96 26.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.794 0.331 . . . . 0.0 110.879 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.487 ' HB1' ' O ' ' A' ' 181' ' ' THR . . . -160.04 160.2 32.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.095 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . 0.564 ' HE2' HD11 ' A' ' 183' ' ' LEU . 77.4 m-85 -115.54 133.57 55.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.892 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.428 HG21 ' CE2' ' A' ' 171' ' ' PHE . 92.9 t -116.68 128.74 73.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.14 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 19.1 tttp -95.87 145.2 25.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.888 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . 0.44 ' CD1' HD12 ' A' ' 153' ' ' LEU . 7.6 m-85 -129.07 171.6 12.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.924 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 91.3 p -85.58 -20.91 28.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.885 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 2.2 m -162.01 176.42 10.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.772 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -77.16 -37.68 53.32 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.864 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -52.82 -65.31 0.58 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.102 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 18.2 mp0 -48.47 -41.29 29.25 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.88 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -58.85 -59.8 4.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.074 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . 0.61 ' HA ' HD12 ' A' ' 208' ' ' ILE . 43.1 tp60 -45.64 -42.02 10.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.937 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -60.48 -52.74 63.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.101 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -62.74 -28.39 69.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.112 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . 0.663 HD11 HD21 ' A' ' 153' ' ' LEU . 93.2 mt -67.41 -75.11 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.121 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -46.25 -43.4 15.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.893 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -55.99 -41.93 75.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.095 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 71.6 mt -100.94 -69.57 0.77 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.873 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' HIS . . . . . 0.637 ' HD1' ' HA ' ' A' ' 225' ' ' VAL . 27.1 t60 -52.4 125.62 16.71 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.902 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 84.6 -10.22 62.66 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.507 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 51.7 m -97.71 -74.43 0.58 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.84 0.353 . . . . 0.0 110.845 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 19.9 mp0 -88.43 166.42 14.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.928 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 216' ' ' THR . . . . . 0.664 HG23 ' O ' ' A' ' 222' ' ' SER . 32.4 m -135.79 106.39 6.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.141 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 217' ' ' MET . . . . . 0.404 ' C ' ' O ' ' A' ' 216' ' ' THR . 15.5 mmt -37.31 156.37 0.09 OUTLIER Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.547 0.689 . . . . 0.0 110.878 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.09 120.61 7.31 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.656 2.237 . . . . 0.0 112.323 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 109.36 -42.63 1.9 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.466 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -76.4 144.3 40.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.767 0.317 . . . . 0.0 111.089 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 3.5 t -93.57 -15.28 25.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.812 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . 0.664 ' O ' HG23 ' A' ' 216' ' ' THR . 67.6 m -100.17 142.09 32.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.904 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 64.7 m -57.72 157.13 7.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.824 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 47.7 tp -48.35 148.81 1.77 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.916 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 0.637 ' HA ' ' HD1' ' A' ' 212' ' ' HIS . 53.0 t -119.73 111.17 31.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.101 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 25.7 t -132.68 101.31 4.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.117 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.81 158.4 42.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.897 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 228' ' ' PHE . . . . . 0.632 ' CE1' HD21 ' A' ' 153' ' ' LEU . 28.6 m-85 -69.97 68.8 0.31 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.887 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . 0.472 ' C ' ' O ' ' A' ' 228' ' ' PHE . . . 32.0 44.22 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.048 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -78.69 155.38 29.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.894 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 231' ' ' THR . . . . . 0.465 ' O ' ' N ' ' A' ' 233' ' ' LYS . 1.7 m -161.97 105.17 1.18 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.161 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -40.2 93.64 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.842 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . 0.465 ' N ' ' O ' ' A' ' 231' ' ' THR . 44.1 tttp -138.32 110.49 7.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.914 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -117.66 131.53 56.63 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.878 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 83.8 p -121.16 39.45 3.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.877 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 108.31 149.41 14.26 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.494 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -76.78 118.35 4.79 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.698 2.265 . . . . 0.0 112.358 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 44.7 t -53.39 156.96 2.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.817 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 41.3 t -166.85 121.05 1.05 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.864 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.379 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.496 -179.978 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.306 0 N-CA-C 112.517 -0.233 . . . . 0.0 112.517 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 40.9 t -129.63 130.09 45.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.875 0.369 . . . . 0.0 110.894 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 38.8 m -111.77 -48.95 3.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.878 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -172.23 57.26 0.16 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.535 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 16.4 m -83.08 130.25 35.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.939 0.4 . . . . 0.0 110.858 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 79.2 p -88.96 165.72 14.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.839 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -129.2 -71.96 0.14 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.454 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 99.3 m -58.87 -49.23 78.56 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.834 0.35 . . . . 0.0 110.892 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -43.92 121.62 2.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.926 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.3 106.19 18.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.837 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 8.8 mm100 -78.91 160.48 71.44 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.617 0.722 . . . . 0.0 110.899 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -45.61 166.92 0.05 OUTLIER 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.65 2.234 . . . . 0.0 112.37 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -76.99 84.7 1.89 Allowed 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.642 2.228 . . . . 0.0 112.303 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . 0.47 ' O ' ' CG ' ' A' ' 150' ' ' HIS . 54.9 p -110.95 159.93 17.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.872 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . 0.47 ' CG ' ' O ' ' A' ' 149' ' ' SER . 29.3 m80 -159.19 157.05 30.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.865 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 6.0 mmp_? 56.42 49.48 14.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.898 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.577 ' HE2' ' CD1' ' A' ' 195' ' ' PHE . 3.8 ttpm? -118.02 160.71 21.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.886 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 40.5 mt -129.65 123.97 32.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.886 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -90.19 119.33 30.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.9 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.737 HG13 HG22 ' A' ' 226' ' ' VAL . 5.1 t -107.22 124.7 63.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.121 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -124.85 -168.37 12.78 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.475 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 18.0 mmt 48.45 35.13 5.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.773 0.32 . . . . 0.0 110.896 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 38.3 mt -89.2 166.15 14.0 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.915 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -104.51 160.08 15.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.874 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 24.1 mttp -84.49 23.98 1.05 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.914 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -109.56 -55.21 2.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.909 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -53.4 146.05 13.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.88 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 57.7 m -126.38 166.37 17.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.864 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -44.13 -40.23 4.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.861 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -55.97 -66.08 0.49 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.872 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -52.81 -48.42 66.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.872 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.513 HG13 ' CE1' ' A' ' 171' ' ' PHE . 93.9 t -57.45 -35.24 48.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.099 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 51.4 ttt180 -63.81 -57.87 8.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.843 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . 0.401 ' O ' ' HG2' ' A' ' 172' ' ' GLU . 8.5 ptm180 -64.15 -53.24 52.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.85 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.741 ' O ' ' HB3' ' A' ' 173' ' ' ALA . 8.5 tp -43.72 -65.26 0.52 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.916 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.513 ' CE1' HG13 ' A' ' 167' ' ' VAL . 10.9 m-85 -53.03 -68.9 0.13 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.884 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.401 ' HG2' ' O ' ' A' ' 169' ' ' ARG . 4.3 pt-20 -45.75 -24.19 0.34 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.894 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.741 ' HB3' ' O ' ' A' ' 170' ' ' LEU . . . -49.4 -21.23 0.84 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.073 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -111.77 -71.37 0.76 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.879 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -112.21 146.83 18.16 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.462 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . 0.45 ' O ' ' CD2' ' A' ' 198' ' ' TYR . 32.6 m120 -51.57 160.3 0.64 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.816 0.341 . . . . 0.0 110.926 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.411 ' CG2' ' N ' ' A' ' 178' ' ' GLU . 19.3 mt -124.73 152.37 30.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.128 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.411 ' N ' ' CG2' ' A' ' 177' ' ' ILE . 9.1 mt-10 -120.49 -28.92 4.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.868 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -155.76 146.78 22.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.871 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 4.8 t -147.32 132.91 18.76 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.927 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 99.5 m -151.32 145.13 25.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.141 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 18.5 mm -97.25 137.48 24.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.14 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.934 HD11 ' CE2' ' A' ' 195' ' ' PHE . 52.9 mt -100.36 98.75 9.36 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.914 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' ARG . . . . . 0.473 ' CB ' ' HA ' ' A' ' 190' ' ' SER . 24.4 ptt180 -154.27 163.4 40.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.853 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -87.47 -147.48 12.48 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.755 -0.735 . . . . 0.0 112.461 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -76.36 -175.72 2.71 Favored 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.688 2.259 . . . . 0.0 112.358 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . 0.444 ' HB3' ' ND2' ' A' ' 189' ' ' ASN . 5.2 t70 41.59 32.94 0.27 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.867 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 44.13 46.04 7.98 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.481 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . 0.444 ' ND2' ' HB3' ' A' ' 187' ' ' ASP . 19.2 m-80 -88.17 69.69 9.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.865 0.364 . . . . 0.0 110.89 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . 0.473 ' HA ' ' CB ' ' A' ' 184' ' ' ARG . 10.8 t -35.91 119.6 0.57 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.876 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 24.5 mmtt -90.82 36.16 0.9 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.918 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 43.28 37.61 3.41 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.468 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . 0.416 ' C ' ' HB2' ' A' ' 183' ' ' LEU . 72.1 m -150.49 150.4 31.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.799 0.333 . . . . 0.0 110.868 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -163.09 169.2 19.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.077 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . 0.934 ' CE2' HD11 ' A' ' 183' ' ' LEU . 18.2 m-85 -122.96 135.77 54.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.853 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.511 HG21 ' CE2' ' A' ' 171' ' ' PHE . 61.3 t -130.75 140.69 48.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.121 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 25.3 ttmt -117.44 146.49 43.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.856 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . 0.45 ' CD2' ' O ' ' A' ' 176' ' ' ASN . 24.6 m-85 -124.23 166.42 15.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.919 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 42.3 t -70.03 -48.74 56.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.828 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 7.3 t -136.82 168.69 19.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.859 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . 0.533 ' O ' ' HB3' ' A' ' 204' ' ' ALA . 4.7 t60 -61.35 -57.34 12.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.85 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . 0.449 ' C ' ' O ' ' A' ' 201' ' ' HIS . . . -33.99 -67.03 0.14 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.093 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 19.4 mp0 -49.83 -39.59 39.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.879 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . 0.533 ' HB3' ' O ' ' A' ' 201' ' ' HIS . . . -55.65 -51.82 65.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.092 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 59.6 tp60 -57.29 -45.18 84.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.876 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -51.93 -47.69 64.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.104 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -69.48 -29.88 67.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.136 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . 0.482 ' O ' ' N ' ' A' ' 212' ' ' HIS . 56.3 mt -66.94 -60.44 2.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.125 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -64.22 -36.95 85.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.869 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -66.6 -35.56 80.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.122 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.705 ' HB3' HD23 ' A' ' 224' ' ' LEU . 84.5 mt -102.51 -69.33 0.79 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.902 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 212' ' ' HIS . . . . . 0.482 ' N ' ' O ' ' A' ' 208' ' ' ILE . 12.2 t60 -62.97 126.19 26.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.835 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 85.7 -4.28 86.0 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.495 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 2.1 m -94.43 -74.12 0.55 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.84 0.353 . . . . 0.0 110.854 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 17.2 pm0 -99.88 175.63 5.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.894 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 216' ' ' THR . . . . . 0.673 HG23 ' O ' ' A' ' 222' ' ' SER . 17.3 m -130.33 101.37 5.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.106 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 13.5 mmt -37.08 134.45 0.68 Allowed Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.608 0.718 . . . . 0.0 110.884 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -48.71 119.88 4.71 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.668 2.246 . . . . 0.0 112.342 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 112.89 -49.86 0.81 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.513 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -73.38 156.76 38.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.813 0.34 . . . . 0.0 111.081 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 94.7 p -98.88 -21.14 16.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.837 -179.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . 0.673 ' O ' HG23 ' A' ' 216' ' ' THR . 1.8 m -100.15 143.31 30.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.855 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 15.1 m -56.88 153.49 10.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.921 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.705 HD23 ' HB3' ' A' ' 211' ' ' LEU . 58.5 tp -40.17 149.62 0.07 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.865 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 0.426 ' HA ' ' ND1' ' A' ' 212' ' ' HIS . 79.9 t -118.35 113.71 42.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.18 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . 0.737 HG22 HG13 ' A' ' 155' ' ' VAL . 20.5 t -138.97 104.97 2.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.15 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 44.7 pttt -127.4 178.96 5.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.862 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -83.44 133.63 34.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.878 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -85.87 96.86 9.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.138 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -109.1 37.0 2.69 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.885 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 231' ' ' THR . . . . . 0.631 HG23 ' O ' ' A' ' 231' ' ' THR . 9.0 t -87.97 80.69 7.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.137 -179.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -170.92 129.38 0.77 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.824 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 16.5 tttt -88.48 103.8 16.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.939 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -107.88 137.14 46.41 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.889 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 32.8 p -124.0 146.8 48.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.865 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -136.17 95.21 0.24 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.451 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -76.99 44.1 1.4 Allowed 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.694 2.262 . . . . 0.0 112.389 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 9.0 m -43.03 -54.3 4.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.885 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 39.8 t -111.13 101.97 10.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.866 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.303 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.474 -179.988 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.34 0 N-CA-C 112.498 -0.241 . . . . 0.0 112.498 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 15.2 t -84.87 120.61 26.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.914 0.388 . . . . 0.0 110.861 -179.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 48.3 p -100.45 158.13 16.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.871 -179.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 117.58 119.91 3.03 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.475 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 32.9 t -107.57 -42.38 4.79 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.913 0.387 . . . . 0.0 110.863 -179.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 6.4 t 47.96 44.3 18.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.874 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -151.02 -38.45 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.476 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 10.1 t -91.77 52.92 2.11 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.873 0.368 . . . . 0.0 110.904 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.405 ' N ' HD12 ' A' ' 144' ' ' LEU . 5.9 mp -80.18 -48.97 12.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.892 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.431 ' O ' ' C ' ' A' ' 146' ' ' GLN . 2.8 ptp85 -113.64 -44.06 3.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.892 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . 0.431 ' C ' ' O ' ' A' ' 145' ' ' ARG . 19.4 mt-30 -36.09 143.59 0.28 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.598 0.713 . . . . 0.0 110.897 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -78.58 112.13 3.11 Favored 'Trans proline' 0 C--O 1.231 0.142 0 C-N-CA 122.707 2.271 . . . . 0.0 112.324 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.438 ' O ' ' C ' ' A' ' 149' ' ' SER . 71.9 Cg_exo -44.58 -45.85 12.74 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.684 2.256 . . . . 0.0 112.308 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . 0.438 ' C ' ' O ' ' A' ' 148' ' ' PRO . 2.3 t 35.05 46.63 0.22 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.877 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . 0.529 ' CG ' ' O ' ' A' ' 150' ' ' HIS . 12.5 p-80 -165.97 117.42 1.05 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.853 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 23.7 ptt180 -108.62 40.97 1.67 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.899 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 5.8 ttpm? -97.62 162.1 13.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.904 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 59.5 mt -136.92 140.72 42.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.891 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.524 ' HB2' ' HB2' ' A' ' 229' ' ' ALA . 35.5 t80 -107.36 121.05 43.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.915 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.566 HG13 HG22 ' A' ' 226' ' ' VAL . 23.9 t -110.26 132.1 59.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.161 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -133.04 -161.5 9.87 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.512 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 19.5 mmt 49.04 30.55 2.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.819 0.342 . . . . 0.0 110.875 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.401 ' HB2' ' C ' ' A' ' 192' ' ' GLY . 82.0 mt -91.05 166.69 12.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.924 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -108.94 155.82 20.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.882 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 36.2 mttp -81.38 44.73 0.81 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.868 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -127.93 -47.42 1.37 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.922 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 14.8 mm-40 -58.73 162.11 4.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.894 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 45.9 m -135.02 174.44 10.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.854 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.451 ' O ' ' CB ' ' A' ' 168' ' ' ARG . 1.4 mp0 -51.35 -35.62 39.26 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.871 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -63.25 -65.89 0.62 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.904 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -42.21 -57.01 2.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.892 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.733 HG13 ' CE1' ' A' ' 171' ' ' PHE . 75.5 t -62.66 -59.89 3.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.12 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . 0.451 ' CB ' ' O ' ' A' ' 164' ' ' GLU . 29.9 ttm-85 -35.29 -63.91 0.31 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.874 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 83.7 mtm180 -59.16 -54.59 45.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.877 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.71 ' O ' ' HB3' ' A' ' 173' ' ' ALA . 16.2 tp -42.8 -66.02 0.41 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.896 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.733 ' CE1' HG13 ' A' ' 167' ' ' VAL . 13.4 m-85 -51.7 -72.06 0.06 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.891 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -41.52 -31.79 0.29 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.915 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.71 ' HB3' ' O ' ' A' ' 170' ' ' LEU . . . -39.62 -30.16 0.07 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.06 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -107.85 -68.83 0.88 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.879 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -111.88 131.75 10.42 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.504 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -48.78 147.71 2.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.852 0.358 . . . . 0.0 110.849 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.639 HG23 ' O ' ' A' ' 197' ' ' LYS . 67.2 mt -112.77 138.66 41.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.119 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 67.7 mm-40 -98.7 -36.23 9.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.842 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -148.6 139.23 22.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.845 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 47.9 t -145.12 138.47 26.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.855 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 18.1 m -152.83 148.94 27.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.199 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 35.2 mm -102.26 134.91 41.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.152 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.597 HD12 ' HB3' ' A' ' 193' ' ' CYS . 29.4 mt -80.81 117.05 21.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.919 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 64.4 mtp180 -132.17 121.14 23.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.843 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -69.48 171.55 40.37 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.513 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -45.57 -41.29 18.65 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.705 2.27 . . . . 0.0 112.332 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -59.92 -40.0 87.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.87 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 121.5 -45.02 1.26 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.484 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -54.07 112.43 0.96 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.812 0.339 . . . . 0.0 110.896 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 23.2 t -45.41 137.58 4.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.826 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.404 ' O ' ' C ' ' A' ' 192' ' ' GLY . 8.7 mtmp? -89.7 47.21 1.44 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.884 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.404 ' C ' ' O ' ' A' ' 191' ' ' LYS . . . 37.37 46.66 1.45 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.507 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . 0.597 ' HB3' HD12 ' A' ' 183' ' ' LEU . 87.1 m -155.19 156.69 36.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.852 0.358 . . . . 0.0 110.881 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -160.61 166.86 28.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.085 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . 0.459 ' CE2' HD21 ' A' ' 183' ' ' LEU . 26.6 m-85 -119.73 119.6 34.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.905 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.494 HG21 ' CE2' ' A' ' 171' ' ' PHE . 21.9 t -114.04 152.34 15.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.138 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.639 ' O ' HG23 ' A' ' 177' ' ' ILE . 23.0 tttp -135.61 137.3 41.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.913 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -113.31 162.43 16.06 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.876 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 11.8 t -65.95 -52.11 52.59 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.873 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 5.7 t -124.0 170.86 10.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.836 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . 0.49 ' O ' ' HB3' ' A' ' 204' ' ' ALA . 6.5 t60 -69.23 -51.03 41.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.854 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -42.74 -64.57 0.59 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.091 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -46.38 -43.07 15.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.88 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . 0.49 ' HB3' ' O ' ' A' ' 201' ' ' HIS . . . -53.07 -62.07 1.89 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.134 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . 0.556 ' HA ' HD12 ' A' ' 208' ' ' ILE . 50.4 tp60 -46.61 -47.06 20.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.905 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -49.19 -57.88 5.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.118 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -54.72 -44.01 73.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.072 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . 0.556 HD12 ' HA ' ' A' ' 205' ' ' GLN . 75.7 mt -51.12 -72.83 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.141 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -54.83 -38.76 67.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.868 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -61.43 -31.4 71.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.111 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 98.5 mt -114.34 -73.85 0.64 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.873 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 212' ' ' HIS . . . . . 0.502 ' N ' ' O ' ' A' ' 208' ' ' ILE . 14.6 t60 -49.5 131.92 20.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.847 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 78.3 -10.24 29.74 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.515 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 25.6 t -99.22 -69.27 0.77 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.818 0.342 . . . . 0.0 110.87 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 7.1 mm-40 -88.11 159.39 18.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.931 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 216' ' ' THR . . . . . 0.47 HG23 ' O ' ' A' ' 222' ' ' SER . 2.9 m -125.34 99.04 5.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.175 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 217' ' ' MET . . . . . 0.409 ' C ' ' O ' ' A' ' 216' ' ' THR . 12.1 mmt -35.96 135.07 0.53 Allowed Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.568 0.699 . . . . 0.0 110.879 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -48.21 121.31 5.93 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.719 2.28 . . . . 0.0 112.331 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 108.06 -48.57 0.93 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.483 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . 0.401 ' O ' HG22 ' A' ' 216' ' ' THR . . . -75.15 144.6 42.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.792 0.33 . . . . 0.0 111.117 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 7.0 t -92.65 -16.0 26.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.872 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . 0.47 ' O ' HG23 ' A' ' 216' ' ' THR . 67.9 m -99.99 138.37 37.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.846 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 66.2 m -52.83 155.71 2.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.857 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.631 HD12 ' H ' ' A' ' 225' ' ' VAL . 50.8 tp -45.57 157.73 0.09 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.89 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 0.631 ' H ' HD12 ' A' ' 224' ' ' LEU . 55.0 t -122.67 104.46 14.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.167 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . 0.624 HG23 ' HG ' ' A' ' 224' ' ' LEU . 21.0 t -134.78 108.87 11.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.106 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.94 -179.54 4.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.852 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -80.5 96.9 6.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.865 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . 0.524 ' HB2' ' HB2' ' A' ' 154' ' ' PHE . . . -50.39 124.86 11.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.096 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -105.33 130.48 53.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.898 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 14.0 t -52.08 156.32 1.62 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.175 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -115.67 -45.9 2.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.87 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -125.29 81.63 1.99 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.935 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -59.86 122.0 13.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.923 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 5.3 p -108.7 155.96 20.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.835 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 147.42 160.12 8.71 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.472 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -76.73 129.52 10.89 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.66 2.24 . . . . 0.0 112.344 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 6.1 t -68.41 150.7 47.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.881 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 90.4 p -106.68 135.49 48.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.859 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.333 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.513 -179.959 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.339 0 N-CA-C 112.497 -0.241 . . . . 0.0 112.497 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 63.6 p -80.63 80.78 7.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.924 0.392 . . . . 0.0 110.862 -179.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 3.7 t -118.64 141.72 48.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.838 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.42 ' O ' ' C ' ' A' ' 140' ' ' SER . . . 47.41 58.66 6.4 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.501 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.42 ' C ' ' O ' ' A' ' 139' ' ' GLY . 19.5 m -36.86 116.43 0.44 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.835 0.35 . . . . 0.0 110.827 -179.771 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 84.1 p -67.16 -46.13 74.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.847 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 138.97 87.94 0.17 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.473 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 68.8 m -104.19 94.29 5.29 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.82 0.343 . . . . 0.0 110.9 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.3 tt -112.72 110.0 19.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.947 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 17.3 ptt180 -143.17 167.05 23.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.914 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -121.2 83.7 39.39 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.604 0.716 . . . . 0.0 110.923 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -47.26 110.42 0.3 Allowed 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.642 2.228 . . . . 0.0 112.326 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.449 ' O ' ' C ' ' A' ' 149' ' ' SER . 72.3 Cg_exo -43.83 102.46 0.04 OUTLIER 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.705 2.27 . . . . 0.0 112.305 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . 0.449 ' C ' ' O ' ' A' ' 148' ' ' PRO . 3.4 m -34.65 128.67 0.44 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.864 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . 0.463 ' CB ' ' HB3' ' A' ' 228' ' ' PHE . 12.0 m80 -162.77 146.61 11.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.836 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 11.2 tpp180 -103.36 -40.0 6.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.921 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.552 ' HE3' ' CD1' ' A' ' 195' ' ' PHE . 19.1 ttpt -88.71 147.04 24.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.93 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.572 HD12 ' CD1' ' A' ' 198' ' ' TYR . 37.9 mt -121.3 127.44 51.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.924 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -92.37 130.97 37.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.855 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.456 HG22 HG13 ' A' ' 226' ' ' VAL . 39.0 t -121.47 126.8 75.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.167 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -127.97 -172.3 13.19 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.513 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 82.2 mmm 51.38 39.54 24.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.773 0.32 . . . . 0.0 110.89 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.473 HD12 ' HA ' ' A' ' 193' ' ' CYS . 50.7 mt -93.39 171.43 8.92 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.936 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -100.44 160.73 14.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.891 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 24.2 mttp -89.87 34.59 0.84 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.91 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -127.92 -43.62 1.51 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.859 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -47.05 155.94 0.25 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.907 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 5.8 m -132.9 171.88 13.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.871 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.464 ' O ' ' CB ' ' A' ' 168' ' ' ARG . 2.9 mp0 -55.24 -37.68 67.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.882 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -64.96 -44.98 87.62 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.874 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 -60.41 -59.39 5.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.874 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.894 HG13 ' CE1' ' A' ' 171' ' ' PHE . 96.2 t -62.17 -39.3 83.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.144 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . 0.464 ' CB ' ' O ' ' A' ' 164' ' ' GLU . 33.2 ttt180 -55.28 -63.13 1.26 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.832 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 74.7 mtt180 -60.91 -54.02 50.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.859 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.722 ' O ' ' HB3' ' A' ' 173' ' ' ALA . 10.0 tp -43.93 -65.64 0.48 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.866 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.894 ' CE1' HG13 ' A' ' 167' ' ' VAL . 10.6 m-85 -51.07 -70.39 0.09 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.879 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -44.14 -30.44 0.77 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.89 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.722 ' HB3' ' O ' ' A' ' 170' ' ' LEU . . . -42.81 -28.05 0.22 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.127 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -106.46 -68.97 0.85 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.889 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -113.42 135.23 12.42 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.521 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -45.71 153.27 0.28 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.784 0.326 . . . . 0.0 110.897 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.416 ' CG2' ' N ' ' A' ' 178' ' ' GLU . 58.2 mt -118.18 153.06 20.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.148 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.416 ' N ' ' CG2' ' A' ' 177' ' ' ILE . 55.6 mt-10 -117.11 -37.72 3.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.885 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -144.7 140.36 28.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.931 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 10.1 t -140.01 134.14 31.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.854 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 86.0 m -153.22 143.74 22.58 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.124 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.407 ' CG1' ' HG3' ' A' ' 164' ' ' GLU . 9.7 mm -104.39 133.31 48.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.141 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.674 HD11 ' CE2' ' A' ' 195' ' ' PHE . 22.1 mt -82.28 116.71 21.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.944 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 79.7 mtm180 -130.64 134.83 47.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.915 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -70.88 168.15 50.27 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.464 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -45.51 -51.02 8.55 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.7 2.266 . . . . 0.0 112.337 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -55.62 -43.23 75.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.843 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 137.55 -50.16 0.83 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.443 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 21.2 m-20 -42.82 125.96 3.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.811 0.339 . . . . 0.0 110.926 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 13.4 t -61.65 136.14 57.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.844 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 34.2 mtmm -84.12 38.12 0.64 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.914 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 43.11 43.38 5.61 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.493 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . 0.473 ' HA ' HD12 ' A' ' 158' ' ' LEU . 80.7 m -154.62 159.55 40.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.826 0.346 . . . . 0.0 110.888 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -161.73 169.13 22.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.07 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . 0.674 ' CE2' HD11 ' A' ' 183' ' ' LEU . 38.2 m-85 -126.58 122.5 35.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.899 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 9.4 t -123.73 147.97 27.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.14 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -118.09 155.94 29.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.88 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . 0.572 ' CD1' HD12 ' A' ' 153' ' ' LEU . 20.8 m-85 -131.58 166.36 21.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.955 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 35.7 t -64.98 -51.54 61.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.858 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 4.8 m -140.51 -177.2 4.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.864 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . 0.441 ' O ' ' C ' ' A' ' 202' ' ' ALA . 13.1 t60 -68.15 -58.68 4.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.852 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . 0.441 ' C ' ' O ' ' A' ' 201' ' ' HIS . . . -34.93 -67.09 0.15 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.106 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -47.44 -47.36 26.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.89 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . 0.415 ' HB3' ' O ' ' A' ' 201' ' ' HIS . . . -52.36 -63.61 1.09 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.104 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . 0.878 ' HA ' HD12 ' A' ' 208' ' ' ILE . 11.0 tp60 -43.36 -45.41 6.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.901 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -52.99 -55.34 24.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.107 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -58.41 -34.67 71.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.139 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . 0.878 HD12 ' HA ' ' A' ' 205' ' ' GLN . 82.5 mt -59.94 -72.6 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.078 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 -52.09 -41.69 62.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.901 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -57.04 -40.96 77.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.109 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 64.7 mt -101.92 -71.12 0.73 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.929 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 212' ' ' HIS . . . . . 0.633 ' HD1' ' HA ' ' A' ' 225' ' ' VAL . 31.0 t60 -54.54 128.78 33.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.903 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 80.21 -1.62 79.88 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.456 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 34.0 t -96.65 -74.34 0.57 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.821 0.343 . . . . 0.0 110.892 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -97.3 -177.46 3.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.911 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 216' ' ' THR . . . . . 0.572 HG23 ' O ' ' A' ' 222' ' ' SER . 60.4 m -133.65 100.99 4.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.125 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 33.0 mmt -39.27 135.08 1.12 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.607 0.718 . . . . 0.0 110.869 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -48.34 114.08 1.05 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.703 2.269 . . . . 0.0 112.343 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 119.07 -51.19 0.77 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.485 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -72.77 155.58 39.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.814 0.34 . . . . 0.0 111.069 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 28.7 t -98.16 -21.15 16.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.898 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . 0.572 ' O ' HG23 ' A' ' 216' ' ' THR . 1.1 t -99.88 154.14 18.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.876 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 57.8 m -58.65 158.54 7.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.832 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.458 ' HG ' HG23 ' A' ' 226' ' ' VAL . 43.1 tp -47.81 152.51 0.73 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.94 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 0.633 ' HA ' ' HD1' ' A' ' 212' ' ' HIS . 98.0 t -118.48 111.46 34.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.139 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . 0.458 HG23 ' HG ' ' A' ' 224' ' ' LEU . 23.7 t -138.37 105.36 3.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.098 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 34.3 pttt -129.13 169.73 14.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.897 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 228' ' ' PHE . . . . . 0.463 ' HB3' ' CB ' ' A' ' 150' ' ' HIS . 59.4 m-85 -76.16 127.9 33.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.917 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -71.92 112.97 8.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.144 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . 0.408 ' O ' ' C ' ' A' ' 231' ' ' THR . 0.9 OUTLIER -92.63 92.12 7.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.878 179.981 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 231' ' ' THR . . . . . 0.408 ' C ' ' O ' ' A' ' 230' ' ' ASP . 55.4 m -37.35 121.84 0.86 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.119 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -98.07 155.31 17.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.869 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 32.0 pttt -149.45 135.67 19.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.871 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -114.51 96.98 6.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.872 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 41.4 t -97.45 154.67 17.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.835 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 101.98 90.97 2.14 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.508 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -77.88 15.76 1.25 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.668 2.245 . . . . 0.0 112.333 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 3.7 t 39.42 41.45 0.7 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.842 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 58.2 m -62.56 86.54 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.808 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.294 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.487 179.948 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.311 0 N-CA-C 112.492 -0.243 . . . . 0.0 112.492 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 11.1 t -139.93 139.72 36.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.875 0.369 . . . . 0.0 110.828 -179.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 94.1 p -51.03 140.22 16.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.884 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -170.43 -155.84 10.71 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.45 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 1.9 m -124.34 41.36 3.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.849 0.357 . . . . 0.0 110.85 -179.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 41.6 t -74.89 98.01 3.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.905 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 124.19 -86.86 0.37 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.518 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' CYS . . . . . 0.404 ' C ' HD12 ' A' ' 144' ' ' LEU . 4.6 m -88.06 135.72 33.3 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.868 0.366 . . . . 0.0 110.888 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.404 HD12 ' C ' ' A' ' 143' ' ' CYS . 7.1 mp -127.32 94.01 3.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.919 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 17.9 ttm180 -91.91 121.93 33.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.897 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 -70.89 155.74 92.96 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.572 0.701 . . . . 0.0 110.923 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -77.25 112.06 3.31 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.653 2.235 . . . . 0.0 112.322 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -43.72 159.31 0.09 OUTLIER 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.686 2.257 . . . . 0.0 112.4 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 1.4 t -92.36 -70.51 0.69 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.859 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 46.1 p-80 -39.54 151.53 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.85 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.467 ' HB2' ' CZ ' ' A' ' 151' ' ' ARG . 17.6 ttm105 -125.6 91.16 3.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.905 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.61 ' HB3' ' HB3' ' A' ' 229' ' ' ALA . 12.4 tttt -105.13 151.08 24.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.9 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 44.4 mt -120.53 129.2 53.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.904 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 29.6 t80 -98.01 119.92 37.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.912 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.446 HG21 ' CZ ' ' A' ' 171' ' ' PHE . 21.6 t -110.27 129.1 65.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.102 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -127.69 -170.56 12.86 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.502 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 11.3 mmt 55.59 36.27 26.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.828 0.347 . . . . 0.0 110.937 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.422 ' HB2' ' C ' ' A' ' 192' ' ' GLY . 38.6 mt -95.55 168.93 10.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.872 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.478 ' ND2' ' O ' ' A' ' 218' ' ' PRO . 12.7 m120 -113.59 162.83 15.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.898 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 38.0 mttp -82.62 48.91 1.38 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.911 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -133.27 -49.49 0.85 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.886 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 16.0 mm-40 -56.65 155.52 7.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.899 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 17.1 m -135.51 176.13 8.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.884 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -47.57 -50.52 23.78 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.903 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -54.92 -58.62 6.86 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.839 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -41.84 -66.02 0.39 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.862 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.772 HG13 ' CE1' ' A' ' 171' ' ' PHE . 65.9 t -55.52 -54.77 21.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.113 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . 0.439 ' C ' ' O ' ' A' ' 167' ' ' VAL . 43.8 ttt180 -35.23 -70.11 0.09 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.875 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 44.3 mmm-85 -58.04 -53.57 56.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.909 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.664 ' O ' ' HB3' ' A' ' 173' ' ' ALA . 19.5 tp -41.37 -66.83 0.3 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.923 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.772 ' CE1' HG13 ' A' ' 167' ' ' VAL . 9.9 m-85 -55.33 -72.84 0.06 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.858 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.45 ' O ' ' N ' ' A' ' 174' ' ' PHE . 0.5 OUTLIER -39.55 -28.26 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.907 -179.907 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.664 ' HB3' ' O ' ' A' ' 170' ' ' LEU . . . -41.41 -24.18 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.112 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . 0.45 ' N ' ' O ' ' A' ' 172' ' ' GLU . 93.7 m-85 -108.09 -69.92 0.83 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.931 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -100.94 -171.64 28.79 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.485 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 33.3 m-20 -98.86 131.67 44.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.771 0.319 . . . . 0.0 110.898 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.417 ' CG2' ' N ' ' A' ' 178' ' ' GLU . 37.1 mt -96.39 151.94 3.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.136 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.417 ' N ' ' CG2' ' A' ' 177' ' ' ILE . 6.8 mt-10 -121.27 -21.51 6.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.905 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -165.85 136.43 3.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.865 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 51.0 t -130.47 141.6 50.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.89 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 83.2 m -153.11 147.65 26.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.158 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 20.1 mm -115.22 137.51 48.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.132 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.699 HD11 ' CE2' ' A' ' 195' ' ' PHE . 34.3 mt -85.57 101.43 12.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.932 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 60.4 mtp180 -119.59 115.42 23.95 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.877 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -42.72 148.19 0.6 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.518 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -45.56 -29.06 4.77 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.678 2.252 . . . . 0.0 112.331 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -70.59 -41.38 72.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.866 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.404 ' O ' ' C ' ' A' ' 189' ' ' ASN . . . 145.16 -67.48 0.42 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.469 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . 0.404 ' C ' ' O ' ' A' ' 188' ' ' GLY . 3.5 p30 -37.14 135.67 0.48 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.847 0.356 . . . . 0.0 110.882 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 17.1 t -69.24 143.14 54.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.895 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 24.0 mtpt -89.68 31.55 0.93 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.952 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.422 ' C ' ' HB2' ' A' ' 158' ' ' LEU . . . 47.19 36.82 10.25 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.5 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 63.6 m -151.3 155.83 39.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.848 0.356 . . . . 0.0 110.843 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -161.04 162.21 31.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.072 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . 0.699 ' CE2' HD11 ' A' ' 183' ' ' LEU . 58.2 m-85 -117.79 142.36 47.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.848 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 45.6 t -129.82 145.34 35.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.091 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 24.7 tttt -113.5 147.48 37.83 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.879 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -132.4 167.9 19.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.945 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 38.1 t -83.96 -40.08 18.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.856 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 3.5 m -138.26 176.61 8.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.854 -179.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . 0.431 ' O ' ' C ' ' A' ' 202' ' ' ALA . 5.3 t60 -74.24 -56.44 4.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.866 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . 0.431 ' C ' ' O ' ' A' ' 201' ' ' HIS . . . -35.56 -63.21 0.36 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.1 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 31.7 mm-40 -49.4 -49.83 43.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.871 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -51.45 -59.28 4.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.143 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . 0.596 ' HA ' HD12 ' A' ' 208' ' ' ILE . 33.8 tp60 -48.27 -55.92 9.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.884 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -44.2 -61.38 1.51 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.067 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -49.05 -49.19 42.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.119 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . 0.596 HD12 ' HA ' ' A' ' 205' ' ' GLN . 66.4 mt -49.54 -74.95 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.123 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -44.47 -44.58 8.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.916 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 210' ' ' ALA . . . . . 0.416 ' HB1' ' CZ ' ' A' ' 174' ' ' PHE . . . -54.24 -43.31 70.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.126 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.428 ' CB ' HD23 ' A' ' 224' ' ' LEU . 7.9 mt -100.29 -68.93 0.79 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.934 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 212' ' ' HIS . . . . . 0.639 ' HD1' ' HA ' ' A' ' 225' ' ' VAL . 29.7 t60 -51.6 126.18 16.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.851 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . 0.442 ' HA2' ' CB ' ' A' ' 223' ' ' SER . . . 82.02 -19.23 10.35 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.518 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 2.5 m -85.5 -73.08 0.46 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.803 0.335 . . . . 0.0 110.872 -179.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 71.1 mt-30 -92.69 167.18 12.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.924 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 216' ' ' THR . . . . . 0.636 HG23 ' O ' ' A' ' 222' ' ' SER . 0.7 OUTLIER -126.95 104.07 7.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.119 -179.917 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 14.5 mmt -39.04 135.23 1.04 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.609 0.719 . . . . 0.0 110.836 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . 0.478 ' O ' ' ND2' ' A' ' 159' ' ' ASN . 76.1 Cg_exo -48.72 122.29 7.81 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.684 2.256 . . . . 0.0 112.375 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 105.03 -44.99 1.36 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.509 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -75.54 143.97 42.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.768 0.318 . . . . 0.0 111.091 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 29.9 t -92.59 -15.5 26.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.882 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . 0.636 ' O ' HG23 ' A' ' 216' ' ' THR . 1.8 m -99.84 146.1 27.0 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.837 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . 0.442 ' CB ' ' HA2' ' A' ' 213' ' ' GLY . 29.4 m -59.63 150.08 28.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.828 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.428 HD23 ' CB ' ' A' ' 211' ' ' LEU . 62.4 tp -41.78 151.62 0.09 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.935 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 0.639 ' HA ' ' HD1' ' A' ' 212' ' ' HIS . 60.1 t -118.34 113.83 43.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.171 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . 0.595 HG12 HG12 ' A' ' 208' ' ' ILE . 46.0 t -136.92 105.2 3.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.153 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 8.3 ptmt -122.14 169.25 11.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.895 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -79.61 117.39 20.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.915 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . 0.61 ' HB3' ' HB3' ' A' ' 152' ' ' LYS . . . -78.82 113.91 17.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.11 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -130.31 76.88 1.75 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.896 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 53.2 m -148.96 125.69 11.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.141 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -60.11 158.3 11.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.842 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . 0.402 ' HD2' ' C ' ' A' ' 233' ' ' LYS . 0.7 OUTLIER -111.28 -58.17 2.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.892 -179.992 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -40.48 142.23 0.44 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.852 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 36.4 p -108.9 96.89 6.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.836 -179.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 147.58 95.21 0.16 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.55 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -75.94 90.56 1.15 Allowed 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.707 2.271 . . . . 0.0 112.327 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 3.3 m -68.68 176.42 2.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.848 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 68.5 m -146.16 107.46 4.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.856 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.496 -180.0 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 N-CA-C 112.522 -0.231 . . . . 0.0 112.522 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 67.7 m -65.81 160.45 23.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.823 0.344 . . . . 0.0 110.909 -179.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 22.6 m -45.18 113.61 0.6 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.857 -179.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 86.45 96.5 0.82 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.53 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 1.4 t -121.28 147.05 46.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.877 0.37 . . . . 0.0 110.878 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 2.1 m -106.2 98.93 8.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.835 -179.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -132.38 -149.95 6.39 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.49 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 70.1 m -143.89 146.41 32.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.82 0.343 . . . . 0.0 110.875 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.7 pp -169.08 140.44 2.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.906 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 10.8 ttp180 -155.78 151.3 27.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.872 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 33.4 mm-40 -106.96 93.46 9.07 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.587 0.708 . . . . 0.0 110.894 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -74.97 168.19 25.39 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.689 2.259 . . . . 0.0 112.375 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -75.72 170.2 20.68 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.681 2.254 . . . . 0.0 112.332 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 4.8 t -97.3 -45.53 6.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.843 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 8.0 p80 -86.59 94.38 9.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.906 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 12.8 ptt180 -117.09 103.61 10.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.868 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.568 ' HD3' ' CD1' ' A' ' 195' ' ' PHE . 24.4 ttmt -130.71 159.11 38.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.899 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.622 HD21 ' CE1' ' A' ' 228' ' ' PHE . 58.0 mt -127.2 121.81 32.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.882 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -95.13 127.03 40.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.864 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.634 HG21 ' HZ ' ' A' ' 171' ' ' PHE . 59.1 t -114.47 133.81 59.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.149 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -128.97 -159.58 9.99 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.49 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 27.8 mtt 41.84 39.88 1.37 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.817 0.341 . . . . 0.0 110.86 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 42.8 mt -95.43 161.4 14.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.943 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.483 ' ND2' ' O ' ' A' ' 218' ' ' PRO . 69.2 m-20 -100.35 165.97 11.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.861 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 65.4 mttt -89.72 40.97 1.02 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.842 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 18.9 mm-40 -127.31 -53.17 1.38 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.858 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -55.13 148.82 13.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.926 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 1.6 t -133.81 176.42 8.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.84 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -47.93 -42.64 27.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.862 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -50.55 -57.66 7.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.89 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . 0.404 ' O ' ' HG2' ' A' ' 169' ' ' ARG . 6.5 m-20 -61.21 -66.63 0.5 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.923 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.604 HG13 ' CE1' ' A' ' 171' ' ' PHE . 59.8 t -42.02 -35.32 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.094 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 25.0 ttm180 -63.88 -61.24 2.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.873 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . 0.404 ' HG2' ' O ' ' A' ' 166' ' ' ASP . 31.6 ptt180 -63.09 -52.13 63.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.887 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.729 ' O ' ' HB3' ' A' ' 173' ' ' ALA . 8.5 tp -44.23 -65.69 0.48 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.89 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.634 ' HZ ' HG21 ' A' ' 155' ' ' VAL . 14.0 m-85 -53.28 -69.41 0.12 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.888 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -44.32 -26.05 0.3 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.94 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.729 ' HB3' ' O ' ' A' ' 170' ' ' LEU . . . -46.74 -20.49 0.13 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.142 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -116.14 -73.61 0.64 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.909 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -109.45 147.22 16.96 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.536 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -52.5 157.58 1.47 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.823 0.344 . . . . 0.0 110.903 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.451 HG23 ' O ' ' A' ' 197' ' ' LYS . 98.0 mt -122.37 147.55 26.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.143 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -102.4 -45.91 4.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.901 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -153.71 151.36 29.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.879 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 52.2 t -138.11 143.28 40.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.893 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 98.5 m -152.17 138.95 18.87 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.119 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 21.3 mm -93.72 127.86 45.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.158 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 1.0 HD11 ' CE2' ' A' ' 195' ' ' PHE . 65.6 mt -90.12 104.61 17.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.899 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' ARG . . . . . 0.476 ' CB ' ' HA ' ' A' ' 190' ' ' SER . 16.7 ptt180 -162.29 150.12 14.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.896 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -61.02 -177.47 2.03 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.54 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -76.71 -14.78 17.42 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.709 2.273 . . . . 0.0 112.321 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -66.93 -47.13 72.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.903 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.447 ' O ' ' N ' ' A' ' 190' ' ' SER . . . 131.8 -45.96 1.1 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.502 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . 0.419 ' O ' ' C ' ' A' ' 190' ' ' SER . 24.3 m-80 -49.94 90.43 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.83 0.348 . . . . 0.0 110.932 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . 0.476 ' HA ' ' CB ' ' A' ' 184' ' ' ARG . 9.3 p -36.14 141.93 0.09 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.841 -179.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.437 ' CG ' ' HA ' ' A' ' 184' ' ' ARG . 28.9 mmtt -94.71 39.87 1.1 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.927 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 39.21 42.79 1.79 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.435 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 71.5 m -154.85 150.01 27.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.834 0.349 . . . . 0.0 110.905 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -161.39 162.91 30.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.075 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . 1.0 ' CE2' HD11 ' A' ' 183' ' ' LEU . 28.0 m-85 -116.98 143.12 46.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.896 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.53 HG11 ' CD2' ' A' ' 171' ' ' PHE . 40.3 t -140.13 138.2 37.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.125 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.451 ' O ' HG23 ' A' ' 177' ' ' ILE . 8.0 ttmm -118.91 148.29 43.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.879 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -122.82 172.22 8.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.93 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 1.2 t -76.14 -49.99 15.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.854 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 58.7 m -125.51 -178.19 4.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.854 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . 0.432 ' O ' ' C ' ' A' ' 202' ' ' ALA . 9.8 t60 -79.66 -63.14 1.48 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.885 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . 0.432 ' C ' ' O ' ' A' ' 201' ' ' HIS . . . -34.35 -60.65 0.41 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.085 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -48.02 -50.42 27.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.93 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -51.99 -59.05 4.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.072 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . 0.794 ' HA ' HD12 ' A' ' 208' ' ' ILE . 13.1 tp60 -44.91 -49.34 11.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.881 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -51.29 -58.32 6.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.131 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -52.59 -37.54 58.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.126 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . 0.794 HD12 ' HA ' ' A' ' 205' ' ' GLN . 77.0 mt -59.23 -74.06 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.095 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -49.92 -42.52 48.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.898 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -53.31 -45.6 69.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.126 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 57.2 mt -99.99 -67.69 0.84 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.9 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 212' ' ' HIS . . . . . 0.491 ' N ' ' O ' ' A' ' 208' ' ' ILE . 9.2 t60 -51.46 127.79 20.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.846 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 77.63 -9.97 26.55 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.472 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 8.3 t -97.74 -66.55 0.89 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.84 0.352 . . . . 0.0 110.879 -179.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 7.3 mm-40 -92.31 163.66 13.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.919 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 216' ' ' THR . . . . . 0.609 HG23 ' O ' ' A' ' 222' ' ' SER . 3.9 m -131.09 101.28 5.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.129 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 217' ' ' MET . . . . . 0.436 ' C ' ' O ' ' A' ' 216' ' ' THR . 0.0 OUTLIER -34.69 131.07 0.45 Allowed Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.548 0.69 . . . . 0.0 110.886 179.859 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . 0.483 ' O ' ' ND2' ' A' ' 159' ' ' ASN . 75.6 Cg_exo -48.89 120.29 5.25 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.699 2.266 . . . . 0.0 112.35 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 107.78 -45.03 1.36 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.499 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -73.48 142.11 46.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.812 0.339 . . . . 0.0 111.084 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 35.6 m -89.17 -16.55 31.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.836 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . 0.609 ' O ' HG23 ' A' ' 216' ' ' THR . 3.9 m -99.87 143.24 30.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.841 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 95.8 p -63.32 152.46 37.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.873 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 27.0 tp -48.0 146.85 2.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.894 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 0.417 ' HA ' ' HD1' ' A' ' 212' ' ' HIS . 68.6 t -119.5 118.27 56.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.129 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . 0.468 HG22 HG22 ' A' ' 155' ' ' VAL . 38.7 t -141.12 116.95 6.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.152 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 18.3 pttt -131.81 172.29 12.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.888 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 228' ' ' PHE . . . . . 0.622 ' CE1' HD21 ' A' ' 153' ' ' LEU . 54.8 m-85 -82.15 95.0 7.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.89 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . 0.426 ' C ' ' O ' ' A' ' 228' ' ' PHE . . . -34.75 122.13 0.53 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.071 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 -163.55 117.76 1.58 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.854 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 29.2 p -102.03 99.16 9.29 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.12 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -166.16 158.5 14.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.833 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 19.9 ttmt -86.86 -56.81 3.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.885 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . 0.446 ' HG2' ' N ' ' A' ' 235' ' ' SER . 18.6 tt0 -159.15 150.79 20.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.862 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . 0.446 ' N ' ' HG2' ' A' ' 234' ' ' GLU . 55.7 m -108.34 175.91 5.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.905 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 156.44 146.68 4.53 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.494 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -77.08 136.59 16.48 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.697 2.265 . . . . 0.0 112.329 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 238' ' ' SER . . . . . 0.416 ' O ' ' C ' ' A' ' 239' ' ' SER . 13.6 t -62.17 101.79 0.25 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.886 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 239' ' ' SER . . . . . 0.416 ' C ' ' O ' ' A' ' 238' ' ' SER . 4.7 t -36.97 -49.56 0.83 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.864 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.345 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.508 -179.982 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.343 0 N-CA-C 112.477 -0.249 . . . . 0.0 112.477 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 12.7 m -128.32 41.77 3.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.905 0.383 . . . . 0.0 110.867 -179.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 28.8 p 45.06 42.06 6.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.841 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -159.28 179.6 34.77 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.481 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 88.1 p -81.38 136.02 35.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.859 0.361 . . . . 0.0 110.862 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 7.7 t -104.03 42.8 1.15 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.813 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -172.03 143.81 7.68 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.492 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 2.2 m -152.8 126.72 8.99 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.86 0.362 . . . . 0.0 110.924 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -43.83 158.65 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.938 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 34.6 mtt-85 -137.72 116.61 12.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.906 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 4.0 pp0? -70.78 143.79 89.93 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.574 0.702 . . . . 0.0 110.929 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -78.24 111.18 3.01 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.672 2.248 . . . . 0.0 112.319 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -74.33 94.01 0.91 Allowed 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.734 2.29 . . . . 0.0 112.381 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 67.4 p -83.61 38.4 0.62 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.888 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 34.1 p-80 -142.43 145.27 33.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.888 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 14.5 mtm-85 -130.95 68.41 1.49 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.875 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.901 ' HB3' ' HB3' ' A' ' 229' ' ' ALA . 9.4 tttp -134.51 159.44 41.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.912 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.492 HD21 HD11 ' A' ' 208' ' ' ILE . 41.8 mt -133.92 121.05 21.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.89 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -93.86 118.37 31.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.841 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.715 HG22 HG13 ' A' ' 226' ' ' VAL . 16.5 t -106.35 131.9 54.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.098 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -130.41 -164.04 11.2 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.507 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 18.7 mmt 40.19 37.95 0.47 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.786 0.327 . . . . 0.0 110.846 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.466 HD21 ' CG1' ' A' ' 155' ' ' VAL . 83.8 mt -85.37 174.01 9.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.914 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.494 ' OD1' ' N ' ' A' ' 160' ' ' LYS . 60.1 t-20 -105.72 150.85 25.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.89 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . 0.494 ' N ' ' OD1' ' A' ' 159' ' ' ASN . 10.3 mptt -86.42 29.45 0.77 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.865 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 15.9 tm0? -111.48 -55.07 2.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.941 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -68.24 163.74 22.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.934 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 58.7 m -130.36 178.75 6.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.866 -179.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -46.9 -41.08 15.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.919 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -55.05 -61.93 1.99 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.826 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -46.8 -55.4 7.97 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.873 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.86 HG13 ' CE1' ' A' ' 171' ' ' PHE . 89.7 t -58.3 -40.27 77.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.104 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . 0.427 ' NH1' ' OE1' ' A' ' 172' ' ' GLU . 2.4 tmm_? -52.67 -62.92 1.34 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.866 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 9.7 mmm180 -59.39 -54.72 43.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.861 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.717 ' O ' ' HB3' ' A' ' 173' ' ' ALA . 9.4 tp -42.73 -66.24 0.39 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.883 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.86 ' CE1' HG13 ' A' ' 167' ' ' VAL . 13.5 m-85 -51.32 -71.85 0.06 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.896 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.455 ' O ' ' N ' ' A' ' 174' ' ' PHE . 3.9 pt-20 -41.9 -31.53 0.34 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.927 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.717 ' HB3' ' O ' ' A' ' 170' ' ' LEU . . . -41.11 -24.44 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.057 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . 0.455 ' N ' ' O ' ' A' ' 172' ' ' GLU . 81.1 m-85 -113.96 -72.62 0.69 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.844 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -104.8 134.35 11.97 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.519 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 34.4 m-20 -49.4 149.16 2.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.791 0.329 . . . . 0.0 110.912 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.408 HD11 ' CB ' ' A' ' 171' ' ' PHE . 70.9 mt -114.07 150.02 16.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.162 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -117.27 -25.68 6.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.925 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -158.19 160.37 37.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.918 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 8.0 t -162.29 141.98 9.65 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.83 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 93.2 m -148.6 139.94 23.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.136 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.418 HD13 ' HB1' ' A' ' 194' ' ' ALA . 48.9 mm -102.18 119.3 50.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.119 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.472 HD11 ' CE2' ' A' ' 195' ' ' PHE . 30.8 mt -80.56 120.24 24.26 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.922 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' ARG . . . . . 0.482 ' O ' ' N ' ' A' ' 189' ' ' ASN . 98.4 mtt180 -119.74 30.21 7.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.893 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 56.88 157.34 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.437 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -48.83 -43.65 34.26 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.692 2.262 . . . . 0.0 112.333 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -54.18 -48.72 70.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.845 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 122.53 30.03 1.22 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.483 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . 0.482 ' N ' ' O ' ' A' ' 184' ' ' ARG . 47.4 m-20 -128.12 133.26 48.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.824 0.345 . . . . 0.0 110.853 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 4.8 t -39.04 131.76 1.38 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.842 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 24.2 mmtt -116.88 34.42 5.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.95 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 47.76 35.9 12.61 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.444 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 75.0 m -148.18 150.48 33.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.765 0.316 . . . . 0.0 110.9 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.418 ' HB1' HD13 ' A' ' 182' ' ' ILE . . . -160.64 152.43 19.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.113 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . 0.472 ' CE2' HD11 ' A' ' 183' ' ' LEU . 25.6 m-85 -102.08 137.42 40.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.895 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.541 HG21 ' CE2' ' A' ' 171' ' ' PHE . 59.1 t -127.42 144.88 35.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.132 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 49.6 tttt -124.21 138.17 54.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.899 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . 0.453 ' CD1' HD12 ' A' ' 153' ' ' LEU . 19.4 m-85 -118.1 173.54 6.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.923 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 48.3 t -81.38 -47.65 12.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.869 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 2.9 t -132.84 153.97 50.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.874 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . 0.441 ' O ' ' C ' ' A' ' 202' ' ' ALA . 23.4 t-80 -52.75 -61.32 2.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.827 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . 0.441 ' C ' ' O ' ' A' ' 201' ' ' HIS . . . -34.06 -62.53 0.31 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.168 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -47.2 -43.42 21.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.849 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . 0.425 ' N ' ' O ' ' A' ' 201' ' ' HIS . . . -57.77 -55.14 38.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.095 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . 0.403 ' HA ' HD12 ' A' ' 208' ' ' ILE . 3.8 tp60 -50.23 -43.35 52.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.907 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -56.59 -57.64 11.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.107 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -56.87 -35.44 68.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.144 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . 0.496 ' O ' ' N ' ' A' ' 212' ' ' HIS . 78.2 mt -59.72 -75.12 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.107 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -47.39 -42.49 22.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.862 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -56.05 -43.46 77.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.119 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 33.0 mt -99.96 -69.08 0.78 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.922 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 212' ' ' HIS . . . . . 0.496 ' N ' ' O ' ' A' ' 208' ' ' ILE . 1.7 t60 -49.7 131.15 21.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.854 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 72.31 1.95 52.48 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.475 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 6.2 t -94.53 -71.29 0.67 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.814 0.34 . . . . 0.0 110.863 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 17.3 pm0 -100.33 175.75 5.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.895 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 216' ' ' THR . . . . . 0.442 ' O ' ' C ' ' A' ' 217' ' ' MET . 4.6 m -134.97 97.87 3.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.159 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 217' ' ' MET . . . . . 0.442 ' C ' ' O ' ' A' ' 216' ' ' THR . 12.4 mmt -34.56 133.18 0.42 Allowed Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.6 0.715 . . . . 0.0 110.868 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -49.01 119.52 4.48 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.68 2.254 . . . . 0.0 112.383 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 112.27 -50.82 0.74 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.516 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -73.03 152.84 41.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.821 0.343 . . . . 0.0 111.093 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 3.6 t -96.69 -19.51 18.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.869 -179.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 1.3 p -99.47 134.85 41.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.865 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . 0.436 ' O ' ' C ' ' A' ' 224' ' ' LEU . 3.5 m -58.02 151.23 18.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.859 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.462 ' HG ' HG23 ' A' ' 226' ' ' VAL . 21.7 tp -35.57 141.76 0.08 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.933 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 90.8 t -114.77 109.2 27.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.146 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . 0.715 HG13 HG22 ' A' ' 155' ' ' VAL . 6.3 t -132.01 105.96 10.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.134 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . 0.411 ' NZ ' ' OD2' ' A' ' 230' ' ' ASP . 11.0 pttp -121.34 -179.1 3.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.871 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -83.34 107.95 16.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.826 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . 0.901 ' HB3' ' HB3' ' A' ' 152' ' ' LYS . . . -43.09 117.08 1.0 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.046 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . 0.411 ' OD2' ' NZ ' ' A' ' 227' ' ' LYS . 3.7 p30 -100.99 128.64 46.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.879 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 38.1 p -133.42 169.99 16.13 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.16 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -158.56 119.0 3.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.882 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 45.7 mtpt -76.4 157.54 32.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.911 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -57.49 -56.55 20.41 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.894 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 33.9 t -73.66 80.43 1.52 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.853 -179.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -67.67 -169.1 4.36 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.508 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -77.08 110.33 3.0 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.7 2.266 . . . . 0.0 112.336 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 2.2 m -70.31 100.48 1.73 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.853 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 29.9 m -73.39 128.07 34.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.847 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.302 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.519 -179.96 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 N-CA-C 112.524 -0.23 . . . . 0.0 112.524 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 41.0 t -112.89 114.34 26.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.907 0.384 . . . . 0.0 110.829 -179.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 1.8 m -95.76 112.56 24.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.839 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 144.46 91.2 0.12 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.502 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 20.8 t -103.1 108.86 20.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.863 0.363 . . . . 0.0 110.895 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 6.2 m -109.98 157.52 19.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.86 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -174.87 -168.66 35.82 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.499 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 27.2 p -69.67 89.8 0.55 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.835 0.35 . . . . 0.0 110.901 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.451 ' O ' ' C ' ' A' ' 145' ' ' ARG . 3.7 mm? -76.06 -43.55 43.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.887 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.456 ' HG3' ' NE2' ' A' ' 146' ' ' GLN . 0.0 OUTLIER -34.55 -39.28 0.08 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.877 179.964 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . 0.456 ' NE2' ' HG3' ' A' ' 145' ' ' ARG . 5.5 pm0 -172.05 143.7 1.38 Allowed Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.599 0.714 . . . . 0.0 110.944 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -78.27 147.57 23.29 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.66 2.24 . . . . 0.0 112.326 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -46.99 162.13 0.17 Allowed 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.658 2.239 . . . . 0.0 112.345 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 66.8 m -60.44 -68.02 0.34 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.869 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 38.0 p-80 -72.52 117.05 13.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.904 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 3.6 ptp85 -106.86 42.9 1.22 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.873 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 11.4 tttp -93.11 160.59 14.79 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.928 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 73.4 mt -133.75 129.82 37.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.861 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -97.38 116.44 29.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.902 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.469 HG22 HG13 ' A' ' 226' ' ' VAL . 47.8 t -110.27 135.46 49.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.134 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -134.31 -156.55 7.88 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.49 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 10.9 mmt 39.49 33.36 0.11 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.819 0.343 . . . . 0.0 110.852 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.418 ' HB2' ' C ' ' A' ' 192' ' ' GLY . 63.9 mt -85.03 169.4 14.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.935 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.461 ' ND2' ' HD2' ' A' ' 218' ' ' PRO . 7.4 p30 -103.44 163.55 12.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.892 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 29.4 mttt -97.96 23.08 8.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.907 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 2.3 tp-100 -109.85 -46.57 3.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.892 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 19.5 mt-30 -65.7 172.24 3.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.908 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 66.7 m -139.69 -177.44 4.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.905 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -59.07 -37.72 77.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.909 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -59.74 -50.82 72.33 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.868 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 39.6 m-20 -58.69 -56.55 20.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.876 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.615 HG13 ' CE1' ' A' ' 171' ' ' PHE . 19.5 t -63.09 -28.29 44.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.08 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 41.7 ttm-85 -63.76 -56.25 16.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.852 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 70.7 mtm180 -62.29 -55.11 31.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.912 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.765 ' O ' ' HB3' ' A' ' 173' ' ' ALA . 9.1 tp -43.38 -65.15 0.52 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.913 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.615 ' CE1' HG13 ' A' ' 167' ' ' VAL . 8.5 m-85 -50.78 -69.29 0.12 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.874 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -46.3 -26.48 0.82 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.877 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.765 ' HB3' ' O ' ' A' ' 170' ' ' LEU . . . -49.36 -19.45 0.52 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.063 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -113.48 -74.68 0.62 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.883 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -107.5 151.56 16.92 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.492 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 46.6 m-80 -62.31 132.71 53.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.797 0.332 . . . . 0.0 110.927 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.421 HG21 ' SG ' ' A' ' 180' ' ' CYS . 84.2 mt -92.25 138.99 18.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.123 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -100.35 -30.48 11.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.915 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -164.54 142.0 6.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.888 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . 0.447 ' SG ' HG13 ' A' ' 196' ' ' VAL . 1.8 m -137.21 138.24 39.96 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.911 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 60.4 m -151.12 132.82 14.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.146 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 44.5 mm -98.52 143.24 13.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.132 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.747 HD11 ' CE2' ' A' ' 195' ' ' PHE . 52.7 mt -95.89 125.89 40.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.896 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' ARG . . . . . 0.457 ' HB2' ' CZ ' ' A' ' 184' ' ' ARG . 18.4 mtm105 -130.64 113.58 14.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.851 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -44.81 156.31 0.28 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.504 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -45.88 -39.78 19.44 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.681 2.254 . . . . 0.0 112.354 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -57.33 -44.1 83.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.881 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 140.02 -43.69 1.12 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.51 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 17.5 m-80 -60.85 147.88 41.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.814 0.34 . . . . 0.0 110.919 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 30.7 t -68.52 140.72 55.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.858 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 63.6 mttt -94.04 37.59 1.09 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.913 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.418 ' C ' ' HB2' ' A' ' 158' ' ' LEU . . . 43.32 40.99 4.89 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.497 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 4.4 p -150.03 151.48 33.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.798 0.333 . . . . 0.0 110.941 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -160.62 150.96 18.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.069 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . 0.747 ' CE2' HD11 ' A' ' 183' ' ' LEU . 50.2 m-85 -108.72 116.3 31.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.914 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.609 HG11 ' CD2' ' A' ' 171' ' ' PHE . 38.8 t -110.04 146.97 14.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.122 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 34.4 tttp -127.1 160.26 31.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.876 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -137.65 164.79 27.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.909 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 41.2 t -71.61 -39.38 70.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.851 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 2.4 t -136.02 171.78 13.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.818 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . 0.408 ' O ' ' C ' ' A' ' 202' ' ' ALA . 40.1 t-80 -69.4 -57.05 5.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.855 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . 0.408 ' C ' ' O ' ' A' ' 201' ' ' HIS . . . -36.75 -61.39 0.54 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.148 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -47.53 -50.58 23.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.865 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -51.43 -57.59 8.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.073 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . 0.511 ' C ' ' CD ' ' A' ' 205' ' ' GLN . 0.0 OUTLIER -47.67 -68.13 0.21 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.887 -179.898 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . 0.407 ' C ' ' O ' ' A' ' 205' ' ' GLN . . . -37.02 -51.82 0.95 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.106 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -59.72 -43.23 94.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.105 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . 0.489 ' O ' ' N ' ' A' ' 212' ' ' HIS . 82.5 mt -56.23 -70.28 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.078 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -54.12 -40.29 67.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.827 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -56.03 -34.07 65.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.122 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 57.8 mt -112.35 -70.83 0.79 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.901 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 212' ' ' HIS . . . . . 0.489 ' N ' ' O ' ' A' ' 208' ' ' ILE . 2.9 t60 -44.28 126.77 5.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.868 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . 0.416 ' CA ' ' HB3' ' A' ' 223' ' ' SER . . . 82.15 -28.1 3.4 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.507 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 25.7 m -90.15 -67.26 0.86 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.819 0.342 . . . . 0.0 110.88 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 -83.3 143.43 30.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.921 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 216' ' ' THR . . . . . 0.684 HG23 ' O ' ' A' ' 222' ' ' SER . 24.3 m -120.15 100.0 6.93 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.158 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 217' ' ' MET . . . . . 0.402 ' C ' ' O ' ' A' ' 216' ' ' THR . 13.6 mmt -37.37 132.65 0.78 Allowed Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.596 0.713 . . . . 0.0 110.907 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . 0.461 ' HD2' ' ND2' ' A' ' 159' ' ' ASN . 75.2 Cg_exo -48.55 122.42 7.83 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.65 2.233 . . . . 0.0 112.32 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 112.54 -52.29 0.65 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.51 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -68.79 150.49 47.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.826 0.346 . . . . 0.0 111.069 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 88.1 p -96.33 -18.36 20.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.903 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . 0.684 ' O ' HG23 ' A' ' 216' ' ' THR . 1.4 t -100.08 146.96 26.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.852 -179.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . 0.416 ' HB3' ' CA ' ' A' ' 213' ' ' GLY . 73.0 m -58.9 155.83 12.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.887 -179.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.441 HD23 ' N ' ' A' ' 212' ' ' HIS . 32.4 tp -49.35 156.09 0.64 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.979 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 0.416 ' N ' ' HG ' ' A' ' 224' ' ' LEU . 57.9 t -127.57 108.17 17.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.124 179.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . 0.469 HG13 HG22 ' A' ' 155' ' ' VAL . 41.2 t -135.03 101.63 3.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.126 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 19.5 pttt -119.01 170.34 9.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.876 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -71.53 104.33 3.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.942 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -50.49 140.01 14.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.12 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -114.56 112.75 23.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.849 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 9.8 t -73.74 -23.03 59.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.135 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -137.77 168.26 20.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.863 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 16.7 ptmt -132.51 164.46 26.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.884 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -123.11 130.5 52.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.884 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 92.3 p -167.33 127.48 1.45 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.879 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -124.44 93.12 0.45 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.526 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -76.56 164.43 30.5 Favored 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.695 2.264 . . . . 0.0 112.313 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 238' ' ' SER . . . . . 0.441 ' O ' ' C ' ' A' ' 239' ' ' SER . 22.9 t -166.56 149.17 6.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.867 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 239' ' ' SER . . . . . 0.441 ' C ' ' O ' ' A' ' 238' ' ' SER . 47.4 m -34.52 -48.73 0.37 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.844 -179.801 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.293 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.477 -179.986 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.287 0 N-CA-C 112.438 -0.265 . . . . 0.0 112.438 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 2.2 m -104.26 -49.06 3.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.88 0.371 . . . . 0.0 110.892 -179.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 9.6 m -80.65 102.66 9.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.824 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 136.98 56.26 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.524 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 32.6 p -91.53 42.48 1.1 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.856 0.36 . . . . 0.0 110.838 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 52.8 p -78.95 135.51 36.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.823 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -169.08 143.33 7.95 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.481 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 86.8 m -119.01 143.27 47.16 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.811 0.338 . . . . 0.0 110.892 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.532 ' C ' HD12 ' A' ' 144' ' ' LEU . 3.4 pp -117.31 141.19 48.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.937 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -104.29 162.32 13.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.907 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -65.54 141.39 97.91 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.612 0.72 . . . . 0.0 110.946 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -78.45 112.25 3.15 Favored 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.725 2.283 . . . . 0.0 112.325 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -45.19 173.11 0.02 OUTLIER 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.678 2.252 . . . . 0.0 112.323 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 59.9 p -94.4 41.16 1.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.854 -179.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 19.0 m80 -141.41 118.25 11.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.904 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 10.7 ttm180 -78.93 77.36 5.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.857 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.647 ' HB3' ' HB3' ' A' ' 229' ' ' ALA . 5.7 tttp -140.16 156.03 46.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.898 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.589 HD12 ' CD1' ' A' ' 198' ' ' TYR . 36.6 mt -130.09 125.11 34.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.9 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -96.73 113.85 25.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.863 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.551 HG13 HG22 ' A' ' 226' ' ' VAL . 22.2 t -104.46 127.65 58.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.135 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.474 ' O ' ' N ' ' A' ' 158' ' ' LEU . . . -128.63 -154.01 8.19 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.434 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.442 ' C ' ' O ' ' A' ' 156' ' ' GLY . 31.0 mtt 34.66 34.15 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.776 0.322 . . . . 0.0 110.868 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.474 ' N ' ' O ' ' A' ' 156' ' ' GLY . 58.5 mt -83.24 174.79 10.44 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.927 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.484 ' ND2' ' H ' ' A' ' 162' ' ' GLN . 3.2 p-10 -104.77 150.17 25.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.906 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 39.3 mttp -85.39 32.5 0.56 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.875 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -120.32 -54.38 2.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.925 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.484 ' H ' ' ND2' ' A' ' 159' ' ' ASN . 3.6 pt20 -56.48 156.78 5.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.919 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 23.0 m -128.13 -177.1 4.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.864 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -51.54 -41.47 61.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.861 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -57.98 -59.29 5.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.863 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -48.73 -61.03 2.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.858 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.827 HG13 ' CE1' ' A' ' 171' ' ' PHE . 91.9 t -55.14 -45.06 77.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.136 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 33.3 mtp180 -51.62 -58.31 6.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.862 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 47.8 mtp180 -62.73 -54.56 37.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.886 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.794 ' O ' ' HB3' ' A' ' 173' ' ' ALA . 11.0 tp -44.14 -65.06 0.56 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.9 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.827 ' CE1' HG13 ' A' ' 167' ' ' VAL . 13.2 m-85 -50.6 -68.36 0.18 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.845 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -47.31 -23.52 0.58 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.849 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.794 ' HB3' ' O ' ' A' ' 170' ' ' LEU . . . -54.19 -14.45 1.13 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.065 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -123.12 -69.01 0.85 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.872 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -113.57 148.05 18.64 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.499 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 35.4 m120 -55.96 153.86 8.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.801 0.334 . . . . 0.0 110.916 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.512 HD11 ' CB ' ' A' ' 171' ' ' PHE . 73.8 mt -118.31 151.51 20.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.162 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -108.85 -39.87 5.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.919 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -164.99 131.93 2.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.933 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 42.3 t -120.78 139.29 53.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.876 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 53.3 m -147.75 129.99 15.59 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.162 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 17.4 mm -93.48 130.32 42.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.146 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.592 HD11 ' CE2' ' A' ' 195' ' ' PHE . 77.7 mt -95.34 109.67 21.79 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.945 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' ARG . . . . . 0.443 ' HB3' ' N ' ' A' ' 190' ' ' SER . 20.5 mtp180 -126.01 26.86 6.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.9 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 62.23 149.89 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.498 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -45.61 -21.04 0.74 Allowed 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.702 2.268 . . . . 0.0 112.334 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -76.92 -41.73 42.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.871 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 119.05 -10.69 11.84 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.483 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -77.46 114.22 16.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.806 0.336 . . . . 0.0 110.912 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . 0.443 ' N ' ' HB3' ' A' ' 184' ' ' ARG . 3.3 t -52.87 137.29 32.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.818 -179.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 10.3 pttp -121.86 29.02 7.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.932 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 57.48 47.31 89.13 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.522 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 24.1 m -152.03 141.92 22.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.842 0.353 . . . . 0.0 110.896 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -162.06 157.9 24.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.095 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . 0.592 ' CE2' HD11 ' A' ' 183' ' ' LEU . 21.1 m-85 -110.82 124.8 52.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.882 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.575 HG11 ' CD2' ' A' ' 171' ' ' PHE . 94.3 t -122.24 139.29 49.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.125 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 41.3 mttm -116.2 144.76 43.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.898 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . 0.589 ' CD1' HD12 ' A' ' 153' ' ' LEU . 19.7 m-85 -119.28 174.72 6.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.91 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 46.6 p -74.5 -52.52 11.71 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.884 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 32.9 p -137.07 -175.72 4.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.874 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . 0.435 ' O ' ' HB3' ' A' ' 204' ' ' ALA . 3.4 t-160 -71.46 -53.85 12.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.885 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -40.76 -62.53 0.78 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.136 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -47.42 -41.72 20.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.884 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . 0.435 ' HB3' ' O ' ' A' ' 201' ' ' HIS . . . -59.27 -56.23 24.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.102 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -47.85 -41.81 24.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.933 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -61.39 -51.91 66.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.118 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -61.84 -23.8 66.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.104 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . 0.499 ' O ' ' N ' ' A' ' 212' ' ' HIS . 53.5 mt -71.92 -71.57 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.15 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . 0.403 ' N ' HG22 ' A' ' 208' ' ' ILE . 5.3 t30 -54.89 -38.91 68.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.905 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 210' ' ' ALA . . . . . . . . . . . . . . . -58.35 -50.74 72.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.12 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 30.7 mt -99.93 -67.56 0.85 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.93 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 212' ' ' HIS . . . . . 0.587 ' CE1' ' HA ' ' A' ' 225' ' ' VAL . 1.5 t60 -49.83 132.77 22.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.863 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 70.12 -2.12 15.27 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.5 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -96.38 -71.36 0.68 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.822 0.344 . . . . 0.0 110.876 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -100.27 166.98 10.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.934 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 216' ' ' THR . . . . . 0.636 HG23 ' O ' ' A' ' 222' ' ' SER . 24.4 m -127.38 94.03 3.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.152 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 217' ' ' MET . . . . . 0.415 ' C ' ' O ' ' A' ' 216' ' ' THR . 17.8 mmt -36.39 136.18 0.55 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.579 0.704 . . . . 0.0 110.843 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -49.24 138.21 29.47 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.634 2.223 . . . . 0.0 112.366 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 100.07 -45.22 1.51 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.505 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -86.31 142.04 28.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.815 0.341 . . . . 0.0 111.095 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 13.9 m -93.49 -12.88 28.67 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.834 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . 0.636 ' O ' HG23 ' A' ' 216' ' ' THR . 3.9 m -100.11 143.09 30.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.88 -179.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 71.3 m -56.04 148.43 17.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.8 -179.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.612 HD12 ' H ' ' A' ' 225' ' ' VAL . 51.3 tp -38.31 158.08 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.893 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 0.612 ' H ' HD12 ' A' ' 224' ' ' LEU . 61.7 t -130.4 105.76 11.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.114 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . 0.551 HG22 HG13 ' A' ' 155' ' ' VAL . 21.5 t -134.04 101.46 3.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.146 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . 0.469 ' HE2' ' CG1' ' A' ' 225' ' ' VAL . 0.7 OUTLIER -130.38 145.29 51.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.896 179.883 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -49.04 137.0 13.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.929 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . 0.647 ' HB3' ' HB3' ' A' ' 152' ' ' LYS . . . -79.74 157.69 27.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.103 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . 0.414 ' O ' ' C ' ' A' ' 231' ' ' THR . 1.6 p30 -147.35 175.32 10.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.889 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 231' ' ' THR . . . . . 0.414 ' C ' ' O ' ' A' ' 230' ' ' ASP . 1.6 m 36.1 47.85 0.48 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.16 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -124.2 113.73 18.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.88 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 34.9 mtmt -65.77 143.19 57.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.899 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 51.1 mm-40 -112.16 125.69 54.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.931 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 1.4 t -62.21 141.5 58.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.901 -179.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -76.67 146.15 32.3 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.516 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -46.61 144.43 7.54 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.695 2.263 . . . . 0.0 112.362 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 96.0 p -164.43 111.22 1.05 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.875 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 4.7 t -135.41 136.74 41.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.859 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.343 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.486 179.999 . . . . . . . . 0 0 . 1 stop_ save_